WO2021178886A1 - Coronavirus disease (covid-19) vaccine - Google Patents

Coronavirus disease (covid-19) vaccine Download PDF

Info

Publication number
WO2021178886A1
WO2021178886A1 PCT/US2021/021200 US2021021200W WO2021178886A1 WO 2021178886 A1 WO2021178886 A1 WO 2021178886A1 US 2021021200 W US2021021200 W US 2021021200W WO 2021178886 A1 WO2021178886 A1 WO 2021178886A1
Authority
WO
WIPO (PCT)
Prior art keywords
virus
sars
cov
nucleic acid
subject
Prior art date
Application number
PCT/US2021/021200
Other languages
French (fr)
Inventor
Matthias J. Schnell
Christoph WIRBLICH
Drishya KURUP
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Priority to JP2022553021A priority Critical patent/JP2023516729A/en
Priority to CN202180032144.3A priority patent/CN116194140A/en
Priority to EP21764958.1A priority patent/EP4114461A1/en
Priority to IL296128A priority patent/IL296128A/en
Priority to CA3170422A priority patent/CA3170422A1/en
Publication of WO2021178886A1 publication Critical patent/WO2021178886A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18411Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18441Use of virus, viral particle or viral elements as a vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20041Use of virus, viral particle or viral elements as a vector
    • C12N2760/20042Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20111Lyssavirus, e.g. rabies virus
    • C12N2760/20141Use of virus, viral particle or viral elements as a vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20211Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20241Use of virus, viral particle or viral elements as a vector
    • C12N2760/20243Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Definitions

  • coronavirus currently called 2019-nCoV or SARS-CoV-2 virus
  • 2019-nCoV coronavirus
  • SARS-CoV-2 virus coronavirus
  • This novel coronavirus is thought to have emerged from a live animal market in Wuhan, China, and has quickly spread in the community with large clusters of human to human transmission.
  • the sequence of several isolates have been determined, and the closest strains are SARS-like bat coronavirus lineages. Little is known about this virus including its susceptibility to anti-viral compounds, ability to replicate in cell lines or host factors regulating replication. Importantly there are no therapeutics available to treat the virus, although investigational studies are underway. Modeling of the current outbreak suggests that the virus could infect >1 billion people and become a yearly epidemic.
  • the present invention addresses and satisfies this need.
  • the present disclosure provides an isolated nucleic acid encoding a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
  • S SARS-CoV-2 spike protein
  • the present disclosure provides a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
  • S SARS-CoV-2 spike protein
  • the present disclosure provides a recombinant virus encoded by a nucleic acid described herein.
  • the nucleic acid encodes a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
  • S SARS-CoV-2 spike protein
  • the present disclosure provides a recombinant fusion protein comprising (a) a glycoprotein (G) of a virus or a portion thereof, and (b) a SARS-CoV-2 spike protein (S) or a portion thereof.
  • G glycoprotein
  • S SARS-CoV-2 spike protein
  • the present disclosure provides a vector comprising a nucleic acid described herein.
  • the nucleic acid encodes a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
  • S SARS-CoV-2 spike protein
  • the present disclosure provides a vaccine comprising a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof, and a pharmaceutically acceptable carrier.
  • S SARS-CoV-2 spike protein
  • the present disclosure provides a method of generating an immune response against a SARS-CoV-2 virus in a subject in need thereof, the method comprising administering to the subject an effective amount of a vaccine described herein.
  • the vaccine comprises a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof, and a pharmaceutically acceptable carrier.
  • the present disclosure provides a method of vaccinating a subject against a SARS-CoV-2 virus, the method comprising administering to the subject an effective amount of the vaccine described herein.
  • the vaccine comprises a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof, and a pharmaceutically acceptable carrier.
  • the present disclosure provides a method of providing immunity against a SARS-CoV-2 virus in a subject, the method comprising administering to the subject an effective amount of the vaccine described herein.
  • the vaccine comprises a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof, and a pharmaceutically acceptable carrier.
  • the present disclosure provides a method of treating and/or preventing a disease or disorder associated with a SARS-CoV-2 virus in a subject in need thereof, the method comprising administering to the subject an effective amount of the vaccine described herein.
  • the vaccine comprises a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof, and a pharmaceutically acceptable carrier.
  • FIG. 1 VSV expressing codon-optimized Covid-Sl.
  • the map shows the viral sequence including the plasmids utilized to create the recombinant virus. The sequence is shown in SEQ ID NO: 1 and features are shown in FIG. 7. The sequence and features are also shown in FIG. 17 (“VSV-COVID19-S1-VSVG”).
  • FIG 2 RABV expressing codon-optimized Covid-Sl.
  • the map shows the viral sequence, including the plasmids utilized to create the recombinant virus.
  • the sequence is shown in SEQ ID NO: 2 and features are shown in FIG. 8.
  • the sequence and features are also shown in FIG. 18 (“BN8R333-Oqn ⁇ 19-81-Bnq”).
  • FIG. 3 MV expressing codon-optimized Covid-S from position 2 of the genome.
  • the map shows the viral sequence, including the plasmids utilized to create the recombinant virus.
  • the sequences is shown in SEQ ID NO: 3 and features are shown in FIG. 9.
  • the sequence and features are also shown in FIG. 21 (“MV-coWuhan-S Position 2”).
  • FIG. 4 MV expressing codon-optimized Covid-S from position 3 of the genome.
  • the map shows the viral sequence, including the plasmids utilized to create the recombinant virus.
  • the sequence is shown in SEQ ID NO: 4 and features are shown in FIG. 10.
  • the sequence and features are also depicted in FIG. 20 (“MV Wu S in position 3”).
  • FIG. 5 MV expressing codon-optimized Covid-S from position 6 of the genome.
  • the map shows the viral sequence, including the plasmids utilized to create the recombinant virus.
  • the sequence is shown in SEQ ID NO: 5 and features are shown in FIG. 11.
  • the sequence and features are also depicted in FIG. 19 (“MV WuhanCoV S in position 6”).
  • FIG. 6 Characterization of RABV (RABV-COV19-S1) and VSV (VSV-COV19- Sl) expressing a chimeric Sl-G fusion protein. SDS-PAGE analysis of purified virions after sucrose gradient purification. Letters indicate the positions of the VSV or RABV L, G, N, P, and M proteins. Numbers to the left indicate the sizes of the molecular mass standards.
  • the Covid-19 SI protein is indicated.
  • the controls show VSV and RABV virions.
  • FIG. 7 shows the features of the map shown in FIG. 1.
  • FIG. 8 shows the features of the map shown in FIG. 2.
  • FIG. 9 shows the features of the map shown in FIG. 3.
  • FIG. 10 shows the features of the map shown in FIG. 4.
  • FIG. 11 shows the features of the map shown in FIG. 5.
  • FIG. 12 Schematic illustration of the 2019-nCoV vaccine constructs used in this study.
  • Spike protein cDNA is inserted between the N and P genes of the SAD-B19- derived RABV virus vaccine vector BNSP333.
  • the BNSP333-S1-G construct expresses a chimeric protein that contains the entire SI domain fused to the C-terminal part of the RABV G glycoprotein (amino acids 428-524), which encompasses the entire cytoplasmic domain (CD), the transmembrane domain (TM), plus 31 amino acids of the ectodomain (E31) of RABV G.
  • spike protein Different structural elements of the spike protein are indicated in the full length construct: signal peptide (SP), receptor-binding domain (RBD), fusion peptide (FP), heptad repeat regions 1 and 2 (HR1 and HR2), transmembrane domain (TM), and cytoplasmic domain (CD).
  • SP signal peptide
  • RBD receptor-binding domain
  • FP fusion peptide
  • HR1 and HR2 heptad repeat regions 1 and 2
  • TM transmembrane domain
  • CD cytoplasmic domain
  • FIG. 13 Schematic illustration of the MERSRAB immunization schedule and challenge with MERS-CoV. Two and three immunization were analyzed with the deactivated vaccine.
  • FIGs. 14A-14C Two or three inoculation with MERSRAB protect animals from weight loss and vaccine induce immune responses control the MERS-CoV challenge viruses to undetectable levels. Animals were immunized and challenge as outlined in FIG. 13.
  • FIG. 15 Two or three inoculation with MERSRAB protect animals from viral replication in the lung. The figure shows that only small amounts of MERS-CoV antigen is detected in lungs of immunized mice at day three after challenge, and no antigen is detected at day six. In contrast, in the lung tissue of animal immunized with the rabies virus vector only large amount of tissue damage and viral antigen can be detected at both time points consistent with the viral load shown in FIG. 14.
  • FIGs. 16A-16B FIG. 16A is a presentation showing formulation of BBV151-A vaccine (BBV151-A1 & BBV151-A2) and FIG.16B is a presentation showing formulation of BBV-151-B vaccine.
  • FIG. 17 shows the sequence and features of “VSV-COVID19-S1-VSVG.
  • FIG. 18 shows the sequence and features of “BNSP333-COVID19-S1-RVG”.
  • FIG. 19 shows the sequence and features of “MV WuhanCoV S in position 6”.
  • FIG. 20 shows the sequence and features of “MV Wu S in position 3”.
  • FIG. 21 shows the sequence and features of “MV-coWuhan-S Position 2”.
  • an element means one element or more than one element.
  • antibody refers to a protein, or polypeptide sequence derived from an immunoglobulin molecule, which specifically binds to a specific epitope on an antigen.
  • Antibodies can be intact immunoglobulins derived from natural sources or from recombinant sources and can be immunoreactive portions of intact immunoglobulins.
  • the antibodies useful in the present invention may exist in a variety of forms including, for example, polyclonal antibodies, monoclonal antibodies, intracellular antibodies (“intrabodies”), Fv, Fab and F(ab)2, as well as single chain antibodies (scFv) and humanized antibodies (Harlow et al., 1998, Using Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory Press, NY; Harlow et al., 1989, Antibodies: A Laboratory Manual, Cold Spring Harbor, New York; Houston et al., 1988, Proc. Natl. Acad. Sci. USA 85:5879-5883; Bird et al., 1988, Science 242:423-426).
  • An antibody may be derived from natural sources or from recombinant sources.
  • Antibodies are typically tetramers of immunoglobulin molecules.
  • ameliorating or “treating” means that the clinical signs and/or the symptoms associated with a disease are lessened as a result of the actions performed.
  • the signs or symptoms to be monitored will be well known to the skilled clinician.
  • the term “about” is meant to encompass variations of ⁇ 20% or ⁇ 10%, more preferably ⁇ 5%, even more preferably ⁇ 1%, and still more preferably ⁇ 0.1% from the specified value, as such variations are appropriate to perform the disclosed methods.
  • biological sample refers to a sample obtained from an organism or from components (e.g., cells) of an organism.
  • the sample may be of any biological tissue or fluid. Frequently the sample will be a “clinical sample” which is a sample derived from a patient.
  • Such samples include, but are not limited to, bone marrow, cardiac tissue, sputum, blood, lymphatic fluid, blood cells (e.g., white cells), tissue or fine needle biopsy samples, urine, peritoneal fluid, and pleural fluid, or cells therefrom.
  • Biological samples may also include sections of tissues such as frozen sections taken for histological purposes.
  • control or " reference” are used interchangeably and refer to a value that is used as a standard of comparison.
  • immunogenicity refers to the innate ability of an antigen or organism to elicit an immune response in an animal when the antigen or organism is administered to the animal.
  • enhancing the immunogenicity refers to increasing the ability of an antigen or organism to elicit an immune response in an animal when the antigen or organism is administered to an animal.
  • the increased ability of an antigen or organism to elicit an immune response can be measured by, among other things, a greater number of antibodies that bind to an antigen or organism, a greater diversity of antibodies to an antigen or organism, a greater number of T-cells specific for an antigen or organism, a greater cytotoxic or helper T-cell response to an antigen or organism, a greater expression of cytokines in response to an antigen, and the like.
  • the terms “eliciting an immune response” or “immunizing” refer to the process of generating a B cell and/or a T cell response against a heterologous protein.
  • the term “antigen” or “Ag” as used herein is defined as a molecule that provokes an immune response. This immune response may involve either antibody production, or the activation of specific immunologically-competent cells, or both.
  • antigens can be derived from recombinant or genomic DNA.
  • any DNA which comprises a nucleotide sequences or a partial nucleotide sequence encoding a protein that elicits an immune response therefore encodes an “antigen” as that term is used herein.
  • an antigen need not be encoded solely by a full- length nucleotide sequence of a gene. It is readily apparent that the present invention includes, but is not limited to, the use of partial nucleotide sequences of more than one gene and that these nucleotide sequences are arranged in various combinations to elicit the desired immune response.
  • an antigen need not be encoded by a “gene” at all. It is readily apparent that an antigen can be generated synthesized or can be derived from a biological sample. Such a biological sample can include, but is not limited to a tissue sample, a tumor sample, a cell or a biological fluid.
  • Heterologous antigens used herein to refer to an antigen that is not endogenous to the organism comprising or expressing an antigen.
  • a virus vaccine vector comprising or expressing a viral or tumor antigen comprises a heterologous antigen.
  • Heterologous protein refers to a protein that elicits a beneficial immune response in a subject (i.e. mammal), irrespective of its source.
  • binding specificity refers to the ability of the humanized antibodies or binding compounds of the invention to bind to a target epitope with a greater affinity than that which results when bound to a non target epitope.
  • specific binding refers to binding to a target with an affinity that is at least 10, 50, 100, 250, 500, or 1000 times greater than the affinity for a non-target epitope.
  • combination therapy is meant that a first agent is administered in conjunction with another agent.
  • “In combination with” or “In conjunction with” refers to administration of one treatment modality in addition to another treatment modality.
  • in combination with refers to administration of one treatment modality before, during, or after delivery of the other treatment modality to the individual. Such combinations are considered to be part of a single treatment regimen or regime.
  • Human immunity or “humoral immune response” both refer to B-cell mediated immunity and are mediated by highly specific antibodies, produced and secreted by B-lymphocytes (B-cells).
  • Prevention refers to the use of a pharmaceutical compositions for the vaccination against a disorder.
  • Adjuvant refers to a substance that is capable of potentiating the immunogenicity of an antigen.
  • Adjuvants can be one substance or a mixture of substances and function by acting directly on the immune system or by providing a slow release of an antigen.
  • examples of adjuvants include, but are not limited to, emulsions (e.g oil in water (o/w) emulsions), aluminium salts, polyanions, bacterial glycopeptides and slow release agents such as Freund's incomplete.
  • Delivery vehicle refers to a composition that helps to target the antigen to specific cells and to facilitate the effective recognition of an antigen by the immune system.
  • the best-known delivery vehicles are liposomes, virosomes, microparticles including microspheres and nanospheres, polymers, bacterial ghosts, bacterial polysaccharides, attenuated bacteria, virus like particles, attenuated viruses and ISCOMS.
  • expression is defined as the transcription and/or translation of a particular nucleotide sequence driven by its promoter.
  • the term “expression cassette” means a nucleic acid sequence capable of directing the transcription and/or translation of a heterologous coding sequence.
  • the expression cassette comprises a promoter sequence operably linked to a sequence encoding a heterologous protein.
  • the expression cassette further comprises at least one regulatory sequence operably linked to the sequence encoding the heterologous protein.
  • “Incorporated into” or “encapsulated in” refers to an antigenic peptide and/or nucleic acid molecule that is/are within a delivery vehicle, such as microparticles, bacterial ghosts, attenuated bacteria, virus like particles, attenuated viruses, ISCOMs, liposomes and preferably virosomes.
  • peptide As used herein, the terms “peptide,” “polypeptide,” and “protein” are used interchangeably, and refer to a compound comprised of amino acid residues covalently linked by peptide bonds.
  • a protein or peptide must contain at least two amino acids, and no limitation is placed on the maximum number of amino acids that may comprise a protein or peptide’s sequence.
  • Polypeptides include any peptide or protein comprising two or more amino acids joined to each other by peptide bonds.
  • the term refers to both short chains, which also commonly are referred to in the art as peptides, oligopeptides and oligomers, for example, and to longer chains, which generally are referred to in the art as proteins, of which there are many types.
  • Polypeptides include, for example, biologically active fragments, substantially homologous polypeptides, oligopeptides, homodimers, heterodimers, variants of polypeptides, modified polypeptides, derivatives, analogs, fusion proteins, among others.
  • the polypeptides include natural peptides, recombinant peptides, synthetic peptides, or a combination thereof.
  • a "fusion protein” as used herein refers to a protein wherein the protein comprises two or more proteins linked together by peptide bonds or other chemical bonds.
  • the proteins can be linked together directly by a peptide or other chemical bond, or with one or more amino acids between the two or more proteins, referred to herein as a spacer.
  • A refers to adenosine
  • C refers to cytosine
  • G refers to guanosine
  • T refers to thymidine
  • U refers to uridine.
  • RNA as used herein is defined as ribonucleic acid.
  • Transform is used herein to refer to a process of introducing an isolated nucleic acid into the interior of an organism.
  • treatment as used within the context of the present invention is meant to include therapeutic treatment as well as prophylactic, or suppressive measures for the disease or disorder.
  • treatment and associated terms such as “treat” and “treating” means the reduction of the progression, severity and/or duration of a disease condition or at least one symptom thereof.
  • treatment therefore refers to any regimen that can benefit a subject.
  • the treatment may be in respect of an existing condition or may be prophylactic (preventative treatment). Treatment may include curative, alleviative or prophylactic effects.
  • References herein to “therapeutic” and “prophylactic” treatments are to be considered in their broadest context.
  • the term “therapeutic” does not necessarily imply that a subject is treated until total recovery.
  • treatment includes the administration of an agent prior to or following the onset of a disease or disorder thereby preventing or removing all signs of the disease or disorder.
  • administration of the agent after clinical manifestation of the disease to combat the symptoms of the disease comprises “treatment” of the disease.
  • Equivalent when used in reference to nucleotide sequences, is understood to refer to nucleotide sequences encoding functionally equivalent polypeptides. Equivalent nucleotide sequences will include sequences that differ by one or more nucleotide substitutions, additions- or deletions, such as allelic variants; and will, therefore, include sequences that differ from the nucleotide sequence of the nucleic acids described herein due to the degeneracy of the genetic code.
  • isolated refers to molecules separated from other DNAs or RNAs, respectively that are present in the natural source of the macromolecule.
  • isolated as used herein also refers to a nucleic acid or peptide that is substantially free of cellular material, viral material, or culture medium when produced by recombinant DNA techniques, or chemical precursors or other chemicals when chemically synthesized.
  • isolated nucleic acid is meant to include nucleic acid fragments, which are not naturally occurring as fragments and would not be found in the natural state.
  • isolated is also used herein to refer to polypeptides, which are isolated from other cellular proteins and is meant to encompass both purified and recombinant polypeptides.
  • An “isolated cell” or “isolated population of cells” is a cell or population of cells that is not present in its natural environment.
  • Identity refers to the subunit sequence identity between two polymeric molecules particularly between two amino acid molecules, such as, between two polypeptide molecules. When two amino acid sequences have the same residues at the same positions; e.g ., if a position in each of two polypeptide molecules is occupied by an Arginine, then they are identical at that position. The identity or extent to which two amino acid sequences have the same residues at the same positions in an alignment is often expressed as a percentage. The identity between two amino acid sequences is a direct function of the number of matching or identical positions; e.g.
  • the two sequences are 50% identical; if 90% of the positions (e.g, 9 of 10), are matched or identical, the two amino acids sequences are 90% identical.
  • a “mutation” as used therein is a change in a DNA sequence resulting in an alteration from its natural state.
  • the mutation can comprise a deletion and/or insertion and/or duplication and/or substitution of at least one deoxyribonucleic acid base such as a purine (adenine and/or thymine) and/or a pyrimidine (guanine and/or cytosine).
  • Mutations may or may not produce discernible changes in the observable characteristics (phenotype) of an organism.
  • nucleic acid refers to polynucleotides such as deoxyribonucleic acid (DNA), and, where appropriate, ribonucleic acid (RNA).
  • DNA deoxyribonucleic acid
  • RNA ribonucleic acid
  • the term should also be understood to include, as equivalents, analogs of either RNA or DNA made from nucleotide analogs, and, as applicable to the embodiment being described, single (sense or antisense) and double-stranded polynucleotides.
  • ESTs, chromosomes, cDNAs, mRNAs, and rRNAs are representative examples of molecules that may be referred to as nucleic acids.
  • nucleic acids include but are not limited to, all nucleic acid sequences which are obtained by any means available in the art, including, without limitation, recombinant means, i.e., the cloning of nucleic acid sequences from a recombinant library or a viral genome, using ordinary cloning technology and PCRTM, and the like, and by synthetic means.
  • recombinant means i.e., the cloning of nucleic acid sequences from a recombinant library or a viral genome, using ordinary cloning technology and PCRTM, and the like, and by synthetic means.
  • A refers to adenosine
  • C refers to cytosine
  • G refers to guanosine
  • T refers to thymidine
  • U refers to uridine.
  • operably linked sequences include both expression control sequences that are contiguous with the gene of interest and expression control sequences that act in trans or at a distance to control the gene of interest.
  • Expression control sequences include appropriate transcription initiation, termination, promoter and enhancer sequences; efficient RNA processing signals such as splicing and polyadenylation (poly A) signals; sequences that stabilize cytoplasmic mRNA; sequences that enhance translation efficiency (i.e., Kozak consensus sequence); sequences that enhance protein stability; and when desired, sequences that enhance secretion of the encoded product.
  • RNA expression and control sequences are numerous expression control sequences, including promoters which are native, constitutive, inducible and/or tissue-specific, are known in the art that may be used in the compositions of the invention. “Operably linked” should be construed to include RNA expression and control sequences in addition to DNA expression and control sequences.
  • promoter as used herein is defined as a DNA sequence recognized by the synthetic machinery of the cell, or introduced synthetic machinery, required to initiate the specific transcription of a polynucleotide sequence.
  • promoter/regulatory sequence means a nucleic acid sequence, which is required for expression of a gene product operably linked to the promoter/regulatory sequence. In some instances, this sequence may be the core promoter sequence and in other instances, this sequence may also include an enhancer sequence and other regulatory elements, which are required for expression of the gene product.
  • the promoter/regulatory sequence may, for example, be one which expresses the gene product in a tissue specific manner.
  • a “constitutive” promoter is a nucleotide sequence which, when operably linked with a polynucleotide which encodes or specifies a gene product, causes the gene product to be produced in a cell under most or all physiological conditions of the cell.
  • an “inducible” promoter is a nucleotide sequence which, when operably linked with a polynucleotide which encodes or specifies a gene product, causes the gene product to be produced in a cell substantially only when an inducer which corresponds to the promoter is present in the cell.
  • the term “pharmaceutical composition” refers to a mixture of at least one compound useful within the invention with other chemical components, such as carriers, stabilizers, diluents, adjuvants, dispersing agents, suspending agents, thickening agents, and/or excipients.
  • the pharmaceutical composition facilitates administration of the compound to an organism. Multiple techniques of administering a compound exist in the art including, but not limited to: intravenous, oral, aerosol, parenteral, ophthalmic, pulmonary and topical administration.
  • pharmaceutically acceptable carrier includes a pharmaceutically acceptable salt, pharmaceutically acceptable material, composition or carrier, such as a liquid or solid filler, diluent, excipient, solvent or encapsulating material, involved in carrying or transporting a compound(s) of the present invention within or to the subject such that it may perform its intended function. Typically, such compounds are carried or transported from one organ, or portion of the body, to another organ, or portion of the body.
  • Each salt or carrier must be “acceptable” in the sense of being compatible with the other ingredients of the formulation, and not injurious to the subject.
  • materials that may serve as pharmaceutically acceptable carriers include: sugars, such as lactose, glucose and sucrose; starches, such as corn starch and potato starch; cellulose, and its derivatives, such as sodium carboxymethyl cellulose, ethyl cellulose and cellulose acetate; powdered tragacanth; malt; gelatin; talc; excipients, such as cocoa butter and suppository waxes; oils, such as peanut oil, cottonseed oil, safflower oil, sesame oil, olive oil, corn oil and soybean oil; glycols, such as propylene glycol; polyols, such as glycerin, sorbitol, mannitol and polyethylene glycol; esters, such as ethyl oleate and ethyl laurate; agar; buffering agents, such as magnesium hydroxide and aluminum hydroxide; alginic acid; pyrogen-free water; isotonic saline; Ringer’
  • “pharmaceutically acceptable carrier” also includes any and all coatings, antibacterial and antifungal agents, and absorption delaying agents, and the like that are compatible with the activity of the compound, and are physiologically acceptable to the subject. Supplementary active compounds may also be incorporated into the compositions.
  • the term “effective amount” or “therapeutically effective amount” means that amount of a composition (e.g ., vaccine composition) or active ingredient (e.g., virus like particles (VLPs), virions, viral vectors, antigen, nucleic acid molecule) necessary to achieve an intended result e.g, to produce an intended immunological, pharmacological, therapeutic and/or protective result (e.g, that amount of VLPs , virions, or viral vectors sufficient to induce a measurable immune response, to prevent a particular disease condition, to reduce the severity of and/or ameliorate the disease condition or at least one symptom and/or condition associated therewith).
  • active ingredient e.g., virus like particles (VLPs), virions, viral vectors, antigen, nucleic acid molecule
  • a “subject” or “patient,” as used therein, may be a human or non-human mammal.
  • Non-human mammals include, for example, livestock and pets, such as ovine, bovine, porcine, canine, feline and murine mammals.
  • the subject is human.
  • the subject is a domestic pet or livestock.
  • the subject is a cat.
  • the subject is a dog.
  • the subject is a ferret.
  • Titers are numerical measures of the concentration of a virus or viral vector compared to a reference sample, where the concentration is determined either by the activity of the virus, or by measuring the number of viruses in a unit volume of buffer.
  • the titer of viral stocks are determined, e.g., by measuring the infectivity of a solution or solutions (typically serial dilutions) of the viruses, e.g., on HeLa cells using the soft agar method (see, Graham & Van Der eb (1973) Virology 52:456-467) or by monitoring resistance conferred to cells, e.g., G418 resistance encoded by the virus or vector, or by quantitating the viruses by UV spectrophotometry (see, Chardonnet & Dales (1970) Virology 40:462-477).
  • Vaccination refers to the process of inoculating a subject with an antigen to elicit an immune response in the subject, that helps to prevent or treat the disease or disorder the antigen is connected with.
  • the term “immunization” is used interchangeably herein with vaccination.
  • a “vector” is a composition of matter which comprises a nucleic acid and which can be used to deliver the nucleic acid to the interior of a cell.
  • vectors are known in the art including, but not limited to, linear polynucleotides, polynucleotides associated with ionic or amphiphilic compounds, plasmids, and viruses.
  • the term “vector” includes an autonomously replicating virus.
  • ranges throughout this disclosure, various aspects of the invention can be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, description of a range such as from 1 to 6 should be considered to have specifically disclosed subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., as well as individual numbers within that range, for example, 1, 2, 2.7, 3, 4, 5, 5.3, and 6. This applies regardless of the breadth of the range.
  • the present invention relates to compositions and methods for generating vaccines against a SARS-CoV-2 virus.
  • SARS-CoV-2 virus is also referred to herein as 2019- nCoV or 2019 Novel Coronavirus.
  • Described herein is a vaccine against the SARS-CoV-2 virus that uses a rabies virus-based vector that has proven to be an efficient vector against emerging and re- emerging infectious diseases. It was previously demonstrated that inactivated rabies virus particles containing MERS-CoV spike SI protein induce potent immune responses against MERS-CoV and RABV and provide protection in animal systems.
  • the 2019-nCoV vaccine described herein has the following advantages:
  • the construct is based on a currently available rabies vaccine product, and therefore will facilitate entry of a vaccine into a clinical phase one study to be prepared within a short time period.
  • Bharat Biotech Ltd (BBIL) produce currently 20 million doses of the RABV vaccine a year.
  • the construct can be manufactured at low cost-of-goods. Rabies vaccines have been commercially produced for decades, costs are well known and are inexpensive. The present vaccine uses the same manufacturing process as the current human rabies vaccine. When vaccinating millions of people in resource-limited areas, a low-cost vaccine is a significant advantage
  • the vaccine should be safe for all population groups.
  • the vaccine is based on the killed rabies vaccine backbone since the rabies vaccine has decades of safe use across diverse populations.
  • the vaccine can be produced by an experienced commercial-scale manufacturing partner, Bharat Biotech, who has successfully met WHO pre-qualification standards for other vaccines, and can move quickly into clinical trials and commercial production.
  • Bharat Biotech meets the FDA, EMA, and WHO PQ standards for cGMP.
  • Advax-SM a unique polysaccharide adjuvant
  • Both the RABV vector and the utilized adjuvant can be stabilized and stored at room temperature.
  • the present invention includes an isolated nucleic acid encoding a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
  • the virus is a rhabdovirus.
  • the virus is a rabies virus, a vesicular stomatitis virus (VSV), or a measles virus.
  • the virus is a rabies virus.
  • the nucleic acid can comprises sequences that are codon-optimized for expression in a cell (e.g., a mammalian cell, a human cell).
  • the SARS-CoV-2 spike protein (S) or the portion thereof comprises the amino acid sequence as set forth in SEQ ID NO: 28:
  • the SARS-CoV-2 spike protein (S) or the portion thereof comprises the amino acid sequence as set forth in SEQ ID NO: 29:
  • the SARS-CoV-2 spike protein (S) or the portion thereof comprises the amino acid sequence as set forth in SEQ ID NO: 30:
  • the SARS-CoV-2 spike protein (S) or the portion thereof comprises the amino acid sequence as set forth in SEQ ID NO: 31 :
  • an N protein (N) or the portion thereof comprising the amino acid sequence as set forth in SEQ ID NO: 32: MATLLRSLALFKRNKDKPPITSGSGGAIRGIKHIIIVPIPGDSSITTRSRLLDRLVRLI GNPD VSGPKLT GALIGIL SLF VESPGQLIQRITDDPD V SIRLLE VVQ SDQ SQ SGLTF ASRGTNMEDEADQYF SHDDPIS SDQSRF GWF GNKEISDIEVQDPEGFNMILGTIL A QIWVLL AK VT APDT AAD SELRRWIK YTQQRRVVGEFRLERKWLD VVRNRIAE DLSLRRFMVALILDIKRTPGNKPRIAEMICDIDTYIVEAGLASFILTIKFGIETMYPA LGLHEF AGEL STLESLMNL Y QQMGET AP YMVILEN SIQNKF S AGS YPLLW S YAM GV GVELEN SMGGLNF GRS
  • the SARS-CoV-2 spike protein (S) or the portion thereof is a variant spike polypeptide comprising one or more alterations (e.g substitution(s), insertion(s), deletion(s), addition(s), modification(s)) in its amino acid sequence relative to the amino acid sequence set forth as SEQ ID NO: 28, 29, 30, or 31.
  • the SARS-CoV-2 spike protein (S) or the portion thereof is a variant spike polypeptide comprising, relative to the amino acid sequence set forth as SEQ ID NO: 28, 29, 30, or 31, at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16,
  • the SARS-CoV-2 spike protein (S) or the portion thereof is a variant spike polypeptide comprising at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but not 100%, sequence identity to the amino acid sequence set forth as SEQ ID NO: 28, 29, 30, or 31.
  • the N protein (N) or the portion thereof is a variant N polypeptide comprising one or more alterations (e.g substitution(s), insertion(s), deletion(s), addition(s), modification(s)) in its amino acid sequence relative to the amino acid sequence set forth as SEQ ID NO: 32.
  • the N protein (N) or the portion thereof is a variant N polypeptide comprising, relative to the amino acid sequence set forth as SEQ ID NO: 32, at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25,
  • the N protein (N) or the portion thereof is a variant N polypeptide comprising at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but not 100%, sequence identity to the amino acid sequence set forth as SEQ ID NO: 32.
  • the recombinant virus expresses a full-length SARS-CoV- 2 spike protein (S). In some other embodiments, the recombinant virus expresses a portion of the SARS-CoV-2 spike protein (S). In one embodiment, the portion of the SARS-CoV-2 spike protein (S) is a receptor binding site of the SARS-CoV-2 spike protein (S). In another embodiment, the portion of the SARS-CoV-2 spike protein (S) is the SI domain. In another embodiment, the portion of the SARS-CoV-2 spike protein (S) is the N-terminal 750 amino acids of the SARS-CoV-2 spike protein (S).
  • the SARS-CoV-2 spike protein (S) or portion thereof is fused to a glycoprotein (G) or a portion thereof.
  • the glycoprotein (G) comprises a mutation substituting arginine with glutamic acid at position 333.
  • the portion of glycoprotein (G) comprises an ectodomain, a cytoplasmic domain, and a transmembrane domain.
  • the portion of the glycoprotein (G) comprises 1 to about 100 amino acids of the ectodomain or a trimerization domain.
  • the portion of the glycoprotein (G) comprises 31 amino acids of the ectodomain.
  • the glycoprotein (G) comprises 31 amino acids of the ectodomain and the full-length cytoplasmic domain.
  • the sequence encoding the SARS-CoV-2 spike protein (S) or portion thereof is codon-optimized for expression in a cell. In some embodiments, the sequence encoding the the SARS-CoV-2 spike protein (S) or portion thereof fused to a glycoprotein (G) or portion thereof is codon-optimized for expression in a cell.
  • the nucleic acid comprises a sequence encoding at least a portion of the genome of the virus. In some embodiments, the isolated nucleic acid comprises the full-length genome.
  • the nucleic acid comprises (a) a sequence encoding at least a portion of the genome of a vesicular stomatitis virus (VSV), and (b) a sequence encoding a protein comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
  • the protein comprising a SARS-CoV-2 spike protein (S) or a portion thereof is a fusion protein comprising a glycoprotein (G) or a portion thereof and a SARS-CoV-2 spike protein (S) or a portion thereof.
  • the fusion protein comprises a glycoprotein (G) or portion thereof fused to the SI domain of a SARS-CoV-2 spike protein (S).
  • nucleic acid comprises the sequence of SEQ ID NO:
  • AGT AC AT C A AT GGGC GT GG AT AGC GGTTT GACTC AC GGGGATTTCC A AGT C
  • TTTTCCACAC AACC AAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACC ATT
  • GGGGC AAC AAACC AATTGAAT AC ATC AAAAAGGAAAGATGGACTGACTC ATT
  • the nucleic acid comprises (a) a sequence encoding at least a portion of the genome of a rabies virus and (b) a sequence encoding a protein comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
  • the at least a portion of the genome of the rabies virus comprises an N gene and a P gene, and the sequence encoding the protein comprising the SARS-CoV-2 spike protein (S) or portion thereof is inserted into a position between the N gene and P gene.
  • the protein comprising a SARS-CoV-2 spike protein (S) or a portion thereof is a fusion protein comprising a glycoprotein (G) or a portion thereof and a SARS-CoV-2 spike protein (S) or a portion thereof.
  • the fusion protein comprises a glycoprotein (G) or portion thereof fused to the SI domain of a SARS-CoV-2 spike protein (S).
  • nucleic acid comprises the sequence of SEQ ID NO:
  • GGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGG C AGT AC AT C A AT GGGC GT GG AT AGC GGTTT GACTC AC GGGGATTTCC A AGT C
  • ATCGCCC AACC AT GGT GAG AT AGCC AAGGTGGGAGAAGGC AAGT ATCGAGA
  • AAAAAAC AAGATCCT AAATCTGAACCTTTGGTT GTTT GATT GTTTTTCTC Atttttg ttgtttatttgttaagcgtGGGTCGGCATGGCATCTCCACCTCCTCGCGGTCCGACCTGGGC
  • the nucleic acid comprises a sequence encoding at least a portion of the genome of a measles virus and (b) a sequence encoding a SARS-CoV-2 spike protein (S) or a portion thereof.
  • the sequence encoding the SARS-CoV-2 spike protein (S) or portion thereof is inserted into position 2, 3, or 6 of the genome of the measles virus.
  • the nucleic acid comprises the sequence of SEQ ID NO: 3, shown below:

Abstract

The present invention includes a vaccine comprising a SARS-CoV-2 spike protein (S) or portion thereof, and methods of use thereof.

Description

CORONA VIRUS DISEASE (COVID-19) VACCINE
CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to U.S. Provisional Application No. 62/986,396 filed March 6, 2020 and to U.S. Provisional Application No. 63/017,241 filed April 29, 2020, each of which is herein incorporated by reference in its entirety.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR
DEVELOPMENT
This invention was made with government support under grant no. 1R21AI158044-01 awarded by the National Institute of Health. The government has certain rights in the invention.
REFERENCE TO SEQUENCE LISTING The Sequence Listing concurrently submitted herewith as a text file named "205961_7055W01_Sequence_Listing.txt," created on March 4, 2021 and having a size of 577,339 bytes is herein incorporated by reference pursuant to 37 C.F.R. § 1.52(e)(5).
BACKGROUND OF THE INVENTION The recently emerged coronavirus, currently called 2019-nCoV or SARS-CoV-2 virus, is rapidly spreading in China and Asia with over 42,000 cases, 500 deaths and cases in 18 countries as of February 10, 2020. This novel coronavirus is thought to have emerged from a live animal market in Wuhan, China, and has quickly spread in the community with large clusters of human to human transmission. The sequence of several isolates have been determined, and the closest strains are SARS-like bat coronavirus lineages. Little is known about this virus including its susceptibility to anti-viral compounds, ability to replicate in cell lines or host factors regulating replication. Importantly there are no therapeutics available to treat the virus, although investigational studies are underway. Modeling of the current outbreak suggests that the virus could infect >1 billion people and become a yearly epidemic.
A need exists for novel methods for generating vaccines to treat Coronaviruses, in particular, COVID-19. The present invention addresses and satisfies this need.
SUMMARY OF THE INVENTION In some aspects, the present disclosure provides an isolated nucleic acid encoding a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
In other aspects, the present disclosure provides a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
In one aspect, the present disclosure provides a recombinant virus encoded by a nucleic acid described herein. In some embodiments, the nucleic acid encodes a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
In another aspect, the present disclosure provides a recombinant fusion protein comprising (a) a glycoprotein (G) of a virus or a portion thereof, and (b) a SARS-CoV-2 spike protein (S) or a portion thereof.
In some aspects, the present disclosure provides a vector comprising a nucleic acid described herein. In one embodiment, the nucleic acid encodes a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
In other aspects, the present disclosure provides a vaccine comprising a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof, and a pharmaceutically acceptable carrier.
In one aspect, the present disclosure provides a method of generating an immune response against a SARS-CoV-2 virus in a subject in need thereof, the method comprising administering to the subject an effective amount of a vaccine described herein. In some embodiments, the vaccine comprises a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof, and a pharmaceutically acceptable carrier.
In another aspect, the present disclosure provides a method of vaccinating a subject against a SARS-CoV-2 virus, the method comprising administering to the subject an effective amount of the vaccine described herein. In some embodiments, the vaccine comprises a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof, and a pharmaceutically acceptable carrier.
In other aspects, the present disclosure provides a method of providing immunity against a SARS-CoV-2 virus in a subject, the method comprising administering to the subject an effective amount of the vaccine described herein. In some embodiments, the vaccine comprises a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof, and a pharmaceutically acceptable carrier.
In some aspects, the present disclosure provides a method of treating and/or preventing a disease or disorder associated with a SARS-CoV-2 virus in a subject in need thereof, the method comprising administering to the subject an effective amount of the vaccine described herein. In some embodiments, the vaccine comprises a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof, and a pharmaceutically acceptable carrier.
BRIEF DESCRIPTION OF THE DRAWINGS
The following detailed description of specific embodiments of the invention will be better understood when read in conjunction with the appended drawings. For the purpose of illustrating the invention, there are shown in the drawings exemplary embodiments. It should be understood, however, that the invention is not limited to the precise arrangements and instrumentalities of the embodiments shown in the drawings.
FIG. 1: VSV expressing codon-optimized Covid-Sl. The map shows the viral sequence including the plasmids utilized to create the recombinant virus. The sequence is shown in SEQ ID NO: 1 and features are shown in FIG. 7. The sequence and features are also shown in FIG. 17 (“VSV-COVID19-S1-VSVG”).
FIG 2: RABV expressing codon-optimized Covid-Sl. The map shows the viral sequence, including the plasmids utilized to create the recombinant virus. The sequence is shown in SEQ ID NO: 2 and features are shown in FIG. 8. The sequence and features are also shown in FIG. 18 (“BN8R333-Oqnΐϋ19-81-Bnq”).
FIG. 3: MV expressing codon-optimized Covid-S from position 2 of the genome. The map shows the viral sequence, including the plasmids utilized to create the recombinant virus. The sequences is shown in SEQ ID NO: 3 and features are shown in FIG. 9. The sequence and features are also shown in FIG. 21 (“MV-coWuhan-S Position 2”).
FIG. 4: MV expressing codon-optimized Covid-S from position 3 of the genome. The map shows the viral sequence, including the plasmids utilized to create the recombinant virus. The sequence is shown in SEQ ID NO: 4 and features are shown in FIG. 10. The sequence and features are also depicted in FIG. 20 (“MV Wu S in position 3”).
FIG. 5: MV expressing codon-optimized Covid-S from position 6 of the genome. The map shows the viral sequence, including the plasmids utilized to create the recombinant virus. The sequence is shown in SEQ ID NO: 5 and features are shown in FIG. 11. The sequence and features are also depicted in FIG. 19 (“MV WuhanCoV S in position 6”). FIG. 6: Characterization of RABV (RABV-COV19-S1) and VSV (VSV-COV19- Sl) expressing a chimeric Sl-G fusion protein. SDS-PAGE analysis of purified virions after sucrose gradient purification. Letters indicate the positions of the VSV or RABV L, G, N, P, and M proteins. Numbers to the left indicate the sizes of the molecular mass standards. The Covid-19 SI protein is indicated. The controls show VSV and RABV virions.
FIG. 7 shows the features of the map shown in FIG. 1.
FIG. 8 shows the features of the map shown in FIG. 2.
FIG. 9 shows the features of the map shown in FIG. 3.
FIG. 10 shows the features of the map shown in FIG. 4.
FIG. 11 shows the features of the map shown in FIG. 5.
FIG. 12: Schematic illustration of the 2019-nCoV vaccine constructs used in this study. Spike protein cDNA is inserted between the N and P genes of the SAD-B19- derived RABV virus vaccine vector BNSP333. The BNSP333-S1-G construct expresses a chimeric protein that contains the entire SI domain fused to the C-terminal part of the RABV G glycoprotein (amino acids 428-524), which encompasses the entire cytoplasmic domain (CD), the transmembrane domain (TM), plus 31 amino acids of the ectodomain (E31) of RABV G. Different structural elements of the spike protein are indicated in the full length construct: signal peptide (SP), receptor-binding domain (RBD), fusion peptide (FP), heptad repeat regions 1 and 2 (HR1 and HR2), transmembrane domain (TM), and cytoplasmic domain (CD).
FIG. 13: Schematic illustration of the MERSRAB immunization schedule and challenge with MERS-CoV. Two and three immunization were analyzed with the deactivated vaccine.
FIGs. 14A-14C: Two or three inoculation with MERSRAB protect animals from weight loss and vaccine induce immune responses control the MERS-CoV challenge viruses to undetectable levels. Animals were immunized and challenge as outlined in FIG. 13.
FIG. 15: Two or three inoculation with MERSRAB protect animals from viral replication in the lung. The figure shows that only small amounts of MERS-CoV antigen is detected in lungs of immunized mice at day three after challenge, and no antigen is detected at day six. In contrast, in the lung tissue of animal immunized with the rabies virus vector only large amount of tissue damage and viral antigen can be detected at both time points consistent with the viral load shown in FIG. 14. FIGs. 16A-16B: FIG. 16A is a presentation showing formulation of BBV151-A vaccine (BBV151-A1 & BBV151-A2) and FIG.16B is a presentation showing formulation of BBV-151-B vaccine.
FIG. 17 shows the sequence and features of “VSV-COVID19-S1-VSVG.
FIG. 18 shows the sequence and features of “BNSP333-COVID19-S1-RVG”.
FIG. 19 shows the sequence and features of “MV WuhanCoV S in position 6”. FIG. 20 shows the sequence and features of “MV Wu S in position 3”.
FIG. 21 shows the sequence and features of “MV-coWuhan-S Position 2”.
DETAILED DESCRIPTION
Definitions
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. Although any methods and materials similar or equivalent to those described herein may be used in the practice for testing of the present invention, the preferred materials and methods are described herein. In describing and claiming the present invention, the following terminology will be used.
It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting.
As used herein, the articles “a” and “an” are used to refer to one or to more than one (i.e., to at least one) of the grammatical object of the article. By way of example, “an element” means one element or more than one element.
The term “antibody” or “Ab” as used herein, refers to a protein, or polypeptide sequence derived from an immunoglobulin molecule, which specifically binds to a specific epitope on an antigen. Antibodies can be intact immunoglobulins derived from natural sources or from recombinant sources and can be immunoreactive portions of intact immunoglobulins. The antibodies useful in the present invention may exist in a variety of forms including, for example, polyclonal antibodies, monoclonal antibodies, intracellular antibodies (“intrabodies”), Fv, Fab and F(ab)2, as well as single chain antibodies (scFv) and humanized antibodies (Harlow et al., 1998, Using Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory Press, NY; Harlow et al., 1989, Antibodies: A Laboratory Manual, Cold Spring Harbor, New York; Houston et al., 1988, Proc. Natl. Acad. Sci. USA 85:5879-5883; Bird et al., 1988, Science 242:423-426). An antibody may be derived from natural sources or from recombinant sources. Antibodies are typically tetramers of immunoglobulin molecules.
The term “ameliorating” or “treating” means that the clinical signs and/or the symptoms associated with a disease are lessened as a result of the actions performed. The signs or symptoms to be monitored will be well known to the skilled clinician.
As used herein when referring to a measurable value such as an amount, a temporal duration, and the like, the term “about” is meant to encompass variations of ±20% or ±10%, more preferably ±5%, even more preferably ±1%, and still more preferably ±0.1% from the specified value, as such variations are appropriate to perform the disclosed methods.
The term “biological” or “biological sample” refers to a sample obtained from an organism or from components (e.g., cells) of an organism. The sample may be of any biological tissue or fluid. Frequently the sample will be a “clinical sample” which is a sample derived from a patient. Such samples include, but are not limited to, bone marrow, cardiac tissue, sputum, blood, lymphatic fluid, blood cells (e.g., white cells), tissue or fine needle biopsy samples, urine, peritoneal fluid, and pleural fluid, or cells therefrom. Biological samples may also include sections of tissues such as frozen sections taken for histological purposes.
As used herein, the terms "control," or " reference " are used interchangeably and refer to a value that is used as a standard of comparison.
The term “ immunogenicity” as used herein, refers to the innate ability of an antigen or organism to elicit an immune response in an animal when the antigen or organism is administered to the animal. Thus, "enhancing the immunogenicity" refers to increasing the ability of an antigen or organism to elicit an immune response in an animal when the antigen or organism is administered to an animal. The increased ability of an antigen or organism to elicit an immune response can be measured by, among other things, a greater number of antibodies that bind to an antigen or organism, a greater diversity of antibodies to an antigen or organism, a greater number of T-cells specific for an antigen or organism, a greater cytotoxic or helper T-cell response to an antigen or organism, a greater expression of cytokines in response to an antigen, and the like.
As used herein, the terms “eliciting an immune response” or “immunizing” refer to the process of generating a B cell and/or a T cell response against a heterologous protein. The term “antigen” or “Ag” as used herein is defined as a molecule that provokes an immune response. This immune response may involve either antibody production, or the activation of specific immunologically-competent cells, or both. The skilled artisan will understand that any macromolecule, including virtually all proteins or peptides, can serve as an antigen. Furthermore, antigens can be derived from recombinant or genomic DNA. A skilled artisan will understand that any DNA, which comprises a nucleotide sequences or a partial nucleotide sequence encoding a protein that elicits an immune response therefore encodes an “antigen” as that term is used herein. Furthermore, one skilled in the art will understand that an antigen need not be encoded solely by a full- length nucleotide sequence of a gene. It is readily apparent that the present invention includes, but is not limited to, the use of partial nucleotide sequences of more than one gene and that these nucleotide sequences are arranged in various combinations to elicit the desired immune response. Moreover, a skilled artisan will understand that an antigen need not be encoded by a “gene” at all. It is readily apparent that an antigen can be generated synthesized or can be derived from a biological sample. Such a biological sample can include, but is not limited to a tissue sample, a tumor sample, a cell or a biological fluid.
“Heterologous antigens” used herein to refer to an antigen that is not endogenous to the organism comprising or expressing an antigen. As an example, a virus vaccine vector comprising or expressing a viral or tumor antigen comprises a heterologous antigen. The term “Heterologous protein” as used herein refers to a protein that elicits a beneficial immune response in a subject (i.e. mammal), irrespective of its source.
The term “specifically binds”, “selectively binds” or “binding specificity” refers to the ability of the humanized antibodies or binding compounds of the invention to bind to a target epitope with a greater affinity than that which results when bound to a non target epitope. In certain embodiments, specific binding refers to binding to a target with an affinity that is at least 10, 50, 100, 250, 500, or 1000 times greater than the affinity for a non-target epitope.
As used herein, by “combination therapy” is meant that a first agent is administered in conjunction with another agent. “In combination with” or “In conjunction with” refers to administration of one treatment modality in addition to another treatment modality. As such, “in combination with” refers to administration of one treatment modality before, during, or after delivery of the other treatment modality to the individual. Such combinations are considered to be part of a single treatment regimen or regime.
“Humoral immunity” or “humoral immune response” both refer to B-cell mediated immunity and are mediated by highly specific antibodies, produced and secreted by B-lymphocytes (B-cells).
“Prevention” refers to the use of a pharmaceutical compositions for the vaccination against a disorder.
“Adjuvant” refers to a substance that is capable of potentiating the immunogenicity of an antigen. Adjuvants can be one substance or a mixture of substances and function by acting directly on the immune system or by providing a slow release of an antigen. Examples of adjuvants include, but are not limited to, emulsions ( e.g oil in water (o/w) emulsions), aluminium salts, polyanions, bacterial glycopeptides and slow release agents such as Freund's incomplete.
“Delivery vehicle” refers to a composition that helps to target the antigen to specific cells and to facilitate the effective recognition of an antigen by the immune system. The best-known delivery vehicles are liposomes, virosomes, microparticles including microspheres and nanospheres, polymers, bacterial ghosts, bacterial polysaccharides, attenuated bacteria, virus like particles, attenuated viruses and ISCOMS.
The term “expression” as used herein is defined as the transcription and/or translation of a particular nucleotide sequence driven by its promoter.
As used herein, the term “expression cassette” means a nucleic acid sequence capable of directing the transcription and/or translation of a heterologous coding sequence. In some embodiments, the expression cassette comprises a promoter sequence operably linked to a sequence encoding a heterologous protein. In some embodiments, the expression cassette further comprises at least one regulatory sequence operably linked to the sequence encoding the heterologous protein.
“Incorporated into” or “encapsulated in” refers to an antigenic peptide and/or nucleic acid molecule that is/are within a delivery vehicle, such as microparticles, bacterial ghosts, attenuated bacteria, virus like particles, attenuated viruses, ISCOMs, liposomes and preferably virosomes.
As used herein, the terms “peptide,” “polypeptide,” and “protein” are used interchangeably, and refer to a compound comprised of amino acid residues covalently linked by peptide bonds. A protein or peptide must contain at least two amino acids, and no limitation is placed on the maximum number of amino acids that may comprise a protein or peptide’s sequence. Polypeptides include any peptide or protein comprising two or more amino acids joined to each other by peptide bonds. As used herein, the term refers to both short chains, which also commonly are referred to in the art as peptides, oligopeptides and oligomers, for example, and to longer chains, which generally are referred to in the art as proteins, of which there are many types. “Polypeptides” include, for example, biologically active fragments, substantially homologous polypeptides, oligopeptides, homodimers, heterodimers, variants of polypeptides, modified polypeptides, derivatives, analogs, fusion proteins, among others. The polypeptides include natural peptides, recombinant peptides, synthetic peptides, or a combination thereof.
A "fusion protein" as used herein refers to a protein wherein the protein comprises two or more proteins linked together by peptide bonds or other chemical bonds. The proteins can be linked together directly by a peptide or other chemical bond, or with one or more amino acids between the two or more proteins, referred to herein as a spacer.
In the context of the present invention, the following abbreviations for the commonly occurring nucleic acid bases are used. “A” refers to adenosine, “C” refers to cytosine, “G” refers to guanosine, “T” refers to thymidine, and “U” refers to uridine.
The term “RNA” as used herein is defined as ribonucleic acid.
"Transform", "transforming", and "transformation "is used herein to refer to a process of introducing an isolated nucleic acid into the interior of an organism.
The term “treatment” as used within the context of the present invention is meant to include therapeutic treatment as well as prophylactic, or suppressive measures for the disease or disorder. As used herein, the term “treatment” and associated terms such as “treat” and “treating” means the reduction of the progression, severity and/or duration of a disease condition or at least one symptom thereof. The term ‘treatment’ therefore refers to any regimen that can benefit a subject. The treatment may be in respect of an existing condition or may be prophylactic (preventative treatment). Treatment may include curative, alleviative or prophylactic effects. References herein to “therapeutic” and “prophylactic” treatments are to be considered in their broadest context. The term “therapeutic” does not necessarily imply that a subject is treated until total recovery. Similarly, “prophylactic” does not necessarily mean that the subject will not eventually contract a disease condition. Thus, for example, the term treatment includes the administration of an agent prior to or following the onset of a disease or disorder thereby preventing or removing all signs of the disease or disorder. As another example, administration of the agent after clinical manifestation of the disease to combat the symptoms of the disease comprises “treatment” of the disease.
The term “equivalent,” when used in reference to nucleotide sequences, is understood to refer to nucleotide sequences encoding functionally equivalent polypeptides. Equivalent nucleotide sequences will include sequences that differ by one or more nucleotide substitutions, additions- or deletions, such as allelic variants; and will, therefore, include sequences that differ from the nucleotide sequence of the nucleic acids described herein due to the degeneracy of the genetic code.
The term “isolated” as used herein with respect to nucleic acids, such as DNA or RNA, refers to molecules separated from other DNAs or RNAs, respectively that are present in the natural source of the macromolecule. The term isolated as used herein also refers to a nucleic acid or peptide that is substantially free of cellular material, viral material, or culture medium when produced by recombinant DNA techniques, or chemical precursors or other chemicals when chemically synthesized. Moreover, an “isolated nucleic acid” is meant to include nucleic acid fragments, which are not naturally occurring as fragments and would not be found in the natural state. The term “isolated” is also used herein to refer to polypeptides, which are isolated from other cellular proteins and is meant to encompass both purified and recombinant polypeptides. An “isolated cell” or “isolated population of cells” is a cell or population of cells that is not present in its natural environment.
“Identity” as used herein refers to the subunit sequence identity between two polymeric molecules particularly between two amino acid molecules, such as, between two polypeptide molecules. When two amino acid sequences have the same residues at the same positions; e.g ., if a position in each of two polypeptide molecules is occupied by an Arginine, then they are identical at that position. The identity or extent to which two amino acid sequences have the same residues at the same positions in an alignment is often expressed as a percentage. The identity between two amino acid sequences is a direct function of the number of matching or identical positions; e.g. , if half (e.g, five positions in a polymer ten amino acids in length) of the positions in two sequences are identical, the two sequences are 50% identical; if 90% of the positions (e.g, 9 of 10), are matched or identical, the two amino acids sequences are 90% identical.
A “mutation” as used therein is a change in a DNA sequence resulting in an alteration from its natural state. The mutation can comprise a deletion and/or insertion and/or duplication and/or substitution of at least one deoxyribonucleic acid base such as a purine (adenine and/or thymine) and/or a pyrimidine (guanine and/or cytosine).
Mutations may or may not produce discernible changes in the observable characteristics (phenotype) of an organism.
As used herein, the term “nucleic acid” refers to polynucleotides such as deoxyribonucleic acid (DNA), and, where appropriate, ribonucleic acid (RNA). The term should also be understood to include, as equivalents, analogs of either RNA or DNA made from nucleotide analogs, and, as applicable to the embodiment being described, single (sense or antisense) and double-stranded polynucleotides. ESTs, chromosomes, cDNAs, mRNAs, and rRNAs are representative examples of molecules that may be referred to as nucleic acids. As used herein, nucleic acids include but are not limited to, all nucleic acid sequences which are obtained by any means available in the art, including, without limitation, recombinant means, i.e., the cloning of nucleic acid sequences from a recombinant library or a viral genome, using ordinary cloning technology and PCR™, and the like, and by synthetic means.
In the context of the present invention, the following abbreviations for the commonly occurring nucleic acid bases are used. “A” refers to adenosine, “C” refers to cytosine, “G” refers to guanosine, “T” refers to thymidine, and “U” refers to uridine.
As used herein, "operably linked" sequences include both expression control sequences that are contiguous with the gene of interest and expression control sequences that act in trans or at a distance to control the gene of interest. Expression control sequences include appropriate transcription initiation, termination, promoter and enhancer sequences; efficient RNA processing signals such as splicing and polyadenylation (poly A) signals; sequences that stabilize cytoplasmic mRNA; sequences that enhance translation efficiency (i.e., Kozak consensus sequence); sequences that enhance protein stability; and when desired, sequences that enhance secretion of the encoded product. There are numerous expression control sequences, including promoters which are native, constitutive, inducible and/or tissue-specific, are known in the art that may be used in the compositions of the invention. “Operably linked” should be construed to include RNA expression and control sequences in addition to DNA expression and control sequences.
The term “promoter” as used herein is defined as a DNA sequence recognized by the synthetic machinery of the cell, or introduced synthetic machinery, required to initiate the specific transcription of a polynucleotide sequence. As used herein, the term “promoter/regulatory sequence” means a nucleic acid sequence, which is required for expression of a gene product operably linked to the promoter/regulatory sequence. In some instances, this sequence may be the core promoter sequence and in other instances, this sequence may also include an enhancer sequence and other regulatory elements, which are required for expression of the gene product. The promoter/regulatory sequence may, for example, be one which expresses the gene product in a tissue specific manner.
A “constitutive” promoter is a nucleotide sequence which, when operably linked with a polynucleotide which encodes or specifies a gene product, causes the gene product to be produced in a cell under most or all physiological conditions of the cell.
An “inducible” promoter is a nucleotide sequence which, when operably linked with a polynucleotide which encodes or specifies a gene product, causes the gene product to be produced in a cell substantially only when an inducer which corresponds to the promoter is present in the cell.
As used herein, the term “pharmaceutical composition” refers to a mixture of at least one compound useful within the invention with other chemical components, such as carriers, stabilizers, diluents, adjuvants, dispersing agents, suspending agents, thickening agents, and/or excipients. The pharmaceutical composition facilitates administration of the compound to an organism. Multiple techniques of administering a compound exist in the art including, but not limited to: intravenous, oral, aerosol, parenteral, ophthalmic, pulmonary and topical administration.
The language “pharmaceutically acceptable carrier” includes a pharmaceutically acceptable salt, pharmaceutically acceptable material, composition or carrier, such as a liquid or solid filler, diluent, excipient, solvent or encapsulating material, involved in carrying or transporting a compound(s) of the present invention within or to the subject such that it may perform its intended function. Typically, such compounds are carried or transported from one organ, or portion of the body, to another organ, or portion of the body. Each salt or carrier must be “acceptable” in the sense of being compatible with the other ingredients of the formulation, and not injurious to the subject. Some examples of materials that may serve as pharmaceutically acceptable carriers include: sugars, such as lactose, glucose and sucrose; starches, such as corn starch and potato starch; cellulose, and its derivatives, such as sodium carboxymethyl cellulose, ethyl cellulose and cellulose acetate; powdered tragacanth; malt; gelatin; talc; excipients, such as cocoa butter and suppository waxes; oils, such as peanut oil, cottonseed oil, safflower oil, sesame oil, olive oil, corn oil and soybean oil; glycols, such as propylene glycol; polyols, such as glycerin, sorbitol, mannitol and polyethylene glycol; esters, such as ethyl oleate and ethyl laurate; agar; buffering agents, such as magnesium hydroxide and aluminum hydroxide; alginic acid; pyrogen-free water; isotonic saline; Ringer’s solution; ethyl alcohol; phosphate buffer solutions; diluent; granulating agent; lubricant; binder; disintegrating agent; wetting agent; emulsifier; coloring agent; release agent; coating agent; sweetening agent; flavoring agent; perfuming agent; preservative; antioxidant; plasticizer; gelling agent; thickener; hardener; setting agent; suspending agent; surfactant; humectant; carrier; stabilizer; and other non-toxic compatible substances employed in pharmaceutical formulations, or any combination thereof. As used herein, “pharmaceutically acceptable carrier” also includes any and all coatings, antibacterial and antifungal agents, and absorption delaying agents, and the like that are compatible with the activity of the compound, and are physiologically acceptable to the subject. Supplementary active compounds may also be incorporated into the compositions.
As used herein, the term “effective amount” or “therapeutically effective amount” means that amount of a composition ( e.g ., vaccine composition) or active ingredient (e.g., virus like particles (VLPs), virions, viral vectors, antigen, nucleic acid molecule) necessary to achieve an intended result e.g, to produce an intended immunological, pharmacological, therapeutic and/or protective result (e.g, that amount of VLPs , virions, or viral vectors sufficient to induce a measurable immune response, to prevent a particular disease condition, to reduce the severity of and/or ameliorate the disease condition or at least one symptom and/or condition associated therewith).
A “subject” or “patient,” as used therein, may be a human or non-human mammal. Non-human mammals include, for example, livestock and pets, such as ovine, bovine, porcine, canine, feline and murine mammals. Preferably, the subject is human. In some embodiments, the subject is a domestic pet or livestock. In some embodiments, the subject is a cat. In some embodiments, the subject is a dog. In some other embodiments, the subject is a ferret.
"Titers" are numerical measures of the concentration of a virus or viral vector compared to a reference sample, where the concentration is determined either by the activity of the virus, or by measuring the number of viruses in a unit volume of buffer. The titer of viral stocks are determined, e.g., by measuring the infectivity of a solution or solutions (typically serial dilutions) of the viruses, e.g., on HeLa cells using the soft agar method (see, Graham & Van Der eb (1973) Virology 52:456-467) or by monitoring resistance conferred to cells, e.g., G418 resistance encoded by the virus or vector, or by quantitating the viruses by UV spectrophotometry (see, Chardonnet & Dales (1970) Virology 40:462-477).
“Vaccination” refers to the process of inoculating a subject with an antigen to elicit an immune response in the subject, that helps to prevent or treat the disease or disorder the antigen is connected with. The term “immunization” is used interchangeably herein with vaccination.
A “vector” is a composition of matter which comprises a nucleic acid and which can be used to deliver the nucleic acid to the interior of a cell. Numerous vectors are known in the art including, but not limited to, linear polynucleotides, polynucleotides associated with ionic or amphiphilic compounds, plasmids, and viruses. In the present disclosure, the term “vector” includes an autonomously replicating virus.
Ranges: throughout this disclosure, various aspects of the invention can be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, description of a range such as from 1 to 6 should be considered to have specifically disclosed subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., as well as individual numbers within that range, for example, 1, 2, 2.7, 3, 4, 5, 5.3, and 6. This applies regardless of the breadth of the range.
Description
The present invention relates to compositions and methods for generating vaccines against a SARS-CoV-2 virus. The SARS-CoV-2 virus is also referred to herein as 2019- nCoV or 2019 Novel Coronavirus.
Described herein is a vaccine against the SARS-CoV-2 virus that uses a rabies virus-based vector that has proven to be an efficient vector against emerging and re- emerging infectious diseases. It was previously demonstrated that inactivated rabies virus particles containing MERS-CoV spike SI protein induce potent immune responses against MERS-CoV and RABV and provide protection in animal systems.
The 2019-nCoV vaccine described herein has the following advantages:
• The construct is based on a currently available rabies vaccine product, and therefore will facilitate entry of a vaccine into a clinical phase one study to be prepared within a short time period. Bharat Biotech Ltd (BBIL) produce currently 20 million doses of the RABV vaccine a year.
• The construct can be rapidly scaled, as needed, for additional clinical trials and commercial manufacture.
• The construct can be manufactured at low cost-of-goods. Rabies vaccines have been commercially produced for decades, costs are well known and are inexpensive. The present vaccine uses the same manufacturing process as the current human rabies vaccine. When vaccinating millions of people in resource-limited areas, a low-cost vaccine is a significant advantage
• The vaccine should be safe for all population groups. In some embodiments, the vaccine is based on the killed rabies vaccine backbone since the rabies vaccine has decades of safe use across diverse populations.
• Proof of concept has been demonstrated by protecting in animal models based on challenge studies with the related MERS-CoV in two mouse models and alpacas (camelid).
• Long-term protection is expected since the RABV vaccine often provides life-long protection.
• The vaccine can be produced by an experienced commercial-scale manufacturing partner, Bharat Biotech, who has successfully met WHO pre-qualification standards for other vaccines, and can move quickly into clinical trials and commercial production. Bharat Biotech meets the FDA, EMA, and WHO PQ standards for cGMP.
• Utilises a unique polysaccharide adjuvant, Advax-SM, that has already been extensively tested in human clinical trials, being shown to enhance both humoral and cellular immunity. Most notably, addition of Advax-SM to prototype cGMP whole cell and recombinant spike protein SARS vaccines, not only enhanced neutralising antibody responses and prevented lung viral replication but also completely prevented vaccine- enhanced eosinophilic lung pathology in response to SARS virus exposure.
• Both the RABV vector and the utilized adjuvant can be stabilized and stored at room temperature.
Constructs
In one aspect, the present invention includes an isolated nucleic acid encoding a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof. In some embodiments, the virus is a rhabdovirus. In some embodiments, the virus is a rabies virus, a vesicular stomatitis virus (VSV), or a measles virus. In a particular embodiment, the virus is a rabies virus. The nucleic acid can comprises sequences that are codon-optimized for expression in a cell (e.g., a mammalian cell, a human cell).
In one embodiment, the SARS-CoV-2 spike protein (S) or the portion thereof comprises the amino acid sequence as set forth in SEQ ID NO: 28:
MF VFLVLLPL V S SQC VNLTTRT QLPP AYTN SFTRGVYYPDKVFRS S VLHSTQDLF LPFF SNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYF ASTEKSNIIRGWIF GTTLD SKTQ SLLIVNNATNVVIK V CEF QF CNDPFLGVYYFIKNNKS WMESEFRVY S S ANN CTFEYVSQPFLMDLEGKQGNFKNLREF VFKNIDGYFKIY SKHTPINLVRDLPQGF S ALEPL VDLPIGINITRF QTLL ALHRS YLTPGD S S SGWT AGAAAYYV GYLQPRTFLL KYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITN LCPF GEVFNATRF AS VY AWNRKRISNC VAD Y S VL YN S ASF STFKC Y GV SPTKLN DLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDS K V GGNYN YL YRLFRK SNLKPFERDI S TEI Y Q AGS TPCN GVEGFNC YFPLQ S Y GF Q PTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVL TESNKKFLPF QQF GRDI ADTTD AVRDPQTLEILDITPC SF GGV S VITPGTNTSNQ VA VL Y QD VNCTEVP VAIH ADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNN S YECD IPIGAGICASYQTQTNSPR.
In another embodiment, the SARS-CoV-2 spike protein (S) or the portion thereof comprises the amino acid sequence as set forth in SEQ ID NO: 29:
MF VFLVLLPL V S SQC VNLTTRT QLPP AYTN SFTRGVYYPDKVFRS S VLHSTQDLF LPFF SNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYF ASTEKSNIIRGWIF GTTLD SKTQ SLLIVNNATNVVIK V CEF QF CNDPFLGVYYHKNNKS WMESEFRVY S S ANN CTFEYVSQPFLMDLEGKQGNFKNLREF VFKNIDGYFKIY SKHTPINLVRDLPQGF S ALEPL VDLPIGINITRF QTLL ALHRS YLTPGD S S SGWT AGAAAYYV GYLQPRTFLL KYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITN LCPF GEVFNATRF AS VY AWNRKRISNC VAD Y S VL YN S ASF STFKC Y GV SPTKLN DLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDS K V GGNYNYL YRLFRK SNLKPFERDI S TEI Y Q AGS TPCN GVEGFNC YFPLQ SY GF Q PTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVL TESNKKFLPF QQF GRDIADTTD AVRDPQTLEILDITPC SF GGV S VITPGTNTSNQ VA VL Y QD VNCTEVP VAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNN S YECD IPIGAGIC AS Y QTQTN SPRRARS VASQ SIIA YTMSLGAEN S VAY SNN SIAIPTNFTIS VTTEILP V SMTKT S VDCTMYICGD STEC SNLLLQ Y GSF CTQLNRALTGI AVEQDK
NT QEVF AQ VKQI YKTPPIKDF GGFNF S QILPDP SKP SKRSFIEDLLFNK VTL AD AGF
IKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFG
AGA ALQIPF AMQM A YRFN GIGVT QN VL YEN QKLI AN QFN S AIGKIQD SL S S T A S A
LGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITG
RLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFP
Q S APHGVVFLHVT YVP AQEKNFTT AP AICHDGKAHFPREGVF V SNGTHWF VT QR
NFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPD
VDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWL
GFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT.
In one embodiment, the SARS-CoV-2 spike protein (S) or the portion thereof comprises the amino acid sequence as set forth in SEQ ID NO: 30:
MF VFLVLLPL V S SQC VNLTTRT QLPP AYTN SFTRGVYYPDKVFRS S VLHSTQDLF LPFF SNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYF ASTEKSNIIRGWIF GTTLD SKTQ SLLIVNNATNVVIK V CEF QF CNDPFLGVYYHKNNKS WMESEFRVY S S ANN CTFEYVSQPFLMDLEGKQGNFKNLREF VFKNIDGYFKIY SKHTPINLVRDLPQGF S ALEPL VDLPIGINITRF QTLL ALHRS YLTPGD S S SGWT AGAAAYYV GYLQPRTFLL KYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITN LCPF GEVFNATRF AS VY AWNRKRISNC VAD Y S VL YN S ASF STFKC Y GV SPTKLN DLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDS K V GGNYN YL YRLFRK SNLKPFERDI S TEI Y Q AGS TPCN GVEGFNC YFPLQ S Y GF Q PTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVL TESNKKFLPF QQF GRDI ADTTD AVRDPQTLEILDITPC SF GGV S VITPGTNTSNQ VA VL Y QD VNCTEVP VAIH ADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNN S YECD IPIGAGICASYQTQTNSPRSVGDEAEDFVEVHLPDVHNQVSGVDLGLPNWGKYV LLSAGALTALMLIIFLMTCCRRVNRSEPTQHNLRGTGREVSVTPQSGKIISSWESH KSGGETRL.
In another embodiment, the SARS-CoV-2 spike protein (S) or the portion thereof comprises the amino acid sequence as set forth in SEQ ID NO: 31 :
MF VFLVLLPL V S SQC VNLTTRT QLPP AYTN SFTRGVYYPDKVFRS S VLHSTQDLF LPFF SNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYF ASTEKSNIIRGWIF GTTLD SKTQSLLIVNNATNVVIKVCEF QF CNDPFLGVYYHKNNKSWMESEFRVY S S ANN CTFEYVSQPFLMDLEGKQGNFKNLREF VFKNIDGYFKIY SKHTPINLVRDLPQGF S ALEPL VDLPIGINITRF QTLL ALHRS YLTPGD S S SGWT AGAAAYYV GYLQPRTFLL KYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITN LCPF GEVFNATRF AS VY AWNRKRISNC VAD Y S VL YN S ASF STFKC Y GV SPTKLN DLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDS K V GGNYN YL YRLFRK SNLKPFERDI S TEI Y Q AGS TPCN GVEGFNC YFPLQ S Y GF Q PTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVL TESNKKFLPF QQF GRDI ADTTD AVRDPQTLEILDITPC SF GGV S VITPGTNTSNQ VA VL Y QD VNCTEVP VAIH ADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNN S YECD IPIGAGICASYQTQTNSPR.
In another embodiment, an N protein (N) or the portion thereof is provided, comprising the amino acid sequence as set forth in SEQ ID NO: 32: MATLLRSLALFKRNKDKPPITSGSGGAIRGIKHIIIVPIPGDSSITTRSRLLDRLVRLI GNPD VSGPKLT GALIGIL SLF VESPGQLIQRITDDPD V SIRLLE VVQ SDQ SQ SGLTF ASRGTNMEDEADQYF SHDDPIS SDQSRF GWF GNKEISDIEVQDPEGFNMILGTIL A QIWVLL AK VT APDT AAD SELRRWIK YTQQRRVVGEFRLERKWLD VVRNRIAE DLSLRRFMVALILDIKRTPGNKPRIAEMICDIDTYIVEAGLASFILTIKFGIETMYPA LGLHEF AGEL STLESLMNL Y QQMGET AP YMVILEN SIQNKF S AGS YPLLW S YAM GV GVELEN SMGGLNF GRS YFDP AYFRLGQEMVRRS AGK V S STL ASELGIT AED A RLVSEIAMHTTEDKISRAVGPRQAQVSFLHGDQSENELPRLGGKEDRRVKQSRGE ARESYRETGPSRASDARAAHLPTGTPLDIDTATESSQDPQDSRRSADALLRLQAM AGISEEQGSDTDTPIVYNDRNLLD.
In another embodiment, the SARS-CoV-2 spike protein (S) or the portion thereof is a variant spike polypeptide comprising one or more alterations ( e.g substitution(s), insertion(s), deletion(s), addition(s), modification(s)) in its amino acid sequence relative to the amino acid sequence set forth as SEQ ID NO: 28, 29, 30, or 31.
In other embodiments, the SARS-CoV-2 spike protein (S) or the portion thereof is a variant spike polypeptide comprising, relative to the amino acid sequence set forth as SEQ ID NO: 28, 29, 30, or 31, at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16,
17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30 or more alterations.
In one embodiment, the SARS-CoV-2 spike protein (S) or the portion thereof is a variant spike polypeptide comprising at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but not 100%, sequence identity to the amino acid sequence set forth as SEQ ID NO: 28, 29, 30, or 31. In another embodiment, the N protein (N) or the portion thereof is a variant N polypeptide comprising one or more alterations ( e.g substitution(s), insertion(s), deletion(s), addition(s), modification(s)) in its amino acid sequence relative to the amino acid sequence set forth as SEQ ID NO: 32.
In other embodiments, the N protein (N) or the portion thereof is a variant N polypeptide comprising, relative to the amino acid sequence set forth as SEQ ID NO: 32, at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25,
26, 27, 28, 29, 30 or more alterations.
In one embodiment, the N protein (N) or the portion thereof is a variant N polypeptide comprising at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but not 100%, sequence identity to the amino acid sequence set forth as SEQ ID NO: 32.
In some embodiments, the recombinant virus expresses a full-length SARS-CoV- 2 spike protein (S). In some other embodiments, the recombinant virus expresses a portion of the SARS-CoV-2 spike protein (S). In one embodiment, the portion of the SARS-CoV-2 spike protein (S) is a receptor binding site of the SARS-CoV-2 spike protein (S). In another embodiment, the portion of the SARS-CoV-2 spike protein (S) is the SI domain. In another embodiment, the portion of the SARS-CoV-2 spike protein (S) is the N-terminal 750 amino acids of the SARS-CoV-2 spike protein (S).
In some embodiments, the SARS-CoV-2 spike protein (S) or portion thereof is fused to a glycoprotein (G) or a portion thereof. In some embodiments, the glycoprotein (G) comprises a mutation substituting arginine with glutamic acid at position 333. In some embodiments, the portion of glycoprotein (G) comprises an ectodomain, a cytoplasmic domain, and a transmembrane domain. In other embodiments, the portion of the glycoprotein (G) comprises 1 to about 100 amino acids of the ectodomain or a trimerization domain. In some embodiments, the portion of the glycoprotein (G) comprises 31 amino acids of the ectodomain. In some embodiments, the glycoprotein (G) comprises 31 amino acids of the ectodomain and the full-length cytoplasmic domain.
In some embodiments, the sequence encoding the SARS-CoV-2 spike protein (S) or portion thereof is codon-optimized for expression in a cell. In some embodiments, the sequence encoding the the SARS-CoV-2 spike protein (S) or portion thereof fused to a glycoprotein (G) or portion thereof is codon-optimized for expression in a cell. In some embodiments, the nucleic acid comprises a sequence encoding at least a portion of the genome of the virus. In some embodiments, the isolated nucleic acid comprises the full-length genome.
In one embodiment, the nucleic acid comprises (a) a sequence encoding at least a portion of the genome of a vesicular stomatitis virus (VSV), and (b) a sequence encoding a protein comprising a SARS-CoV-2 spike protein (S) or a portion thereof. In some embodiments, the protein comprising a SARS-CoV-2 spike protein (S) or a portion thereof is a fusion protein comprising a glycoprotein (G) or a portion thereof and a SARS-CoV-2 spike protein (S) or a portion thereof. In some embodiments, the fusion protein comprises a glycoprotein (G) or portion thereof fused to the SI domain of a SARS-CoV-2 spike protein (S).
In another embodiment, the nucleic acid comprises the sequence of SEQ ID NO:
1, shown below:
CTGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCG
CAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCT
TCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGG
GGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAA
CTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTT
TCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAA
CTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATT
TTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAA
CGCGAATTTTAACAAAATATTAACGCTTACAATTTCCATTCGCCATTCAGGCT
GCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAG
CTGGCGAA AGGGGGAT GT GCTGC AAGGCGATT AAGTT GGGT AACGCC AGGGT
TTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAGcgcgccCTAGTTATTAA
TAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCGCGT
TACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGC
CCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTT
CC ATT GACGT C AAT GGGT GGAGT ATTT ACGGT AAACTGCCC ACTT GGC AGT AC
ATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAA
ATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTT
GGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGG
C AGT AC AT C A AT GGGC GT GG AT AGC GGTTT GACTC AC GGGGATTTCC A AGT C
TCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGC
GTGTACGGTGGGAGGTCTATATAAGCAGAGCTCTCTGGCTAACTAGAGAACC
CACTGCTTACTGGCTTATCGAAATTAATACGACTCACTATAGGGAGACCCAA
GCTGGCTAGGGTCTTCGTCTGATGAGTCCGTGAGGACGAAACCCGGCGTACC
GGGT C ACGAAGAC AAAC AAACC ATT ATT ATC ATT AAAAGGCTC AGGAGAAAC
TTTAACAGTAATCAAAATGTCTGTTACAGTCAAGAGAATCATTGACAACACA
GTCATAGTTCCAAAACTTCCTGCAAATGAGGATCCAGTGGAATACCCGGCAG
ATTACTTCAGAAAATCAAAGGAGATTCCTCTTTACATCAATACTACAAAAAGT
TTGTCAGATCTAAGAGGATATGTCTACCAAGGCCTCAAATCCGGAAATGTAT
C AAT CAT AC AT GT C AAC AGCT ACTT GT AT GGAGC ATT AAAGGAC ATCCGGGG
T AAGTT GGAT AAAGATT GGT C AAGTTTCGGAAT AAAC ATCGGGAAAGC AGGG
GATACAATCGGAATATTTGACCTTGTATCCTTGAAAGCCCTGGACGGCGTACT
TCCAGATGGAGTATCGGATGCTTCCAGAACCAGCGCAGATGACAAATGGTTG
CCTTTGTATCTACTTGGCTTATACAGAGTGGGCAGAACACAAATGCCTGAATA
C AGA A A A A AGCTC AT GGAT GGGCTGAC A A AT C A AT GCA A A AT GATC A AT G A
ACAGTTTGAACCTCTTGTGCCAGAAGGTCGTGACATTTTTGATGTGTGGGGAA
ATGACAGTAATTACACAAAAATTGTCGCTGCAGTGGACATGTTCTTCCACATG
TTCAAAAAACATGAATGTGCCTCGTTCAGATACGGAACTATTGTTTCCAGATT
CAAAGATTGTGCTGCATTGGCAACATTTGGACACCTCTGCAAAATAACCGGA
ATGTCTACAGAAGATGTAACGACCTGGATCTTGAACCGAGAAGTTGCAGATG
AAATGGTCCAAATGATGCTTCCAGGCCAAGAAATTGACAAGGCCGATTCATA
CATGCCTTATTTGATCGACTTTGGATTGTCTTCTAAGTCTCCATATTCTTCCGT
CAAAAACCCTGCCTTCCACTTCTGGGGGCAATTGACAGCTCTTCTGCTCAGAT
CCACCAGAGCAAGGAATGCCCGACAGCCTGATGACATTGAGTATACATCTCT
TACTACAGCAGGTTTGTTGTACGCTTATGCAGTAGGATCCTCTGCCGACTTGG
CACAACAGTTTTGTGTTGGAGATAACAAATACACTCCAGATGATAGTACCGG
AGGATTGACGACTAATGCACCGCCACAAGGCAGAGATGTGGTCGAATGGCTC
GGATGGTTTGAAGATCAAAACAGAAAACCGACTCCTGATATGATGCAGTATG
CGA A A AGAGC AGT CAT GT C AC T GC A AGGCC T A AGAGAGA AGAC A ATT GGC A
AGTATGCTAAGTCAGAATTTGACAAATGACCCTATAATTCTCAGATCACCTAT
TATATATTATGCTACATATGAAAAAAACTAACAGATATCATGGATAATCTCAC
AAAAGTTCGTGAGTATCTCAAGTCCTATTCTCGTCTGGATCAGGCGGTAGGAG
AG AT AG AT GAGATCGAAGC AC AACGAGCTGAAAAGTCC AATT ATGAGTTGTT
CCAAGAGGATGGAGTGGAAGAGCATACTAAGCCCTCTTATTTTCAGGCAGCA GAT GATTCTGAC AC AGAATCTGAACC AGAAATTGAAGAC AAT C AAGGTTT GT
ATGCACCAGATCCAGAAGCTGAGCAAGTTGAAGGCTTTATACAGGGGCCTTT
AG AT GAC T AT GC AGAT GAGGA AGT GGAT GTTGT ATTT ACTT C GGACTGGA A A
CAGCCTGAGCTTGAATCTGACGAGCATGGAAAGACCTTACGGTTGACATCGC
C AGAGGGTTT AAGTGGAGAGC AGAAATCCC AGT GGCTTTCGACGATT AAAGC
AGTCGT GC AAAGT GCC AAAT ACTGGAATCTGGC AGAGTGC AC ATTT GAAGC A
T C GGG AG A AGGGGT C ATT AT G A AGG AGC GC C AG AT A AC TC C GGAT GT AT AT A
AGGTCACTCCAGTGATGAACACACATCCGTCCCAATCAGAAGCAGTATCAGA
TGTTTGGTCTCTCTCAAAGACATCCATGACTTTCCAACCCAAGAAAGCAAGTC
TTCAGCCTCTCACCATATCCTTGGATGAATTGTTCTCATCTAGAGGAGAGTTC
ATCTCTGTCGGAGGTGACGGACGAATGTCTCATAAAGAGGCCATCCTGCTCG
GCCTGAGATACAAAAAGTTGTACAATCAGGCGAGAGTCAAATATTCTCTGTA
GACT AT GAAAAAAAGT AAC AGAT ATC ACGATCT AAGTGTT ATCCC AATCC AT
TC AT C AT G AGTT C C TT A A AG A AG AT TC TC GGT C T G A AGGGG A A AGGT A AG A A
ATCTAAGAAATTAGGGATCGCACCACCCCCTTATGAAGAGGACACTAGCATG
GAGTATGCTCCGAGCGCTCCAATTGACAAATCCTATTTTGGAGTTGACGAGAT
GGACACCTATGATCCGAATCAATTAAGATATGAGAAATTCTTCTTTACAGTGA
AAATGACGGTTAGATCTAATCGTCCGTTCAGAACATACTCAGATGTGGCAGC
CGCTGT ATCCC ATT GGG AT C AC ATGT AC ATCGGAAT GGC AGGGAAACGTCCC
TTCTACAAAATCTTGGCTTTTTTGGGTTCTTCTAATCTAAAGGCCACTCCAGCG
GT ATT GGC AGAT C A AGGT C AACC AGAGT AT C AC ACTC ACTGCGAAGGC AGGG
CTTATTTGCCACATAGGATGGGGAAGACCCCTCCCATGCTCAATGTACCAGA
GC ACTT C AG A AG ACC ATT C AAT AT AGGTCTTT AC A AGGGAACGATT GAGCTC
ACAATGACCATCTACGATGATGAGTCACTGGAAGCAGCTCCTATGATCTGGG
AT C ATTT C AATTCTTCC A AATTTTCTGATTT C AGAGAGAAGGCCTT AATGTTT G
GCCTGATTGTCGAGAAAAAGGCATCTGGAGCGTGGGTCCTGGATTCTATCAG
CCACTTCAAATGAGCTAGTCTAACTTCTAGCTTCTGAACAATCCCCGGTTTAC
TCAGTCTCTCCTAATTCCAGCCTCTCGAACAACTAATATCCTGTCTTTTCTATC
CCTATGAAAAAAACTAACAGAGATCGATCTGTTTACGCGTCACTATGAAGTG
CCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGT
TTTTCCACAC AACC AAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACC ATT
ATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCC
AT AC AAGT C AAAAT GCCC AAGAGT C AC AAGGCT ATTC AAGC AGACGGTTGGA
TGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCG AAGTATATAACACAGTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAA
GGAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCT
CCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCC
AGGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGA
TTC AC AGTT CAT C AACGGAAAAT GC AGC AATT AC AT ATGCCCC ACTGTCC AT A
ACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAAC
CTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCT
GGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGA
GGC AAGGCCTGC AAAAT GC AAT ACTGC AAGC ATT GGGGAGT C AGACTCCC AT
CAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTC
CCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGA
TGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAG
AAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAG
CTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATG
GTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCA
AT C C T C T C A AG A AT GGT C GG A AT GAT C AGT GG A AC T AC C AC AG A A AGGG A AC
T GT GGGAT GAC T GGGC ACC AT AT GA AGACGT GGA A ATT GGACC C A AT GGAGT
TCTGAGG ACC AGTT C AGGAT AT AAGTTTCCTTT AT AC AT GATTGGAC AT GGT A
TGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCT
CACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGG
TGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGT
AGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGA
CTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACC
AAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAA
CTCAAATCCTGCTAGGTATGAAAAAAACTAACaGATATCACGCTCGAGCGTAC
GCCACCATGTTCGTGTTTCTGGTGCTGCTGCCTCTGGTGAGCTCCCAGTGCGT
GAACCTGACCACAAGGACCCAGCTGCCCCCTGCCTATACCAATTCCTTCACAC
GGGGCGTGTACTATCCCGACAAGGTGTTCCGGAGCAGCGTGCTGCACTCCAC
ACAGGATCTGTTTCTGCCTTTCTTTTCTAACGTGACCTGGTTCCACGCCATCCA
CGTGAGCGGCACCAATGGCACAAAGCGGTTCGACAATCCAGTGCTGCCCTTT
AACGATGGCGTGTACTTCGCCTCCACCGAGAAGTCTAACATCATCAGAGGCT
GGATCTTTGGCACCACACTGGACAGCAAGACACAGTCCCTGCTGATCGTGAA
CAATGCCACCAACGTGGTCATCAAGGTGTGCGAGTTCCAGTTTTGTAATGATC
C ATTCCTGGGCGT GT ACT AT C AC AAGAAC AAT AAGTCTTGGAT GGAGAGCGA GTTTCGCGTGTATTCCTCTGCCAACAATTGCACATTTGAGTACGTGTCCCAGC
CCTTCCTGATGGACCTGGAGGGCAAGCAGGGCAATTTCAAGAACCTGAGGGA
GTTCGTGTTTAAGAATATCGATGGCTACTTCAAAATCTACTCCAAGCACACCC
CAATCAACCTGGTGCGCGACCTGCCACAGGGCTTCTCTGCCCTGGAGCCACTG
GTGGATCTGCCCATCGGCATCAACATCACCCGGTTTCAGACACTGCTGGCCCT
GCACAGAAGCTACCTGACACCAGGCGACAGCTCCTCTGGATGGACCGCAGGA
GCAGCAGCCTACTATGTGGGCTATCTGCAGCCCAGGACCTTCCTGCTGAAGTA
CAACGAGAATGGCACCATCACAGACGCCGTGGATTGCGCCCTGGATCCCCTG
TCTGAGACCAAGTGTACACTGAAGAGCTTTACCGTGGAGAAGGGCATCTATC
AGACAAGCAATTTCAGGGTGCAGCCTACCGAGTCCATCGTGCGCTTTCCCAAT
ATCACAAACCTGTGCCCTTTTGGCGAGGTGTTCAACGCAACCCGCTTCGCCAG
CGTGTACGCCTGGAATAGGAAGCGCATCTCCAACTGCGTGGCCGACTATTCT
GTGCTGTACAACAGCGCCTCCTTCTCTACCTTTAAGTGCTATGGCGTGAGCCC
CACAAAGCTGAATGACCTGTGCTTTACCAACGTGTACGCCGATTCCTTCGTGA
TCAGGGGCGACGAGGTGCGCCAGATCGCACCAGGACAGACAGGCAAGATCG
CAGACTACAATTATAAGCTGCCTGACGATTTCACCGGCTGCGTGATCGCCTGG
AACTCTAACAATCTGGATAGCAAAGTGGGCGGCAACTACAATTATCTGTACC
GGCTGTTTAGAAAGTCTAATCTGAAGCCATTCGAGAGGGACATCTCCACAGA
AATCTACCAGGCCGGCTCTACCCCCTGCAATGGCGTGGAGGGCTTTAACTGTT
ATTTCCCTCTGCAGAGCTACGGCTTCCAGCCAACAAACGGCGTGGGCTATCA
GCCCTACCGCGTGGTGGTGCTGTCTTTTGAGCTGCTGCACGCACCTGCAACAG
T GTGCGGACC AA AGAAGAGC ACC AATCTGGT GAAGAAC AAGT GCGT GAACTT
CAACTTCAACGGACTGACCGGAACAGGCGTGCTGACCGAGTCCAACAAGAAG
TTCCTGCCTTTTCAGCAGTTCGGCAGGGACATCGCAGATACCACAGACGCCGT
GCGCGACCCTCAGACCCTGGAGATCCTGGACATCACACCATGCTCCTTCGGC
GGCGTGTCTGTGATCACACCAGGCACCAATACAAGCAACCAGGTGGCCGTGC
TGTATCAGGACGTGAATTGTACCGAGGTGCCAGTGGCAATCCACGCAGATCA
GCTGACCCCTACATGGCGGGTGTACTCTACCGGCAGCAACGTGTTCCAGACA
AGAGCCGGATGCCTGATCGGAGCAGAGCACGTGAACAATAGCTATGAGTGCG
ACATCCCTATCGGCGCCGGCATCTGTGCCTCCTACCAGACCCAGACAAACTCC
CCAAGGTCTGTGGGCGATACAGGCCTGTCCAAGAATCCAATCGAGCTGGTAG
AGGGCTGGTTCAGCAGTTGGAAAAGCTCCATCGCCTCCTTTTTCTTTATCATC
GGCCTGATCATCGGACTGTTCCTGGTGCTCCGCGTGGGTATCCACCTGTGCAT
CAAGCTGAAGCACACCAAGAAAAGACAGATTTATACAGACATCGAGATGAA CCGCCTGGGAAAGTGAGCTAGCCAGATTCTTCATGTTTGGACCAAATCAACTT
GTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATG
AAAAAAACTAACAGCAATCATGGAAGTCCACGATTTTGAGACCGACGAGTTC
AATGATTTCAATGAAGATGACTATGCCACAAGAGAATTCCTGAATCCCGATG
AGCGCATGACGTACTTGAATCATGCTGATTACAATTTGAATTCTCCTCTAATT
AGTGATGATATTGACAATTTGATCAGGAAATTCAATTCTCTTCCGATTCCCTC
GATGTGGGATAGTAAGAACTGGGATGGAGTTCTTGAGATGTTAACATCATGT
C A AGC C A ATCC C ATCTC A AC ATCTC AGAT GC AT A A AT GGAT GGGA AGTT GGT
TAATGTCTGATAATCATGATGCCAGTCAAGGGTATAGTTTTTTACATGAAGTG
GACAAAGAGGCAGAAATAACATTTGACGTGGTGGAGACCTTCATCCGCGGCT
GGGGC AAC AAACC AATTGAAT AC ATC AAAAAGGAAAGATGGACTGACTC ATT
CAAAATTCTCGCTTATTTGTGTCAAAAGTTTTTGGACTTACACAAGTTGACAT
TAATCTTAAATGCTGTCTCTGAGGTGGAATTGCTCAACTTGGCGAGGACTTTC
AAAGGCAAAGTCAGAAGAAGTTCTCATGGAACGAACATATGCAGGATTAGG
GTTCCCAGCTTGGGTCCTACTTTTATTTCAGAAGGATGGGCTTACTTCAAGAA
ACTTGATATTCTAATGGACCGAAACTTTCTGTTAATGGTCAAAGATGTGATTA
T AGGGAGGAT GCA A AC GGT GC T ATC CAT GGT AT GT AG A AT AGAC A AC CTGTT
CTCAGAGCAAGACATCTTCTCCCTTCTAAATATCTACAGAATTGGAGATAAAA
TTGTGGAGAGGCAGGGAAATTTTTCTTATGACTTGATTAAAATGGTGGAACCG
ATATGCAACTTGAAGCTGATGAAATTAGCAAGAGAATCAAGGCCTTTAGTCC
C AC AATTCCCTC ATTTTGAAAATC AT AT C AAGACTTCTGTT GAT GAAGGGGC A
A A A AT T G AC C G AGGT AT A AG ATT C C T C C AT GAT C AG AT A AT G AGT GT G A A A A
CAGTGGATCTCACACTGGTGATTTATGGATCGTTCAGACATTGGGGTCATCCT
TTTATAGATTATTACACTGGACTAGAAAAATTACATTCCCAAGTAACCATGAA
GAAAGATATTGATGTGTCATATGCAAAAGCACTTGCAAGTGATTTAGCTCGG
ATTGTTCTATTTCAACAGTTCAATGATCATAAAAAGTGGTTCGTGAATGGAGA
CTTGCTCCCTCATGATCATCCCTTTAAAAGTCATGTTAAAGAAAATACATGGC
CCACAGCTGCTCAAGTTCAAGATTTTGGAGATAAATGGCATGAACTTCCGCTG
ATTAAATGTTTTGAAATACCCGACTTACTAGACCCATCGATAATATACTCTGA
C A A A AGTC ATT C A AT GA AT AGGT C AGAGGT GTTGA A AC AT GTCCGA AT GA AT
CCGAACACTCCTATCCCTAGTAAAAAGGTGTTGCAGACTATGTTGGACACAA
AGGCTACCAATTGGAAAGAATTTCTTAAAGAGATTGATGAGAAGGGCTTAGA
TGATGAT GATCT AATT ATT GGTCTT AAAGGAAAGGAGAGGGAACTGAAGTTG
GCAGGTAGATTTTTCTCCCTAATGTCTTGGAAATTGCGAGAATACTTTGTAAT TACCGAATATTTGATAAAGACTCATTTCGTCCCTATGTTTAAAGGCCTGACAA
TGGCGGACGATCTAACTGCAGTCATTAAAAAGATGTTAGATTCCTCATCCGGC
C AAGGATT GAAGT CAT ATGAGGC AATTT GC AT AGCC AAT C AC ATT GATT ACG
AAAAATGGAATAACCACCAAAGGAAGTTATCAAACGGCCCAGTGTTCCGAGT
TATGGGCCAGTTCTTAGGTTATCCATCCTTAATCGAGAGAACTCATGAATTTT
TT GAGAAAAGTCTT AT AT ACT AC AAT GGAAGACC AGACTTGAT GCGT GTT C A
CAACAACACACTGATCAATTCAACCTCCCAACGAGTTTGTTGGCAAGGACAA
G AGGGT GG AC T GG A AGGT C T AC GGC A A A A AGG AT GG AC T ATC C T C A AT C T AC
TGGTTATTCAAAGAGAGGCTAAAATCAGAAACACTGCTGTCAAAGTCTTGGC
ACAAGGTGATAATCAAGTTATTTGCACACAGTATAAAACGAAGAAATCGAGA
AACGTT GT AGAATT AC AGGGT GCTCTC AAT C AAAT GGTTTCT AAT AATGAGAA
AATT AT GACTGC AATC AA AAT AGGGAC AGGGAAGTT AGGACTTTT GAT AAAT
GACGATGAGACT AT GC AATCTGC AGATT ACTTGAATT AT GGAAAAAT ACCGA
TTTTCCGTGGAGTGATTAGAGGGTTAGAGACCAAGAGATGGTCACGAGTGAC
TTGTGTCACCAATGACCAAATACCCACTTGTGCTAATATAATGAGCTCAGTTT
CCACAAATGCTCTCACCGTAGCTCATTTTGCTGAGAACCCAATCAATGCCATG
ATACAGTACAATTATTTTGGGACATTTGCTAGACTCTTGTTGATGATGCATGA
TCCTGCTCTTCGTCAATCATTGTATGAAGTTCAAGATAAGATACCGGGCTTGC
ACAGTTCTACTTTCAAATACGCCATGTTGTATTTGGACCCTTCCATTGGAGGA
GTGTCGGGCATGTCTTTGTCCAGGTTTTTGATTAGAGCCTTCCCAGATCCCGT
AACAGAAAGTCTCTCATTCTGGAGATTCATCCATGTACATGCTCGAAGTGAGC
ATCTGAAGGAGAT GAGT GC AGT ATTTGGAAACCCCGAGAT AGCC AAGTTTCG
AATAACTCACATAGACAAGCTAGTAGAAGATCCAACCTCTCTGAACATCGCT
ATGGGAATGAGTCCAGCGAACTTGTTAAAGACTGAGGTTAAAAAATGCTTAA
TCGAATCAAGACAAACCATCAGGAACCAGGTGATTAAGGATGCAACCATATA
TTTGTATCATGAAGAGGATCGGCTCAGAAGTTTCTTATGGTCAATAAATCCTC
TGTTCCCTAGATTTTTAAGTGAATTCAAATCAGGCACTTTTTTGGGAGTCGCA
GACGGGCTCATCAGTCTATTTCAAAATTCTCGTACTATTCGGAACTCCTTTAA
G A A A A AGT ATC AT AGGG A ATT GG AT GAT T T GAT TGT G AGG AGT G AGGT ATC C
TCTTTGAC AC ATTT AGGGAAACTTC ATTTGAGAAGGGGAT CAT GT AAAAT GT G
GACATGTTCAGCTACTCATGCTGACACATTAAGATACAAATCCTGGGGCCGT
ACAGTTATTGGGACAACTGTACCCCATCCATTAGAAATGTTGGGTCCACAAC
ATCGAAAAGAGACTCCTTGTGCACCATGTAACACATCAGGGTTCAATTATGTT
TCTGTGCATTGTCCAGACGGGATCCATGACGTCTTTAGTTCACGGGGACCATT GCCTGCTTATCTAGGGTCTAAAACATCTGAATCTACATCTATTTTGCAGCCTT
GGGAAAGGGAAAGCAAAGTCCCACTGATTAAAAGAGCTACACGTCTTAGAG
ATGCTATCTCTTGGTTTGTTGAACCCGACTCTAAACTAGCAATGACTATACTT
TCTAACATCCACTCTTTAACAGGCGAAGAATGGACCAAAAGGCAGCATGGGT
TCAAAAGAACAGGGTCTGCCCTTCATAGGTTTTCGACATCTCGGATGAGCCAT
GGTGGGTTCGCATCTCAGAGCACTGCAGCATTGACCAGGTTGATGGCAACTA
CAGACACCATGAGGGATCTGGGAGATCAGAATTTCGACTTTTTATTCCAAGC
AACGTTGCTCTATGCTCAAATTACCACCACTGTTGCAAGAGACGGATGGATC
ACCAGTTGTACAGATCATTATCATATTGCCTGTAAGTCCTGTTTGAGACCCAT
AGAAGAGATCACCCTGGACTCAAGTATGGACTACACGCCCCCAGATGTATCC
CAT GT GC T G A AG AC AT GG AGG A AT GGGG A AGGT T C GT GGGG AC A AG AG AT A
AAACAGATCTATCCTTTAGAAGGGAATTGGAAGAATTTAGCACCTGCTGAGC
AATCCTATCAAGTCGGCAGATGTATAGGTTTTCTATATGGAGACTTGGCGTAT
AGAAAATCTACTCATGCCGAGGACAGTTCTCTATTTCCTCTATCTATACAAGG
TCGTATTAGAGGTCGAGGTTTCTTAAAAGGGTTGCTAGACGGATTAATGAGA
GCAAGTTGCTGCCAAGTAATACACCGGAGAAGTCTGGCTCATTTGAAGAGGC
CGGCCAACGCAGTGTACGGAGGTTTGATTTACTTGATTGATAAATTGAGTGTA
TCACCTCCATTCCTTTCTCTTACTAGATCAGGACCTATTAGAGACGAATTAGA
AACGATTCCCCACAAGATCCCAACCTCCTATCCGACAAGCAACCGTGATATG
GGGGTGATTGTCAGAAATTACTTCAAATACCAATGCCGTCTAATTGAAAAGG
GAAAATACAGATCACATTATTCACAATTATGGTTATTCTCAGATGTCTTATCC
ATAGACTTCATTGGACCATTCTCTATTTCCACCACCCTCTTGCAAATCCTATAC
AAGCCATTTTTATCTGGGAAAGATAAGAATGAGTTGAGAGAGCTGGCAAATC
TTTCTTC ATT GCT AAGAT C AGGAGAGGGGTGGGAAGAC AT AC ATGT GAAATT
CTTCACCAAGGACATATTATTGTGTCCAGAGGAAATCAGACATGCTTGCAAG
TTCGGGATTGCTAAGGATAATAATAAAGACATGAGCTATCCCCCTTGGGGAA
GGGAATCCAGAGGGACAATTACAACAATCCCTGTTTATTATACGACCACCCC
TTACCCAAAGATGCTAGAGATGCCTCCAAGAATCCAAAATCCCCTGCTGTCC
GGAATCAGGTTGGGCCAATTACCAACTGGCGCTCATTATAAAATTCGGAGTA
TATTACATGGAATGGGAATCCATTACAGGGACTTCTTGAGTTGTGGAGACGG
CTCCGGAGGGAT GACTGCTGC ATT ACT ACGAGAAAAT GT GC AT AGC AGAGGA
ATATTCAATAGTCTGTTAGAATTATCAGGGTCAGTCATGCGAGGCGCCTCTCC
TGAGCCCCCCAGTGCCCTAGAAACTTTAGGAGGAGATAAATCGAGATGTGTA
AAT GGTGAAAC AT GTT GGGAAT ATCC ATCTGACTT AT GT GACCC AAGGACTT GGGACTATTTCCTCCGACTCAAAGCAGGCTTGGGGCTTCAAATTGATTTAATT
GTAATGGATATGGAAGTTCGGGATTCTTCTACTAGCCTGAAAATTGAGACGA
ATGTTAGAAATTATGTGCACCGGATTTTGGATGAGCAAGGAGTTTTAATCTAC
A AG AC TT AT GGA AC AT AT ATTTGT GAGAGC GA A A AGA AT GC AGT A AC A AT C C
TTGGTCCCATGTTCAAGACGGTCGACTTAGTTCAAACAGAATTTAGTAGTTCT
C A A AC GT C T G A AGT AT AT AT GGT AT GT A A AGGTT T G A AG A A AT T A AT C GAT G
AACCCAATCCCGATTGGTCTTCCATCAATGAATCCTGGAAAAACCTGTACGCA
TTCCAGTCATCAGAACAGGAATTTGCCAGAGCAAAGAAGGTTAGTACATACT
TTACCTTGACAGGTATTCCCTCCCAATTCATTCCTGATCCTTTTGTAAACATTG
AGACTATGCTACAAATATTCGGAGTACCCACGGGTGTGTCTCATGCGGCTGCC
TTAAAATCATCTGATAGACCTGCAGATTTATTGACCATTAGCCTTTTTTATATG
GCGATT AT ATCGT ATT AT AAC AT C AAT CAT AT C AG AGT AGGACCGAT ACCTCC
GAACCCCCCATCAGATGGAATTGCACAAAATGTGGGGATCGCTATAACTGGT
ATAAGCTTTTGGCTGAGTTTGATGGAGAAAGACATTCCACTATATCAACAGTG
TTTAGCAGTTATCCAGCAATCATTCCCGATTAGGTGGGAGGCTGTTTCAGTAA
AAGGAGGAT AC AAGC AGAAGT GGAGT ACT AGAGGT GATGGGCTCCC AAAAG
ATACCCGAACTTCAGACTCCTTGGCCCCAATCGGGAACTGGATCAGATCTCTG
GAATTGGTCCGAAACCAAGTTCGTCTAAATCCATTCAATGAGATCTTGTTCAA
T C AGCT AT GTCGT AC AGTGGAT AAT C ATTT GAAAT GGT C AAATTT GCGA AGAA
AC AC AGGAAT GATT GAAT GGAT C AAT AGACGAATTTC AAAAGAAGACCGGT C
T AT AC T GAT GT T G A AG AGT G AC C T AC AC G AGG A A A AC TC TT GG AG AG AT T A A
AAAATCATGAGGAGACTCCAAACTTTAAGTATGAAAAAAACTTTGATCCTTA
AGACCCTCTTGTGGTTTTTATTTTTTATCTGGTTTTGTGGTCTTCGTGGGTCGG
CATGGCATCTCCACCTCCTCGCGGTCCGACCTGGGCATCCGAAGGAGGACGC
ACGTCCACTCGGATGGCTAAGGGAGAGCCAGAAAATAACTAGTGGATCCGGC
TGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAA
TAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCT
GAAAGtCGCGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTT
ATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGC
CTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGC
CCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAA
CGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCAC
TGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAA
AGGC GGT AAT ACGGTT AT C C AC AGA AT C AGGGGAT AAC GC AGG A A AGA AC A TGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGC
TGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGC
T C AAGTC AGAGGT GGCGA AACCCGAC AGGACT AT AAAGAT ACC AGGCGTTT C
CCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGA
TACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACG
CTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGC
ACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTT
GAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTA
ACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTG
GTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGC
TGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACA
AACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCA
GAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCT
C AGT GGA AC GA A A ACTC AC GTT A AGGGATTTT GGT CAT GAGATT AT C A A A A A
GGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAA
AGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGC
ACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGT
CGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACC
AGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTC
CATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTA
ATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCG
TCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTAC
ATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCG
TTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTG
CATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGA
GTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTT
GCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGT
GCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCA
TCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATG
CCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTT
CCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATA CAT ATTTGAAT GT ATTT AGAAAAAT AAAC AAAT AGGGGTTCCGCGC AC ATTT C CCCGAAAAGTGCCAC.
In one embodiment, the nucleic acid comprises (a) a sequence encoding at least a portion of the genome of a rabies virus and (b) a sequence encoding a protein comprising a SARS-CoV-2 spike protein (S) or a portion thereof. In some embodiments, the at least a portion of the genome of the rabies virus comprises an N gene and a P gene, and the sequence encoding the protein comprising the SARS-CoV-2 spike protein (S) or portion thereof is inserted into a position between the N gene and P gene. In some embodiments, the protein comprising a SARS-CoV-2 spike protein (S) or a portion thereof is a fusion protein comprising a glycoprotein (G) or a portion thereof and a SARS-CoV-2 spike protein (S) or a portion thereof. In some embodiments, the fusion protein comprises a glycoprotein (G) or portion thereof fused to the SI domain of a SARS-CoV-2 spike protein (S).
In another embodiment, the nucleic acid comprises the sequence of SEQ ID NO:
2, shown below:
CTGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCG
CAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCT
TCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGG
GGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAA
CTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTT
TCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAA
CTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATT
TTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAA
CGCGAATTTTAACAAAATATTAACGCTTACAATTTCCATTCGCCATTCAGGCT
GCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAG
CTGGCGAA AGGGGGAT GT GCTGC AAGGCGATT AAGTT GGGT AACGCC AGGGT
TTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAGcgcgccCTAGTTATTAA
TAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCGCGT
TACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGC
CCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTT
CC ATT GACGT C AAT GGGT GGAGT ATTT ACGGT AAACTGCCC ACTT GGC AGT AC
ATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAA
ATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTT
GGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGG C AGT AC AT C A AT GGGC GT GG AT AGC GGTTT GACTC AC GGGGATTTCC A AGT C
TCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC
TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGC
GTGTACGGTGGGAGGTCTATATAAGCAGAGCTCTCTGGCTAACTAGAGAACC
CACTGCTTACTGGCTTATCGAAATTAATACGACTCACTATAGGGAGACCCAA
GCTGGCTAGATTAAGCGTCTGATGAGTCCGTGAGGACGAAACCCGGCGTACC
GGGTCACGCTTAACAACCAGATCAAAGAAAAAACAGACATTGTCAATTGCAA
AGCAAAAATGTAACACCCCTACAATGGATGCCGACAAGATTGTATTCAAAGT
CAATAATCAGGTGGTCTCTTTGAAGCCTGAGATTATCGTGGATCAATATGAGT
ACAAGTACCCTGCCATCAAAGATTTGAAAAAGCCCTGTATAACCCTAGGAAA
GGCTCCCGATTTAAATAAAGCATACAAGTCAGTTTTGTCAGGCATGAGCGCC
GCCAAACTTAATCCTGACGATGTATGTTCCTATTTGGCAGCGGCAATGCAGTT
TTTTGAGGGGACATGTCCGGAAGACTGGACCAGCTATGGAATTGTGATTGCA
CGAAAAGGAGATAAGATCACCCCAGGTTCTCTGGTGGAGATAAAACGTACTG
AT GT AGAAGGGAATT GGGCTCTGAC AGGAGGC ATGGAACTGAC AAGAGACC
CCACTGTCCCTGAGCATGCGTCCTTAGTCGGTCTTCTCTTGAGTCTGTATAGGT
T GAGC AAAAT ATCCGGGC AAAAC ACTGGT AACT AT AAGAC AAAC ATTGC AGA
CAGGATAGAGCAGATTTTTGAGACAGCCCCTTTTGTTAAAATCGTGGAACAC
CATACTCTAATGACAACTCACAAaATGTGTGCTAATTGGAGTACTATACCAAA
CTTCAGATTTTTGGCCGGAACCTATGACATGTTTTTCTCCCGGATTGAGCATCT
ATATTCAGCAATCAGAGTGGGCACAGTTGTCACTGCTTATGAAGACTGTTCAG
GACTGGTATCATTTACTGGGTTCATAAAACAAATCAATCTCACCGCTAGAGA
GGCAATACTATATTTCTTCCACAAGAACTTTGAGGAAGAGATAAGAAGAATG
TTTGAGCCAGGGCAGGAGACAGCTGTTCCTCACTCTTATTTCATCCACTTCCG
TTCACTAGGCTTGAGTGGGAAATCTCCTTATTCATCAAATGCTGTTGGTCACG
TGTTCAATCTCATTCACTTTGTAGGATGCTATATGGGTCAAGTCAGATCCCTA
AATGCAACGGTTATTGCTGCATGTGCTCCTCATGAAATGTCTGTTCTAGGGGG
CTATCTGGGAGAGGAATTCTTCGGGAAAGGGACATTTGAAAGAAGATTCTTC
AGAGATGAGAAAGAACTTCAAGAATACGAGGCGGCTGAACTGACAAAGACT
GACGTAGCACTGGCAGATGATGGAACTGTCAACTCTGACGACGAGGACTACT
TTTCAGGTGAAACCAGAAGTCCGGAGGCTGTTTATACTCGAATCATGATGAA
T GGAGGTCGACT AAAGAGATCTC AC AT ACGGAGAT ATGTCTC AGT C AGTTCC
AATCATCAAGCCCGTCCAAACTCATTCGCCGAGTTTCTAAAC AAGAC ATATTC
GAGTGACTCATAAcatgaaaaaaactaacacccctcccGTACGCCACCATGTTCGTGTTTCT GGTGCTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAACCTGACCACAAGGACC
CAGCTGCCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACTATCCCGA
CAAGGTGTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTTCTGCCTT
TCTTTTCTAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCACCAATGGC
ACAAAGCGGTTCGACAATCCAGTGCTGCCCTTTAACGATGGCGTGTACTTCGC
CTCCACCGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCACCACACTG
GACAGCAAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAACGTGGTCA
TCAAGGTGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGTGTACTAT
CACAAGAACAATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTATTCCTCTG
CCAACAATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGACCTGGAG
GGC AAGC AGGGC AATTT C AAGAACCTGAGGGAGTTCGT GTTT AAGAAT ATCG
ATGGCTACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGTGCGCGA
CCTGCCACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCATCGGCA
TCAACATCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTACCTGAC
ACCAGGCGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTACTATGTG
GGCTATCTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATGGCACCA
TCACAGACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAAGTGTAC
ACTGAAGAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAATTTCAGG
GTGCAGCCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCTGTGCCC
TTTTGGCGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCTGGAATA
GGAAGCGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAACAGCGC
CTCCTTCTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGAATGACC
TGTGCTTTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGACGAGGTG
CGCCAGATCGCACCAGGACAGACAGGCAAGATCGCAGACTACAATTATAAGC
TGCCTGACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAATCTGGAT
AGCAAAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGAAAGTCTA
ATCTGAAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGGCCGGCTC
TACCCCCTGCAATGGCGTGGAgGGCTTTAACTGTTATTTCCCTCTGCAGAgCTA
CgGCTTCCAGCCAACAAACGGCGTGGGCTATCAGCCCTACCGCGTGGTGGTGC
TGTCTTTTGAGCTGCTGCACGCACcTGCAACAGTGTGCGGACCAAAGAAGAGC
ACCAATCTGGTGAAGAACAAGTGCGTGAACTTCAACTTCAACGGACTGACCG
GAACAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTTCAGCAGTT
CGGCAGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCTCAGACCCTG
GAGATCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGTGATCACACC AGGCACCAATACAAGCAACCAGGTGGCCGTGCTGTATCAGGACGTGAATTGT
ACCGAGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTACATGGCGGG
TGTACTCTACCGGCAGCAACGTGTTCCAGACAAGAGCCGGATGCCTGATCGG
AGCAGAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATCGGCGCCGGC
ATCTGTGCCTCCTACCAGACCCAGACAAACTCCCCAAGGTCTGTGGGAGATG
AGGCCGAAGACTTTGTGGAAGTCCACCTGCCTGATGTGCATAACCAGGTGTC
TGGCGTCGACCTGGGACTGCCAAATTGGGGCAAGTACGTGCTGCTGAGTGCT
GGAGCACTGACTGCCCTGATGCTGATCATTTTCCTGATGACCTGCTGTCGGCG
CGTGAACAGAAGTGAGCCCACTCAGCACAATCTGCGAGGAACCGGGAGAGA
AGTGTCAGTCACACCTCAGAGCGGGAAAATCATTAGTAGTTGGGAATCACAT
AAAAGCGGGGGCGAGACCAGGCTGTGAGCTAGCCATGAAAAAAACTAACAC
CCCTCCTTTCGAACCATCCCAAACATGAGCAAGATCTTTGTCAATCCTAGTGC
TATTAGAGCCGGTCTGGCCGATCTTGAGATGGCTGAAGAAACTGTTGATCTG
AT C A AT AGA A AT ATCGA AGAC A AT C AGGCTC ATCTC C A AGGGGA ACC C AT AG
AGGTGGACAATCTCCCTGAGGATATGGGGCGACTTCACCTGGATGATGGAAA
ATCGCCC AACC AT GGT GAG AT AGCC AAGGTGGGAGAAGGC AAGT ATCGAGA
GGACTTTCAGATGGATGAAGGAGAGGATCCTAGCTTCCTGTTCCAGTCATACC
T GGA A A AT GTT GGAGT C C A A AT AGT C AGAC A A AT GAGGT C AGG AGAGAGATT
TCTCAAGATATGGTCACAGACCGTAGAAGAGATTATATCCTATGTCGCGGTC
AACTTTCCCAACCCTCCAGGAAAGTCTTCAGAGGATAAATCAACCCAGACTA
CTGGCCGAGAGCTC AAGAAGGAGAC AAC ACCC ACTCCTTCTC AGAGAGA AAG
CCAATCATCGAAAGCCAGGATGGCGGCTCAAATTGCTTCTGGCCCTCCAGCC
CTTGAATGGTCGGCTACCAATGAAGAGGATGATCTATCAGTGGAGGCTGAGA
TCGCTCACCAGATTGCAGAAAGTTTCTCCAAAAAATATAAGTTTCCCTCTCGA
TCCTCAGGGATACTCTTGTATAATTTTGAGCAATTGAAAATGAACCTTGATGA
TATAGTTAAAGAGGCAAAAAATGTACCAGGTGTGACCCGTTTAGCCCATGAC
GGGTCCAAACTCCCCCTAAGATGTGTACTGGGATGGGTCGCTTTGGCCAACTC
TAAGAAATTCCAGTTGTTAGTCGAATCCGACAAGCTGAGTAAAATCATGCAA
GATGACTTGAATCGCTATACATCTTGCTAACCGAACCTCTCCCCTCAGTCCCT
CTAGACAATAAAATCCGAGATGTCCCAAAGTCAACATGAAAAAAACAGGCA
ACACCACTGATAAAATGAACCTCCTACGTAAGATAGTGAAAAACCGCAGGGA
CGAGGACACTCAAAAATCCTCTCCCGCGTCAGCCCCTCTGGATGACGATGAC
TTGTGGCTTCCACCCCCTGAATACGTCCCGCTGAAAGAACTTACAGGCAAGA
AGAACATGAGGAACTTTTGTATCAACGGAAGGGTTAAAGTGTGTAGCCCGAA TGGTTACTCGTTCAGGATCCTGCGGCACATTCTGAAATCATTCGACGAGATAT
ATTCTGGGAATCATAGGATGATCGGGTTAGTCAAAGTGGTTATTGGACTGGCT
TTGTCAGGATCTCCAGTCCCTGAGGGCCTGAACTGGGTATACAAATTGAGGA
GAACCTTTATCTTCCAGTGGGCTGATTCCAGGGGCCCTCTTGAAGGGGAGGA
GT T GG A AT AC T C T C AGG AG AT C AC TT GGG AT GAT GAT ACT G AGT T C GT C GG AT
T GCA A AT A AGAGT GATT GC A A A AC AGT GT CAT AT C C AGGGC AGAGTCTGGT G
TATCAACATGAACCCGAGAGCATGTCAACTATGGTCTGACATGTCTCTTCAGA
CACAAAGGTCCGAAGAGGACAAAGATTCCTCTCTGCTTCTAGAATAATCAGA
TTATATCCCGCAAATTTATCACTTGTTTACCTCTGGAGGAGAGAACATATGGG
CTCAACTCCAACCCTTGGGAGCAATATAACAAAAAACATGTTATGGTGCCAT
TAAACCGCTGCATTTCATCAAAGTCAAGTTGATTACCTTTACATTTTGATCCTC
TTGGATGTGAAAAAAACTATTAACATCCCTCAAAAGACcccgggAAAGATGGTT
CCTCAGGCTCTCCTGTTTGTACCCCTTCTGGTTTTTCCATTGTGTTTTGGGAAA
TTCCCTATTTACACGATACCAGACAAGCTTGGTCCCTGGAGTCCGATTGACAT
ACATCACCTCAGCTGCCCAAACAATTTGGTAGTGGAGGACGAAGGATGCACC
AACCTGTCAGGGTTCTCCTACATGGAACTTAAAGTTGGATACATCTTAGCCAT
A A A AGT GA AC GGGTT C AC TT GC AC AGGC GTT GT GACGGAGGC T GA A AC CT AC
ACTAACTTCGTTGGTTATGTCACAACCACGTTCAAAAGAAAGCATTTCCGCCC
AACACCAGATGCATGTAGAGCCGCGTACAACTGGAAGATGGCCGGTGACCCC
AGATATGAAGAGTCTCTACACAATCCGTACCCTGACTACCGCTGGCTTCGAAC
TGTAAAAACCACCAAGGAGTCTCTCGTTATCATATCTCCAAGTGTGGCAGATT
TGGACCCATATGACAGATCCCTTCACTCGAGGGTCTTCCCTAGCGGGAAGTGC
TCAGGAGTAGCGGTGTCTTCTACCTACTGCTCCACTAACCACGATTACACCAT
TTGGATGCCCGAGAATCCGAGACTAGGGATGTCTTGTGACATTTTTACCAATA
GT AGAGGGAAGAGAGC ATCC AAAGGGAGT GAGACTT GCGGCTTTGT AGAT G
AAAGAGGCCTATATAAGTCTTTAAAAGGAGCATGCAAACTCAAGTTATGTGG
AGTTCTAGGACTTAGACTTATGGATGGAACATGGGTCTCGATGCAAACATCA
AATGAAACCAAATGGTGCCCTCCCGATAAGTTGGTGAACCTGCACGACTTTC
GCTC AGACGAAATTGAGC ACCTT GTT GT AGAGGAGTTGGT C AGGAAGAGAGA
GGAGT GTCTGGAT GC AC T AGAGT C CAT CAT GAC A AC C A AGT C AGT GAGTTT C
AGACGTCTCAGTCATTTAAGAAAACTTGTCCCTGGGTTTGGAAAAGCATATAC
CAT ATT C A AC A AGAC CTT GAT GGA AGCC GAT GCTC AC T AC A AGT C AGT Cgag A
CTTGGAATGAGATCCTCCCTTCAAAAGGGTGTTTAAGAGTTGGGGGGAGGTG
TCATCCTCATGTGAACGGGGTGTTTTTCAATGGTATAATATTAGGACCTGACG GCAATGTCTTAATCCCAGAGATGCAATCATCCCTCCTCCAGCAACATATGGAG
TTGTTGGAATCCTCGGTTATCCCCCTTGTGCACCCCCTGGCAGACCCGTCTAC
CGTTTTCAAGGACGGTGACGAGGCTGAGGATTTTGTTGAAGTTCACCTTCCCG
ATGTGCACAATCAGGTCTCAGGAGTTGACTTGGGTCTCCCGAACTGGGGGAA
GTATGTATTACTGAGTGCAGGGGCCCTGACTGCCTTGATGTTGATAATTTTCC
T GAT GAC AT GTT GT AGA AGAGT C A ATCGAT C AGA AC CT ACGC A AC AC A ATCT
CAGAGGGACAGGGAGGGAGGTGTCAGTCACTCCCCAAAGCGGGAAGATCAT
ATCTT CAT GGGAAT C AC AC AAGAGT GGGGGTGAGACC AGACTGT AAttaattaaCG
TCCTTTCAACGATCCAAGTCcatgaaaaaaactaacacccctcccgtacctagcTTATAAAGTGCT
GGGT C ATCT AAGCTTTTCAGTCGAGAAAAAAAC ATT AGATCAGAAGAACAAC
TGGCAACACTTCTCAACCTGAGACTTACTTCAAGATGCTCGATCCTGGAGAGG
TCTATGATGACCCTATTGACCCAATCGAGTTAGAGGCTGAACCCAGAGGAAC
CCCCATTGTCCCCAACATCTTGAGGAACTCTGACTACAATCTCAACTCTCCTT
T GAT AG A AG AT C C T GC T AG AC T A AT GT T AG A AT GGTT A A A A AC AGGG A AT AG
ACCTTATCGGATGACTCTAACAGACAATTGCTCCAGGTCTTTCAGAGTTTTGA
AAGATTATTTCAAGAAGGTAGATTTGGGTTCTCTCAAGGTGGGCGGAATGGC
TGCACAGTCAATGATTTCTCTCTGGTTATATGGTGCCCACTCTGAATCCAACA
GGAGCCGGAGATGTATAACAGACTTGGCCCATTTCTATTCCAAGTCGTCCCCC
ATAGAGAAGCTGTTGAATCTCACGCTAGGAAATAGAGGGCTGAGAATCCCCC
C AGAGGGAGT GTT A AGTT GCC TT GAGAGGGTT GATT AT GAT A AT GC ATTTGG
AAGGTATCTTGCCAACACGTATTCCTCTTACTTGTTCTTCCATGTAATCACCTT
ATACATGAACGCCCTAGACTGGGATGAAGAAAAGACCATCCTAGCATTATGG
AAAGATTTAACCTCAGTGGACATCGGGAAGGACTTGGTAAAGTTCAAAGACC
AAATATGGGGACTGCTGATCGTGACAAAGGACTTTGTTTACTCCCAAAGTTCC
AATTGTCTTTTTGACAGAAACTACACACTTATGCTAAAAGATCTTTTCTTGTCT
CGCTTCAACTCCTTAATGGTCTTGCTCTCTCCCCCAGAGCCCCGATACTCAGA
TGACTTGATATCTCAACTATGCCAGCTGTACATTGCTGGGGATCAAGTCTTGT
CTATGTGTGGAAACTCCGGCTATGAAGTCATCAAAATATTGGAGCCATATGTC
GTGAATAGTTTAGTCCAGAGAGCAGAAAAGTTTAGGCCTCTCATTCATTCCTT
GGG AG AC TT TC C T GT AT TT AT A A A AG AC A AGGT A AGT C A AC TT G A AG AG AC G
TTCGGTCCCTGTGCAAGAAGGTTCTTTAGGGCTCTGGATCAATTCGACAACAT
ACATGACTTGGTTTTTGTGTTTGGCTGTTACAGGCATTGGGGGCACCCATATA
TAGATTATCGAAAGGGTCTGTCAAAACTATATGATCAGGTTCACCTTAAAAA
A AT GAT AG AT A AGTCC T AC C AGGAGT GC TT AGC A AGC GACC T AGC C AGGAGG ATCCTTAGATGGGGTTTTGATAAGTACTCCAAGTGGTATCTGGATTCAAGATT
CCTAGCCCGAGACCACCCCTTGACTCCTTATATCAAAACCCAAACATGGCCAC
CCAAACATATTGTAGACTTGGTGGGGGATACATGGCACAAGCTCCCGATCAC
GCAGATCTTTGAGATTCCTGAATCAATGGATCCGTCAGAAATATTGGATGAC
AAATCACATTCTTTCACCAGAACGAGACTAGCTTCTTGGCTGTCAGAAAACCG
AGGGGGGCCTGTTCCTAGCGAAAAAGTTATTATCACGGCCCTGTCTAAGCCG
CCTGTCAATCCCCGAGAGTTTCTGAGGTCTATAGACCTCGGAGGATTGCCAGA
TGAAGACTTGATAATTGGCCTCAAGCCAAAGGAACGGGAATTGAAGATTGAA
GGTCGATTCTTTGCTCTAATGTCATGGAATCTAAGATTGTATTTTGTCATCACT
GAAAAACTCTTGGCCAACTACATCTTGCCACTTTTTGACGCGCTGACTATGAC
AGACAACCTGAACAAGGTGTTTAAAAAGCTGATCGACAGGGTCACCGGGCAA
GGGCTTTTGGACTATTCAAGGGTCACATATGCATTTCACCTGGACTATGAAAA
GT GGAAC AACC AT C A AAGATT AGAGT C AAC AGAGGAT GT ATTTTCTGTCCT A
GATCAAGTGTTTGGATTGAAGAGAGTGTTTTCTAGAACACACGAGTTTTTTCA
AAAGGCCTGGATCTATTATTCAGACAGATCAGACCTCATCGGGTTACGGGAG
GATCAAATATACTGCTTAGATGCGTCCAACGGCCCAACCTGTTGGAATGGCC
AGGATGGCGGGCTAGAAGGCTTACGGCAGAAGGGCTGGAGTCTAGTCAGCTT
ATTGAT GAT AG AT AGAG A AT C TC A A AT C AGGA AC AC A AGA AC C A A A AT AC T A
GCTCAAGGAGACAACCAGGTTTTATGTCCGACATACATGTTGTCGCCAGGGC
T ATC T C A AG AGGGGC TCCTCTAT G A AT T GG AG AG A AT AT C A AGGA AT GC AC T
TTCGATATACAGAGCCGTCGAGGAAGGGGCATCTAAGCTAGGGCTGATCATC
AAGAAAGAAGAGACCATGTGTAGTTATGACTTCCTCATCTATGGAAAAACCC
CTTT GTTT AGAGGT A AC AT ATT GGT GCC T GAGT C C A A A AG AT GGGC C AGAGT
CTCTTGCGTCTCTAATGACCAAATAGTCAACCTCGCCAATATAATGTCGACAG
TGTCCACCAATGCGCTAACAGTGGCACAACACTCTCAATCTTTGATCAAACCG
ATGAGGGATTTTCTGCTCATGTCAGTACAGGCAGTCTTTCACTACCTGCTATT
T AGCCC AATCTT AAAGGGA AGAGTTT AC AAGATTCTGAGCGCTGAAGGGGAG
AGCTTTCTCCTAGCCATGTCAAGGATAATCTATCTAGATCCTTCTTTGGGAGG
GATATCTGGAATGTCCCTCGGAAGATTCCATATACGACAGTTCTCAGACCCTG
TCTCTGAAGGGTTATCCTTCTGGAGAGAGATCTGGTTAAGCTCCCAAGAGTCC
T GGATT C ACGCGTT GT GT C AAGAGGCTGGAAACCC AGATCTTGGAGAGAGAA
CACTCGAGAGCTTCACTCGCCTTCTAGAAGATCCGACCACCTTAAATATCAGA
GGAGGGGCCAGTCCTACCATTCTACTCAAGGATGCAATCAGAAAGGCTTTAT
AT GACGAGGT GGAC AAGGTGGAAAATT C AGAGTTTCGAGAGGC AATCCTGTT GTCCAAGACCCATAGAGATAATTTTATACTCTTCTTAATATCTGTTGAGCCTC
TGTTTCCTCGATTTCTCAGTGAGCTATTCAGTTCGTCTTTTTTGGGAATCCCCG
AGTCAATCATTGGATTGATACAAAACTCCCGAACGATAAGAAGGCAGTTTAG
AAAGAGTCTCTCAAAAACTTTAGAAGAATCCTTCTACAACTCAGAGATCCAC
GGGATTAGTCGGATGACCCAGACACCTCAGAGGGTTGGGGGGGTGTGGCCTT
GCTCTTCAGAGAGGGCAGATCTACTTAGGGAGATCTCTTGGGGAAGAAAAGT
GGTAGGCACGACAGTTCCTCACCCTTCTGAGATGTTGGGATTACTTCCCAAGT
CCTCTATTTCTTGCACTTGTGGAGCAACAGGAGGAGGCAATCCTAGAGTTTCT
GTATCAGTACTCCCGTCCTTTGATCAGTCATTTTTTTCACGAGGCCCCCTAAA
GGGATACTTGGGCTCGTCCACCTCTATGTCGACCCAGCTATTCCATGCATGGG
A A A A AGT C AC T A AT GT TC AT GT GGT G A AG AG AGC TC T AT C GT T A A A AG A AT C
TATAAACTGGTTCATTACTAGAGATTCCAACTTGGCTCAAGCTCTAATTAGGA
ACATTATGTCTCTGACAGGCCCTGATTTCCCTCTAGAGGAGGCCCCTGTCTTC
AAAAGGACGGGGTCAGCCTTGCATAGGTTCAAGTCTGCCAGATACAGCGAAG
GAGGGTATTCTTCTGTCTGCCCGAACCTCCTCTCTCATATTTCTGTTAGTACAG
ACACCATGTCTGATTTGACCCAAGACGGGAAGAACTACGATTTCATGTTCCA
GCC ATT GATGCTTT ATGC AC AGAC ATGGAC AT C AGAGCTGGT AC AG AG AG AC
ACAAGGCTAAGAGACTCTACGTTTCATTGGCACCTCCGATGCAACAGGTGTG
TGAGACCCATTGACGACGTGACCCTGGAGACCTCTCAGATCTTCGAGTTTCCG
GATGTGTCGAAAAGAATATCCAGAATGGTTTCTGGGGCTGTGCCTCACTTCCA
GAGGCTTCCCGATATCCGTCTGAGACCAGGAGATTTTGAATCTCTAAGCGGTA
GAGAAAAGTCTCACCATATCGGATCAGCTCAGGGGCTCTTATACTCAATCTTA
GTGGCAATTCACGACTCAGGATACAATGATGGAACCATCTTCCCTGTCAACAT
ATACGGCAAGGTTTCCCCTAGAGACTATTTGAGAGGGCTCGCAAGGGGAGTA
TTGATAGGATCCTCGATTTGCTTCTTGACAAGAATGACAAATATCAATATTAA
TAGACCTCTTGAATTGGTCTCAGGGGTAATCTCATATATTCTCCTGAGGCTAG
ATAACCATCCCTCCTTGTACATAATGCTCAGAGAACCGTCTCTTAGAGGAGAG
ATATTTTCTATCCCTCAGAAAATCCCCGCCGCTTATCCAACCACTATGAAAGA
AGGCAACAGATCAATCTTGTGTTATCTCCAACATGTGCTACGCTATGAGCGAG
AGATAATCACGGCGTCTCCAGAGAATGACTGGCTATGGATCTTTTCAGACTTT
AGAAGTGCCAAAATGACGTACCTATCCCTCATTACTTACCAGTCTCATCTTCT
ACTCC AGAGGGTTGAGAGAAACCT ATCT AAGAGT AT GAGAGAT A ACCTGCGA
CAATTGAGTTCTTTGATGAGGCAGGTGCTGGGCGGGCACGGAGAAGATACCT
TAGAGTCAGACGACAACATTCAACGACTGCTAAAAGACTCTTTACGAAGGAC AAGAT GGGTGGATC AAGAGGT GCGCC ATGC AGCT AGAACC AT GACTGGAGAT
T AC AGCCCC AAC AAGAAGGT GTCCCGT AAGGT AGGATGTT C AGAAT GGGTCT
GCTCTGCTCAACAGGTTGCAGTCTCTACCTCAGCAAACCCGGCCCCTGTCTCG
GAGCTTGACATAAGGGCCCTCTCTAAGAGGTTCCAGAACCCTTTGATCTCGGG
CTTGAGAGTGGTTCAGTGGGCAACCGGTGCTCATTATAAGCTTAAGCCTATTC
TAGATGATCTCAATGTTTTCCCATCTCTCTGCCTTGTAGTTGGGGACGGGTCA
GGGGGGATATCAAGGGCAGTCCTCAACATGTTTCCAGATGCCAAGCTTGTGT
TCAACAGTCTTTTAGAGGTGAATGACCTGATGGCTTCCGGAACACATCCACTG
CCTCCTTCAGCAATCATGAGGGGAGGAAATGATATCGTCTCCAGAGTGATAG
ATCTTGACTCAATCTGGGAAAAACCGTCCGACTTGAGAAACTTGGCAACCTG
GAAATACTTCCAGTCAGTCCAAAAGCAGGTCAACATGTCCTATGACCTCATTA
TTTGCGATGCAGAAGTTACTGACATTGCATCTATCAACCGGATCACCCTGTTA
ATGTCCGATTTTGCATTGTCTATAGATGGACCACTCTATTTGGTCTTCAAAACT
TATGGGACTATGCTAGTAAATCCAAACTACAAGGCTATTCAACACCTGTCAA
GAGCGTTCCCCTCGGTCACAGGGTTTATCACCCAAGTAACTTCGTCTTTTTCA
TCTGAGCTCTACCTCCGATTCTCCAAACGAGGGAAGTTTTTCAGAGATGCTGA
GTACTTGACCTCTTCCACCCTTCGAGAAATGAGCCTTGTGTTATTCAATTGTA
GCAGCCCCAAGAGTGAGATGCAGAGAGCTCGTTCCTTGAACTATCAGGATCT
TGTGAGAGGATTTCCTGAAGAAATCATATCAAATCCTTACAATGAGATGATC
ATAACTCTGATTGACAGTGATGTAGAATCTTTTCTAGTCCACAAGATGGTTGA
TGATCTTGAGTTACAGAGGGGAACTCTGTCTAAAGTGGCTATCATTATAGCCA
TCATGATAGTTTTCTCCAACAGAGTCTTCAACGTTTCCAAACCCCTAACTGAC
CCCTCGTTCTATCCACCGTCTGATCCCAAAATCCTGAGGCACTTCAACATATG
TTGCAGTACTATGATGTATCTATCTACTGCTTTAGGTGACGTCCCTAGCTTCGC
AAGACTTCACGACCTGTATAACAGACCTATAACTTATTACTTCAGAAAGCAA
GTCATTCGAGGGAACGTTTATCTATCTTGGAGTTGGTCCAACGACACCTCAGT
GTTCAAAAGGGTAGCCTGTAATTCTAGCCTGAGTCTGTCATCTCACTGGATCA
GGTTGATTTACAAGATAGTGAAGACTACCAGACTCGTTGGCAGCATCAAGGA
TCT ATCC AGAGAAGT GGAAAGAC ACCTT CAT AGGT AC AAC AGGTGGAT C ACC
CTAGAGGATATCAGATCTAGATCATCCCTACTAGACTACAGTTGCCTGTGAAC
CGGATACTCCTGGAAGCCTGCCCATGCTAAGACTCTTGTGTGATGTATCTTGA
AAAAAAC AAGATCCT AAATCTGAACCTTTGGTT GTTT GATT GTTTTTCTC Atttttg ttgtttatttgttaagcgtGGGTCGGCATGGCATCTCCACCTCCTCGCGGTCCGACCTGGGC
ATCCGAAGGAGGACGCACGTCCACTCGGATGGCTAAGGGAGagccagaaGGATC CGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGA
GCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTT
T GCTGAAAGtCGCGCTT GGCGT AAT CAT GGT CAT AGCTGTTTCCTGTGT GAAA
TTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGT
AAAGCCTGGGGT GCCT AAT GAGTGAGCT A ACTC AC ATT AATT GCGTTGCGCTC
ACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCG
GCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTaCGCTTCCTCG
CTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCA
CTC AAAGGCGGT AAT ACGGTT ATCC AC AGAAT C AGGGGAT AACGC AGGAAA
GAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGC
GTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATC
GAC GCTC A AGT C AGAGGT GGC GA A AC CCG AC AGGAC T AT A A AG AT ACC AGG
CGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTA
CCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGC
TCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTG
TGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATC
GTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCAC
TGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTG
AAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCG
CTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGC
AAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTAC
GCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCT
GAC GCTC AGT GGAACGAA AACTC ACGTT AAGGGATTTT GGT C ATGAGATT AT
CAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAG
TGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACT
CCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGT
GCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAA
T AAACC AGCC AGCCGGAAGGGCCGAGCGC AGAAGT GGTCCTGC AACTTT ATC
CGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGC
CAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCA
CGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCG
AGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTC
CGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCA GCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACT
GGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTT
GCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTT
AAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATC
TTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATC
TTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGC
A A A AT GCC GC A A A A A AGGGA AT A AGGGC GAC AC GGA A AT GTT GA AT ACTC A
TACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGA
GCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCG
CACATTTCCCCGAAAAGTGCCAC.
In one embodiment, the nucleic acid comprises a sequence encoding at least a portion of the genome of a measles virus and (b) a sequence encoding a SARS-CoV-2 spike protein (S) or a portion thereof. In some embodiments, the sequence encoding the SARS-CoV-2 spike protein (S) or portion thereof is inserted into position 2, 3, or 6 of the genome of the measles virus.
In one embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 3, shown below:
GGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGC
AGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTT
CCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGG
GGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAA
CTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTT
TCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAA
CTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATT
TTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAA
CGCGAATTTTAACAAAATATTAACGTTTACAATTTCGCGCCATTCGCCATTCA
GGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACG
CCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCA
GGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGCGCGCCGTTAAT
ACGACTCACTATAGGGAGACCCAAGCTGGCTAGCTTTGTTTGGTCTGATGAGT
CCCGTGAGGACGAAACCCGGCGTACCGGGTCACCAAACAAAGTTGGGTAAG
GATAGTTCAATCAATGATCATCTTCTAGTGCACTTAGGATTCAAGATCCTATT
AT C AGGGAC AAGAGC AGGATT AGGGAT ATCCGAGAT GGCC AC ACTTTT A AGG
AGCTTAGCATTGTTCAAAAGAAACAAGGACAAACCACCCATTACATCAGGAT CCGGTGGAGCCATCAGAGGAATCAAACACATTATTATAGTACCAATCCCTGG
AGATTCCTCAATTACCACTCGATCCAGACTTCTGGACCGGTTGGTGAGGTTAA
TTGGAAACCCGGATGTGAGCGGGCCCAAACTAACAGGGGCACTAATAGGTAT
ATTATCCTTATTTGTGGAGTCTCCAGGTCAATTGATTCAGAGGATCACCGATG
ACCCTGACGTTAGCATAAGGCTGTTAGAGGTTGTCCAGAGTGACCAGTCACA
ATCTGGCCTTACCTTCGCATCAAGAGGTACCAACATGGAGGATGAGGCGGAC
CAATACTTTTCACATGATGATCCAATTAGTAGTGATCAATCCAGGTTCGGATG
GTTCGGGAAC AAGGAAATCTC AGAT ATTGAAGT GC AAGACCCTGAGGGATT C
AACATGATTCTGGGTACCATCCTAGCCCAAATTTGGGTCTTGCTCGCAAAGGC
GGTTACGGCCCCAGACACGGCAGCTGATTCGGAGCTAAGAAGGTGGATAAAG
TACACCCAACAAAGAAGGGTAGTTGGTGAATTTAGATTGGAGAGAAAATGGT
TGGATGTGGTGAGGAACAGGATTGCCGAGGACCTCTCCTTACGCCGATTCAT
GGTCGCTCTAATCCTGGATATCAAGAGAACACCCGGAAACAAACCCAGGATT
GCTGAAAT GAT ATGT GAC ATTGAT AC AT AT ATCGT AGAGGC AGGATT AGCC A
GTTTTATCCTGACTATTAAGTTTGGGATAGAAACTATGTATCCTGCTCTTGGA
CTGCATGAATTTGCTGGTGAGTTATCCACACTTGAGTCCTTGATGAACCTTTA
CCAGCAAATGGGGGAAACTGCACCCTACATGGTAATCCTGGAGAACTCAATT
CAGAACAAGTTCAGTGCAGGATCATACCCTCTGCTCTGGAGCTATGCCATGG
GAGT AGGAGT GGAACTTGAAAACTCC AT GGGAGGTTT GAACTTT GGCCGATC
TTACTTTGATCCAGCATATTTTAGATTAGGGCAAGAGATGGTAAGGAGGTCA
GCTGGAAAGGT C AGTTCC AC ATT GGC ATCTGAACTCGGT AT C ACTGCCGAGG
AT GC AAGGCTT GTTTC AGAGATTGC AAT GC AT ACT ACTGAGGAC A AGATC AG
TAGAGCGGTTGGACCCAGACAAGCCCAAGTATCATTTCTACACGGTGATCAA
AGTGAGAATGAGCTACCGAGATTGGGGGGCAAGGAAGATAGGAGGGTCAAA
C AGAGT C GAGGAGA AGC C AGGGAGAGCT AC AGAGA A ACC GGGCC C AGC AGA
GCAAGTGATGCGAGAGCTGCCCATCTTCCAACCGGCACACCCCTAGACATTG
ACACTGCAACGGAGTCCAGCCAAGATCCGCAGGACAGTCGAAGGTCAGCTGA
CGCCCTGCTT AGGCTGC AAGCC AT GGC AGGAATCTCGGAAGAAC AAGGCTC A
GACACGGACACCCCTATAGTGTACAATGACAGAAATCTTCTAGACTAGGTGC
GAGAGGCCGAGGGCCAGAACAACATCCGCCTACCATCCATCATTGTTATAAA
AAACTTAGGAACCAggtccacacaGagtgatACGCGTACGCCACCATGTTCGTGTTTCT
GGTGCTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAACCTGACCACAAGGACC
CAGCTGCCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACTATCCCGA
CAAGGTGTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTTCTGCCTT TCTTTTCTAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCACCAATGGC
ACAAAGCGGTTCGACAATCCAGTGCTGCCCTTTAACGATGGCGTGTACTTCGC
CTCCACCGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCACCACACTG
GACAGCAAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAACGTGGTCA
TCAAGGTGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGTGTACTAT
CACAAGAACAATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTATTCCTCTG
CCAACAATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGACCTGGAG
GGC AAGC AGGGC AATTT C AAGAACCTGAGGGAGTTCGT GTTT AAGAAT ATCG
ATGGCTACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGTGCGCGA
CCTGCCACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCATCGGCA
TCAACATCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTACCTGAC
ACCAGGCGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTACTATGTG
GGCTATCTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATGGCACCA
TCACAGACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAAGTGTAC
ACTGAAGAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAATTTCAGG
GTGCAGCCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCTGTGCCC
TTTTGGCGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCTGGAATA
GGAAGCGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAACAGCGC
CTCCTTCTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGAATGACC
TGTGCTTTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGACGAGGTG
CGCCAGATCGCACCAGGACAGACAGGCAAGATCGCAGACTACAATTATAAGC
TGCCTGACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAATCTGGAT
AGCAAAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGAAAGTCTA
ATCTGAAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGGCCGGCTC
TACCCCCTGCAATGGCGTGGAGGGCTTTAACTGTTATTTCCCTCTGCAGAGCT
ACGGCTTCCAGCCAACAAACGGCGTGGGCTATCAGCCCTACCGCGTGGTGGT
GCTGTCTTTTGAGCTGCTGCACGCACCTGCAACAGTGTGCGGACCAAAGAAG
AGCACCAATCTGGTGAAGAACAAGTGCGTGAACTTCAACTTCAACGGACTGA
CCGGAACAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTTCAGCA
GTTCGGCAGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCTCAGACC
CTGGAGATCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGTGATCAC
ACC AGGC ACC AAT AC AAGC AACC AGGT GGCCGTGCTGT AT C AGGACGT GAAT
TGTACCGAGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTACATGGC
GGGTGTACTCTACCGGCAGCAACGTGTTCCAGACAAGAGCCGGATGCCTGAT CGGAGCAGAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATCGGCGCC
GGCATCTGTGCCTCCTACCAGACCCAGACAAACTCCCCAAGGAGAGCACGGT
CTGTGGCCAGCCAGTCCATCATCGCCTATACCATGAGCCTGGGCGCCGAGAA
TTCCGTGGCCTACTCCAACAATTCTATCGCCATCCCTACCAACTTCACAATCT
CCGTGACCACAGAGATCCTGCCAGTGAGCATGACCAAGACATCCGTGGACTG
CACAATGTATATCTGTGGCGATTCCACCGAGTGCTCTAACCTGCTGCTGCAGT
ACGGCTCTTTTTGTACCCAGCTGAATAGAGCCCTGACAGGCATCGCCGTGGA
GC AGGAC AAGA AC AC AC AGGAGGT GTTCGCCC AGGT GAAGC AAATCT AC AA
GACCCCACCCATCAAGGACTTTGGCGGCTTCAACTTCAGCCAGATCCTGCCCG
ATCCTAGCAAGCCATCCAAGCGGTCTTTTATCGAGGACCTGCTGTTCAACAAG
GTGACCCTGGCCGATGCCGGCTTCATCAAGCAGTATGGCGATTGCCTGGGCG
ACATCGCCGCCAGAGACCTGATCTGTGCCCAGAAGTTTAATGGCCTGACCGT
GCTGCCTCCACTGCTGACAGATGAGATGATCGCCCAGTACACATCTGCCCTGC
TGGCCGGAACCATCACAAGCGGATGGACCTTCGGCGCAGGAGCCGCCCTGCA
GATCCCCTTTGCCATGCAGATGGCCTATCGGTTCAACGGCATCGGCGTGACCC
AGAATGTGCTGTACGAGAACCAGAAGCTGATCGCCAATCAGTTTAACTCCGC
CATCGGCAAGATCCAGGACTCTCTGAGCTCCACAGCCAGCGCCCTGGGCAAG
CTGCAGGATGTGGTGAATCAGAACGCCCAGGCCCTGAATACCCTGGTGAAGC
AGCTGTCTAGCAACTTCGGCGCCATCTCCTCTGTGCTGAATGACATCCTGAGC
CGGCTGGAC AAGGT GGAGGC AGAGGT GC AGATCGACCGGCTGAT C AC AGGC
AGACTGCAGTCCCTGCAGACCTACGTGACACAGCAGCTGATCAGGGCAGCAG
AGATCAGGGCCTCTGCCAATCTGGCCGCCACCAAGATGAGCGAGTGCGTGCT
GGGCCAGTCCAAGAGAGTGGACTTTTGTGGCAAGGGCTATCACCTGATGAGC
TTCCCACAGTCCGCCCCTCACGGAGTGGTGTTTCTGCACGTGACCTACGTGCC
AGCCCAGGAGAAGAACTTCACCACAGCACCAGCAATCTGCCACGATGGCAAG
GCACACTTTCCTAGGGAGGGCGTGTTCGTGAGCAACGGCACCCACTGGTTTGT
GACACAGCGCAATTTCTACGAGCCACAGATCATCACCACAGACAATACATTC
GTGTCCGGCAACTGTGACGTGGTCATCGGCATCGTGAACAATACCGTGTATG
ATCCTCTGCAGCCAGAGCTGGACTCTTTTAAGGAGGAGCTGGATAAGTACTTC
AAGAATCACACCAGCCCCGACGTGGATCTGGGCGACATCTCTGGCATCAATG
CCAGCGTGGTGAACATCCAGAAGGAGATCGACAGGCTGAACGAGGTGGCCA
AGAATCTGAACGAGTCCCTGATCGATCTGCAGGAGCTGGGCAAGTATGAGCA
GTACATCAAGTGGCCCTGGTATATCTGGCTGGGCTTCATCGCCGGCCTGATCG
CCATCGTGATGGTGACCATCATGCTGTGCTGTATGACAAGCTGCTGTTCCTGC CTGAAGGGCTGCTGTTCTTGTGGCAGCTGCTGTAAGTTTGATGAGGACGATAG
CGAGCCTGTGCTGAAGGGCGTGAAGCTGCACTACACCTGATAGCTAGCGATC
GCGTGCGAGAGGCCAGAACAACATCCGCCTACCATCCATCATTGTTATAAAA
AACTTAGGAACCAGGTCCACACAGCCGCCAGCCCATCAACCATCCACTCCCA
CGATTGGAGCC AAT GGC AGAAGAGC AGGC ACGCC AT GTC AAAAACGGACTG
GAATGCATCCGGGCTCTCAAGGCCGAGCCCATCGGCTCACTGGCCATCGAGG
AAGCT AT GGC AGC ATGGT C AGAAAT ATC AGAC AACCC AGGAC AGGAGCGAG
CCACCTGCAGGGAAGAGAAGGCAGGCAGTTCGGGTCTCAGCAAACCATGCCT
CTCAGCAATTGGATCAACTGAAGGCGGTGCACCTCGCATCCGCGGTCAGGGA
CCTGGAGAGAGCGAT GACGACGCTGAA ACTTT GGGAATCCCCCC AAGAAAT C
TCCAGGCATCAAGCACTGGGTTACAGTGTTATTACGTTTATGATCACAGCGGT
GA AGC GGTT A AGGGA AT C C A AG AT GCTGACTCT AT CAT GGTTC A AT C AGGC C
TTGATGGTGATAGCACCCTCTCAGGAGGAGACAATGAATCTGAAAACAGCGA
T GTGGAT ATTGGCGAACCTGAT ACCGAGGGAT AT GCT AT C ACTGACCGGGGA
TCTGCTCCCATCTCTATGGGGTTCAGGGCTTCTGATGTTGAAACTGCAGAAGG
AGGGGAGATCCACGAGCTCCTGAGACTCCAATCCAGAGGCAACAACTTTCCG
AAGCTTGGGAAAACTCTCAATGTTCCTCCGCCCCCGGACCCCGGTAGGGCCA
GCACTTCCGGGACACCCATTAAAAAGGGCACAGACGCGAGATTAGCCTCATT
T GGAACGGAGATCGCGTCTTT ATT GAC AGGTGGT GC AACCC AATGT GCTCGA
AAGTCACCCTCGGAACCATCAGGGCCAGGTGCACCTGCGGGGAATGTCCCCG
AGT GT GT G AGC A AT GC C GC AC T GAT AC AGG AGT GG AC AC C C G A AT C T GGT AC
CACAATCTCCCCGAGATCCCAGAATAATGAAGAAGGGGGAGACTATTATGAT
GATGAGCTGTTCTCTGATGTCCAAGATATTAAAACAGCCTTGGCCAAAATAC
ACGAGGATAATCAGAAGATAATCTCCAAGCTAGAATCACTGCTGTTATTGAA
GGGAGAAGTTGAGTCAATTAAGAAGCAGATCAACAGGCAAAATATCAGCAT
ATCCACCCTGGAAGGACACCTCTCAAGCATCATGATCGCCATTCCTGGACTTG
GGAAGGATCCCAACGACCCCACTGCAGATGTCGAAATCAATCCCGACTTGAA
ACCCATCATAGGCAGAGATTCAGGCCGAGCACTGGCCGAAGTTCTCAAGAAA
CCCGTTGCCAGCCGACAACTCCAAGGAATGACAAATGGACGGACCAGTTCCA
GAGGAC AGCTGCTGAAGGAATTTC AGCT AAAGCCGATCGGGAAAAAGATGA
GCTCAGCCGTCGGGTTTGTTCCTGACACCGGCCCTGCATCACGCAGTGTAATC
CGCTCCATTATAAAATCCAGCCGGCTAGAGGAGGATCGGAAGCGTTACCTGA
TGACTCTCCTTGATGATATCAAAGGAGCCAATGATCTTGCCAAGTTCCACCAG
ATGCTGATGAAGATAATAATGAAGTAGCTACAGCTCAACTTACCTGCCAACC CCATGCCAGTCGACCCACCTAGTACAACCTAAATCCATTATAAAAAACTTAG
GAGCAAAGTGATTGCCTCCCAAGGTCCACAATGACAGAGACCTACGACTTCG
ACAAGTCGGCATGGGACATCAAAGGGTCGATCGCTCCGATACAACCCACCAC
CTACAGTGATGGCAGGCTGGTGCCCCAGGTCAGAGTCATAGATCCTGGTCTA
GGC GAC AGGA AGGAT GA AT GC THAT GT AC AT GTTTCTGC T GGGGGTT GTT GA
GGACAGCGATTCCCTAGGGCCTCCAATCGGGCGAGCATTTGGGTTCCTGCCCT
TAGGTGTTGGCAGATCCACAGCAAAGCCCGAAAAACTCCTCAAAGAGGCCAC
T GAGCTT GAC AT AGTTGTT AGACGT AC AGC AGGGCTC AATGAAAAACTGGT G
TTCTACAACAACACCCCACTAACTCTCCTCACACCTTGGAGAAAGGTCCTAAC
AACAGGGAGTGTCTTCAACGCAAACCAAGTGTGCAATGCGGTTAATCTGATA
CCGCTCGATACCCCGCAGAGGTTCCGTGTTGTTTATATGAGCATCACCCGTCT
TTCGGAT AACGGGT ATT AC ACCGTTCCT AGAAGAAT GCTGGAATT C AGATCG
GTCAATGCAGTGGCCTTCAACCTGCTGGTGACCCTTAGGATTGACAAGGCGA
TAGGCCCTGGGAAGATCATCGACAATACAGAGCAACTTCCTGAGGCAACATT
T ATGGTCC AC ATCGGGAACTTC AGGAGAAAGAAGAGT GAAGTCT ACTCTGCC
GATT ATTGC AAAAT GAAAATCGAAAAGAT GGGCCTGGTTTTTGC ACTTGGT G
GGATAGGGGGCACCAGTCTTCACATTAGAAGCACAGGCAAAATGAGCAAGA
CTCTCCATGCACAACTCGGGTTCAAGAAGACCTTATGTTACCCGCTGATGGAT
ATCAATGAAGACCTTAATCGATTACTCTGGAGGAGCAGATGCAAGATAGTAA
GAATCCAGGCAGTTTTGCAGCCATCAGTTCCTCAAGAATTCCGCATTTACGAC
GACGTGATCATAAATGATGACCAAGGACTATTCAAAGTTCTGTAGACCGTAG
TGCCCAGCAATGCCCGAAAACGACCCCCCTCACAATGACAGCCAGAAGGCCC
GGACAAAAAAGCCCCCTCCGAAAGACTCCACGGACCAAGCGAGAGGCCAGC
CAGCAGCCGACGGCAAGCGCGAACACCAGGCGGCCCCAGCACAGAACAGCC
CTGACACAAGGCCACCACCAGCCACCCCAATCTGCATCCTCCTCGTGGGACC
CCCGAGGACCAACCCCCAAGGCTGCCCCCGATCCAAACCACCAACCGCATCC
CCACCACCCCCGGGAAAGAAACCCCCAGCAATTGGAAGGCCCCTCCCCCTCT
TCCTCAACACAAGAACTCCACAACCGAACCGCACAAGCGACCGAGGTGACCC
AACCGCAGGCATCCGACTCCCTAGACAGATCCTCTCTCCCCGGCAAACTAAA
CAAAACTTAGGGCCAAGGAACATACACACCCAACAGAACCCAGACCCCGGC
CCACGGCGCCGCGCCCCCAACCCCCGACAACCAGAGGGAGCCCCCAACCAAT
CCCGCCGGCTCCCCCGGTGCCCACAGGCAGGGACACCAACCCCCGAACAGAC
CCAGCACCCAACCATCGACAATCCAAGACGGGGGGGCCCCCCCAAAAAAAG
GCCCCCAGGGGCCGACAGCCAGCACCGCGAGGAAGCCCACCCACCCCACAC ACGACCACGGCAACCAAACCAGAACCCAGACCACCCTGGGCCACCAGCTCCC
AGACTCGGCCATCACCCCGCAGAAAGGAAAGGCCACAACCCGCGCACCCCA
GCCCCGATCCGGCGGGGAGCCACCCAACCCGAACCAGCACCCAAGAGCGATC
CCCGAAGGACCCCCGAACCGCAAAGGACATCAGTATCCCACAGCCTCTCCAA
GTCCCCCGGTCTCCTCCTCTTCTCGAAGGGACCAAAAGATCAATCCACCACAC
CCGACGACACTCAACTCCCCACCCCTAAAGGAGACACCGGGAATCCCAGAAT
CAAGACTCATCCAATGTCCATCATGGGTCTCAAGGTGAACGTCTCTGCCATAT
TCATGGCAGTACTGTTAACTCTCCAAACACCCACCGGTCAAATCCATTGGGGC
A ATCTCTCT A AGAT AGGGGT GGT AGGA AT AGGA AGT GC A AGC T AC A A AGTT A
TGACTCGTTCCAGCCATCAATCATTAGTCATAAAATTAATGCCCAATATAACT
CTCCTCAATAACTGCACGAGGGTAGAGATTGCAGAATACAGGAGACTACTGA
GAACAGTTTTGGAACCAATTAGAGATGCACTTAATGCAATGACCCAGAATAT
AAGACCGGTTCAGAGTGTAGCTTCAAGTAGGAGACACAAGAGATTTGCGGGA
GTAGTCCTGGCAGGTGCGGCCCTAGGCGTTGCCACAGCTGCTCAGATAACAG
CCGGCATTGCACTTCACCAGTCCATGCTGAACTCTCAAGCCATCGACAATCTG
AGAGCGAGCCTGGAAACTACTAATCAGGCAATTGAGACAATCAGACAAGCA
GGGCAGGAGATGATATTGGCTGTTCAGGGTGTCCAAGACTACATCAATAATG
AGCTGATACCGTCTATGAACCAACTATCTTGTGATTTAATCGGCCAGAAGCTC
GGGCTCAAATTGCTCAGATACTATACAGAAATCCTGTCATTATTTGGCCCCAG
TTTACGGGACCCCATATCTGCGGAGATATCTATCCAGGCTTTGAGCTATGCGC
TTGGAGGAGAC AT C AAT AAGGT GTT AGAAAAGCTCGGAT AC AGTGGAGGTGA
TTTACTGGGCATCTTAGAGAGCGGAGGAATAAAGGCCCGGATAACTCACGTC
GACACAGAGTCCTACTTCATTGTCCTCAGTATAGCCTATCCGACGCTGTCCGA
GATTAAGGGGGTGATTGTCCACCGGCTAGAGGGGGTCTCGTACAACATAGGC
TCTCAAGAGTGGTATACCACTGTGCCCAAGTATGTTGCAACCCAAGGGTACCT
TATCTCGAATTTTGATGAGTCATCGTGTACTTTCATGCCAGAGGGGACTGTGT
GCAGCCAAAATGCCTTGTACCCGATGAGTCCTCTGCTCCAAGAATGCCTCCGG
GGGTACACCAAGTCCTGTGCTCGTACACTCGTATCCGGGTCTTTTGGGAACCG
GTTCATTTTATCACAAGGGAACCTAATAGCCAATTGTGCATCAATCCTTTGCA
AGT GTT AC AC AAC AGGAACGAT C ATT AAT C AAGACCCTGAC AAGATCCT AAC
ATACATTGCTGCCGATCACTGCCCGGTAGTCGAGGTGAACGGCGTGACCATC
CAAGTCGGGAGCAGGAGGTATCCAGACGCTGTGTACTTGCACAGAATTGACC
TCGGTCCTCCCATATCATTGGAGAGGTTGGACGTAGGGACAAATCTGGGGAA
TGCAATTGCTAAGTTGGAGGATGCCAAGGAATTGTTGGAGTCATCGGACCAG ATATTGAGGAGTATGAAAGGTTTATCGAGCACTAGCATAGTCTACATCCTGAT
TGCAGTGTGTCTTGGAGGGTTGATAGGGATCCCCGCTTTAATATGTTGCTGCA
GGGGGC GTT GT A AC A A A A AGGGAGA AC A AGTT GGT AT GT C A AGACC AGGCC
TAAAGCCTGATCTTACGGGAACATCAAAATCCTATGTAAGGTCGCTCTGATCC
TCTACAACTCTTGAAACACAAATGTCCCACAAGTCTCCTCTTCGTCATCAAGC
AACCACCGCACCCAGCATCAAGCCCACCTGAAATTATCTCCGGCTTCCCTCTG
GCCGAACAATATCGGTAGTTAATTAAAACTTAGGGTGCAAGATCATCGATAA
TGTCACCACAACGAGACCGGATAAATGCCTTCTACAAAGATAACCCCCATCC
C AAGGGAAGT AGGAT AGT C ATT A AC AGAGAAC ATCTT AT GATT GAT AGACCT
TATGTTTTGCTGGCTGTTCTGTTTGTCATGTTTCTGAGCTTGATCGGGTTGCTA
GCCATTGCAGGAATTCGACTTCATCGGGCAGCCATCTACACCGCAGAGATCC
ATAAAAGCCTCAGCACCAATCTAGATGTAACTAACTCAATCGAGCATCAGGT
CAAGGACGTGCTGACACCACTCTTCAAAATCATCGGTGATGAAGTGGGCCTG
AGGAC ACC T C AGAGATT C AC T GAC CT AGT GA A ATT A AT C TC T G AC A AG ATT A
AATTCCTTAATCCGGATAGGGAGTACGACTTCAGAGATCTCACTTGGTGTATC
AACCCGCCAGAGAGAATCAAATTGGATTATGATCAATACTGTGCAGATGTGG
CTGCTGAAGAGCTCATGAATGCATTGGTGAACTCAACTCTACTGGAGACCAG
AACAACCAATCAGTTCCTAGCTGTCTCAAAGGGAAACTGCTCAGGGCCCACT
ACAATCAGAGGTCAATTCTCAAACATGTCGCTGTCCCTGTTAGACTTGTATTT
AGGTCGAGGTTACAATGTGTCATCTATAGTCACTATGACATCCCAGGGAATGT
AT GGGGGAACTT ACCT AGT GGAAAAGCCT AATCTGAGC AGC AAAAGGTC AGA
GTTGTCACAACTGAGCATGTACCGAGTGTTTGAAGTAGGTGTTATCAGAAATC
CGGGTTTGGGGGCTCCGGTGTTCCATATGACAAACTATCTTGAGCAACCAGTC
AGT AATGATCTC AGC AACTGT AT GGT GGCTTT GGGGGAGCTC AAACTCGC AG
CCCTTTGTCACGGGGAAGATTCTATCACAATTCCCTATCAGGGATCAGGGAA
AGGTGTCAGCTTCCAGCTCGTCAAGCTAGGTGTCTGGAAATCCCCAACCGAC
ATGCAATCCTGGGTCCCCTTATCAACGGATGATCCAGTGATAGACAGGCTTTA
CCTCTCATCTCACAGAGGTGTTATCGCTGACAACCAAGCAAAATGGGCTGTCC
CGAC AAC ACGAAC AGAT GAC AAGTT GCGAAT GG AG AC AT GCTTCC AAC AGGC
GTGTAAGGGTAAAATCCAAGCACTCTGCGAGAATCCCGAGTGGGCACCATTG
AAGGATAACAGGATTCCTTCATACGGGGTCTTGTCTGTTGATCTGAGTCTGAC
AGTTGAGCTTAAAATCAAAATTGCTTCGGGATTCGGGCCATTGATCACACAC
GGTTCAGGGATGGACCTATACAAATCCAACCACAACAATGTGTATTGGCTGA
CTATCCCGCCAATGAAGAACCTAGCCTTAGGTGTAATCAACACATTGGAGTG GATACCGAGATTCAAGGTTAGTCCCTACCTCTTCACTGTCCCAATTAAGGAAG
CAGGCGAAGACTGCCATGCCCCAACATACCTACCTGCGGAGGTGGATGGTGA
TGTCAAACTCAGTTCCAATCTGGTGATTCTACCTGGTCAAGATCTCCAATATG
TTTTGGCAACCTACGATACTTCCAGGGTTGAACATGCTGTGGTTTATTACGTTT
ACAGCCCAAGCCGCTCATTTTCTTACTTTTATCCTTTTAGGTTGCCTATAAAGG
GGGTCCCCATCGAATTACAAGTGGAATGCTTCACATGGGACCAAAAACTCTG
GTGCCGTCACTTCTGTGTGCTTGCGGACTCAGAATCTGGTGGACATATCACTC
ACTCTGGGATGGTGGGCATGGGAGTCAGCTGCACAGTCACCCGGGAAGATGG
AACCAATCGCAGATAGGGCTGCTAGTGAACCAATCACATGATGTCACCCAGA
CAT C AGGC AT ACCC ACT AGTGT GAAAT AGAC ATC AGAATT AAGAAA AACGT A
GGGTCCAAGTGGTTCCCCGTTATGGACTCGCTATCTGTCAACCAGATCTTATA
CCCTGAAGTTCACCTAGATAGCCCGATAGTTACCAATAAGATAGTAGCCATC
CTGGAGTATGCTCGAGTCCCTCACGCTTACAGCCTGGAGGACCCTACACTGTG
TCAGAACATCAAGCACCGCCTAAAAAACGGATTTTCCAACCAAATGATTATA
AACAATGTGGAAGTTGGGAATGTCATCAAGTCCAAGCTTAGGAGTTATCCGG
CCCACTCTCATATTCCATATCCAAATTGTAATCAGGATTTATTTAACATAGAA
GACAAAGAGTCAACGAGGAAGATCCGTGAACTCCTCAAAAAGGGGAATTCG
CTGTACTCCAAAGTCAGTGATAAGGTTTTCCAATGCTTAAGGGACACTAACTC
ACGGCTT GGCCT AGGCTCCGAATT GAGGGAGGAC AT C AAGGAGA AAGTT ATT
AACTTGGGAGTTTACATGCACAGCTCCCAGTGGTTTGAGCCCTTTCTGTTTTG
GTTTACAGTCAAGACTGAGATGAGGTCAGTGATTAAATCACAAACCCATACT
TGCCATAGGAGGAGACACACACCTGTATTCTTCACTGGTAGTTCAGTTGAGTT
GCTAATCTCTCGTGACCTTGTTGCTATAATCAGTAAAGAGTCTCAACATGTAT
ATTACCTGACATTTGAACTGGTTTTGATGTATTGTGATGTCATAGAGGGGAGG
TTAATGACAGAGACCGCTATGACTATTGATGCTAGGTATACAGAGCTTCTAG
GAAGAGTCAGATACATGTGGAAACTGATAGATGGTTTCTTCCCTGCACTCGG
GAATCCAACTTATCAAATTGTAGCCATGCTGGAGCCTCTTTCACTTGCTTACC
T GC AGCTGAGGGAT AT AAC AGT AGAACTC AGAGGT GCTTTCCTT AACC ACTG
CTTTACTGAAATACATGATGTTCTTGACCAAAACGGGTTTTCTGATGAAGGTA
CTTATCATGAGTTAACTGAAGCTCTAGATTACATTTTCATAACTGATGACATA
CATCTGACAGGGGAGATTTTCTCATTTTTCAGAAGTTTCGGCCACCCCAGACT
T GA AGC AGT A ACGGC T GC T GA A A AT GTT AGGA A AT AC AT GA AT C AGCC T AAA
GTCATTGTGTATGAGACTCTGATGAAAGGTCATGCCATATTTTGTGGAATCAT
AATCAACGGCTATCGTGACAGGCACGGAGGCAGTTGGCCACCGCTGACCCTC CCCCTGCATGCTGCAGACACAATCCGGAATGCTCAAGCTTCAGGTGAAGGGT
TAACACATGAGCAGTGCGTTGATAACTGGAAATCTTTTGCTGGAGTGAAATTT
GGCTGCTTTATGCCTCTTAGCCTGGATAGTGATCTGACAATGTACCTAAAGGA
CAAGGCACTTGCTGCTCTCCAAAGGGAATGGGATTCAGTTTACCCGAAAGAG
TTCCTGCGTTACGACCCTCCCAAGGGAACCGGGTCACGGAGGCTTGTAGATG
TTTTCCTTAATGATTCGAGCTTTGACCCATATGATGTGATAATGTATGTTGTAA
GTGGAGCTTACCTCCATGACCCTGAGTTCAACCTGTCTTACAGCCTGAAAGAA
AAGGAGATC A AGGAAAC AGGT AGACTTTTT GCT AAAAT GACTT AC AAAAT GA
GGGCATGCCAAGTGATTGCTGAAAATCTAATCTCAAACGGGATTGGCAAATA
TTTT AAGGAC AAT GGGAT GGCC AAGGAT GAGC ACGATTT GACT AAGGC ACTC
CACACTCTAGCTGTCTCAGGAGTCCCCAAAGATCTCAAAGAAAGTCACAGGG
GGGGGCCAGTCTTAAAAACCTACTCCCGAAGCCCAGTCCACACAAGTACCAG
GAACGTGAGAGCAGCAAAAGGGTTTATAGGGTTCCCTCAAGTAATTCGGCAG
GACCAAGACACTGATCATCCGGAGAATATGGAAGCTTACGAGACAGTCAGTG
C ATTT AT C ACGACTGATCTC AAGAAGT ACTGCCTT AATT GGAGAT ATGAGACC
ATCAGCTTGTTTGCACAGAGGCTAAATGAGATTTACGGATTGCCCTCATTTTT
CCAGTGGCTGCATAAGAGGCTTGAGACCTCTGTCCTGTATGTAAGTGACCCTC
ATTGCCCCCCCGACCTTGACGCCCATATCCCGTTATATAAAGTCCCCAATGAT
C AAATCTTC ATT AAGT ACCCT AT GGGAGGT AT AGAAGGGT ATT GTC AGAAGC
TGTGGACCATCAGCACCATTCCCTATCTATACCTGGCTGCTTATGAGAGCGGA
GTAAGGATTGCTTCGTTAGTGCAAGGGGACAATCAGACCATAGCCGTAACAA
AAAGGGTACCCAGCACATGGCCCTACAACCTTAAGAAACGGGAAGCTGCTAG
AGT AACT AGAGATT ACTTT GT AATTCTT AGGC AAAGGCT AC AT GAT ATTGGCC
ATCACCTCAAGGCAAATGAGACAATTGTTTCATCACATTTTTTTGTCTATTCA
A A AGGA AT AT ATT AT GAT GGGC T AC TT GT GT C CCA AT C AC TC A AGAGC ATCG
C AAGAT GT GT ATTCTGGTC AGAGACT AT AGTT GAT GAAAC AAGGGC AGC ATG
CAGTAATATTGCTACAACAATGGCTAAAAGCATCGAGAGAGGTTATGACCGT
TACCTTGCATATTCCCTGAACGTCCTAAAAGTGATACAGCAAATTCTGATCTC
TCTTGGCTTCACAATCAATTCAACCATGACCCGGGATGTAGTCATACCCCTCC
TCACAAACAACGACCTCTTAATAAGGATGGCACTGTTGCCCGCTCCTATTGGG
GGGAT G A ATT AT C T G A AT AT GAGC AGGC T GT TT GT C AG A A AC ATC GGT GAT C
CAGTAACATCATCAATTGCTGATCTCAAGAGAATGATTCTCGCCTCACTAATG
CCTGAAGAGACCCTCCATCAGGTAATGACACAACAACCGGGGGACTCTTCAT
TCCTAGACTGGGCTAGCGACCCTTACTCAGCAAATCTTGTATGTGTCCAGAGC ATCACTAGACTCCTCAAGAACATAACTGCAAGGTTTGTCCTGATCCATAGTCC
AAACCC AAT GTT AAAAGGATT ATTCC AT GATGAC AGT A A AG A AG AGG AC GAG
GGACTGGCGGCATTCCTCATGGACAGGCATATTATAGTACCTAGGGCAGCTC
ATGAAATCCTGGATCATAGTGTCACAGGGGCAAGAGAGTCTATTGCAGGCAT
GCTGGAT ACC AC AAAAGGCTT GATTCGAGCC AGC AT GAGGAAGGGGGGTTT A
ACCTCTCGAGTGATAACCAGATTGTCCAATTATGACTATGAACAATTCAGAGC
AGGGAT GGT GCT ATT GAC AGGAAGAA AGAGAAAT GTCCTC ATTGAC AAAGA
GT CAT GTT C AGT GC AGC T GGCGAGAGC TCT A AGA AGCC AT AT GT GGGC GAGG
CTAGCTCGAGGACGGCCTATTTACGGCCTTGAGGTCCCTGATGTACTAGAATC
TATGCGAGGCCACCTTATTCGGCGTCATGAGACATGTGTCATCTGCGAGTGTG
GATCAGTCAACTACGGATGGTTTTTTGTCCCCTCGGGTTGCCAACTGGATGAT
ATTGAC AAGGAAACATCATCCTTGAGAGTCCCATATATTGGTTCTACCACTGA
TGAGAGAACAGACATGAAGCTTGCCTTCGTAAGAGCCCCAAGTCGATCCTTG
CGATCTGCTGTTAGAATAGCAACAGTGTACTCATGGGCTTACGGTGATGATG
ATAGCTCTTGGAACGAAGCCTGGTTGTTGGCTAGGCAAAGGGCCAATGTGAG
CCTGGAGGAGCTAAGGGTGATCACTCCCATCTCAACTTCGACTAATTTAGCGC
AT AGGTT GAGGGATCGT AGC ACTC AAGT GAAAT ACTC AGGT AC ATCCCTTGT
CCGAGTGGCGAGGTATACCACAATCTCCAACGACAATCTCTCATTTGTCATAT
C AGAT A AGA AGGTTGAT AC T A AC TTT AT AT AC C A AC A AGG A AT GC TTCT AGG
GTTGGGTGTTTTAGAAACATTGTTTCGACTCGAGAAAGATACCGGATCATCTA
ACACGGTATTACATCTTCACGTCGAAACAGATTGTTGCGTGATCCCGATGATA
GATCATCCCAGGATACCCAGCTCCCGCAAGCTAGAGCTGAGGGCAGAGCTAT
GTACCAACCCATTGATATATGATAATGCACCTTTAATTGACAGAGATGCAAC
AAGGCTATACACCCAGAGCCATAGGAGGCACCTTGTGGAATTTGTTACATGG
TCCACACCCCAACTATATCACATTTTAGCTAAGTCCACAGCACTATCTATGAT
TGACCTGGTAACAAAATTTGAGAAGGACCATATGAATGAAATTTCAGCTCTC
ATAGGGGATGACGATATCAATAGTTTCATAACTGAGTTTCTGCTCATAGAGCC
AAGATTATTCACTATCTACTTGGGCCAGTGTGCGGCCATCAATTGGGCATTTG
ATGTACATTATCATAGACCATCAGGGAAATATCAGATGGGTGAGCTGTTGTC
ATCGTTCCTTTCTAGAATGAGCAAAGGAGTGTTTAAGGTGCTTGTCAATGCTC
TAAGCCACCCAAAGATCTACAAGAAATTCTGGCATTGTGGTATTATAGAGCC
TATCCATGGTCCTTCACTTGATGCTCAAAACTTGCACACAACTGTGTGCAACA
TGGTTTACACATGCTATATGACCTACCTCGACCTGTTGTTGAATGAAGAGTTA
GAAGAGTTCACATTTCTCTTGTGTGAAAGCGACGAGGATGTAGTACCGGACA GATTCGACAACATCCAGGCAAAACACTTATGTGTTCTGGCAGATTTGTACTGT
C A AC C AGGGAC CTGCC C AC C A ATTC GAGGT C T A AGACC GGT AGAGA A AT GT G
CAGTTCTAACCGACCATATCAAGGCAGAGGCTATGTTATCTCCAGCAGGATCT
TCGTGGAACATAAATCCAATTATTGTAGACCATTACTCATGCTCCCTGACTTA
TCTCCGGCGAGGATCGATCAAACAGATAAGATTGAGAGTTGATCCAGGATTC
ATTTTCGACGCCCTCGCTGAGGTAAATGTCAGTCAGCCAAAGATCGGCAGCA
ACAACATCTCAAATATGAGCATCAAGGCTTTCAGACCCCCACACGATGATGT
TGCAAAATTGCTCAAAGATATCAACACAAGCAAGCACAATCTTCCCATTTCA
GGGGGCAATCTCGCCAATTATGAAATCCATGCTTTCCGCAGAATCGGGTTGA
ACTC ATCTGCTTGCT AC AAAGCTGTT GAG AT AT C AAC ATT AATT AGGAGAT GC
CTTGAGCC AGGGGAGGACGGCTT GTTCTTGGGT GAGGGATCGGGTTCT AT GTT
GAT C ACTT AT AAGGAGAT ACTT AAACT AAAC AAGT GCTTCT AT AAT AGT GGG
GTTTCCGCCAATTCTAGATCTGGTCAAAGGGAATTAGCACCCTATCCCTCCGA
AGTTGGCCTTGTCGAACACAGAATGGGAGTAGGTAATATTGTCAAAGTGCTC
TTTAACGGGAGGCCCGAAGTCACGTGGGTAGGCAGTGTAGATTGCTTCAATT
TCATAGTTAGTAATATCCCTACCTCTAGTGTGGGGTTTATCCATTCAGATATA
GAGACCTTGCCTGAC AAAGAT ACT AT AGAGAAGCT AGAGGAATTGGC AGCC A
TCTT ATCGAT GGCTCTGCTCCTGGGC A AAAT AGGAT C AAT ACTGGT GATT AAG
CTTATGCCTTTCAGCGGGGATTTTGTTCAGGGATTTATAAGTTATGTAGGGTC
TCATTATAGAGAAGTGAACCTTGTATACCCTAGATACAGCAACTTCATATCTA
CTGAATCTTATTTGGTTATGACAGATCTCAAGGCTAACCGGCTAATGAATCCT
GAAAAGATT AAGC AGC AGAT AATT GAAT C ATCTGTGAGGACTTC ACCTGGAC
TTATAGGTCACATCCTATCCATTAAGCAACTAAGCTGCATACAAGCAATTGTG
GGAGACGC AGTT AGT AGAGGT GAT ATC A ATCCT ACTCTGAAAAAACTT AC AC
CTATAGAGCAGGTGCTGATCAATTGCGGGTTGGCAATTAACGGACCTAAGCT
GTGCAAAGAATTGATCCACCATGATGTTGCCTCAGGGCAAGATGGATTGCTT
AATTCTATACTCATCCTCTACAGGGAGTTGGCAAGATTCAAAGACAACCAAA
GAAGT C AAC AAGGGAT GTTCC ACGCCT ACCCCGT ATTGGT AAGT AGC AGGC A
ACGAGAACTTATATCTAGGATCACCCGCAAATTTTGGGGGCACATTCTTCTTT
ACTCCGGGAAC AAA AAGTTGAT AAAT AAGTTT ATCC AGAATCTC AAGTCCGG
CTATCTGATACTAGACTTACACCAGAATATCTTCGTTAAGAATCTATCCAAGT
C AGAGAAAC AGATT ATT ATGACGGGGGGTTT GAAACGT GAGT GGGTTTTT AA
GGT A AC AGT C A AGG AG AC C A A AG A AT GGT AT A AGTT AGT C GG AT AC AGT GC C
CTGATTAAGGACTAATTGGTTGAACTCCGGAACCCTAATCCTGCCCTAGGTGG TTAGGCATTATTTGCAATATATTAAAGAAAACTTTGAAAATACGAAGTTTCTA
TTCCCAGCTTTGTCTGGTggccggcatAgtcccagcctcctcgctggcgctggctgggcaacattccgaggg gaccgtccccAcggtaatggcgaatgggacgcggccgatccggctgctaacaaagcccgaaaggaagctgagttggctgct gGcGcTGgctgGgcaataactagcataaccccttggggcctctaaacgggtcttgaggggttttttgctgaaaggaggaact atatccggatgcGGCCGCGCGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGA
AATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGT
GT AAAGCCTGGGGT GCCT AAT GAGT GAGCT AACTC AC ATT AATT GCGTT GCG
CTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAA
TCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCC
TCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGC
TC AC T C A A AGGC GGT AAT AC GGTT ATC C AC AG A AT C AGGGG AT A AC GC AGG A
A AG A AC AT GT G AGC A A A AGGC C AGC A A A AGGC C AGG A AC C GT A A A A AGGC C
GCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAA
TCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAG
GCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTT
ACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAG
CTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCT
GTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTAT
CGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCA
CTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTT
GAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGC
GCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGG
CAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTA
CGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTC
T GACGCTC AGT GGAACGAAAACTC ACGTT AAGGGATTTTGGT CAT GAG ATT A
TCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATC
AATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCA
GTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGA
CTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCA
GTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGC
AAT AAACC AGCC AGCCGGAAGGGCCGAGCGC AGAAGT GGTCCTGC A ACTTT A
TCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTC
GCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGT
CACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGG CGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCC
TCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGG
CAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTG
ACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGA
GTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAAC
TTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGG
ATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTG
ATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAA
GGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATAC
TCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCA
TGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCC
GCGCACATTTCCCCGAAAAGTGCCACCTG.
In another embodiment, the nucleic acid comprises the sequence of SEQ ID NO:
4, shown below:
GGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGC
AGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTT
CCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGG
GGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAA
CTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTT
TCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAA
CTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATT
TTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAA
CGCGAATTTTAACAAAATATTAACGTTTACAATTTCGCGCCATTCGCCATTCA
GGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACG
CCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCA
GGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGCGCGCCGTTAAT
ACGACTCACTATAGGGAGACCCAAGCTGGCTAGCTTTGTTTGGTCTGATGAGT
CCCGTGAGGACGAAACCCGGCGTACCGGGTCACCAAACAAAGTTGGGTAAG
GATAGTTCAATCAATGATCATCTTCTAGTGCACTTAGGATTCAAGATCCTATT
AT C AGGGAC AAGAGC AGGATT AGGGAT ATCCGAGAT GGCC AC ACTTTT A AGG
AGCTTAGCATTGTTCAAAAGAAACAAGGACAAACCACCCATTACATCAGGAT
CCGGTGGAGCCATCAGAGGAATCAAACACATTATTATAGTACCAATCCCTGG
AGATTCCTCAATTACCACTCGATCCAGACTTCTGGACCGGTTGGTGAGGTTAA
TTGGAAACCCGGATGTGAGCGGGCCCAAACTAACAGGGGCACTAATAGGTAT ATTATCCTTATTTGTGGAGTCTCCAGGTCAATTGATTCAGAGGATCACCGATG
ACCCTGACGTTAGCATAAGGCTGTTAGAGGTTGTCCAGAGTGACCAGTCACA
ATCTGGCCTTACCTTCGCATCAAGAGGTACCAACATGGAGGATGAGGCGGAC
CAATACTTTTCACATGATGATCCAATTAGTAGTGATCAATCCAGGTTCGGATG
GTTCGGGAAC AAGGAAATCTC AGAT ATTGAAGT GC AAGACCCTGAGGGATT C
AACATGATTCTGGGTACCATCCTAGCCCAAATTTGGGTCTTGCTCGCAAAGGC
GGTTACGGCCCCAGACACGGCAGCTGATTCGGAGCTAAGAAGGTGGATAAAG
TACACCCAACAAAGAAGGGTAGTTGGTGAATTTAGATTGGAGAGAAAATGGT
TGGATGTGGTGAGGAACAGGATTGCCGAGGACCTCTCCTTACGCCGATTCAT
GGTCGCTCTAATCCTGGATATCAAGAGAACACCCGGAAACAAACCCAGGATT
GCTGAAAT GAT ATGT GAC ATTGAT AC AT AT ATCGT AGAGGC AGGATT AGCC A
GTTTTATCCTGACTATTAAGTTTGGGATAGAAACTATGTATCCTGCTCTTGGA
CTGCATGAATTTGCTGGTGAGTTATCCACACTTGAGTCCTTGATGAACCTTTA
CCAGCAAATGGGGGAAACTGCACCCTACATGGTAATCCTGGAGAACTCAATT
CAGAACAAGTTCAGTGCAGGATCATACCCTCTGCTCTGGAGCTATGCCATGG
GAGT AGGAGT GGAACTTGAAAACTCC AT GGGAGGTTT GAACTTT GGCCGATC
TTACTTTGATCCAGCATATTTTAGATTAGGGCAAGAGATGGTAAGGAGGTCA
GCTGGAAAGGT C AGTTCC AC ATT GGC ATCTGAACTCGGT AT C ACTGCCGAGG
AT GC AAGGCTT GTTTC AGAGATTGC AAT GC AT ACT ACTGAGGAC A AGATC AG
TAGAGCGGTTGGACCCAGACAAGCCCAAGTATCATTTCTACACGGTGATCAA
AGTGAGAATGAGCTACCGAGATTGGGGGGCAAGGAAGATAGGAGGGTCAAA
C AGAGT C GAGGAGA AGC C AGGGAGAGCT AC AGAGA A ACC GGGCC C AGC AGA
GCAAGTGATGCGAGAGCTGCCCATCTTCCAACCGGCACACCCCTAGACATTG
ACACTGCAACGGAGTCCAGCCAAGATCCGCAGGACAGTCGAAGGTCAGCTGA
CGCCCTGCTT AGGCTGC AAGCC AT GGC AGGAATCTCGGAAGAAC AAGGCTC A
GACACGGACACCCCTATAGTGTACAATGACAGAAATCTTCTAGACTAGGTGC
GAGAGGCCGAGGGCCAGAACAACATCCGCCTACCATCCATCATTGTTATAAA
AAACTTAGGAACCAGGTCCACACAGCCGCCAGCCCATCAACCATCCACTCCC
ACGATTGGAGCCAATGGCAGAAGAGCAGGCACGCCATGTCAAAAACGGACT
GGAATGCATCCGGGCTCTCAAGGCCGAGCCCATCGGCTCACTGGCCATCGAG
GA AGC TAT GGC AGC AT GGTC AGA A AT AT C AGAC A AC CC AGGAC AGGAGC GA
GCCACCTGCAGGGAAGAGAAGGCAGGCAGTTCGGGTCTCAGCAAACCATGCC
TCTCAGCAATTGGATCAACTGAAGGCGGTGCACCTCGCATCCGCGGTCAGGG
ACCTGGAGAGAGCGATGACGACGCTGAAACTTTGGGAATCCCCCCAAGAAAT CTCCAGGCATCAAGCACTGGGTTACAGTGTTATTACGTTTATGATCACAGCGG
TGAAGCGGTTAAGGGAATCCAAGATGCTGACTCTATCATGGTTCAATCAGGC
CTTGATGGT GAT AGC ACCCTCTC AGGAGGAGAC AAT GAATCTGAAAAC AGCG
ATGTGGATATTGGCGAACCTGATACCGAGGGATATGCTATCACTGACCGGGG
ATCTGCTCCCATCTCTATGGGGTTCAGGGCTTCTGATGTTGAAACTGCAGAAG
GAGGGGAGATCCACGAGCTCCTGAGACTCCAATCCAGAGGCAACAACTTTCC
GAAGCTTGGGAAAACTCTCAATGTTCCTCCGCCCCCGGACCCCGGTAGGGCC
AGCACTTCCGGGACACCCATTAAAAAGGGCACAGACGCGAGATTAGCCTCAT
TTGGAACGGAGATCGCGTCTTTATTGACAGGTGGTGCAACCCAATGTGCTCG
AAAGTCACCCTCGGAACCATCAGGGCCAGGTGCACCTGCGGGGAATGTCCCC
GAGTGTGTGAGCAATGCCGCACTGATACAGGAGTGGACACCCGAATCTGGTA
CCACAATCTCCCCGAGATCCCAGAATAATGAAGAAGGGGGAGACTATTATGA
TGATGAGCTGTTCTCTGATGTCCAAGATATTAAAACAGCCTTGGCCAAAATAC
ACGAGGATAATCAGAAGATAATCTCCAAGCTAGAATCACTGCTGTTATTGAA
GGGAGAAGTTGAGTCAATTAAGAAGCAGATCAACAGGCAAAATATCAGCAT
ATCCACCCTGGAAGGACACCTCTCAAGCATCATGATCGCCATTCCTGGACTTG
GGAAGGATCCCAACGACCCCACTGCAGATGTCGAAATCAATCCCGACTTGAA
ACCCATCATAGGCAGAGATTCAGGCCGAGCACTGGCCGAAGTTCTCAAGAAA
CCCGTTGCCAGCCGACAACTCCAAGGAATGACAAATGGACGGACCAGTTCCA
GAGGAC AGCTGCTGAAGGAATTTC AGCT AAAGCCGATCGGGAAAAAGATGA
GCTCAGCCGTCGGGTTTGTTCCTGACACCGGCCCTGCATCACGCAGTGTAATC
CGCTCCATTATAAAATCCAGCCGGCTAGAGGAGGATCGGAAGCGTTACCTGA
TGACTCTCCTTGATGATATCAAAGGAGCCAATGATCTTGCCAAGTTCCACCAG
ATGCTGATGAAGATAATAATGAAGTAGCTACAGCTCAACTTACCTGCCAACC
CCATGCCAGTCGATCATCCATCATTGTTATAAAAAACTTAGGAACCAggtccacac aGagtgatACGCGTACGCCACCATGTTCGTGTTTCTGGTGCTGCTGCCTCTGGTGA
GCTCCCAGTGCGTGAACCTGACCACAAGGACCCAGCTGCCCCCTGCCTATAC
CAATTCCTTCACACGGGGCGTGTACTATCCCGACAAGGTGTTCCGGAGCAGC
GTGCTGCACTCCACACAGGATCTGTTTCTGCCTTTCTTTTCTAACGTGACCTGG
TTCCACGCCATCCACGTGAGCGGCACCAATGGCACAAAGCGGTTCGACAATC
CAGTGCTGCCCTTTAACGATGGCGTGTACTTCGCCTCCACCGAGAAGTCTAAC
ATCATCAGAGGCTGGATCTTTGGCACCACACTGGACAGCAAGACACAGTCCC
TGCTGATCGTGAACAATGCCACCAACGTGGTCATCAAGGTGTGCGAGTTCCA
GTTTTGTAATGATCCATTCCTGGGCGTGTACTATCACAAGAACAATAAGTCTT GGATGGAGAGCGAGTTTCGCGTGTATTCCTCTGCCAACAATTGCACATTTGAG
TACGTGTCCCAGCCCTTCCTGATGGACCTGGAGGGCAAGCAGGGCAATTTCA
AGAACCTGAGGGAGTTCGTGTTTAAGAATATCGATGGCTACTTCAAAATCTA
CTCCAAGCACACCCCAATCAACCTGGTGCGCGACCTGCCACAGGGCTTCTCTG
CCCTGGAGCCACTGGTGGATCTGCCCATCGGCATCAACATCACCCGGTTTCAG
ACACTGCTGGCCCTGCACAGAAGCTACCTGACACCAGGCGACAGCTCCTCTG
GATGGACCGCAGGAGCAGCAGCCTACTATGTGGGCTATCTGCAGCCCAGGAC
CTTCCTGCTGAAGTACAACGAGAATGGCACCATCACAGACGCCGTGGATTGC
GCCCTGGATCCCCTGTCTGAGACCAAGTGTACACTGAAGAGCTTTACCGTGG
AGAAGGGCATCTATCAGACAAGCAATTTCAGGGTGCAGCCTACCGAGTCCAT
CGTGCGCTTTCCCAATATCACAAACCTGTGCCCTTTTGGCGAGGTGTTCAACG
CAACCCGCTTCGCCAGCGTGTACGCCTGGAATAGGAAGCGCATCTCCAACTG
CGTGGCCGACTATTCTGTGCTGTACAACAGCGCCTCCTTCTCTACCTTTAAGT
GCTATGGCGTGAGCCCCACAAAGCTGAATGACCTGTGCTTTACCAACGTGTA
CGCCGATTCCTTCGTGATCAGGGGCGACGAGGTGCGCCAGATCGCACCAGGA
CAGACAGGCAAGATCGCAGACTACAATTATAAGCTGCCTGACGATTTCACCG
GCTGCGT GATCGCCTGGAACTCT AAC AATCTGGAT AGC AAAGT GGGCGGC AA
CTACAATTATCTGTACCGGCTGTTTAGAAAGTCTAATCTGAAGCCATTCGAGA
GGGACATCTCCACAGAAATCTACCAGGCCGGCTCTACCCCCTGCAATGGCGT
GGAGGGCTTTAACTGTTATTTCCCTCTGCAGAGCTACGGCTTCCAGCCAACAA
ACGGCGTGGGCTATCAGCCCTACCGCGTGGTGGTGCTGTCTTTTGAGCTGCTG
C ACGC ACCTGC AAC AGTGT GCGGACC AAAGAAGAGC ACC AATCTGGT GAAG
AACAAGTGCGTGAACTTCAACTTCAACGGACTGACCGGAACAGGCGTGCTGA
CCGAGTCCAACAAGAAGTTCCTGCCTTTTCAGCAGTTCGGCAGGGACATCGC
AGATACCACAGACGCCGTGCGCGACCCTCAGACCCTGGAGATCCTGGACATC
ACACCATGCTCCTTCGGCGGCGTGTCTGTGATCACACCAGGCACCAATACAA
GCAACCAGGTGGCCGTGCTGTATCAGGACGTGAATTGTACCGAGGTGCCAGT
GGCAATCCACGCAGATCAGCTGACCCCTACATGGCGGGTGTACTCTACCGGC
AGC AAC GT GTTCC AGAC AAGAGCCGGAT GCCTGATCGGAGC AGAGC ACGTGA
ACAATAGCTATGAGTGCGACATCCCTATCGGCGCCGGCATCTGTGCCTCCTAC
CAGACCCAGACAAACTCCCCAAGGAGAGCACGGTCTGTGGCCAGCCAGTCCA
TCATCGCCTATACCATGAGCCTGGGCGCCGAGAATTCCGTGGCCTACTCCAAC
AATTCTATCGCCATCCCTACCAACTTCACAATCTCCGTGACCACAGAGATCCT
GCC AGT GAGC AT GACC AAGAC ATCCGTGGACTGC AC AATGT AT ATCTGT GGC GATTCCACCGAGTGCTCTAACCTGCTGCTGCAGTACGGCTCTTTTTGTACCCA
GCTGAAT AGAGCCCTGAC AGGC ATCGCCGT GGAGC AGGAC AAGAAC AC AC A
GGAGGTGTTCGCCCAGGTGAAGCAAATCTACAAGACCCCACCCATCAAGGAC
TTTGGCGGCTTCAACTTCAGCCAGATCCTGCCCGATCCTAGCAAGCCATCCAA
GCGGTCTTTTATCGAGGACCTGCTGTTCAACAAGGTGACCCTGGCCGATGCCG
GCTTCATCAAGCAGTATGGCGATTGCCTGGGCGACATCGCCGCCAGAGACCT
GATCTGTGCCCAGAAGTTTAATGGCCTGACCGTGCTGCCTCCACTGCTGACAG
ATGAGATGATCGCCCAGTACACATCTGCCCTGCTGGCCGGAACCATCACAAG
CGGATGGACCTTCGGCGCAGGAGCCGCCCTGCAGATCCCCTTTGCCATGCAG
ATGGCCTATCGGTTCAACGGCATCGGCGTGACCCAGAATGTGCTGTACGAGA
ACCAGAAGCTGATCGCCAATCAGTTTAACTCCGCCATCGGCAAGATCCAGGA
CTCTCTGAGCTCCACAGCCAGCGCCCTGGGCAAGCTGCAGGATGTGGTGAAT
CAGAACGCCCAGGCCCTGAATACCCTGGTGAAGCAGCTGTCTAGCAACTTCG
GCGCCATCTCCTCTGTGCTGAATGACATCCTGAGCCGGCTGGACAAGGTGGA
GGCAGAGGTGCAGATCGACCGGCTGATCACAGGCAGACTGCAGTCCCTGCAG
ACCTACGTGACACAGCAGCTGATCAGGGCAGCAGAGATCAGGGCCTCTGCCA
ATCTGGCCGCCACCAAGATGAGCGAGTGCGTGCTGGGCCAGTCCAAGAGAGT
GGACTTTTGTGGCAAGGGCTATCACCTGATGAGCTTCCCACAGTCCGCCCCTC
ACGGAGTGGTGTTTCTGCACGTGACCTACGTGCCAGCCCAGGAGAAGAACTT
CACCACAGCACCAGCAATCTGCCACGATGGCAAGGCACACTTTCCTAGGGAG
GGCGTGTTCGTGAGCAACGGCACCCACTGGTTTGTGACACAGCGCAATTTCTA
CGAGCCACAGATCATCACCACAGACAATACATTCGTGTCCGGCAACTGTGAC
GTGGTCATCGGCATCGTGAACAATACCGTGTATGATCCTCTGCAGCCAGAGCT
GGACTCTTTTAAGGAGGAGCTGGATAAGTACTTCAAGAATCACACCAGCCCC
GACGTGGATCTGGGCGACATCTCTGGCATCAATGCCAGCGTGGTGAACATCC
AGAAGGAGATCGACAGGCTGAACGAGGTGGCCAAGAATCTGAACGAGTCCC
TGATCGATCTGCAGGAGCTGGGCAAGTATGAGCAGTACATCAAGTGGCCCTG
GTATATCTGGCTGGGCTTCATCGCCGGCCTGATCGCCATCGTGATGGTGACCA
TCATGCTGTGCTGTATGACAAGCTGCTGTTCCTGCCTGAAGGGCTGCTGTTCT
TGTGGCAGCTGCTGTAAGTTTGATGAGGACGATAGCGAGCCTGTGCTGAAGG
GCGTGAAGCTGCACTACACCTGATAGCTAGCGATCGCCCACCTAGTACAACC
T AAATCC ATT AT AAAAAACTT AGGAGC AAAGTGATTGCCTCCC AAGGTCC AC
AATGACAGAGACCTACGACTTCGACAAGTCGGCATGGGACATCAAAGGGTCG
ATCGCTCCGATACAACCCACCACCTACAGTGATGGCAGGCTGGTGCCCCAGG TC AGAGT CAT AG AT C CTGGT C T AGGC GAC AGGA AGGAT GA AT GC THAT GT A
CATGTTTCTGCTGGGGGTTGTTGAGGACAGCGATTCCCTAGGGCCTCCAATCG
GGCGAGCATTTGGGTTCCTGCCCTTAGGTGTTGGCAGATCCACAGCAAAGCC
CGAAAAACTCCTCAAAGAGGCCACTGAGCTTGACATAGTTGTTAGACGTACA
GCAGGGCTCAATGAAAAACTGGTGTTCTACAACAACACCCCACTAACTCTCC
TCACACCTTGGAGAAAGGTCCTAACAACAGGGAGTGTCTTCAACGCAAACCA
AGTGTGCAATGCGGTTAATCTGATACCGCTCGATACCCCGCAGAGGTTCCGTG
TTGTTTATATGAGCATCACCCGTCTTTCGGATAACGGGTATTACACCGTTCCT
AGAAGAAT GCTGGAATTC AGATCGGT C AATGC AGT GGCCTT C AACCTGCTGG
TGACCCTTAGGATTGACAAGGCGATAGGCCCTGGGAAGATCATCGACAATAC
AGAGCAACTTCCTGAGGCAACATTTATGGTCCACATCGGGAACTTCAGGAGA
AAGAAGAGT GAAGTCT ACTCTGCCGATT ATT GC A AAATGA AAATCGAAAAGA
TGGGCCTGGTTTTTGCACTTGGTGGGATAGGGGGCACCAGTCTTCACATTAGA
AGCACAGGCAAAATGAGCAAGACTCTCCATGCACAACTCGGGTTCAAGAAGA
CCTTATGTTACCCGCTGATGGATATCAATGAAGACCTTAATCGATTACTCTGG
AGGAGC AGAT GC AAGAT AGT AAGAATCC AGGC AGTTTTGC AGCC AT C AGTTC
CTCAAGAATTCCGCATTTACGACGACGTGATCATAAATGATGACCAAGGACT
ATTCAAAGTTCTGTAGACCGTAGTGCCCAGCAATGCCCGAAAACGACCCCCC
TCACAATGACAGCCAGAAGGCCCGGACAAAAAAGCCCCCTCCGAAAGACTCC
ACGGACCAAGCGAGAGGCCAGCCAGCAGCCGACGGCAAGCGCGAACACCAG
GCGGCCCCAGCACAGAACAGCCCTGACACAAGGCCACCACCAGCCACCCCAA
TCTGCATCCTCCTCGTGGGACCCCCGAGGACCAACCCCCAAGGCTGCCCCCG
ATCCAAACCACCAACCGCATCCCCACCACCCCCGGGAAAGAAACCCCCAGCA
ATTGGAAGGCCCCTCCCCCTCTTCCTCAACACAAGAACTCCACAACCGAACC
GCACAAGCGACCGAGGTGACCCAACCGCAGGCATCCGACTCCCTAGACAGAT
CCTCTCTCCCCGGCAAACTAAACAAAACTTAGGGCCAAGGAACATACACACC
CAACAGAACCCAGACCCCGGCCCACGGCGCCGCGCCCCCAACCCCCGACAAC
CAGAGGGAGCCCCCAACCAATCCCGCCGGCTCCCCCGGTGCCCACAGGCAGG
GACACCAACCCCCGAACAGACCCAGCACCCAACCATCGACAATCCAAGACGG
GGGGGCCCCCCCAAAAAAAGGCCCCCAGGGGCCGACAGCCAGCACCGCGAG
GAAGCCCACCCACCCCACACACGACCACGGCAACCAAACCAGAACCCAGAC
CACCCTGGGCCACCAGCTCCCAGACTCGGCCATCACCCCGCAGAAAGGAAAG
GCCACAACCCGCGCACCCCAGCCCCGATCCGGCGGGGAGCCACCCAACCCGA
ACCAGCACCCAAGAGCGATCCCCGAAGGACCCCCGAACCGCAAAGGACATC AGTATCCCACAGCCTCTCCAAGTCCCCCGGTCTCCTCCTCTTCTCGAAGGGAC
CAAAAGATCAATCCACCACACCCGACGACACTCAACTCCCCACCCCTAAAGG
AGACACCGGGAATCCCAGAATCAAGACTCATCCAATGTCCATCATGGGTCTC
AAGGTGAACGTCTCTGCCATATTCATGGCAGTACTGTTAACTCTCCAAACACC
C AC CGGT C A A ATCC ATT GGGGC A AT C TC TC T A AG AT AGGGGT GGT AGGA AT A
GGAAGTGCAAGCTACAAAGTTATGACTCGTTCCAGCCATCAATCATTAGTCAT
AAAATTAATGCCCAATATAACTCTCCTCAATAACTGCACGAGGGTAGAGATT
GCAGAATACAGGAGACTACTGAGAACAGTTTTGGAACCAATTAGAGATGCAC
TTAATGCAATGACCCAGAATATAAGACCGGTTCAGAGTGTAGCTTCAAGTAG
GAGACACAAGAGATTTGCGGGAGTAGTCCTGGCAGGTGCGGCCCTAGGCGTT
GCCACAGCTGCTCAGATAACAGCCGGCATTGCACTTCACCAGTCCATGCTGA
ACTCTCAAGCCATCGACAATCTGAGAGCGAGCCTGGAAACTACTAATCAGGC
AATTGAGACAATCAGACAAGCAGGGCAGGAGATGATATTGGCTGTTCAGGGT
GTCCAAGACTACATCAATAATGAGCTGATACCGTCTATGAACCAACTATCTTG
TGATTTAATCGGCCAGAAGCTCGGGCTCAAATTGCTCAGATACTATACAGAA
ATCCTGTCATTATTTGGCCCCAGTTTACGGGACCCCATATCTGCGGAGATATC
TATCCAGGCTTTGAGCTATGCGCTTGGAGGAGACATCAATAAGGTGTTAGAA
AAGCTCGGATACAGTGGAGGTGATTTACTGGGCATCTTAGAGAGCGGAGGAA
TAAAGGCCCGGATAACTCACGTCGACACAGAGTCCTACTTCATTGTCCTCAGT
ATAGCCTATCCGACGCTGTCCGAGATTAAGGGGGTGATTGTCCACCGGCTAG
AGGGGGTCTCGT AC AAC AT AGGCTCTC AAGAGT GGT AT ACC ACTGT GCCC AA
GTATGTTGCAACCCAAGGGTACCTTATCTCGAATTTTGATGAGTCATCGTGTA
CTTTCATGCCAGAGGGGACTGTGTGCAGCCAAAATGCCTTGTACCCGATGAG
TCCTCTGCTCCAAGAATGCCTCCGGGGGTACACCAAGTCCTGTGCTCGTACAC
TCGTATCCGGGTCTTTTGGGAACCGGTTCATTTTATCACAAGGGAACCTAATA
GCCAATTGTGCATCAATCCTTTGCAAGTGTTACACAACAGGAACGATCATTAA
TCAAGACCCTGACAAGATCCTAACATACATTGCTGCCGATCACTGCCCGGTA
GTCGAGGT GAACGGCGT GACC ATCC AAGTCGGGAGC AGGAGGT ATCC AGAC
GCTGTGTACTTGCACAGAATTGACCTCGGTCCTCCCATATCATTGGAGAGGTT
GGACGT AGGGAC AAATCTGGGGAAT GC AATT GCT A AGTT GGAGGAT GCC AAG
GAATTGTT GGAGT C ATCGGACC AGAT ATT GAGGAGT ATGAAAGGTTT ATCGA
GCACTAGCATAGTCTACATCCTGATTGCAGTGTGTCTTGGAGGGTTGATAGGG
ATCCCCGCTTT AAT AT GTT GCTGC AGGGGGCGTTGT AAC AAAAAGGGAGAAC
AAGTTGGTATGTCAAGACCAGGCCTAAAGCCTGATCTTACGGGAACATCAAA ATCCTATGTAAGGTCGCTCTGATCCTCTACAACTCTTGAAACACAAATGTCCC
ACAAGTCTCCTCTTCGTCATCAAGCAACCACCGCACCCAGCATCAAGCCCACC
TGAAATTATCTCCGGCTTCCCTCTGGCCGAACAATATCGGTAGTTAATTAAAA
CTTAGGGTGCAAGATCATCGATAATGTCACCACAACGAGACCGGATAAATGC
CTTCTACAAAGATAACCCCCATCCCAAGGGAAGTAGGATAGTCATTAACAGA
GAACATCTTATGATTGATAGACCTTATGTTTTGCTGGCTGTTCTGTTTGTCATG
TTTCTGAGCTTGATCGGGTTGCTAGCCATTGCAGGAATTCGACTTCATCGGGC
AGCCATCTACACCGCAGAGATCCATAAAAGCCTCAGCACCAATCTAGATGTA
ACTAACTCAATCGAGCATCAGGTCAAGGACGTGCTGACACCACTCTTCAAAA
TCATCGGTGATGAAGTGGGCCTGAGGACACCTCAGAGATTCACTGACCTAGT
GAAATTAATCTCTGACAAGATTAAATTCCTTAATCCGGATAGGGAGTACGAC
TT C AGAGATCTC ACTT GGT GT AT C A ACCCGCC AGAGAGAAT C AAATTGGATT
AT GATC AAT ACTGT GC AGAT GT GGCTGCTGAAGAGCTC AT GAATGC ATT GGT
GAACTCAACTCTACTGGAGACCAGAACAACCAATCAGTTCCTAGCTGTCTCA
AAGGGAAACTGCTCAGGGCCCACTACAATCAGAGGTCAATTCTCAAACATGT
CGCTGTCCCTGTTAGACTTGTATTTAGGTCGAGGTTACAATGTGTCATCTATA
GTCACTATGACATCCCAGGGAATGTATGGGGGAACTTACCTAGTGGAAAAGC
CTAATCTGAGCAGCAAAAGGTCAGAGTTGTCACAACTGAGCATGTACCGAGT
GTTTGAAGTAGGTGTTATCAGAAATCCGGGTTTGGGGGCTCCGGTGTTCCATA
TGACAAACTATCTTGAGCAACCAGTCAGTAATGATCTCAGCAACTGTATGGT
GGCTTTGGGGGAGCTCAAACTCGCAGCCCTTTGTCACGGGGAAGATTCTATC
AC A ATTCCC T AT C AGGGAT C AGGGA A AGGT GT C AGC TTCC AGC T C GT C A AGC
TAGGTGTCTGGAAATCCCCAACCGACATGCAATCCTGGGTCCCCTTATCAACG
GATGATCCAGTGATAGACAGGCTTTACCTCTCATCTCACAGAGGTGTTATCGC
TGACAACCAAGCAAAATGGGCTGTCCCGACAACACGAACAGATGACAAGTTG
CGAATGGAGACATGCTTCCAACAGGCGTGTAAGGGTAAAATCCAAGCACTCT
GCGAGAATCCCGAGTGGGCACCATTGAAGGATAACAGGATTCCTTCATACGG
GGTCTTGTCTGTTGATCTGAGTCTGACAGTTGAGCTTAAAATCAAAATTGCTT
CGGGATTCGGGCCATTGATCACACACGGTTCAGGGATGGACCTATACAAATC
CAACCACAACAATGTGTATTGGCTGACTATCCCGCCAATGAAGAACCTAGCC
TTAGGTGTAATCAACACATTGGAGTGGATACCGAGATTCAAGGTTAGTCCCT
ACCTCTTCACTGTCCCAATTAAGGAAGCAGGCGAAGACTGCCATGCCCCAAC
ATACCTACCTGCGGAGGTGGATGGTGATGTCAAACTCAGTTCCAATCTGGTG
ATTCTACCTGGTCAAGATCTCCAATATGTTTTGGCAACCTACGATACTTCCAG GGTTGAACATGCTGTGGTTTATTACGTTTACAGCCCAAGCCGCTCATTTTCTT
ACTTTTATCCTTTTAGGTTGCCTATAAAGGGGGTCCCCATCGAATTACAAGTG
GAATGCTTCACATGGGACCAAAAACTCTGGTGCCGTCACTTCTGTGTGCTTGC
GGACTC AGA AT C T GGT GGAC AT AT C ACTC ACTCTGGGAT GGT GGGC AT GGG A
GT C AGCTGC AC AGT C ACCCGGGAAGAT GGAACC AATCGC AGAT AGGGCTGCT
AGTGAACCAATCACATGATGTCACCCAGACATCAGGCATACCCACTAGTGTG
AAAT AG AC AT C AGAATT AAGAAAAACGT AGGGTCC AAGT GGTTCCCCGTT AT
GGACTCGCTATCTGTCAACCAGATCTTATACCCTGAAGTTCACCTAGATAGCC
CGATAGTTACCAATAAGATAGTAGCCATCCTGGAGTATGCTCGAGTCCCTCAC
GCTTACAGCCTGGAGGACCCTACACTGTGTCAGAACATCAAGCACCGCCTAA
AAAACGGATTTTCCAACCAAATGATTATAAACAATGTGGAAGTTGGGAATGT
CATCAAGTCCAAGCTTAGGAGTTATCCGGCCCACTCTCATATTCCATATCCAA
ATTGT A ATC AGGATTT ATTT A AC AT AGA AG AC A A AG AGT C A AC GAGGA AGAT
CCGTGAACTCCTCAAAAAGGGGAATTCGCTGTACTCCAAAGTCAGTGATAAG
GTTTTCCAATGCTTAAGGGACACTAACTCACGGCTTGGCCTAGGCTCCGAATT
GAGGGAGGACATCAAGGAGAAAGTTATTAACTTGGGAGTTTACATGCACAGC
TCCCAGTGGTTTGAGCCCTTTCTGTTTTGGTTTACAGTCAAGACTGAGATGAG
GTCAGTGATTAAATCACAAACCCATACTTGCCATAGGAGGAGACACACACCT
GTATTCTTCACTGGTAGTTCAGTTGAGTTGCTAATCTCTCGTGACCTTGTTGCT
ATAATCAGTAAAGAGTCTCAACATGTATATTACCTGACATTTGAACTGGTTTT
GATGTATTGTGATGTCATAGAGGGGAGGTTAATGACAGAGACCGCTATGACT
ATTGAT GCT AGGT AT AC AGAGC TTCT AGGA AGAGT C AGAT AC AT GT GGA A AC
TGATAGATGGTTTCTTCCCTGCACTCGGGAATCCAACTTATCAAATTGTAGCC
ATGCTGGAGCCTCTTTCACTTGCTTACCTGCAGCTGAGGGATATAACAGTAGA
ACTCAGAGGTGCTTTCCTTAACCACTGCTTTACTGAAATACATGATGTTCTTG
ACCAAAACGGGTTTTCTGATGAAGGTACTTATCATGAGTTAACTGAAGCTCTA
GATTACATTTTCATAACTGATGACATACATCTGACAGGGGAGATTTTCTCATT
TTTCAGAAGTTTCGGCCACCCCAGACTTGAAGCAGTAACGGCTGCTGAAAAT
GT T AGGA A AT AC AT G A AT C AGC C T A A AGT C ATT GT GT AT GAG AC TC T GAT G A
AAGGT CAT GCC AT ATTTT GT GGAAT CAT AAT C AACGGCT ATCGTGAC AGGC A
CGGAGGCAGTTGGCCACCGCTGACCCTCCCCCTGCATGCTGCAGACACAATC
CGGAATGCTCAAGCTTCAGGTGAAGGGTTAACACATGAGCAGTGCGTTGATA
ACTGGAAATCTTTTGCTGGAGTGAAATTTGGCTGCTTTATGCCTCTTAGCCTG
GATAGTGATCTGACAATGTACCTAAAGGACAAGGCACTTGCTGCTCTCCAAA GGGAATGGGATTCAGTTTACCCGAAAGAGTTCCTGCGTTACGACCCTCCCAA
GGGAACCGGGTCACGGAGGCTTGTAGATGTTTTCCTTAATGATTCGAGCTTTG
ACCCATATGATGTGATAATGTATGTTGTAAGTGGAGCTTACCTCCATGACCCT
GAGTTCAACCTGTCTTACAGCCTGAAAGAAAAGGAGATCAAGGAAACAGGTA
GACTTTTTGCTAAAATGACTTACAAAATGAGGGCATGCCAAGTGATTGCTGA
AAATCT AATCTC AAACGGGATTGGC AAAT ATTTT AAGGAC AAT GGGAT GGCC
AAGGATGAGCACGATTTGACTAAGGCACTCCACACTCTAGCTGTCTCAGGAG
TCCCC AAAGATCTC AAAGAAAGTC AC AGGGGGGGGCC AGTCTT AAA AACCT A
CTCCCGAAGCCCAGTCCACACAAGTACCAGGAACGTGAGAGCAGCAAAAGG
GTTTATAGGGTTCCCTCAAGTAATTCGGCAGGACCAAGACACTGATCATCCG
GAGAATATGGAAGCTTACGAGACAGTCAGTGCATTTATCACGACTGATCTCA
AGAAGTACTGCCTTAATTGGAGATATGAGACCATCAGCTTGTTTGCACAGAG
GCTAAATGAGATTTACGGATTGCCCTCATTTTTCCAGTGGCTGCATAAGAGGC
TTGAGACCTCTGTCCTGTATGTAAGTGACCCTCATTGCCCCCCCGACCTTGAC
GCCCATATCCCGTTATATAAAGTCCCCAATGATCAAATCTTCATTAAGTACCC
T AT GGGAGGT AT AGA AGGGT ATT GT C AGA AGCTGT GGAC CAT C AGC ACC ATT
CCCTATCTATACCTGGCTGCTTATGAGAGCGGAGTAAGGATTGCTTCGTTAGT
GCAAGGGGACAATCAGACCATAGCCGTAACAAAAAGGGTACCCAGCACATG
GCCCTACAACCTTAAGAAACGGGAAGCTGCTAGAGTAACTAGAGATTACTTT
GTAATTCTTAGGCAAAGGCTACATGATATTGGCCATCACCTCAAGGCAAATG
AGAC AATT GTTT CAT C AC ATTTTTTTGTCT ATTC A AAAGGAAT AT ATT ATGAT G
GGCTACTTGTGTCCCAATCACTCAAGAGCATCGCAAGATGTGTATTCTGGTCA
GAG AC TAT AGTTGAT GA A AC A AGGGC AGC AT GC AGT AAT ATT GCT AC A AC A A
TGGCTAAAAGCATCGAGAGAGGTTATGACCGTTACCTTGCATATTCCCTGAAC
GTCCTAAAAGTGATACAGCAAATTCTGATCTCTCTTGGCTTCACAATCAATTC
AACCATGACCCGGGATGTAGTCATACCCCTCCTCACAAACAACGACCTCTTA
ATAAGGATGGCACTGTTGCCCGCTCCTATTGGGGGGATGAATTATCTGAATAT
GAGCAGGCTGTTTGTCAGAAACATCGGTGATCCAGTAACATCATCAATTGCT
GATCTCAAGAGAATGATTCTCGCCTCACTAATGCCTGAAGAGACCCTCCATCA
GGTAATGACACAACAACCGGGGGACTCTTCATTCCTAGACTGGGCTAGCGAC
CCTTACTCAGCAAATCTTGTATGTGTCCAGAGCATCACTAGACTCCTCAAGAA
CATAACTGCAAGGTTTGTCCTGATCCATAGTCCAAACCCAATGTTAAAAGGAT
T ATTCC ATGAT GAC AGT AAAGAAGAGGACGAGGGACTGGCGGC ATTCCTC AT
GGACAGGCATATTATAGTACCTAGGGCAGCTCATGAAATCCTGGATCATAGT GT C AC AGGGGC AAGAGAGTCT ATT GC AGGC AT GCTGGAT ACC AC AAA AGGCT
TGATTCGAGCCAGCATGAGGAAGGGGGGTTTAACCTCTCGAGTGATAACCAG
ATTGTCC AATT ATGACT AT GAAC A ATT C AGAGC AGGGAT GGT GCT ATT GAC A
GGAAGA AAGAGAAAT GTCCTC ATTGAC AAAGAGT CAT GTT C AGTGC AGCTGG
CGAGAGCTCTAAGAAGCCATATGTGGGCGAGGCTAGCTCGAGGACGGCCTAT
TTACGGCCTTGAGGTCCCTGATGTACTAGAATCTATGCGAGGCCACCTTATTC
GGCGTCATGAGACATGTGTCATCTGCGAGTGTGGATCAGTCAACTACGGATG
GTTTTTTGTCCCCTCGGGTTGCCAACTGGATGATATTGACAAGGAAACATCAT
CCTTGAGAGTCCCATATATTGGTTCTACCACTGATGAGAGAACAGACATGAA
GCTTGCCTTCGTAAGAGCCCCAAGTCGATCCTTGCGATCTGCTGTTAGAATAG
C A AC AGT GT AC T CAT GGGC TT AC GGT GAT GAT GAT AGC TC TT GGA AC GA AGC
CTGGTTGTTGGCTAGGCAAAGGGCCAATGTGAGCCTGGAGGAGCTAAGGGTG
ATCACTCCCATCTCAACTTCGACTAATTTAGCGCATAGGTTGAGGGATCGTAG
CACTCAAGTGAAATACTCAGGTACATCCCTTGTCCGAGTGGCGAGGTATACC
ACAATCTCCAACGACAATCTCTCATTTGTCATATCAGATAAGAAGGTTGATAC
TAACTTTATATACCAACAAGGAATGCTTCTAGGGTTGGGTGTTTTAGAAACAT
TGTTTCGACTCGAGAAAGATACCGGATCATCTAACACGGTATTACATCTTCAC
GTCGAAACAGATTGTTGCGTGATCCCGATGATAGATCATCCCAGGATACCCA
GCTCCCGCAAGCTAGAGCTGAGGGCAGAGCTATGTACCAACCCATTGATATA
TGAT AAT GC ACCTTT AATT GAC AG AG AT GC AAC AAGGCT AT AC ACCC AGAGC
CATAGGAGGCACCTTGTGGAATTTGTTACATGGTCCACACCCCAACTATATCA
CATTTTAGCTAAGTCCACAGCACTATCTATGATTGACCTGGTAACAAAATTTG
AGAAGGACC AT AT GAAT GAAATTTC AGCTCTC AT AGGGGAT GAC GAT AT C AA
TAGTTTCATAACTGAGTTTCTGCTCATAGAGCCAAGATTATTCACTATCTACTT
GGGCCAGTGTGCGGCCATCAATTGGGCATTTGATGTACATTATCATAGACCAT
CAGGGAAATATCAGATGGGTGAGCTGTTGTCATCGTTCCTTTCTAGAATGAGC
AAAGGAGTGTTTAAGGTGCTTGTCAATGCTCTAAGCCACCCAAAGATCTACA
AGAAATTCTGGCATTGTGGTATTATAGAGCCTATCCATGGTCCTTCACTTGAT
GCTCAAAACTTGCACACAACTGTGTGCAACATGGTTTACACATGCTATATGAC
CTACCTCGACCTGTTGTTGAATGAAGAGTTAGAAGAGTTCACATTTCTCTTGT
GTGAAAGCGACGAGGATGTAGTACCGGACAGATTCGACAACATCCAGGCAA
AACACTTATGTGTTCTGGCAGATTTGTACTGTCAACCAGGGACCTGCCCACCA
ATTCGAGGTCTAAGACCGGTAGAGAAATGTGCAGTTCTAACCGACCATATCA
AGGCAGAGGCTATGTTATCTCCAGCAGGATCTTCGTGGAACATAAATCCAAT TATTGTAGACCATTACTCATGCTCCCTGACTTATCTCCGGCGAGGATCGATCA
AACAGATAAGATTGAGAGTTGATCCAGGATTCATTTTCGACGCCCTCGCTGA
GGTAAATGTCAGTCAGCCAAAGATCGGCAGCAACAACATCTCAAATATGAGC
ATCAAGGCTTTCAGACCCCCACACGATGATGTTGCAAAATTGCTCAAAGATA
TCAACACAAGCAAGCACAATCTTCCCATTTCAGGGGGCAATCTCGCCAATTAT
GAAATCCATGCTTTCCGCAGAATCGGGTTGAACTCATCTGCTTGCTACAAAGC
TGTTGAGATATCAACATTAATTAGGAGATGCCTTGAGCCAGGGGAGGACGGC
TTGTTCTTGGGTGAGGGATCGGGTTCTATGTTGATCACTTATAAGGAGATACT
TAAACTAAACAAGTGCTTCTATAATAGTGGGGTTTCCGCCAATTCTAGATCTG
GTCAAAGGGAATTAGCACCCTATCCCTCCGAAGTTGGCCTTGTCGAACACAG
AATGGGAGTAGGTAATATTGTCAAAGTGCTCTTTAACGGGAGGCCCGAAGTC
ACGTGGGTAGGCAGTGTAGATTGCTTCAATTTCATAGTTAGTAATATCCCTAC
CTCTAGTGTGGGGTTTATCCATTCAGATATAGAGACCTTGCCTGACAAAGATA
CTATAGAGAAGCTAGAGGAATTGGCAGCCATCTTATCGATGGCTCTGCTCCTG
GGCAAAATAGGATCAATACTGGTGATTAAGCTTATGCCTTTCAGCGGGGATTT
T GTT C AGGGATTT AT A AGTT AT GT AGGGT C TC ATT AT AGAGA AGT GA ACC TT G
TATACCCTAGATACAGCAACTTCATATCTACTGAATCTTATTTGGTTATGACA
GATCTC AAGGCT AACCGGCT AAT GAATCCTGAAAAGATT AAGC AGC AGAT AA
TTGAATCATCTGTGAGGACTTCACCTGGACTTATAGGTCACATCCTATCCATT
AAGCAACTAAGCTGCATACAAGCAATTGTGGGAGACGCAGTTAGTAGAGGTG
ATATCAATCCTACTCTGAAAAAACTTACACCTATAGAGCAGGTGCTGATCAAT
TGCGGGTTGGCAATTAACGGACCTAAGCTGTGCAAAGAATTGATCCACCATG
ATGTTGCCTCAGGGCAAGATGGATTGCTTAATTCTATACTCATCCTCTACAGG
GAGTTGGCAAGATTCAAAGACAACCAAAGAAGTCAACAAGGGATGTTCCAC
GCCTACCCCGTATTGGTAAGTAGCAGGCAACGAGAACTTATATCTAGGATCA
CCCGCAAATTTTGGGGGCACATTCTTCTTTACTCCGGGAACAAAAAGTTGATA
AATAAGTTTATCCAGAATCTCAAGTCCGGCTATCTGATACTAGACTTACACCA
GAATATCTTCGTTAAGAATCTATCCAAGTCAGAGAAACAGATTATTATGACG
GGGGGTTTGAAACGTGAGTGGGTTTTTAAGGTAACAGTCAAGGAGACCAAAG
AATGGTATAAGTTAGTCGGATACAGTGCCCTGATTAAGGACTAATTGGTTGA
ACTCCGGAACCCTAATCCTGCCCTAGGTGGTTAGGCATTATTTGCAATATATT
AAAGAAAACTTTGAAAATACGAAGTTTCTATTCCCAGCTTTGTCTGGTggccggc atAgtcccagcctcctcgctggcgctggctgggcaacattccgaggggaccgtccccAcggtaatggcgaatgggacgcgg ccgatccggctgctaacaaagcccgaaaggaagctgagttggctgctgGcGcTGgctgGgcaataactagcataacccctt ggggcctctaaacgggtcttgaggggttttttgctgaaaggaggaactatatccggatgcGGCCGCGCGCTTGGC
GTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTC
CACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATG
AGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGG
GAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGG
CGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTC
GGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGG
TT ATCC AC AGA AT C AGGGGAT A AC GC AGG A A AGA AC AT GT GAGC A A A AGGC
CAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATA
GGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTG
GCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCC
CTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTT
CTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAG
TTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTC
AGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTA
AGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAG
CGAGGT AT GT AGGCGGT GCT AC AGAGTTCTTGAAGT GGT GGCCT AACT ACGG
CTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCT
TCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAG
CGGT GGTTTTTTT GTTTGC AAGC AGC AGATT ACGCGC AGAAAA AAAGGATCT
CAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAA
ACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAG
ATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTA
AACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGA
TCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTA
CGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGA
CCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGG
GCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAA
TTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAAC
GTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGC
TTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGT
TGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAG
TTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGT CATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATA
CGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAA
AACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGT
TCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACC
AGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGA
ATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTA
TTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTA
TTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCC
ACCTG.
In still another embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 5, shown below:
GGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGC
AGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTT
CCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGG
GGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAA
CTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTT
TCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAA
CTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATT
TTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAA
CGCGAATTTTAACAAAATATTAACGTTTACAATTTCGCGCCATTCGCCATTCA
GGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACG
CCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCA
GGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGCGCGCCGTTAAT
ACGACTCACTATAGGGAGACCCAAGCTGGCTAGCTTTGTTTGGTCTGATGAGT
CCCGTGAGGACGAAACCCGGCGTACCGGGTCACCAAACAAAGTTGGGTAAG
GATAGTTCAATCAATGATCATCTTCTAGTGCACTTAGGATTCAAGATCCTATT
AT C AGGGAC AAGAGC AGGATT AGGGAT ATCCGAGAT GGCC AC ACTTTT A AGG
AGCTTAGCATTGTTCAAAAGAAACAAGGACAAACCACCCATTACATCAGGAT
CCGGTGGAGCCATCAGAGGAATCAAACACATTATTATAGTACCAATCCCTGG
AGATTCCTCAATTACCACTCGATCCAGACTTCTGGACCGGTTGGTGAGGTTAA
TTGGAAACCCGGATGTGAGCGGGCCCAAACTAACAGGGGCACTAATAGGTAT
ATTATCCTTATTTGTGGAGTCTCCAGGTCAATTGATTCAGAGGATCACCGATG
ACCCTGACGTTAGCATAAGGCTGTTAGAGGTTGTCCAGAGTGACCAGTCACA
ATCTGGCCTTACCTTCGCATCAAGAGGTACCAACATGGAGGATGAGGCGGAC CAATACTTTTCACATGATGATCCAATTAGTAGTGATCAATCCAGGTTCGGATG
GTTCGGGAAC AAGGAAATCTC AGAT ATTGAAGT GC AAGACCCTGAGGGATT C
AACATGATTCTGGGTACCATCCTAGCCCAAATTTGGGTCTTGCTCGCAAAGGC
GGTTACGGCCCCAGACACGGCAGCTGATTCGGAGCTAAGAAGGTGGATAAAG
TACACCCAACAAAGAAGGGTAGTTGGTGAATTTAGATTGGAGAGAAAATGGT
TGGATGTGGTGAGGAACAGGATTGCCGAGGACCTCTCCTTACGCCGATTCAT
GGTCGCTCTAATCCTGGATATCAAGAGAACACCCGGAAACAAACCCAGGATT
GCTGAAAT GAT ATGT GAC ATTGAT AC AT AT ATCGT AGAGGC AGGATT AGCC A
GTTTTATCCTGACTATTAAGTTTGGGATAGAAACTATGTATCCTGCTCTTGGA
CTGCATGAATTTGCTGGTGAGTTATCCACACTTGAGTCCTTGATGAACCTTTA
CCAGCAAATGGGGGAAACTGCACCCTACATGGTAATCCTGGAGAACTCAATT
CAGAACAAGTTCAGTGCAGGATCATACCCTCTGCTCTGGAGCTATGCCATGG
GAGT AGGAGT GGAACTTGAAAACTCC AT GGGAGGTTT GAACTTT GGCCGATC
TTACTTTGATCCAGCATATTTTAGATTAGGGCAAGAGATGGTAAGGAGGTCA
GCTGGAAAGGT C AGTTCC AC ATT GGC ATCTGAACTCGGT AT C ACTGCCGAGG
AT GC AAGGCTT GTTTC AGAGATTGC AAT GC AT ACT ACTGAGGAC A AGATC AG
TAGAGCGGTTGGACCCAGACAAGCCCAAGTATCATTTCTACACGGTGATCAA
AGTGAGAATGAGCTACCGAGATTGGGGGGCAAGGAAGATAGGAGGGTCAAA
C AGAGT C GAGGAGA AGC C AGGGAGAGCT AC AGAGA A ACC GGGCC C AGC AGA
GCAAGTGATGCGAGAGCTGCCCATCTTCCAACCGGCACACCCCTAGACATTG
ACACTGCAACGGAGTCCAGCCAAGATCCGCAGGACAGTCGAAGGTCAGCTGA
CGCCCTGCTT AGGCTGC AAGCC AT GGC AGGAATCTCGGAAGAAC AAGGCTC A
GACACGGACACCCCTATAGTGTACAATGACAGAAATCTTCTAGACTAGGTGC
GAGAGGCCGAGGGCCAGAACAACATCCGCCTACCATCCATCATTGTTATAAA
AAACTTAGGAACCAGGTCCACACAGCCGCCAGCCCATCAACCATCCACTCCC
ACGATTGGAGCCAATGGCAGAAGAGCAGGCACGCCATGTCAAAAACGGACT
GGAATGCATCCGGGCTCTCAAGGCCGAGCCCATCGGCTCACTGGCCATCGAG
GA AGC TAT GGC AGC AT GGTC AGA A AT AT C AGAC A AC CC AGGAC AGGAGC GA
GCCACCTGCAGGGAAGAGAAGGCAGGCAGTTCGGGTCTCAGCAAACCATGCC
TCTCAGCAATTGGATCAACTGAAGGCGGTGCACCTCGCATCCGCGGTCAGGG
ACCTGGAGAGAGCGATGACGACGCTGAAACTTTGGGAATCCCCCCAAGAAAT
CTCCAGGCATCAAGCACTGGGTTACAGTGTTATTACGTTTATGATCACAGCGG
TGAAGCGGTTAAGGGAATCCAAGATGCTGACTCTATCATGGTTCAATCAGGC
CTTGATGGT GAT AGC ACCCTCTC AGGAGGAGAC AAT GAATCTGAAAAC AGCG ATGTGGATATTGGCGAACCTGATACCGAGGGATATGCTATCACTGACCGGGG
ATCTGCTCCCATCTCTATGGGGTTCAGGGCTTCTGATGTTGAAACTGCAGAAG
GAGGGGAGATCCACGAGCTCCTGAGACTCCAATCCAGAGGCAACAACTTTCC
GAAGCTTGGGAAAACTCTCAATGTTCCTCCGCCCCCGGACCCCGGTAGGGCC
AGCACTTCCGGGACACCCATTAAAAAGGGCACAGACGCGAGATTAGCCTCAT
TTGGAACGGAGATCGCGTCTTTATTGACAGGTGGTGCAACCCAATGTGCTCG
AAAGTCACCCTCGGAACCATCAGGGCCAGGTGCACCTGCGGGGAATGTCCCC
GAGTGTGTGAGCAATGCCGCACTGATACAGGAGTGGACACCCGAATCTGGTA
CCACAATCTCCCCGAGATCCCAGAATAATGAAGAAGGGGGAGACTATTATGA
TGATGAGCTGTTCTCTGATGTCCAAGATATTAAAACAGCCTTGGCCAAAATAC
ACGAGGATAATCAGAAGATAATCTCCAAGCTAGAATCACTGCTGTTATTGAA
GGGAGAAGTTGAGTCAATTAAGAAGCAGATCAACAGGCAAAATATCAGCAT
ATCCACCCTGGAAGGACACCTCTCAAGCATCATGATCGCCATTCCTGGACTTG
GGAAGGATCCCAACGACCCCACTGCAGATGTCGAAATCAATCCCGACTTGAA
ACCCATCATAGGCAGAGATTCAGGCCGAGCACTGGCCGAAGTTCTCAAGAAA
CCCGTTGCCAGCCGACAACTCCAAGGAATGACAAATGGACGGACCAGTTCCA
GAGGAC AGCTGCTGAAGGAATTTC AGCT AAAGCCGATCGGGAAAAAGATGA
GCTCAGCCGTCGGGTTTGTTCCTGACACCGGCCCTGCATCACGCAGTGTAATC
CGCTCCATTATAAAATCCAGCCGGCTAGAGGAGGATCGGAAGCGTTACCTGA
TGACTCTCCTTGATGATATCAAAGGAGCCAATGATCTTGCCAAGTTCCACCAG
ATGCTGATGAAGATAATAATGAAGTAGCTACAGCTCAACTTACCTGCCAACC
CCATGCCAGTCGACCCACCTAGTACAACCTAAATCCATTATAAAAAACTTAG
GAGCAAAGTGATTGCCTCCCAAGGTCCACAATGACAGAGACCTACGACTTCG
ACAAGTCGGCATGGGACATCAAAGGGTCGATCGCTCCGATACAACCCACCAC
CTACAGTGATGGCAGGCTGGTGCCCCAGGTCAGAGTCATAGATCCTGGTCTA
GGC GAC AGGA AGGAT GA AT GC THAT GT AC AT GTTTCTGC T GGGGGTT GTT GA
GGACAGCGATTCCCTAGGGCCTCCAATCGGGCGAGCATTTGGGTTCCTGCCCT
TAGGTGTTGGCAGATCCACAGCAAAGCCCGAAAAACTCCTCAAAGAGGCCAC
T GAGCTT GAC AT AGTTGTT AGACGT AC AGC AGGGCTC AATGAAAAACTGGT G
TTCTACAACAACACCCCACTAACTCTCCTCACACCTTGGAGAAAGGTCCTAAC
AACAGGGAGTGTCTTCAACGCAAACCAAGTGTGCAATGCGGTTAATCTGATA
CCGCTCGATACCCCGCAGAGGTTCCGTGTTGTTTATATGAGCATCACCCGTCT
TTCGGAT AACGGGT ATT AC ACCGTTCCT AGAAGAAT GCTGGAATT C AGATCG
GTCAATGCAGTGGCCTTCAACCTGCTGGTGACCCTTAGGATTGACAAGGCGA TAGGCCCTGGGAAGATCATCGACAATACAGAGCAACTTCCTGAGGCAACATT
T ATGGTCC AC ATCGGGAACTTC AGGAGAAAGAAGAGT GAAGTCT ACTCTGCC
GATT ATTGC AAAAT GAAAATCGAAAAGAT GGGCCTGGTTTTTGC ACTTGGT G
GGATAGGGGGCACCAGTCTTCACATTAGAAGCACAGGCAAAATGAGCAAGA
CTCTCCATGCACAACTCGGGTTCAAGAAGACCTTATGTTACCCGCTGATGGAT
ATCAATGAAGACCTTAATCGATTACTCTGGAGGAGCAGATGCAAGATAGTAA
GAATCCAGGCAGTTTTGCAGCCATCAGTTCCTCAAGAATTCCGCATTTACGAC
GACGTGATCATAAATGATGACCAAGGACTATTCAAAGTTCTGTAGACCGTAG
TGCCCAGCAATGCCCGAAAACGACCCCCCTCACAATGACAGCCAGAAGGCCC
GGACAAAAAAGCCCCCTCCGAAAGACTCCACGGACCAAGCGAGAGGCCAGC
CAGCAGCCGACGGCAAGCGCGAACACCAGGCGGCCCCAGCACAGAACAGCC
CTGACACAAGGCCACCACCAGCCACCCCAATCTGCATCCTCCTCGTGGGACC
CCCGAGGACCAACCCCCAAGGCTGCCCCCGATCCAAACCACCAACCGCATCC
CCACCACCCCCGGGAAAGAAACCCCCAGCAATTGGAAGGCCCCTCCCCCTCT
TCCTCAACACAAGAACTCCACAACCGAACCGCACAAGCGACCGAGGTGACCC
AACCGCAGGCATCCGACTCCCTAGACAGATCCTCTCTCCCCGGCAAACTAAA
CAAAACTTAGGGCCAAGGAACATACACACCCAACAGAACCCAGACCCCGGC
CCACGGCGCCGCGCCCCCAACCCCCGACAACCAGAGGGAGCCCCCAACCAAT
CCCGCCGGCTCCCCCGGTGCCCACAGGCAGGGACACCAACCCCCGAACAGAC
CCAGCACCCAACCATCGACAATCCAAGACGGGGGGGCCCCCCCAAAAAAAG
GCCCCCAGGGGCCGACAGCCAGCACCGCGAGGAAGCCCACCCACCCCACAC
ACGACCACGGCAACCAAACCAGAACCCAGACCACCCTGGGCCACCAGCTCCC
AGACTCGGCCATCACCCCGCAGAAAGGAAAGGCCACAACCCGCGCACCCCA
GCCCCGATCCGGCGGGGAGCCACCCAACCCGAACCAGCACCCAAGAGCGATC
CCCGAAGGACCCCCGAACCGCAAAGGACATCAGTATCCCACAGCCTCTCCAA
GTCCCCCGGTCTCCTCCTCTTCTCGAAGGGACCAAAAGATCAATCCACCACAC
CCGACGACACTCAACTCCCCACCCCTAAAGGAGACACCGGGAATCCCAGAAT
CAAGACTCATCCAATGTCCATCATGGGTCTCAAGGTGAACGTCTCTGCCATAT
TCATGGCAGTACTGTTAACTCTCCAAACACCCACCGGTCAAATCCATTGGGGC
A ATCTCTCT A AGAT AGGGGT GGT AGGA AT AGGA AGT GC A AGC T AC A A AGTT A
TGACTCGTTCCAGCCATCAATCATTAGTCATAAAATTAATGCCCAATATAACT
CTCCTCAATAACTGCACGAGGGTAGAGATTGCAGAATACAGGAGACTACTGA
GAACAGTTTTGGAACCAATTAGAGATGCACTTAATGCAATGACCCAGAATAT
AAGACCGGTTCAGAGTGTAGCTTCAAGTAGGAGACACAAGAGATTTGCGGGA GTAGTCCTGGCAGGTGCGGCCCTAGGCGTTGCCACAGCTGCTCAGATAACAG
CCGGCATTGCACTTCACCAGTCCATGCTGAACTCTCAAGCCATCGACAATCTG
AGAGCGAGCCTGGAAACTACTAATCAGGCAATTGAGACAATCAGACAAGCA
GGGCAGGAGATGATATTGGCTGTTCAGGGTGTCCAAGACTACATCAATAATG
AGCTGATACCGTCTATGAACCAACTATCTTGTGATTTAATCGGCCAGAAGCTC
GGGCTCAAATTGCTCAGATACTATACAGAAATCCTGTCATTATTTGGCCCCAG
TTTACGGGACCCCATATCTGCGGAGATATCTATCCAGGCTTTGAGCTATGCGC
TTGGAGGAGAC AT C AAT AAGGT GTT AGAAAAGCTCGGAT AC AGTGGAGGTGA
TTTACTGGGCATCTTAGAGAGCGGAGGAATAAAGGCCCGGATAACTCACGTC
GACACAGAGTCCTACTTCATTGTCCTCAGTATAGCCTATCCGACGCTGTCCGA
GATTAAGGGGGTGATTGTCCACCGGCTAGAGGGGGTCTCGTACAACATAGGC
TCTCAAGAGTGGTATACCACTGTGCCCAAGTATGTTGCAACCCAAGGGTACCT
TATCTCGAATTTTGATGAGTCATCGTGTACTTTCATGCCAGAGGGGACTGTGT
GCAGCCAAAATGCCTTGTACCCGATGAGTCCTCTGCTCCAAGAATGCCTCCGG
GGGTACACCAAGTCCTGTGCTCGTACACTCGTATCCGGGTCTTTTGGGAACCG
GTTCATTTTATCACAAGGGAACCTAATAGCCAATTGTGCATCAATCCTTTGCA
AGT GTT AC AC AAC AGGAACGAT C ATT AAT C AAGACCCTGAC AAGATCCT AAC
ATACATTGCTGCCGATCACTGCCCGGTAGTCGAGGTGAACGGCGTGACCATC
CAAGTCGGGAGCAGGAGGTATCCAGACGCTGTGTACTTGCACAGAATTGACC
TCGGTCCTCCCATATCATTGGAGAGGTTGGACGTAGGGACAAATCTGGGGAA
TGCAATTGCTAAGTTGGAGGATGCCAAGGAATTGTTGGAGTCATCGGACCAG
ATATTGAGGAGTATGAAAGGTTTATCGAGCACTAGCATAGTCTACATCCTGAT
TGCAGTGTGTCTTGGAGGGTTGATAGGGATCCCCGCTTTAATATGTTGCTGCA
GGGGGC GTT GT A AC A A A A AGGGAGA AC A AGTT GGT AT GT C A AGACC AGGCC
TAAAGCCTGATCTTACGGGAACATCAAAATCCTATGTAAGGTCGCTCTGATCC
TCTACAACTCTTGAAACACAAATGTCCCACAAGTCTCCTCTTCGTCATCAAGC
AACCACCGCACCCAGCATCAAGCCCACCTGAAATTATCTCCGGCTTCCCTCTG
GCCGAACAATATCGGTAGTTAATTAAAACTTAGGGTGCAAGATCATCGATAA
TGTCACCACAACGAGACCGGATAAATGCCTTCTACAAAGATAACCCCCATCC
C AAGGGAAGT AGGAT AGT C ATT A AC AGAGAAC ATCTT AT GATT GAT AGACCT
TATGTTTTGCTGGCTGTTCTGTTTGTCATGTTTCTGAGCTTGATCGGGTTGCTA
GCCATTGCAGGAATTCGACTTCATCGGGCAGCCATCTACACCGCAGAGATCC
ATAAAAGCCTCAGCACCAATCTAGATGTAACTAACTCAATCGAGCATCAGGT
CAAGGACGTGCTGACACCACTCTTCAAAATCATCGGTGATGAAGTGGGCCTG AGGAC ACC T C AGAGATT C AC T GAC CT AGT GA A ATT A AT C TC T G AC A AG ATT A
AATTCCTTAATCCGGATAGGGAGTACGACTTCAGAGATCTCACTTGGTGTATC
AACCCGCCAGAGAGAATCAAATTGGATTATGATCAATACTGTGCAGATGTGG
CTGCTGAAGAGCTCATGAATGCATTGGTGAACTCAACTCTACTGGAGACCAG
AACAACCAATCAGTTCCTAGCTGTCTCAAAGGGAAACTGCTCAGGGCCCACT
ACAATCAGAGGTCAATTCTCAAACATGTCGCTGTCCCTGTTAGACTTGTATTT
AGGTCGAGGTTACAATGTGTCATCTATAGTCACTATGACATCCCAGGGAATGT
AT GGGGGAACTT ACCT AGT GGAAAAGCCT AATCTGAGC AGC AAAAGGTC AGA
GTTGTCACAACTGAGCATGTACCGAGTGTTTGAAGTAGGTGTTATCAGAAATC
CGGGTTTGGGGGCTCCGGTGTTCCATATGACAAACTATCTTGAGCAACCAGTC
AGT AATGATCTC AGC AACTGT AT GGT GGCTTT GGGGGAGCTC AAACTCGC AG
CCCTTTGTCACGGGGAAGATTCTATCACAATTCCCTATCAGGGATCAGGGAA
AGGTGTCAGCTTCCAGCTCGTCAAGCTAGGTGTCTGGAAATCCCCAACCGAC
ATGCAATCCTGGGTCCCCTTATCAACGGATGATCCAGTGATAGACAGGCTTTA
CCTCTCATCTCACAGAGGTGTTATCGCTGACAACCAAGCAAAATGGGCTGTCC
CGAC AAC ACGAAC AGAT GAC AAGTT GCGAAT GG AG AC AT GCTTCC AAC AGGC
GTGTAAGGGTAAAATCCAAGCACTCTGCGAGAATCCCGAGTGGGCACCATTG
AAGGATAACAGGATTCCTTCATACGGGGTCTTGTCTGTTGATCTGAGTCTGAC
AGTTGAGCTTAAAATCAAAATTGCTTCGGGATTCGGGCCATTGATCACACAC
GGTTCAGGGATGGACCTATACAAATCCAACCACAACAATGTGTATTGGCTGA
CTATCCCGCCAATGAAGAACCTAGCCTTAGGTGTAATCAACACATTGGAGTG
GATACCGAGATTCAAGGTTAGTCCCTACCTCTTCACTGTCCCAATTAAGGAAG
CAGGCGAAGACTGCCATGCCCCAACATACCTACCTGCGGAGGTGGATGGTGA
TGTCAAACTCAGTTCCAATCTGGTGATTCTACCTGGTCAAGATCTCCAATATG
TTTTGGCAACCTACGATACTTCCAGGGTTGAACATGCTGTGGTTTATTACGTTT
ACAGCCCAAGCCGCTCATTTTCTTACTTTTATCCTTTTAGGTTGCCTATAAAGG
GGGTCCCCATCGAATTACAAGTGGAATGCTTCACATGGGACCAAAAACTCTG
GTGCCGTCACTTCTGTGTGCTTGCGGACTCAGAATCTGGTGGACATATCACTC
ACTCTGGGATGGTGGGCATGGGAGTCAGCTGCACAGTCACCCGGGAAGATGG
AACCAATCGCAGATAGGGCTGCTAGTGAACCAATCACATGATGTCACCCAGA
CATCAGGCATACCCACCATCCATCATTGTTATAAAAAACTTAGGAACCAGGT
CCACACAGAGTGATACGCGTACGCCACCATGTTCGTGTTTCTGGTGCTGCTGC
CTCTGGTGAGCTCCCAGTGCGTGAACCTGACCACAAGGACCCAGCTGCCCCC
TGCCTATACCAATTCCTTCACACGGGGCGTGTACTATCCCGACAAGGTGTTCC GGAGCAGCGTGCTGCACTCCACACAGGATCTGTTTCTGCCTTTCTTTTCTAAC
GTGACCTGGTTCCACGCCATCCACGTGAGCGGCACCAATGGCACAAAGCGGT
TCGACAATCCAGTGCTGCCCTTTAACGATGGCGTGTACTTCGCCTCCACCGAG
AAGTCT AAC AT CAT C AGAGGCTGGATCTTT GGC ACC AC ACTGGAC AGC AAGA
CACAGTCCCTGCTGATCGTGAACAATGCCACCAACGTGGTCATCAAGGTGTG
CGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGTGTACTATCACAAGAACA
ATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTATTCCTCTGCCAACAATTGC
ACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGACCTGGAGGGCAAGCAGG
GCAATTTCAAGAACCTGAGGGAGTTCGTGTTTAAGAATATCGATGGCTACTTC
AAAATCTACTCCAAGCACACCCCAATCAACCTGGTGCGCGACCTGCCACAGG
GCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCATCGGCATCAACATCACC
CGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTACCTGACACCAGGCGACA
GCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTACTATGTGGGCTATCTGCA
GCCCAGGACCTTCCTGCTGAAGTACAACGAGAATGGCACCATCACAGACGCC
GTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAAGTGTACACTGAAGAGCTT
T ACCGT GGAGAAGGGC ATCT ATC AGAC AAGC AATTT C AGGGT GC AGCCT ACC
GAGTCCATCGTGCGCTTTCCCAATATCACAAACCTGTGCCCTTTTGGCGAGGT
GTTCAACGC AACCCGCTTCGCCAGCGTGTACGCCTGGAATAGG AAGC GC ATC
TCCAACTGCGTGGCCGACTATTCTGTGCTGTACAACAGCGCCTCCTTCTCTAC
CTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGAATGACCTGTGCTTTACCA
ACGTGTACGCCGATTCCTTCGTGATCAGGGGCGACGAGGTGCGCCAGATCGC
ACCAGGACAGACAGGCAAGATCGCAGACTACAATTATAAGCTGCCTGACGAT
TTC ACCGGCTGCGT GATCGCCTGGAACTCT AAC AATCTGGAT AGC AAAGTGG
GCGGCAACTACAATTATCTGTACCGGCTGTTTAGAAAGTCTAATCTGAAGCCA
TTCGAGAGGGACATCTCCACAGAAATCTACCAGGCCGGCTCTACCCCCTGCA
ATGGCGTGGAGGGCTTTAACTGTTATTTCCCTCTGCAGAGCTACGGCTTCCAG
CCAACAAACGGCGTGGGCTATCAGCCCTACCGCGTGGTGGTGCTGTCTTTTGA
GCTGCTGC ACGC ACCTGC AAC AGT GTGCGGACC A AAGAAGAGC ACC AATCTG
GTGAAGAACAAGTGCGTGAACTTCAACTTCAACGGACTGACCGGAACAGGCG
TGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTTCAGCAGTTCGGCAGGGA
CATCGCAGATACCACAGACGCCGTGCGCGACCCTCAGACCCTGGAGATCCTG
GACATCACACCATGCTCCTTCGGCGGCGTGTCTGTGATCACACCAGGCACCA
ATACAAGCAACCAGGTGGCCGTGCTGTATCAGGACGTGAATTGTACCGAGGT
GCCAGTGGCAATCCACGCAGATCAGCTGACCCCTACATGGCGGGTGTACTCT ACCGGCAGCAACGTGTTCCAGACAAGAGCCGGATGCCTGATCGGAGCAGAGC
ACGTGAACAATAGCTATGAGTGCGACATCCCTATCGGCGCCGGCATCTGTGC
CTCCTACCAGACCCAGACAAACTCCCCAAGGAGAGCACGGTCTGTGGCCAGC
CAGTCCATCATCGCCTATACCATGAGCCTGGGCGCCGAGAATTCCGTGGCCTA
CTCCAACAATTCTATCGCCATCCCTACCAACTTCACAATCTCCGTGACCACAG
AGATCCTGCCAGTGAGCATGACCAAGACATCCGTGGACTGCACAATGTATAT
CTGTGGCGATTCCACCGAGTGCTCTAACCTGCTGCTGCAGTACGGCTCTTTTT
GTACCCAGCTGAATAGAGCCCTGACAGGCATCGCCGTGGAGCAGGACAAGA
ACACACAGGAGGTGTTCGCCCAGGTGAAGCAAATCTACAAGACCCCACCCAT
CAAGGACTTTGGCGGCTTCAACTTCAGCCAGATCCTGCCCGATCCTAGCAAGC
CATCCAAGCGGTCTTTTATCGAGGACCTGCTGTTCAACAAGGTGACCCTGGCC
GATGCCGGCTTCATCAAGCAGTATGGCGATTGCCTGGGCGACATCGCCGCCA
GAGACCTGATCTGTGCCCAGAAGTTTAATGGCCTGACCGTGCTGCCTCCACTG
CTGACAGATGAGATGATCGCCCAGTACACATCTGCCCTGCTGGCCGGAACCA
TCACAAGCGGATGGACCTTCGGCGCAGGAGCCGCCCTGCAGATCCCCTTTGC
CATGCAGATGGCCTATCGGTTCAACGGCATCGGCGTGACCCAGAATGTGCTG
TACGAGAACCAGAAGCTGATCGCCAATCAGTTTAACTCCGCCATCGGCAAGA
TCCAGGACTCTCTGAGCTCCACAGCCAGCGCCCTGGGCAAGCTGCAGGATGT
GGTGAATCAGAACGCCCAGGCCCTGAATACCCTGGTGAAGCAGCTGTCTAGC
AACTTCGGCGCCATCTCCTCTGTGCTGAATGACATCCTGAGCCGGCTGGACAA
GGTGGAGGCAGAGGTGCAGATCGACCGGCTGATCACAGGCAGACTGCAGTCC
CTGCAGACCTACGTGACACAGCAGCTGATCAGGGCAGCAGAGATCAGGGCCT
CTGCCAATCTGGCCGCCACCAAGATGAGCGAGTGCGTGCTGGGCCAGTCCAA
GAGAGTGGACTTTTGTGGCAAGGGCTATCACCTGATGAGCTTCCCACAGTCC
GCCCCTCACGGAGTGGTGTTTCTGCACGTGACCTACGTGCCAGCCCAGGAGA
AGAACTT C ACC AC AGC ACC AGC AATCTGCC ACGAT GGC AAGGC AC ACTTTCC
TAGGGAGGGCGTGTTCGTGAGCAACGGCACCCACTGGTTTGTGACACAGCGC
AATTTCTACGAGCCACAGATCATCACCACAGACAATACATTCGTGTCCGGCA
ACTGTGACGTGGTCATCGGCATCGTGAACAATACCGTGTATGATCCTCTGCAG
CCAGAGCTGGACTCTTTTAAGGAGGAGCTGGATAAGTACTTCAAGAATCACA
CCAGCCCCGACGTGGATCTGGGCGACATCTCTGGCATCAATGCCAGCGTGGT
GA AC AT C C AGA AGG AGATCGAC AGGC T GA AC GAGGT GGC C A AG A AT C T GA A
CGAGTCCCTGATCGATCTGCAGGAGCTGGGCAAGTATGAGCAGTACATCAAG
TGGCCCTGGTATATCTGGCTGGGCTTCATCGCCGGCCTGATCGCCATCGTGAT GGTGACCATCATGCTGTGCTGTATGACAAGCTGCTGTTCCTGCCTGAAGGGCT
GCTGTTCTTGTGGCAGCTGCTGTAAGTTTGATGAGGACGATAGCGAGCCTGTG
CTGAAGGGCGTGAAGCTGCACTACACCTGAGCTAGCGATCGCACTAGTGTGA
AAT AGAC ATC AGAATT AAGAAAA ACGT AGGGTCC AAGTGGTTCCCCGTT AT G
GACTCGCTATCTGTCAACCAGATCTTATACCCTGAAGTTCACCTAGATAGCCC
GATAGTTACCAATAAGATAGTAGCCATCCTGGAGTATGCTCGAGTCCCTCAC
GCTTACAGCCTGGAGGACCCTACACTGTGTCAGAACATCAAGCACCGCCTAA
AAAACGGATTTTCCAACCAAATGATTATAAACAATGTGGAAGTTGGGAATGT
CATCAAGTCCAAGCTTAGGAGTTATCCGGCCCACTCTCATATTCCATATCCAA
ATTGT A ATC AGGATTT ATTT A AC AT AGA AGAC A A AGAGT C A AC GAGGA AGAT
CCGTGAACTCCTCAAAAAGGGGAATTCGCTGTACTCCAAAGTCAGTGATAAG
GTTTTCCAATGCTTAAGGGACACTAACTCACGGCTTGGCCTAGGCTCCGAATT
GAGGGAGGACATCAAGGAGAAAGTTATTAACTTGGGAGTTTACATGCACAGC
TCCCAGTGGTTTGAGCCCTTTCTGTTTTGGTTTACAGTCAAGACTGAGATGAG
GTCAGTGATTAAATCACAAACCCATACTTGCCATAGGAGGAGACACACACCT
GTATTCTTCACTGGTAGTTCAGTTGAGTTGCTAATCTCTCGTGACCTTGTTGCT
ATAATCAGTAAAGAGTCTCAACATGTATATTACCTGACATTTGAACTGGTTTT
GATGTATTGTGATGTCATAGAGGGGAGGTTAATGACAGAGACCGCTATGACT
ATTGAT GCT AGGT AT AC AGAGC TTCT AGGA AGAGT C AGAT AC AT GT GGA A AC
TGATAGATGGTTTCTTCCCTGCACTCGGGAATCCAACTTATCAAATTGTAGCC
ATGCTGGAGCCTCTTTCACTTGCTTACCTGCAGCTGAGGGATATAACAGTAGA
ACTCAGAGGTGCTTTCCTTAACCACTGCTTTACTGAAATACATGATGTTCTTG
ACCAAAACGGGTTTTCTGATGAAGGTACTTATCATGAGTTAACTGAAGCTCTA
GATTACATTTTCATAACTGATGACATACATCTGACAGGGGAGATTTTCTCATT
TTTCAGAAGTTTCGGCCACCCCAGACTTGAAGCAGTAACGGCTGCTGAAAAT
GT T AGGA A AT AC AT G A AT C AGC C T A A AGT C ATT GT GT AT GAG AC TC T GAT G A
AAGGT CAT GCC AT ATTTT GT GGAAT CAT AAT C AACGGCT ATCGTGAC AGGC A
CGGAGGCAGTTGGCCACCGCTGACCCTCCCCCTGCATGCTGCAGACACAATC
CGGAATGCTCAAGCTTCAGGTGAAGGGTTAACACATGAGCAGTGCGTTGATA
ACTGGAAATCTTTTGCTGGAGTGAAATTTGGCTGCTTTATGCCTCTTAGCCTG
GATAGTGATCTGACAATGTACCTAAAGGACAAGGCACTTGCTGCTCTCCAAA
GGGAATGGGATTCAGTTTACCCGAAAGAGTTCCTGCGTTACGACCCTCCCAA
GGGAACCGGGTCACGGAGGCTTGTAGATGTTTTCCTTAATGATTCGAGCTTTG
ACCCATATGATGTGATAATGTATGTTGTAAGTGGAGCTTACCTCCATGACCCT GAGTTCAACCTGTCTTACAGCCTGAAAGAAAAGGAGATCAAGGAAACAGGTA
GACTTTTTGCTAAAATGACTTACAAAATGAGGGCATGCCAAGTGATTGCTGA
AAATCT AATCTC AAACGGGATTGGC AAAT ATTTT AAGGAC AAT GGGAT GGCC
AAGGATGAGCACGATTTGACTAAGGCACTCCACACTCTAGCTGTCTCAGGAG
TCCCC AAAGATCTC AAAGAAAGTC AC AGGGGGGGGCC AGTCTT AAA AACCT A
CTCCCGAAGCCCAGTCCACACAAGTACCAGGAACGTGAGAGCAGCAAAAGG
GTTTATAGGGTTCCCTCAAGTAATTCGGCAGGACCAAGACACTGATCATCCG
GAGAATATGGAAGCTTACGAGACAGTCAGTGCATTTATCACGACTGATCTCA
AGAAGTACTGCCTTAATTGGAGATATGAGACCATCAGCTTGTTTGCACAGAG
GCTAAATGAGATTTACGGATTGCCCTCATTTTTCCAGTGGCTGCATAAGAGGC
TTGAGACCTCTGTCCTGTATGTAAGTGACCCTCATTGCCCCCCCGACCTTGAC
GCCCATATCCCGTTATATAAAGTCCCCAATGATCAAATCTTCATTAAGTACCC
T AT GGGAGGT AT AGA AGGGT ATT GT C AGA AGCTGT GGAC CAT C AGC ACC ATT
CCCTATCTATACCTGGCTGCTTATGAGAGCGGAGTAAGGATTGCTTCGTTAGT
GCAAGGGGACAATCAGACCATAGCCGTAACAAAAAGGGTACCCAGCACATG
GCCCTACAACCTTAAGAAACGGGAAGCTGCTAGAGTAACTAGAGATTACTTT
GTAATTCTTAGGCAAAGGCTACATGATATTGGCCATCACCTCAAGGCAAATG
AGAC AATT GTTT CAT C AC ATTTTTTTGTCT ATTC A AAAGGAAT AT ATT ATGAT G
GGCTACTTGTGTCCCAATCACTCAAGAGCATCGCAAGATGTGTATTCTGGTCA
GAG AC TAT AGTTGAT GA A AC A AGGGC AGC AT GC AGT AAT ATT GCT AC A AC A A
TGGCTAAAAGCATCGAGAGAGGTTATGACCGTTACCTTGCATATTCCCTGAAC
GTCCTAAAAGTGATACAGCAAATTCTGATCTCTCTTGGCTTCACAATCAATTC
AACCATGACCCGGGATGTAGTCATACCCCTCCTCACAAACAACGACCTCTTA
ATAAGGATGGCACTGTTGCCCGCTCCTATTGGGGGGATGAATTATCTGAATAT
GAGCAGGCTGTTTGTCAGAAACATCGGTGATCCAGTAACATCATCAATTGCT
GATCTCAAGAGAATGATTCTCGCCTCACTAATGCCTGAAGAGACCCTCCATCA
GGTAATGACACAACAACCGGGGGACTCTTCATTCCTAGACTGGGCTAGCGAC
CCTTACTCAGCAAATCTTGTATGTGTCCAGAGCATCACTAGACTCCTCAAGAA
CATAACTGCAAGGTTTGTCCTGATCCATAGTCCAAACCCAATGTTAAAAGGAT
T ATTCC ATGAT GAC AGT AAAGAAGAGGACGAGGGACTGGCGGC ATTCCTC AT
GGACAGGCATATTATAGTACCTAGGGCAGCTCATGAAATCCTGGATCATAGT
GT C AC AGGGGC AAGAGAGTCT ATT GC AGGC AT GCTGGAT ACC AC AAA AGGCT
TGATTCGAGCCAGCATGAGGAAGGGGGGTTTAACCTCTCGAGTGATAACCAG
ATTGTCC AATT ATGACT AT GAAC A ATT C AGAGC AGGGAT GGT GCT ATT GAC A GGAAGA AAGAGAAAT GTCCTC ATTGAC AAAGAGT CAT GTT C AGTGC AGCTGG
CGAGAGCTCTAAGAAGCCATATGTGGGCGAGGCTAGCTCGAGGACGGCCTAT
TTACGGCCTTGAGGTCCCTGATGTACTAGAATCTATGCGAGGCCACCTTATTC
GGCGTCATGAGACATGTGTCATCTGCGAGTGTGGATCAGTCAACTACGGATG
GTTTTTTGTCCCCTCGGGTTGCCAACTGGATGATATTGACAAGGAAACATCAT
CCTTGAGAGTCCCATATATTGGTTCTACCACTGATGAGAGAACAGACATGAA
GCTTGCCTTCGTAAGAGCCCCAAGTCGATCCTTGCGATCTGCTGTTAGAATAG
C A AC AGT GT AC T CAT GGGC TT ACGGT GAT GAT GAT AGC TC TT GGA AC GA AGC
CTGGTTGTTGGCTAGGCAAAGGGCCAATGTGAGCCTGGAGGAGCTAAGGGTG
ATCACTCCCATCTCAACTTCGACTAATTTAGCGCATAGGTTGAGGGATCGTAG
CACTCAAGTGAAATACTCAGGTACATCCCTTGTCCGAGTGGCGAGGTATACC
ACAATCTCCAACGACAATCTCTCATTTGTCATATCAGATAAGAAGGTTGATAC
TAACTTTATATACCAACAAGGAATGCTTCTAGGGTTGGGTGTTTTAGAAACAT
TGTTTCGACTCGAGAAAGATACCGGATCATCTAAC ACGGT ATT ACATCTTCAC
GTCGAAACAGATTGTTGCGTGATCCCGATGATAGATCATCCCAGGATACCCA
GCTCCCGCAAGCTAGAGCTGAGGGCAGAGCTATGTACCAACCCATTGATATA
TGAT AAT GC ACCTTT AATT GAC AGAGAT GC AAC AAGGCT AT AC ACCC AGAGC
CATAGGAGGCACCTTGTGGAATTTGTTACATGGTCCACACCCCAACTATATCA
CATTTTAGCTAAGTCCACAGCACTATCTATGATTGACCTGGTAACAAAATTTG
AGAAGGACC AT AT GAAT GAAATTTC AGCTCTC AT AGGGGAT GAC GAT AT C AA
TAGTTTCATAACTGAGTTTCTGCTCATAGAGCCAAGATTATTCACTATCTACTT
GGGCCAGTGTGCGGCCATCAATTGGGCATTTGATGTACATTATCATAGACCAT
CAGGGAAATATCAGATGGGTGAGCTGTTGTCATCGTTCCTTTCTAGAATGAGC
AAAGGAGTGTTTAAGGTGCTTGTCAATGCTCTAAGCCACCCAAAGATCTACA
AGAAATTCTGGCATTGTGGTATTATAGAGCCTATCCATGGTCCTTCACTTGAT
GCTCAAAACTTGCACACAACTGTGTGCAACATGGTTTACACATGCTATATGAC
CTACCTCGACCTGTTGTTGAATGAAGAGTTAGAAGAGTTCACATTTCTCTTGT
GTGAAAGCGACGAGGATGTAGTACCGGACAGATTCGACAACATCCAGGCAA
AACACTTATGTGTTCTGGCAGATTTGTACTGTCAACCAGGGACCTGCCCACCA
ATTCGAGGTCTAAGACCGGTAGAGAAATGTGCAGTTCTAACCGACCATATCA
AGGCAGAGGCTATGTTATCTCCAGCAGGATCTTCGTGGAACATAAATCCAAT
TATTGTAGACCATTACTCATGCTCCCTGACTTATCTCCGGCGAGGATCGATCA
AACAGATAAGATTGAGAGTTGATCCAGGATTCATTTTCGACGCCCTCGCTGA
GGTAAATGTCAGTCAGCCAAAGATCGGCAGCAACAACATCTCAAATATGAGC ATCAAGGCTTTCAGACCCCCACACGATGATGTTGCAAAATTGCTCAAAGATA
TCAACACAAGCAAGCACAATCTTCCCATTTCAGGGGGCAATCTCGCCAATTAT
GAAATCCATGCTTTCCGCAGAATCGGGTTGAACTCATCTGCTTGCTACAAAGC
TGTTGAGATATCAACATTAATTAGGAGATGCCTTGAGCCAGGGGAGGACGGC
TTGTTCTTGGGTGAGGGATCGGGTTCTATGTTGATCACTTATAAGGAGATACT
TAAACTAAACAAGTGCTTCTATAATAGTGGGGTTTCCGCCAATTCTAGATCTG
GTCAAAGGGAATTAGCACCCTATCCCTCCGAAGTTGGCCTTGTCGAACACAG
AATGGGAGTAGGTAATATTGTCAAAGTGCTCTTTAACGGGAGGCCCGAAGTC
ACGTGGGTAGGCAGTGTAGATTGCTTCAATTTCATAGTTAGTAATATCCCTAC
CTCTAGTGTGGGGTTTATCCATTCAGATATAGAGACCTTGCCTGACAAAGATA
CTATAGAGAAGCTAGAGGAATTGGCAGCCATCTTATCGATGGCTCTGCTCCTG
GGCAAAATAGGATCAATACTGGTGATTAAGCTTATGCCTTTCAGCGGGGATTT
T GTT C AGGGATTT AT A AGTT AT GT AGGGT C TC ATT AT AGAGA AGT GA ACC TT G
TATACCCTAGATACAGCAACTTCATATCTACTGAATCTTATTTGGTTATGACA
GATCTC AAGGCT AACCGGCT AAT GAATCCTGAAAAGATT AAGC AGC AGAT AA
TTGAATCATCTGTGAGGACTTCACCTGGACTTATAGGTCACATCCTATCCATT
AAGCAACTAAGCTGCATACAAGCAATTGTGGGAGACGCAGTTAGTAGAGGTG
ATATCAATCCTACTCTGAAAAAACTTACACCTATAGAGCAGGTGCTGATCAAT
TGCGGGTTGGCAATTAACGGACCTAAGCTGTGCAAAGAATTGATCCACCATG
ATGTTGCCTCAGGGCAAGATGGATTGCTTAATTCTATACTCATCCTCTACAGG
GAGTTGGCAAGATTCAAAGACAACCAAAGAAGTCAACAAGGGATGTTCCAC
GCCTACCCCGTATTGGTAAGTAGCAGGCAACGAGAACTTATATCTAGGATCA
CCCGCAAATTTTGGGGGCACATTCTTCTTTACTCCGGGAACAAAAAGTTGATA
AATAAGTTTATCCAGAATCTCAAGTCCGGCTATCTGATACTAGACTTACACCA
GAATATCTTCGTTAAGAATCTATCCAAGTCAGAGAAACAGATTATTATGACG
GGGGGTTTGAAACGTGAGTGGGTTTTTAAGGTAACAGTCAAGGAGACCAAAG
AATGGTATAAGTTAGTCGGATACAGTGCCCTGATTAAGGACTAATTGGTTGA
ACTCCGGAACCCTAATCCTGCCCTAGGTGGTTAGGCATTATTTGCAATATATT
AAAGAAAACTTTGAAAATACGAAGTTTCTATTCCCAGCTTTGTCTGGTggccggc atAgtcccagcctcctcgctggcgctggctgggcaacattccgaggggaccgtccccAcggtaatggcgaatgggacgcgg ccgatccggctgctaacaaagcccgaaaggaagctgagttggctgctgGcGcTGgctgGgcaataactagcataacccctt ggggcctctaaacgggtcttgaggggttttttgctgaaaggaggaactatatccggatgcGGCCGCGCGCTTGGC
GTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTC
CACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATG AGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGG
GAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGG
CGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTC
GGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGG
TT ATCC AC AGA AT C AGGGGAT A AC GC AGG A A AGA AC AT GT GAGC A A A AGGC
CAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATA
GGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTG
GCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCC
CTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTT
CTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAG
TTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTC
AGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTA
AGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAG
CGAGGT AT GT AGGCGGT GCT AC AGAGTTCTTGAAGT GGT GGCCT AACT ACGG
CTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCT
TCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAG
CGGT GGTTTTTTT GTTTGC AAGC AGC AGATT ACGCGC AGAAAA AAAGGATCT
CAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAA
ACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAG
ATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTA
AACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGA
TCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTA
CGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGA
CCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGG
GCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAA
TTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAAC
GTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGC
TTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGT
TGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAG
TTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGT
CATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATA
CGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAA
AACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGT TCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACC
AGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGA
ATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTA
TTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTA
TTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCC
ACCTG.
In one embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 6, shown below (RABV vector: Coravax Vl-China (RABVG-E31)): ACGCTTAACAACCAGATCAAAGAAAAAACAGACATTGTCAATTGCAAAGCAA AAATGTAACACCCCTACAATGGATGCCGACAAGATTGTATTCAAAGTCAATA AT C AGGT GGT C TC TT T G A AGC C T GAG AT T AT C GT GG AT C A AT AT G AGT AC A AG TACCCTGCCATCAAAGATTTGAAAAAGCCCTGTATAACCCTAGGAAAGGCTC CCGATTTAAATAAAGCATACAAGTCAGTTTTGTCAGGCATGAGCGCCGCCAA ACTTAATCCTGACGATGTATGTTCCTATTTGGCAGCGGCAATGCAGTTTTTTG AGGGGACATGTCCGGAAGACTGGACCAGCTATGGAATTGTGATTGCACGAAA AGGAGATAAGATCACCCCAGGTTCTCTGGTGGAGATAAAACGTACTGATGTA GAAGGGAATT GGGCTCTGAC AGGAGGC AT GGAACTGAC AAGAGACCCC ACT GTCCCTGAGCATGCGTCCTTAGTCGGTCTTCTCTTGAGTCTGTATAGGTTGAG CAAAATATCCGGGCAAAACACTGGTAACTATAAGACAAACATTGCAGACAGG ATAGAGCAGATTTTTGAGACAGCCCCTTTTGTTAAAATCGTGGAACACCATAC TC T A AT GAC A AC TC AC A Aa AT GT GT GCT A ATT GGAGT ACT AT AC C A A AC TTC A GATTTTTGGCCGGAACCTATGACATGTTTTTCTCCCGGATTGAGCATCTATATT CAGCAATCAGAGTGGGCACAGTTGTCACTGCTTATGAAGACTGTTCAGGACT GGTATCATTTACTGGGTTCATAAAACAAATCAATCTCACCGCTAGAGAGGCA ATACTATATTTCTTCCACAAGAACTTTGAGGAAGAGATAAGAAGAATGTTTG AGCCAGGGCAGGAGACAGCTGTTCCTCACTCTTATTTCATCCACTTCCGTTCA CTAGGCTTGAGTGGGAAATCTCCTTATTCATCAAATGCTGTTGGTCACGTGTT CAATCTCATTCACTTTGTAGGATGCTATATGGGTCAAGTCAGATCCCTAAATG CAACGGTTATTGCTGCATGTGCTCCTCATGAAATGTCTGTTCTAGGGGGCTAT CTGGGAGAGGAATTCTTCGGGAAAGGGAC ATTTGAAAGAAGATTCTTC AGAG AT GAG A A AG A AC TT C A AG A AT AC G AGGC GGC T G A AC T GAC A A AG AC T GAC G TAGCACTGGCAGATGATGGAACTGTCAACTCTGACGACGAGGACTACTTTTC AGGT GAAACC AGAAGTCCGGAGGCTGTTT AT ACTCGAAT CAT GAT GAAT GGA GGTCGACTAAAGAGATCTCACATACGGAGATATGTCTCAGTCAGTTCCAATC ATCAAGCCCGTCCAAACTCATTCGCCGAGTTTCTAAACAAGACATATTCGAGT
GACTCATAAcatgaaaaaaactaacacccctcccGTACGCCACCATGTTCGTGTTTCTGGTG
CTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAACCTGACCACAAGGACCCAGC
TGCCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACTATCCCGACAAG
GTGTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTTCTGCCTTTCTT
TTCTAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCACCAATGGCACA
AAGCGGTTCGACAATCCAGTGCTGCCCTTTAACGATGGCGTGTACTTCGCCTC
CACCGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCACCACACTGGAC
AGCAAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAACGTGGTCATCA
AGGTGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGTGTACTATCAC
AAGAACAATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTATTCCTCTGCCA
ACAATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGACCTGGAGGGC
AAGCAGGGCAATTTCAAGAACCTGAGGGAGTTCGTGTTTAAGAATATCGATG
GCTACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGTGCGCGACCTG
CCACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCATCGGCATCAA
CATCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTACCTGACACCA
GGCGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTACTATGTGGGCT
ATCTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATGGCACCATCAC
AGACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAAGTGTACACTG
AAGAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAATTTCAGGGTGC
AGCCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCTGTGCCCTTTT
GGCGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCTGGAATAGGA
AGCGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAACAGCGCCTCC
TTCTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGAATGACCTGTG
CTTTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGACGAGGTGCGCC
AGATCGCACCAGGACAGACAGGCAAGATCGCAGACTACAATTATAAGCTGCC
TGACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAATCTGGATAGCA
AAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGAAAGTCTAATCTG
AAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGGCCGGCTCTACCC
CCTGCAATGGCGTGGAgGGCTTTAACTGTTATTTCCCTCTGCAGAgCTACgGCT
TCCAGCCAACAAACGGCGTGGGCTATCAGCCCTACCGCGTGGTGGTGCTGTC
TTTTGAGCTGCTGCACGCACcTGCAACAGTGTGCGGACCAAAGAAGAGCACC
A ATCTGGT GA AGA AC A AGT GCGT GA AC TT C A AC TT C A AC GGACTGACC GGA A
CAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTTCAGCAGTTCGGC AGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCTCAGACCCTGGAGA
TCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGTGATCACACCAGGC
ACCAATACAAGCAACCAGGTGGCCGTGCTGTATCAGGACGTGAATTGTACCG
AGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTACATGGCGGGTGTA
CTCTACCGGCAGCAACGTGTTCCAGACAAGAGCCGGATGCCTGATCGGAGCA
GAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATCGGCGCCGGCATCT
GTGCCTCCTACCAGACCCAGACAAACTCCCCAAGGTCTGTGGGAGATGAGGC
CGAAGACTTTGTGGAAGTCCACCTGCCTGATGTGCATAACCAGGTGTCTGGC
GTCGACCTGGGACTGCCAAATTGGGGCAAGTACGTGCTGCTGAGTGCTGGAG
CACTGACTGCCCTGATGCTGATCATTTTCCTGATGACCTGCTGTCGGCGCGTG
AACAGAAGTGAGCCCACTCAGCACAATCTGCGAGGAACCGGGAGAGAAGTG
T C AGTC AC ACCTC AGAGCGGGAAAATC ATT AGT AGTT GGGAATC AC AT AAAA
GCGGGGGCGAGACCAGGCTGTGAGCTAGCCATGAAAAAAACTAACACCCCTC
CTTTCGAACCATCCCAAACATGAGCAAGATCTTTGTCAATCCTAGTGCTATTA
GAGCCGGTCTGGCCGATCTTGAGATGGCTGAAGAAACTGTTGATCTGATCAA
T AGAAAT ATCGAAGAC AAT C AGGCTC ATCTCC AAGGGGAACCC AT AGAGGT G
GACAATCTCCCTGAGGATATGGGGCGACTTCACCTGGATGATGGAAAATCGC
CC AACC ATGGT GAG AT AGCC AAGGTGGGAGAAGGC AAGT ATCGAGAGGACT
TTCAGATGGATGAAGGAGAGGATCCTAGCTTCCTGTTCCAGTCATACCTGGA
A A AT GTT GGAGTCC A A AT AGT C AG AC A A AT GAGGT C AGGAGAGAGATTTC T C
AAGATATGGTCACAGACCGTAGAAGAGATTATATCCTATGTCGCGGTCAACT
TTCCCAACCCTCCAGGAAAGTCTTCAGAGGATAAATCAACCCAGACTACTGG
CCGAGAGCTCAAGAAGGAGACAACACCCACTCCTTCTCAGAGAGAAAGCCA
ATCATCGAAAGCCAGGATGGCGGCTCAAATTGCTTCTGGCCCTCCAGCCCTTG
AAT GGT C GGCT AC C A AT GA AGAGGAT GAT C T AT C AGT GGAGGC T GAGAT C GC
TCACCAGATTGCAGAAAGTTTCTCCAAAAAATATAAGTTTCCCTCTCGATCCT
CAGGGATACTCTTGTATAATTTTGAGCAATTGAAAATGAACCTTGATGATATA
GTTAAAGAGGCAAAAAATGTACCAGGTGTGACCCGTTTAGCCCATGACGGGT
CCAAACTCCCCCTAAGATGTGTACTGGGATGGGTCGCTTTGGCCAACTCTAAG
AAATTCC AGTTGTT AGTCGAATCCGAC AAGCTGAGT AAAAT CAT GC AAGAT G
ACTTGAATCGCTATACATCTTGCTAACCGAACCTCTCCCCTCAGTCCCTCTAG
AC A AT A A A ATCC GAGAT GT C CCA A AGT C A AC AT GA A A A A A AC AGGC A AC AC
CACTGATAAAATGAACCTCCTACGT AAGAT AGTGAAAAACCGCAGGGACGAG
GACACTCAAAAATCCTCTCCCGCGTCAGCCCCTCTGGATGACGATGACTTGTG GCTTCCACCCCCTGAATACGTCCCGCTGAAAGAACTTACAGGCAAGAAGAAC
ATGAGGAACTTTTGTATCAACGGAAGGGTTAAAGTGTGTAGCCCGAATGGTT
ACTCGTTCAGGATCCTGCGGCACATTCTGAAATCATTCGACGAGATATATTCT
GGGAATCATAGGATGATCGGGTTAGTCAAAGTGGTTATTGGACTGGCTTTGTC
AGGATCTCCAGTCCCTGAGGGCCTGAACTGGGTATACAAATTGAGGAGAACC
TTTATCTTCCAGTGGGCTGATTCCAGGGGCCCTCTTGAAGGGGAGGAGTTGGA
ATACTCTCAGGAGATCACTTGGGATGATGATACTGAGTTCGTCGGATTGCAA
AT A AGAGT GATT GC A A A AC AGT GTC AT ATCC AGGGC AGAGT C T GGT GT ATC A
ACATGAACCCGAGAGCATGTCAACTATGGTCTGACATGTCTCTTCAGACACA
AAGGTCCGAAGAGGAC AAAGATTCCTCTCTGCTTCT AGAAT AAT C AG ATT AT
ATCCCGCAAATTTATCACTTGTTTACCTCTGGAGGAGAGAACATATGGGCTCA
ACTCC AACCCTT GGGAGC AAT AT AAC AAAAAAC ATGTT AT GGT GCC ATT AAA
CCGCTGCATTTCATCAAAGTCAAGTTGATTACCTTTACATTTTGATCCTCTTGG
AT GTGAA AAAAACT ATT AAC ATCCCTC AAAAGACcccggg AAAGATGGTTCCTC
AGGCTCTCCTGTTTGTACCCCTTCTGGTTTTTCCATTGTGTTTTGGGAAATTCC
CTATTTACACGATACCAGACAAGCTTGGTCCCTGGAGTCCGATTGACATACAT
CACCTCAGCTGCCCAAACAATTTGGTAGTGGAGGACGAAGGATGCACCAACC
TGTCAGGGTTCTCCTACATGGAACTTAAAGTTGGATACATCTTAGCCATAAAA
GTGAACGGGTTCACTTGCACAGGCGTTGTGACGGAGGCTGAAACCTACACTA
ACTTCGTTGGTTATGTCACAACCACGTTCAAAAGAAAGCATTTCCGCCCAACA
CCAGATGCATGTAGAGCCGCGTACAACTGGAAGATGGCCGGTGACCCCAGAT
ATGAAGAGTCTCTACACAATCCGTACCCTGACTACCGCTGGCTTCGAACTGTA
AAAACCACCAAGGAGTCTCTCGTTATCATATCTCCAAGTGTGGCAGATTTGGA
CCCATATGACAGATCCCTTCACTCGAGGGTCTTCCCTAGCGGGAAGTGCTCAG
GAGTAGCGGTGTCTTCTACCTACTGCTCCACTAACCACGATTACACCATTTGG
ATGCCCGAGAATCCGAGACTAGGGATGTCTTGTGACATTTTTACCAATAGTAG
AGGGAAGAGAGC ATCC AAAGGG AGT GAGACTT GCGGCTTTGT AG AT GAAAG
AGGCCTATATAAGTCTTTAAAAGGAGCATGCAAACTCAAGTTATGTGGAGTT
CT AGGAC TT AGACTT AT GGAT GGA AC AT GGGT C TC GAT GCA A AC AT C A A AT G
AAACCAAATGGTGCCCTCCCGATAAGTTGGTGAACCTGCACGACTTTCGCTCA
GAC GA A ATT GAGC AC CTTGTTGT AGAGGAGTT GGT C AGG A AGAGAGAGGAGT
GTCTGGATGCACTAGAGTCCATCATGACAACCAAGTCAGTGAGTTTCAGACG
TCTCAGTCATTTAAGAAAACTTGTCCCTGGGTTTGGAAAAGCATATACCATAT
TCAACAAGACCTTGATGGAAGCCGATGCTCACTACAAGTCAGTCgagACTTGG AATGAGATCCTCCCTTCAAAAGGGTGTTTAAGAGTTGGGGGGAGGTGTCATC
CTC AT GTGAACGGGGT GTTTTT C AAT GGT AT AAT ATT AGGACCTGACGGC AAT
GTCTTAATCCCAGAGATGCAATCATCCCTCCTCCAGCAACATATGGAGTTGTT
GGAATCCTCGGTTATCCCCCTTGTGCACCCCCTGGCAGACCCGTCTACCGTTT
TCAAGGACGGTGACGAGGCTGAGGATTTTGTTGAAGTTCACCTTCCCGATGTG
C AC AAT C AGGTCTC AGGAGTTGACTT GGGTCTCCCGAACTGGGGGAAGT AT G
TATTACTGAGTGCAGGGGCCCTGACTGCCTTGATGTTGATAATTTTCCTGATG
ACATGTTGTAGAAGAGTCAATCGATCAGAACCTACGCAACACAATCTCAGAG
GGACAGGGAGGGAGGTGTCAGTCACTCCCCAAAGCGGGAAGATCATATCTTC
AT GGG A AT C AC AC A AG AGT GGGGGT GAG AC C AG AC T GT A AttaattaaC GT C C T TT
CAACGATCCAAGTCcatgaaaaaaactaacacccctcccgtacctagcTTATAAAGTGCTGGGTC
ATCTAAGCTTTTCAGTCGAGAAAAAAACATTAGATCAGAAGAACAACTGGCA
ACACTTCTCAACCTGAGACTTACTTCAAGATGCTCGATCCTGGAGAGGTCTAT
GATGACCCTATTGACCCAATCGAGTTAGAGGCTGAACCCAGAGGAACCCCCA
TTGTCCCCAACATCTTGAGGAACTCTGACTACAATCTCAACTCTCCTTTGATA
GAAGATCCTGCTAGACTAATGTTAGAATGGTTAAAAACAGGGAATAGACCTT
ATCGGATGACTCTAACAGACAATTGCTCCAGGTCTTTCAGAGTTTTGAAAGAT
T ATTTC A AGAAGGT AGATTT GGGTTCTCTC AAGGTGGGCGGAAT GGCTGC AC
AGTCAATGATTTCTCTCTGGTTATATGGTGCCCACTCTGAATCCAACAGGAGC
CGGAGATGTATAACAGACTTGGCCCATTTCTATTCCAAGTCGTCCCCCATAGA
GAAGCTGTTGAATCTCACGCTAGGAAATAGAGGGCTGAGAATCCCCCCAGAG
GGAGTGTTAAGTTGCCTTGAGAGGGTTGATTATGATAATGCATTTGGAAGGTA
TCTTGCCAACACGTATTCCTCTTACTTGTTCTTCCATGTAATCACCTTATACAT
GAACGCCCTAGACTGGGATGAAGAAAAGACCATCCTAGCATTATGGAAAGAT
TT AACCTC AGT GGAC ATCGGGA AGGACTT GGT AAAGTT C AAAGACC AAAT AT
GGGGACTGCTGATCGTGACAAAGGACTTTGTTTACTCCCAAAGTTCCAATTGT
CTTTTTGACAGAAACTACACACTTATGCTAAAAGATCTTTTCTTGTCTCGCTTC
AACTCCTTAATGGTCTTGCTCTCTCCCCCAGAGCCCCGATACTCAGATGACTT
GATATCTCAACTATGCCAGCTGTACATTGCTGGGGATCAAGTCTTGTCTATGT
GT GGAAACTCCGGCT ATGAAGTC AT C AAAAT ATT GGAGCC AT AT GTCGT GAA
TAGTTTAGTCCAGAGAGCAGAAAAGTTTAGGCCTCTCATTCATTCCTTGGGAG
ACTTTCCTGT ATTT AT AAAAGAC AAGGT AAGT C AACTT GAAGAGACGTTCGGT
CCCTGTGCAAGAAGGTTCTTTAGGGCTCTGGATCAATTCGACAACATACATGA
CTTGGTTTTTGTGTTTGGCTGTTACAGGCATTGGGGGCACCCATATATAGATT ATCGAAAGGGTCTGTCAAAACTATATGATCAGGTTCACCTTAAAAAAATGAT
AGATAAGTCCTACCAGGAGTGCTTAGCAAGCGACCTAGCCAGGAGGATCCTT
AGATGGGGTTTTGATAAGTACTCCAAGTGGTATCTGGATTCAAGATTCCTAGC
CCGAGACCACCCCTTGACTCCTTATATCAAAACCCAAACATGGCCACCCAAA
CATATTGTAGACTTGGTGGGGGATACATGGCACAAGCTCCCGATCACGCAGA
TCTTTGAGATTCCTGAATCAATGGATCCGTCAGAAATATTGGATGACAAATCA
CATTCTTTCACCAGAACGAGACTAGCTTCTTGGCTGTCAGAAAACCGAGGGG
GGCCTGTTCCTAGCGAAAAAGTTATTATCACGGCCCTGTCTAAGCCGCCTGTC
AATCCCCGAGAGTTTCTGAGGTCTATAGACCTCGGAGGATTGCCAGATGAAG
ACTTGATAATTGGCCTCAAGCCAAAGGAACGGGAATTGAAGATTGAAGGTCG
ATTCTTTGCTCTAATGTCATGGAATCTAAGATTGTATTTTGTCATCACTGAAAA
ACTCTTGGCCAACTACATCTTGCCACTTTTTGACGCGCTGACTATGACAGACA
ACCTGAACAAGGTGTTTAAAAAGCTGATCGACAGGGTCACCGGGCAAGGGCT
TTTGGACTATTCAAGGGTCACATATGCATTTCACCTGGACTATGAAAAGTGGA
ACAACCATCAAAGATTAGAGTCAACAGAGGATGTATTTTCTGTCCTAGATCA
AGT GTTTGGATT GAAGAGAGT GTTTTCT AGAAC AC ACGAGTTTTTT C AAAAGG
CCTGGATCTATTATTCAGACAGATCAGACCTCATCGGGTTACGGGAGGATCA
AATATACTGCTTAGATGCGTCCAACGGCCCAACCTGTTGGAATGGCCAGGAT
GGCGGGCTAGAAGGCTTACGGCAGAAGGGCTGGAGTCTAGTCAGCTTATTGA
T GAT AGAT AGAGAATCTC AA ATC AGGAAC AC AAGAACC AAAAT ACT AGCTC A
AGGAGACAACCAGGTTTTATGTCCGACATACATGTTGTCGCCAGGGCTATCTC
AAGAGGGGCTCCTCTATGAATTGGAGAGAATATCAAGGAATGCACTTTCGAT
AT AC AG AGC C GT C G AGG A AGGGGC AT C T A AGC T AGGGC T GAT CATC A AG A A
AGAAGAGACCATGTGTAGTTATGACTTCCTCATCTATGGAAAAACCCCTTTGT
TT AGAGGT AAC AT ATT GGT GCCTGAGTCC AAAAGAT GGGCC AGAGTCTCTTG
CGTCTCTAATGACCAAATAGTCAACCTCGCCAATATAATGTCGACAGTGTCCA
CCAATGCGCTAACAGTGGCACAACACTCTCAATCTTTGATCAAACCGATGAG
GGATTTTCTGCTCATGTCAGTACAGGCAGTCTTTCACTACCTGCTATTTAGCCC
AATCTT AAAGGGA AGAGTTT AC AAGATTCTGAGCGCTGAAGGGGAGAGCTTT
CTCCTAGCCATGTCAAGGATAATCTATCTAGATCCTTCTTTGGGAGGGATATC
TGGAATGTCCCTCGGAAGATTCCATATACGACAGTTCTCAGACCCTGTCTCTG
AAGGGTTATCCTTCTGGAGAGAGATCTGGTTAAGCTCCCAAGAGTCCTGGATT
C ACGCGTTGT GT C AAGAGGCTGGAAACCC AGATCTTGGAGAGAGAAC ACTCG
AGAGCTTCACTCGCCTTCTAGAAGATCCGACCACCTTAAATATCAGAGGAGG GGCCAGTCCTACCATTCTACTCAAGGATGCAATCAGAAAGGCTTTATATGAC
GAGGT GGAC AAGGTGGA AAATT C AGAGTTTCGAGAGGC AATCCTGTT GTCC A
AGACCCATAGAGATAATTTTATACTCTTCTTAATATCTGTTGAGCCTCTGTTTC
CTCGATTTCTCAGTGAGCTATTCAGTTCGTCTTTTTTGGGAATCCCCGAGTCAA
TCATTGGATTGATACAAAACTCCCGAACGATAAGAAGGCAGTTTAGAAAGAG
TCTCTCAAAAACTTTAGAAGAATCCTTCTACAACTCAGAGATCCACGGGATTA
GTCGGATGACCCAGACACCTCAGAGGGTTGGGGGGGTGTGGCCTTGCTCTTC
AGAGAGGGC AGATCT ACTT AGGGAGATCTCTT GGGGAAGAAAAGT GGT AGG
CACGACAGTTCCTCACCCTTCTGAGATGTTGGGATTACTTCCCAAGTCCTCTA
TTTCTTGCACTTGTGGAGCAACAGGAGGAGGCAATCCTAGAGTTTCTGTATCA
GTACTCCCGTCCTTTGATCAGTCATTTTTTTCACGAGGCCCCCTAAAGGGATA
CTTGGGCTCGTCCACCTCTATGTCGACCCAGCTATTCCATGCATGGGAAAAAG
T C ACT A AT GTT CAT GT GGT GA AGAGAGCTCT AT C GTT A A A AGA ATCT AT A A AC
TGGTTCATTACTAGAGATTCCAACTTGGCTCAAGCTCTAATTAGGAACATTAT
GTCTCTGACAGGCCCTGATTTCCCTCTAGAGGAGGCCCCTGTCTTCAAAAGGA
CGGGGTCAGCCTTGCATAGGTTCAAGTCTGCCAGATACAGCGAAGGAGGGTA
TTCTTCTGTCTGCCCGAACCTCCTCTCTCATATTTCTGTTAGTACAGACACCAT
GTCTGATTTGACCCAAGACGGGAAGAACTACGATTTCATGTTCCAGCCATTGA
TGCTTTATGCACAGACATGGACATCAGAGCTGGTACAGAGAGACACAAGGCT
AAGAGACTCTACGTTTCATTGGCACCTCCGATGCAACAGGTGTGTGAGACCC
ATTGACGACGTGACCCTGGAGACCTCTCAGATCTTCGAGTTTCCGGATGTGTC
GAAAAGAATATCCAGAATGGTTTCTGGGGCTGTGCCTCACTTCCAGAGGCTTC
CCGATATCCGTCTGAGACCAGGAGATTTTGAATCTCTAAGCGGTAGAGAAAA
GTCTCACCATATCGGATCAGCTCAGGGGCTCTTATACTCAATCTTAGTGGCAA
TTCACGACTCAGGATACAATGATGGAACCATCTTCCCTGTCAACATATACGGC
AAGGTTTCCCCT AGAGACT ATTT GAGAGGGCTCGC AAGGGGAGT ATT GAT AG
GATCCTCGATTTGCTTCTTGACAAGAATGACAAATATCAATATTAATAGACCT
CTTGAATTGGTCTCAGGGGTAATCTCATATATTCTCCTGAGGCTAGATAACCA
TCCCTCCTTGTACATAATGCTCAGAGAACCGTCTCTTAGAGGAGAGATATTTT
CTATCCCTCAGAAAATCCCCGCCGCTTATCCAACCACTATGAAAGAAGGCAA
CAGATCAATCTTGTGTTATCTCCAACATGTGCTACGCTATGAGCGAGAGATAA
TCACGGCGTCTCCAGAGAATGACTGGCTATGGATCTTTTCAGACTTTAGAAGT
GCCAAAATGACGTACCTATCCCTCATTACTTACCAGTCTCATCTTCTACTCCA
GAGGGTTGAGAGAAACCTATCTAAGAGTATGAGAGATAACCTGCGACAATTG AGTTCTTTGATGAGGCAGGTGCTGGGCGGGCACGGAGAAGATACCTTAGAGT
CAGACGACAACATTCAACGACTGCTAAAAGACTCTTTACGAAGGACAAGATG
GGT GGATC AAGAGGT GCGCC ATGC AGCT AGAACC AT GACTGGAGATT AC AGC
CCCAACAAGAAGGTGTCCCGTAAGGTAGGATGTTCAGAATGGGTCTGCTCTG
CTCAACAGGTTGCAGTCTCTACCTCAGCAAACCCGGCCCCTGTCTCGGAGCTT
GACATAAGGGCCCTCTCTAAGAGGTTCCAGAACCCTTTGATCTCGGGCTTGAG
AGTGGTTCAGTGGGCAACCGGTGCTCATTATAAGCTTAAGCCTATTCTAGATG
ATCTCAATGTTTTCCCATCTCTCTGCCTTGTAGTTGGGGACGGGTCAGGGGGG
ATATCAAGGGCAGTCCTCAACATGTTTCCAGATGCCAAGCTTGTGTTCAACAG
TCTTTTAGAGGTGAATGACCTGATGGCTTCCGGAACACATCCACTGCCTCCTT
CAGCAATCATGAGGGGAGGAAATGATATCGTCTCCAGAGTGATAGATCTTGA
CTCAATCTGGGAAAAACCGTCCGACTTGAGAAACTTGGCAACCTGGAAATAC
TTCCAGTCAGTCCAAAAGCAGGTCAACATGTCCTATGACCTCATTATTTGCGA
TGCAGAAGTTACTGACATTGCATCTATCAACCGGATCACCCTGTTAATGTCCG
ATTTTGCATTGTCTATAGATGGACCACTCTATTTGGTCTTCAAAACTTATGGG
ACTATGCTAGTAAATCCAAACTACAAGGCTATTCAACACCTGTCAAGAGCGT
TCCCCTCGGTCACAGGGTTTATCACCCAAGTAACTTCGTCTTTTTCATCTGAGC
TCTACCTCCGATTCTCCAAACGAGGGAAGTTTTTCAGAGATGCTGAGTACTTG
ACCTCTTCCACCCTTCGAGAAATGAGCCTTGTGTTATTCAATTGTAGCAGCCC
CAAGAGTGAGATGCAGAGAGCTCGTTCCTTGAACTATCAGGATCTTGTGAGA
GGATTTCCTGAAGAAATCATATCAAATCCTTACAATGAGATGATCATAACTCT
GATTGAC AGT GATGT AGAATCTTTTCT AGTCC AC AAGAT GGTT GAT GATCTT G
AGTTACAGAGGGGAACTCTGTCTAAAGTGGCTATCATTATAGCCATCATGAT
AGTTTTCTCCAACAGAGTCTTCAACGTTTCCAAACCCCTAACTGACCCCTCGT
TCTATCCACCGTCTGATCCCAAAATCCTGAGGCACTTCAACATATGTTGCAGT
ACTATGATGTATCTATCTACTGCTTTAGGTGACGTCCCTAGCTTCGCAAGACT
TCACGACCTGTATAACAGACCTATAACTTATTACTTCAGAAAGCAAGTCATTC
GAGGGA AC GTTT AT C T ATCTTGGAGTT GGT C C A AC GAC AC CTC AGT GTT C A A A
AGGGTAGCCTGTAATTCTAGCCTGAGTCTGTCATCTCACTGGATCAGGTTGAT
TTAC AAGAT AGTGAAGACTACCAGACTCGTTGGCAGCATCAAGGATCTATCC
AGAGAAGTGGAAAGACACCTTCATAGGTACAACAGGTGGATCACCCTAGAG
GATATCAGATCTAGATCATCCCTACTAGACTACAGTTGCCTGTGAACCGGATA
CTCCTGGAAGCCTGCCCATGCTAAGACTCTTGTGTGATGTATCTTGAAAAAAA CAAGATCCTAAATCTGAACCTTTGGTTGTTTGATTGTTTTTCTCAtttttgttgtttatttgtt aagcgt.
In another embodiment, the nucleic acid comprises the sequence of SEQ ID NO:
7, shown below (RABV vector: Coravax Vl-South Africa (RABVG-E31)):
ACGCTTAACAACCAGATCAAAGAAAAAACAGACATTGTCAATTGCAAAGCAA
AAATGTAACACCCCTACAATGGATGCCGACAAGATTGTATTCAAAGTCAATA
AT C AGGT GGT C TC TT T G A AGC C T GAG AT T AT C GT GG AT C A AT AT G AGT AC A AG
TACCCTGCCATCAAAGATTTGAAAAAGCCCTGTATAACCCTAGGAAAGGCTC
CCGATTTAAATAAAGCATACAAGTCAGTTTTGTCAGGCATGAGCGCCGCCAA
ACTTAATCCTGACGATGTATGTTCCTATTTGGCAGCGGCAATGCAGTTTTTTG
AGGGGACATGTCCGGAAGACTGGACCAGCTATGGAATTGTGATTGCACGAAA
AGGAGATAAGATCACCCCAGGTTCTCTGGTGGAGATAAAACGTACTGATGTA
GAAGGGAATT GGGCTCTGAC AGGAGGC AT GGAACTGAC AAGAGACCCC ACT
GTCCCTGAGCATGCGTCCTTAGTCGGTCTTCTCTTGAGTCTGTATAGGTTGAG
CAAAATATCCGGGCAAAACACTGGTAACTATAAGACAAACATTGCAGACAGG
ATAGAGCAGATTTTTGAGACAGCCCCTTTTGTTAAAATCGTGGAACACCATAC
TC T A AT GAC A AC TC AC A Aa AT GT GT GCT A ATT GGAGT ACT AT AC C A A AC TTC A
GATTTTTGGCCGGAACCTATGACATGTTTTTCTCCCGGATTGAGCATCTATATT
CAGCAATCAGAGTGGGCACAGTTGTCACTGCTTATGAAGACTGTTCAGGACT
GGTATCATTTACTGGGTTCATAAAACAAATCAATCTCACCGCTAGAGAGGCA
ATACTATATTTCTTCCACAAGAACTTTGAGGAAGAGATAAGAAGAATGTTTG
AGCCAGGGCAGGAGACAGCTGTTCCTCACTCTTATTTCATCCACTTCCGTTCA
CTAGGCTTGAGTGGGAAATCTCCTTATTCATCAAATGCTGTTGGTCACGTGTT
CAATCTCATTCACTTTGTAGGATGCTATATGGGTCAAGTCAGATCCCTAAATG
CAACGGTTATTGCTGCATGTGCTCCTCATGAAATGTCTGTTCTAGGGGGCTAT
CTGGGAGAGGAATTCTTCGGGAAAGGGAC ATTTGAAAGAAGATTCTTC AGAG
AT GAG A A AG A AC TT C A AG A AT AC G AGGC GGC T G A AC T GAC A A AG AC T GAC G
TAGCACTGGCAGATGATGGAACTGTCAACTCTGACGACGAGGACTACTTTTC
AGGT GAAACC AGAAGTCCGGAGGCTGTTT AT ACTCGAAT CAT GAT GAAT GGA
GGTCGACTAAAGAGATCTCACATACGGAGATATGTCTCAGTCAGTTCCAATC
ATCAAGCCCGTCCAAACTCATTCGCCGAGTTTCTAAACAAGACATATTCGAGT
GACTCATAAcatgaaaaaaactaacacccctcccGTACGCCACCATGTTCGTGTTTCTGGTG
CTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAACTTCACCACAAGGACCCAGCT
GCCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACTATCCCGACAAGG TGTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTTCTGCCTTTCTTTT
CTAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCACCAATGGCACAAA
GCGGTTCGCCAATCCAGTGCTGCCCTTTAACGATGGCGTGTACTTCGCCTCCA
CCGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCACCACACTGGACAG
CAAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAACGTGGTCATCAAG
GTGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGTGTACTATCACAA
GAACAATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTATTCCTCTGCCAAC
AATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGACCTGGAGGGCAA
GC AGGGC AATTT C AAGAACCTGAGGGAGTTCGT GTTT AAGAAT ATCGAT GGC
TACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGTGCGCGGCCTGCC
ACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCATCGGCATCAACA
TCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTACCTGACACCAGG
CGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTACTATGTGGGCTAT
CTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATGGCACCATCACAG
ACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAAGTGTACACTGAA
GAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAATTTCAGGGTGCAG
CCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCTGTGCCCTTTTGG
CGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCTGGAATAGGAAG
CGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAACAGCGCCTCCTT
CTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGAATGACCTGTGCT
TTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGACGAGGTGCGCCA
GATCGC ACC AGGAC AGAC AGGC AAT ATCGC AGACT AC AATT AT AAGCTGCCT
GACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAATCTGGATAGCA
AAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGAAAGTCTAATCTG
AAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGGCCGGCTCTACCC
CCTGCAATGGCGTGAAGGGCTTTAACTGTTATTTCCCTCTGCAGAGCTACGGC
TTCCAGCCAACATATGGCGTGGGCTATCAGCCCTACCGCGTGGTGGTGCTGTC
TTTTGAGCTGCTGCACGCACCTGCAACAGTGTGCGGACCAAAGAAGAGCACC
A ATCTGGT GA AGA AC A AGT GCGT GA AC TT C A AC TT C A AC GGACTGACC GGA A
CAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTTCAGCAGTTCGGC
AGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCTCAGACCCTGGAGA
TCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGTGATCAC ACC AGGC
ACCAATACAAGCAACCAGGTGGCCGTGCTGTATCAGGGCGTGAATTGTACCG
AGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTACATGGCGGGTGTA CTCTACCGGCAGCAACGTGTTCCAGACAAGAGCCGGATGCCTGATCGGAGCA
GAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATCGGCGCCGGCATCT
GTGCCTCCTACCAGACCCAGACAAACTCCCCaagGTCTGTGGGAGATGAGGCC
GAAGACTTTGTGGAAGTCCACCTGCCTGATGTGCATAACCAGGTGTCTGGCGT
CGACCTGGGACTGCCAAATTGGGGCAAGTACGTGCTGCTGAGTGCTGGAGCA
CTGACTGCCCTGATGCTGATCATTTTCCTGATGACCTGCTGTCGGCGCGTGAA
C AGAAGTGAGCCC ACTC AGC AC AATCTGCGAGGAACCGGGAGAGAAGT GT C
AGT C AC ACCTC AGAGCGGGAAAAT C ATT AGT AGTTGGGAAT C AC AT AAAAGC
GGGGGCGAGACCAGGCTGTGAGCTAGCCATGAAAAAAACTAACACCCCTCCT
TTCGAACCATCCCAAACATGAGCAAGATCTTTGTCAATCCTAGTGCTATTAGA
GCCGGTCTGGCCGATCTTGAGATGGCTGAAGAAACTGTTGATCTGATCAATA
GAAAT ATCGAAGAC AATC AGGCTC ATCTCC AAGGGGAACCC AT AGAGGTGGA
CAATCTCCCTGAGGATATGGGGCGACTTCACCTGGATGATGGAAAATCGCCC
AACC AT GGT GAG AT AGCC AAGGTGGGAGAAGGC A AGT ATCGAGAGGACTTT
C AGATGGAT GAAGGAGAGGATCCT AGCTTCCTGTTCC AGT CAT ACCTGGAAA
AT GTT GGAGTCC AA AT AGT C AGAC AAAT GAGGT C AGGAGAGAGATTTCTC AA
GATATGGTCACAGACCGTAGAAGAGATTATATCCTATGTCGCGGTCAACTTTC
CCAACCCTCCAGGAAAGTCTTCAGAGGATAAATCAACCCAGACTACTGGCCG
AGAGCTCAAGAAGGAGACAACACCCACTCCTTCTCAGAGAGAAAGCCAATCA
TCGAAAGCCAGGATGGCGGCTCAAATTGCTTCTGGCCCTCCAGCCCTTGAATG
GTCGGCTACCAATGAAGAGGATGATCTATCAGTGGAGGCTGAGATCGCTCAC
CAGATTGCAGAAAGTTTCTCCAAAAAATATAAGTTTCCCTCTCGATCCTCAGG
GAT ACTCTTGT AT A ATTTT GAGC A ATT GAAAAT GAACCTT GATGAT AT AGTT A
AAGAGGCAAAAAATGTACCAGGTGTGACCCGTTTAGCCCATGACGGGTCCAA
ACTCCCCCTAAGATGTGTACTGGGATGGGTCGCTTTGGCCAACTCTAAGAAAT
TCC AGTTGTT AGTCGAATCCGAC AAGCTGAGT AAAAT CAT GC AAGATGACTT
GAATCGCTATACATCTTGCTAACCGAACCTCTCCCCTCAGTCCCTCTAGACAA
TAAAATCCGAGATGTCCCAAAGTCAACATGAAAAAAACAGGCAACACCACTG
ATAAAATGAACCTCCTACGTAAGATAGTGAAAAACCGCAGGGACGAGGACA
CTCAAAAATCCTCTCCCGCGTCAGCCCCTCTGGATGACGATGACTTGTGGCTT
CCACCCCCTGAATACGTCCCGCTGAAAGAACTTACAGGCAAGAAGAACATGA
GGAACTTTTGTATCAACGGAAGGGTTAAAGTGTGTAGCCCGAATGGTTACTC
GTTCAGGATCCTGCGGCACATTCTGAAATCATTCGACGAGATATATTCTGGGA
ATCATAGGATGATCGGGTTAGTCAAAGTGGTTATTGGACTGGCTTTGTCAGGA TCTCCAGTCCCTGAGGGCCTGAACTGGGTATACAAATTGAGGAGAACCTTTAT
CTTCCAGTGGGCTGATTCCAGGGGCCCTCTTGAAGGGGAGGAGTTGGAATAC
TCTCAGGAGATCACTTGGGATGATGATACTGAGTTCGTCGGATTGCAAATAA
GAGTGATTGCAAAACAGTGTCATATCCAGGGCAGAGTCTGGTGTATCAACAT
GAACCCGAGAGCATGTCAACTATGGTCTGACATGTCTCTTCAGACACAAAGG
TCCGAAGAGGACAAAGATTCCTCTCTGCTTCTAGAATAATCAGATTATATCCC
GCAAATTTATCACTTGTTTACCTCTGGAGGAGAGAACATATGGGCTCAACTCC
AACCCTTGGGAGCAATATAACAAAAAACATGTTATGGTGCCATTAAACCGCT
GCATTTCATCAAAGTCAAGTTGATTACCTTTACATTTTGATCCTCTTGGATGTG
AAAAAAACT ATT AAC ATCCCTC AAAAGACcccggg AAAGAT GGTTCCTC AGGCT
CTCCTGTTTGTACCCCTTCTGGTTTTTCCATTGTGTTTTGGGAAATTCCCTATTT
AC AC GAT ACC AG AC A AGC TT GGT C CC T GGAGTCC GATT GAC AT AC AT C AC CT
CAGCTGCCCAAACAATTTGGTAGTGGAGGACGAAGGATGCACCAACCTGTCA
GGGTTCTCCTACATGGAACTTAAAGTTGGATACATCTTAGCCATAAAAGTGA
ACGGGTTCACTTGCACAGGCGTTGTGACGGAGGCTGAAACCTACACTAACTT
CGTTGGTTATGTCACAACCACGTTCAAAAGAAAGCATTTCCGCCCAACACCA
GATGCATGTAGAGCCGCGTACAACTGGAAGATGGCCGGTGACCCCAGATATG
AAGAGTCTCTACACAATCCGTACCCTGACTACCGCTGGCTTCGAACTGTAAAA
ACCACCAAGGAGTCTCTCGTTATCATATCTCCAAGTGTGGCAGATTTGGACCC
ATATGACAGATCCCTTCACTCGAGGGTCTTCCCTAGCGGGAAGTGCTCAGGA
GTAGCGGTGTCTTCTACCTACTGCTCCACTAACCACGATTACACCATTTGGAT
GCCCGAGAATCCGAGACTAGGGATGTCTTGTGACATTTTTACCAATAGTAGA
GGGAAGAGAGC ATCC AAAGGGAGT GAGACTT GCGGCTTTGT AGAT GAAAGA
GGCCTATATAAGTCTTTAAAAGGAGCATGCAAACTCAAGTTATGTGGAGTTCT
AGGACTT AGACTT AT GGATGGAAC AT GGGTCTCGAT GC AAAC ATC AAAT GAA
ACCAAATGGTGCCCTCCCGATAAGTTGGTGAACCTGCACGACTTTCGCTCAGA
CGAAATTGAGCACCTTGTTGTAGAGGAGTTGGTCAGGAAGAGAGAGGAGTGT
CTGGATGCACTAGAGTCCATCATGACAACCAAGTCAGTGAGTTTCAGACGTC
TCAGTCATTTAAGAAAACTTGTCCCTGGGTTTGGAAAAGCATATACCATATTC
AACAAGACCTTGATGGAAGCCGATGCTCACTACAAGTCAGTCgagACTTGGAA
TGAGATCCTCCCTTCAAAAGGGTGTTTAAGAGTTGGGGGGAGGTGTCATCCTC
ATGTGAACGGGGTGTTTTTCAATGGTATAATATTAGGACCTGACGGCAATGTC
TTAATCCCAGAGATGCAATCATCCCTCCTCCAGCAACATATGGAGTTGTTGGA
ATCCTCGGTTATCCCCCTTGTGCACCCCCTGGCAGACCCGTCTACCGTTTTCA AGGACGGTGACGAGGCTGAGGATTTTGTTGAAGTTCACCTTCCCGATGTGCA
CAATCAGGTCTCAGGAGTTGACTTGGGTCTCCCGAACTGGGGGAAGTATGTA
TTACTGAGTGCAGGGGCCCTGACTGCCTTGATGTTGATAATTTTCCTGATGAC
AT GTT GT AGAAGAGT C AATCGAT C AGAACCT ACGC AAC AC AATCTC AGAGGG
AC AGGGAGGGAGGT GT C AGTC ACTCCCC AAAGCGGGAAGATC AT ATCTTC AT
GGGAATCACACAAGAGTGGGGGTGAGACCAGACTGTAAttaattaaCGTCCTTTCA
AC GAT C C A AGTCcatgaaaaaaactaacacccctcccgtacctagcTT AT A A AGT GC T GGGT CAT
CT AAGCTTTT C AGTCGAGAAA AAAAC ATT AGATC AGAAGAAC AACTGGC AAC
ACTTCTCAACCTGAGACTTACTTCAAGATGCTCGATCCTGGAGAGGTCTATGA
TGACCCTATTGACCCAATCGAGTTAGAGGCTGAACCCAGAGGAACCCCCATT
GTCCCCAACATCTTGAGGAACTCTGACTACAATCTCAACTCTCCTTTGATAGA
AGATCCTGCTAGACTAATGTTAGAATGGTTAAAAACAGGGAATAGACCTTAT
CGGATGACTCTAACAGACAATTGCTCCAGGTCTTTCAGAGTTTTGAAAGATTA
TTTCAAGAAGGTAGATTTGGGTTCTCTCAAGGTGGGCGGAATGGCTGCACAG
TCAATGATTTCTCTCTGGTTATATGGTGCCCACTCTGAATCCAACAGGAGCCG
GAGATGTATAACAGACTTGGCCCATTTCTATTCCAAGTCGTCCCCCATAGAGA
AGCTGTTGAATCTCACGCTAGGAAATAGAGGGCTGAGAATCCCCCC AGAGGG
AGT GTT A AGTT GCC TT GAGAGGGTTG ATT AT GAT A AT GC ATTTGGA AGGT AT C
TTGCCAACACGTATTCCTCTTACTTGTTCTTCCATGTAATCACCTTATACATGA
ACGCCCTAGACTGGGATGAAGAAAAGACCATCCTAGCATTATGGAAAGATTT
A AC CTC AGT GGAC ATCGGGA AGGAC TT GGT A A AGTTC A A AGAC C A A AT AT GG
GGACTGCTGATCGTGACAAAGGACTTTGTTTACTCCCAAAGTTCCAATTGTCT
TTTTGACAGAAACTACACACTTATGCTAAAAGATCTTTTCTTGTCTCGCTTCA
ACTCCTTAATGGTCTTGCTCTCTCCCCCAGAGCCCCGATACTCAGATGACTTG
ATATCTCAACTATGCCAGCTGTACATTGCTGGGGATCAAGTCTTGTCTATGTG
TGGAAACTCCGGCTATGAAGTCATCAAAATATTGGAGCCATATGTCGTGAAT
AGTTTAGTCCAGAGAGCAGAAAAGTTTAGGCCTCTCATTCATTCCTTGGGAGA
CTTTCCTGTATTTATAAAAGACAAGGTAAGTCAACTTGAAGAGACGTTCGGTC
CCTGTGCAAGAAGGTTCTTTAGGGCTCTGGATCAATTCGACAACATACATGAC
TTGGTTTTTGTGTTTGGCTGTTACAGGCATTGGGGGCACCCATATATAGATTA
TCGAAAGGGTCTGTCAAAACTATATGATCAGGTTCACCTTAAAAAAATGATA
GATAAGTCCTACCAGGAGTGCTTAGCAAGCGACCTAGCCAGGAGGATCCTTA
GAT GGGGTTTT GAT AAGT ACTCC AAGT GGT ATCTGGATT C A AGATTCCT AGCC
CGAGACCACCCCTTGACTCCTTATATCAAAACCCAAACATGGCCACCCAAAC AT ATT GT AGACTTGGT GGGGGAT AC ATGGC AC AAGCTCCCGAT C ACGC AGAT
CTTTGAGATTCCTGAATCAATGGATCCGTCAGAAATATTGGATGACAAATCAC
ATTCTTTCACCAGAACGAGACTAGCTTCTTGGCTGTCAGAAAACCGAGGGGG
GCCTGTTCCTAGCGAAAAAGTTATTATCACGGCCCTGTCTAAGCCGCCTGTCA
ATCCCCGAGAGTTTCTGAGGTCT AT AGACCTCGGAGGATT GCC AGATGAAGA
CTTGATAATTGGCCTCAAGCCAAAGGAACGGGAATTGAAGATTGAAGGTCGA
TTCTTTGCTCTAATGTCATGGAATCTAAGATTGTATTTTGTCATCACTGAAAAA
CTCTTGGCCAACTACATCTTGCCACTTTTTGACGCGCTGACTATGACAGACAA
CCTGAACAAGGTGTTTAAAAAGCTGATCGACAGGGTCACCGGGCAAGGGCTT
TTGGACTATTCAAGGGTCACATATGCATTTCACCTGGACTATGAAAAGTGGA
ACAACCATCAAAGATTAGAGTCAACAGAGGATGTATTTTCTGTCCTAGATCA
AGT GTTTGGATT GAAGAGAGT GTTTTCT AGAAC AC ACGAGTTTTTT C AAAAGG
CCTGGATCTATTATTCAGACAGATCAGACCTCATCGGGTTACGGGAGGATCA
AATATACTGCTTAGATGCGTCCAACGGCCCAACCTGTTGGAATGGCCAGGAT
GGCGGGCTAGAAGGCTTACGGCAGAAGGGCTGGAGTCTAGTCAGCTTATTGA
T GAT AGAT AGAGAATCTC AA ATC AGGAAC AC AAGAACC AAAAT ACT AGCTC A
AGGAGACAACCAGGTTTTATGTCCGACATACATGTTGTCGCCAGGGCTATCTC
AAGAGGGGCTCCTCTATGAATTGGAGAGAATATCAAGGAATGCACTTTCGAT
AT AC AG AGC C GT C G AGG A AGGGGC AT C T A AGC T AGGGC T GAT CATC A AG A A
AGAAGAGACCATGTGTAGTTATGACTTCCTCATCTATGGAAAAACCCCTTTGT
TT AGAGGT AAC AT ATT GGT GCCTGAGTCC AAAAGAT GGGCC AGAGTCTCTTG
CGTCTCTAATGACCAAATAGTCAACCTCGCCAATATAATGTCGACAGTGTCCA
CCAATGCGCTAACAGTGGCACAACACTCTCAATCTTTGATCAAACCGATGAG
GGATTTTCTGCTCATGTCAGTACAGGCAGTCTTTCACTACCTGCTATTTAGCCC
AATCTT AAAGGGA AGAGTTT AC AAGATTCTGAGCGCTGAAGGGGAGAGCTTT
CTCCTAGCCATGTCAAGGATAATCTATCTAGATCCTTCTTTGGGAGGGATATC
TGGAATGTCCCTCGGAAGATTCCATATACGACAGTTCTCAGACCCTGTCTCTG
AAGGGTTATCCTTCTGGAGAGAGATCTGGTTAAGCTCCCAAGAGTCCTGGATT
C ACGCGTTGT GT C AAGAGGCTGGAAACCC AGATCTTGGAGAGAGAAC ACTCG
AGAGCTTCACTCGCCTTCTAGAAGATCCGACCACCTTAAATATCAGAGGAGG
GGCCAGTCCTACCATTCTACTCAAGGATGCAATCAGAAAGGCTTTATATGAC
GAGGT GGAC AAGGTGGA AAATT C AGAGTTTCGAGAGGC AATCCTGTT GTCC A
AGACCCATAGAGATAATTTTATACTCTTCTTAATATCTGTTGAGCCTCTGTTTC
CTCGATTTCTCAGTGAGCTATTCAGTTCGTCTTTTTTGGGAATCCCCGAGTCAA TCATTGGATTGATACAAAACTCCCGAACGATAAGAAGGCAGTTTAGAAAGAG
TCTCTCAAAAACTTTAGAAGAATCCTTCTACAACTCAGAGATCCACGGGATTA
GTCGGATGACCCAGACACCTCAGAGGGTTGGGGGGGTGTGGCCTTGCTCTTC
AGAGAGGGC AGATCT ACTT AGGGAGATCTCTT GGGGAAGAAAAGT GGT AGG
CACGACAGTTCCTCACCCTTCTGAGATGTTGGGATTACTTCCCAAGTCCTCTA
TTTCTTGCACTTGTGGAGCAACAGGAGGAGGCAATCCTAGAGTTTCTGTATCA
GTACTCCCGTCCTTTGATCAGTCATTTTTTTCACGAGGCCCCCTAAAGGGATA
CTTGGGCTCGTCCACCTCTATGTCGACCCAGCTATTCCATGCATGGGAAAAAG
T C ACT A AT GTT CAT GT GGT GA AGAGAGCTCT AT C GTT A A A AGA ATCT AT A A AC
TGGTTCATTACTAGAGATTCCAACTTGGCTCAAGCTCTAATTAGGAACATTAT
GTCTCTGACAGGCCCTGATTTCCCTCTAGAGGAGGCCCCTGTCTTCAAAAGGA
CGGGGTCAGCCTTGCATAGGTTCAAGTCTGCCAGATACAGCGAAGGAGGGTA
TTCTTCTGTCTGCCCGAACCTCCTCTCTCATATTTCTGTTAGTACAGACACCAT
GTCTGATTTGACCCAAGACGGGAAGAACTACGATTTCATGTTCCAGCCATTGA
TGCTTTATGCACAGACATGGACATCAGAGCTGGTACAGAGAGACACAAGGCT
AAGAGACTCTACGTTTCATTGGCACCTCCGATGCAACAGGTGTGTGAGACCC
ATTGACGACGTGACCCTGGAGACCTCTCAGATCTTCGAGTTTCCGGATGTGTC
GAAAAGAATATCCAGAATGGTTTCTGGGGCTGTGCCTCACTTCCAGAGGCTTC
CCGATATCCGTCTGAGACCAGGAGATTTTGAATCTCTAAGCGGTAGAGAAAA
GTCTCACCATATCGGATCAGCTCAGGGGCTCTTATACTCAATCTTAGTGGCAA
TTCACGACTCAGGATACAATGATGGAACCATCTTCCCTGTCAACATATACGGC
AAGGTTTCCCCT AGAGACT ATTT GAGAGGGCTCGC AAGGGGAGT ATT GAT AG
GATCCTCGATTTGCTTCTTGACAAGAATGACAAATATCAATATTAATAGACCT
CTTGAATTGGTCTCAGGGGTAATCTCATATATTCTCCTGAGGCTAGATAACCA
TCCCTCCTTGTACATAATGCTCAGAGAACCGTCTCTTAGAGGAGAGATATTTT
CTATCCCTCAGAAAATCCCCGCCGCTTATCCAACCACTATGAAAGAAGGCAA
CAGATCAATCTTGTGTTATCTCCAACATGTGCTACGCTATGAGCGAGAGATAA
TCACGGCGTCTCCAGAGAATGACTGGCTATGGATCTTTTCAGACTTTAGAAGT
GCCAAAATGACGTACCTATCCCTCATTACTTACCAGTCTCATCTTCTACTCCA
GAGGGTTGAGAGAAACCTATCTAAGAGTATGAGAGATAACCTGCGACAATTG
AGTTCTTTGATGAGGCAGGTGCTGGGCGGGCACGGAGAAGATACCTTAGAGT
CAGACGACAACATTCAACGACTGCTAAAAGACTCTTTACGAAGGACAAGATG
GGT GGATC AAGAGGT GCGCC ATGC AGCT AGAACC AT GACTGGAGATT AC AGC
CCCAACAAGAAGGTGTCCCGTAAGGTAGGATGTTCAGAATGGGTCTGCTCTG CTCAACAGGTTGCAGTCTCTACCTCAGCAAACCCGGCCCCTGTCTCGGAGCTT
GACATAAGGGCCCTCTCTAAGAGGTTCCAGAACCCTTTGATCTCGGGCTTGAG
AGTGGTTCAGTGGGCAACCGGTGCTCATTATAAGCTTAAGCCTATTCTAGATG
ATCTCAATGTTTTCCCATCTCTCTGCCTTGTAGTTGGGGACGGGTCAGGGGGG
ATATCAAGGGCAGTCCTCAACATGTTTCCAGATGCCAAGCTTGTGTTCAACAG
TCTTTTAGAGGTGAATGACCTGATGGCTTCCGGAACACATCCACTGCCTCCTT
CAGCAATCATGAGGGGAGGAAATGATATCGTCTCCAGAGTGATAGATCTTGA
CTCAATCTGGGAAAAACCGTCCGACTTGAGAAACTTGGCAACCTGGAAATAC
TTCCAGTCAGTCCAAAAGCAGGTCAACATGTCCTATGACCTCATTATTTGCGA
TGCAGAAGTTACTGACATTGCATCTATCAACCGGATCACCCTGTTAATGTCCG
ATTTTGCATTGTCTATAGATGGACCACTCTATTTGGTCTTCAAAACTTATGGG
ACTATGCTAGTAAATCCAAACTACAAGGCTATTCAACACCTGTCAAGAGCGT
TCCCCTCGGTCACAGGGTTTATCACCCAAGTAACTTCGTCTTTTTCATCTGAGC
TCTACCTCCGATTCTCCAAACGAGGGAAGTTTTTCAGAGATGCTGAGTACTTG
ACCTCTTCCACCCTTCGAGAAATGAGCCTTGTGTTATTCAATTGTAGCAGCCC
CAAGAGTGAGATGCAGAGAGCTCGTTCCTTGAACTATCAGGATCTTGTGAGA
GGATTTCCTGAAGAAATCATATCAAATCCTTACAATGAGATGATCATAACTCT
GATTGAC AGT GATGT AGAATCTTTTCT AGTCC AC AAGAT GGTT GAT GATCTT G
AGTTACAGAGGGGAACTCTGTCTAAAGTGGCTATCATTATAGCCATCATGAT
AGTTTTCTCCAACAGAGTCTTCAACGTTTCCAAACCCCTAACTGACCCCTCGT
TCTATCCACCGTCTGATCCCAAAATCCTGAGGCACTTCAACATATGTTGCAGT
ACTATGATGTATCTATCTACTGCTTTAGGTGACGTCCCTAGCTTCGCAAGACT
TCACGACCTGTATAACAGACCTATAACTTATTACTTCAGAAAGCAAGTCATTC
GAGGGA AC GTTT AT C T ATCTTGGAGTT GGT C C A AC GAC AC CTC AGT GTT C A A A
AGGGTAGCCTGTAATTCTAGCCTGAGTCTGTCATCTCACTGGATCAGGTTGAT
TTAC AAGAT AGTGAAGACTACCAGACTCGTTGGCAGCATCAAGGATCTATCC
AGAGAAGTGGAAAGACACCTTCATAGGTACAACAGGTGGATCACCCTAGAG
GATATCAGATCTAGATCATCCCTACTAGACTACAGTTGCCTGTGAACCGGATA
CTCCTGGAAGCCTGCCCATGCTAAGACTCTTGTGTGATGTATCTTGAAAAAAA
CAAGATCCTAAATCTGAACCTTTGGTTGTTTGATTGTTTTTCTCAtttttgttgtttatttgtt aagcgt.
In some embodiments, the nucleic acid comprises the sequence of SEQ ID NO: 8, shown below (RABY vector: Coravax V2-China (RABVG-E51)): ACGCTTAACAACCAGATCAAAGAAAAAACAGACATTGTCAATTGCAAAGCAA
AAATGTAACACCCCTACAATGGATGCCGACAAGATTGTATTCAAAGTCAATA
AT C AGGT GGT C TC TT T G A AGC C T GAG AT T AT C GT GG AT C A AT AT G AGT AC A AG
TACCCTGCCATCAAAGATTTGAAAAAGCCCTGTATAACCCTAGGAAAGGCTC
CCGATTTAAATAAAGCATACAAGTCAGTTTTGTCAGGCATGAGCGCCGCCAA
ACTTAATCCTGACGATGTATGTTCCTATTTGGCAGCGGCAATGCAGTTTTTTG
AGGGGACATGTCCGGAAGACTGGACCAGCTATGGAATTGTGATTGCACGAAA
AGGAGATAAGATCACCCCAGGTTCTCTGGTGGAGATAAAACGTACTGATGTA
GAAGGGAATT GGGCTCTGAC AGGAGGC AT GGAACTGAC AAGAGACCCC ACT
GTCCCTGAGCATGCGTCCTTAGTCGGTCTTCTCTTGAGTCTGTATAGGTTGAG
CAAAATATCCGGGCAAAACACTGGTAACTATAAGACAAACATTGCAGACAGG
ATAGAGCAGATTTTTGAGACAGCCCCTTTTGTTAAAATCGTGGAACACCATAC
TC T A AT GAC A AC TC AC A Aa AT GT GT GCT A ATT GGAGT ACT AT AC C A A AC TTC A
GATTTTTGGCCGGAACCTATGACATGTTTTTCTCCCGGATTGAGCATCTATATT
CAGCAATCAGAGTGGGCACAGTTGTCACTGCTTATGAAGACTGTTCAGGACT
GGTATCATTTACTGGGTTCATAAAACAAATCAATCTCACCGCTAGAGAGGCA
ATACTATATTTCTTCCACAAGAACTTTGAGGAAGAGATAAGAAGAATGTTTG
AGCCAGGGCAGGAGACAGCTGTTCCTCACTCTTATTTCATCCACTTCCGTTCA
CTAGGCTTGAGTGGGAAATCTCCTTATTCATCAAATGCTGTTGGTCACGTGTT
CAATCTCATTCACTTTGTAGGATGCTATATGGGTCAAGTCAGATCCCTAAATG
CAACGGTTATTGCTGCATGTGCTCCTCATGAAATGTCTGTTCTAGGGGGCTAT
CTGGGAGAGGAATTCTTCGGGAAAGGGAC ATTTGAAAGAAGATTCTTC AGAG
AT GAG A A AG A AC TT C A AG A AT AC G AGGC GGC T G A AC T GAC A A AG AC T GAC G
TAGCACTGGCAGATGATGGAACTGTCAACTCTGACGACGAGGACTACTTTTC
AGGT GAAACC AGAAGTCCGGAGGCTGTTT AT ACTCGAAT CAT GAT GAAT GGA
GGTCGACTAAAGAGATCTCACATACGGAGATATGTCTCAGTCAGTTCCAATC
ATCAAGCCCGTCCAAACTCATTCGCCGAGTTTCTAAACAAGACATATTCGAGT
GACTCATAAcatgaaaaaaactaacacccctcccgtacgCCACCATGTTCGTGTTTCTGGTGCT
GCTGCCTCTGGTGAGCTCCCAGTGCGTGAACCTGACCACAAGGACCCAGCTG
CCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACTATCCCGACAAGGT
GTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTTCTGCCTTTCTTTTC
TAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCACCAATGGCACAAAG
CGGTTCGACAATCCAGTGCTGCCCTTTAACGATGGCGTGTACTTCGCCTCCAC
CGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCACCACACTGGACAGC AAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAACGTGGTCATCAAGG
TGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGTGTACTATCACAAG
AACAATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTATTCCTCTGCCAACA
ATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGACCTGGAGGGCAAG
C AGGGC AATTT C AAGAACCTGAGGGAGTTCGT GTTT AAGAAT ATCGATGGCT
ACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGTGCGCGACCTGCC
ACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCATCGGCATCAACA
TCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTACCTGACACCAGG
CGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTACTATGTGGGCTAT
CTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATGGCACCATCACAG
ACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAAGTGTACACTGAA
GAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAATTTCAGGGTGCAG
CCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCTGTGCCCTTTTGG
CGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCTGGAATAGGAAG
CGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAACAGCGCCTCCTT
CTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGAATGACCTGTGCT
TTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGACGAGGTGCGCCA
GATCGCACCAGGACAGACAGGCAAGATCGCAGACTACAATTATAAGCTGCCT
GACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAATCTGGATAGCA
AAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGAAAGTCTAATCTG
AAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGGCCGGCTCTACCC
CCTGCAATGGCGTGGAGGGCTTTAACTGTTATTTCCCTCTGCAGAGCTACGGC
TTCCAGCCAACAAACGGCGTGGGCTATCAGCCCTACCGCGTGGTGGTGCTGT
CTTTTGAGCTGCTGCACGCACCTGCAACAGTGTGCGGACCAAAGAAGAGCAC
CAATCTGGTGAAGAACAAGTGCGTGAACTTCAACTTCAACGGACTGACCGGA
ACAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTTCAGCAGTTCG
GCAGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCTCAGACCCTGGA
GATCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGTGATCACACCAG
GCACCAATACAAGCAACCAGGTGGCCGTGCTGTATcAGGACGTGAATTGTAC
CGAGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTACATGGCGGGTG
TACTCTACCGGCAGCAACGTGTTCCAGACAAGAGCCGGATGCCTGATCGGAG
CAGAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATCGGCGCCGGCAT
CTGTGCCTCCTACCAGACCCAGACAAACTCCCCAGAATCAAGCGTGATTCCTC
TGGTCCATCCACTGGCAGATCCCTCCACAGTGTTCAAAGACGGAGATGAGGC CGAAGACTTTGTGGAAGTCCACCTGCCTGATGTGCATAACCAGGTGTCTGGC
GTCGACCTGGGACTGCCAAATTGGGGCAAGTACGTGCTGCTGAGTGCTGGAG
CACTGACTGCCCTGATGCTGATCATTTTCCTGATGACCTGCTGTCGGCGCGTG
AACAGAAGTGAGCCCACTCAGCACAATCTGCGAGGAACCGGGAGAGAAGTG
T C AGTC AC ACCTC AGAGCGGGAAAATC ATT AGT AGTT GGGAATC AC AT AAAA
GCGGGGGCGAGACCAGGCTGTGAgctagcCATGAAAAAAACTAACACCCCTCCT
TTCGAACCATCCCAAACATGAGCAAGATCTTTGTCAATCCTAGTGCTATTAGA
GCCGGTCTGGCCGATCTTGAGATGGCTGAAGAAACTGTTGATCTGATCAATA
GAAAT ATCGAAGAC AATC AGGCTC ATCTCC AAGGGGAACCC AT AGAGGTGGA
CAATCTCCCTGAGGATATGGGGCGACTTCACCTGGATGATGGAAAATCGCCC
AACC AT GGT GAG AT AGCC AAGGTGGGAGAAGGC A AGT ATCGAGAGGACTTT
C AGATGGAT GAAGGAGAGGATCCT AGCTTCCTGTTCC AGT CAT ACCTGGAAA
AT GTT GGAGTCC AA AT AGT C AGAC AAAT GAGGT C AGGAGAGAGATTTCTC AA
GATATGGTCACAGACCGTAGAAGAGATTATATCCTATGTCGCGGTCAACTTTC
CCAACCCTCCAGGAAAGTCTTCAGAGGATAAATCAACCCAGACTACTGGCCG
AGAGCTCAAGAAGGAGACAACACCCACTCCTTCTCAGAGAGAAAGCCAATCA
TCGAAAGCCAGGATGGCGGCTCAAATTGCTTCTGGCCCTCCAGCCCTTGAATG
GTCGGCTACCAATGAAGAGGATGATCTATCAGTGGAGGCTGAGATCGCTCAC
CAGATTGCAGAAAGTTTCTCCAAAAAATATAAGTTTCCCTCTCGATCCTCAGG
GAT ACTCTTGT AT A ATTTT GAGC A ATT GAAAAT GAACCTT GATGAT AT AGTT A
AAGAGGCAAAAAATGTACCAGGTGTGACCCGTTTAGCCCATGACGGGTCCAA
ACTCCCCCTAAGATGTGTACTGGGATGGGTCGCTTTGGCCAACTCTAAGAAAT
TCC AGTTGTT AGTCGAATCCGAC AAGCTGAGT AAAAT CAT GC AAGATGACTT
GAATCGCTATACATCTTGCTAACCGAACCTCTCCCCTCAGTCCCTCTAGACAA
TAAAATCCGAGATGTCCCAAAGTCAACATGAAAAAAACAGGCAACACCACTG
ATAAAATGAACCTCCTACGTAAGATAGTGAAAAACCGCAGGGACGAGGACA
CTCAAAAATCCTCTCCCGCGTCAGCCCCTCTGGATGACGATGACTTGTGGCTT
CCACCCCCTGAATACGTCCCGCTGAAAGAACTTACAGGCAAGAAGAACATGA
GGAACTTTTGTATCAACGGAAGGGTTAAAGTGTGTAGCCCGAATGGTTACTC
GTTCAGGATCCTGCGGCACATTCTGAAATCATTCGACGAGATATATTCTGGGA
ATCATAGGATGATCGGGTTAGTCAAAGTGGTTATTGGACTGGCTTTGTCAGGA
TCTCCAGTCCCTGAGGGCCTGAACTGGGTATACAAATTGAGGAGAACCTTTAT
CTTCCAGTGGGCTGATTCCAGGGGCCCTCTTGAAGGGGAGGAGTTGGAATAC
TCTCAGGAGATCACTTGGGATGATGATACTGAGTTCGTCGGATTGCAAATAA GAGTGATTGCAAAACAGTGTCATATCCAGGGCAGAGTCTGGTGTATCAACAT
GAACCCGAGAGCATGTCAACTATGGTCTGACATGTCTCTTCAGACACAAAGG
TCCGAAGAGGACAAAGATTCCTCTCTGCTTCTAGAATAATCAGATTATATCCC
GCAAATTTATCACTTGTTTACCTCTGGAGGAGAGAACATATGGGCTCAACTCC
AACCCTTGGGAGCAATATAACAAAAAACATGTTATGGTGCCATTAAACCGCT
GCATTTCATCAAAGTCAAGTTGATTACCTTTACATTTTGATCCTCTTGGATGTG
AAAAAAACT ATT AAC ATCCCTC AAAAGACcccggg AAAGAT GGTTCCTC AGGCT
CTCCTGTTTGTACCCCTTCTGGTTTTTCCATTGTGTTTTGGGAAATTCCCTATTT
AC AC GAT ACC AG AC A AGC TT GGT C CC T GGAGTCC GATT GAC AT AC AT C AC CT
CAGCTGCCCAAACAATTTGGTAGTGGAGGACGAAGGATGCACCAACCTGTCA
GGGTTCTCCTACATGGAACTTAAAGTTGGATACATCTTAGCCATAAAAGTGA
ACGGGTTCACTTGCACAGGCGTTGTGACGGAGGCTGAAACCTACACTAACTT
CGTTGGTTATGTCACAACCACGTTCAAAAGAAAGCATTTCCGCCCAACACCA
GATGCATGTAGAGCCGCGTACAACTGGAAGATGGCCGGTGACCCCAGATATG
AAGAGTCTCTACACAATCCGTACCCTGACTACCGCTGGCTTCGAACTGTAAAA
ACCACCAAGGAGTCTCTCGTTATCATATCTCCAAGTGTGGCAGATTTGGACCC
ATATGACAGATCCCTTCACTCGAGGGTCTTCCCTAGCGGGAAGTGCTCAGGA
GTAGCGGTGTCTTCTACCTACTGCTCCACTAACCACGATTACACCATTTGGAT
GCCCGAGAATCCGAGACTAGGGATGTCTTGTGACATTTTTACCAATAGTAGA
GGGAAGAGAGC ATCC AAAGGGAGT GAGACTT GCGGCTTTGT AGAT GAAAGA
GGCCTATATAAGTCTTTAAAAGGAGCATGCAAACTCAAGTTATGTGGAGTTCT
AGGACTT AGACTT AT GGATGGAAC AT GGGTCTCGAT GC AAAC ATC AAAT GAA
ACCAAATGGTGCCCTCCCGATAAGTTGGTGAACCTGCACGACTTTCGCTCAGA
CGAAATTGAGCACCTTGTTGTAGAGGAGTTGGTCAGGAAGAGAGAGGAGTGT
CTGGATGCACTAGAGTCCATCATGACAACCAAGTCAGTGAGTTTCAGACGTC
TCAGTCATTTAAGAAAACTTGTCCCTGGGTTTGGAAAAGCATATACCATATTC
AACAAGACCTTGATGGAAGCCGATGCTCACTACAAGTCAGTCgagACTTGGAA
TGAGATCCTCCCTTCAAAAGGGTGTTTAAGAGTTGGGGGGAGGTGTCATCCTC
ATGTGAACGGGGTGTTTTTCAATGGTATAATATTAGGACCTGACGGCAATGTC
TTAATCCCAGAGATGCAATCATCCCTCCTCCAGCAACATATGGAGTTGTTGGA
ATCCTCGGTTATCCCCCTTGTGCACCCCCTGGCAGACCCGTCTACCGTTTTCA
AGGACGGTGACGAGGCTGAGGATTTTGTTGAAGTTCACCTTCCCGATGTGCA
CAATCAGGTCTCAGGAGTTGACTTGGGTCTCCCGAACTGGGGGAAGTATGTA
TTACTGAGTGCAGGGGCCCTGACTGCCTTGATGTTGATAATTTTCCTGATGAC AT GTT GT AGAAGAGT C AATCGAT C AGAACCT ACGC AAC AC AATCTC AGAGGG
AC AGGGAGGGAGGT GT C AGTC ACTCCCC AAAGCGGGAAGATC AT ATCTTC AT
GGGAATCACACAAGAGTGGGGGTGAGACCAGACTGTAAttaattaaCGTCCTTTCA
AC GAT C C A AGTCcatgaaaaaaactaacacccctcccgtacctagcTT AT A A AGT GC T GGGT CAT
CT AAGCTTTT C AGTCGAGAAA AAAAC ATT AGATC AGAAGAAC AACTGGC AAC
ACTTCTCAACCTGAGACTTACTTCAAGATGCTCGATCCTGGAGAGGTCTATGA
TGACCCTATTGACCCAATCGAGTTAGAGGCTGAACCCAGAGGAACCCCCATT
GTCCCCAACATCTTGAGGAACTCTGACTACAATCTCAACTCTCCTTTGATAGA
AGATCCTGCTAGACTAATGTTAGAATGGTTAAAAACAGGGAATAGACCTTAT
CGGATGACTCTAACAGACAATTGCTCCAGGTCTTTCAGAGTTTTGAAAGATTA
TTTCAAGAAGGTAGATTTGGGTTCTCTCAAGGTGGGCGGAATGGCTGCACAG
TCAATGATTTCTCTCTGGTTATATGGTGCCCACTCTGAATCCAACAGGAGCCG
GAGATGTATAACAGACTTGGCCCATTTCTATTCCAAGTCGTCCCCCATAGAGA
AGCTGTTGAATCTCACGCTAGGAAATAGAGGGCTGAGAATCCCCCC AGAGGG
AGT GTT A AGTT GCC TT GAGAGGGTTG ATT AT GAT A AT GC ATTTGGA AGGT AT C
TTGCCAACACGTATTCCTCTTACTTGTTCTTCCATGTAATCACCTTATACATGA
ACGCCCTAGACTGGGATGAAGAAAAGACCATCCTAGCATTATGGAAAGATTT
A AC CTC AGT GGAC ATCGGGA AGGAC TT GGT A A AGTTC A A AGAC C A A AT AT GG
GGACTGCTGATCGTGACAAAGGACTTTGTTTACTCCCAAAGTTCCAATTGTCT
TTTTGACAGAAACTACACACTTATGCTAAAAGATCTTTTCTTGTCTCGCTTCA
ACTCCTTAATGGTCTTGCTCTCTCCCCCAGAGCCCCGATACTCAGATGACTTG
ATATCTCAACTATGCCAGCTGTACATTGCTGGGGATCAAGTCTTGTCTATGTG
TGGAAACTCCGGCTATGAAGTCATCAAAATATTGGAGCCATATGTCGTGAAT
AGTTTAGTCCAGAGAGCAGAAAAGTTTAGGCCTCTCATTCATTCCTTGGGAGA
CTTTCCTGTATTTATAAAAGACAAGGTAAGTCAACTTGAAGAGACGTTCGGTC
CCTGTGCAAGAAGGTTCTTTAGGGCTCTGGATCAATTCGACAACATACATGAC
TTGGTTTTTGTGTTTGGCTGTTACAGGCATTGGGGGCACCCATATATAGATTA
TCGAAAGGGTCTGTCAAAACTATATGATCAGGTTCACCTTAAAAAAATGATA
GATAAGTCCTACCAGGAGTGCTTAGCAAGCGACCTAGCCAGGAGGATCCTTA
GAT GGGGTTTT GAT AAGT ACTCC AAGT GGT ATCTGGATT C A AGATTCCT AGCC
CGAGACCACCCCTTGACTCCTTATATCAAAACCCAAACATGGCCACCCAAAC
AT ATT GT AGACTTGGT GGGGGAT AC ATGGC AC AAGCTCCCGAT C ACGC AG AT
CTTTGAGATTCCTGAATCAATGGATCCGTCAGAAATATTGGATGACAAATCAC
ATTCTTTCACCAGAACGAGACTAGCTTCTTGGCTGTCAGAAAACCGAGGGGG GCCTGTTCCTAGCGAAAAAGTTATTATCACGGCCCTGTCTAAGCCGCCTGTCA
ATCCCCGAGAGTTTCTGAGGTCT AT AGACCTCGGAGGATT GCC AGATGAAGA
CTTGATAATTGGCCTCAAGCCAAAGGAACGGGAATTGAAGATTGAAGGTCGA
TTCTTTGCTCTAATGTCATGGAATCTAAGATTGTATTTTGTCATCACTGAAAAA
CTCTTGGCCAACTACATCTTGCCACTTTTTGACGCGCTGACTATGACAGACAA
CCTGAACAAGGTGTTTAAAAAGCTGATCGACAGGGTCACCGGGCAAGGGCTT
TTGGACTATTCAAGGGTCACATATGCATTTCACCTGGACTATGAAAAGTGGA
ACAACCATCAAAGATTAGAGTCAACAGAGGATGTATTTTCTGTCCTAGATCA
AGT GTTTGGATT GAAGAGAGT GTTTTCT AGAAC AC ACGAGTTTTTT C AAAAGG
CCTGGATCTATTATTCAGACAGATCAGACCTCATCGGGTTACGGGAGGATCA
AATATACTGCTTAGATGCGTCCAACGGCCCAACCTGTTGGAATGGCCAGGAT
GGCGGGCTAGAAGGCTTACGGCAGAAGGGCTGGAGTCTAGTCAGCTTATTGA
T GAT AGAT AGAGAATCTC AA ATC AGGAAC AC AAGAACC AAAAT ACT AGCTC A
AGGAGACAACCAGGTTTTATGTCCGACATACATGTTGTCGCCAGGGCTATCTC
AAGAGGGGCTCCTCTATGAATTGGAGAGAATATCAAGGAATGCACTTTCGAT
AT AC AG AGC C GT C G AGG A AGGGGC AT C T A AGC T AGGGC T GAT CATC A AG A A
AGAAGAGACCATGTGTAGTTATGACTTCCTCATCTATGGAAAAACCCCTTTGT
TT AGAGGT AAC AT ATT GGT GCCTGAGTCC AAAAGAT GGGCC AGAGTCTCTTG
CGTCTCTAATGACCAAATAGTCAACCTCGCCAATATAATGTCGACAGTGTCCA
CCAATGCGCTAACAGTGGCACAACACTCTCAATCTTTGATCAAACCGATGAG
GGATTTTCTGCTCATGTCAGTACAGGCAGTCTTTCACTACCTGCTATTTAGCCC
AATCTT AAAGGGA AGAGTTT AC AAGATTCTGAGCGCTGAAGGGGAGAGCTTT
CTCCTAGCCATGTCAAGGATAATCTATCTAGATCCTTCTTTGGGAGGGATATC
TGGAATGTCCCTCGGAAGATTCCATATACGACAGTTCTCAGACCCTGTCTCTG
AAGGGTTATCCTTCTGGAGAGAGATCTGGTTAAGCTCCCAAGAGTCCTGGATT
C ACGCGTTGT GT C AAGAGGCTGGAAACCC AGATCTTGGAGAGAGAAC ACTCG
AGAGCTTCACTCGCCTTCTAGAAGATCCGACCACCTTAAATATCAGAGGAGG
GGCCAGTCCTACCATTCTACTCAAGGATGCAATCAGAAAGGCTTTATATGAC
GAGGT GGAC AAGGTGGA AAATT C AGAGTTTCGAGAGGC AATCCTGTT GTCC A
AGACCCATAGAGATAATTTTATACTCTTCTTAATATCTGTTGAGCCTCTGTTTC
CTCGATTTCTCAGTGAGCTATTCAGTTCGTCTTTTTTGGGAATCCCCGAGTCAA
TCATTGGATTGATACAAAACTCCCGAACGATAAGAAGGCAGTTTAGAAAGAG
TCTCTCAAAAACTTTAGAAGAATCCTTCTACAACTCAGAGATCCACGGGATTA
GTCGGATGACCCAGACACCTCAGAGGGTTGGGGGGGTGTGGCCTTGCTCTTC AGAGAGGGC AGATCT ACTT AGGGAGATCTCTT GGGGAAGAAAAGT GGT AGG
CACGACAGTTCCTCACCCTTCTGAGATGTTGGGATTACTTCCCAAGTCCTCTA
TTTCTTGCACTTGTGGAGCAACAGGAGGAGGCAATCCTAGAGTTTCTGTATCA
GTACTCCCGTCCTTTGATCAGTCATTTTTTTCACGAGGCCCCCTAAAGGGATA
CTTGGGCTCGTCCACCTCTATGTCGACCCAGCTATTCCATGCATGGGAAAAAG
T C ACT A AT GTT CAT GT GGT GA AGAGAGCTCT AT C GTT A A A AGA ATCT AT A A AC
TGGTTCATTACTAGAGATTCCAACTTGGCTCAAGCTCTAATTAGGAACATTAT
GTCTCTGACAGGCCCTGATTTCCCTCTAGAGGAGGCCCCTGTCTTCAAAAGGA
CGGGGTCAGCCTTGCATAGGTTCAAGTCTGCCAGATACAGCGAAGGAGGGTA
TTCTTCTGTCTGCCCGAACCTCCTCTCTCATATTTCTGTTAGTACAGACACCAT
GTCTGATTTGACCCAAGACGGGAAGAACTACGATTTCATGTTCCAGCCATTGA
TGCTTTATGCACAGACATGGACATCAGAGCTGGTACAGAGAGACACAAGGCT
AAGAGACTCTACGTTTCATTGGCACCTCCGATGCAACAGGTGTGTGAGACCC
ATTGACGACGTGACCCTGGAGACCTCTCAGATCTTCGAGTTTCCGGATGTGTC
GAAAAGAATATCCAGAATGGTTTCTGGGGCTGTGCCTCACTTCCAGAGGCTTC
CCGATATCCGTCTGAGACCAGGAGATTTTGAATCTCTAAGCGGTAGAGAAAA
GTCTCACCATATCGGATCAGCTCAGGGGCTCTTATACTCAATCTTAGTGGCAA
TTCACGACTCAGGATACAATGATGGAACCATCTTCCCTGTCAACATATACGGC
AAGGTTTCCCCT AGAGACT ATTT GAGAGGGCTCGC AAGGGGAGT ATT GAT AG
GATCCTCGATTTGCTTCTTGACAAGAATGACAAATATCAATATTAATAGACCT
CTTGAATTGGTCTCAGGGGTAATCTCATATATTCTCCTGAGGCTAGATAACCA
TCCCTCCTTGTACATAATGCTCAGAGAACCGTCTCTTAGAGGAGAGATATTTT
CTATCCCTCAGAAAATCCCCGCCGCTTATCCAACCACTATGAAAGAAGGCAA
CAGATCAATCTTGTGTTATCTCCAACATGTGCTACGCTATGAGCGAGAGATAA
TCACGGCGTCTCCAGAGAATGACTGGCTATGGATCTTTTCAGACTTTAGAAGT
GCCAAAATGACGTACCTATCCCTCATTACTTACCAGTCTCATCTTCTACTCCA
GAGGGTTGAGAGAAACCTATCTAAGAGTATGAGAGATAACCTGCGACAATTG
AGTTCTTTGATGAGGCAGGTGCTGGGCGGGCACGGAGAAGATACCTTAGAGT
CAGACGACAACATTCAACGACTGCTAAAAGACTCTTTACGAAGGACAAGATG
GGT GGATC AAGAGGT GCGCC ATGC AGCT AGAACC AT GACTGGAGATT AC AGC
CCCAACAAGAAGGTGTCCCGTAAGGTAGGATGTTCAGAATGGGTCTGCTCTG
CTCAACAGGTTGCAGTCTCTACCTCAGCAAACCCGGCCCCTGTCTCGGAGCTT
GACATAAGGGCCCTCTCTAAGAGGTTCCAGAACCCTTTGATCTCGGGCTTGAG
AGTGGTTCAGTGGGCAACCGGTGCTCATTATAAGCTTAAGCCTATTCTAGATG ATCTCAATGTTTTCCCATCTCTCTGCCTTGTAGTTGGGGACGGGTCAGGGGGG
ATATCAAGGGCAGTCCTCAACATGTTTCCAGATGCCAAGCTTGTGTTCAACAG
TCTTTTAGAGGTGAATGACCTGATGGCTTCCGGAACACATCCACTGCCTCCTT
CAGCAATCATGAGGGGAGGAAATGATATCGTCTCCAGAGTGATAGATCTTGA
CTCAATCTGGGAAAAACCGTCCGACTTGAGAAACTTGGCAACCTGGAAATAC
TTCCAGTCAGTCCAAAAGCAGGTCAACATGTCCTATGACCTCATTATTTGCGA
TGCAGAAGTTACTGACATTGCATCTATCAACCGGATCACCCTGTTAATGTCCG
ATTTTGCATTGTCTATAGATGGACCACTCTATTTGGTCTTCAAAACTTATGGG
ACTATGCTAGTAAATCCAAACTACAAGGCTATTCAACACCTGTCAAGAGCGT
TCCCCTCGGTCACAGGGTTTATCACCCAAGTAACTTCGTCTTTTTCATCTGAGC
TCTACCTCCGATTCTCCAAACGAGGGAAGTTTTTCAGAGATGCTGAGTACTTG
ACCTCTTCCACCCTTCGAGAAATGAGCCTTGTGTTATTCAATTGTAGCAGCCC
CAAGAGTGAGATGCAGAGAGCTCGTTCCTTGAACTATCAGGATCTTGTGAGA
GGATTTCCTGAAGAAATCATATCAAATCCTTACAATGAGATGATCATAACTCT
GATTGAC AGT GATGT AGAATCTTTTCT AGTCC AC AAGAT GGTT GAT GATCTT G
AGTTACAGAGGGGAACTCTGTCTAAAGTGGCTATCATTATAGCCATCATGAT
AGTTTTCTCCAACAGAGTCTTCAACGTTTCCAAACCCCTAACTGACCCCTCGT
TCTATCCACCGTCTGATCCCAAAATCCTGAGGCACTTCAACATATGTTGCAGT
ACTATGATGTATCTATCTACTGCTTTAGGTGACGTCCCTAGCTTCGCAAGACT
TCACGACCTGTATAACAGACCTATAACTTATTACTTCAGAAAGCAAGTCATTC
GAGGGA AC GTTT AT C T ATCTTGGAGTT GGT C C A AC GAC AC CTC AGT GTT C A A A
AGGGTAGCCTGTAATTCTAGCCTGAGTCTGTCATCTCACTGGATCAGGTTGAT
TTAC AAGAT AGTGAAGACTACCAGACTCGTTGGCAGCATCAAGGATCTATCC
AGAGAAGTGGAAAGACACCTTCATAGGTACAACAGGTGGATCACCCTAGAG
GATATCAGATCTAGATCATCCCTACTAGACTACAGTTGCCTGTGAACCGGATA
CTCCTGGAAGCCTGCCCATGCTAAGACTCTTGTGTGATGTATCTTGAAAAAAA
CAAGATCCTAAATCTGAACCTTTGGTTGTTTGATTGTTTTTCTCAtttttgttgtttatttgtt aagcgt.
In other embodiments, the nucleic acid comprises the sequence of SEQ ID NO: 9, shown below (RABV vector: Coravax V2 South Africa (S1-RABVG-E51)): ACGCTTAACAACCAGATCAAAGAAAAAACAGACATTGTCAATTGCAAAGCAA AAATGTAACACCCCTACAATGGATGCCGACAAGATTGTATTCAAAGTCAATA AT C AGGT GGT C TC TT T G A AGC C T GAG AT T AT C GT GG AT C A AT AT G AGT AC A AG TACCCTGCCATCAAAGATTTGAAAAAGCCCTGTATAACCCTAGGAAAGGCTC CCGATTTAAATAAAGCATACAAGTCAGTTTTGTCAGGCATGAGCGCCGCCAA
ACTTAATCCTGACGATGTATGTTCCTATTTGGCAGCGGCAATGCAGTTTTTTG
AGGGGACATGTCCGGAAGACTGGACCAGCTATGGAATTGTGATTGCACGAAA
AGGAGATAAGATCACCCCAGGTTCTCTGGTGGAGATAAAACGTACTGATGTA
GAAGGGAATT GGGCTCTGAC AGGAGGC AT GGAACTGAC AAGAGACCCC ACT
GTCCCTGAGCATGCGTCCTTAGTCGGTCTTCTCTTGAGTCTGTATAGGTTGAG
CAAAATATCCGGGCAAAACACTGGTAACTATAAGACAAACATTGCAGACAGG
ATAGAGCAGATTTTTGAGACAGCCCCTTTTGTTAAAATCGTGGAACACCATAC
TC T A AT GAC A AC TC AC A Aa AT GT GT GCT A ATT GGAGT ACT AT AC C A A AC TTC A
GATTTTTGGCCGGAACCTATGACATGTTTTTCTCCCGGATTGAGCATCTATATT
CAGCAATCAGAGTGGGCACAGTTGTCACTGCTTATGAAGACTGTTCAGGACT
GGTATCATTTACTGGGTTCATAAAACAAATCAATCTCACCGCTAGAGAGGCA
ATACTATATTTCTTCCACAAGAACTTTGAGGAAGAGATAAGAAGAATGTTTG
AGCCAGGGCAGGAGACAGCTGTTCCTCACTCTTATTTCATCCACTTCCGTTCA
CTAGGCTTGAGTGGGAAATCTCCTTATTCATCAAATGCTGTTGGTCACGTGTT
CAATCTCATTCACTTTGTAGGATGCTATATGGGTCAAGTCAGATCCCTAAATG
CAACGGTTATTGCTGCATGTGCTCCTCATGAAATGTCTGTTCTAGGGGGCTAT
CTGGGAGAGGAATTCTTCGGGAAAGGGAC ATTTGAAAGAAGATTCTTC AGAG
AT GAG A A AG A AC TT C A AG A AT AC G AGGC GGC T G A AC T GAC A A AG AC T GAC G
TAGCACTGGCAGATGATGGAACTGTCAACTCTGACGACGAGGACTACTTTTC
AGGT GAAACC AGAAGTCCGGAGGCTGTTT AT ACTCGAAT CAT GAT GAAT GGA
GGTCGACTAAAGAGATCTCACATACGGAGATATGTCTCAGTCAGTTCCAATC
ATCAAGCCCGTCCAAACTCATTCGCCGAGTTTCTAAACAAGACATATTCGAGT
GACTCATAAcatgaaaaaaactaacacccctcccgtacgCCACCATGTTCGTGTTTCTGGTGCT
GCTGCCTCTGGTGAGCTCCCAGTGCGTGAACTTCACCACAAGGACCCAGCTG
CCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACTATCCCGACAAGGT
GTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTTCTGCCTTTCTTTTC
TAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCACCAATGGCACAAAG
CGGTTCGCCAATCCAGTGCTGCCCTTTAACGATGGCGTGTACTTCGCCTCCAC
CGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCACCACACTGGACAGC
AAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAACGTGGTCATCAAGG
TGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGTGTACTATCACAAG
AACAATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTATTCCTCTGCCAACA
ATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGACCTGGAGGGCAAG C AGGGC AATTT C AAGAACCTGAGGGAGTTCGT GTTT AAGAAT ATCGATGGCT
ACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGTGCGCGGCCTGCC
ACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCATCGGCATCAACA
TCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTACCTGACACCAGG
CGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTACTATGTGGGCTAT
CTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATGGCACCATCACAG
ACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAAGTGTACACTGAA
GAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAATTTCAGGGTGCAG
CCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCTGTGCCCTTTTGG
CGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCTGGAATAGGAAG
CGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAACAGCGCCTCCTT
CTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGAATGACCTGTGCT
TTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGACGAGGTGCGCCA
GATCGC ACC AGGAC AGAC AGGC AAT ATCGC AGACT AC AATT AT AAGCTGCCT
GACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAATCTGGATAGCA
AAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGAAAGTCTAATCTG
AAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGGCCGGCTCTACCC
CCTGCAATGGCGTGAAGGGCTTTAACTGTTATTTCCCTCTGCAGAGCTACGGC
TTCCAGCCAACATATGGCGTGGGCTATCAGCCCTACCGCGTGGTGGTGCTGTC
TTTTGAGCTGCTGCACGCACCTGCAACAGTGTGCGGACCAAAGAAGAGCACC
A ATCTGGT GA AGA AC A AGT GCGT GA AC TT C A AC TT C A AC GGACTGACC GGA A
CAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTTCAGCAGTTCGGC
AGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCTCAGACCCTGGAGA
TCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGTGATCAC ACC AGGC
ACCAATACAAGCAACCAGGTGGCCGTGCTGTATCAGGGCGTGAATTGTACCG
AGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTACATGGCGGGTGTA
CTCTACCGGCAGCAACGTGTTCCAGACAAGAGCCGGATGCCTGATCGGAGCA
GAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATCGGCGCCGGCATCT
GTGCCTCCTACCAGACCCAGACAAACTCCCCAGAATCAAGCGTGATTCCTCTG
GTCCATCCACTGGCAGATCCCTCCACAGTGTTCAAAGACGGAGATGAGGCCG
AAGACTTTGTGGAAGTCCACCTGCCTGATGTGCATAACCAGGTGTCTGGCGTC
GACCTGGGACTGCC AAATT GGGGC AAGT ACGT GCTGCTGAGT GCTGGAGC AC
TGACTGCCCTGATGCTGATCATTTTCCTGATGACCTGCTGTCGGCGCGTGAAC
AG A AGT G AGC C C AC TC AGC AC AAT C T GC G AGG A AC C GGG AG AG A AGT GT C A GT C AC AC CTC AGAGC GGGA A A AT C ATT AGT AGTT GGGA AT C AC AT A A A AGCG
GGGGCGAGACC AGGCTGT GAgctagcC AT GAAAAAAACT AAC ACCCCTCCTTT C
GAACCATCCCAAACATGAGCAAGATCTTTGTCAATCCTAGTGCTATTAGAGCC
GGTCTGGCCGATCTTGAGAT GGCTGAAGAAACTGTT GATCTGATC AAT AGAA
AT AT C GA AG AC A AT C AGGC TC AT C TCC A AGGGGA ACC C AT AGAGGT GGAC A A
TCTCCCTGAGGATATGGGGCGACTTCACCTGGATGATGGAAAATCGCCCAAC
CATGGTGAGATAGCCAAGGTGGGAGAAGGCAAGTATCGAGAGGACTTTCAG
ATGGATGAAGGAGAGGATCCTAGCTTCCTGTTCCAGTCATACCTGGAAAATG
TTGGAGTCC AAAT AGTC AGAC AAAT GAGGT C AGGAGAGAGATTTCTC AAGAT
ATGGTCACAGACCGTAGAAGAGATTATATCCTATGTCGCGGTCAACTTTCCCA
ACCCTCCAGGAAAGTCTTCAGAGGATAAATCAACCCAGACTACTGGCCGAGA
GCTCAAGAAGGAGACAACACCCACTCCTTCTCAGAGAGAAAGCCAATCATCG
AAAGCCAGGATGGCGGCTCAAATTGCTTCTGGCCCTCCAGCCCTTGAATGGTC
GGCT ACC AAT GAAGAGGAT GATCT ATC AGT GGAGGCTGAGATCGCTC ACC AG
ATTGCAGAAAGTTTCTCCAAAAAATATAAGTTTCCCTCTCGATCCTCAGGGAT
ACTCTTGTATAATTTTGAGCAATTGAAAATGAACCTTGATGATATAGTTAAAG
AGGC A AAAAAT GT ACC AGGT GT GACCCGTTT AGCCC AT GACGGGTCC AAACT
CCCCCTAAGATGTGTACTGGGATGGGTCGCTTTGGCCAACTCTAAGAAATTCC
AGTTGTT AGTCGAATCCGAC AAGCTGAGT AAAAT CAT GC AAGAT GACTTGAA
TCGCTATACATCTTGCTAACCGAACCTCTCCCCTCAGTCCCTCTAGACAATAA
AATCCGAGATGTCCCAAAGTCAACATGAAAAAAAC AGGC AAC ACC ACTGATA
AAATGAACCTCCTACGTAAGATAGTGAAAAACCGCAGGGACGAGGACACTC
AAAAATCCTCTCCCGCGTCAGCCCCTCTGGATGACGATGACTTGTGGCTTCCA
CCCCCTGAATACGTCCCGCTGAAAGAACTTACAGGCAAGAAGAACATGAGGA
ACTTTTGTATCAACGGAAGGGTTAAAGTGTGTAGCCCGAATGGTTACTCGTTC
AGGATCCTGCGGCACATTCTGAAATCATTCGACGAGATATATTCTGGGAATC
ATAGGATGATCGGGTTAGTCAAAGTGGTTATTGGACTGGCTTTGTCAGGATCT
CCAGTCCCTGAGGGCCTGAACTGGGTATACAAATTGAGGAGAACCTTTATCTT
CCAGTGGGCTGATTCCAGGGGCCCTCTTGAAGGGGAGGAGTTGGAATACTCT
CAGGAGATCACTTGGGATGATGATACTGAGTTCGTCGGATTGCAAATAAGAG
T GATT GCA A A AC AGT GTC AT ATCC AGGGC AGAGTCTGGT GT AT C A AC AT GA A
CCCGAGAGCATGTCAACTATGGTCTGACATGTCTCTTCAGACACAAAGGTCC
GAAGAGGACAAAGATTCCTCTCTGCTTCTAGAATAATCAGATTATATCCCGCA
AATTTATCACTTGTTTACCTCTGGAGGAGAGAACATATGGGCTCAACTCCAAC CCTT GGGAGC AAT AT AAC AAAAAAC AT GTT ATGGT GCC ATT AAACCGCTGC A
TTTCATCAAAGTCAAGTTGATTACCTTTACATTTTGATCCTCTTGGATGTGAAA
AAAACTATTAACATCCCTCAAAAGACcccgggAAAGATGGTTCCTCAGGCTCTC
CTGTTTGTACCCCTTCTGGTTTTTCCATTGTGTTTTGGGAAATTCCCTATTTAC
ACGATACCAGACAAGCTTGGTCCCTGGAGTCCGATTGACATACATCACCTCA
GCTGCCCAAACAATTTGGTAGTGGAGGACGAAGGATGCACCAACCTGTCAGG
GTTCTCCTACATGGAACTTAAAGTTGGATACATCTTAGCCATAAAAGTGAACG
GGTTCACTTGCACAGGCGTTGTGACGGAGGCTGAAACCTACACTAACTTCGTT
GGTTATGTCACAACCACGTTCAAAAGAAAGCATTTCCGCCCAACACCAGATG
CATGTAGAGCCGCGTACAACTGGAAGATGGCCGGTGACCCCAGATATGAAGA
GTCTCTACACAATCCGTACCCTGACTACCGCTGGCTTCGAACTGTAAAAACCA
CCAAGGAGTCTCTCGTTATCATATCTCCAAGTGTGGCAGATTTGGACCCATAT
GACAGATCCCTTCACTCGAGGGTCTTCCCTAGCGGGAAGTGCTCAGGAGTAG
CGGTGTCTTCTACCTACTGCTCCACTAACCACGATTACACCATTTGGATGCCC
GAGAATCCGAGACT AGGGAT GTCTT GT GAC ATTTTT ACC AAT AGT AGAGGGA
AGAGAGC ATCC AAAGGGAGT GAGACTTGCGGCTTT GT AG AT GAAAGAGGCCT
ATATAAGTCTTTAAAAGGAGCATGCAAACTCAAGTTATGTGGAGTTCTAGGA
CTTAGACTTATGGATGGAACATGGGTCTCGATGCAAACATCAAATGAAACCA
AATGGTGCCCTCCCGATAAGTTGGTGAACCTGCACGACTTTCGCTCAGACGA
A ATTGAGC ACC TT GTT GT AGAGGAGTT GGT C AGGA AGAGAGAGGAGT GTCTG
GATGCACTAGAGTCCATCATGACAACCAAGTCAGTGAGTTTCAGACGTCTCA
GTCATTTAAGAAAACTTGTCCCTGGGTTTGGAAAAGCATATACCATATTCAAC
AAGACCTTGAT GGAAGCCGAT GCTC ACT AC AAGT C AGT Cgag ACTT GGAAT GA
GATCCTCCCTTCAAAAGGGTGTTTAAGAGTTGGGGGGAGGTGTCATCCTCATG
TGAACGGGGTGTTTTTCAATGGTATAATATTAGGACCTGACGGCAATGTCTTA
ATCCCAGAGATGCAATCATCCCTCCTCCAGCAACATATGGAGTTGTTGGAATC
CTCGGTTATCCCCCTTGTGCACCCCCTGGCAGACCCGTCTACCGTTTTCAAGG
ACGGTGACGAGGCTGAGGATTTTGTTGAAGTTCACCTTCCCGATGTGCACAAT
CAGGTCTCAGGAGTTGACTTGGGTCTCCCGAACTGGGGGAAGTATGTATTACT
GAGTGCAGGGGCCCTGACTGCCTTGATGTTGATAATTTTCCTGATGACATGTT
GT AGAAGAGTC AATCGAT C AGAACCT ACGC AAC AC AATCTC AGAGGGAC AG
GGAGGGAGGTGTCAGTCACTCCCCAAAGCGGGAAGATCATATCTTCATGGGA
ATCACACAAGAGTGGGGGTGAGACCAGACTGTAAttaattaaCGTCCTTTCAACGA
TCC A AGTCcatgaaaaaaactaacacccctcccgtacctagcTT AT A A AGT GC T GGGT C ATCT A AG CTTTTCAGTCGAGAAAAAAACATTAGATCAGAAGAACAACTGGCAACACTTC
TCAACCTGAGACTTACTTCAAGATGCTCGATCCTGGAGAGGTCTATGATGACC
CTATTGACCCAATCGAGTTAGAGGCTGAACCCAGAGGAACCCCCATTGTCCC
CAACATCTTGAGGAACTCTGACTACAATCTCAACTCTCCTTTGATAGAAGATC
CTGCT AGACT AATGTT AGAATGGTT AAAAAC AGGGAAT AGACCTT ATCGGAT
GACTCTAACAGACAATTGCTCCAGGTCTTTCAGAGTTTTGAAAGATTATTTCA
AGAAGGTAGATTTGGGTTCTCTCAAGGTGGGCGGAATGGCTGCACAGTCAAT
GATTTCTCTCTGGTTATATGGTGCCCACTCTGAATCCAACAGGAGCCGGAGAT
GTATAACAGACTTGGCCCATTTCTATTCCAAGTCGTCCCCCATAGAGAAGCTG
TTGAATCTCACGCTAGGAAATAGAGGGCTGAGAATCCCCCCAGAGGGAGTGT
T A AGTT GCC TT GAGAGGGTTGATT AT GAT A AT GC ATTT GGA AGGT AT C TT GCC
AACACGTATTCCTCTTACTTGTTCTTCCATGTAATCACCTTATACATGAACGCC
CTAGACTGGGATGAAGAAAAGACCATCCTAGCATTATGGAAAGATTTAACCT
C AGT GG AC ATC GGG A AGG AC TT GGT A A AGT T C A A AG AC C A A AT AT GGGG AC T
GCTGATCGTGACAAAGGACTTTGTTTACTCCCAAAGTTCCAATTGTCTTTTTG
ACAGAAACTACACACTTATGCTAAAAGATCTTTTCTTGTCTCGCTTCAACTCC
TTAATGGTCTTGCTCTCTCCCCCAGAGCCCCGATACTCAGATGACTTGATATC
TCAACTATGCCAGCTGTACATTGCTGGGGATCAAGTCTTGTCTATGTGTGGAA
ACTCCGGCTATGAAGTCATCAAAATATTGGAGCCATATGTCGTGAATAGTTTA
GTCCAGAGAGCAGAAAAGTTTAGGCCTCTCATTCATTCCTTGGGAGACTTTCC
TGTATTTATAAAAGACAAGGTAAGTCAACTTGAAGAGACGTTCGGTCCCTGT
GCAAGAAGGTTCTTTAGGGCTCTGGATCAATTCGACAACATACATGACTTGGT
TTTTGTGTTTGGCTGTTACAGGCATTGGGGGCACCCATATATAGATTATCGAA
AGGGTCTGTC AAAACT AT ATGAT C AGGTTC ACCTT AAAAAAATGAT AG AT AA
GTCCTACCAGGAGTGCTTAGCAAGCGACCTAGCCAGGAGGATCCTTAGATGG
GGTTTTGATAAGTACTCCAAGTGGTATCTGGATTCAAGATTCCTAGCCCGAGA
CCACCCCTTGACTCCTTATATCAAAACCCAAACATGGCCACCCAAACATATTG
T AGACTT GGT GGGGGAT AC AT GGC AC AAGCTCCCGAT C ACGC AGATCTTTGA
GATTCCTGAATCAATGGATCCGTCAGAAATATTGGATGACAAATCACATTCTT
TCACCAGAACGAGACTAGCTTCTTGGCTGTCAGAAAACCGAGGGGGGCCTGT
TCCTAGCGAAAAAGTTATTATCACGGCCCTGTCTAAGCCGCCTGTCAATCCCC
GAGAGTTTCTGAGGTCT AT AGACCTCGGAGGATT GCC AG AT GAAGACTTGAT
AATTGGCCTCAAGCCAAAGGAACGGGAATTGAAGATTGAAGGTCGATTCTTT
GCTCTAATGTCATGGAATCTAAGATTGTATTTTGTCATCACTGAAAAACTCTT GGCCAACTACATCTTGCCACTTTTTGACGCGCTGACTATGACAGACAACCTGA
ACAAGGTGTTTAAAAAGCTGATCGACAGGGTCACCGGGCAAGGGCTTTTGGA
CTATTCAAGGGTCACATATGCATTTCACCTGGACTATGAAAAGTGGAACAAC
CAT C AAAGATT AGAGTC AAC AGAGGAT GT ATTTTCTGTCCT AGATC AAGT GTT
T GGATT GAAGAGAGT GTTTTCT AGAAC AC ACGAGTTTTTTC AAAAGGCCTGGA
TCTATTATTCAGACAGATCAGACCTCATCGGGTTACGGGAGGATCAAATATA
CTGCTTAGATGCGTCCAACGGCCCAACCTGTTGGAATGGCCAGGATGGCGGG
CT AGAAGGCTT ACGGC AGAAGGGCTGGAGTCT AGT C AGCTT ATT GAT GAT AG
AT AGAGAATCTC AAAT C AGGAAC AC A AGAACC AAAAT ACT AGCTC AAGGAG
ACAACCAGGTTTTATGTCCGACATACATGTTGTCGCCAGGGCTATCTCAAGAG
GGGCTCCTCTATGAATTGGAGAGAATATCAAGGAATGCACTTTCGATATACA
GAGCCGTCGAGGAAGGGGCATCTAAGCTAGGGCTGATCATCAAGAAAGAAG
AGACCATGTGTAGTTATGACTTCCTCATCTATGGAAAAACCCCTTTGTTTAGA
GGTAACATATTGGTGCCTGAGTCCAAAAGATGGGCCAGAGTCTCTTGCGTCTC
T A AT GAC C A A AT AGT C A ACC T C GCC A AT AT A AT GTCG AC AGT GT C C AC C A AT
GCGCTAACAGTGGCACAACACTCTCAATCTTTGATCAAACCGATGAGGGATT
TTCTGCTCATGTCAGTACAGGCAGTCTTTCACTACCTGCTATTTAGCCCAATCT
T AAAGGGAAGAGTTT AC AAGATTCTGAGCGCTGAAGGGGAGAGCTTTCTCCT
AGCCATGTCAAGGATAATCTATCTAGATCCTTCTTTGGGAGGGATATCTGGAA
TGTCCCTCGGAAGATTCCATATACGACAGTTCTCAGACCCTGTCTCTGAAGGG
TTATCCTTCTGGAGAGAGATCTGGTTAAGCTCCCAAGAGTCCTGGATTCACGC
GTTGTGTCAAGAGGCTGGAAACCCAGATCTTGGAGAGAGAACACTCGAGAGC
TTCACTCGCCTTCTAGAAGATCCGACCACCTTAAATATCAGAGGAGGGGCCA
GTCCTACCATTCTACTCAAGGATGCAATCAGAAAGGCTTTATATGACGAGGT
GGAC AAGGT GGAAAATTC AGAGTTTCGAGAGGC AATCCTGTTGTCC A AGACC
CATAGAGATAATTTTATACTCTTCTTAATATCTGTTGAGCCTCTGTTTCCTCGA
TTTCTCAGTGAGCTATTCAGTTCGTCTTTTTTGGGAATCCCCGAGTCAATCATT
GGATTGATACAAAACTCCCGAACGATAAGAAGGCAGTTTAGAAAGAGTCTCT
CAAAAACTTTAGAAGAATCCTTCTACAACTCAGAGATCCACGGGATTAGTCG
GATGACCCAGACACCTCAGAGGGTTGGGGGGGTGTGGCCTTGCTCTTCAGAG
AGGGCAGATCTACTTAGGGAGATCTCTTGGGGAAGAAAAGTGGTAGGCACGA
CAGTTCCTCACCCTTCTGAGATGTTGGGATTACTTCCCAAGTCCTCTATTTCTT
GCACTTGTGGAGCAACAGGAGGAGGCAATCCTAGAGTTTCTGTATCAGTACT
CCCGTCCTTTGATCAGTCATTTTTTTCACGAGGCCCCCTAAAGGGATACTTGG GCTCGTCCACCTCTATGTCGACCCAGCTATTCCATGCATGGGAAAAAGTCACT
A AT GTT CAT GT GGT GA AGAGAGCTCT AT C GTT A A A AGA ATCT AT A A AC T GGTT
CATTACTAGAGATTCCAACTTGGCTCAAGCTCTAATTAGGAACATTATGTCTC
TGACAGGCCCTGATTTCCCTCTAGAGGAGGCCCCTGTCTTCAAAAGGACGGG
GTCAGCCTTGCATAGGTTCAAGTCTGCCAGATACAGCGAAGGAGGGTATTCT
TCTGTCTGCCCGAACCTCCTCTCTCATATTTCTGTTAGTACAGACACCATGTCT
GATTTGACCCAAGACGGGAAGAACTACGATTTCATGTTCCAGCCATTGATGCT
TT AT GC AC AG AC AT GGAC ATC AGAGCTGGT AC AGAGAGAC AC AAGGCT AAG
AGACTCTACGTTTCATTGGCACCTCCGATGCAACAGGTGTGTGAGACCCATTG
ACGACGTGACCCTGGAGACCTCTCAGATCTTCGAGTTTCCGGATGTGTCGAAA
AGAATATCCAGAATGGTTTCTGGGGCTGTGCCTCACTTCCAGAGGCTTCCCGA
TATCCGTCTGAGACCAGGAGATTTTGAATCTCTAAGCGGTAGAGAAAAGTCT
CACCATATCGGATCAGCTCAGGGGCTCTTATACTCAATCTTAGTGGCAATTCA
CGACTCAGGATACAATGATGGAACCATCTTCCCTGTCAACATATACGGCAAG
GTTTCCCCT AGAGACT ATTT GAGAGGGCTCGC AAGGGGAGT ATT GAT AGGAT
CCTCGATTTGCTTCTTGACAAGAATGACAAATATCAATATTAATAGACCTCTT
GAATTGGTCTCAGGGGTAATCTCATATATTCTCCTGAGGCTAGATAACCATCC
CTCCTTGTACATAATGCTCAGAGAACCGTCTCTTAGAGGAGAGATATTTTCTA
TCCCTCAGAAAATCCCCGCCGCTTATCCAACCACTATGAAAGAAGGCAACAG
ATCAATCTTGTGTTATCTCCAACATGTGCTACGCTATGAGCGAGAGATAATCA
CGGCGTCTCCAGAGAATGACTGGCTATGGATCTTTTCAGACTTTAGAAGTGCC
AAAATGACGTACCTATCCCTCATTACTTACCAGTCTCATCTTCTACTCCAGAG
GGTTGAGAGAAACCTATCTAAGAGTATGAGAGATAACCTGCGACAATTGAGT
TCTTTGATGAGGCAGGTGCTGGGCGGGCACGGAGAAGATACCTTAGAGTCAG
ACGACAACATTCAACGACTGCTAAAAGACTCTTTACGAAGGACAAGATGGGT
GGATCAAGAGGTGCGCCATGCAGCTAGAACCATGACTGGAGATTACAGCCCC
AAC AAGAAGGT GTCCCGT AAGGT AGGAT GTTC AGAATGGGTCTGCTCTGCTC
AACAGGTTGCAGTCTCTACCTCAGCAAACCCGGCCCCTGTCTCGGAGCTTGAC
ATAAGGGCCCTCTCTAAGAGGTTCCAGAACCCTTTGATCTCGGGCTTGAGAGT
GGTTCAGTGGGCAACCGGTGCTCATTATAAGCTTAAGCCTATTCTAGATGATC
TCAATGTTTTCCCATCTCTCTGCCTTGTAGTTGGGGACGGGTCAGGGGGGATA
TCAAGGGCAGTCCTCAACATGTTTCCAGATGCCAAGCTTGTGTTCAACAGTCT
TTTAGAGGTGAATGACCTGATGGCTTCCGGAACACATCCACTGCCTCCTTCAG
CAATCATGAGGGGAGGAAATGATATCGTCTCCAGAGTGATAGATCTTGACTC AATCTGGGAAAAACCGTCCGACTTGAGAAACTTGGCAACCTGGAAATACTTC
CAGTCAGTCCAAAAGCAGGTCAACATGTCCTATGACCTCATTATTTGCGATGC
AGAAGTTACTGACATTGCATCTATCAACCGGATCACCCTGTTAATGTCCGATT
TTGCATTGTCTATAGATGGACCACTCTATTTGGTCTTCAAAACTTATGGGACT
ATGCTAGTAAATCCAAACTACAAGGCTATTCAACACCTGTCAAGAGCGTTCC
CCTCGGTCACAGGGTTTATCACCCAAGTAACTTCGTCTTTTTCATCTGAGCTCT
ACCTCCGATTCTCCAAACGAGGGAAGTTTTTCAGAGATGCTGAGTACTTGACC
TCTTCCACCCTTCGAGAAATGAGCCTTGTGTTATTCAATTGTAGCAGCCCCAA
G AGT GAG AT GC AG AG AGC T C GT TC C TT G A AC TAT C AGG AT C T T GT G AG AGG A
TTTCCTGAAGAAATCATATCAAATCCTTACAATGAGATGATCATAACTCTGAT
TGACAGTGATGTAGAATCTTTTCTAGTCCACAAGATGGTTGATGATCTTGAGT
T AC AGAGGGGA AC TC T GTCT A A AGT GGCT ATC ATT AT AGC CAT CAT GAT AGTT
TTCTCCAACAGAGTCTTCAACGTTTCCAAACCCCTAACTGACCCCTCGTTCTA
TCCACCGTCTGATCCCAAAATCCTGAGGCACTTCAACATATGTTGCAGTACTA
TGATGTATCTATCTACTGCTTTAGGTGACGTCCCTAGCTTCGCAAGACTTCAC
GACCTGTATAACAGACCTATAACTTATTACTTCAGAAAGCAAGTCATTCGAG
GGA AC GTTT ATCT ATCTT GGAGTT GGT C C A AC GAC AC CTC AGT GTT C A A A AGG
GTAGCCTGTAATTCTAGCCTGAGTCTGTCATCTCACTGGATCAGGTTGATTTA
C AAGAT AGTGAAGACT ACC AGACTCGTT GGC AGC AT C AAGGATCT ATCC AGA
GAAGTGGAAAGACACCTTCATAGGTACAACAGGTGGATCACCCTAGAGGATA
TCAGATCTAGATCATCCCTACTAGACTACAGTTGCCTGTGAACCGGATACTCC
TGGAAGCCTGCCCATGCTAAGACTCTTGTGTGATGTATCTTGAAAAAAACAA
GATCCTAAATCTGAACCTTTGGTTGTTTGATTGTTTTTCTCAtttttgttgtttatttgttaagc gt-
In one embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 10, shown below (RABV vector: Coravax V3-China (S1-VSVG-E26)): ACGCTTAACAACCAGATCAAAGAAAAAACAGACATTGTCAATTGCAAAGCAA AAATGTAACACCCCTACAATGGATGCCGACAAGATTGTATTCAAAGTCAATA AT C AGGT GGT C TC TT T G A AGC C T GAG AT T AT C GT GG AT C A AT AT G AGT AC A AG TACCCTGCCATCAAAGATTTGAAAAAGCCCTGTATAACCCTAGGAAAGGCTC CCGATTTAAATAAAGCATACAAGTCAGTTTTGTCAGGCATGAGCGCCGCCAA ACTTAATCCTGACGATGTATGTTCCTATTTGGCAGCGGCAATGCAGTTTTTTG AGGGGACATGTCCGGAAGACTGGACCAGCTATGGAATTGTGATTGCACGAAA AGGAGATAAGATCACCCCAGGTTCTCTGGTGGAGATAAAACGTACTGATGTA GAAGGGAATT GGGCTCTGAC AGGAGGC AT GGAACTGAC AAGAGACCCC ACT
GTCCCTGAGCATGCGTCCTTAGTCGGTCTTCTCTTGAGTCTGTATAGGTTGAG
CAAAATATCCGGGCAAAACACTGGTAACTATAAGACAAACATTGCAGACAGG
ATAGAGCAGATTTTTGAGACAGCCCCTTTTGTTAAAATCGTGGAACACCATAC
TC T A AT GAC A AC TC AC A Aa AT GT GT GCT A ATT GGAGT ACT AT AC C A A AC TTC A
GATTTTTGGCCGGAACCTATGACATGTTTTTCTCCCGGATTGAGCATCTATATT
CAGCAATCAGAGTGGGCACAGTTGTCACTGCTTATGAAGACTGTTCAGGACT
GGTATCATTTACTGGGTTCATAAAACAAATCAATCTCACCGCTAGAGAGGCA
ATACTATATTTCTTCCACAAGAACTTTGAGGAAGAGATAAGAAGAATGTTTG
AGCCAGGGCAGGAGACAGCTGTTCCTCACTCTTATTTCATCCACTTCCGTTCA
CTAGGCTTGAGTGGGAAATCTCCTTATTCATCAAATGCTGTTGGTCACGTGTT
CAATCTCATTCACTTTGTAGGATGCTATATGGGTCAAGTCAGATCCCTAAATG
CAACGGTTATTGCTGCATGTGCTCCTCATGAAATGTCTGTTCTAGGGGGCTAT
CTGGGAGAGGAATTCTTCGGGAAAGGGAC ATTTGAAAGAAGATTCTTC AGAG
AT GAG A A AG A AC TT C A AG A AT AC G AGGC GGC T G A AC T GAC A A AG AC T GAC G
TAGCACTGGCAGATGATGGAACTGTCAACTCTGACGACGAGGACTACTTTTC
AGGT GAAACC AGAAGTCCGGAGGCTGTTT AT ACTCGAAT CAT GAT GAAT GGA
GGTCGACTAAAGAGATCTCACATACGGAGATATGTCTCAGTCAGTTCCAATC
ATCAAGCCCGTCCAAACTCATTCGCCGAGTTTCTAAACAAGACATATTCGAGT
GACTCATAAcatgaaaaaaactaacacccctcccGTACGCCACCATGTTCGTGTTTCTGGTG
CTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAACCTGACCACAAGGACCCAGC
TGCCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACTATCCCGACAAG
GTGTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTTCTGCCTTTCTT
TTCTAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCACCAATGGCACA
AAGCGGTTCGACAATCCAGTGCTGCCCTTTAACGATGGCGTGTACTTCGCCTC
CACCGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCACCACACTGGAC
AGCAAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAACGTGGTCATCA
AGGTGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGTGTACTATCAC
AAGAACAATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTATTCCTCTGCCA
ACAATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGACCTGGAGGGC
AAGCAGGGCAATTTCAAGAACCTGAGGGAGTTCGTGTTTAAGAATATCGATG
GCTACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGTGCGCGACCTG
CCACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCATCGGCATCAA
CATCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTACCTGACACCA GGCGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTACTATGTGGGCT
ATCTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATGGCACCATCAC
AGACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAAGTGTACACTG
AAGAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAATTTCAGGGTGC
AGCCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCTGTGCCCTTTT
GGCGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCTGGAATAGGA
AGCGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAACAGCGCCTCC
TTCTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGAATGACCTGTG
CTTTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGACGAGGTGCGCC
AGATCGCACCAGGACAGACAGGCAAGATCGCAGACTACAATTATAAGCTGCC
TGACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAATCTGGATAGCA
AAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGAAAGTCTAATCTG
AAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGGCCGGCTCTACCC
CCTGCAATGGCGTGGAGGGCTTTAACTGTTATTTCCCTCTGCAGAGCTACGGC
TTCCAGCCAACAAACGGCGTGGGCTATCAGCCCTACCGCGTGGTGGTGCTGT
CTTTTGAGCTGCTGCACGCACCTGCAACAGTGTGCGGACCAAAGAAGAGCAC
CAATCTGGTGAAGAACAAGTGCGTGAACTTCAACTTCAACGGACTGACCGGA
ACAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTTCAGCAGTTCG
GCAGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCTCAGACCCTGGA
GATCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGTGATCACACCAG
GC AC C A AT AC A AGC A AC C AGGT GGCC GT GC T GT AT C AGGAC GT GA ATT GT AC
CGAGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTACATGGCGGGTG
TACTCTACCGGCAGCAACGTGTTCCAGACAAGAGCCGGATGCCTGATCGGAG
CAGAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATCGGCGCCGGCAT
CTGTGCCTCCTACCAGACCCAGACAAACTCCCCAAGGTCTGTGGGCGATACA
GGCCTGTCCAAGAATCCAATCGAGCTGGTAGAGGGCTGGTTCAGCAGTTGGA
AAAGCTCCATCGCCTCCTTTTTCTTTATCATCGGCCTGATCATCGGACTGTTCC
TGGTGCTCCGCGTGGGTATCCACCTGTGCATCAAGCTGAAGCACACCAAGAA
AAGACAGATTTATACAGACATCGAGATGAACCGCCTGGGAAAGTGAGCTAGC
CATGAAAAAAACTAACACCCCTCCTTTCGAACCATCCCAAACATGAGCAAGA
TCTTTGTCAATCCTAGTGCTATTAGAGCCGGTCTGGCCGATCTTGAGATGGCT
GAAGAAACTGTTGATCTGATCAATAGAAATATCGAAGACAATCAGGCTCATC
TCCAAGGGGAACCCATAGAGGTGGACAATCTCCCTGAGGATATGGGGCGACT
TC ACC T GGAT GAT GGA A A AT C GCC C A AC CAT GGT GAGAT AGCC A AGGT GGGA GAAGGCAAGTATCGAGAGGACTTTCAGATGGATGAAGGAGAGGATCCTAGCT
TCCTGTTCCAGTCATACCTGGAAAATGTTGGAGTCCAAATAGTCAGACAAAT
GAGGT C AGGAGAGAGATTTCTC AAGAT AT GGT C AC AGACCGT AGAAGAGATT
ATATCCTATGTCGCGGTCAACTTTCCCAACCCTCCAGGAAAGTCTTCAGAGGA
TAAATCAACCCAGACTACTGGCCGAGAGCTCAAGAAGGAGACAACACCCACT
CCTTCTCAGAGAGAAAGCCAATCATCGAAAGCCAGGATGGCGGCTCAAATTG
CTTCTGGCCCTCCAGCCCTTGAATGGTCGGCTACCAATGAAGAGGATGATCTA
TCAGTGGAGGCTGAGATCGCTCACCAGATTGCAGAAAGTTTCTCCAAAAAAT
ATAAGTTTCCCTCTCGATCCTCAGGGATACTCTTGTATAATTTTGAGCAATTG
A A A AT GA ACC TT GAT GAT AT AGTT A A AG AGGC A A A A A AT GT ACC AGGT GT GA
CCCGTTTAGCCCATGACGGGTCCAAACTCCCCCTAAGATGTGTACTGGGATGG
GTCGCTTTGGCCAACTCTAAGAAATTCCAGTTGTTAGTCGAATCCGACAAGCT
GAGTAAAATCATGCAAGATGACTTGAATCGCTATACATCTTGCTAACCGAAC
CTCTCCCCTCAGTCCCTCTAGACAATAAAATCCGAGATGTCCCAAAGTCAACA
TGAAAAAAACAGGCAACACCACTGATAAAATGAACCTCCTACGTAAGATAGT
GAAAAACCGCAGGGACGAGGACACTCAAAAATCCTCTCCCGCGTCAGCCCCT
CTGGATGACGATGACTTGTGGCTTCCACCCCCTGAATACGTCCCGCTGAAAGA
ACTTACAGGCAAGAAGAACATGAGGAACTTTTGTATCAACGGAAGGGTTAAA
GTGTGTAGCCCGAATGGTTACTCGTTCAGGATCCTGCGGCACATTCTGAAATC
ATTC GACGAGAT AT ATTCTGGGA AT CAT AGGAT GAT C GGGTT AGT C A A AGT G
GTTATTGGACTGGCTTTGTCAGGATCTCCAGTCCCTGAGGGCCTGAACTGGGT
ATACAAATTGAGGAGAACCTTTATCTTCCAGTGGGCTGATTCCAGGGGCCCTC
TTGAAGGGGAGGAGTTGGAATACTCTCAGGAGATCACTTGGGATGATGATAC
T GAGTTCGTCGGATTGC AAAT AAGAGT GATT GC AAAAC AGT GTC AT ATCC AG
GGCAGAGTCTGGTGTATCAACATGAACCCGAGAGCATGTCAACTATGGTCTG
ACATGTCTCTTCAGACACAAAGGTCCGAAGAGGACAAAGATTCCTCTCTGCTT
CTAGAATAATCAGATTATATCCCGCAAATTTATCACTTGTTTACCTCTGGAGG
AGAGA AC AT AT GGGC T C A ACTCC A AC CC TT GGGAGC A AT AT A AC A A A A A AC A
TGTTATGGTGCCATTAAACCGCTGCATTTCATCAAAGTCAAGTTGATTACCTT
TACATTTTGATCCTCTTGGATGTGAAAAAAACTATTAACATCCCTCAAAAGAC cccgggAAAGATGGTTCCTCAGGCTCTCCTGTTTGTACCCCTTCTGGTTTTTCCAT
TGTGTTTTGGGAAATTCCCTATTTACACGATACCAGACAAGCTTGGTCCCTGG
AGTCCGATTGACATACATCACCTCAGCTGCCCAAACAATTTGGTAGTGGAGG
ACGAAGGATGCACCAACCTGTCAGGGTTCTCCTACATGGAACTTAAAGTTGG ATACATCTTAGCCATAAAAGTGAACGGGTTCACTTGCACAGGCGTTGTGACG
GAGGCTGAAACCTACACTAACTTCGTTGGTTATGTCACAACCACGTTCAAAA
GAAAGCATTTCCGCCCAACACCAGATGCATGTAGAGCCGCGTACAACTGGAA
GATGGCCGGTGACCCCAGATATGAAGAGTCTCTACACAATCCGTACCCTGAC
TACCGCTGGCTTCGAACTGTAAAAACCACCAAGGAGTCTCTCGTTATCATATC
TCCAAGTGTGGCAGATTTGGACCCATATGACAGATCCCTTCACTCGAGGGTCT
TCCCTAGCGGGAAGTGCTCAGGAGTAGCGGTGTCTTCTACCTACTGCTCCACT
AACCACGATTACACCATTTGGATGCCCGAGAATCCGAGACTAGGGATGTCTT
GTGACATTTTTACCAATAGTAGAGGGAAGAGAGCATCCAAAGGGAGTGAGAC
TTGCGGCTTTGTAGATGAAAGAGGCCTATATAAGTCTTTAAAAGGAGCATGC
AAACTCAAGTTATGTGGAGTTCTAGGACTTAGACTTATGGATGGAACATGGG
TCTCGATGCAAACATCAAATGAAACCAAATGGTGCCCTCCCGATAAGTTGGT
GAACCTGCACGACTTTCGCTCAGACGAAATTGAGCACCTTGTTGTAGAGGAG
TTGGTCAGGAAGAGAGAGGAGTGTCTGGATGCACTAGAGTCCATCATGACAA
CCAAGTCAGTGAGTTTCAGACGTCTCAGTCATTTAAGAAAACTTGTCCCTGGG
TTTGGAAAAGCATATACCATATTCAACAAGACCTTGATGGAAGCCGATGCTC
ACTACAAGTCAGTCgagACTTGGAATGAGATCCTCCCTTCAAAAGGGTGTTTA
AGAGTTGGGGGGAGGTGTCATCCTCATGTGAACGGGGTGTTTTTCAATGGTAT
AATATTAGGACCTGACGGCAATGTCTTAATCCCAGAGATGCAATCATCCCTCC
TCCAGCAACATATGGAGTTGTTGGAATCCTCGGTTATCCCCCTTGTGCACCCC
CTGGCAGACCCGTCTACCGTTTTCAAGGACGGTGACGAGGCTGAGGATTTTGT
TGAAGTTCACCTTCCCGATGTGCACAATCAGGTCTCAGGAGTTGACTTGGGTC
TCCCGAACTGGGGGAAGT ATGT ATT ACTGAGT GC AGGGGCCCTGACTGCCTT
GATGTTGATAATTTTCCTGATGACATGTTGTAGAAGAGTCAATCGATCAGAAC
CTACGCAACACAATCTCAGAGGGACAGGGAGGGAGGTGTCAGTCACTCCCCA
AAGCGGGAAGAT CAT ATCTTC ATGGGAAT C AC AC A AGAGTGGGGGTGAGACC
AG AC T GT A AttaattaaC GT C CTTT C A AC GATCC A AGT C catgaaaaaaactaacacccctcccgta cctagcTTATAAAGTGCTGGGTCATCTAAGCTTTTCAGTCGAGAAAAAAACATTA
GATCAGAAGAACAACTGGCAACACTTCTCAACCTGAGACTTACTTCAAGATG
CTCGATCCTGGAGAGGTCTATGATGACCCTATTGACCCAATCGAGTTAGAGG
CTGAACCCAGAGGAACCCCCATTGTCCCCAACATCTTGAGGAACTCTGACTA
CAATCTCAACTCTCCTTTGATAGAAGATCCTGCTAGACTAATGTTAGAATGGT
TAAAAACAGGGAATAGACCTTATCGGATGACTCTAACAGACAATTGCTCCAG
GTCTTTCAGAGTTTTGAAAGATTATTTCAAGAAGGTAGATTTGGGTTCTCTCA AGGT GGGCGGAAT GGCTGC AC AGT C AAT GATTTCTCTCTGGTT AT ATGGT GCC
CACTCTGAATCCAACAGGAGCCGGAGATGTATAACAGACTTGGCCCATTTCT
ATTCCAAGTCGTCCCCCATAGAGAAGCTGTTGAATCTCACGCTAGGAAATAG
AGGGCTGAGAATCCCCCCAGAGGGAGTGTTAAGTTGCCTTGAGAGGGTTGAT
TATGATAATGCATTTGGAAGGTATCTTGCCAACACGTATTCCTCTTACTTGTTC
TTCC ATGT AAT C ACCTT AT AC AT GAACGCCCT AGACTGGGAT GAAGAAAAGA
CCATCCTAGCATTATGGAAAGATTTAACCTCAGTGGACATCGGGAAGGACTT
GGTAAAGTTCAAAGACCAAATATGGGGACTGCTGATCGTGACAAAGGACTTT
GTTTACTCCCAAAGTTCCAATTGTCTTTTTGACAGAAACTACACACTTATGCT
AAAAGATCTTTTCTTGTCTCGCTTCAACTCCTTAATGGTCTTGCTCTCTCCCCC
AGAGCCCCGATACTCAGATGACTTGATATCTCAACTATGCCAGCTGTACATTG
CTGGGGATCAAGTCTTGTCTATGTGTGGAAACTCCGGCTATGAAGTCATCAAA
AT ATT GGAGCC AT ATGTCGT GAAT AGTTT AGTCC AGAGAGC AGAAAAGTTT A
GGCCTCTCATTCATTCCTTGGGAGACTTTCCTGTATTTATAAAAGACAAGGTA
AGTCAACTTGAAGAGACGTTCGGTCCCTGTGCAAGAAGGTTCTTTAGGGCTCT
GGATCAATTCGACAACATACATGACTTGGTTTTTGTGTTTGGCTGTTACAGGC
ATTGGGGGCACCCATATATAGATTATCGAAAGGGTCTGTCAAAACTATATGA
TCAGGTTCACCTTAAAAAAATGATAGATAAGTCCTACCAGGAGTGCTTAGCA
AGCGACCTAGCCAGGAGGATCCTTAGATGGGGTTTTGATAAGTACTCCAAGT
GGTATCTGGATTCAAGATTCCTAGCCCGAGACCACCCCTTGACTCCTTATATC
AAAACCCAAACATGGCCACCCAAACATATTGTAGACTTGGTGGGGGATACAT
GGCACAAGCTCCCGATCACGCAGATCTTTGAGATTCCTGAATCAATGGATCC
GTCAGAAATATTGGATGACAAATCACATTCTTTCACCAGAACGAGACTAGCT
TCTT GGCTGTC AGAAAACCGAGGGGGGCCTGTTCCT AGCGAAA AAGTT ATT A
TCACGGCCCTGTCTAAGCCGCCTGTCAATCCCCGAGAGTTTCTGAGGTCTATA
GACCTCGGAGGATTGCCAGATGAAGACTTGATAATTGGCCTCAAGCCAAAGG
AACGGGAATTGAAGATTGAAGGTCGATTCTTTGCTCTAATGTCATGGAATCTA
AGATTGTATTTTGTCATCACTGAAAAACTCTTGGCCAACTACATCTTGCCACT
TTTTGACGCGCTGACTATGACAGACAACCTGAACAAGGTGTTTAAAAAGCTG
ATCGACAGGGTCACCGGGCAAGGGCTTTTGGACTATTCAAGGGTCACATATG
C ATTTC ACCTGGACT AT GAAAAGT GGAAC AACC AT C AAAGATT AG AGT C AAC
AGAGGAT GT ATTTTCTGTCCT AGAT C AAGT GTTTGGATT GAAGAGAGTGTTTT
CTAGAACACACGAGTTTTTTCAAAAGGCCTGGATCTATTATTCAGACAGATCA
GACCTCATCGGGTTACGGGAGGATCAAATATACTGCTTAGATGCGTCCAACG GCCCAACCTGTTGGAATGGCCAGGATGGCGGGCTAGAAGGCTTACGGCAGAA
GGGCTGGAGTCT AGT C AGCTT ATT GAT GAT AG AT AGAGAATCTC AAAT C AGG
AAC AC AAGAACC AAAAT ACT AGCTC A AGGAGAC AACC AGGTTTT ATGTCCGA
CATACATGTTGTCGCCAGGGCTATCTCAAGAGGGGCTCCTCTATGAATTGGAG
AG A AT AT C A AGG A AT GC AC TTTC GAT AT AC AGAGCC GT C GAGGA AGGGGC AT
CTAAGCTAGGGCTGATCATCAAGAAAGAAGAGACCATGTGTAGTTATGACTT
CCTCATCTATGGAAAAACCCCTTTGTTTAGAGGTAACATATTGGTGCCTGAGT
CCAAAAGATGGGCCAGAGTCTCTTGCGTCTCTAATGACCAAATAGTCAACCT
CGCCAATATAATGTCGACAGTGTCCACCAATGCGCTAACAGTGGCACAACAC
TCTCAATCTTTGATCAAACCGATGAGGGATTTTCTGCTCATGTCAGTACAGGC
AGTCTTTCACTACCTGCTATTTAGCCCAATCTTAAAGGGAAGAGTTTACAAGA
TTCTGAGCGCTGAAGGGGAGAGCTTTCTCCTAGCCATGTCAAGGATAATCTAT
CTAGATCCTTCTTTGGGAGGGATATCTGGAATGTCCCTCGGAAGATTCCATAT
ACGACAGTTCTCAGACCCTGTCTCTGAAGGGTTATCCTTCTGGAGAGAGATCT
GGTTAAGCTCCCAAGAGTCCTGGATTCACGCGTTGTGTCAAGAGGCTGGAAA
CCCAGATCTTGGAGAGAGAACACTCGAGAGCTTCACTCGCCTTCTAGAAGAT
CCGACCACCTTAAATATCAGAGGAGGGGCCAGTCCTACCATTCTACTCAAGG
AT GC AAT C AGA AAGGCTTT AT ATGACGAGGT GGAC AAGGTGGAAAATTC AGA
GTTTCGAGAGGCAATCCTGTTGTCCAAGACCCATAGAGATAATTTTATACTCT
TCTTAATATCTGTTGAGCCTCTGTTTCCTCGATTTCTCAGTGAGCTATTCAGTT
CGTCTTTTTTGGGAATCCCCGAGTCAATCATTGGATTGATACAAAACTCCCGA
AC GAT A AGA AGGC AGTTT AGA A AGAGT C TC T C A A A A AC TTT AGA AG A AT C CT
TCTACAACTCAGAGATCCACGGGATTAGTCGGATGACCCAGACACCTCAGAG
GGTTGGGGGGGTGT GGCCTT GCTCTTC AGAGAGGGC AGATCT ACTT AGGGAG
ATCTCTTGGGGAAGAAAAGTGGTAGGCACGACAGTTCCTCACCCTTCTGAGA
TGTTGGGATTACTTCCCAAGTCCTCTATTTCTTGCACTTGTGGAGCAACAGGA
GGAGGCAATCCTAGAGTTTCTGTATCAGTACTCCCGTCCTTTGATCAGTCATT
TTTTTCACGAGGCCCCCTAAAGGGATACTTGGGCTCGTCCACCTCTATGTCGA
C C C AGC TATTCCAT GC AT GGG A A A A AGT C AC T AAT GT TC AT GT GGT G A AG AG
AGCTCTATCGTTAAAAGAATCTATAAACTGGTTCATTACTAGAGATTCCAACT
TGGCTCAAGCTCTAATTAGGAACATTATGTCTCTGACAGGCCCTGATTTCCCT
CTAGAGGAGGCCCCTGTCTTCAAAAGGACGGGGTCAGCCTTGCATAGGTTCA
AGTCTGCCAGATACAGCGAAGGAGGGTATTCTTCTGTCTGCCCGAACCTCCTC
TCTCATATTTCTGTTAGTACAGACACCATGTCTGATTTGACCCAAGACGGGAA GAACTACGATTTCATGTTCCAGCCATTGATGCTTTATGCACAGACATGGACAT
CAGAGCTGGTACAGAGAGACACAAGGCTAAGAGACTCTACGTTTCATTGGCA
CCTCCGATGCAACAGGTGTGTGAGACCCATTGACGACGTGACCCTGGAGACC
TCTCAGATCTTCGAGTTTCCGGATGTGTCGAAAAGAATATCCAGAATGGTTTC
TGGGGCTGTGCCTCACTTCCAGAGGCTTCCCGATATCCGTCTGAGACCAGGAG
ATTTTGAATCTCTAAGCGGTAGAGAAAAGTCTCACCATATCGGATCAGCTCA
GGGGCTCTTATACTCAATCTTAGTGGCAATTCACGACTCAGGATACAATGATG
GAACCATCTTCCCTGTCAACATATACGGCAAGGTTTCCCCTAGAGACTATTTG
AGAGGGCTCGCAAGGGGAGTATTGATAGGATCCTCGATTTGCTTCTTGACAA
GAAT GAC AAAT ATC AAT ATT AAT AGACCTCTT GAATT GGTCTC AGGGGT AAT C
TCATATATTCTCCTGAGGCTAGATAACCATCCCTCCTTGTACATAATGCTCAG
AGAACCGTCTCTTAGAGGAGAGATATTTTCTATCCCTCAGAAAATCCCCGCCG
CTTATCCAACCACTATGAAAGAAGGCAACAGATCAATCTTGTGTTATCTCCAA
CAT GT GCT ACGCT AT GAGCGAGAGAT AAT C ACGGCGTCTCC AGAGAAT GACT
GGCTATGGATCTTTTCAGACTTTAGAAGTGCCAAAATGACGTACCTATCCCTC
ATTACTTACCAGTCTCATCTTCTACTCCAGAGGGTTGAGAGAAACCTATCTAA
GAGTATGAGAGATAACCTGCGACAATTGAGTTCTTTGATGAGGCAGGTGCTG
GGC GGGC AC GG AG A AG AT ACC TT AGAGT C AGAC GAC A AC ATT C A AC GACTGC
T AAAAGACTCTTT ACGA AGGAC AAGAT GGGTGGATC A AGAGGT GCGCC ATGC
AGCTAGAACCATGACTGGAGATTACAGCCCCAACAAGAAGGTGTCCCGTAAG
GTAGGATGTTCAGAATGGGTCTGCTCTGCTCAACAGGTTGCAGTCTCTACCTC
AGCAAACCCGGCCCCTGTCTCGGAGCTTGACATAAGGGCCCTCTCTAAGAGG
TTCCAGAACCCTTTGATCTCGGGCTTGAGAGTGGTTCAGTGGGCAACCGGTGC
TCATTATAAGCTTAAGCCTATTCTAGATGATCTCAATGTTTTCCCATCTCTCTG
CCTT GT AGTT GGGGACGGGTC AGGGGGGAT AT C AAGGGC AGTCCTC AAC AT G
TTTCCAGATGCCAAGCTTGTGTTCAACAGTCTTTTAGAGGTGAATGACCTGAT
GGCTTCCGG AAC ACATCCACTGCCTCCTTCAGCAATCATGAGGGGAGG AAAT
GATATCGTCTCCAGAGTGATAGATCTTGACTCAATCTGGGAAAAACCGTCCG
ACTTGAGAAACTTGGCAACCTGGAAATACTTCCAGTCAGTCCAAAAGCAGGT
CAACATGTCCTATGACCTCATTATTTGCGATGCAGAAGTTACTGACATTGCAT
CTATCAACCGGATCACCCTGTTAATGTCCGATTTTGCATTGTCTATAGATGGA
CCACTCTATTTGGTCTTCAAAACTTATGGGACTATGCTAGTAAATCCAAACTA
CAAGGCTATTCAACACCTGTCAAGAGCGTTCCCCTCGGTCACAGGGTTTATCA
CCCAAGTAACTTCGTCTTTTTCATCTGAGCTCTACCTCCGATTCTCCAAACGA GGGAAGTTTTTCAGAGATGCTGAGTACTTGACCTCTTCCACCCTTCGAGAAAT
GAGCCTTGTGTTATTCAATTGTAGCAGCCCCAAGAGTGAGATGCAGAGAGCT
CGTTCCTTGAACTATCAGGATCTTGTGAGAGGATTTCCTGAAGAAATCATATC
AAATCCTTACAATGAGATGATCATAACTCTGATTGACAGTGATGTAGAATCTT
TTCTAGTCCACAAGATGGTTGATGATCTTGAGTTACAGAGGGGAACTCTGTCT
AAAGTGGCTATCATTATAGCCATCATGATAGTTTTCTCCAACAGAGTCTTCAA
CGTTTCCAAACCCCTAACTGACCCCTCGTTCTATCCACCGTCTGATCCCAAAA
TCCTGAGGCACTTCAACATATGTTGCAGTACTATGATGTATCTATCTACTGCT
TTAGGTGACGTCCCTAGCTTCGCAAGACTTCACGACCTGTATAACAGACCTAT
AACTTATTACTTCAGAAAGCAAGTCATTCGAGGGAACGTTTATCTATCTTGGA
GTTGGTCCAACGACACCTCAGTGTTCAAAAGGGTAGCCTGTAATTCTAGCCTG
AGTCTGTCATCTCACTGGATCAGGTTGATTTACAAGATAGTGAAGACTACCAG
ACTCGTTGGCAGCATCAAGGATCTATCCAGAGAAGTGGAAAGACACCTTCAT
AGGTACAACAGGTGGATCACCCTAGAGGATATCAGATCTAGATCATCCCTAC
TAGACTACAGTTGCCTGTGAACCGGATACTCCTGGAAGCCTGCCCATGCTAA
GACTCTTGTGTGATGTATCTTGAAAAAAACAAGATCCTAAATCTGAACCTTTG
GTTGTTTGATTGTTTTTCTCAtttttgttgtttatttgttaagcgt.
In one embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 11, shown below (RABV vector: Coravax V3-South Africa (S1-VSVG-E26)): ACGCTTAACAACCAGATCAAAGAAAAAACAGACATTGTCAATTGCAAAGCAA AAATGTAACACCCCTACAATGGATGCCGACAAGATTGTATTCAAAGTCAATA AT C AGGT GGT C TC TT T G A AGC C T GAG AT T AT C GT GG AT C A AT AT G AGT AC A AG TACCCTGCCATCAAAGATTTGAAAAAGCCCTGTATAACCCTAGGAAAGGCTC CCGATTTAAATAAAGCATACAAGTCAGTTTTGTCAGGCATGAGCGCCGCCAA ACTTAATCCTGACGATGTATGTTCCTATTTGGCAGCGGCAATGCAGTTTTTTG AGGGGACATGTCCGGAAGACTGGACCAGCTATGGAATTGTGATTGCACGAAA AGGAGATAAGATCACCCCAGGTTCTCTGGTGGAGATAAAACGTACTGATGTA GAAGGGAATT GGGCTCTGAC AGGAGGC AT GGAACTGAC AAGAGACCCC ACT GTCCCTGAGCATGCGTCCTTAGTCGGTCTTCTCTTGAGTCTGTATAGGTTGAG CAAAATATCCGGGCAAAACACTGGTAACTATAAGACAAACATTGCAGACAGG ATAGAGCAGATTTTTGAGACAGCCCCTTTTGTTAAAATCGTGGAACACCATAC TC T A AT GAC A AC TC AC A Aa AT GT GT GCT A ATT GGAGT ACT AT AC C A A AC TTC A GATTTTTGGCCGGAACCTATGACATGTTTTTCTCCCGGATTGAGCATCTATATT CAGCAATCAGAGTGGGCACAGTTGTCACTGCTTATGAAGACTGTTCAGGACT GGTATCATTTACTGGGTTCATAAAACAAATCAATCTCACCGCTAGAGAGGCA
ATACTATATTTCTTCCACAAGAACTTTGAGGAAGAGATAAGAAGAATGTTTG
AGCCAGGGCAGGAGACAGCTGTTCCTCACTCTTATTTCATCCACTTCCGTTCA
CTAGGCTTGAGTGGGAAATCTCCTTATTCATCAAATGCTGTTGGTCACGTGTT
CAATCTCATTCACTTTGTAGGATGCTATATGGGTCAAGTCAGATCCCTAAATG
CAACGGTTATTGCTGCATGTGCTCCTCATGAAATGTCTGTTCTAGGGGGCTAT
CTGGGAGAGGAATTCTTCGGGAAAGGGAC ATTTGAAAGAAGATTCTTC AGAG
AT GAG A A AG A AC TT C A AG A AT AC G AGGC GGC T G A AC T G AC A A AG AC T G AC G
TAGCACTGGCAGATGATGGAACTGTCAACTCTGACGACGAGGACTACTTTTC
AGGT GAAACC AGAAGTCCGGAGGCTGTTT AT ACTCGAAT CAT GAT GAAT GGA
GGTCGACTAAAGAGATCTCACATACGGAGATATGTCTCAGTCAGTTCCAATC
ATCAAGCCCGTCCAAACTCATTCGCCGAGTTTCTAAACAAGACATATTCGAGT
GACTCATAAcatgaaaaaaactaacacccctcccGTACGCCACCATGTTCGTGTTTCTGGTG
CTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAACTTCACCACAAGGACCCAGCT
GCCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACTATCCCGACAAGG
TGTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTTCTGCCTTTCTTTT
CTAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCACCAATGGCACAAA
GCGGTTCGCCAATCCAGTGCTGCCCTTTAACGATGGCGTGTACTTCGCCTCCA
CCGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCACCACACTGGACAG
CAAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAACGTGGTCATCAAG
GTGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGTGTACTATCACAA
GAACAATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTATTCCTCTGCCAAC
AATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGACCTGGAGGGCAA
GC AGGGC AATTT C AAGAACCTGAGGGAGTTCGT GTTT AAGAAT ATCGAT GGC
TACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGTGCGCGGCCTGCC
ACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCATCGGCATCAACA
TCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTACCTGACACCAGG
CGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTACTATGTGGGCTAT
CTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATGGCACCATCACAG
ACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAAGTGTACACTGAA
GAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAATTTCAGGGTGCAG
CCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCTGTGCCCTTTTGG
CGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCTGGAATAGGAAG
CGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAACAGCGCCTCCTT CTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGAATGACCTGTGCT
TTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGACGAGGTGCGCCA
GATCGC ACC AGGAC AGAC AGGC AAT ATCGC AGACT AC AATT AT AAGCTGCCT
GACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAATCTGGATAGCA
AAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGAAAGTCTAATCTG
AAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGGCCGGCTCTACCC
CCTGCAATGGCGTGAAGGGCTTTAACTGTTATTTCCCTCTGCAGAGCTACGGC
TTCCAGCCAACATATGGCGTGGGCTATCAGCCCTACCGCGTGGTGGTGCTGTC
TTTTGAGCTGCTGCACGCACCTGCAACAGTGTGCGGACCAAAGAAGAGCACC
A ATCTGGT GA AGA AC A AGT GCGT GA AC TT C A AC TT C A AC GGACTGACC GGA A
CAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTTCAGCAGTTCGGC
AGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCTCAGACCCTGGAGA
TCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGTGATCAC ACC AGGC
ACCAATACAAGCAACCAGGTGGCCGTGCTGTATCAGGGCGTGAATTGTACCG
AGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTACATGGCGGGTGTA
CTCTACCGGCAGCAACGTGTTCCAGACAAGAGCCGGATGCCTGATCGGAGCA
GAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATCGGCGCCGGCATCT
GTGCCTCCTACCAGACCCAGACAAACTCCCCAAGGTCTGTGGGCGATACAGG
CCTGTCCAAGAATCCAATCGAGCTGGTAGAGGGCTGGTTCAGCAGTTGGAAA
AGCTCCATCGCCTCCTTTTTCTTTATCATCGGCCTGATCATCGGACTGTTCCTG
GTGCTCCGCGTGGGTATCCACCTGTGCATCAAGCTGAAGCACACCAAGAAAA
GACAGATTTATACAGACATCGAGATGAACCGCCTGGGAAAGTGAGCTAGCCA
TGAAAAAAACTAACACCCCTCCTTTCGAACCATCCCAAACATGAGCAAGATC
TTTGTCAATCCTAGTGCTATTAGAGCCGGTCTGGCCGATCTTGAGATGGCTGA
AGAAACTGTTGATCTGAT C AAT AGAAAT ATCGAAGAC AATC AGGCTC ATCTC
C AAGGGGAACCC AT AGAGGT GGAC AAT CTCCCTGAGGAT AT GGGGCGACTT C
ACCTGGATGATGGAAAATCGCCCAACCATGGTGAGATAGCCAAGGTGGGAG
AAGGC AAGT ATCGAGAGGACTTTC AGAT GGAT GAAGGAGAGGATCCT AGCTT
CCTGTTCCAGTCATACCTGGAAAATGTTGGAGTCCAAATAGTCAGACAAATG
AGGT C AGGAG AGAGATTTC TC A AGAT AT GGT C AC AGAC CGT AGA AGAGATT A
TATCCTATGTCGCGGTCAACTTTCCCAACCCTCCAGGAAAGTCTTCAGAGGAT
AAATCAACCCAGACTACTGGCCGAGAGCTCAAGAAGGAGACAACACCCACTC
CTTCTCAGAGAGAAAGCCAATCATCGAAAGCCAGGATGGCGGCTCAAATTGC
TTCTGGCCCTCCAGCCCTTGAATGGTCGGCTACCAATGAAGAGGATGATCTAT C AGT GGAGGCTGAGATCGCTC ACC AGATTGC AGAAAGTTTCTCC AAAAAAT A
TAAGTTTCCCTCTCGATCCTCAGGGATACTCTTGTATAATTTTGAGCAATTGA
A A AT G A AC C TT GAT GAT AT AGT T A A AG AGGC A A A A A AT GT ACC AGGT GT G AC
CCGTTTAGCCCATGACGGGTCCAAACTCCCCCTAAGATGTGTACTGGGATGG
GTCGCTTTGGCCAACTCTAAGAAATTCCAGTTGTTAGTCGAATCCGACAAGCT
GAGTAAAATCATGCAAGATGACTTGAATCGCTATACATCTTGCTAACCGAAC
CTCTCCCCTCAGTCCCTCTAGACAATAAAATCCGAGATGTCCCAAAGTCAACA
TGAAAAAAACAGGCAACACCACTGATAAAATGAACCTCCTACGTAAGATAGT
GAAAAACCGCAGGGACGAGGACACTCAAAAATCCTCTCCCGCGTCAGCCCCT
CTGGATGACGATGACTTGTGGCTTCCACCCCCTGAATACGTCCCGCTGAAAGA
ACTTACAGGCAAGAAGAACATGAGGAACTTTTGTATCAACGGAAGGGTTAAA
GTGTGTAGCCCGAATGGTTACTCGTTCAGGATCCTGCGGCACATTCTGAAATC
ATTC GACGAGAT AT ATTCTGGGA AT CAT AGGAT GAT C GGGTT AGT C A A AGT G
GTTATTGGACTGGCTTTGTCAGGATCTCCAGTCCCTGAGGGCCTGAACTGGGT
ATACAAATTGAGGAGAACCTTTATCTTCCAGTGGGCTGATTCCAGGGGCCCTC
TTGAAGGGGAGGAGTTGGAATACTCTCAGGAGATCACTTGGGATGATGATAC
T GAGTTCGTCGGATTGC AAAT AAGAGT GATT GC AAAAC AGT GTC AT ATCC AG
GGCAGAGTCTGGTGTATCAACATGAACCCGAGAGCATGTCAACTATGGTCTG
ACATGTCTCTTCAGACACAAAGGTCCGAAGAGGACAAAGATTCCTCTCTGCTT
CTAGAATAATCAGATTATATCCCGCAAATTTATCACTTGTTTACCTCTGGAGG
AGAGA AC AT AT GGGC T C A ACTCC A AC CC TT GGGAGC A AT AT A AC A A A A A AC A
TGTTATGGTGCCATTAAACCGCTGCATTTCATCAAAGTCAAGTTGATTACCTT
TACATTTTGATCCTCTTGGATGTGAAAAAAACTATTAACATCCCTCAAAAGAC cccgggAAAGATGGTTCCTCAGGCTCTCCTGTTTGTACCCCTTCTGGTTTTTCCAT
TGTGTTTTGGGAAATTCCCTATTTACACGATACCAGACAAGCTTGGTCCCTGG
AGTCCGATTGACATACATCACCTCAGCTGCCCAAACAATTTGGTAGTGGAGG
ACGAAGGATGCACCAACCTGTCAGGGTTCTCCTACATGGAACTTAAAGTTGG
ATACATCTTAGCCATAAAAGTGAACGGGTTCACTTGCACAGGCGTTGTGACG
GAGGCTGAAACCTACACTAACTTCGTTGGTTATGTCACAACCACGTTCAAAA
GAAAGCATTTCCGCCCAACACCAGATGCATGTAGAGCCGCGTACAACTGGAA
GATGGCCGGTGACCCCAGATATGAAGAGTCTCTACACAATCCGTACCCTGAC
TACCGCTGGCTTCGAACTGTAAAAACCACCAAGGAGTCTCTCGTTATCATATC
TCCAAGTGTGGCAGATTTGGACCCATATGACAGATCCCTTCACTCGAGGGTCT
TCCCTAGCGGGAAGTGCTCAGGAGTAGCGGTGTCTTCTACCTACTGCTCCACT AACCACGATTACACCATTTGGATGCCCGAGAATCCGAGACTAGGGATGTCTT
GTGACATTTTTACCAATAGTAGAGGGAAGAGAGCATCCAAAGGGAGTGAGAC
TTGCGGCTTTGTAGATGAAAGAGGCCTATATAAGTCTTTAAAAGGAGCATGC
AAACTCAAGTTATGTGGAGTTCTAGGACTTAGACTTATGGATGGAACATGGG
TCTCGATGCAAACATCAAATGAAACCAAATGGTGCCCTCCCGATAAGTTGGT
GAACCTGCACGACTTTCGCTCAGACGAAATTGAGCACCTTGTTGTAGAGGAG
TTGGTCAGGAAGAGAGAGGAGTGTCTGGATGCACTAGAGTCCATCATGACAA
CCAAGTCAGTGAGTTTCAGACGTCTCAGTCATTTAAGAAAACTTGTCCCTGGG
TTTGGAAAAGCATATACCATATTCAACAAGACCTTGATGGAAGCCGATGCTC
ACTACAAGTCAGTCgagACTTGGAATGAGATCCTCCCTTCAAAAGGGTGTTTA
AGAGTTGGGGGGAGGTGTCATCCTCATGTGAACGGGGTGTTTTTCAATGGTAT
AATATTAGGACCTGACGGCAATGTCTTAATCCCAGAGATGCAATCATCCCTCC
TCCAGCAACATATGGAGTTGTTGGAATCCTCGGTTATCCCCCTTGTGCACCCC
CTGGCAGACCCGTCTACCGTTTTCAAGGACGGTGACGAGGCTGAGGATTTTGT
TGAAGTTCACCTTCCCGATGTGCACAATCAGGTCTCAGGAGTTGACTTGGGTC
TCCCGAACTGGGGGAAGT ATGT ATT ACTGAGT GC AGGGGCCCTGACTGCCTT
GATGTTGATAATTTTCCTGATGACATGTTGTAGAAGAGTCAATCGATCAGAAC
CTACGCAACACAATCTCAGAGGGACAGGGAGGGAGGTGTCAGTCACTCCCCA
AAGCGGGAAGAT CAT ATCTTC ATGGGAAT C AC AC A AGAGTGGGGGTGAGACC
AG AC T GT A AttaattaaC GT C CTTT C A AC GATCC A AGT C catgaaaaaaactaacacccctcccgta cctagcTTATAAAGTGCTGGGTCATCTAAGCTTTTCAGTCGAGAAAAAAACATTA
GATCAGAAGAACAACTGGCAACACTTCTCAACCTGAGACTTACTTCAAGATG
CTCGATCCTGGAGAGGTCTATGATGACCCTATTGACCCAATCGAGTTAGAGG
CTGAACCCAGAGGAACCCCCATTGTCCCCAACATCTTGAGGAACTCTGACTA
CAATCTCAACTCTCCTTTGATAGAAGATCCTGCTAGACTAATGTTAGAATGGT
TAAAAACAGGGAATAGACCTTATCGGATGACTCTAACAGACAATTGCTCCAG
GTCTTTCAGAGTTTTGAAAGATTATTTCAAGAAGGTAGATTTGGGTTCTCTCA
AGGT GGGCGGAAT GGCTGC AC AGT C AAT GATTTCTCTCTGGTT AT ATGGT GCC
CACTCTGAATCCAACAGGAGCCGGAGATGTATAACAGACTTGGCCCATTTCT
ATTCCAAGTCGTCCCCCATAGAGAAGCTGTTGAATCTCACGCTAGGAAATAG
AGGGCTGAGAATCCCCCCAGAGGGAGTGTTAAGTTGCCTTGAGAGGGTTGAT
TATGATAATGCATTTGGAAGGTATCTTGCCAACACGTATTCCTCTTACTTGTTC
TTCC ATGT AAT C ACCTT AT AC AT GAACGCCCT AGACTGGGAT GAAGAAAAGA
CCATCCTAGCATTATGGAAAGATTTAACCTCAGTGGACATCGGGAAGGACTT GGTAAAGTTCAAAGACCAAATATGGGGACTGCTGATCGTGACAAAGGACTTT
GTTTACTCCCAAAGTTCCAATTGTCTTTTTGACAGAAACTACACACTTATGCT
AAAAGATCTTTTCTTGTCTCGCTTCAACTCCTTAATGGTCTTGCTCTCTCCCCC
AGAGCCCCGATACTCAGATGACTTGATATCTCAACTATGCCAGCTGTACATTG
CTGGGGATCAAGTCTTGTCTATGTGTGGAAACTCCGGCTATGAAGTCATCAAA
AT ATT GGAGCC AT ATGTCGT GAAT AGTTT AGTCC AGAGAGC AGAAAAGTTT A
GGCCTCTCATTCATTCCTTGGGAGACTTTCCTGTATTTATAAAAGACAAGGTA
AGTCAACTTGAAGAGACGTTCGGTCCCTGTGCAAGAAGGTTCTTTAGGGCTCT
GGATCAATTCGACAACATACATGACTTGGTTTTTGTGTTTGGCTGTTACAGGC
ATTGGGGGCACCCATATATAGATTATCGAAAGGGTCTGTCAAAACTATATGA
TCAGGTTCACCTTAAAAAAATGATAGATAAGTCCTACCAGGAGTGCTTAGCA
AGCGACCTAGCCAGGAGGATCCTTAGATGGGGTTTTGATAAGTACTCCAAGT
GGTATCTGGATTCAAGATTCCTAGCCCGAGACCACCCCTTGACTCCTTATATC
AAAACCCAAACATGGCCACCCAAACATATTGTAGACTTGGTGGGGGATACAT
GGCACAAGCTCCCGATCACGCAGATCTTTGAGATTCCTGAATCAATGGATCC
GTCAGAAATATTGGATGACAAATCACATTCTTTCACCAGAACGAGACTAGCT
TCTT GGCTGTC AGAAAACCGAGGGGGGCCTGTTCCT AGCGAAAA AGTT ATT A
TCACGGCCCTGTCTAAGCCGCCTGTCAATCCCCGAGAGTTTCTGAGGTCTATA
GACCTCGGAGGATTGCCAGATGAAGACTTGATAATTGGCCTCAAGCCAAAGG
AACGGGAATTGAAGATTGAAGGTCGATTCTTTGCTCTAATGTCATGGAATCTA
AGATTGTATTTTGTCATCACTGAAAAACTCTTGGCCAACTACATCTTGCCACT
TTTTGACGCGCTGACTATGACAGACAACCTGAACAAGGTGTTTAAAAAGCTG
ATCGACAGGGTCACCGGGCAAGGGCTTTTGGACTATTCAAGGGTCACATATG
C ATTTC ACCTGGACT AT GAAAAGT GGAAC AACC AT C AAAGATT AGAGT C AAC
AGAGGAT GT ATTTTCTGTCCT AGAT C AAGT GTTTGGATT GAAGAGAGTGTTTT
CTAGAACACACGAGTTTTTTCAAAAGGCCTGGATCTATTATTCAGACAGATCA
GACCTCATCGGGTTACGGGAGGATCAAATATACTGCTTAGATGCGTCCAACG
GCCCAACCTGTTGGAATGGCCAGGATGGCGGGCTAGAAGGCTTACGGCAGAA
GGGCTGGAGTCT AGT C AGCTT ATT GAT GAT AGAT AGAGAATCTC AAAT C AGG
AAC AC AAGAACC AAAAT ACT AGCTC A AGGAGAC AACC AGGTTTT ATGTCCGA
CATACATGTTGTCGCCAGGGCTATCTCAAGAGGGGCTCCTCTATGAATTGGAG
AG A AT AT C A AGG A AT GC AC TTTC GAT AT AC AGAGCC GT C GAGGA AGGGGC AT
CTAAGCTAGGGCTGATCATCAAGAAAGAAGAGACCATGTGTAGTTATGACTT
CCTCATCTATGGAAAAACCCCTTTGTTTAGAGGTAACATATTGGTGCCTGAGT CCAAAAGATGGGCCAGAGTCTCTTGCGTCTCTAATGACCAAATAGTCAACCT
CGCCAATATAATGTCGACAGTGTCCACCAATGCGCTAACAGTGGCACAACAC
TCTCAATCTTTGATCAAACCGATGAGGGATTTTCTGCTCATGTCAGTACAGGC
AGTCTTTCACTACCTGCTATTTAGCCCAATCTTAAAGGGAAGAGTTTACAAGA
TTCTGAGCGCTGAAGGGGAGAGCTTTCTCCTAGCCATGTCAAGGATAATCTAT
CTAGATCCTTCTTTGGGAGGGATATCTGGAATGTCCCTCGGAAGATTCCATAT
ACGACAGTTCTCAGACCCTGTCTCTGAAGGGTTATCCTTCTGGAGAGAGATCT
GGTTAAGCTCCCAAGAGTCCTGGATTCACGCGTTGTGTCAAGAGGCTGGAAA
CCCAGATCTTGGAGAGAGAACACTCGAGAGCTTCACTCGCCTTCTAGAAGAT
CCGACCACCTTAAATATCAGAGGAGGGGCCAGTCCTACCATTCTACTCAAGG
AT GC AAT C AGA AAGGCTTT AT ATGACGAGGT GGAC AAGGTGGAAAATTC AGA
GTTTCGAGAGGCAATCCTGTTGTCCAAGACCCATAGAGATAATTTTATACTCT
TCTTAATATCTGTTGAGCCTCTGTTTCCTCGATTTCTCAGTGAGCTATTCAGTT
CGTCTTTTTTGGGAATCCCCGAGTCAATCATTGGATTGATACAAAACTCCCGA
AC GAT A AGA AGGC AGTTT AGA A AGAGT C TC T C A A A A AC TTT AGA AG A AT C CT
TCTACAACTCAGAGATCCACGGGATTAGTCGGATGACCCAGACACCTCAGAG
GGTTGGGGGGGTGT GGCCTT GCTCTTC AGAGAGGGC AGATCT ACTT AGGGAG
ATCTCTTGGGGAAGAAAAGTGGTAGGCACGACAGTTCCTCACCCTTCTGAGA
TGTTGGGATTACTTCCCAAGTCCTCTATTTCTTGCACTTGTGGAGCAACAGGA
GGAGGCAATCCTAGAGTTTCTGTATCAGTACTCCCGTCCTTTGATCAGTCATT
TTTTTCACGAGGCCCCCTAAAGGGATACTTGGGCTCGTCCACCTCTATGTCGA
C C C AGC TATTCCAT GC AT GGG A A A A AGT C AC T AAT GT TC AT GT GGT G A AG AG
AGCTCTATCGTTAAAAGAATCTATAAACTGGTTCATTACTAGAGATTCCAACT
TGGCTCAAGCTCTAATTAGGAACATTATGTCTCTGACAGGCCCTGATTTCCCT
CTAGAGGAGGCCCCTGTCTTCAAAAGGACGGGGTCAGCCTTGCATAGGTTCA
AGTCTGCCAGATACAGCGAAGGAGGGTATTCTTCTGTCTGCCCGAACCTCCTC
TCTCATATTTCTGTTAGTACAGACACCATGTCTGATTTGACCCAAGACGGGAA
GAACTACGATTTCATGTTCCAGCCATTGATGCTTTATGCACAGACATGGACAT
CAGAGCTGGTACAGAGAGACACAAGGCTAAGAGACTCTACGTTTCATTGGCA
CCTCCGATGCAACAGGTGTGTGAGACCCATTGACGACGTGACCCTGGAGACC
TCTCAGATCTTCGAGTTTCCGGATGTGTCGAAAAGAATATCCAGAATGGTTTC
TGGGGCTGTGCCTCACTTCCAGAGGCTTCCCGATATCCGTCTGAGACCAGGAG
ATTTTGAATCTCTAAGCGGTAGAGAAAAGTCTCACCATATCGGATCAGCTCA
GGGGCTCTTATACTCAATCTTAGTGGCAATTCACGACTCAGGATACAATGATG GAACCATCTTCCCTGTCAACATATACGGCAAGGTTTCCCCTAGAGACTATTTG
AGAGGGCTCGCAAGGGGAGTATTGATAGGATCCTCGATTTGCTTCTTGACAA
GAAT GAC AAAT ATC AAT ATT AAT AGACCTCTT GAATT GGTCTC AGGGGT AAT C
TCATATATTCTCCTGAGGCTAGATAACCATCCCTCCTTGTACATAATGCTCAG
AGAACCGTCTCTTAGAGGAGAGATATTTTCTATCCCTCAGAAAATCCCCGCCG
CTTATCCAACCACTATGAAAGAAGGCAACAGATCAATCTTGTGTTATCTCCAA
CAT GT GCT ACGCT AT GAGCGAGAGAT AAT C ACGGCGTCTCC AGAGAAT GACT
GGCTATGGATCTTTTCAGACTTTAGAAGTGCCAAAATGACGTACCTATCCCTC
ATTACTTACCAGTCTCATCTTCTACTCCAGAGGGTTGAGAGAAACCTATCTAA
GAGTATGAGAGATAACCTGCGACAATTGAGTTCTTTGATGAGGCAGGTGCTG
GGC GGGC AC GG AG A AG AT ACC TT AGAGT C AGAC GAC A AC ATT C A AC GACTGC
T AAAAGACTCTTT ACGA AGGAC AAGAT GGGTGGATC A AGAGGT GCGCC ATGC
AGCTAGAACCATGACTGGAGATTACAGCCCCAACAAGAAGGTGTCCCGTAAG
GTAGGATGTTCAGAATGGGTCTGCTCTGCTCAACAGGTTGCAGTCTCTACCTC
AGCAAACCCGGCCCCTGTCTCGGAGCTTGACATAAGGGCCCTCTCTAAGAGG
TTCCAGAACCCTTTGATCTCGGGCTTGAGAGTGGTTCAGTGGGCAACCGGTGC
TCATTATAAGCTTAAGCCTATTCTAGATGATCTCAATGTTTTCCCATCTCTCTG
CCTT GT AGTT GGGGACGGGTC AGGGGGGAT AT C AAGGGC AGTCCTC AAC AT G
TTTCCAGATGCCAAGCTTGTGTTCAACAGTCTTTTAGAGGTGAATGACCTGAT
GGCTTCCGG AAC ACATCCACTGCCTCCTTCAGCAATCATGAGGGGAGG AAAT
GATATCGTCTCCAGAGTGATAGATCTTGACTCAATCTGGGAAAAACCGTCCG
ACTTGAGAAACTTGGCAACCTGGAAATACTTCCAGTCAGTCCAAAAGCAGGT
CAACATGTCCTATGACCTCATTATTTGCGATGCAGAAGTTACTGACATTGCAT
CTATCAACCGGATCACCCTGTTAATGTCCGATTTTGCATTGTCTATAGATGGA
CCACTCTATTTGGTCTTCAAAACTTATGGGACTATGCTAGTAAATCCAAACTA
CAAGGCTATTCAACACCTGTCAAGAGCGTTCCCCTCGGTCACAGGGTTTATCA
CCCAAGTAACTTCGTCTTTTTCATCTGAGCTCTACCTCCGATTCTCCAAACGA
GGGAAGTTTTTCAGAGATGCTGAGTACTTGACCTCTTCCACCCTTCGAGAAAT
GAGCCTTGTGTTATTCAATTGTAGCAGCCCCAAGAGTGAGATGCAGAGAGCT
CGTTCCTTGAACTATCAGGATCTTGTGAGAGGATTTCCTGAAGAAATCATATC
AAATCCTTACAATGAGATGATCATAACTCTGATTGACAGTGATGTAGAATCTT
TTCTAGTCCACAAGATGGTTGATGATCTTGAGTTACAGAGGGGAACTCTGTCT
AAAGTGGCTATCATTATAGCCATCATGATAGTTTTCTCCAACAGAGTCTTCAA
CGTTTCCAAACCCCTAACTGACCCCTCGTTCTATCCACCGTCTGATCCCAAAA TCCTGAGGCACTTCAACATATGTTGCAGTACTATGATGTATCTATCTACTGCT
TTAGGTGACGTCCCTAGCTTCGCAAGACTTCACGACCTGTATAACAGACCTAT
AACTTATTACTTCAGAAAGCAAGTCATTCGAGGGAACGTTTATCTATCTTGGA
GTTGGTCCAACGACACCTCAGTGTTCAAAAGGGTAGCCTGTAATTCTAGCCTG
AGTCTGTCATCTCACTGGATCAGGTTGATTTACAAGATAGTGAAGACTACCAG
ACTCGTTGGCAGCATCAAGGATCTATCCAGAGAAGTGGAAAGACACCTTCAT
AGGTACAACAGGTGGATCACCCTAGAGGATATCAGATCTAGATCATCCCTAC
TAGACTACAGTTGCCTGTGAACCGGATACTCCTGGAAGCCTGCCCATGCTAA
GACTCTTGTGTGATGTATCTTGAAAAAAACAAGATCCTAAATCTGAACCTTTG
GTTGTTTGATTGTTTTTCTCAtttttgttgtttatttgttaagcgt.
In one embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 12, shown below (RABV vector: Coravax V4-China (S1-RABVG-T2A-P)): ACGCTTAACAACCAGATCAAAGAAAAAACAGACATTGTCAATTGCAAAGCAA AAATGTAACACCCCTACAATGGATGCCGACAAGATTGTATTCAAAGTCAATA AT C AGGT GGT C TC TT T G A AGC C T GAG AT T AT C GT GG AT C A AT AT G AGT AC A AG TACCCTGCCATCAAAGATTTGAAAAAGCCCTGTATAACCCTAGGAAAGGCTC CCGATTTAAATAAAGCATACAAGTCAGTTTTGTCAGGCATGAGCGCCGCCAA ACTTAATCCTGACGATGTATGTTCCTATTTGGCAGCGGCAATGCAGTTTTTTG AGGGGACATGTCCGGAAGACTGGACCAGCTATGGAATTGTGATTGCACGAAA AGGAGATAAGATCACCCCAGGTTCTCTGGTGGAGATAAAACGTACTGATGTA GAAGGGAATT GGGCTCTGAC AGGAGGC AT GGAACTGAC AAGAGACCCC ACT GTCCCTGAGCATGCGTCCTTAGTCGGTCTTCTCTTGAGTCTGTATAGGTTGAG CAAAATATCCGGGCAAAACACTGGTAACTATAAGACAAACATTGCAGACAGG ATAGAGCAGATTTTTGAGACAGCCCCTTTTGTTAAAATCGTGGAACACCATAC TC T A AT GAC A AC TC AC A Aa AT GT GT GCT A ATT GGAGT ACT AT AC C A A AC TTC A GATTTTTGGCCGGAACCTATGACATGTTTTTCTCCCGGATTGAGCATCTATATT CAGCAATCAGAGTGGGCACAGTTGTCACTGCTTATGAAGACTGTTCAGGACT GGTATCATTTACTGGGTTCATAAAACAAATCAATCTCACCGCTAGAGAGGCA ATACTATATTTCTTCCACAAGAACTTTGAGGAAGAGATAAGAAGAATGTTTG AGCCAGGGCAGGAGACAGCTGTTCCTCACTCTTATTTCATCCACTTCCGTTCA CTAGGCTTGAGTGGGAAATCTCCTTATTCATCAAATGCTGTTGGTCACGTGTT CAATCTCATTCACTTTGTAGGATGCTATATGGGTCAAGTCAGATCCCTAAATG CAACGGTTATTGCTGCATGTGCTCCTCATGAAATGTCTGTTCTAGGGGGCTAT CTGGGAGAGGAATTCTTCGGGAAAGGGAC ATTTGAAAGAAGATTCTTC AGAG AT GAG A A AG A AC TT C A AG A AT AC G AGGC GGC T G A AC T G AC A A AG AC T G AC G
TAGCACTGGCAGATGATGGAACTGTCAACTCTGACGACGAGGACTACTTTTC
AGGT GAAACC AGAAGTCCGGAGGCTGTTT AT ACTCGAAT CAT GAT GAAT GGA
GGTCGACTAAAGAGATCTCACATACGGAGATATGTCTCAGTCAGTTCCAATC
ATCAAGCCCGTCCAAACTCATTCGCCGAGTTTCTAAACAAGACATATTCGAGT
GACTCATAAcatgaaaaaaactaacacccctcccgtacgGCCACCATGTTCGTGTTTCTGGTGC
TGCTGCCTCTGGTGAGCTCCCAGTGCGTGAACCTGACCACAAGGACCCAGCT
GCCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACTATCCCGACAAGG
TGTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTTCTGCCTTTCTTTT
CTAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCACCAATGGCACAAA
GCGGTTCGACAATCCAGTGCTGCCCTTTAACGATGGCGTGTACTTCGCCTCCA
CCGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCACCACACTGGACAG
CAAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAACGTGGTCATCAAG
GTGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGTGTACTATCACAA
GAACAATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTATTCCTCTGCCAAC
AATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGACCTGGAGGGCAA
GC AGGGC AATTT C AAGAACCTGAGGGAGTTCGT GTTT AAGAAT ATCGAT GGC
TACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGTGCGCGACCTGCC
ACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCATCGGCATCAACA
TCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTACCTGACACCAGG
CGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTACTATGTGGGCTAT
CTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATGGCACCATCACAG
ACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAAGTGTACACTGAA
GAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAATTTCAGGGTGCAG
CCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCTGTGCCCTTTTGG
CGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCTGGAATAGGAAG
CGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAACAGCGCCTCCTT
CTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGAATGACCTGTGCT
TTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGACGAGGTGCGCCA
GATCGCACCAGGACAGACAGGCAAGATCGCAGACTACAATTATAAGCTGCCT
GACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAATCTGGATAGCA
AAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGAAAGTCTAATCTG
AAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGGCCGGCTCTACCC
CCTGCAATGGCGTGGAGGGCTTTAACTGTTATTTCCCTCTGCAGAGCTACGGC TTCCAGCCAACAAACGGCGTGGGCTATCAGCCCTACCGCGTGGTGGTGCTGT
CTTTTGAGCTGCTGCACGCACCTGCAACAGTGTGCGGACCAAAGAAGAGCAC
CAATCTGGTGAAGAACAAGTGCGTGAACTTCAACTTCAACGGACTGACCGGA
ACAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTTCAGCAGTTCG
GCAGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCTCAGACCCTGGA
GATCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGTGATCACACCAG
GC AC C A AT AC A AGC A AC C AGGT GGCC GT GC T GT AT C AGGAC GT GA ATT GT AC
CGAGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTACATGGCGGGTG
TACTCTACCGGCAGCAACGTGTTCCAGACAAGAGCCGGATGCCTGATCGGAG
CAGAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATCGGCGCCGGCAT
CTGTGCCTCCTACCAGACCCAGACAAACTCCCCAAGGTCTGTGGGAGATGAG
GCCGAAGACTTTGTGGAAGTCCACCTGCCTGATGTGCATAACCAGGTGTCTG
GCGTCGACCTGGGACTGCCAAATTGGGGCAAGTACGTGCTGCTGAGTGCTGG
AGCACTGACTGCCCTGATGCTGATCATTTTCCTGATGACCTGCTGTCGGCGCG
TGAAC AGAAGT GAGCCC ACTC AGC AC AATCTGCGAGGAACCGGGAGAGAAG
TGTCAGTCACACCTCAGAGCGGGAAAATCATTAGTAGTTGGGAATCACATAA
AAGCGGGGGCGAGACCAGGCTGggatccggctccggcgagggcaggggaagtctactaacatgcgggg acgtggaggaaaatcccggccccATGAGCAAGATCTTTGTCAATCCTAGTGCTATTAGAGC
CGGTCTGGCCGATCTTGAGATGGCTGAAGAAACTGTTGATCTGATCAATAGA
A AT AT C GA AG AC A AT C AGGC TC AT C TCC A AGGGGA ACC C AT AG AGGT GGAC A
ATCTCCCTGAGGATATGGGGCGACTTCACCTGGATGATGGAAAATCGCCCAA
CC ATGGTGAGAT AGCC AAGGT GGGAGAAGGC AAGT ATCGAGAGGACTTTC A
GATGGATGAAGGAGAGGATCCTAGCTTCCTGTTCCAGTCATACCTGGAAAAT
GTTGGAGTCC AAAT AGTC AGAC AAAT GAGGT C AGGAGAGAGATTTCTC AAGA
TATGGTCACAGACCGTAGAAGAGATTATATCCTATGTCGCGGTCAACTTTCCC
AACCCTCCAGGAAAGTCTTCAGAGGATAAATCAACCCAGACTACTGGCCGAG
AGCTCAAGAAGGAGACAACACCCACTCCTTCTCAGAGAGAAAGCCAATCATC
GAAAGCCAGGATGGCGGCTCAAATTGCTTCTGGCCCTCCAGCCCTTGAATGG
TCGGCT ACC AATGAAGAGGAT GATCT ATC AGT GGAGGCTGAGATCGCTC ACC
AGATTGCAGAAAGTTTCTCCAAAAAATATAAGTTTCCCTCTCGATCCTCAGGG
ATACTCTTGTATAATTTTGAGCAATTGAAAATGAACCTTGATGATATAGTTAA
AGAGGC AAAAAAT GT ACC AGGTGTGACCCGTTT AGCCC AT GACGGGTCC AAA
CTCCCCCTAAGATGTGTACTGGGATGGGTCGCTTTGGCCAACTCTAAGAAATT
CCAGTTGTTAGTCGAATCCGACAAGCTGAGTAAAATCATGCAAGATGACTTG AATCGCTATACATCTTGCTAACCGAACCTCTCCCCTCAGTCCCTCTAGACAAT
AAAATCCGAGATGTCCCAAAGTCAACATGAAAAAAACAGGCAACACCACTG
ATAAAATGAACCTCCTACGTAAGATAGTGAAAAACCGCAGGGACGAGGACA
CTCAAAAATCCTCTCCCGCGTCAGCCCCTCTGGATGACGATGACTTGTGGCTT
CCACCCCCTGAATACGTCCCGCTGAAAGAACTTACAGGCAAGAAGAACATGA
GGAACTTTTGTATCAACGGAAGGGTTAAAGTGTGTAGCCCGAATGGTTACTC
GTTCAGGATCCTGCGGCACATTCTGAAATCATTCGACGAGATATATTCTGGGA
ATCATAGGATGATCGGGTTAGTCAAAGTGGTTATTGGACTGGCTTTGTCAGGA
TCTCCAGTCCCTGAGGGCCTGAACTGGGTATACAAATTGAGGAGAACCTTTAT
CTTCCAGTGGGCTGATTCCAGGGGCCCTCTTGAAGGGGAGGAGTTGGAATAC
TCTCAGGAGATCACTTGGGATGATGATACTGAGTTCGTCGGATTGCAAATAA
GAGTGATTGCAAAACAGTGTCATATCCAGGGCAGAGTCTGGTGTATCAACAT
GAACCCGAGAGCATGTCAACTATGGTCTGACATGTCTCTTCAGACACAAAGG
TCCGAAGAGGACAAAGATTCCTCTCTGCTTCTAGAATAATCAGATTATATCCC
GCAAATTTATCACTTGTTTACCTCTGGAGGAGAGAACATATGGGCTCAACTCC
AACCCTTGGGAGCAATATAACAAAAAACATGTTATGGTGCCATTAAACCGCT
GCATTTCATCAAAGTCAAGTTGATTACCTTTACATTTTGATCCTCTTGGATGTG
AAAAAA ACT ATT AAC ATCCCTC AAAAGACCccggg A AAGAT GGTTCCTC AGGCT
CTCCTGTTTGTACCCCTTCTGGTTTTTCCATTGTGTTTTGGGAAATTCCCTATTT
AC AC GAT ACC AG AC A AGC TT GGT C CC T GGAGTCC GATT GAC AT AC AT C AC CT
CAGCTGCCCAAACAATTTGGTAGTGGAGGACGAAGGATGCACCAACCTGTCA
GGGTTCTCCTACATGGAACTTAAAGTTGGATACATCTTAGCCATAAAAGTGA
ACGGGTTCACTTGCACAGGCGTTGTGACGGAGGCTGAAACCTACACTAACTT
CGTTGGTTATGTCACAACCACGTTCAAAAGAAAGCATTTCCGCCCAACACCA
GATGCATGTAGAGCCGCGTACAACTGGAAGATGGCCGGTGACCCCAGATATG
AAGAGTCTCTACACAATCCGTACCCTGACTACCGCTGGCTTCGAACTGTAAAA
ACCACCAAGGAGTCTCTCGTTATCATATCTCCAAGTGTGGCAGATTTGGACCC
ATATGACAGATCCCTTCACTCGAGGGTCTTCCCTAGCGGGAAGTGCTCAGGA
GTAGCGGTGTCTTCTACCTACTGCTCCACTAACCACGATTACACCATTTGGAT
GCCCGAGAATCCGAGACTAGGGATGTCTTGTGACATTTTTACCAATAGTAGA
GGGAAGAGAGC ATCC AAAGGGAGT GAGACTT GCGGCTTTGT AGAT GAAAGA
GGCCTATATAAGTCTTTAAAAGGAGCATGCAAACTCAAGTTATGTGGAGTTCT
AGGACTT AGACTT AT GGATGGAAC AT GGGTCTCGAT GC AAAC ATC AAAT GAA
ACCAAATGGTGCCCTCCCGATAAGTTGGTGAACCTGCACGACTTTCGCTCAGA CGAAATTGAGCACCTTGTTGTAGAGGAGTTGGTCAGGAAGAGAGAGGAGTGT
CTGGATGCACTAGAGTCCATCATGACAACCAAGTCAGTGAGTTTCAGACGTC
TCAGTCATTTAAGAAAACTTGTCCCTGGGTTTGGAAAAGCATATACCATATTC
AACAAGACCTTGATGGAAGCCGATGCTCACTACAAGTCAGTCgagACTTGGAA
TGAGATCCTCCCTTCAAAAGGGTGTTTAAGAGTTGGGGGGAGGTGTCATCCTC
ATGTGAACGGGGTGTTTTTCAATGGTATAATATTAGGACCTGACGGCAATGTC
TTAATCCCAGAGATGCAATCATCCCTCCTCCAGCAACATATGGAGTTGTTGGA
ATCCTCGGTTATCCCCCTTGTGCACCCCCTGGCAGACCCGTCTACCGTTTTCA
AGGACGGTGACGAGGCTGAGGATTTTGTTGAAGTTCACCTTCCCGATGTGCA
CAATCAGGTCTCAGGAGTTGACTTGGGTCTCCCGAACTGGGGGAAGTATGTA
TTACTGAGTGCAGGGGCCCTGACTGCCTTGATGTTGATAATTTTCCTGATGAC
AT GTT GT AGAAGAGT C AATCGAT C AGAACCT ACGC AAC AC AATCTC AGAGGG
AC AGGGAGGGAGGT GT C AGTC ACTCCCC AAAGCGGGAAGATC AT ATCTTC AT
GGGAATCACACAAGAGTGGGGGTGAGACCAGACTGTAAttaattaaCGTCCTTTCA
AC GAT C C A AGTCcatgaaaaaaactaacacccctcccgtacctagcTT AT A A AGT GC T GGGT CAT
CT AAGCTTTT C AGTCGAGAAA AAAAC ATT AGATC AGAAGAAC AACTGGC AAC
ACTTCTCAACCTGAGACTTACTTCAAGATGCTCGATCCTGGAGAGGTCTATGA
TGACCCTATTGACCCAATCGAGTTAGAGGCTGAACCCAGAGGAACCCCCATT
GTCCCCAACATCTTGAGGAACTCTGACTACAATCTCAACTCTCCTTTGATAGA
AGATCCTGCTAGACTAATGTTAGAATGGTTAAAAACAGGGAATAGACCTTAT
CGGATGACTCTAACAGACAATTGCTCCAGGTCTTTCAGAGTTTTGAAAGATTA
TTTCAAGAAGGTAGATTTGGGTTCTCTCAAGGTGGGCGGAATGGCTGCACAG
TCAATGATTTCTCTCTGGTTATATGGTGCCCACTCTGAATCCAACAGGAGCCG
GAGATGTATAACAGACTTGGCCCATTTCTATTCCAAGTCGTCCCCCATAGAGA
AGCTGTTGAATCTCACGCTAGGAAATAGAGGGCTGAGAATCCCCCC AGAGGG
AGT GTT A AGTT GCC TT GAGAGGGTTG ATT AT GAT A AT GC ATTTGGA AGGT AT C
TTGCCAACACGTATTCCTCTTACTTGTTCTTCCATGTAATCACCTTATACATGA
ACGCCCTAGACTGGGATGAAGAAAAGACCATCCTAGCATTATGGAAAGATTT
A AC CTC AGT GGAC ATCGGGA AGGAC TT GGT A A AGTTC A A AGAC C A A AT AT GG
GGACTGCTGATCGTGACAAAGGACTTTGTTTACTCCCAAAGTTCCAATTGTCT
TTTTGACAGAAACTACACACTTATGCTAAAAGATCTTTTCTTGTCTCGCTTCA
ACTCCTTAATGGTCTTGCTCTCTCCCCCAGAGCCCCGATACTCAGATGACTTG
ATATCTCAACTATGCCAGCTGTACATTGCTGGGGATCAAGTCTTGTCTATGTG
TGGAAACTCCGGCTATGAAGTCATCAAAATATTGGAGCCATATGTCGTGAAT AGTTTAGTCCAGAGAGCAGAAAAGTTTAGGCCTCTCATTCATTCCTTGGGAGA
CTTTCCTGTATTTATAAAAGACAAGGTAAGTCAACTTGAAGAGACGTTCGGTC
CCTGTGCAAGAAGGTTCTTTAGGGCTCTGGATCAATTCGACAACATACATGAC
TTGGTTTTTGTGTTTGGCTGTTACAGGCATTGGGGGCACCCATATATAGATTA
TCGAAAGGGTCTGTCAAAACTATATGATCAGGTTCACCTTAAAAAAATGATA
GATAAGTCCTACCAGGAGTGCTTAGCAAGCGACCTAGCCAGGAGGATCCTTA
GAT GGGGTTTT GAT AAGT ACTCC AAGT GGT ATCTGGATT C A AGATTCCT AGCC
CGAGACCACCCCTTGACTCCTTATATCAAAACCCAAACATGGCCACCCAAAC
AT ATT GT AGACTTGGT GGGGGAT AC ATGGC AC AAGCTCCCGAT C ACGC AGAT
CTTTGAGATTCCTGAATCAATGGATCCGTCAGAAATATTGGATGACAAATCAC
ATTCTTTCACCAGAACGAGACTAGCTTCTTGGCTGTCAGAAAACCGAGGGGG
GCCTGTTCCTAGCGAAAAAGTTATTATCACGGCCCTGTCTAAGCCGCCTGTCA
ATCCCCGAGAGTTTCTGAGGTCT AT AGACCTCGGAGGATT GCC AGATGAAGA
CTTGATAATTGGCCTCAAGCCAAAGGAACGGGAATTGAAGATTGAAGGTCGA
TTCTTTGCTCTAATGTCATGGAATCTAAGATTGTATTTTGTCATCACTGAAAAA
CTCTTGGCCAACTACATCTTGCCACTTTTTGACGCGCTGACTATGACAGACAA
CCTGAACAAGGTGTTTAAAAAGCTGATCGACAGGGTCACCGGGCAAGGGCTT
TTGGACTATTCAAGGGTCACATATGCATTTCACCTGGACTATGAAAAGTGGA
ACAACCATCAAAGATTAGAGTCAACAGAGGATGTATTTTCTGTCCTAGATCA
AGT GTTTGGATT GAAGAGAGT GTTTTCT AGAAC AC ACGAGTTTTTT C AAAAGG
CCTGGATCTATTATTCAGACAGATCAGACCTCATCGGGTTACGGGAGGATCA
AATATACTGCTTAGATGCGTCCAACGGCCCAACCTGTTGGAATGGCCAGGAT
GGCGGGCTAGAAGGCTTACGGCAGAAGGGCTGGAGTCTAGTCAGCTTATTGA
T GAT AGAT AGAGAATCTC AA ATC AGGAAC AC AAGAACC AAAAT ACT AGCTC A
AGGAGACAACCAGGTTTTATGTCCGACATACATGTTGTCGCCAGGGCTATCTC
AAGAGGGGCTCCTCTATGAATTGGAGAGAATATCAAGGAATGCACTTTCGAT
AT AC AG AGC C GT C G AGG A AGGGGC AT C T A AGC T AGGGC T GAT CATC A AG A A
AGAAGAGACCATGTGTAGTTATGACTTCCTCATCTATGGAAAAACCCCTTTGT
TT AGAGGT AAC AT ATT GGT GCCTGAGTCC AAAAGAT GGGCC AGAGTCTCTTG
CGTCTCTAATGACCAAATAGTCAACCTCGCCAATATAATGTCGACAGTGTCCA
CCAATGCGCTAACAGTGGCACAACACTCTCAATCTTTGATCAAACCGATGAG
GGATTTTCTGCTCATGTCAGTACAGGCAGTCTTTCACTACCTGCTATTTAGCCC
AATCTT AAAGGGA AGAGTTT AC AAGATTCTGAGCGCTGAAGGGGAGAGCTTT
CTCCTAGCCATGTCAAGGATAATCTATCTAGATCCTTCTTTGGGAGGGATATC TGGAATGTCCCTCGGAAGATTCCATATACGACAGTTCTCAGACCCTGTCTCTG
AAGGGTTATCCTTCTGGAGAGAGATCTGGTTAAGCTCCCAAGAGTCCTGGATT
C ACGCGTTGT GT C AAGAGGCTGGAAACCC AGATCTTGGAGAGAGAAC ACTCG
AGAGCTTCACTCGCCTTCTAGAAGATCCGACCACCTTAAATATCAGAGGAGG
GGCCAGTCCTACCATTCTACTCAAGGATGCAATCAGAAAGGCTTTATATGAC
GAGGT GGAC AAGGTGGA AAATT C AGAGTTTCGAGAGGC AATCCTGTT GTCC A
AGACCCATAGAGATAATTTTATACTCTTCTTAATATCTGTTGAGCCTCTGTTTC
CTCGATTTCTCAGTGAGCTATTCAGTTCGTCTTTTTTGGGAATCCCCGAGTCAA
TCATTGGATTGATACAAAACTCCCGAACGATAAGAAGGCAGTTTAGAAAGAG
TCTCTCAAAAACTTTAGAAGAATCCTTCTACAACTCAGAGATCCACGGGATTA
GTCGGATGACCCAGACACCTCAGAGGGTTGGGGGGGTGTGGCCTTGCTCTTC
AGAGAGGGC AGATCT ACTT AGGGAGATCTCTT GGGGAAGAAAAGT GGT AGG
CACGACAGTTCCTCACCCTTCTGAGATGTTGGGATTACTTCCCAAGTCCTCTA
TTTCTTGCACTTGTGGAGCAACAGGAGGAGGCAATCCTAGAGTTTCTGTATCA
GTACTCCCGTCCTTTGATCAGTCATTTTTTTCACGAGGCCCCCTAAAGGGATA
CTTGGGCTCGTCCACCTCTATGTCGACCCAGCTATTCCATGCATGGGAAAAAG
T C ACT A AT GTT CAT GT GGT GA AGAGAGCTCT AT C GTT A A A AGA ATCT AT A A AC
TGGTTCATTACTAGAGATTCCAACTTGGCTCAAGCTCTAATTAGGAACATTAT
GTCTCTGACAGGCCCTGATTTCCCTCTAGAGGAGGCCCCTGTCTTCAAAAGGA
CGGGGTCAGCCTTGCATAGGTTCAAGTCTGCCAGATACAGCGAAGGAGGGTA
TTCTTCTGTCTGCCCGAACCTCCTCTCTCATATTTCTGTTAGTACAGACACCAT
GTCTGATTTGACCCAAGACGGGAAGAACTACGATTTCATGTTCCAGCCATTGA
TGCTTTATGCACAGACATGGACATCAGAGCTGGTACAGAGAGACACAAGGCT
AAGAGACTCTACGTTTCATTGGCACCTCCGATGCAACAGGTGTGTGAGACCC
ATTGACGACGTGACCCTGGAGACCTCTCAGATCTTCGAGTTTCCGGATGTGTC
GAAAAGAATATCCAGAATGGTTTCTGGGGCTGTGCCTCACTTCCAGAGGCTTC
CCGATATCCGTCTGAGACCAGGAGATTTTGAATCTCTAAGCGGTAGAGAAAA
GTCTCACCATATCGGATCAGCTCAGGGGCTCTTATACTCAATCTTAGTGGCAA
TTCACGACTCAGGATACAATGATGGAACCATCTTCCCTGTCAACATATACGGC
AAGGTTTCCCCT AGAGACT ATTT GAGAGGGCTCGC AAGGGGAGT ATT GAT AG
GATCCTCGATTTGCTTCTTGACAAGAATGACAAATATCAATATTAATAGACCT
CTTGAATTGGTCTCAGGGGTAATCTCATATATTCTCCTGAGGCTAGATAACCA
TCCCTCCTTGTACATAATGCTCAGAGAACCGTCTCTTAGAGGAGAGATATTTT
CTATCCCTCAGAAAATCCCCGCCGCTTATCCAACCACTATGAAAGAAGGCAA CAGATCAATCTTGTGTTATCTCCAACATGTGCTACGCTATGAGCGAGAGATAA
TCACGGCGTCTCCAGAGAATGACTGGCTATGGATCTTTTCAGACTTTAGAAGT
GCCAAAATGACGTACCTATCCCTCATTACTTACCAGTCTCATCTTCTACTCCA
GAGGGTTGAGAGAAACCTATCTAAGAGTATGAGAGATAACCTGCGACAATTG
AGTTCTTTGATGAGGCAGGTGCTGGGCGGGCACGGAGAAGATACCTTAGAGT
CAGACGACAACATTCAACGACTGCTAAAAGACTCTTTACGAAGGACAAGATG
GGT GGATC AAGAGGT GCGCC ATGC AGCT AGAACC AT GACTGGAGATT AC AGC
CCCAACAAGAAGGTGTCCCGTAAGGTAGGATGTTCAGAATGGGTCTGCTCTG
CTCAACAGGTTGCAGTCTCTACCTCAGCAAACCCGGCCCCTGTCTCGGAGCTT
GACATAAGGGCCCTCTCTAAGAGGTTCCAGAACCCTTTGATCTCGGGCTTGAG
AGTGGTTCAGTGGGCAACCGGTGCTCATTATAAGCTTAAGCCTATTCTAGATG
ATCTCAATGTTTTCCCATCTCTCTGCCTTGTAGTTGGGGACGGGTCAGGGGGG
ATATCAAGGGCAGTCCTCAACATGTTTCCAGATGCCAAGCTTGTGTTCAACAG
TCTTTTAGAGGTGAATGACCTGATGGCTTCCGGAACACATCCACTGCCTCCTT
CAGCAATCATGAGGGGAGGAAATGATATCGTCTCCAGAGTGATAGATCTTGA
CTCAATCTGGGAAAAACCGTCCGACTTGAGAAACTTGGCAACCTGGAAATAC
TTCCAGTCAGTCCAAAAGCAGGTCAACATGTCCTATGACCTCATTATTTGCGA
TGCAGAAGTTACTGACATTGCATCTATCAACCGGATCACCCTGTTAATGTCCG
ATTTTGCATTGTCTATAGATGGACCACTCTATTTGGTCTTCAAAACTTATGGG
ACTATGCTAGTAAATCCAAACTACAAGGCTATTCAACACCTGTCAAGAGCGT
TCCCCTCGGTCACAGGGTTTATCACCCAAGTAACTTCGTCTTTTTCATCTGAGC
TCTACCTCCGATTCTCCAAACGAGGGAAGTTTTTCAGAGATGCTGAGTACTTG
ACCTCTTCCACCCTTCGAGAAATGAGCCTTGTGTTATTCAATTGTAGCAGCCC
CAAGAGTGAGATGCAGAGAGCTCGTTCCTTGAACTATCAGGATCTTGTGAGA
GGATTTCCTGAAGAAATCATATCAAATCCTTACAATGAGATGATCATAACTCT
GATTGAC AGT GATGT AGAATCTTTTCT AGTCC AC AAGAT GGTT GAT GATCTT G
AGTTACAGAGGGGAACTCTGTCTAAAGTGGCTATCATTATAGCCATCATGAT
AGTTTTCTCCAACAGAGTCTTCAACGTTTCCAAACCCCTAACTGACCCCTCGT
TCTATCCACCGTCTGATCCCAAAATCCTGAGGCACTTCAACATATGTTGCAGT
ACTATGATGTATCTATCTACTGCTTTAGGTGACGTCCCTAGCTTCGCAAGACT
TCACGACCTGTATAACAGACCTATAACTTATTACTTCAGAAAGCAAGTCATTC
GAGGGA AC GTTT AT C T ATCTTGGAGTT GGT C C A AC GAC AC CTC AGT GTT C A A A
AGGGTAGCCTGTAATTCTAGCCTGAGTCTGTCATCTCACTGGATCAGGTTGAT
TTAC AAGAT AGTGAAGACTACCAGACTCGTTGGCAGCATCAAGGATCTATCC AGAGAAGTGGAAAGACACCTTCATAGGTACAACAGGTGGATCACCCTAGAG
GATATCAGATCTAGATCATCCCTACTAGACTACAGTTGCCTGTGAACCGGATA
CTCCTGGAAGCCTGCCCATGCTAAGACTCTTGTGTGATGTATCTTGAAAAAAA
CAAGATCCTAAATCTGAACCTTTGGTTGTTTGATTGTTTTTCTCAtttttgttgtttatttgtt aagcgt
In one embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 13, shown below (RABV vector: Coravax V4 South Africa):
ACGCTTAACAACCAGATCAAAGAAAAAACAGACATTGTCAATTGCAAAGCAA
AAATGTAACACCCCTACAATGGATGCCGACAAGATTGTATTCAAAGTCAATA
AT C AGGT GGT C TC TT T G A AGC C T GAG AT T AT C GT GG AT C A AT AT G AGT AC A AG
TACCCTGCCATCAAAGATTTGAAAAAGCCCTGTATAACCCTAGGAAAGGCTC
CCGATTTAAATAAAGCATACAAGTCAGTTTTGTCAGGCATGAGCGCCGCCAA
ACTTAATCCTGACGATGTATGTTCCTATTTGGCAGCGGCAATGCAGTTTTTTG
AGGGGACATGTCCGGAAGACTGGACCAGCTATGGAATTGTGATTGCACGAAA
AGGAGATAAGATCACCCCAGGTTCTCTGGTGGAGATAAAACGTACTGATGTA
GAAGGGAATT GGGCTCTGAC AGGAGGC AT GGAACTGAC AAGAGACCCC ACT
GTCCCTGAGCATGCGTCCTTAGTCGGTCTTCTCTTGAGTCTGTATAGGTTGAG
CAAAATATCCGGGCAAAACACTGGTAACTATAAGACAAACATTGCAGACAGG
ATAGAGCAGATTTTTGAGACAGCCCCTTTTGTTAAAATCGTGGAACACCATAC
TC T A AT GAC A AC TC AC A Aa AT GT GT GCT A ATT GGAGT ACT AT AC C A A AC TTC A
GATTTTTGGCCGGAACCTATGACATGTTTTTCTCCCGGATTGAGCATCTATATT
CAGCAATCAGAGTGGGCACAGTTGTCACTGCTTATGAAGACTGTTCAGGACT
GGTATCATTTACTGGGTTCATAAAACAAATCAATCTCACCGCTAGAGAGGCA
ATACTATATTTCTTCCACAAGAACTTTGAGGAAGAGATAAGAAGAATGTTTG
AGCCAGGGCAGGAGACAGCTGTTCCTCACTCTTATTTCATCCACTTCCGTTCA
CTAGGCTTGAGTGGGAAATCTCCTTATTCATCAAATGCTGTTGGTCACGTGTT
CAATCTCATTCACTTTGTAGGATGCTATATGGGTCAAGTCAGATCCCTAAATG
CAACGGTTATTGCTGCATGTGCTCCTCATGAAATGTCTGTTCTAGGGGGCTAT
CTGGGAGAGGAATTCTTCGGGAAAGGGAC ATTTGAAAGAAGATTCTTC AGAG
AT GAG A A AG A AC TT C A AG A AT AC G AGGC GGC T G A AC T GAC A A AG AC T GAC G
TAGCACTGGCAGATGATGGAACTGTCAACTCTGACGACGAGGACTACTTTTC
AGGT GAAACC AGAAGTCCGGAGGCTGTTT AT ACTCGAAT CAT GAT GAAT GGA
GGTCGACTAAAGAGATCTCACATACGGAGATATGTCTCAGTCAGTTCCAATC
ATCAAGCCCGTCCAAACTCATTCGCCGAGTTTCTAAACAAGACATATTCGAGT GACTCATAAcatgaaaaaaactaacacccctcccgtacgGCCACCATGTTCGTGTTTCTGGTGC
TGCTGCCTCTGGTGAGCTCCCAGTGCGTGAACTTCACCACAAGGACCCAGCTG
CCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACTATCCCGACAAGGT
GTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTTCTGCCTTTCTTTTC
TAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCACCAATGGCACAAAG
CGGTTCGCCAATCCAGTGCTGCCCTTTAACGATGGCGTGTACTTCGCCTCCAC
CGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCACCACACTGGACAGC
AAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAACGTGGTCATCAAGG
TGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGTGTACTATCACAAG
AACAATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTATTCCTCTGCCAACA
ATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGACCTGGAGGGCAAG
C AGGGC AATTT C AAGAACCTGAGGGAGTTCGT GTTT AAGAAT ATCGATGGCT
ACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGTGCGCGGCCTGCC
ACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCATCGGCATCAACA
TCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTACCTGACACCAGG
CGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTACTATGTGGGCTAT
CTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATGGCACCATCACAG
ACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAAGTGTACACTGAA
GAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAATTTCAGGGTGCAG
CCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCTGTGCCCTTTTGG
CGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCTGGAATAGGAAG
CGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAACAGCGCCTCCTT
CTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGAATGACCTGTGCT
TTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGACGAGGTGCGCCA
GATCGC ACC AGGAC AGAC AGGC AAT ATCGC AGACT AC AATT AT AAGCTGCCT
GACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAATCTGGATAGCA
AAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGAAAGTCTAATCTG
AAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGGCCGGCTCTACCC
CCTGCAATGGCGTGAAGGGCTTTAACTGTTATTTCCCTCTGCAGAGCTACGGC
TTCCAGCCAACATATGGCGTGGGCTATCAGCCCTACCGCGTGGTGGTGCTGTC
TTTTGAGCTGCTGCACGCACCTGCAACAGTGTGCGGACCAAAGAAGAGCACC
A ATCTGGT GA AGA AC A AGT GCGT GA AC TT C A AC TT C A AC GGACTGACC GGA A
CAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTTCAGCAGTTCGGC
AGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCTCAGACCCTGGAGA TCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGTGATCACACCAGGC
ACCAATACAAGCAACCAGGTGGCCGTGCTGTATCAGGGCGTGAATTGTACCG
AGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTACATGGCGGGTGTA
CTCTACCGGCAGCAACGTGTTCCAGACAAGAGCCGGATGCCTGATCGGAGCA
GAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATCGGCGCCGGCATCT
GTGCCTCCTACCAGACCCAGACAAACTCCCCAGAATCAAGCGTGATTCCTCTG
GTCCATCCACTGGCAGATCCCTCCACAGTGTTCAAAGACGGAGATGAGGCCG
AAGACTTTGTGGAAGTCCACCTGCCTGATGTGCATAACCAGGTGTCTGGCGTC
GACCTGGGACTGCC AAATT GGGGC AAGT ACGT GCTGCTGAGT GCTGGAGC AC
TGACTGCCCTGATGCTGATCATTTTCCTGATGACCTGCTGTCGGCGCGTGAAC
AG AAGT G AGC C C AC TC AGC AC A AT C T GC G AGG A AC C GGG AG AG A AGT GT C A
GT C AC AC CTC AGAGC GGGA A A AT C ATT AGT AGTT GGGA AT C AC AT A A A AGCG
GGGGCGAGACCAGGCTGggatccggctccggcgagggcaggggaagtctactaacatgcggggacgtggag gaaaatcccggccccATGAGCAAGATCTTTGTCAATCCTAGTGCTATTAGAGCCGGTC
TGGCCGATCTTGAGATGGCTGAAGAAACTGTTGATCTGATCAATAGAAATAT
CGAAGACAATCAGGCTCATCTCCAAGGGGAACCCATAGAGGTGGACAATCTC
CCTGAGGATATGGGGCGACTTCACCTGGATGATGGAAAATCGCCCAACCATG
GT GAG AT AGCC A AGGT GGGAG A AGGC A AGT AT C GAGAGGACTTT C AGAT GG
ATGAAGGAGAGGATCCTAGCTTCCTGTTCCAGTCATACCTGGAAAATGTTGG
AGTCC AA AT AGT C AGAC AAAT GAGGT C AGGAGAGAGATTTCTC AAGAT AT GG
TCACAGACCGTAGAAGAGATTATATCCTATGTCGCGGTCAACTTTCCCAACCC
TCCAGGAAAGTCTTCAGAGGATAAATCAACCCAGACTACTGGCCGAGAGCTC
AAGAAGGAGACAACACCCACTCCTTCTCAGAGAGAAAGCCAATCATCGAAA
GCCAGGATGGCGGCTCAAATTGCTTCTGGCCCTCCAGCCCTTGAATGGTCGGC
T ACC AATGAAGAGGATGATCT AT C AGT GGAGGCTGAGATCGCTC ACC AGATT
GCAGAAAGTTTCTCCAAAAAATATAAGTTTCCCTCTCGATCCTCAGGGATACT
CTTGTATAATTTTGAGCAATTGAAAATGAACCTTGATGATATAGTTAAAGAGG
CAAAAAATGTACCAGGTGTGACCCGTTTAGCCCATGACGGGTCCAAACTCCC
CCTAAGATGTGTACTGGGATGGGTCGCTTTGGCCAACTCTAAGAAATTCCAGT
T GTT AGT C GA AT C CGAC A AGC T GAGT A A A AT CAT GCA AGAT GAC TT GA ATCG
CTATACATCTTGCTAACCGAACCTCTCCCCTCAGTCCCTCTAGACAATAAAAT
CC GAGAT GT C CC A A AGTC A AC AT GA A A A A A AC AGGC A AC AC C AC T GAT AAA
ATGAACCTCCTACGTAAGATAGTGAAAAACCGCAGGGACGAGGACACTCAA
AAATCCTCTCCCGCGTCAGCCCCTCTGGATGACGATGACTTGTGGCTTCCACC CCCTGAATACGTCCCGCTGAAAGAACTTACAGGCAAGAAGAACATGAGGAAC
TTTTGTATCAACGGAAGGGTTAAAGTGTGTAGCCCGAATGGTTACTCGTTCAG
GATCCTGCGGCACATTCTGAAATCATTCGACGAGATATATTCTGGGAATCATA
GGATGATCGGGTTAGTCAAAGTGGTTATTGGACTGGCTTTGTCAGGATCTCCA
GTCCCTGAGGGCCTGAACTGGGTATACAAATTGAGGAGAACCTTTATCTTCCA
GT GGGCTGATTCC AGGGGCCCTCTT GAAGGGGAGGAGTT GGAAT ACTCTC AG
GAG AT C AC TT GGG AT GAT GAT ACT G AGT T C GT C GG AT T GCA A AT A AG AGT G A
TTGCAAAACAGTGTCATATCCAGGGCAGAGTCTGGTGTATCAACATGAACCC
GAGAGCATGTCAACTATGGTCTGACATGTCTCTTCAGACACAAAGGTCCGAA
GAGGACAAAGATTCCTCTCTGCTTCTAGAATAATCAGATTATATCCCGCAAAT
TTATCACTTGTTTACCTCTGGAGGAGAGAACATATGGGCTCAACTCCAACCCT
TGGGAGCAATATAACAAAAAACATGTTATGGTGCCATTAAACCGCTGCATTT
CATCAAAGTCAAGTTGATTACCTTTACATTTTGATCCTCTTGGATGTGAAAAA
AACTATTAACATCCCTCAAAAGACCccgggAAAGATGGTTCCTCAGGCTCTCCT
GTTTGTACCCCTTCTGGTTTTTCCATTGTGTTTTGGGAAATTCCCTATTTACAC
GATACCAGACAAGCTTGGTCCCTGGAGTCCGATTGACATACATCACCTCAGCT
GCCCAAACAATTTGGTAGTGGAGGACGAAGGATGCACCAACCTGTCAGGGTT
CTCCTACATGGAACTTAAAGTTGGATACATCTTAGCCATAAAAGTGAACGGG
TTCACTTGCACAGGCGTTGTGACGGAGGCTGAAACCTACACTAACTTCGTTGG
TTATGTCACAACCACGTTCAAAAGAAAGCATTTCCGCCCAACACCAGATGCA
TGTAGAGCCGCGTACAACTGGAAGATGGCCGGTGACCCCAGATATGAAGAGT
CTCTACACAATCCGTACCCTGACTACCGCTGGCTTCGAACTGTAAAAACCACC
AAGGAGTCTCTCGTTATCATATCTCCAAGTGTGGCAGATTTGGACCCATATGA
CAGATCCCTTCACTCGAGGGTCTTCCCTAGCGGGAAGTGCTCAGGAGTAGCG
GTGTCTTCTACCTACTGCTCCACTAACCACGATTACACCATTTGGATGCCCGA
GA ATCC GAGACT AGGGAT GT C TT GT G AC ATTTTT AC C A AT AGT AG AGGGA AG
AGAGC ATCC AAAGGGAGTGAGACTT GCGGCTTT GT AG AT GAAAGAGGCCT AT
ATAAGTCTTTAAAAGGAGCATGCAAACTCAAGTTATGTGGAGTTCTAGGACTT
AG AC TT AT GG AT GG A AC AT GGGT C T C GAT GCA A AC AT C A A AT G A A AC C A A AT
GGTGCCCTCCCGATAAGTTGGTGAACCTGCACGACTTTCGCTCAGACGAAATT
GAGC ACCTTGTTGT AGAGGAGTT GGT C AGGAAGAGAGAGGAGTGTCTGGAT G
CACTAGAGTCCATCATGACAACCAAGTCAGTGAGTTTCAGACGTCTCAGTCAT
TTAAGAAAACTTGTCCCTGGGTTTGGAAAAGCATATACCATATTCAACAAGA
CCTT GAT GGAAGCCGAT GCTC ACT AC AAGT C AGT Cgag ACTT GGAAT GAG AT C CTCCCTT C A AAAGGGTGTTT AAGAGTT GGGGGGAGGT GT C ATCCTC ATGT GA
ACGGGGTGTTTTTCAATGGTATAATATTAGGACCTGACGGCAATGTCTTAATC
CCAGAGATGCAATCATCCCTCCTCCAGCAACATATGGAGTTGTTGGAATCCTC
GGTTATCCCCCTTGTGCACCCCCTGGCAGACCCGTCTACCGTTTTCAAGGACG
GTGACGAGGCTGAGGATTTTGTTGAAGTTCACCTTCCCGATGTGCACAATCAG
GTCTCAGGAGTTGACTTGGGTCTCCCGAACTGGGGG AAGT ATGT ATT ACTGA
GTGCAGGGGCCCTGACTGCCTTGATGTTGATAATTTTCCTGATGACATGTTGT
AGAAGAGTCAATCGATCAGAACCTACGCAACACAATCTCAGAGGGACAGGG
AGGGAGGT GTC AGT C ACTCCCC AAAGCGGGAAGAT CAT ATCTTC AT GGGAAT
CACACAAGAGTGGGGGTGAGACCAGACTGTAAttaattaaCGTCCTTTCAACGATC
C A AGT C catgaaaaaaactaacacccctcccgtacctagcTT AT A A AGT GC T GGGT C ATCT A AGCT
TTTCAGTCGAGAAAAAAACATTAGATCAGAAGAACAACTGGCAACACTTCTC
AACCTGAGACTTACTTCAAGATGCTCGATCCTGGAGAGGTCTATGATGACCCT
ATTGACCCAATCGAGTTAGAGGCTGAACCCAGAGGAACCCCCATTGTCCCCA
ACATCTTGAGGAACTCTGACTACAATCTCAACTCTCCTTTGATAGAAGATCCT
GCTAGACTAATGTTAGAATGGTTAAAAACAGGGAATAGACCTTATCGGATGA
CTCTAACAGACAATTGCTCCAGGTCTTTCAGAGTTTTGAAAGATTATTTCAAG
AAGGTAGATTTGGGTTCTCTCAAGGTGGGCGGAATGGCTGCACAGTCAATGA
TTTCTCTCTGGTTATATGGTGCCCACTCTGAATCCAACAGGAGCCGGAGATGT
ATAACAGACTTGGCCCATTTCTATTCCAAGTCGTCCCCCATAGAGAAGCTGTT
GAATCTCACGCTAGGAAATAGAGGGCTGAGAATCCCCCCAGAGGGAGTGTTA
AGTTGCCTTGAGAGGGTTGATTATGATAATGCATTTGGAAGGTATCTTGCCAA
CACGTATTCCTCTTACTTGTTCTTCCATGTAATCACCTTATACATGAACGCCCT
AGACTGGGATGAAGAAAAGACCATCCTAGCATTATGGAAAGATTTAACCTCA
GT GGAC ATCGGGA AGGACTTGGT AA AGTT C AAAGACC AAAT AT GGGGACTGC
TGATCGTGACAAAGGACTTTGTTTACTCCCAAAGTTCCAATTGTCTTTTTGAC
AGAAACTACACACTTATGCTAAAAGATCTTTTCTTGTCTCGCTTCAACTCCTT
AATGGTCTTGCTCTCTCCCCCAGAGCCCCGATACTCAGATGACTTGATATCTC
AACTATGCCAGCTGTACATTGCTGGGGATCAAGTCTTGTCTATGTGTGGAAAC
TCCGGC T AT GA AGT CAT C A A A AT ATT GGAGC CAT AT GT C GT GA AT AGTTT AGT
CCAGAGAGCAGAAAAGTTTAGGCCTCTCATTCATTCCTTGGGAGACTTTCCTG
TATTTATAAAAGACAAGGTAAGTCAACTTGAAGAGACGTTCGGTCCCTGTGC
AAGAAGGTTCTTTAGGGCTCTGGATCAATTCGACAACATACATGACTTGGTTT
TTGTGTTTGGCTGTTACAGGCATTGGGGGCACCCATATATAGATTATCGAAAG GGTCTGTC A A A ACT AT AT GAT C AGGTT C ACC TT A A A A A A AT GAT AG AT A AGT
CC T AC C AGGAGT GC TT AGC A AGC GACC T AGC C AGGAGGAT C CTT AGAT GGGG
TTTTGATAAGTACTCCAAGTGGTATCTGGATTCAAGATTCCTAGCCCGAGACC
ACCCCTTGACTCCTTATATCAAAACCCAAACATGGCCACCCAAACATATTGTA
GACTTGGTGGGGGATACATGGCACAAGCTCCCGATCACGCAGATCTTTGAGA
TTCCTGAATCAATGGATCCGTCAGAAATATTGGATGACAAATCACATTCTTTC
ACCAGAACGAGACTAGCTTCTTGGCTGTCAGAAAACCGAGGGGGGCCTGTTC
CTAGCGAAAAAGTTATTATCACGGCCCTGTCTAAGCCGCCTGTCAATCCCCGA
GAGTTTCTGAGGTCTATAGACCTCGGAGGATTGCCAGATGAAGACTTGATAA
TTGGCCTC AAGCC AAAGGAACGGGAATTGAAGATT GAAGGTCGATTCTTTGC
TCTAATGTCATGGAATCTAAGATTGTATTTTGTCATCACTGAAAAACTCTTGG
CCAACTACATCTTGCCACTTTTTGACGCGCTGACTATGACAGACAACCTGAAC
AAGGTGTTTAAAAAGCTGATCGACAGGGTCACCGGGCAAGGGCTTTTGGACT
ATTC AAGGGT C AC AT AT GC ATTT C ACCTGGACT AT GAAAAGT GGAAC AACC A
TCAAAGATTAGAGTCAACAGAGGATGTATTTTCTGTCCTAGATCAAGTGTTTG
GATTGAAGAGAGTGTTTTCTAGAACACACGAGTTTTTTCAAAAGGCCTGGATC
T ATT ATT C AGAC AGAT C AGACCTC ATCGGGTT ACGGGAGGAT C AAAT AT ACT
GCTTAGATGCGTCCAACGGCCCAACCTGTTGGAATGGCCAGGATGGCGGGCT
AGA AGGC TT ACGGC AGA AGGGCTGG AGT C T AGT C AGC TT ATT GAT GAT AGAT
AGAGAATCTC AAAT C AGGAAC AC A AGAACC AAAAT ACT AGCTC A AGGAGAC
AACCAGGTTTTATGTCCGACATACATGTTGTCGCCAGGGCTATCTCAAGAGGG
GCTCCTCTATGAATTGGAGAGAATATCAAGGAATGCACTTTCGATATACAGA
GC C GT C G AGG A AGGGGC ATC T A AGC T AGGGC T GAT CAT C A AG A A AG A AG AG
ACCATGTGTAGTTATGACTTCCTCATCTATGGAAAAACCCCTTTGTTTAGAGG
TAACATATTGGTGCCTGAGTCCAAAAGATGGGCCAGAGTCTCTTGCGTCTCTA
ATGACCAAATAGTCAACCTCGCCAATATAATGTCGACAGTGTCCACCAATGC
GCTAACAGTGGCACAACACTCTCAATCTTTGATCAAACCGATGAGGGATTTTC
TGCTCATGTCAGTACAGGCAGTCTTTCACTACCTGCTATTTAGCCCAATCTTA
AAGGGAAGAGTTT AC AAGATTCTGAGCGCTGAAGGGGAGAGCTTTCTCCT AG
CCATGTCAAGGATAATCTATCTAGATCCTTCTTTGGGAGGGATATCTGGAATG
TCCCTCGGAAGATTCCATATACGACAGTTCTCAGACCCTGTCTCTGAAGGGTT
ATCCTTCTGGAGAGAGATCTGGTTAAGCTCCCAAGAGTCCTGGATTCACGCGT
T GTGT C AAGAGGCTGGAAACCC AGATCTTGGAGAGAGAAC ACTCGAGAGCTT
CACTCGCCTTCTAGAAGATCCGACCACCTTAAATATCAGAGGAGGGGCCAGT CCTACCATTCTACTCAAGGATGCAATCAGAAAGGCTTTATATGACGAGGTGG
ACAAGGTGGAAAATTCAGAGTTTCGAGAGGCAATCCTGTTGTCCAAGACCCA
TAGAGATAATTTTATACTCTTCTTAATATCTGTTGAGCCTCTGTTTCCTCGATT
TCTCAGTGAGCTATTCAGTTCGTCTTTTTTGGGAATCCCCGAGTCAATCATTG
GATTGATACAAAACTCCCGAACGATAAGAAGGCAGTTTAGAAAGAGTCTCTC
AAAAACTTTAGAAGAATCCTTCTACAACTCAGAGATCCACGGGATTAGTCGG
ATGACCCAGACACCTCAGAGGGTTGGGGGGGTGTGGCCTTGCTCTTCAGAGA
GGGCAGATCTACTTAGGGAGATCTCTTGGGGAAGAAAAGTGGTAGGCACGAC
AGTTCCTCACCCTTCTGAGATGTTGGGATTACTTCCCAAGTCCTCTATTTCTTG
C AC TT GT GGAGC A AC AGGAGGAGGC A ATCC T AGAGTTTC T GT AT C AGT ACTC
CCGTCCTTTGATCAGTCATTTTTTTCACGAGGCCCCCTAAAGGGATACTTGGG
CTCGTCCACCTCTATGTCGACCCAGCTATTCCATGCATGGGAAAAAGTCACTA
AT GTT CAT GT GGT G A AG AG AGC T C T ATC GTT A A A AG A AT C T AT A A AC T GGTT C
ATTACTAGAGATTCCAACTTGGCTCAAGCTCTAATTAGGAACATTATGTCTCT
GACAGGCCCTGATTTCCCTCTAGAGGAGGCCCCTGTCTTCAAAAGGACGGGG
T C AGCCTT GC AT AGGTT C A AGTCTGCC AGAT AC AGCGAAGGAGGGT ATTCTTC
TGTCTGCCCGAACCTCCTCTCTCATATTTCTGTTAGTACAGACACCATGTCTGA
TTTGACCCAAGACGGGAAGAACTACGATTTCATGTTCCAGCCATTGATGCTTT
AT GC AC AG AC AT GGAC AT C AGAGCTGGT AC AGAGAGAC AC AAGGCT AAGAG
ACTCTACGTTTCATTGGCACCTCCGATGCAACAGGTGTGTGAGACCCATTGAC
GACGTGACCCTGGAGACCTCTCAGATCTTCGAGTTTCCGGATGTGTCGAAAA
GAATATCCAGAATGGTTTCTGGGGCTGTGCCTCACTTCCAGAGGCTTCCCGAT
ATCCGTCTGAGACCAGGAGATTTTGAATCTCTAAGCGGTAGAGAAAAGTCTC
ACCATATCGGATCAGCTCAGGGGCTCTTATACTCAATCTTAGTGGCAATTCAC
GACTCAGGATACAATGATGGAACCATCTTCCCTGTCAACATATACGGCAAGG
TTTCCCCTAGAGACTATTTGAGAGGGCTCGCAAGGGGAGTATTGATAGGATC
CTCGATTTGCTTCTTGACAAGAATGACAAATATCAATATTAATAGACCTCTTG
AATTGGTCTCAGGGGTAATCTCATATATTCTCCTGAGGCTAGATAACCATCCC
TCCTTGTACATAATGCTCAGAGAACCGTCTCTTAGAGGAGAGATATTTTCTAT
CCCTCAGAAAATCCCCGCCGCTTATCCAACCACTATGAAAGAAGGCAACAGA
TCAATCTTGTGTTATCTCCAACATGTGCTACGCTATGAGCGAGAGATAATCAC
GGCGTCTCCAGAGAATGACTGGCTATGGATCTTTTCAGACTTTAGAAGTGCCA
AAATGACGTACCTATCCCTCATTACTTACCAGTCTCATCTTCTACTCCAGAGG
GTTGAGAGAA ACCT ATCT AAGAGT ATGAGAGAT AACCTGCGAC A ATT GAGTT CTTTGATGAGGCAGGTGCTGGGCGGGCACGGAGAAGATACCTTAGAGTCAGA
CGACAACATTCAACGACTGCTAAAAGACTCTTTACGAAGGACAAGATGGGTG
GATCAAGAGGTGCGCCATGCAGCTAGAACCATGACTGGAGATTACAGCCCCA
AC AAGAAGGTGTCCCGT AAGGT AGGAT GTT C AGAAT GGGTCTGCTCTGCTC A
ACAGGTTGCAGTCTCTACCTCAGCAAACCCGGCCCCTGTCTCGGAGCTTGACA
TAAGGGCCCTCTCTAAGAGGTTCCAGAACCCTTTGATCTCGGGCTTGAGAGTG
GTTCAGTGGGCAACCGGTGCTCATTATAAGCTTAAGCCTATTCTAGATGATCT
CAATGTTTTCCCATCTCTCTGCCTTGTAGTTGGGGACGGGTCAGGGGGGATAT
CAAGGGCAGTCCTCAACATGTTTCCAGATGCCAAGCTTGTGTTCAACAGTCTT
TTAGAGGTGAATGACCTGATGGCTTCCGGAACACATCCACTGCCTCCTTCAGC
AATCATGAGGGGAGGAAATGATATCGTCTCCAGAGTGATAGATCTTGACTCA
ATCTGGGAAAAACCGTCCGACTTGAGAAACTTGGCAACCTGGAAATACTTCC
AGTCAGTCCAAAAGCAGGTCAACATGTCCTATGACCTCATTATTTGCGATGCA
GAAGTTACTGACATTGCATCTATCAACCGGATCACCCTGTTAATGTCCGATTT
TGCATTGTCTATAGATGGACCACTCTATTTGGTCTTCAAAACTTATGGGACTA
TGCTAGTAAATCCAAACTACAAGGCTATTCAACACCTGTCAAGAGCGTTCCCC
TCGGTCACAGGGTTTATCACCCAAGTAACTTCGTCTTTTTCATCTGAGCTCTAC
CTCCGATTCTCCAAACGAGGGAAGTTTTTCAGAGATGCTGAGTACTTGACCTC
TTCCACCCTTCGAGAAATGAGCCTTGTGTTATTCAATTGTAGCAGCCCCAAGA
GT GAG AT GC AGAGAGCTCGTTCCTTGAACT AT C AGGATCTTGT GAGAGGATTT
CCTGAAGAAATCATATCAAATCCTTACAATGAGATGATCATAACTCTGATTGA
CAGTGATGTAGAATCTTTTCTAGTCCACAAGATGGTTGATGATCTTGAGTTAC
AGAGGGGAACTCTGTCTAAAGTGGCTATCATTATAGCCATCATGATAGTTTTC
TCCAACAGAGTCTTCAACGTTTCCAAACCCCTAACTGACCCCTCGTTCTATCC
ACCGTCTGATCCCAAAATCCTGAGGCACTTCAACATATGTTGCAGTACTATGA
TGTATCTATCTACTGCTTTAGGTGACGTCCCTAGCTTCGCAAGACTTCACGAC
CTGTATAACAGACCTATAACTTATTACTTCAGAAAGCAAGTCATTCGAGGGA
ACGTTTATCTATCTTGGAGTTGGTCCAACGACACCTCAGTGTTCAAAAGGGTA
GCCTGTAATTCTAGCCTGAGTCTGTCATCTCACTGGATCAGGTTGATTTACAA
GATAGTGAAGACTACCAGACTCGTTGGCAGCATCAAGGATCTATCCAGAGAA
GTGGAAAGACACCTTCATAGGTACAACAGGTGGATCACCCTAGAGGATATCA
GATCTAGATCATCCCTACTAGACTACAGTTGCCTGTGAACCGGATACTCCTGG
AAGCCTGCCCATGCTAAGACTCTTGTGTGATGTATCTTGAAAAAAACAAGAT
CCT AAATCTGAACCTTT GGTT GTTT GATT GTTTTTCTC Atttttgttgtttatttgttaagcgt In one embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 14, shown below (RABV vector: Coravax V5 China):
ACGCTTAACAACCAGATCAAAGAAAAAACAGACATTGTCAATTGCAAAGCAA
AAATGTAACACCCCTACAATGGATGCCGACAAGATTGTATTCAAAGTCAATA
AT C AGGT GGT C TC TT T G A AGC C T GAG AT T AT C GT GG AT C A AT AT G AGT AC A AG
TACCCTGCCATCAAAGATTTGAAAAAGCCCTGTATAACCCTAGGAAAGGCTC
CCGATTTAAATAAAGCATACAAGTCAGTTTTGTCAGGCATGAGCGCCGCCAA
ACTTAATCCTGACGATGTATGTTCCTATTTGGCAGCGGCAATGCAGTTTTTTG
AGGGGACATGTCCGGAAGACTGGACCAGCTATGGAATTGTGATTGCACGAAA
AGGAGATAAGATCACCCCAGGTTCTCTGGTGGAGATAAAACGTACTGATGTA
GAAGGGAATT GGGCTCTGAC AGGAGGC AT GGAACTGAC AAGAGACCCC ACT
GTCCCTGAGCATGCGTCCTTAGTCGGTCTTCTCTTGAGTCTGTATAGGTTGAG
CAAAATATCCGGGCAAAACACTGGTAACTATAAGACAAACATTGCAGACAGG
ATAGAGCAGATTTTTGAGACAGCCCCTTTTGTTAAAATCGTGGAACACCATAC
TCTAATGACAACTCACAAAATGTGTGCTAATTGGAGTACTATACCAAACTTCA
GATTTTTGGCCGGAACCTATGACATGTTTTTCTCCCGGATTGAGCATCTATATT
CAGCAATCAGAGTGGGCACAGTTGTCACTGCTTATGAAGACTGTTCAGGACT
GGTATCATTTACTGGGTTCATAAAACAAATCAATCTCACCGCTAGAGAGGCA
ATACTATATTTCTTCCACAAGAACTTTGAGGAAGAGATAAGAAGAATGTTTG
AGCCAGGGCAGGAGACAGCTGTTCCTCACTCTTATTTCATCCACTTCCGTTCA
CTAGGCTTGAGTGGGAAATCTCCTTATTCATCAAATGCTGTTGGTCACGTGTT
CAATCTCATTCACTTTGTAGGATGCTATATGGGTCAAGTCAGATCCCTAAATG
CAACGGTTATTGCTGCATGTGCTCCTCATGAAATGTCTGTTCTAGGGGGCTAT
CTGGGAGAGGAATTCTTCGGGAAAGGGAC ATTTGAAAGAAGATTCTTC AGAG
AT GAG A A AG A AC TT C A AG A AT AC G AGGC GGC T G A AC T G AC A A AG AC T G AC G
TAGCACTGGCAGATGATGGAACTGTCAACTCTGACGACGAGGACTACTTTTC
AGGT GAAACC AGAAGTCCGGAGGCTGTTT AT ACTCGAAT CAT GAT GAAT GGA
GGTCGACTAAAGAGATCTCACATACGGAGATATGTCTCAGTCAGTTCCAATC
ATCAAGCCCGTCCAAACTCATTCGCCGAGTTTCTAAACAAGACATATTCGAGT
GACTCATAAGAAGTTGAATAACAAAATGCCGGAAATCTACGGATTGTGTATA
TCCATCATGAAAAAAACTAACACCCCTCCTTTCGAACCATCCCAAACATGAG
CAAGATCTTTGTCAATCCTAGTGCTATTAGAGCCGGTCTGGCCGATCTTGAGA
T GGCTGAAGAAACTGTTGATCTGAT C AAT AGAAAT ATCGAAGAC AAT C AGGC
TCATCTCCAAGGGGAACCCATAGAGGTGGACAATCTCCCTGAGGATATGGGG CGACTTCACCTGGATGATGGAAAATCGCCCAACCATGGTGAGATAGCCAAGG
T GGG AG A AGGC A AGT ATC G AG AGG AC T T T C AG AT GG AT G A AGG AG AGG AT C
CTAGCTTCCTGTTCCAGTCATACCTGGAAAATGTTGGAGTCCAAATAGTCAGA
CAAATGAGGTCAGGAGAGAGATTTCTCAAGATATGGTCACAGACCGTAGAAG
AGATTATATCCTATGTCGCGGTCAACTTTCCCAACCCTCCAGGAAAGTCTTCA
GAGGATAAATCAACCCAGACTACTGGCCGAGAGCTCAAGAAGGAGACAACA
CCCACTCCTTCTCAGAGAGAAAGCCAATCATCGAAAGCCAGGATGGCGGCTC
AAATTGCTTCTGGCCCTCCAGCCCTTGAATGGTCGGCTACCAATGAAGAGGAT
GATCTATCAGTGGAGGCTGAGATCGCTCACCAGATTGCAGAAAGTTTCTCCA
AAAAATATAAGTTTCCCTCTCGATCCTCAGGGATACTCTTGTATAATTTTGAG
C AATTGAAAAT GAACCTTGAT GAT AT AGTT AAAGAGGC AAAAAAT GT ACC AG
GTGTGACCCGTTTAGCCCATGACGGGTCCAAACTCCCCCTAAGATGTGTACTG
GGATGGGTCGCTTTGGCCAACTCTAAGAAATTCCAGTTGTTAGTCGAATCCGA
CAAGCTGAGTAAAATCATGCAAGATGACTTGAATCGCTATACATCTTGCTAA
CCGAACCTCTCCCCTCAGTCCCTCTAGACAATAAAATCCGAGATGTCCCAAAG
TCAACATGAAAAAAACAGGCAACACCACTGATAAAATGAACCTCCTACGTAA
GATAGTGAAAAACCGCAGGGACGAGGACACTCAAAAATCCTCTCCCGCGTCA
GCCCCTCTGGATGACGATGACTTGTGGCTTCCACCCCCTGAATACGTCCCGCT
GA A AGA ACTT AC AGGC A AG A AG A AC AT GAGGA AC TTTTGT AT C A AC GGA AG
GGTTAAAGTGTGTAGCCCGAATGGTTACTCGTTCAGGATCCTGCGGCACATTC
TGAAATCATTCGACGAGATATATTCTGGGAATCATAGGATGATCGGGTTAGTC
AAAGTGGTTATTGGACTGGCTTTGTCAGGATCTCCAGTCCCTGAGGGCCTGAA
CTGGGTATACAAATTGAGGAGAACCTTTATCTTCCAGTGGGCTGATTCCAGGG
GCCCTCTTGAAGGGGAGGAGTTGGAATACTCTCAGGAGATCACTTGGGATGA
T GAT AC T G AGTTCGTCGGATTGC A A AT A AG AGT GATT GCA A A AC AGT GT CAT
ATCC AGGGC AGAGTCTGGT GT AT C AAC AT GAACCCGAGAGC ATGT C AACT AT
GGTCTGACATGTCTCTTCAGACACAAAGGTCCGAAGAGGACAAAGATTCCTC
TCTGCTTCTAGAATAATCAGATTATATCCCGCAAATTTATCACTTGTTTACCTC
TGGAGGAGAGAACATATGGGCTCAACTCCAACCCTTGGGAGCAATATAACAA
AAAAC AT GTT ATGGT GCC ATT AAACCGCTGC ATTT CAT C AAAGTC AAGTT GAT
TACCTTTACATTTTGATCCTCTTGGATGTGAAAAAAACTATTAACATCCCTCA
AAAGACCccgggccaccATGTTCGTGTTTCTGGTGCTGCTGCCTCTGGTGAGCTCC
CAGTGCGTGAACCTGACCACAAGGACCCAGCTGCCCCCTGCCTATACCAATT
CCTTCACACGGGGCGTGTACTATCCCGACAAGGTGTTCCGGAGCAGCGTGCT GCACTCCACACAGGATCTGTTTCTGCCTTTCTTTTCTAACGTGACCTGGTTCCA
CGCCATCCACGTGAGCGGCACCAATGGCACAAAGCGGTTCGACAATCCAGTG
CTGCCCTTTAACGATGGCGTGTACTTCGCCTCCACCGAGAAGTCTAACATCAT
CAGAGGCTGGATCTTTGGCACCACACTGGACAGCAAGACACAGTCCCTGCTG
ATCGTGAACAATGCCACCAACGTGGTCATCAAGGTGTGCGAGTTCCAGTTTTG
TAATGATCCATTCCTGGGCGTGTACTATCACAAGAACAATAAGTCTTGGATGG
AGAGCGAGTTTCGCGTGTATTCCTCTGCCAACAATTGCACATTTGAGTACGTG
TCCCAGCCCTTCCTGATGGACCTGGAGGGCAAGCAGGGCAATTTCAAGAACC
TGAGGGAGTTCGTGTTTAAGAATATCGATGGCTACTTCAAAATCTACTCCAAG
CACACCCCAATCAACCTGGTGCGCGACCTGCCACAGGGCTTCTCTGCCCTGGA
GCCACTGGTGGATCTGCCCATCGGCATCAACATCACCCGGTTTCAGACACTGC
TGGCCCTGCACAGAAGCTACCTGACACCAGGCGACAGCTCCTCTGGATGGAC
CGCAGGAGCAGCAGCCTACTATGTGGGCTATCTGCAGCCCAGGACCTTCCTG
CTGAAGTACAACGAGAATGGCACCATCACAGACGCCGTGGATTGCGCCCTGG
ATCCCCTGTCTGAGACCAAGTGTACACTGAAGAGCTTTACCGTGGAGAAGGG
CATCTATCAGACAAGCAATTTCAGGGTGCAGCCTACCGAGTCCATCGTGCGCT
TTCCCAATATCACAAACCTGTGCCCTTTTGGCGAGGTGTTCAACGCAACCCGC
TTCGCCAGCGTGTACGCCTGGAATAGGAAGCGCATCTCCAACTGCGTGGCCG
ACTATTCTGTGCTGTACAACAGCGCCTCCTTCTCTACCTTTAAGTGCTATGGC
GTGAGCCCCACAAAGCTGAATGACCTGTGCTTTACCAACGTGTACGCCGATTC
CTTCGTGATCAGGGGCGACGAGGTGCGCCAGATCGCACCAGGACAGACAGGC
AAGATCGCAGACTACAATTATAAGCTGCCTGACGATTTCACCGGCTGCGTGA
TCGCCTGGAACTCTAACAATCTGGATAGCAAAGTGGGCGGCAACTACAATTA
TCTGTACCGGCTGTTTAGAAAGTCTAATCTGAAGCCATTCGAGAGGGACATCT
CCACAGAAATCTACCAGGCCGGCTCTACCCCCTGCAATGGCGTGGAgGGCTTT
AACTGTTATTTCCCTCTGCAGAgCTACgGCTTCCAGCCAACAAACGGCGTGGG
CTATCAGCCCTACCGCGTGGTGGTGCTGTCTTTTGAGCTGCTGCACGCACcTG
C A AC AGT GT GC GGACC A A AGA AGAGC AC C A ATCTGGT GA AGA AC A AGT GC G
TGAACTTCAACTTCAACGGACTGACCGGAACAGGCGTGCTGACCGAGTCCAA
CAAGAAGTTCCTGCCTTTTCAGCAGTTCGGCAGGGACATCGCAGATACCACA
GACGCCGTGCGCGACCCTCAGACCCTGGAGATCCTGGACATCACACCATGCT
CCTTCGGCGGCGTGTCTGTGATCACACCAGGCACCAATACAAGCAACCAGGT
GGCCGT GCTGT AT C AGGACGT GAATT GT ACCGAGGTGCC AGT GGC AATCC AC
GCAGATCAGCTGACCCCTACATGGCGGGTGTACTCTACCGGCAGCAACGTGT TCCAGACAAGAGCCGGATGCCTGATCGGAGCAGAGCACGTGAACAATAGCTA
TGAGTGCGACATCCCTATCGGCGCCGGCATCTGTGCCTCCTACCAGACCCAGA
CAAACTCCCCAAGGTCTgtgggaGATGAGGCCGAAGACTTTGTGGAAGTCCACC
TGCCTGATGTGCATAACCAGGTGTCTGGCGTCGACCTGGGACTGCCAAATTG
GGGCAAGTACGTGCTGCTGAGTGCTGGAGCACTGACTGCCCTGATGCTGATC
ATTTTCCTGATGACCTGCTGTCGGCGCGTGAACAGAAGTGAGCCCACTCAGC
AC AATCTGCGAGGAACCGGGAGAGAAGT GTC AGT C AC ACCTC AGAGCGGGA
AAAT C ATT AGT AGTTGGGAAT C AC AT AAAAGCGGGGGCGAGACC AGGCTGgg atccggctccggcgagggcaggggaagtctactaacatgcggggacgtggaggaaaatcccggccccATGGTTCCT
CAGGCTCTCCTGTTTGTACCCCTTCTGGTTTTTCCATTGTGTTTTGGGAAATTC
CCTATTTACACGATACCAGACAAGCTTGGTCCCTGGAGTCCGATTGACATACA
TCACCTCAGCTGCCCAAACAATTTGGTAGTGGAGGACGAAGGATGCACCAAC
CTGTCAGGGTTCTCCTACATGGAACTTAAAGTTGGATACATCTTAGCCATAAA
AGTGAACGGGTTCACTTGCACAGGCGTTGTGACGGAGGCTGAAACCTACACT
AACTTCGTTGGTTATGTCACAACCACGTTCAAAAGAAAGCATTTCCGCCCAAC
ACCAGATGCATGTAGAGCCGCGTACAACTGGAAGATGGCCGGTGACCCCAGA
TATGAAGAGTCTCTACACAATCCGTACCCTGACTACCGCTGGCTTCGAACTGT
AAAAACCACCAAGGAGTCTCTCGTTATCATATCTCCAAGTGTGGCAGATTTGG
ACCCATATGACAGATCCCTTCACTCGAGGGTCTTCCCTAGCGGGAAGTGCTCA
GGAGTAGCGGTGTCTTCTACCTACTGCTCCACTAACCACGATTACACCATTTG
GATGCCCGAGAATCCGAGACTAGGGATGTCTTGTGACATTTTTACCAATAGTA
GAGGGAAGAGAGC ATCC AAAGGGAGT GAGACTT GCGGCTTT GT AGATGAAA
G AGGC C T AT AT A AGT C T TT A A A AGG AGC AT GCA A AC T C A AGTT AT GT GG AGT
TCTAGGACTTAGACTTATGGATGGAACATGGGTCTCGATGCAAACATCAAAT
GAAACCAAATGGTGCCCTCCCGATAAGTTGGTGAACCTGCACGACTTTCGCTC
AGACGAAATTGAGCACCTTGTTGTAGAGGAGTTGGTCAGGAAGAGAGAGGA
GTGTCTGGATGCACTAGAGTCCATCATGACAACCAAGTCAGTGAGTTTCAGA
CGTCTCAGTCATTTAAGAAAACTTGTCCCTGGGTTTGGAAAAGCATATACCAT
ATTCAACAAGACCTTGATGGAAGCCGATGCTCACTACAAGTCAGTCgagACTT
GGAAT GAGATCCTCCCTT C AAAAGGGT GTTT A AGAGTT GGGGGGAGGTGT C A
TCCTC AT GTGAACGGGGT GTTTTT C AAT GGT AT AAT ATT AGGACCTGACGGC A
ATGTCTTAATCCCAGAGATGCAATCATCCCTCCTCCAGCAACATATGGAGTTG
TTGGAATCCTCGGTTATCCCCCTTGTGCACCCCCTGGCAGACCCGTCTACCGT
TTTCAAGGACGGTGACGAGGCTGAGGATTTTGTTGAAGTTCACCTTCCCGATG TGCACAATCAGGTCTCAGGAGTTGACTTGGGTCTCCCGAACTGGGGGAAGTA
TGTATTACTGAGTGCAGGGGCCCTGACTGCCTTGATGTTGATAATTTTCCTGA
TGACATGTTGTAGAAGAGTCAATCGATCAGAACCTACGCAACACAATCTCAG
AGGGACAGGGAGGGAGGTGTCAGTCACTCCCCAAAGCGGGAAGATCATATCT
T CAT GGGAATC AC AC AAGAGT GGGGGT GAGACC AGACTGT AAgctagcTT AT A A
AGTGCTGGGTCATCTAAGCTTTTCAGTCGAGAAAAAAACATTAGATCAGAAG
AACAACTGGCAACACTTCTCAACCTGAGACTTACTTCAAGATGCTCGATCCTG
GAGAGGTCTATGATGACCCTATTGACCCAATCGAGTTAGAGGCTGAACCCAG
AGGAACCCCCATTGTCCCCAACATCTTGAGGAACTCTGACTACAATCTCAACT
CTCCTTTGATAGAAGATCCTGCTAGACTAATGTTAGAATGGTTAAAAACAGG
GAATAGACCTTATCGGATGACTCTAACAGACAATTGCTCCAGGTCTTTCAGAG
TTTTGAAAGATTATTTCAAGAAGGTAGATTTGGGTTCTCTCAAGGTGGGCGGA
ATGGCTGCACAGTCAATGATTTCTCTCTGGTTATATGGTGCCCACTCTGAATC
CAACAGGAGCCGGAGATGTATAACAGACTTGGCCCATTTCTATTCCAAGTCG
TCCCCCATAGAGAAGCTGTTGAATCTCACGCTAGGAAATAGAGGGCTGAGAA
TCCCCCCAGAGGGAGTGTTAAGTTGCCTTGAGAGGGTTGATTATGATAATGC
ATTTGGAAGGTATCTTGCCAACACGTATTCCTCTTACTTGTTCTTCCATGTAAT
CACCTTATACATGAACGCCCTAGACTGGGATGAAGAAAAGACCATCCTAGCA
TTATGGAAAGATTTAACCTCAGTGGACATCGGGAAGGACTTGGTAAAGTTCA
AAGACCAAATATGGGGACTGCTGATCGTGACAAAGGACTTTGTTTACTCCCA
AAGTTCCAATTGTCTTTTTGACAGAAACTACACACTTATGCTAAAAGATCTTT
TCTTGTCTCGCTTCAACTCCTTAATGGTCTTGCTCTCTCCCCCAGAGCCCCGAT
ACTCAGATGACTTGATATCTCAACTATGCCAGCTGTACATTGCTGGGGATCAA
GTCTTGTCTATGTGTGGAAACTCCGGCTATGAAGTCATCAAAATATTGGAGCC
ATATGTCGTGAATAGTTTAGTCCAGAGAGCAGAAAAGTTTAGGCCTCTCATTC
ATTCCTTGGGAGACTTTCCTGTATTTATAAAAGACAAGGTAAGTCAACTTGAA
GAGACGTTCGGTCCCTGTGCAAGAAGGTTCTTTAGGGCTCTGGATCAATTCGA
CAACATACATGACTTGGTTTTTGTGTTTGGCTGTTACAGGCATTGGGGGCACC
CATATATAGATTATCGAAAGGGTCTGTCAAAACTATATGATCAGGTTCACCTT
A A A A A A AT GAT AG AT A AGTCC T AC C AGGAGT GC TT AGC A AGCGAC CT AGCC A
GGAGGATCCTTAGATGGGGTTTTGATAAGTACTCCAAGTGGTATCTGGATTCA
AGATTCCTAGCCCGAGACCACCCCTTGACTCCTTATATCAAAACCCAAACATG
GCCACCCAAACATATTGTAGACTTGGTGGGGGATACATGGCACAAGCTCCCG
ATCACGCAGATCTTTGAGATTCCTGAATCAATGGATCCGTCAGAAATATTGGA TGACAAATCACATTCTTTCACCAGAACGAGACTAGCTTCTTGGCTGTCAGAAA
ACCGAGGGGGGCCTGTTCCTAGCGAAAAAGTTATTATCACGGCCCTGTCTAA
GCCGCCTGTCAATCCCCGAGAGTTTCTGAGGTCTATAGACCTCGGAGGATTGC
C AGAT GA AGAC TT GAT A ATT GGCC T C A AGCC A A AGGA AC GGGA ATTGA AGAT
TGAAGGTCGATTCTTTGCTCTAATGTCATGGAATCTAAGATTGTATTTTGTCAT
CACTGAAAAACTCTTGGCCAACTACATCTTGCCACTTTTTGACGCGCTGACTA
T GAC AGAC AACCTGAAC AAGGT GTTT AAAAAGCTGATCGAC AGGGT C ACCGG
GCAAGGGCTTTTGGACTATTCAAGGGTCACATATGCATTTCACCTGGACTATG
AAAAGTGGAACAACCATCAAAGATTAGAGTCAACAGAGGATGTATTTTCTGT
CCTAGATCAAGTGTTTGGATTGAAGAGAGTGTTTTCTAGAACACACGAGTTTT
TTCAAAAGGCCTGGATCTATTATTCAGACAGATCAGACCTCATCGGGTTACGG
GAGGATCAAATATACTGCTTAGATGCGTCCAACGGCCCAACCTGTTGGAATG
GCC AGGAT GGCGGGCT AGAAGGCTT ACGGC AGAAGGGCTGGAGTCT AGT C A
GCTT ATT GAT GAT AGAT AGAGAATCTC AAATC AGGAAC AC AAGAACC AAAAT
ACTAGCTCAAGGAGACAACCAGGTTTTATGTCCGACATACATGTTGTCGCCA
GGGC T AT C T C A AG AGGGGC TCCTCTAT G A ATT GG AG AG A AT AT C A AGGA AT G
CACTTTCGATATACAGAGCCGTCGAGGAAGGGGCATCTAAGCTAGGGCTGAT
CAT C A AG A A AG A AG AG AC CAT GT GT AGTT AT GAC TTCCTC ATCT AT GGA A A A
ACCCCTTTGTTTAGAGGTAACATATTGGTGCCTGAGTCCAAAAGATGGGCCA
GAGTCTCTTGCGTCTCTAATGACCAAATAGTCAACCTCGCCAATATAATGTCG
ACAGTGTCCACCAATGCGCTAACAGTGGCACAACACTCTCAATCTTTGATCAA
ACCGATGAGGGATTTTCTGCTCATGTCAGTACAGGCAGTCTTTCACTACCTGC
TATTTAGCCCAATCTTAAAGGGAAGAGTTTACAAGATTCTGAGCGCTGAAGG
GGAGAGCTTTCTCCTAGCCATGTCAAGGATAATCTATCTAGATCCTTCTTTGG
GAGGGAT ATCTGGAATGTCCCTCGGAAGATTCC AT AT ACGAC AGTTCTC AGA
CCCTGTCTCTGAAGGGTTATCCTTCTGGAGAGAGATCTGGTTAAGCTCCCAAG
AGTCCTGGATTCACGCGTTGTGTCAAGAGGCTGGAAACCCAGATCTTGGAGA
GAGAACACTCGAGAGCTTCACTCGCCTTCTAGAAGATCCGACCACCTTAAAT
AT C AG AGG AGGGGC C AGTCC T AC C ATTCT ACTC A AGGAT GCA AT C AGA A AGG
CTTT AT ATGACGAGGT GG AC AAGGT GGAAAATTC AGAGTTTCGAGAGGC AAT
CCTGTTGTCCAAGACCCATAGAGATAATTTTATACTCTTCTTAATATCTGTTGA
GCCTCTGTTTCCTCGATTTCTCAGTGAGCTATTCAGTTCGTCTTTTTTGGGAAT
CCCCGAGTCAATCATTGGATTGATACAAAACTCCCGAACGATAAGAAGGCAG
TTT AGAAAGAGTCTCTC AAAAACTTT AGAAGAATCCTTCT AC AACTC AGAGAT CC ACGGGATT AGTCGGATGACCC AGAC ACCTC AGAGGGTT GGGGGGGT GT GG
CCTTGCTCTTCAGAGAGGGCAGATCTACTTAGGGAGATCTCTTGGGGAAGAA
AAGTGGTAGGCACGACAGTTCCTCACCCTTCTGAGATGTTGGGATTACTTCCC
AAGTCCTCTATTTCTTGCACTTGTGGAGCAACAGGAGGAGGCAATCCTAGAG
TTTCTGTATCAGTACTCCCGTCCTTTGATCAGTCATTTTTTTCACGAGGCCCCC
TAAAGGGATACTTGGGCTCGTCCACCTCTATGTCGACCCAGCTATTCCATGCA
T GGG A A A A AGT C AC T A AT GT TC AT GT GGT G A AG AG AGC TC T AT C GT T A A A AG
AATCTATAAACTGGTTCATTACTAGAGATTCCAACTTGGCTCAAGCTCTAATT
AGGAACATTATGTCTCTGACAGGCCCTGATTTCCCTCTAGAGGAGGCCCCTGT
CTTCAAAAGGACGGGGTCAGCCTTGCATAGGTTCAAGTCTGCCAGATACAGC
GAAGGAGGGTATTCTTCTGTCTGCCCGAACCTCCTCTCTCATATTTCTGTTAGT
ACAGACACCATGTCTGATTTGACCCAAGACGGGAAGAACTACGATTTCATGT
TCC AGCC ATTGAT GCTTT AT GC AC AGAC AT GGAC ATC AGAGCTGGT AC AG AG
AGACACAAGGCTAAGAGACTCTACGTTTCATTGGCACCTCCGATGCAACAGG
TGTGTGAGACCCATTGACGACGTGACCCTGGAGACCTCTCAGATCTTCGAGTT
TCCGGATGTGTCGAAAAGAATATCCAGAATGGTTTCTGGGGCTGTGCCTCACT
TCCAGAGGCTTCCCGATATCCGTCTGAGACCAGGAGATTTTGAATCTCTAAGC
GGTAGAGAAAAGTCTCACCATATCGGATCAGCTCAGGGGCTCTTATACTCAA
TCTTAGTGGCAATTCACGACTCAGGATACAATGATGGAACCATCTTCCCTGTC
AACATATACGGCAAGGTTTCCCCTAGAGACTATTTGAGAGGGCTCGCAAGGG
GAGT ATT GAT AGGATCCTCGATTT GCTTCTT GAC AAGAATGAC AAAT ATC AAT
ATTAATAGACCTCTTGAATTGGTCTCAGGGGTAATCTCATATATTCTCCTGAG
GCTAGATAACCATCCCTCCTTGTACATAATGCTCAGAGAACCGTCTCTTAGAG
GAGAGATATTTTCTATCCCTCAGAAAATCCCCGCCGCTTATCCAACCACTATG
AAAGAAGGCAACAGATCAATCTTGTGTTATCTCCAACATGTGCTACGCTATG
AGCGAGAGATAATCACGGCGTCTCCAGAGAATGACTGGCTATGGATCTTTTC
AGACTTTAGAAGTGCCAAAATGACGTACCTATCCCTCATTACTTACCAGTCTC
ATCTTCTACTCCAGAGGGTTGAGAGAAACCTATCTAAGAGTATGAGAGATAA
CCTGCGACAATTGAGTTCTTTGATGAGGCAGGTGCTGGGCGGGCACGGAGAA
GATACCTTAGAGTCAGACGACAACATTCAACGACTGCTAAAAGACTCTTTAC
GAAGGAC AAGAT GGGTGGATC AAGAGGT GCGCC AT GC AGCT AGAACC AT GA
CTGGAGATTACAGCCCCAACAAGAAGGTGTCCCGTAAGGTAGGATGTTCAGA
ATGGGTCTGCTCTGCTCAACAGGTTGCAGTCTCTACCTCAGCAAACCCGGCCC
CTGTCTCGGAGCTTGACATAAGGGCCCTCTCTAAGAGGTTCCAGAACCCTTTG ATCTCGGGCTTGAGAGTGGTTC AGT GGGC AACCGGT GCTC ATT AT AAGCTT AA
GCCTATTCTAGATGATCTCAATGTTTTCCCATCTCTCTGCCTTGTAGTTGGGGA
CGGGTCAGGGGGGATATCAAGGGCAGTCCTCAACATGTTTCCAGATGCCAAG
CTTGTGTTCAACAGTCTTTTAGAGGTGAATGACCTGATGGCTTCCGGAACACA
TCCACTGCCTCCTTCAGCAATCATGAGGGGAGGAAATGATATCGTCTCCAGA
GTGATAGATCTTGACTCAATCTGGGAAAAACCGTCCGACTTGAGAAACTTGG
CAACCTGGAAATACTTCCAGTCAGTCCAAAAGCAGGTCAACATGTCCTATGA
CCTCATTATTTGCGATGCAGAAGTTACTGACATTGCATCTATCAACCGGATCA
CCCTGTTAATGTCCGATTTTGCATTGTCTATAGATGGACCACTCTATTTGGTCT
T C A A A AC TT AT GGGAC T AT GCT AGT A A ATCC A A ACT AC A AGGC T ATTC A AC A
CCTGTCAAGAGCGTTCCCCTCGGTCACAGGGTTTATCACCCAAGTAACTTCGT
CTTTTTCATCTGAGCTCTACCTCCGATTCTCCAAACGAGGGAAGTTTTTCAGA
GATGCTGAGTACTTGACCTCTTCCACCCTTCGAGAAATGAGCCTTGTGTTATT
CAATTGTAGCAGCCCCAAGAGTGAGATGCAGAGAGCTCGTTCCTTGAACTAT
C AGGATCTT GTGAGAGGATTTCCTGAAGAAAT CAT AT C AAATCCTT AC AAT G
AGATGATCATAACTCTGATTGACAGTGATGTAGAATCTTTTCTAGTCCACAAG
AT GGTT GAT GAT C TT GAGTT AC AGAGGGGA AC TC T GTCT A A AGT GGCT AT CAT
TATAGCCATCATGATAGTTTTCTCCAACAGAGTCTTCAACGTTTCCAAACCCC
TAACTGACCCCTCGTTCTATCCACCGTCTGATCCCAAAATCCTGAGGCACTTC
AACATATGTTGCAGTACTATGATGTATCTATCTACTGCTTTAGGTGACGTCCC
TAGCTTCGCAAGACTTCACGACCTGTATAACAGACCTATAACTTATTACTTCA
GAAAGCAAGTCATTCGAGGGAACGTTTATCTATCTTGGAGTTGGTCCAACGA
CACCTCAGTGTTCAAAAGGGTAGCCTGTAATTCTAGCCTGAGTCTGTCATCTC
ACTGGAT C AGGTTGATTT AC AAGAT AGT GAAGACT ACC AGACTCGTT GGC AG
CATCAAGGATCTATCCAGAGAAGTGGAAAGACACCTTCATAGGTACAACAGG
TGGATCACCCTAGAGGATATCAGATCTAGATCATCCCTACTAGACTACAGTTG
CCTGTGAACCGGATACTCCTGGAAGCCTGCCCATGCTAAGACTCTTGTGTGAT
GTATCTTGAAAAAAACAAGATCCTAAATCTGAACCTTTGGTTGTTTGATTGTT
TTTCTCATTTTTGTTGTTTATTTGTTAAGCGT.
In one embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 15, shown below (RABV vector: Coravax V5 South Africa):
ACGCTTAACAACCAGATCAAAGAAAAAACAGACATTGTCAATTGCAAAGCAA AAATGTAACACCCCTACAATGGATGCCGACAAGATTGTATTCAAAGTCAATA AT C AGGT GGT C TC TT T G A AGC C T GAG AT T AT C GT GG AT C A AT AT G AGT AC A AG TACCCTGCCATCAAAGATTTGAAAAAGCCCTGTATAACCCTAGGAAAGGCTC
CCGATTTAAATAAAGCATACAAGTCAGTTTTGTCAGGCATGAGCGCCGCCAA
ACTTAATCCTGACGATGTATGTTCCTATTTGGCAGCGGCAATGCAGTTTTTTG
AGGGGACATGTCCGGAAGACTGGACCAGCTATGGAATTGTGATTGCACGAAA
AGGAGATAAGATCACCCCAGGTTCTCTGGTGGAGATAAAACGTACTGATGTA
GAAGGGAATT GGGCTCTGAC AGGAGGC AT GGAACTGAC AAGAGACCCC ACT
GTCCCTGAGCATGCGTCCTTAGTCGGTCTTCTCTTGAGTCTGTATAGGTTGAG
CAAAATATCCGGGCAAAACACTGGTAACTATAAGACAAACATTGCAGACAGG
ATAGAGCAGATTTTTGAGACAGCCCCTTTTGTTAAAATCGTGGAACACCATAC
TCTAATGACAACTCACAAAATGTGTGCTAATTGGAGTACTATACCAAACTTCA
GATTTTTGGCCGGAACCTATGACATGTTTTTCTCCCGGATTGAGCATCTATATT
CAGCAATCAGAGTGGGCACAGTTGTCACTGCTTATGAAGACTGTTCAGGACT
GGTATCATTTACTGGGTTCATAAAACAAATCAATCTCACCGCTAGAGAGGCA
ATACTATATTTCTTCCACAAGAACTTTGAGGAAGAGATAAGAAGAATGTTTG
AGCCAGGGCAGGAGACAGCTGTTCCTCACTCTTATTTCATCCACTTCCGTTCA
CTAGGCTTGAGTGGGAAATCTCCTTATTCATCAAATGCTGTTGGTCACGTGTT
CAATCTCATTCACTTTGTAGGATGCTATATGGGTCAAGTCAGATCCCTAAATG
CAACGGTTATTGCTGCATGTGCTCCTCATGAAATGTCTGTTCTAGGGGGCTAT
CTGGGAGAGGAATTCTTCGGGAAAGGGAC ATTTGAAAGAAGATTCTTC AGAG
AT GAG A A AG A AC TT C A AG A AT AC G AGGC GGC T G A AC T G AC A A AG AC T G AC G
TAGCACTGGCAGATGATGGAACTGTCAACTCTGACGACGAGGACTACTTTTC
AGGT GAAACC AGAAGTCCGGAGGCTGTTT AT ACTCGAAT CAT GAT GAAT GGA
GGTCGACTAAAGAGATCTCACATACGGAGATATGTCTCAGTCAGTTCCAATC
ATCAAGCCCGTCCAAACTCATTCGCCGAGTTTCTAAACAAGACATATTCGAGT
GACTCATAAGAAGTTGAATAACAAAATGCCGGAAATCTACGGATTGTGTATA
TCCATCATGAAAAAAACTAACACCCCTCCTTTCGAACCATCCCAAACATGAG
CAAGATCTTTGTCAATCCTAGTGCTATTAGAGCCGGTCTGGCCGATCTTGAGA
T GGCTGAAGAAACTGTTGATCTGAT C AAT AGAAAT ATCGAAGAC AAT C AGGC
TCATCTCCAAGGGGAACCCATAGAGGTGGACAATCTCCCTGAGGATATGGGG
CGACTTCACCTGGATGATGGAAAATCGCCCAACCATGGTGAGATAGCCAAGG
T GGG AG A AGGC A AGT ATC G AG AGG AC T T T C AG AT GG AT G A AGG AG AGG AT C
CTAGCTTCCTGTTCCAGTCATACCTGGAAAATGTTGGAGTCCAAATAGTCAGA
CAAATGAGGTCAGGAGAGAGATTTCTCAAGATATGGTCACAGACCGTAGAAG
AGATTATATCCTATGTCGCGGTCAACTTTCCCAACCCTCCAGGAAAGTCTTCA GAGGATAAATCAACCCAGACTACTGGCCGAGAGCTCAAGAAGGAGACAACA
CCCACTCCTTCTCAGAGAGAAAGCCAATCATCGAAAGCCAGGATGGCGGCTC
AAATTGCTTCTGGCCCTCCAGCCCTTGAATGGTCGGCTACCAATGAAGAGGAT
GATCTATCAGTGGAGGCTGAGATCGCTCACCAGATTGCAGAAAGTTTCTCCA
AAAAATATAAGTTTCCCTCTCGATCCTCAGGGATACTCTTGTATAATTTTGAG
C AATTGAAAAT GAACCTTGAT GAT AT AGTT AAAGAGGC AAAAAAT GT ACC AG
GTGTGACCCGTTTAGCCCATGACGGGTCCAAACTCCCCCTAAGATGTGTACTG
GGATGGGTCGCTTTGGCCAACTCTAAGAAATTCCAGTTGTTAGTCGAATCCGA
CAAGCTGAGTAAAATCATGCAAGATGACTTGAATCGCTATACATCTTGCTAA
CCGAACCTCTCCCCTCAGTCCCTCTAGACAATAAAATCCGAGATGTCCCAAAG
TCAACATGAAAAAAACAGGCAACACCACTGATAAAATGAACCTCCTACGTAA
GATAGTGAAAAACCGCAGGGACGAGGACACTCAAAAATCCTCTCCCGCGTCA
GCCCCTCTGGATGACGATGACTTGTGGCTTCCACCCCCTGAATACGTCCCGCT
GA A AGA ACTT AC AGGC A AG A AG A AC AT GAGGA AC TTTTGT AT C A AC GGA AG
GGTTAAAGTGTGTAGCCCGAATGGTTACTCGTTCAGGATCCTGCGGCACATTC
TGAAATCATTCGACGAGATATATTCTGGGAATCATAGGATGATCGGGTTAGTC
AAAGTGGTTATTGGACTGGCTTTGTCAGGATCTCCAGTCCCTGAGGGCCTGAA
CTGGGTATACAAATTGAGGAGAACCTTTATCTTCCAGTGGGCTGATTCCAGGG
GCCCTCTTGAAGGGGAGGAGTTGGAATACTCTCAGGAGATCACTTGGGATGA
T GAT AC T G AGTTCGTCGGATTGC A A AT A AGAGT GATT GC A A A AC AGT GT CAT
ATCC AGGGC AGAGTCTGGT GT AT C AAC AT GAACCCGAGAGC ATGT C AACT AT
GGTCTGACATGTCTCTTCAGACACAAAGGTCCGAAGAGGACAAAGATTCCTC
TCTGCTTCTAGAATAATCAGATTATATCCCGCAAATTTATCACTTGTTTACCTC
TGGAGGAGAGAACATATGGGCTCAACTCCAACCCTTGGGAGCAATATAACAA
AAAAC AT GTT ATGGT GCC ATT AAACCGCTGC ATTT CAT C AAAGTC AAGTT GAT
TACCTTTACATTTTGATCCTCTTGGATGTGAAAAAAACTATTAACATCCCTCA
AAAGACCccgggccaccATGTTCGTGTTTCTGGTGCTGCTGCCTCTGGTGAGCTCC
CAGTGCGTGAACTTCACCACAAGGACCCAGCTGCCCCCTGCCTATACCAATTC
CTTCACACGGGGCGTGTACTATCCCGACAAGGTGTTCCGGAGCAGCGTGCTG
CACTCCACACAGGATCTGTTTCTGCCTTTCTTTTCTAACGTGACCTGGTTCCAC
GCCATCCACGTGAGCGGCACCAATGGCACAAAGCGGTTCGCCAATCCAGTGC
TGCCCTTTAACGATGGCGTGTACTTCGCCTCCACCGAGAAGTCTAACATCATC
AGAGGCTGGATCTTTGGCACCACACTGGACAGCAAGACACAGTCCCTGCTGA
TCGT GAAC AAT GCC ACC AAC GT GGT CAT C AAGGT GTGCGAGTTCC AGTTTT GT AATGATCCATTCCTGGGCGTGTACTATCACAAGAACAATAAGTCTTGGATGG
AGAGCGAGTTTCGCGTGTATTCCTCTGCCAACAATTGCACATTTGAGTACGTG
TCCCAGCCCTTCCTGATGGACCTGGAGGGCAAGCAGGGCAATTTCAAGAACC
TGAGGGAGTTCGTGTTTAAGAATATCGATGGCTACTTCAAAATCTACTCCAAG
CACACCCCAATCAACCTGGTGCGCGGCCTGCCACAGGGCTTCTCTGCCCTGGA
GCCACTGGTGGATCTGCCCATCGGCATCAACATCACCCGGTTTCAGACACTGC
TGGCCCTGCACAGAAGCTACCTGACACCAGGCGACAGCTCCTCTGGATGGAC
CGCAGGAGCAGCAGCCTACTATGTGGGCTATCTGCAGCCCAGGACCTTCCTG
CTGAAGTACAACGAGAATGGCACCATCACAGACGCCGTGGATTGCGCCCTGG
ATCCCCTGTCTGAGACCAAGTGTACACTGAAGAGCTTTACCGTGGAGAAGGG
CATCTATCAGACAAGCAATTTCAGGGTGCAGCCTACCGAGTCCATCGTGCGCT
TTCCCAATATCACAAACCTGTGCCCTTTTGGCGAGGTGTTCAACGCAACCCGC
TTCGCCAGCGTGTACGCCTGGAATAGGAAGCGCATCTCCAACTGCGTGGCCG
ACTATTCTGTGCTGTACAACAGCGCCTCCTTCTCTACCTTTAAGTGCTATGGC
GTGAGCCCCACAAAGCTGAATGACCTGTGCTTTACCAACGTGTACGCCGATTC
CTTCGTGATCAGGGGCGACGAGGTGCGCCAGATCGCACCAGGACAGACAGGC
AATATCGCAGACTACAATTATAAGCTGCCTGACGATTTCACCGGCTGCGTGAT
CGCCTGGAACTCTAACAATCTGGATAGCAAAGTGGGCGGCAACTACAATTAT
CTGTACCGGCTGTTTAGAAAGTCTAATCTGAAGCCATTCGAGAGGGACATCTC
CACAGAAATCTACCAGGCCGGCTCTACCCCCTGCAATGGCGTGAAGGGCTTT
AACTGTTATTTCCCTCTGCAGAGCTACGGCTTCCAGCCAACATATGGCGTGGG
CTATCAGCCCTACCGCGTGGTGGTGCTGTCTTTTGAGCTGCTGCACGCACCTG
C A AC AGT GT GC GGACC A A AGA AGAGC AC C A ATCTGGT GA AGA AC A AGT GC G
TGAACTTCAACTTCAACGGACTGACCGGAACAGGCGTGCTGACCGAGTCCAA
CAAGAAGTTCCTGCCTTTTCAGCAGTTCGGCAGGGACATCGCAGATACCACA
GACGCCGTGCGCGACCCTCAGACCCTGGAGATCCTGGACATCACACCATGCT
CCTTCGGCGGCGTGTCTGTGATCACACCAGGCACCAATACAAGCAACCAGGT
GGCCGT GCTGT AT C AGGGCGT GAATT GT ACCGAGGTGCC AGT GGC AATCC AC
GCAGATCAGCTGACCCCTACATGGCGGGTGTACTCTACCGGCAGCAACGTGT
TCCAGACAAGAGCCGGATGCCTGATCGGAGCAGAGCACGTGAACAATAGCTA
TGAGTGCGACATCCCTATCGGCGCCGGCATCTGTGCCTCCTACCAGACCCAGA
CAAACTCCCCAGAATCAAGCGTGATTCCTCTGGTCCATCCACTGGCAGATCCC
TCCACAGTGTTCAAAGACGGAGATGAGGCCGAAGACTTTGTGGAAGTCCACC
TGCCTGATGTGCATAACCAGGTGTCTGGCGTCGACCTGGGACTGCCAAATTG GGGCAAGTACGTGCTGCTGAGTGCTGGAGCACTGACTGCCCTGATGCTGATC
ATTTTCCTGATGACCTGCTGTCGGCGCGTGAACAGAAGTGAGCCCACTCAGC
AC AATCTGCGAGGAACCGGGAGAGAAGT GTC AGT C AC ACCTC AGAGCGGGA
AAAT C ATT AGT AGTTGGGAAT C AC AT AAAAGCGGGGGCGAGACC AGGCTGgg atccggctccggcgagggcaggggaagtctactaacatgcggggacgtggaggaaaatcccggccccATGGTTCCT
CAGGCTCTCCTGTTTGTACCCCTTCTGGTTTTTCCATTGTGTTTTGGGAAATTC
CCTATTTACACGATACCAGACAAGCTTGGTCCCTGGAGTCCGATTGACATACA
TCACCTCAGCTGCCCAAACAATTTGGTAGTGGAGGACGAAGGATGCACCAAC
CTGTCAGGGTTCTCCTACATGGAACTTAAAGTTGGATACATCTTAGCCATAAA
AGTGAACGGGTTCACTTGCACAGGCGTTGTGACGGAGGCTGAAACCTACACT
AACTTCGTTGGTTATGTCACAACCACGTTCAAAAGAAAGCATTTCCGCCCAAC
ACCAGATGCATGTAGAGCCGCGTACAACTGGAAGATGGCCGGTGACCCCAGA
TATGAAGAGTCTCTACACAATCCGTACCCTGACTACCGCTGGCTTCGAACTGT
AAAAACCACCAAGGAGTCTCTCGTTATCATATCTCCAAGTGTGGCAGATTTGG
ACCCATATGACAGATCCCTTCACTCGAGGGTCTTCCCTAGCGGGAAGTGCTCA
GGAGTAGCGGTGTCTTCTACCTACTGCTCCACTAACCACGATTACACCATTTG
GATGCCCGAGAATCCGAGACTAGGGATGTCTTGTGACATTTTTACCAATAGTA
GAGGGAAGAGAGC ATCC AAAGGGAGT GAGACTT GCGGCTTT GT AGATGAAA
G AGGC C T AT AT A AGT C T TT A A A AGG AGC AT GCA A AC T C A AGTT AT GT GG AGT
TCTAGGACTTAGACTTATGGATGGAACATGGGTCTCGATGCAAACATCAAAT
GAAACCAAATGGTGCCCTCCCGATAAGTTGGTGAACCTGCACGACTTTCGCTC
AGACGAAATTGAGCACCTTGTTGTAGAGGAGTTGGTCAGGAAGAGAGAGGA
GTGTCTGGATGCACTAGAGTCCATCATGACAACCAAGTCAGTGAGTTTCAGA
CGTCTCAGTCATTTAAGAAAACTTGTCCCTGGGTTTGGAAAAGCATATACCAT
ATTCAACAAGACCTTGATGGAAGCCGATGCTCACTACAAGTCAGTCgagACTT
GGAAT GAGATCCTCCCTT C AAAAGGGT GTTT A AGAGTT GGGGGGAGGTGT C A
TCCTC AT GTGAACGGGGT GTTTTT C AAT GGT AT AAT ATT AGGACCTGACGGC A
ATGTCTTAATCCCAGAGATGCAATCATCCCTCCTCCAGCAACATATGGAGTTG
TTGGAATCCTCGGTTATCCCCCTTGTGCACCCCCTGGCAGACCCGTCTACCGT
TTTCAAGGACGGTGACGAGGCTGAGGATTTTGTTGAAGTTCACCTTCCCGATG
TGCACAATCAGGTCTCAGGAGTTGACTTGGGTCTCCCGAACTGGGGGAAGTA
TGTATTACTGAGTGCAGGGGCCCTGACTGCCTTGATGTTGATAATTTTCCTGA
TGACATGTTGTAGAAGAGTCAATCGATCAGAACCTACGCAACACAATCTCAG
AGGGACAGGGAGGGAGGTGTCAGTCACTCCCCAAAGCGGGAAGATCATATCT T CAT GGGAATC AC AC AAGAGT GGGGGT GAGACC AGACTGT AAgctagcTT AT A A
AGTGCTGGGTCATCTAAGCTTTTCAGTCGAGAAAAAAACATTAGATCAGAAG
AACAACTGGCAACACTTCTCAACCTGAGACTTACTTCAAGATGCTCGATCCTG
GAGAGGTCTATGATGACCCTATTGACCCAATCGAGTTAGAGGCTGAACCCAG
AGGAACCCCCATTGTCCCCAACATCTTGAGGAACTCTGACTACAATCTCAACT
CTCCTTTGATAGAAGATCCTGCTAGACTAATGTTAGAATGGTTAAAAACAGG
GAATAGACCTTATCGGATGACTCTAACAGACAATTGCTCCAGGTCTTTCAGAG
TTTTGAAAGATTATTTCAAGAAGGTAGATTTGGGTTCTCTCAAGGTGGGCGGA
ATGGCTGCACAGTCAATGATTTCTCTCTGGTTATATGGTGCCCACTCTGAATC
CAACAGGAGCCGGAGATGTATAACAGACTTGGCCCATTTCTATTCCAAGTCG
TCCCCCATAGAGAAGCTGTTGAATCTCACGCTAGGAAATAGAGGGCTGAGAA
TCCCCCCAGAGGGAGTGTTAAGTTGCCTTGAGAGGGTTGATTATGATAATGC
ATTTGGAAGGTATCTTGCCAACACGTATTCCTCTTACTTGTTCTTCCATGTAAT
CACCTTATACATGAACGCCCTAGACTGGGATGAAGAAAAGACCATCCTAGCA
TTATGGAAAGATTTAACCTCAGTGGACATCGGGAAGGACTTGGTAAAGTTCA
AAGACCAAATATGGGGACTGCTGATCGTGACAAAGGACTTTGTTTACTCCCA
AAGTTCCAATTGTCTTTTTGACAGAAACTACACACTTATGCTAAAAGATCTTT
TCTTGTCTCGCTTCAACTCCTTAATGGTCTTGCTCTCTCCCCCAGAGCCCCGAT
ACTCAGATGACTTGATATCTCAACTATGCCAGCTGTACATTGCTGGGGATCAA
GTCTTGTCTATGTGTGGAAACTCCGGCTATGAAGTCATCAAAATATTGGAGCC
ATATGTCGTGAATAGTTTAGTCCAGAGAGCAGAAAAGTTTAGGCCTCTCATTC
ATTCCTTGGGAGACTTTCCTGTATTTATAAAAGACAAGGTAAGTCAACTTGAA
GAGACGTTCGGTCCCTGTGCAAGAAGGTTCTTTAGGGCTCTGGATCAATTCGA
CAACATACATGACTTGGTTTTTGTGTTTGGCTGTTACAGGCATTGGGGGCACC
CATATATAGATTATCGAAAGGGTCTGTCAAAACTATATGATCAGGTTCACCTT
A A A A A A AT GAT AG AT A AGTCC T AC C AGGAGT GC TT AGC A AGCGAC CT AGCC A
GGAGGATCCTTAGATGGGGTTTTGATAAGTACTCCAAGTGGTATCTGGATTCA
AGATTCCTAGCCCGAGACCACCCCTTGACTCCTTATATCAAAACCCAAACATG
GCCACCCAAACATATTGTAGACTTGGTGGGGGATACATGGCACAAGCTCCCG
ATCACGCAGATCTTTGAGATTCCTGAATCAATGGATCCGTCAGAAATATTGGA
TGACAAATCACATTCTTTCACCAGAACGAGACTAGCTTCTTGGCTGTCAGAAA
ACCGAGGGGGGCCTGTTCCTAGCGAAAAAGTTATTATCACGGCCCTGTCTAA
GCCGCCTGTCAATCCCCGAGAGTTTCTGAGGTCTATAGACCTCGGAGGATTGC
C AGAT GA AGAC TT GAT A ATT GGCC T C A AGCC A A AGGA AC GGGA ATTGA AGAT TGAAGGTCGATTCTTTGCTCTAATGTCATGGAATCTAAGATTGTATTTTGTCAT
CACTGAAAAACTCTTGGCCAACTACATCTTGCCACTTTTTGACGCGCTGACTA
T GAC AGAC AACCTGAAC AAGGT GTTT AAAAAGCTGATCGAC AGGGT C ACCGG
GCAAGGGCTTTTGGACTATTCAAGGGTCACATATGCATTTCACCTGGACTATG
AAAAGTGGAACAACCATCAAAGATTAGAGTCAACAGAGGATGTATTTTCTGT
CCTAGATCAAGTGTTTGGATTGAAGAGAGTGTTTTCTAGAACACACGAGTTTT
TTCAAAAGGCCTGGATCTATTATTCAGACAGATCAGACCTCATCGGGTTACGG
GAGGATCAAATATACTGCTTAGATGCGTCCAACGGCCCAACCTGTTGGAATG
GCC AGGAT GGCGGGCT AGAAGGCTT ACGGC AGAAGGGCTGGAGTCT AGT C A
GCTT ATT GAT GAT AG AT AGAGAATCTC AAATC AGGAAC AC AAGAACC AAAAT
ACTAGCTCAAGGAGACAACCAGGTTTTATGTCCGACATACATGTTGTCGCCA
GGGC T AT C T C A AG AGGGGC TCCTCTAT G A ATT GG AG AG A AT AT C A AGG A AT G
CACTTTCGATATACAGAGCCGTCGAGGAAGGGGCATCTAAGCTAGGGCTGAT
CAT C A AG A A AG A AG AG AC CAT GT GT AGTT AT GAC TTCCTC ATCT AT GGA A A A
ACCCCTTTGTTTAGAGGTAACATATTGGTGCCTGAGTCCAAAAGATGGGCCA
GAGTCTCTTGCGTCTCTAATGACCAAATAGTCAACCTCGCCAATATAATGTCG
ACAGTGTCCACCAATGCGCTAACAGTGGCACAACACTCTCAATCTTTGATCAA
ACCGATGAGGGATTTTCTGCTCATGTCAGTACAGGCAGTCTTTCACTACCTGC
TATTTAGCCCAATCTTAAAGGGAAGAGTTTACAAGATTCTGAGCGCTGAAGG
GGAGAGCTTTCTCCTAGCCATGTCAAGGATAATCTATCTAGATCCTTCTTTGG
GAGGGAT ATCTGGAATGTCCCTCGGAAGATTCC AT AT ACGAC AGTTCTC AGA
CCCTGTCTCTGAAGGGTTATCCTTCTGGAGAGAGATCTGGTTAAGCTCCCAAG
AGTCCTGGATTCACGCGTTGTGTCAAGAGGCTGGAAACCCAGATCTTGGAGA
GAGAACACTCGAGAGCTTCACTCGCCTTCTAGAAGATCCGACCACCTTAAAT
AT C AG AGG AGGGGC C AGTCC T AC C ATTCT ACTC A AGGAT GCA AT C AGA A AGG
CTTT AT ATGACGAGGT GG AC AAGGT GGAAAATTC AGAGTTTCGAGAGGC AAT
CCTGTTGTCCAAGACCCATAGAGATAATTTTATACTCTTCTTAATATCTGTTGA
GCCTCTGTTTCCTCGATTTCTCAGTGAGCTATTCAGTTCGTCTTTTTTGGGAAT
CCCCGAGTCAATCATTGGATTGATACAAAACTCCCGAACGATAAGAAGGCAG
TTT AGAAAGAGTCTCTC AAAAACTTT AGAAGAATCCTTCT AC AACTC AGAGAT
CC ACGGGATT AGTCGGATGACCC AGAC ACCTC AGAGGGTT GGGGGGGT GT GG
CCTTGCTCTTCAGAGAGGGCAGATCTACTTAGGGAGATCTCTTGGGGAAGAA
AAGTGGTAGGCACGACAGTTCCTCACCCTTCTGAGATGTTGGGATTACTTCCC
AAGTCCTCTATTTCTTGCACTTGTGGAGCAACAGGAGGAGGCAATCCTAGAG TTTCTGTATCAGTACTCCCGTCCTTTGATCAGTCATTTTTTTCACGAGGCCCCC
TAAAGGGATACTTGGGCTCGTCCACCTCTATGTCGACCCAGCTATTCCATGCA
T GGG A A A A AGT C AC T A AT GT TC AT GT GGT G A AG AG AGC TC T AT C GT T A A A AG
AATCTATAAACTGGTTCATTACTAGAGATTCCAACTTGGCTCAAGCTCTAATT
AGGAACATTATGTCTCTGACAGGCCCTGATTTCCCTCTAGAGGAGGCCCCTGT
CTTCAAAAGGACGGGGTCAGCCTTGCATAGGTTCAAGTCTGCCAGATACAGC
GAAGGAGGGTATTCTTCTGTCTGCCCGAACCTCCTCTCTCATATTTCTGTTAGT
ACAGACACCATGTCTGATTTGACCCAAGACGGGAAGAACTACGATTTCATGT
TCC AGCC ATTGAT GCTTT AT GC AC AG AC AT GGAC ATC AGAGCTGGT AC AG AG
AGACACAAGGCTAAGAGACTCTACGTTTCATTGGCACCTCCGATGCAACAGG
TGTGTGAGACCCATTGACGACGTGACCCTGGAGACCTCTCAGATCTTCGAGTT
TCCGGATGTGTCGAAAAGAATATCCAGAATGGTTTCTGGGGCTGTGCCTCACT
TCCAGAGGCTTCCCGATATCCGTCTGAGACCAGGAGATTTTGAATCTCTAAGC
GGTAGAGAAAAGTCTCACCATATCGGATCAGCTCAGGGGCTCTTATACTCAA
TCTTAGTGGCAATTCACGACTCAGGATACAATGATGGAACCATCTTCCCTGTC
AACATATACGGCAAGGTTTCCCCTAGAGACTATTTGAGAGGGCTCGCAAGGG
GAGT ATT GAT AGGATCCTCGATTT GCTTCTT GAC AAGAATGAC AAAT ATC AAT
ATTAATAGACCTCTTGAATTGGTCTCAGGGGTAATCTCATATATTCTCCTGAG
GCTAGATAACCATCCCTCCTTGTACATAATGCTCAGAGAACCGTCTCTTAGAG
GAGAGATATTTTCTATCCCTCAGAAAATCCCCGCCGCTTATCCAACCACTATG
AAAGAAGGCAACAGATCAATCTTGTGTTATCTCCAACATGTGCTACGCTATG
AGCGAGAGATAATCACGGCGTCTCCAGAGAATGACTGGCTATGGATCTTTTC
AGACTTTAGAAGTGCCAAAATGACGTACCTATCCCTCATTACTTACCAGTCTC
ATCTTCTACTCCAGAGGGTTGAGAGAAACCTATCTAAGAGTATGAGAGATAA
CCTGCGACAATTGAGTTCTTTGATGAGGCAGGTGCTGGGCGGGCACGGAGAA
GATACCTTAGAGTCAGACGACAACATTCAACGACTGCTAAAAGACTCTTTAC
GAAGGAC AAGAT GGGTGGATC AAGAGGT GCGCC AT GC AGCT AGAACC AT GA
CTGGAGATTACAGCCCCAACAAGAAGGTGTCCCGTAAGGTAGGATGTTCAGA
ATGGGTCTGCTCTGCTCAACAGGTTGCAGTCTCTACCTCAGCAAACCCGGCCC
CTGTCTCGGAGCTTGACATAAGGGCCCTCTCTAAGAGGTTCCAGAACCCTTTG
ATCTCGGGCTTGAGAGTGGTTC AGT GGGC AACCGGT GCTC ATT AT AAGCTT AA
GCCTATTCTAGATGATCTCAATGTTTTCCCATCTCTCTGCCTTGTAGTTGGGGA
CGGGTCAGGGGGGATATCAAGGGCAGTCCTCAACATGTTTCCAGATGCCAAG
CTTGTGTTCAACAGTCTTTTAGAGGTGAATGACCTGATGGCTTCCGGAACACA TCCACTGCCTCCTTCAGCAATCATGAGGGGAGGAAATGATATCGTCTCCAGA
GTGATAGATCTTGACTCAATCTGGGAAAAACCGTCCGACTTGAGAAACTTGG
CAACCTGGAAATACTTCCAGTCAGTCCAAAAGCAGGTCAACATGTCCTATGA
CCTCATTATTTGCGATGCAGAAGTTACTGACATTGCATCTATCAACCGGATCA
CCCTGTTAATGTCCGATTTTGCATTGTCTATAGATGGACCACTCTATTTGGTCT
T C A A A AC TT AT GGGAC T AT GCT AGT A A ATCC A A ACT AC A AGGC T ATTC A AC A
CCTGTCAAGAGCGTTCCCCTCGGTCACAGGGTTTATCACCCAAGTAACTTCGT
CTTTTTCATCTGAGCTCTACCTCCGATTCTCCAAACGAGGGAAGTTTTTCAGA
GATGCTGAGTACTTGACCTCTTCCACCCTTCGAGAAATGAGCCTTGTGTTATT
CAATTGTAGCAGCCCCAAGAGTGAGATGCAGAGAGCTCGTTCCTTGAACTAT
C AGGATCTT GTGAGAGGATTTCCTGAAGAAAT CAT AT C AAATCCTT AC AAT G
AGATGATCATAACTCTGATTGACAGTGATGTAGAATCTTTTCTAGTCCACAAG
AT GGTT GAT GAT C TT GAGTT AC AGAGGGGA AC TC T GTCT A A AGT GGCT AT CAT
TATAGCCATCATGATAGTTTTCTCCAACAGAGTCTTCAACGTTTCCAAACCCC
TAACTGACCCCTCGTTCTATCCACCGTCTGATCCCAAAATCCTGAGGCACTTC
AACATATGTTGCAGTACTATGATGTATCTATCTACTGCTTTAGGTGACGTCCC
TAGCTTCGCAAGACTTCACGACCTGTATAACAGACCTATAACTTATTACTTCA
GAAAGCAAGTCATTCGAGGGAACGTTTATCTATCTTGGAGTTGGTCCAACGA
CACCTCAGTGTTCAAAAGGGTAGCCTGTAATTCTAGCCTGAGTCTGTCATCTC
ACTGGAT C AGGTTGATTT AC AAGAT AGT GAAGACT ACC AGACTCGTT GGC AG
CATCAAGGATCTATCCAGAGAAGTGGAAAGACACCTTCATAGGTACAACAGG
TGGATCACCCTAGAGGATATCAGATCTAGATCATCCCTACTAGACTACAGTTG
CCTGTGAACCGGATACTCCTGGAAGCCTGCCCATGCTAAGACTCTTGTGTGAT
GTATCTTGAAAAAAACAAGATCCTAAATCTGAACCTTTGGTTGTTTGATTGTT
TTTCTCATTTTTGTTGTTTATTTGTTAAGCGT.
In one embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 16, shown below (RABV vector: Coravax V6 China):
ACGCTTAACAACCAGATCAAAGAAAAAACAGACATTGTCAATTGCAAAGCAA
AAATGTAACACCCCTACAATGGATGCCGACAAGATTGTATTCAAAGTCAATA
AT C AGGT GGT C TC TT T G A AGC C T GAG AT T AT C GT GG AT C A AT AT G AGT AC A AG
TACCCTGCCATCAAAGATTTGAAAAAGCCCTGTATAACCCTAGGAAAGGCTC
CCGATTTAAATAAAGCATACAAGTCAGTTTTGTCAGGCATGAGCGCCGCCAA
ACTTAATCCTGACGATGTATGTTCCTATTTGGCAGCGGCAATGCAGTTTTTTG
AGGGGACATGTCCGGAAGACTGGACCAGCTATGGAATTGTGATTGCACGAAA AGGAGATAAGATCACCCCAGGTTCTCTGGTGGAGATAAAACGTACTGATGTA
GAAGGGAATT GGGCTCTGAC AGGAGGC AT GGAACTGAC AAGAGACCCC ACT
GTCCCTGAGCATGCGTCCTTAGTCGGTCTTCTCTTGAGTCTGTATAGGTTGAG
CAAAATATCCGGGCAAAACACTGGTAACTATAAGACAAACATTGCAGACAGG
ATAGAGCAGATTTTTGAGACAGCCCCTTTTGTTAAAATCGTGGAACACCATAC
TCTAATGACAACTCACAAAATGTGTGCTAATTGGAGTACTATACCAAACTTCA
GATTTTTGGCCGGAACCTATGACATGTTTTTCTCCCGGATTGAGCATCTATATT
CAGCAATCAGAGTGGGCACAGTTGTCACTGCTTATGAAGACTGTTCAGGACT
GGTATCATTTACTGGGTTCATAAAACAAATCAATCTCACCGCTAGAGAGGCA
ATACTATATTTCTTCCACAAGAACTTTGAGGAAGAGATAAGAAGAATGTTTG
AGCCAGGGCAGGAGACAGCTGTTCCTCACTCTTATTTCATCCACTTCCGTTCA
CTAGGCTTGAGTGGGAAATCTCCTTATTCATCAAATGCTGTTGGTCACGTGTT
CAATCTCATTCACTTTGTAGGATGCTATATGGGTCAAGTCAGATCCCTAAATG
CAACGGTTATTGCTGCATGTGCTCCTCATGAAATGTCTGTTCTAGGGGGCTAT
CTGGGAGAGGAATTCTTCGGGAAAGGGAC ATTTGAAAGAAGATTCTTC AGAG
AT GAG A A AG A AC TT C A AG A AT AC G AGGC GGC T G A AC T G AC A A AG AC T G AC G
TAGCACTGGCAGATGATGGAACTGTCAACTCTGACGACGAGGACTACTTTTC
AGGT GAAACC AGAAGTCCGGAGGCTGTTT AT ACTCGAAT CAT GAT GAAT GGA
GGTCGACTAAAGAGATCTCACATACGGAGATATGTCTCAGTCAGTTCCAATC
ATCAAGCCCGTCCAAACTCATTCGCCGAGTTTCTAAACAAGACATATTCGAGT
GACTCATAAGAAGTTGAATAACAAAATGCCGGAAATCTACGGATTGTGTATA
TCCATCATGAAAAAAACTAACACCCCTCCTTTCGAACCATCCCAAACATGAG
CAAGATCTTTGTCAATCCTAGTGCTATTAGAGCCGGTCTGGCCGATCTTGAGA
T GGCTGAAGAAACTGTTGATCTGAT C AAT AGAAAT ATCGAAGAC AAT C AGGC
TCATCTCCAAGGGGAACCCATAGAGGTGGACAATCTCCCTGAGGATATGGGG
CGACTTCACCTGGATGATGGAAAATCGCCCAACCATGGTGAGATAGCCAAGG
T GGG AG A AGGC A AGT ATC G AG AGG AC T T T C AG AT GG AT G A AGG AG AGG AT C
CTAGCTTCCTGTTCCAGTCATACCTGGAAAATGTTGGAGTCCAAATAGTCAGA
CAAATGAGGTCAGGAGAGAGATTTCTCAAGATATGGTCACAGACCGTAGAAG
AGATTATATCCTATGTCGCGGTCAACTTTCCCAACCCTCCAGGAAAGTCTTCA
GAGGATAAATCAACCCAGACTACTGGCCGAGAGCTCAAGAAGGAGACAACA
CCCACTCCTTCTCAGAGAGAAAGCCAATCATCGAAAGCCAGGATGGCGGCTC
AAATTGCTTCTGGCCCTCCAGCCCTTGAATGGTCGGCTACCAATGAAGAGGAT
GATCTATCAGTGGAGGCTGAGATCGCTCACCAGATTGCAGAAAGTTTCTCCA AAAAATATAAGTTTCCCTCTCGATCCTCAGGGATACTCTTGTATAATTTTGAG
C AATTGAAAAT GAACCTTGATGAT AT AGTT AAAGAGGC AAAAAAT GT ACC AG
GTGTGACCCGTTTAGCCCATGACGGGTCCAAACTCCCCCTAAGATGTGTACTG
GGATGGGTCGCTTTGGCCAACTCTAAGAAATTCCAGTTGTTAGTCGAATCCGA
CAAGCTGAGTAAAATCATGCAAGATGACTTGAATCGCTATACATCTTGCTAA
CCGAACCTCTCCCCTCAGTCCCTCTAGACAATAAAATCCGAGATGTCCCAAAG
TCAACATGAAAAAAACAGGCAACACCACTGATAAAATGAACCTCCTACGTAA
GATAGTGAAAAACCGCAGGGACGAGGACACTCAAAAATCCTCTCCCGCGTCA
GCCCCTCTGGATGACGATGACTTGTGGCTTCCACCCCCTGAATACGTCCCGCT
GA A AGA ACTT AC AGGC A AG A AG A AC AT GAGGA AC TTTTGT AT C A AC GGA AG
GGTTAAAGTGTGTAGCCCGAATGGTTACTCGTTCAGGATCCTGCGGCACATTC
TGAAATCATTCGACGAGATATATTCTGGGAATCATAGGATGATCGGGTTAGTC
AAAGTGGTTATTGGACTGGCTTTGTCAGGATCTCCAGTCCCTGAGGGCCTGAA
CTGGGTATACAAATTGAGGAGAACCTTTATCTTCCAGTGGGCTGATTCCAGGG
GCCCTCTTGAAGGGGAGGAGTTGGAATACTCTCAGGAGATCACTTGGGATGA
T GAT AC T G AGTTCGTCGGATTGC A A AT A AGAGT GATT GC A A A AC AGT GT CAT
ATCC AGGGC AGAGTCTGGT GT AT C AAC AT GAACCCGAGAGC ATGT C AACT AT
GGTCTGACATGTCTCTTCAGACACAAAGGTCCGAAGAGGACAAAGATTCCTC
TCTGCTTCTAGAATAATCAGATTATATCCCGCAAATTTATCACTTGTTTACCTC
TGGAGGAGAGAACATATGGGCTCAACTCCAACCCTTGGGAGCAATATAACAA
AAAAC AT GTT ATGGT GCC ATT AAACCGCTGC ATTT CAT C AAAGTC AAGTT GAT
TACCTTTACATTTTGATCCTCTTGGATGTGAAAAAAACTATTAACATCCCTCA
AAAGACCccgggAAAGATGGTTCCTCAGGCTCTCCTGTTTGTACCCCTTCTGGTT
TTTCCATTGTGTTTTGGGAAATTCCCTATTTACACGATACCAGACAAGCTTGG
TCCCTGGAGTCCGATTGACATACATCACCTCAGCTGCCCAAACAATTTGGTAG
TGGAGGACGAAGGATGCACCAACCTGTCAGGGTTCTCCTACATGGAACTTAA
AGTTGGATACATCTTAGCCATAAAAGTGAACGGGTTCACTTGCACAGGCGTT
GTGACGGAGGCTGAAACCTACACTAACTTCGTTGGTTATGTCACAACCACGTT
CAAAAGAAAGCATTTCCGCCC AAC ACCAGATGC ATGT AGAGCCGCGTAC AAC
TGGAAGATGGCCGGTGACCCCAGATATGAAGAGTCTCTACACAATCCGTACC
CTGACTACCGCTGGCTTCGAACTGTAAAAACCACCAAGGAGTCTCTCGTTATC
ATATCTCCAAGTGTGGCAGATTTGGACCCATATGACAGATCCCTTCACTCGAG
GGTCTTCCCTAGCGGGAAGTGCTCAGGAGTAGCGGTGTCTTCTACCTACTGCT
CCACTAACCACGATTACACCATTTGGATGCCCGAGAATCCGAGACTAGGGAT GTCTTGTGACATTTTTACCAATAGTAGAGGGAAGAGAGCATCCAAAGGGAGT
GAGACTTGCGGCTTTGT AG AT GAAAGAGGCCT AT AT AAGTCTTT AAAAGGAG
CAT GC A A ACTC A AGTT AT GT GGAGTTC T AGGAC TT AG AC TT AT GGAT GGA AC
ATGGGTCTCGATGCAAACATCAAATGAAACCAAATGGTGCCCTCCCGATAAG
TTGGTGAACCTGCACGACTTTCGCTCAGACGAAATTGAGCACCTTGTTGTAGA
GGAGTTGGTCAGGAAGAGAGAGGAGTGTCTGGATGCACTAGAGTCCATCATG
AC A AC C A AGT C AGT GAGTTT C AGAC GTCTC AGT C ATTT A AGA A A AC TT GT C CC
T GGGTTTGGAAAAGC AT AT ACC AT ATTC AAC AAGACCTTGAT GGAAGCCGAT
GCTCACTACAAGTCAGTCgagACTTGGAATGAGATCCTCCCTTCAAAAGGGTG
TTTAAGAGTTGGGGGGAGGTGTCATCCTCATGTGAACGGGGTGTTTTTCAATG
GTATAATATTAGGACCTGACGGCAATGTCTTAATCCCAGAGATGCAATCATCC
CTCCTCCAGCAACATATGGAGTTGTTGGAATCCTCGGTTATCCCCCTTGTGCA
CCCCCTGGCAGACCCGTCTACCGTTTTCAAGGACGGTGACGAGGCTGAGGAT
TTTGTTGAAGTTCACCTTCCCGATGTGCACAATCAGGTCTCAGGAGTTGACTT
GGGTCTCCCGAACTGGGGGAAGT AT GT ATT ACTGAGTGC AGGGGCCCTGACT
GCCTT GATGTT GAT AATTTTCCTGAT GAC AT GTTGT AGAAGAGT C AATCGAT C
AGAACCTACGCAACACAATCTCAGAGGGACAGGGAGGGAGGTGTCAGTCAC
T C CC C A A AGC GGGA AGAT CAT ATCTTC AT GGGA AT C AC AC A AG AGT GGGGGT
GAG AC C AGAC T GT A AttaattaaC GT C CTTT C A AC GAT C C A AGTCcatgaaaaaaactaacac ccctcccgtacgaccATGTTCGTGTTTCTGGTGCTGCTGCCTCTGGTGAGCTCCCAGTG
CGTGAACCTGACCACAAGGACCCAGCTGCCCCCTGCCTATACCAATTCCTTCA
CACGGGGCGTGTACTATCCCGACAAGGTGTTCCGGAGCAGCGTGCTGCACTC
CACACAGGATCTGTTTCTGCCTTTCTTTTCTAACGTGACCTGGTTCCACGCCAT
CCACGTGAGCGGCACCAATGGCACAAAGCGGTTCGACAATCCAGTGCTGCCC
TTTAACGATGGCGTGTACTTCGCCTCCACCGAGAAGTCTAACATCATCAGAGG
CTGGATCTTTGGCACCACACTGGACAGCAAGACACAGTCCCTGCTGATCGTG
AACAATGCCACCAACGTGGTCATCAAGGTGTGCGAGTTCCAGTTTTGTAATG
ATCCATTCCTGGGCGTGTACTATCACAAGAACAATAAGTCTTGGATGGAGAG
CGAGTTTCGCGTGTATTCCTCTGCCAACAATTGCACATTTGAGTACGTGTCCC
AGCCCTTCCTGATGGACCTGGAGGGCAAGCAGGGCAATTTCAAGAACCTGAG
GGAGTTCGTGTTTAAGAATATCGATGGCTACTTCAAAATCTACTCCAAGCACA
CCCCAATCAACCTGGTGCGCGACCTGCCACAGGGCTTCTCTGCCCTGGAGCCA
CTGGTGGATCTGCCCATCGGCATCAACATCACCCGGTTTCAGACACTGCTGGC
CCTGCACAGAAGCTACCTGACACCAGGCGACAGCTCCTCTGGATGGACCGCA GGAGCAGCAGCCTACTATGTGGGCTATCTGCAGCCCAGGACCTTCCTGCTGA
AGTACAACGAGAATGGCACCATCACAGACGCCGTGGATTGCGCCCTGGATCC
CCTGTCTGAGACCAAGTGTACACTGAAGAGCTTTACCGTGGAGAAGGGCATC
TATCAGACAAGCAATTTCAGGGTGCAGCCTACCGAGTCCATCGTGCGCTTTCC
CAATATCACAAACCTGTGCCCTTTTGGCGAGGTGTTCAACGCAACCCGCTTCG
CCAGCGTGTACGCCTGGAATAGGAAGCGCATCTCCAACTGCGTGGCCGACTA
TTCTGTGCTGTACAACAGCGCCTCCTTCTCTACCTTTAAGTGCTATGGCGTGA
GCCCCACAAAGCTGAATGACCTGTGCTTTACCAACGTGTACGCCGATTCCTTC
GTGATCAGGGGCGACGAGGTGCGCCAGATCGCACCAGGACAGACAGGCAAG
ATCGCAGACTACAATTATAAGCTGCCTGACGATTTCACCGGCTGCGTGATCGC
CTGGAACTCTAACAATCTGGATAGCAAAGTGGGCGGCAACTACAATTATCTG
TACCGGCTGTTTAGAAAGTCTAATCTGAAGCCATTCGAGAGGGACATCTCCA
CAGAAATCTACCAGGCCGGCTCTACCCCCTGCAATGGCGTGGAgGGCTTTAAC
TGTTATTTCCCTCTGCAGAgCTACgGCTTCCAGCCAACAAACGGCGTGGGCTA
TCAGCCCTACCGCGTGGTGGTGCTGTCTTTTGAGCTGCTGCACGCACcTGCAA
C AGT GT GCGGACC AA AGAAGAGC ACC AATCTGGTGAAGAAC AAGT GCGT GA
ACTTCAACTTCAACGGACTGACCGGAACAGGCGTGCTGACCGAGTCCAACAA
GAAGTTCCTGCCTTTTCAGCAGTTCGGCAGGGACATCGCAGATACCACAGAC
GCCGTGCGCGACCCTCAGACCCTGGAGATCCTGGACATCACACCATGCTCCTT
CGGCGGCGTGTCTGTGATCACACCAGGCACCAATACAAGCAACCAGGTGGCC
GTGCTGTATCAGGACGTGAATTGTACCGAGGTGCCAGTGGCAATCCACGCAG
ATCAGCTGACCCCTACATGGCGGGTGTACTCTACCGGCAGCAACGTGTTCCA
GACAAGAGCCGGATGCCTGATCGGAGCAGAGCACGTGAACAATAGCTATGA
GTGCGACATCCCTATCGGCGCCGGCATCTGTGCCTCCTACCAGACCCAGACA
AACTCCCCAAGGTCTGTGGGAGATGAGGCCGAAGACTTTGTGGAAGTCCACC
TGCCTGATGTGCATAACCAGGTGTCTGGCGTCGACCTGGGACTGCCAAATTG
GGGCAAGTACGTGCTGCTGAGTGCTGGAGCACTGACTGCCCTGATGCTGATC
ATTTTCCTGATGACCTGCTGTCGGCGCGTGAACAGAAGTGAGCCCACTCAGC
AC AATCTGCGAGGAACCGGGAGAGAAGT GTC AGT C AC ACCTC AGAGCGGGA
AAAT C ATT AGT AGTTGGGAAT C AC AT AAAAGCGGGGGCGAGACC AGGCTGgg atccggctccggcgagggcaggggaagtctactaacatgcggggacgtggaggaaaatcccggccccATGCTCGAT
CCTGGAGAGGTCTATGATGACCCTATTGACCCAATCGAGTTAGAGGCTGAAC
CCAGAGGAACCCCCATTGTCCCCAACATCTTGAGGAACTCTGACTACAATCTC
AACTCTCCTTTGATAGAAGATCCTGCTAGACTAATGTTAGAATGGTTAAAAAC AGGGAATAGACCTTATCGGATGACTCTAACAGACAATTGCTCCAGGTCTTTCA
GAGTTTTGAAAGATT ATTT C AAGAAGGT AGATTTGGGTTCTCTC AAGGT GGGC
GGAATGGCTGCACAGTCAATGATTTCTCTCTGGTTATATGGTGCCCACTCTGA
ATCCAACAGGAGCCGGAGATGTATAACAGACTTGGCCCATTTCTATTCCAAG
TCGTCCCCCATAGAGAAGCTGTTGAATCTCACGCTAGGAAATAGAGGGCTGA
GAATCCCCCCAGAGGGAGTGTTAAGTTGCCTTGAGAGGGTTGATTATGATAA
TGCATTTGG AAGGT ATCTTGCCAACACGTATTCCTCTTACTTGTTCTTCCATGT
AATCACCTTATACATGAACGCCCTAGACTGGGATGAAGAAAAGACCATCCTA
GC ATT ATGGA AAGATTT AACCTC AGT GGAC ATCGGGAAGGACTT GGT AAAGT
T C AAAGACC AAAT AT GGGGACTGCTGATCGT GAC AAAGGACTTTGTTT ACTC
CCAAAGTTCCAATTGTCTTTTTGACAGAAACTACACACTTATGCTAAAAGATC
TTTTCTTGTCTCGCTTCAACTCCTTAATGGTCTTGCTCTCTCCCCCAGAGCCCC
GATACTCAGATGACTTGATATCTCAACTATGCCAGCTGTACATTGCTGGGGAT
CAAGTCTTGTCTATGTGTGGAAACTCCGGCTATGAAGTCATCAAAATATTGGA
GCC AT AT GTCGT GAAT AGTTT AGTCC AGAGAGC AGAAAAGTTT AGGCCTCTC
ATTCATTCCTTGGGAGACTTTCCTGTATTTATAAAAGACAAGGTAAGTCAACT
T GAAGAGACGTTCGGTCCCTGT GC AAGAAGGTTCTTT AGGGCTCTGGAT C AAT
TCGACAACATACATGACTTGGTTTTTGTGTTTGGCTGTTACAGGCATTGGGGG
C AC CC AT AT AT AG ATT AT C GA A AGGGTCTGT C A A A AC T AT AT GATC AGGTT C A
CCTTAAAAAAATGATAGATAAGTCCTACCAGGAGTGCTTAGCAAGCGACCTA
GCCAGGAGGATCCTTAGATGGGGTTTTGATAAGTACTCCAAGTGGTATCTGG
ATTCAAGATTCCTAGCCCGAGACCACCCCTTGACTCCTTATATCAAAACCCAA
ACATGGCCACCCAAACATATTGTAGACTTGGTGGGGGATACATGGCACAAGC
TCCCGATCACGCAGATCTTTGAGATTCCTGAATCAATGGATCCGTCAGAAATA
TTGGATGACAAATCACATTCTTTCACCAGAACGAGACTAGCTTCTTGGCTGTC
AGAAAACCGAGGGGGGCCTGTTCCTAGCGAAAAAGTTATTATCACGGCCCTG
TCTAAGCCGCCTGTCAATCCCCGAGAGTTTCTGAGGTCTATAGACCTCGGAGG
ATTGCCAGATGAAGACTTGATAATTGGCCTCAAGCCAAAGGAACGGGAATTG
AAGATTGAAGGTCGATTCTTTGCTCTAATGTCATGGAATCTAAGATTGTATTT
TGTCATCACTGAAAAACTCTTGGCCAACTACATCTTGCCACTTTTTGACGCGC
T GACT ATGAC AGAC AACCTGAAC AAGGTGTTT AAA AAGCTGATCGAC AGGGT
CACCGGGCAAGGGCTTTTGGACTATTCAAGGGTCACATATGCATTTCACCTGG
ACT AT GAAAAGT GGAAC AACC AT C AA AGATT AG AGT C AAC AGAGGATGT ATT
TTCTGTCCTAGATCAAGTGTTTGGATTGAAGAGAGTGTTTTCTAGAACACACG AGTTTTTTCAAAAGGCCTGGATCTATTATTCAGACAGATCAGACCTCATCGGG
TTACGGGAGGATCAAATATACTGCTTAGATGCGTCCAACGGCCCAACCTGTT
GGAATGGCCAGGATGGCGGGCTAGAAGGCTTACGGCAGAAGGGCTGGAGTC
T AGTC AGCTT ATTGATGAT AG AT AGAGAATCTC AAAT C AGGAAC AC AAGAAC
CAAAATACTAGCTCAAGGAGACAACCAGGTTTTATGTCCGACATACATGTTG
TCGCC AGGGCT ATCTC AAGAGGGGCTCCTCT AT GAATT GGAGAGAAT ATC AA
GGAATGCACTTTCGATATACAGAGCCGTCGAGGAAGGGGCATCTAAGCTAGG
GCTGAT CAT C AAGAAAGA AGAGACC AT GT GT AGTT AT GACTTCCTC ATCT ATG
GAAAAACCCCTTTGTTTAGAGGTAACATATTGGTGCCTGAGTCCAAAAGATG
GGCCAGAGTCTCTTGCGTCTCTAATGACCAAATAGTCAACCTCGCCAATATAA
TGTCGACAGTGTCCACCAATGCGCTAACAGTGGCACAACACTCTCAATCTTTG
ATCAAACCGATGAGGGATTTTCTGCTCATGTCAGTACAGGCAGTCTTTCACTA
CCTGCTATTTAGCCCAATCTTAAAGGGAAGAGTTTACAAGATTCTGAGCGCTG
AAGGGGAGAGCTTTCTCCTAGCCATGTCAAGGATAATCTATCTAGATCCTTCT
TTGGGAGGGATATCTGGAATGTCCCTCGGAAGATTCCATATACGACAGTTCTC
AGACCCTGTCTCTGAAGGGTTATCCTTCTGGAGAGAGATCTGGTTAAGCTCCC
AAGAGTCCTGGATTCACGCGTTGTGTCAAGAGGCTGGAAACCCAGATCTTGG
AGAGAGAACACTCGAGAGCTTCACTCGCCTTCTAGAAGATCCGACCACCTTA
A AT ATC AGAGGAGGGGC C AGTCC T AC C ATTCT AC T C A AGGAT GCA AT C AGA A
AGGCTTT AT AT GACGAGGT GGAC AAGGT GGAAAATTC AGAGTTTCGAGAGGC
AATCCTGTTGTCCAAGACCCATAGAGATAATTTTATACTCTTCTTAATATCTGT
TGAGCCTCTGTTTCCTCGATTTCTCAGTGAGCTATTCAGTTCGTCTTTTTTGGG
AATCCCCGAGTCAATCATTGGATTGATACAAAACTCCCGAACGATAAGAAGG
CAGTTTAGAAAGAGTCTCTCAAAAACTTTAGAAGAATCCTTCTACAACTCAG
AGATCCACGGGATTAGTCGGATGACCCAGACACCTCAGAGGGTTGGGGGGGT
GT GGCCTTGCTCTT C AGAGAGGGC AGATCT ACTT AGGGAGATCTCTT GGGGA
AGAAAAGTGGTAGGCACGACAGTTCCTCACCCTTCTGAGATGTTGGGATTAC
TTCCCAAGTCCTCTATTTCTTGCACTTGTGGAGCAACAGGAGGAGGCAATCCT
AGAGTTTCTGTATCAGTACTCCCGTCCTTTGATCAGTCATTTTTTTCACGAGGC
CCCCTAAAGGGATACTTGGGCTCGTCCACCTCTATGTCGACCCAGCTATTCCA
T GC AT GGG A A A A AGT C AC T A AT GTT CAT GT GGT G A AG AG AGC TC T AT C GT T A
AAAGAATCTATAAACTGGTTCATTACTAGAGATTCCAACTTGGCTCAAGCTCT
AATTAGGAACATTATGTCTCTGACAGGCCCTGATTTCCCTCTAGAGGAGGCCC
CTGTCTTCAAAAGGACGGGGTCAGCCTTGCATAGGTTCAAGTCTGCCAGATA CAGCGAAGGAGGGTATTCTTCTGTCTGCCCGAACCTCCTCTCTCATATTTCTG
TTAGTACAGACACCATGTCTGATTTGACCCAAGACGGGAAGAACTACGATTT
CATGTTCCAGCCATTGATGCTTTATGCACAGACATGGACATCAGAGCTGGTAC
AGAGAGACACAAGGCTAAGAGACTCTACGTTTCATTGGCACCTCCGATGCAA
CAGGTGTGTGAGACCCATTGACGACGTGACCCTGGAGACCTCTCAGATCTTC
GAGTTTCCGGATGTGTCGAAAAGAATATCCAGAATGGTTTCTGGGGCTGTGC
CTCACTTCCAGAGGCTTCCCGATATCCGTCTGAGACCAGGAGATTTTGAATCT
CTAAGCGGTAGAGAAAAGTCTCACCATATCGGATCAGCTCAGGGGCTCTTAT
ACTCAATCTTAGTGGCAATTCACGACTCAGGATACAATGATGGAACCATCTTC
CCTGTCAACATATACGGCAAGGTTTCCCCTAGAGACTATTTGAGAGGGCTCGC
AAGGGGAGTATTGATAGGATCCTCGATTTGCTTCTTGACAAGAATGACAAAT
ATCAATATTAATAGACCTCTTGAATTGGTCTCAGGGGTAATCTCATATATTCT
CCTGAGGCTAGATAACCATCCCTCCTTGTACATAATGCTCAGAGAACCGTCTC
TTAGAGGAGAGATATTTTCTATCCCTCAGAAAATCCCCGCCGCTTATCCAACC
ACTATGAAAGAAGGCAACAGATCAATCTTGTGTTATCTCCAACATGTGCTAC
GCTATGAGCGAGAGATAATCACGGCGTCTCCAGAGAATGACTGGCTATGGAT
CTTTTCAGACTTTAGAAGTGCCAAAATGACGTACCTATCCCTCATTACTTACC
AGTCTCATCTTCTACTCCAGAGGGTTGAGAGAAACCTATCTAAGAGTATGAG
AG AT AACCTGCGAC A ATT GAGTTCTTT GAT GAGGC AGGT GCTGGGCGGGC AC
GGAGAAGATACCTTAGAGTCAGACGACAACATTCAACGACTGCTAAAAGACT
CTTTACGAAGGACAAGATGGGTGGATCAAGAGGTGCGCCATGCAGCTAGAAC
CAT GACTGGAGATT AC AGCCCC A AC AAGAAGGT GTCCCGT AAGGT AGGATGT
TCAGAATGGGTCTGCTCTGCTCAACAGGTTGCAGTCTCTACCTCAGCAAACCC
GGCCCCTGTCTCGGAGCTTGACATAAGGGCCCTCTCTAAGAGGTTCCAGAAC
CCTTTGATCTCGGGCTTGAGAGTGGTTCAGTGGGCAACCGGTGCTCATTATAA
GCTTAAGCCTATTCTAGATGATCTCAATGTTTTCCCATCTCTCTGCCTTGTAGT
T GGGGACGGGT C AGGGGGGAT AT C AAGGGC AGTCCTC AAC ATGTTTCC AGAT
GCCAAGCTTGTGTTCAACAGTCTTTTAGAGGTGAATGACCTGATGGCTTCCGG
AACACATCCACTGCCTCCTTCAGCAATCATGAGGGGAGGAAATGATATCGTC
TCCAGAGTGATAGATCTTGACTCAATCTGGGAAAAACCGTCCGACTTGAGAA
ACTTGGCAACCTGGAAATACTTCCAGTCAGTCCAAAAGCAGGTCAACATGTC
CTATGACCTCATTATTTGCGATGCAGAAGTTACTGACATTGCATCTATCAACC
GGATCACCCTGTTAATGTCCGATTTTGCATTGTCTATAGATGGACCACTCTAT
TTGGTCTTCAAAACTTATGGGACTATGCTAGTAAATCCAAACTACAAGGCTAT TCAACACCTGTCAAGAGCGTTCCCCTCGGTCACAGGGTTTATCACCCAAGTAA
CTTCGTCTTTTTCATCTGAGCTCTACCTCCGATTCTCCAAACGAGGGAAGTTTT
TCAGAGATGCTGAGTACTTGACCTCTTCCACCCTTCGAGAAATGAGCCTTGTG
TTATTCAATTGTAGCAGCCCCAAGAGTGAGATGCAGAGAGCTCGTTCCTTGA
ACTATCAGGATCTTGTGAGAGGATTTCCTGAAGAAATCATATCAAATCCTTAC
AATGAGATGATCATAACTCTGATTGACAGTGATGTAGAATCTTTTCTAGTCCA
CAAGATGGTTGATGATCTTGAGTTACAGAGGGGAACTCTGTCTAAAGTGGCT
ATCATTATAGCCATCATGATAGTTTTCTCCAACAGAGTCTTCAACGTTTCCAA
ACCCCTAACTGACCCCTCGTTCTATCCACCGTCTGATCCCAAAATCCTGAGGC
ACTTCAACATATGTTGCAGTACTATGATGTATCTATCTACTGCTTTAGGTGAC
GTCCCTAGCTTCGCAAGACTTCACGACCTGTATAACAGACCTATAACTTATTA
CTTCAGAAAGCAAGTCATTCGAGGGAACGTTTATCTATCTTGGAGTTGGTCCA
ACGACACCTCAGTGTTCAAAAGGGTAGCCTGTAATTCTAGCCTGAGTCTGTCA
TCTCACTGGATCAGGTTGATTTACAAGATAGTGAAGACTACCAGACTCGTTGG
CAGCATCAAGGATCTATCCAGAGAAGTGGAAAGACACCTTCATAGGTACAAC
AGGTGGATCACCCTAGAGGATATCAGATCTAGATCATCCCTACTAGACTACA
GTTGCCTGTGAACCGGATACTCCTGGAAGCCTGCCCATGCTAAGACTCTTGTG
T GATGT ATCTT GAAAAAAAC AAGATCCT AAATCTGAACCTTTGGTTGTTTGAT
TGTTTTTCTCATTTTTGTTGTTTATTTGTTAAGCGT.
In one embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 17, shown below (RABV vector: Coravax V6 South Africa):
ACGCTTAACAACCAGATCAAAGAAAAAACAGACATTGTCAATTGCAAAGCAA
AAATGTAACACCCCTACAATGGATGCCGACAAGATTGTATTCAAAGTCAATA
AT C AGGT GGT C TC TT T G A AGC C T GAG AT T AT C GT GG AT C A AT AT G AGT AC A AG
TACCCTGCCATCAAAGATTTGAAAAAGCCCTGTATAACCCTAGGAAAGGCTC
CCGATTTAAATAAAGCATACAAGTCAGTTTTGTCAGGCATGAGCGCCGCCAA
ACTTAATCCTGACGATGTATGTTCCTATTTGGCAGCGGCAATGCAGTTTTTTG
AGGGGACATGTCCGGAAGACTGGACCAGCTATGGAATTGTGATTGCACGAAA
AGGAGATAAGATCACCCCAGGTTCTCTGGTGGAGATAAAACGTACTGATGTA
GAAGGGAATT GGGCTCTGAC AGGAGGC AT GGAACTGAC AAGAGACCCC ACT
GTCCCTGAGCATGCGTCCTTAGTCGGTCTTCTCTTGAGTCTGTATAGGTTGAG
CAAAATATCCGGGCAAAACACTGGTAACTATAAGACAAACATTGCAGACAGG
ATAGAGCAGATTTTTGAGACAGCCCCTTTTGTTAAAATCGTGGAACACCATAC
TCTAATGACAACTCACAAAATGTGTGCTAATTGGAGTACTATACCAAACTTCA GATTTTTGGCCGGAACCTATGACATGTTTTTCTCCCGGATTGAGCATCTATATT
CAGCAATCAGAGTGGGCACAGTTGTCACTGCTTATGAAGACTGTTCAGGACT
GGTATCATTTACTGGGTTCATAAAACAAATCAATCTCACCGCTAGAGAGGCA
ATACTATATTTCTTCCACAAGAACTTTGAGGAAGAGATAAGAAGAATGTTTG
AGCCAGGGCAGGAGACAGCTGTTCCTCACTCTTATTTCATCCACTTCCGTTCA
CTAGGCTTGAGTGGGAAATCTCCTTATTCATCAAATGCTGTTGGTCACGTGTT
CAATCTCATTCACTTTGTAGGATGCTATATGGGTCAAGTCAGATCCCTAAATG
CAACGGTTATTGCTGCATGTGCTCCTCATGAAATGTCTGTTCTAGGGGGCTAT
CTGGGAGAGGAATTCTTCGGGAAAGGGAC ATTTGAAAGAAGATTCTTC AGAG
AT GAG A A AG A AC TT C A AG A AT AC G AGGC GGC T G A AC T G AC A A AG AC T G AC G
TAGCACTGGCAGATGATGGAACTGTCAACTCTGACGACGAGGACTACTTTTC
AGGT GAAACC AGAAGTCCGGAGGCTGTTT AT ACTCGAAT CAT GAT GAAT GGA
GGTCGACTAAAGAGATCTCACATACGGAGATATGTCTCAGTCAGTTCCAATC
ATCAAGCCCGTCCAAACTCATTCGCCGAGTTTCTAAACAAGACATATTCGAGT
GACTCATAAGAAGTTGAATAACAAAATGCCGGAAATCTACGGATTGTGTATA
TCCATCATGAAAAAAACTAACACCCCTCCTTTCGAACCATCCCAAACATGAG
CAAGATCTTTGTCAATCCTAGTGCTATTAGAGCCGGTCTGGCCGATCTTGAGA
T GGCTGAAGAAACTGTTGATCTGAT C AAT AGAAAT ATCGAAGAC AAT C AGGC
TCATCTCCAAGGGGAACCCATAGAGGTGGACAATCTCCCTGAGGATATGGGG
CGACTTCACCTGGATGATGGAAAATCGCCCAACCATGGTGAGATAGCCAAGG
T GGG AG A AGGC A AGT ATC G AG AGG AC T T T C AG AT GG AT G A AGG AG AGG AT C
CTAGCTTCCTGTTCCAGTCATACCTGGAAAATGTTGGAGTCCAAATAGTCAGA
CAAATGAGGTCAGGAGAGAGATTTCTCAAGATATGGTCACAGACCGTAGAAG
AGATTATATCCTATGTCGCGGTCAACTTTCCCAACCCTCCAGGAAAGTCTTCA
GAGGATAAATCAACCCAGACTACTGGCCGAGAGCTCAAGAAGGAGACAACA
CCCACTCCTTCTCAGAGAGAAAGCCAATCATCGAAAGCCAGGATGGCGGCTC
AAATTGCTTCTGGCCCTCCAGCCCTTGAATGGTCGGCTACCAATGAAGAGGAT
GATCTATCAGTGGAGGCTGAGATCGCTCACCAGATTGCAGAAAGTTTCTCCA
AAAAATATAAGTTTCCCTCTCGATCCTCAGGGATACTCTTGTATAATTTTGAG
C AATTGAAAAT GAACCTTGATGAT AT AGTT AAAGAGGC AAAAAAT GT ACC AG
GTGTGACCCGTTTAGCCCATGACGGGTCCAAACTCCCCCTAAGATGTGTACTG
GGATGGGTCGCTTTGGCCAACTCTAAGAAATTCCAGTTGTTAGTCGAATCCGA
CAAGCTGAGTAAAATCATGCAAGATGACTTGAATCGCTATACATCTTGCTAA
CCGAACCTCTCCCCTCAGTCCCTCTAGACAATAAAATCCGAGATGTCCCAAAG TCAACATGAAAAAAACAGGCAACACCACTGATAAAATGAACCTCCTACGTAA
GATAGTGAAAAACCGCAGGGACGAGGACACTCAAAAATCCTCTCCCGCGTCA
GCCCCTCTGGATGACGATGACTTGTGGCTTCCACCCCCTGAATACGTCCCGCT
GA A AGA ACTT AC AGGC A AG A AG A AC AT GAGGA AC TTTTGT AT C A AC GGA AG
GGTTAAAGTGTGTAGCCCGAATGGTTACTCGTTCAGGATCCTGCGGCACATTC
TGAAATCATTCGACGAGATATATTCTGGGAATCATAGGATGATCGGGTTAGTC
AAAGTGGTTATTGGACTGGCTTTGTCAGGATCTCCAGTCCCTGAGGGCCTGAA
CTGGGTATACAAATTGAGGAGAACCTTTATCTTCCAGTGGGCTGATTCCAGGG
GCCCTCTTGAAGGGGAGGAGTTGGAATACTCTCAGGAGATCACTTGGGATGA
T GAT AC T G AGTTCGTCGGATTGC A A AT A AGAGT GATT GC A A A AC AGT GT CAT
ATCC AGGGC AGAGTCTGGT GT AT C AAC AT GAACCCGAGAGC ATGT C AACT AT
GGTCTGACATGTCTCTTCAGACACAAAGGTCCGAAGAGGACAAAGATTCCTC
TCTGCTTCTAGAATAATCAGATTATATCCCGCAAATTTATCACTTGTTTACCTC
TGGAGGAGAGAACATATGGGCTCAACTCCAACCCTTGGGAGCAATATAACAA
AAAAC AT GTT ATGGT GCC ATT AAACCGCTGC ATTT CAT C AAAGTC AAGTT GAT
TACCTTTACATTTTGATCCTCTTGGATGTGAAAAAAACTATTAACATCCCTCA
AAAGACCccgggAAAGATGGTTCCTCAGGCTCTCCTGTTTGTACCCCTTCTGGTT
TTTCCATTGTGTTTTGGGAAATTCCCTATTTACACGATACCAGACAAGCTTGG
TCCCTGGAGTCCGATTGACATACATCACCTCAGCTGCCCAAACAATTTGGTAG
TGGAGGACGAAGGATGCACCAACCTGTCAGGGTTCTCCTACATGGAACTTAA
AGTTGGATACATCTTAGCCATAAAAGTGAACGGGTTCACTTGCACAGGCGTT
GTGACGGAGGCTGAAACCTACACTAACTTCGTTGGTTATGTCACAACCACGTT
CAAAAGAAAGCATTTCCGCCC AAC ACCAGATGC ATGT AGAGCCGCGTAC AAC
TGGAAGATGGCCGGTGACCCCAGATATGAAGAGTCTCTACACAATCCGTACC
CTGACTACCGCTGGCTTCGAACTGTAAAAACCACCAAGGAGTCTCTCGTTATC
ATATCTCCAAGTGTGGCAGATTTGGACCCATATGACAGATCCCTTCACTCGAG
GGTCTTCCCTAGCGGGAAGTGCTCAGGAGTAGCGGTGTCTTCTACCTACTGCT
CCACTAACCACGATTACACCATTTGGATGCCCGAGAATCCGAGACTAGGGAT
GTCTTGTGACATTTTTACCAATAGTAGAGGGAAGAGAGCATCCAAAGGGAGT
GAGACTTGCGGCTTTGT AG AT GAAAGAGGCCT AT AT AAGTCTTT AAAAGGAG
CAT GC A A ACTC A AGTT AT GT GGAGTTC T AGGAC TT AG AC TT AT GGAT GGA AC
ATGGGTCTCGATGCAAACATCAAATGAAACCAAATGGTGCCCTCCCGATAAG
TTGGTGAACCTGCACGACTTTCGCTCAGACGAAATTGAGCACCTTGTTGTAGA
GGAGTTGGTCAGGAAGAGAGAGGAGTGTCTGGATGCACTAGAGTCCATCATG AC A AC C A AGT C AGT GAGTTT C AGAC GTCTC AGT C ATTT A AGA A A AC TT GT C CC
T GGGTTTGGAAAAGC AT AT ACC AT ATTC AAC AAGACCTTGAT GGAAGCCGAT
GCTCACTACAAGTCAGTCgagACTTGGAATGAGATCCTCCCTTCAAAAGGGTG
TTTAAGAGTTGGGGGGAGGTGTCATCCTCATGTGAACGGGGTGTTTTTCAATG
GTATAATATTAGGACCTGACGGCAATGTCTTAATCCCAGAGATGCAATCATCC
CTCCTCCAGCAACATATGGAGTTGTTGGAATCCTCGGTTATCCCCCTTGTGCA
CCCCCTGGCAGACCCGTCTACCGTTTTCAAGGACGGTGACGAGGCTGAGGAT
TTTGTTGAAGTTCACCTTCCCGATGTGCACAATCAGGTCTCAGGAGTTGACTT
GGGTCTCCCGAACTGGGGGAAGT AT GT ATT ACTGAGTGC AGGGGCCCTGACT
GCCTT GATGTT GAT AATTTTCCTGAT GAC AT GTTGT AGAAGAGT C AATCGAT C
AGAACCTACGCAACACAATCTCAGAGGGACAGGGAGGGAGGTGTCAGTCAC
T C CC C A A AGC GGGA AGAT CAT ATCTTC AT GGGA AT C AC AC A AG AGT GGGGGT
GAG AC C AGAC T GT A AttaattaaC GT C CTTT C A AC GAT C C A AGTCcatgaaaaaaactaacac ccctcccgtacgaccATGTTCGTGTTTCTGGTGCTGCTGCCTCTGGTGAGCTCCCAGTG
CGTGAACTTCACCACAAGGACCCAGCTGCCCCCTGCCTATACCAATTCCTTCA
CACGGGGCGTGTACTATCCCGACAAGGTGTTCCGGAGCAGCGTGCTGCACTC
CACACAGGATCTGTTTCTGCCTTTCTTTTCTAACGTGACCTGGTTCCACGCCAT
CCACGTGAGCGGCACCAATGGCACAAAGCGGTTCGCCAATCCAGTGCTGCCC
TTTAACGATGGCGTGTACTTCGCCTCCACCGAGAAGTCTAACATCATCAGAGG
CTGGATCTTTGGCACCACACTGGACAGCAAGACACAGTCCCTGCTGATCGTG
AACAATGCCACCAACGTGGTCATCAAGGTGTGCGAGTTCCAGTTTTGTAATG
ATCCATTCCTGGGCGTGTACTATCACAAGAACAATAAGTCTTGGATGGAGAG
CGAGTTTCGCGTGTATTCCTCTGCCAACAATTGCACATTTGAGTACGTGTCCC
AGCCCTTCCTGATGGACCTGGAGGGCAAGCAGGGCAATTTCAAGAACCTGAG
GGAGTTCGTGTTTAAGAATATCGATGGCTACTTCAAAATCTACTCCAAGCACA
CCCCAATCAACCTGGTGCGCGGCCTGCCACAGGGCTTCTCTGCCCTGGAGCCA
CTGGTGGATCTGCCCATCGGCATCAACATCACCCGGTTTCAGACACTGCTGGC
CCTGCACAGAAGCTACCTGACACCAGGCGACAGCTCCTCTGGATGGACCGCA
GGAGCAGCAGCCTACTATGTGGGCTATCTGCAGCCCAGGACCTTCCTGCTGA
AGTACAACGAGAATGGCACCATCACAGACGCCGTGGATTGCGCCCTGGATCC
CCTGTCTGAGACCAAGTGTACACTGAAGAGCTTTACCGTGGAGAAGGGCATC
TATCAGACAAGCAATTTCAGGGTGCAGCCTACCGAGTCCATCGTGCGCTTTCC
CAATATCACAAACCTGTGCCCTTTTGGCGAGGTGTTCAACGCAACCCGCTTCG
CCAGCGTGTACGCCTGGAATAGGAAGCGCATCTCCAACTGCGTGGCCGACTA TTCTGTGCTGTACAACAGCGCCTCCTTCTCTACCTTTAAGTGCTATGGCGTGA
GCCCCACAAAGCTGAATGACCTGTGCTTTACCAACGTGTACGCCGATTCCTTC
GTGATCAGGGGCGACGAGGTGCGCCAGATCGCACCAGGACAGACAGGCAAT
ATCGCAGACTACAATTATAAGCTGCCTGACGATTTCACCGGCTGCGTGATCGC
CTGGAACTCTAACAATCTGGATAGCAAAGTGGGCGGCAACTACAATTATCTG
TACCGGCTGTTTAGAAAGTCTAATCTGAAGCCATTCGAGAGGGACATCTCCA
CAGAAATCTACCAGGCCGGCTCTACCCCCTGCAATGGCGTGAAGGGCTTTAA
CTGTTATTTCCCTCTGCAGAGCTACGGCTTCCAGCCAACATATGGCGTGGGCT
ATCAGCCCTACCGCGTGGTGGTGCTGTCTTTTGAGCTGCTGCACGCACCTGCA
AC AGT GT GCGGAC C A A AGA AGAGC AC C A ATCTGGT GA AGA AC A AGT GC GT G
AACTTCAACTTCAACGGACTGACCGGAACAGGCGTGCTGACCGAGTCCAACA
AGAAGTTCCTGCCTTTTCAGCAGTTCGGCAGGGACATCGCAGATACCACAGA
CGCCGTGCGCGACCCTCAGACCCTGGAGATCCTGGACATCACACCATGCTCCT
TCGGCGGCGTGTCTGTGATCACACCAGGCACCAATACAAGCAACCAGGTGGC
CGTGCTGTATCAGGGCGTGAATTGTACCGAGGTGCCAGTGGCAATCCACGCA
GATCAGCTGACCCCTACATGGCGGGTGTACTCTACCGGCAGCAACGTGTTCC
AGACAAGAGCCGGATGCCTGATCGGAGCAGAGCACGTGAACAATAGCTATG
AGTGCGACATCCCTATCGGCGCCGGCATCTGTGCCTCCTACCAGACCCAGAC
AAACTCCCCAGAATCAAGCGTGATTCCTCTGGTCCATCCACTGGCAGATCCCT
CCACAGTGTTCAAAGACGGAGATGAGGCCGAAGACTTTGTGGAAGTCCACCT
GCCTGATGTGCATAACCAGGTGTCTGGCGTCGACCTGGGACTGCCAAATTGG
GGCAAGTACGTGCTGCTGAGTGCTGGAGCACTGACTGCCCTGATGCTGATCA
TTTTCCTGATGACCTGCTGTCGGCGCGTGAACAGAAGTGAGCCCACTCAGCAC
AATCTGCGAGGAACCGGGAGAGAAGT GT C AGT C AC ACCTC AGAGC GGGAAA
ATCATTAGTAGTTGGGAATCACATAAAAGCGGGGGCGAGACCAGGCTGggatcc ggctccggcgagggcaggggaagtctactaacatgcggggacgtggaggaaaatcccggcccc AT GC T C GAT C C
TGGAGAGGTCTATGATGACCCTATTGACCCAATCGAGTTAGAGGCTGAACCC
AGAGGAACCCCCATTGTCCCCAACATCTTGAGGAACTCTGACTACAATCTCA
ACTCTCCTTTGATAGAAGATCCTGCTAGACTAATGTTAGAATGGTTAAAAACA
GGGAATAGACCTTATCGGATGACTCTAACAGACAATTGCTCCAGGTCTTTCAG
AGTTTTGAAAGATTATTTCAAGAAGGTAGATTTGGGTTCTCTCAAGGTGGGCG
GAATGGCTGCACAGTCAATGATTTCTCTCTGGTTATATGGTGCCCACTCTGAA
TCCAACAGGAGCCGGAGATGTATAACAGACTTGGCCCATTTCTATTCCAAGTC
GTCCCCCATAGAGAAGCTGTTGAATCTCACGCTAGGAAATAGAGGGCTGAGA ATCCCCCCAGAGGGAGTGTTAAGTTGCCTTGAGAGGGTTGATTATGATAATG
CATTTGGAAGGTATCTTGCCAACACGTATTCCTCTTACTTGTTCTTCCATGTAA
TCACCTTATACATGAACGCCCTAGACTGGGATGAAGAAAAGACCATCCTAGC
ATTATGGAAAGATTTAACCTCAGTGGACATCGGGAAGGACTTGGTAAAGTTC
AAAGACCAAATATGGGGACTGCTGATCGTGACAAAGGACTTTGTTTACTCCC
AAAGTTCCAATTGTCTTTTTGACAGAAACTACACACTTATGCTAAAAGATCTT
TTCTTGTCTCGCTTCAACTCCTTAATGGTCTTGCTCTCTCCCCCAGAGCCCCGA
TACTCAGATGACTTGATATCTCAACTATGCCAGCTGTACATTGCTGGGGATCA
AGTCTTGTCTATGTGTGGAAACTCCGGCTATGAAGTCATCAAAATATTGGAGC
CATATGTCGTGAATAGTTTAGTCCAGAGAGCAGAAAAGTTTAGGCCTCTCATT
CATTCCTTGGGAGACTTTCCTGTATTTATAAAAGACAAGGTAAGTCAACTTGA
AGAGACGTTCGGTCCCTGTGCAAGAAGGTTCTTTAGGGCTCTGGATCAATTCG
ACAACATACATGACTTGGTTTTTGTGTTTGGCTGTTACAGGCATTGGGGGCAC
CC AT AT AT AG ATT AT C GA A AGGGTCTGT C A A A AC T AT AT GAT C AGGTT C AC CT
TAAAAAAATGATAGATAAGTCCTACCAGGAGTGCTTAGCAAGCGACCTAGCC
AGGAGGATCCTTAGATGGGGTTTTGATAAGTACTCCAAGTGGTATCTGGATTC
AAGATTCCTAGCCCGAGACCACCCCTTGACTCCTTATATCAAAACCCAAACAT
GGC C ACC C A A AC AT ATT GT AG AC TT GGT GGGGGAT AC AT GGC AC A AGC TC CC
GATCACGCAGATCTTTGAGATTCCTGAATCAATGGATCCGTCAGAAATATTGG
ATGACAAATCACATTCTTTCACCAGAACGAGACTAGCTTCTTGGCTGTCAGAA
AACCGAGGGGGGCCTGTTCCTAGCGAAAAAGTTATTATCACGGCCCTGTCTA
AGCCGCCTGTCAATCCCCGAGAGTTTCTGAGGTCTATAGACCTCGGAGGATTG
CC AGATGAAGACTT GAT AATT GGCCTC AAGCC AAAGGAACGGGAATTGAAGA
TTGAAGGTCGATTCTTTGCTCTAATGTCATGGAATCTAAGATTGTATTTTGTCA
TCACTGAAAAACTCTTGGCCAACTACATCTTGCCACTTTTTGACGCGCTGACT
AT GAC AGAC AACCTGAAC AAGGT GTTT AAAAAGCTGATCGAC AGGGT C ACCG
GGCAAGGGCTTTTGGACTATTCAAGGGTCACATATGCATTTCACCTGGACTAT
GAAAAGTGGAACAACCATCAAAGATTAGAGTCAACAGAGGATGTATTTTCTG
TCCTAGATCAAGTGTTTGGATTGAAGAGAGTGTTTTCTAGAACACACGAGTTT
TTT C AAAAGGCCTGGATCT ATT ATT C AGAC AG AT C AGACCTC ATCGGGTT ACG
GGAGGATCAAATATACTGCTTAGATGCGTCCAACGGCCCAACCTGTTGGAAT
GGCCAGGATGGCGGGCTAGAAGGCTTACGGCAGAAGGGCTGGAGTCTAGTC
AGCTTATTGATGATAGATAGAGAATCTCAAATCAGGAACACAAGAACCAAAA
TACTAGCTCAAGGAGACAACCAGGTTTTATGTCCGACATACATGTTGTCGCCA GGGC T AT C T C A AG AGGGGC TCCTCTAT G A ATT GG AG AG A AT AT C A AGG A AT G
CACTTTCGATATACAGAGCCGTCGAGGAAGGGGCATCTAAGCTAGGGCTGAT
CAT C A AG A A AG A AG AG AC CAT GT GT AGTT AT GAC TTCCTC ATCT AT GGA A A A
ACCCCTTTGTTTAGAGGTAACATATTGGTGCCTGAGTCCAAAAGATGGGCCA
GAGTCTCTTGCGTCTCTAATGACCAAATAGTCAACCTCGCCAATATAATGTCG
ACAGTGTCCACCAATGCGCTAACAGTGGCACAACACTCTCAATCTTTGATCAA
ACCGATGAGGGATTTTCTGCTCATGTCAGTACAGGCAGTCTTTCACTACCTGC
TATTTAGCCCAATCTTAAAGGGAAGAGTTTACAAGATTCTGAGCGCTGAAGG
GGAGAGCTTTCTCCTAGCCATGTCAAGGATAATCTATCTAGATCCTTCTTTGG
GAGGGAT ATCTGGAATGTCCCTCGGAAGATTCC AT AT ACGAC AGTTCTC AGA
CCCTGTCTCTGAAGGGTTATCCTTCTGGAGAGAGATCTGGTTAAGCTCCCAAG
AGTCCTGGATTCACGCGTTGTGTCAAGAGGCTGGAAACCCAGATCTTGGAGA
GAGAACACTCGAGAGCTTCACTCGCCTTCTAGAAGATCCGACCACCTTAAAT
AT C AG AGG AGGGGC C AGTCC T AC C ATTCT ACTC A AGGAT GCA AT C AGA A AGG
CTTT AT ATGACGAGGT GGAC AAGGT GGAAAATTC AGAGTTTCGAGAGGC AAT
CCTGTTGTCCAAGACCCATAGAGATAATTTTATACTCTTCTTAATATCTGTTGA
GCCTCTGTTTCCTCGATTTCTCAGTGAGCTATTCAGTTCGTCTTTTTTGGGAAT
CCCCGAGTCAATCATTGGATTGATACAAAACTCCCGAACGATAAGAAGGCAG
TTT AGAAAGAGTCTCTC AAAAACTTT AGAAGAATCCTTCT AC AACTC AGAGAT
CC ACGGGATT AGTCGGATGACCC AGAC ACCTC AGAGGGTT GGGGGGGT GT GG
CCTTGCTCTTCAGAGAGGGCAGATCTACTTAGGGAGATCTCTTGGGGAAGAA
AAGTGGTAGGCACGACAGTTCCTCACCCTTCTGAGATGTTGGGATTACTTCCC
AAGTCCTCTATTTCTTGCACTTGTGGAGCAACAGGAGGAGGCAATCCTAGAG
TTTCTGTATCAGTACTCCCGTCCTTTGATCAGTCATTTTTTTCACGAGGCCCCC
TAAAGGGATACTTGGGCTCGTCCACCTCTATGTCGACCCAGCTATTCCATGCA
T GGG A A A A AGT C AC T AAT GT TC AT GT GGT G A AG AG AGC TC T AT C GT T A A A AG
AATCTATAAACTGGTTCATTACTAGAGATTCCAACTTGGCTCAAGCTCTAATT
AGGAACATTATGTCTCTGACAGGCCCTGATTTCCCTCTAGAGGAGGCCCCTGT
CTTCAAAAGGACGGGGTCAGCCTTGCATAGGTTCAAGTCTGCCAGATACAGC
GAAGGAGGGTATTCTTCTGTCTGCCCGAACCTCCTCTCTCATATTTCTGTTAGT
ACAGACACCATGTCTGATTTGACCCAAGACGGGAAGAACTACGATTTCATGT
TCC AGCC ATTGAT GCTTT AT GC AC AGAC AT GGAC ATC AGAGCTGGT AC AG AG
AGACACAAGGCTAAGAGACTCTACGTTTCATTGGCACCTCCGATGCAACAGG
TGTGTGAGACCCATTGACGACGTGACCCTGGAGACCTCTCAGATCTTCGAGTT TCCGGATGTGTCGAAAAGAATATCCAGAATGGTTTCTGGGGCTGTGCCTCACT
TCCAGAGGCTTCCCGATATCCGTCTGAGACCAGGAGATTTTGAATCTCTAAGC
GGTAGAGAAAAGTCTCACCATATCGGATCAGCTCAGGGGCTCTTATACTCAA
TCTTAGTGGCAATTCACGACTCAGGATACAATGATGGAACCATCTTCCCTGTC
AACATATACGGCAAGGTTTCCCCTAGAGACTATTTGAGAGGGCTCGCAAGGG
GAGT ATT GAT AGGATCCTCGATTT GCTTCTT GAC AAGAATGAC AAAT ATC AAT
ATTAATAGACCTCTTGAATTGGTCTCAGGGGTAATCTCATATATTCTCCTGAG
GCTAGATAACCATCCCTCCTTGTACATAATGCTCAGAGAACCGTCTCTTAGAG
GAGAGATATTTTCTATCCCTCAGAAAATCCCCGCCGCTTATCCAACCACTATG
AAAGAAGGCAACAGATCAATCTTGTGTTATCTCCAACATGTGCTACGCTATG
AGCGAGAGATAATCACGGCGTCTCCAGAGAATGACTGGCTATGGATCTTTTC
AGACTTTAGAAGTGCCAAAATGACGTACCTATCCCTCATTACTTACCAGTCTC
ATCTTCTACTCCAGAGGGTTGAGAGAAACCTATCTAAGAGTATGAGAGATAA
CCTGCGACAATTGAGTTCTTTGATGAGGCAGGTGCTGGGCGGGCACGGAGAA
GATACCTTAGAGTCAGACGACAACATTCAACGACTGCTAAAAGACTCTTTAC
GAAGGAC AAGAT GGGTGGATC AAGAGGT GCGCC AT GC AGCT AGAACC AT GA
CTGGAGATTACAGCCCCAACAAGAAGGTGTCCCGTAAGGTAGGATGTTCAGA
ATGGGTCTGCTCTGCTCAACAGGTTGCAGTCTCTACCTCAGCAAACCCGGCCC
CTGTCTCGGAGCTTGACATAAGGGCCCTCTCTAAGAGGTTCCAGAACCCTTTG
ATCTCGGGCTTGAGAGTGGTTC AGT GGGC AACCGGT GCTC ATT AT AAGCTT AA
GCCTATTCTAGATGATCTCAATGTTTTCCCATCTCTCTGCCTTGTAGTTGGGGA
CGGGTCAGGGGGGATATCAAGGGCAGTCCTCAACATGTTTCCAGATGCCAAG
CTTGTGTTCAACAGTCTTTTAGAGGTGAATGACCTGATGGCTTCCGGAACACA
TCCACTGCCTCCTTCAGCAATCATGAGGGGAGGAAATGATATCGTCTCCAGA
GTGATAGATCTTGACTCAATCTGGGAAAAACCGTCCGACTTGAGAAACTTGG
CAACCTGGAAATACTTCCAGTCAGTCCAAAAGCAGGTCAACATGTCCTATGA
CCTCATTATTTGCGATGCAGAAGTTACTGACATTGCATCTATCAACCGGATCA
CCCTGTTAATGTCCGATTTTGCATTGTCTATAGATGGACCACTCTATTTGGTCT
T C A A A AC TT AT GGGAC T AT GCT AGT A A ATCC A A ACT AC A AGGC T ATTC A AC A
CCTGTCAAGAGCGTTCCCCTCGGTCACAGGGTTTATCACCCAAGTAACTTCGT
CTTTTTCATCTGAGCTCTACCTCCGATTCTCCAAACGAGGGAAGTTTTTCAGA
GATGCTGAGTACTTGACCTCTTCCACCCTTCGAGAAATGAGCCTTGTGTTATT
CAATTGTAGCAGCCCCAAGAGTGAGATGCAGAGAGCTCGTTCCTTGAACTAT
C AGGATCTT GTGAGAGGATTTCCTGAAGAAAT CAT AT C AAATCCTT AC AAT G AGATGATCATAACTCTGATTGACAGTGATGTAGAATCTTTTCTAGTCCACAAG
AT GGTT GAT GAT C TT GAGTT AC AGAGGGGA AC TC T GTCT A A AGT GGCT AT CAT
TATAGCCATCATGATAGTTTTCTCCAACAGAGTCTTCAACGTTTCCAAACCCC
TAACTGACCCCTCGTTCTATCCACCGTCTGATCCCAAAATCCTGAGGCACTTC
AACATATGTTGCAGTACTATGATGTATCTATCTACTGCTTTAGGTGACGTCCC
TAGCTTCGCAAGACTTCACGACCTGTATAACAGACCTATAACTTATTACTTCA
GAAAGCAAGTCATTCGAGGGAACGTTTATCTATCTTGGAGTTGGTCCAACGA
CACCTCAGTGTTCAAAAGGGTAGCCTGTAATTCTAGCCTGAGTCTGTCATCTC
ACTGGAT C AGGTTGATTT AC AAGAT AGT GAAGACT ACC AGACTCGTT GGC AG
CATCAAGGATCTATCCAGAGAAGTGGAAAGACACCTTCATAGGTACAACAGG
TGGATCACCCTAGAGGATATCAGATCTAGATCATCCCTACTAGACTACAGTTG
CCTGTGAACCGGATACTCCTGGAAGCCTGCCCATGCTAAGACTCTTGTGTGAT
GTATCTTGAAAAAAACAAGATCCTAAATCTGAACCTTTGGTTGTTTGATTGTT
TTTCTCATTTTTGTTGTTTATTTGTTAAGCGT.
In one embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 18, shown below (VSV vector: Convac VI China):
ACGAAGAC AAAC AAACC ATT ATT AT C ATT AAAAGGCTC AGGAGAAACTTT AA
C AGT AAT C AAA ATGTCTGTT AC AGTC AAGAGAAT C ATTGAC AAC AC AGTC AT
AGTTCCAAAACTTCCTGCAAATGAGGATCCAGTGGAATACCCGGCAGATTAC
TTCAGAAAATCAAAGGAGATTCCTCTTTACATCAATACTACAAAAAGTTTGTC
AGATCTAAGAGGATATGTCTACCAAGGCCTCAAATCCGGAAATGTATCAATC
AT AC AT GT C A AC AGC T AC TT GT AT GG AGC ATT A A AGG AC ATC C GGGGT A AGT
T GG AT A A AG AT T GGT C A AGTT T C GG A AT AAAC ATC GGG A A AGC AGGGG AT AC
AATCGGAATATTTGACCTTGTATCCTTGAAAGCCCTGGACGGCGTACTTCCAG
AT GGAGT ATCGGAT GCTTCC AGAACC AGCGC AGAT GAC AAAT GGTT GCCTTT
GT AT C T AC TT GGCTT AT AC AG AGT GGGC AG A AC AC A A AT GCC T GA AT AC AGA
A A A A AGC TC AT GGAT GGGC T GAC A A AT C A AT GCA A A AT GAT C A AT GA AC AGT
TTGAACCTCTTGTGCCAGAAGGTCGTGACATTTTTGATGTGTGGGGAAATGAC
AGTAATTACACAAAAATTGTCGCTGCAGTGGACATGTTCTTCCACATGTTCAA
AAAACATGAATGTGCCTCGTTCAGATACGGAACTATTGTTTCCAGATTCAAAG
ATTGTGCTGCATTGGCAACATTTGGACACCTCTGCAAAATAACCGGAATGTCT
ACAGAAGATGTAACGACCTGGATCTTGAACCGAGAAGTTGCAGATGAAATGG
TCCAAATGATGCTTCCAGGCCAAGAAATTGACAAGGCCGATTCATACATGCC
TTATTTGATCGACTTTGGATTGTCTTCTAAGTCTCCATATTCTTCCGTCAAAAA CCCTGCCTTCCACTTCTGGGGGCAATTGACAGCTCTTCTGCTCAGATCCACCA
GAGCAAGGAATGCCCGACAGCCTGATGACATTGAGTATACATCTCTTACTAC
AGCAGGTTTGTTGTACGCTTATGCAGTAGGATCCTCTGCCGACTTGGCACAAC
AGTTTTGTGTTGGAGATAACAAATACACTCCAGATGATAGTACCGGAGGATT
GACGACTAATGCACCGCCACAAGGCAGAGATGTGGTCGAATGGCTCGGATGG
T TT G A AG AT C A A A AC AG A A A AC C G AC TC C T GAT AT GAT GC AGT AT GC G A A A A
GAGCAGTCATGTCACTGCAAGGCCTAAGAGAGAAGACAATTGGCAAGTATGC
TAAGTCAGAATTTGACAAATGACCCTATAATTCTCAGATCACCTATTATATAT
TATGCTACATATGAAAAAAACTAACAGATATCATGGATAATCTCACAAAAGT
TCGTGAGTATCTCAAGTCCTATTCTCGTCTGGATCAGGCGGTAGGAGAGATAG
ATGAGATCGAAGCACAACGAGCTGAAAAGTCCAATTATGAGTTGTTCCAAGA
GGATGGAGTGGAAGAGCATACTAAGCCCTCTTATTTTCAGGCAGCAGATGAT
TCTGAC AC AGA AT C T GA AC C AG A A ATT GA AG AC A AT C A AGGTTT GT AT GC AC
CAGATCCAGAAGCTGAGCAAGTTGAAGGCTTTATACAGGGGCCTTTAGATGA
CT AT GC AGAT GAGGAAGT GGAT GTT GT ATTT ACTTCGGACTGGAAAC AGCCT
GAGCTTGAATCTGACGAGCATGGAAAGACCTTACGGTTGACATCGCCAGAGG
GTTTAAGTGGAGAGCAGAAATCCCAGTGGCTTTCGACGATTAAAGCAGTCGT
GC AAAGTGCC AAAT ACTGGAATCTGGC AGAGT GC AC ATTTGAAGC ATCGGGA
G A AGGGGT C AT T AT G A AGG AGC GC C AG AT A AC T C C GGAT GT AT AT A AGGT C A
CTCCAGTGATGAACACACATCCGTCCCAATCAGAAGCAGTATCAGATGTTTG
GTCTCTCTCAAAGACATCCATGACTTTCCAACCCAAGAAAGCAAGTCTTCAGC
CTCTCACCATATCCTTGGATGAATTGTTCTCATCTAGAGGAGAGTTCATCTCT
GTCGGAGGTGACGGACGAATGTCTCATAAAGAGGCCATCCTGCTCGGCCTGA
GATACAAAAAGTTGTACAATCAGGCGAGAGTCAAATATTCTCTGTAGACTAT
GAAAAAAAGTAACAGATATCACGATCTAAGTGTTATCCCAATCCATTCATCA
T G AGTT C C TT A A AG A AG AT TC TC GGT C T G A AGGGG A A AGGT A AG A A AT C T A A
GAAATTAGGGATCGCACCACCCCCTTATGAAGAGGACACTAGCATGGAGTAT
GCTCCGAGCGCTCCAATTGACAAATCCTATTTTGGAGTTGACGAGATGGACA
CCTATGATCCGAATCAATTAAGATATGAGAAATTCTTCTTTACAGTGAAAATG
ACGGTTAGATCTAATCGTCCGTTCAGAACATACTCAGATGTGGCAGCCGCTGT
ATCCCATTGGGATCACATGTACATCGGAATGGCAGGGAAACGTCCCTTCTAC
AAAATCTTGGCTTTTTTGGGTTCTTCTAATCTAAAGGCCACTCCAGCGGTATT
GGCAGATCAAGGTCAACCAGAGTATCACACTCACTGCGAAGGCAGGGCTTAT
TTGCCACATAGGATGGGGAAGACCCCTCCCATGCTCAATGTACCAGAGCACT T C AGAAGACC ATTC AAT AT AGGTCTTT AC AAGGGAACGATTGAGCTC AC A AT
GACCATCTACGATGATGAGTCACTGGAAGCAGCTCCTATGATCTGGGATCATT
TCAATTCTTCCAAATTTTCTGATTTCAGAGAGAAGGCCTTAATGTTTGGCCTG
ATTGTCGAGAAAAAGGCATCTGGAGCGTGGGTCCTGGATTCTATCAGCCACT
TCAAATGAGCTAGTCTAACTTCTAGCTTCTGAACAATCCCCGGTTTACTCAGT
CTCTCCTAATTCCAGCCTCTCGAACAACTAATATCCTGTCTTTTCTATCCCTAT
GAAAAAAACTAACAGAGATCGATCTGTTTACGCGTCACTATGAAGTGCCTTTT
GTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCC
ACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGC
CCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCATAC
A AGT C A A A AT GCC C A AGAGTC AC A AGGC T ATT C A AGC AGACGGTT GGAT GT G
TCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGT
ATATAACACAGTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGA
AAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCT
C AAAGTT GTGGAT AT GC AACTGT GACGGAT GCCGAAGC AGT GATTGTCC AGG
TGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCA
CAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTC
TACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCA
TTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGA
AAGGAGGGC AC AGGGTT C AGAAGT AACT ACTTTGCTT AT GAAACTGGAGGC A
AGGCCTGC AAAAT GC AAT ACTGC AAGC ATT GGGGAGTC AGACTCCC ATC AGG
TGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTG
AATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTA
AGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAAC
CTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATC
TTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCT
C T C A AG A AT GGT C GG A AT GAT C AGT GG A AC T AC C AC AG A A AGGG A AC TGT GG
GAT GACTGGGC ACC AT AT GAAGACGT GGAAATTGGACCC AAT GGAGTTCTGA
GGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTG
GACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACAT
TCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATA
CTGGGCT ATCC AAAAATCC AATCGAGCTTGT AGAAGGTT GGTTC AGT AGTT G
GAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATT CTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGA
AAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAA
ATCCTGCTAGGTATGAAAAAAACTAACaGATATCACGCTCGAGCGTACGCCA
CCATGTTCGTGTTTCTGGTGCTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAAC
CTGACCACAAGGACCCAGCTGCCCCCTGCCTATACCAATTCCTTCACACGGGG
CGTGTACTATCCCGACAAGGTGTTCCGGAGCAGCGTGCTGCACTCCACACAG
GATCTGTTTCTGCCTTTCTTTTCTAACGTGACCTGGTTCCACGCCATCCACGTG
AGCGGCACCAATGGCACAAAGCGGTTCGACAATCCAGTGCTGCCCTTTAACG
ATGGCGTGTACTTCGCCTCCACCGAGAAGTCTAACATCATCAGAGGCTGGAT
CTTTGGCACCACACTGGACAGCAAGACACAGTCCCTGCTGATCGTGAACAAT
GCCACCAACGTGGTCATCAAGGTGTGCGAGTTCCAGTTTTGTAATGATCCATT
CC T GGGC GT GT AC T AT C AC A AG A AC A AT A AGT C TT GGAT GGAGAGC GAGTTT
CGCGTGTATTCCTCTGCCAACAATTGCACATTTGAGTACGTGTCCCAGCCCTT
CCTGAT GGACCTGGAGGGC AAGC AGGGC AATTT C AAGA ACCTGAGGGAGTT C
GTGTTTAAGAATATCGATGGCTACTTCAAAATCTACTCCAAGCACACCCCAAT
CAACCTGGTGCGCGACCTGCCACAGGGCTTCTCTGCCCTGGAGCCACTGGTG
GATCTGCCCATCGGCATCAACATCACCCGGTTTCAGACACTGCTGGCCCTGCA
CAGAAGCTACCTGACACCAGGCGACAGCTCCTCTGGATGGACCGCAGGAGCA
GCAGCCTACTATGTGGGCTATCTGCAGCCCAGGACCTTCCTGCTGAAGTACAA
CGAGAATGGCACCATCACAGACGCCGTGGATTGCGCCCTGGATCCCCTGTCT
GAGACCAAGTGTACACTGAAGAGCTTTACCGTGGAGAAGGGCATCTATCAGA
CAAGCAATTTCAGGGTGCAGCCTACCGAGTCCATCGTGCGCTTTCCCAATATC
ACAAACCTGTGCCCTTTTGGCGAGGTGTTCAACGCAACCCGCTTCGCCAGCGT
GTACGCCTGGAATAGGAAGCGCATCTCCAACTGCGTGGCCGACTATTCTGTG
CTGTACAACAGCGCCTCCTTCTCTACCTTTAAGTGCTATGGCGTGAGCCCCAC
AAAGCTGAATGACCTGTGCTTTACCAACGTGTACGCCGATTCCTTCGTGATCA
GGGGCGACGAGGTGCGCCAGATCGCACCAGGACAGACAGGCAAGATCGCAG
ACTACAATTATAAGCTGCCTGACGATTTCACCGGCTGCGTGATCGCCTGGAAC
TC T A AC A AT C T GGAT AGC A A AGT GGGC GGC A AC T AC A AT T AT C T GT AC C GGC
TGTTTAGAAAGTCTAATCTGAAGCCATTCGAGAGGGACATCTCCACAGAAAT
CTACCAGGCCGGCTCTACCCCCTGCAATGGCGTGGAGGGCTTTAACTGTTATT
TCCCTCTGCAGAGCTACGGCTTCCAGCCAACAAACGGCGTGGGCTATCAGCC
CTACCGCGTGGTGGTGCTGTCTTTTGAGCTGCTGCACGCACCTGCAACAGTGT
GCGGACC A AAGAAGAGC ACC AATCTGGT GAAGAAC AAGT GCGT GAACTTC A ACTTC AACGGACTGACCGGAAC AGGCGT GCTGACCGAGTCC A AC AAGAAGTT
CCTGCCTTTTCAGCAGTTCGGCAGGGACATCGCAGATACCACAGACGCCGTG
CGCGACCCTCAGACCCTGGAGATCCTGGACATCACACCATGCTCCTTCGGCG
GCGTGTCTGTGATCACACCAGGCACCAATACAAGCAACCAGGTGGCCGTGCT
GT ATC AGGACGT GAATTGT ACCGAGGT GCC AGT GGC AATCC ACGC AGAT C AG
CTGACCCCTACATGGCGGGTGTACTCTACCGGCAGCAACGTGTTCCAGACAA
GAGCCGGATGCCTGATCGGAGCAGAGCACGTGAACAATAGCTATGAGTGCGA
CATCCCTATCGGCGCCGGCATCTGTGCCTCCTACCAGACCCAGACAAACTCCC
CAAGGTCTGTGGGCGATACAGGCCTGTCCAAGAATCCAATCGAGCTGGTAGA
GGGCTGGTTCAGCAGTTGGAAAAGCTCCATCGCCTCCTTTTTCTTTATCATCG
GCCTGATCATCGGACTGTTCCTGGTGCTCCGCGTGGGTATCCACCTGTGCATC
A AGC T GA AGC AC AC C A AGA A A AGAC AGATTT AT AC AGAC ATCGAGAT GA AC
CGCCTGGGAAAGTGAGCTAGCCAGATTCTTCATGTTTGGACCAAATCAACTTG
TGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGA
AAAAAACTAACAGCAATCATGGAAGTCCACGATTTTGAGACCGACGAGTTCA
ATGATTTCAATGAAGATGACTATGCCACAAGAGAATTCCTGAATCCCGATGA
GCGCATGACGTACTTGAATCATGCTGATTACAATTTGAATTCTCCTCTAATTA
GTGATGATATTGACAATTTGATCAGGAAATTCAATTCTCTTCCGATTCCCTCG
ATGTGGGATAGTAAGAACTGGGATGGAGTTCTTGAGATGTTAACATCATGTC
A AGC C A AT C CC ATCTC A AC AT C TC AGAT GC AT A A AT GGAT GGGA AGTT GGTT
A AT GT C T GAT A AT CAT GAT GC C AGT C A AGGGT AT AGTTTTTT AC AT GA AGT GG
AC AA AGAGGC AGAAAT AAC ATTT GACGT GGT GGAGACCTT C ATCCGCGGCTG
GGGCAACAAACCAATTGAATACATCAAAAAGGAAAGATGGACTGACTCATTC
AAAATTCTCGCTTATTTGTGTCAAAAGTTTTTGGACTTACACAAGTTGACATT
AATCTTAAATGCTGTCTCTGAGGTGGAATTGCTCAACTTGGCGAGGACTTTCA
AAGGCAAAGTCAGAAGAAGTTCTCATGGAACGAACATATGCAGGATTAGGGT
TCCCAGCTTGGGTCCTACTTTTATTTCAGAAGGATGGGCTTACTTCAAGAAAC
TTGATATTCTAATGGACCGAAACTTTCTGTTAATGGTCAAAGATGTGATTATA
GGGAGGATGCAAACGGTGCTATCCATGGTATGTAGAATAGACAACCTGTTCT
CAGAGCAAGACATCTTCTCCCTTCTAAATATCTACAGAATTGGAGATAAAATT
GTGGAGAGGCAGGGAAATTTTTCTTATGACTTGATTAAAATGGTGGAACCGA
TATGCAACTTGAAGCTGATGAAATTAGCAAGAGAATCAAGGCCTTTAGTCCC
ACAATTCCCTCATTTTGAAAATCATATCAAGACTTCTGTTGATGAAGGGGCAA
AAATTGACCGAGGT AT AAGATTCCTCC AT GAT C AGAT AATGAGT GT GAAAAC AGTGGATCTCACACTGGTGATTTATGGATCGTTCAGACATTGGGGTCATCCTT
TTATAGATTATTACACTGGACTAGAAAAATTACATTCCCAAGTAACCATGAA
GAAAGATATTGATGTGTCATATGCAAAAGCACTTGCAAGTGATTTAGCTCGG
ATTGTTCTATTTCAACAGTTCAATGATCATAAAAAGTGGTTCGTGAATGGAGA
CTTGCTCCCTCATGATCATCCCTTTAAAAGTCATGTTAAAGAAAATACATGGC
CCACAGCTGCTCAAGTTCAAGATTTTGGAGATAAATGGCATGAACTTCCGCTG
ATTAAATGTTTTGAAATACCCGACTTACTAGACCCATCGATAATATACTCTGA
C A A A AGTC ATT C A AT GA AT AGGT C AGAGGT GTTGA A AC AT GTCCGA AT GA AT
CCGAACACTCCTATCCCTAGTAAAAAGGTGTTGCAGACTATGTTGGACACAA
AGGCTACCAATTGGAAAGAATTTCTTAAAGAGATTGATGAGAAGGGCTTAGA
TGATGAT GATCT AATT ATT GGTCTT AAAGGAAAGGAGAGGGAACTGAAGTTG
GCAGGTAGATTTTTCTCCCTAATGTCTTGGAAATTGCGAGAATACTTTGTAAT
TACCGAATATTTGATAAAGACTCATTTCGTCCCTATGTTTAAAGGCCTGACAA
TGGCGGACGATCTAACTGCAGTCATTAAAAAGATGTTAGATTCCTCATCCGGC
C AAGGATT GAAGT CAT ATGAGGC AATTT GC AT AGCC AAT C AC ATT GATT ACG
AAAAATGGAATAACCACCAAAGGAAGTTATCAAACGGCCCAGTGTTCCGAGT
TATGGGCCAGTTCTTAGGTTATCCATCCTTAATCGAGAGAACTCATGAATTTT
TT GAGAAAAGTCTT AT AT ACT AC AAT GGAAGACC AGACTTGAT GCGT GTT C A
CAACAACACACTGATCAATTCAACCTCCCAACGAGTTTGTTGGCAAGGACAA
G AGGGT GG AC T GG A AGGT C T AC GGC A A A A AGG AT GG AC T ATC C T C A AT C T AC
TGGTTATTCAAAGAGAGGCTAAAATCAGAAACACTGCTGTCAAAGTCTTGGC
ACAAGGTGATAATCAAGTTATTTGCACACAGTATAAAACGAAGAAATCGAGA
AACGTT GT AG AATT AC AGGGT GCTCTC AAT C AAAT GGTTTCT AAT AATGAGAA
AATT AT GACTGC AATC AA AAT AGGGAC AGGGAAGTT AGGACTTTT GAT AAAT
GACGATGAGACT AT GC AATCTGC AGATT ACTTGAATT AT GGAAAAAT ACCGA
TTTTCCGTGGAGTGATTAGAGGGTTAGAGACCAAGAGATGGTCACGAGTGAC
TTGTGTCACCAATGACCAAATACCCACTTGTGCTAATATAATGAGCTCAGTTT
CCACAAATGCTCTCACCGTAGCTCATTTTGCTGAGAACCCAATCAATGCCATG
ATACAGTACAATTATTTTGGGACATTTGCTAGACTCTTGTTGATGATGCATGA
TCCTGCTCTTCGTCAATCATTGTATGAAGTTCAAGATAAGATACCGGGCTTGC
ACAGTTCTACTTTCAAATACGCCATGTTGTATTTGGACCCTTCCATTGGAGGA
GTGTCGGGCATGTCTTTGTCCAGGTTTTTGATTAGAGCCTTCCCAGATCCCGT
AACAGAAAGTCTCTCATTCTGGAGATTCATCCATGTACATGCTCGAAGTGAGC
ATCTGAAGGAGAT GAGT GC AGT ATTTGGAAACCCCGAGAT AGCC AAGTTTCG AATAACTCACATAGACAAGCTAGTAGAAGATCCAACCTCTCTGAACATCGCT
ATGGGAATGAGTCCAGCGAACTTGTTAAAGACTGAGGTTAAAAAATGCTTAA
TCGAATCAAGACAAACCATCAGGAACCAGGTGATTAAGGATGCAACCATATA
TTTGTATCATGAAGAGGATCGGCTCAGAAGTTTCTTATGGTCAATAAATCCTC
TGTTCCCTAGATTTTTAAGTGAATTCAAATCAGGCACTTTTTTGGGAGTCGCA
GACGGGCTCATCAGTCTATTTCAAAATTCTCGTACTATTCGGAACTCCTTTAA
G A A A A AGT ATC AT AGGG A ATT GG AT GAT T T GAT TGT G AGG AGT G AGGT ATC C
TCTTTGAC AC ATTT AGGGAAACTTC ATTTGAGAAGGGGAT CAT GT AAAAT GT G
GACATGTTCAGCTACTCATGCTGACACATTAAGATACAAATCCTGGGGCCGT
ACAGTTATTGGGACAACTGTACCCCATCCATTAGAAATGTTGGGTCCACAAC
ATCGAAAAGAGACTCCTTGTGCACCATGTAACACATCAGGGTTCAATTATGTT
TCTGTGCATTGTCCAGACGGGATCCATGACGTCTTTAGTTCACGGGGACCATT
GCCTGCTTATCTAGGGTCTAAAACATCTGAATCTACATCTATTTTGCAGCCTT
GGGAAAGGGAAAGCAAAGTCCCACTGATTAAAAGAGCTACACGTCTTAGAG
ATGCTATCTCTTGGTTTGTTGAACCCGACTCTAAACTAGCAATGACTATACTT
TCTAACATCCACTCTTTAACAGGCGAAGAATGGACCAAAAGGCAGCATGGGT
TCAAAAGAACAGGGTCTGCCCTTCATAGGTTTTCGACATCTCGGATGAGCCAT
GGTGGGTTCGCATCTCAGAGCACTGCAGCATTGACCAGGTTGATGGCAACTA
CAGACACCATGAGGGATCTGGGAGATCAGAATTTCGACTTTTTATTCCAAGC
AACGTTGCTCTATGCTCAAATTACCACCACTGTTGCAAGAGACGGATGGATC
ACCAGTTGTACAGATCATTATCATATTGCCTGTAAGTCCTGTTTGAGACCCAT
AGAAGAGATCACCCTGGACTCAAGTATGGACTACACGCCCCCAGATGTATCC
CAT GT GC T G A AG AC AT GG AGG A AT GGGG A AGGT T C GT GGGG AC A AG AG AT A
AAACAGATCTATCCTTTAGAAGGGAATTGGAAGAATTTAGCACCTGCTGAGC
AATCCTATCAAGTCGGCAGATGTATAGGTTTTCTATATGGAGACTTGGCGTAT
AGAAAATCTACTCATGCCGAGGACAGTTCTCTATTTCCTCTATCTATACAAGG
TCGTATTAGAGGTCGAGGTTTCTTAAAAGGGTTGCTAGACGGATTAATGAGA
GCAAGTTGCTGCCAAGTAATACACCGGAGAAGTCTGGCTCATTTGAAGAGGC
CGGCCAACGCAGTGTACGGAGGTTTGATTTACTTGATTGATAAATTGAGTGTA
TCACCTCCATTCCTTTCTCTTACTAGATCAGGACCTATTAGAGACGAATTAGA
AACGATTCCCCACAAGATCCCAACCTCCTATCCGACAAGCAACCGTGATATG
GGGGTGATTGTCAGAAATTACTTCAAATACCAATGCCGTCTAATTGAAAAGG
GAAAATACAGATCACATTATTCACAATTATGGTTATTCTCAGATGTCTTATCC
ATAGACTTCATTGGACCATTCTCTATTTCCACCACCCTCTTGCAAATCCTATAC AAGCCATTTTTATCTGGGAAAGATAAGAATGAGTTGAGAGAGCTGGCAAATC
TTTCTTC ATT GCT AAGAT C AGGAGAGGGGTGGGAAGAC AT AC ATGT GAAATT
CTTCACCAAGGACATATTATTGTGTCCAGAGGAAATCAGACATGCTTGCAAG
TTCGGGATTGCTAAGGATAATAATAAAGACATGAGCTATCCCCCTTGGGGAA
GGGAATCCAGAGGGACAATTACAACAATCCCTGTTTATTATACGACCACCCC
TTACCCAAAGATGCTAGAGATGCCTCCAAGAATCCAAAATCCCCTGCTGTCC
GGAATCAGGTTGGGCCAATTACCAACTGGCGCTCATTATAAAATTCGGAGTA
TATTACATGGAATGGGAATCCATTACAGGGACTTCTTGAGTTGTGGAGACGG
CTCCGGAGGGAT GACTGCTGC ATT ACT ACGAGAAAAT GT GC AT AGC AGAGGA
ATATTCAATAGTCTGTTAGAATTATCAGGGTCAGTCATGCGAGGCGCCTCTCC
TGAGCCCCCCAGTGCCCTAGAAACTTTAGGAGGAGATAAATCGAGATGTGTA
AAT GGTGAAAC AT GTT GGGAAT ATCC ATCTGACTT AT GT GACCC AAGGACTT
GGGACTATTTCCTCCGACTCAAAGCAGGCTTGGGGCTTCAAATTGATTTAATT
GTAATGGATATGGAAGTTCGGGATTCTTCTACTAGCCTGAAAATTGAGACGA
ATGTTAGAAATTATGTGCACCGGATTTTGGATGAGCAAGGAGTTTTAATCTAC
A AG AC TT AT GGA AC AT AT ATTTGT GAG AGC GA A A AGA AT GC AGT A AC A AT C C
TTGGTCCCATGTTCAAGACGGTCGACTTAGTTCAAACAGAATTTAGTAGTTCT
C A A AC GT C T G A AGT AT AT AT GGT AT GT A A AGGTT T G A AG A A AT T AAT C GAT G
AACCCAATCCCGATTGGTCTTCCATCAATGAATCCTGGAAAAACCTGTACGCA
TTCCAGTCATCAGAACAGGAATTTGCCAGAGCAAAGAAGGTTAGTACATACT
TTACCTTGACAGGTATTCCCTCCCAATTCATTCCTGATCCTTTTGTAAACATTG
AGACTATGCTACAAATATTCGGAGTACCCACGGGTGTGTCTCATGCGGCTGCC
TTAAAATCATCTGATAGACCTGCAGATTTATTGACCATTAGCCTTTTTTATATG
GCGATT AT ATCGT ATT AT AAC AT C AAT CAT AT C AG AGT AGGACCGAT ACCTCC
GAACCCCCCATCAGATGGAATTGCACAAAATGTGGGGATCGCTATAACTGGT
ATAAGCTTTTGGCTGAGTTTGATGGAGAAAGACATTCCACTATATCAACAGTG
TTTAGCAGTTATCCAGCAATCATTCCCGATTAGGTGGGAGGCTGTTTCAGTAA
AAGGAGGAT AC AAGC AGAAGT GGAGT ACT AGAGGT GATGGGCTCCC AAAAG
ATACCCGAACTTCAGACTCCTTGGCCCCAATCGGGAACTGGATCAGATCTCTG
GAATTGGTCCGAAACCAAGTTCGTCTAAATCCATTCAATGAGATCTTGTTCAA
T C AGCT AT GTCGT AC AGTGGAT AAT C ATTT GAAAT GGT C AAATTT GCGA AGAA
AC AC AGGAAT GATT GAAT GGAT C AAT AGACGAATTTC AAAAGAAGACCGGT C
T AT AC T GAT GT T G A AG AGT G AC C T AC AC G AGG A A A AC TC TT GG AG AG AT T A A AAAATCATGAGGAGACTCCAAACTTTAAGTATGAAAAAAACTTTGATCCTTA
AGACCCTCTTGTGGTTTTTATTTTTTATCTGGTTTTGTGGTCTTCGT.
In another embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 19, shown below (VSV vector: Convac VI South Africa):
ACGAAGAC AAAC AAACC ATT ATT AT C ATT AAAAGGCTC AGGAGAAACTTT AA
C AGT AAT C AAA ATGTCTGTT AC AGTC AAGAGAAT C ATTGAC AAC AC AGTC AT
AGTTCCAAAACTTCCTGCAAATGAGGATCCAGTGGAATACCCGGCAGATTAC
TTCAGAAAATCAAAGGAGATTCCTCTTTACATCAATACTACAAAAAGTTTGTC
AGATCTAAGAGGATATGTCTACCAAGGCCTCAAATCCGGAAATGTATCAATC
AT AC AT GT C A AC AGC T AC TT GT AT GG AGC ATT A A AGG AC ATC C GGGGT A AGT
TGGATAAAGATTGGTCAAGTTTCGGAATAAACATCGGGAAAGCAGGGGATAC
AATCGGAATATTTGACCTTGTATCCTTGAAAGCCCTGGACGGCGTACTTCCAG
AT GGAGT ATCGGAT GCTTCC AGAACC AGCGC AGAT GAC AAAT GGTT GCCTTT
GTATCTACTTGGCTTATACAGAGTGGGCAGAACACAAATGCCTGAATACAGA
A A A A AGC TC AT GGAT GGGC T GAC A A AT C A AT GCA A A AT GAT C A AT GA AC AGT
TTGAACCTCTTGTGCCAGAAGGTCGTGACATTTTTGATGTGTGGGGAAATGAC
AGTAATTACACAAAAATTGTCGCTGCAGTGGACATGTTCTTCCACATGTTCAA
AAAACATGAATGTGCCTCGTTCAGATACGGAACTATTGTTTCCAGATTCAAAG
ATTGTGCTGCATTGGCAACATTTGGACACCTCTGCAAAATAACCGGAATGTCT
ACAGAAGATGTAACGACCTGGATCTTGAACCGAGAAGTTGCAGATGAAATGG
TCCAAATGATGCTTCCAGGCCAAGAAATTGACAAGGCCGATTCATACATGCC
TTATTTGATCGACTTTGGATTGTCTTCTAAGTCTCCATATTCTTCCGTCAAAAA
CCCTGCCTTCCACTTCTGGGGGCAATTGACAGCTCTTCTGCTCAGATCCACCA
GAGCAAGGAATGCCCGACAGCCTGATGACATTGAGTATACATCTCTTACTAC
AGCAGGTTTGTTGTACGCTTATGCAGTAGGATCCTCTGCCGACTTGGCACAAC
AGTTTTGTGTTGGAGATAACAAATACACTCCAGATGATAGTACCGGAGGATT
GACGACTAATGCACCGCCACAAGGCAGAGATGTGGTCGAATGGCTCGGATGG
T TT G A AG AT C A A A AC AG A A A AC C GAC TC C T GAT AT GAT GC AGT AT GC G A A A A
GAGCAGTCATGTCACTGCAAGGCCTAAGAGAGAAGACAATTGGCAAGTATGC
TAAGTCAGAATTTGACAAATGACCCTATAATTCTCAGATCACCTATTATATAT
TATGCTACATATGAAAAAAACTAACAGATATCATGGATAATCTCACAAAAGT
TCGTGAGTATCTCAAGTCCTATTCTCGTCTGGATCAGGCGGTAGGAGAGATAG
ATGAGATCGAAGCACAACGAGCTGAAAAGTCCAATTATGAGTTGTTCCAAGA
GGATGGAGTGGAAGAGCATACTAAGCCCTCTTATTTTCAGGCAGCAGATGAT TCTGAC AC AGA AT C T GA AC C AG A A ATT GA AG AC A AT C A AGGTTT GT AT GC AC
CAGATCCAGAAGCTGAGCAAGTTGAAGGCTTTATACAGGGGCCTTTAGATGA
CT AT GC AGAT GAGGAAGT GGAT GTT GT ATTT ACTTCGGACTGGAAAC AGCCT
GAGCTTGAATCTGACGAGCATGGAAAGACCTTACGGTTGACATCGCCAGAGG
GTTTAAGTGGAGAGCAGAAATCCCAGTGGCTTTCGACGATTAAAGCAGTCGT
GC AAAGTGCC AAAT ACTGGAATCTGGC AGAGT GC AC ATTTGAAGC ATCGGGA
G A AGGGGT C AT T AT G A AGG AGC GC C AG AT A AC T C C GGAT GT AT AT A AGGT C A
CTCCAGTGATGAACACACATCCGTCCCAATCAGAAGCAGTATCAGATGTTTG
GTCTCTCTCAAAGACATCCATGACTTTCCAACCCAAGAAAGCAAGTCTTCAGC
CTCTCACCATATCCTTGGATGAATTGTTCTCATCTAGAGGAGAGTTCATCTCT
GTCGGAGGTGACGGACGAATGTCTCATAAAGAGGCCATCCTGCTCGGCCTGA
GATACAAAAAGTTGTACAATCAGGCGAGAGTCAAATATTCTCTGTAGACTAT
GAAAAAAAGTAACAGATATCACGATCTAAGTGTTATCCCAATCCATTCATCA
T G AGTT C C TT A A AG A AG AT TC TC GGT C T G A AGGGG A A AGGT A AG A A AT C T A A
GAAATTAGGGATCGCACCACCCCCTTATGAAGAGGACACTAGCATGGAGTAT
GCTCCGAGCGCTCCAATTGACAAATCCTATTTTGGAGTTGACGAGATGGACA
CCTATGATCCGAATCAATTAAGATATGAGAAATTCTTCTTTACAGTGAAAATG
ACGGTTAGATCTAATCGTCCGTTCAGAACATACTCAGATGTGGCAGCCGCTGT
ATCCCATTGGGATCACATGTACATCGGAATGGCAGGGAAACGTCCCTTCTAC
AAAATCTTGGCTTTTTTGGGTTCTTCTAATCTAAAGGCCACTCCAGCGGTATT
GGCAGATCAAGGTCAACCAGAGTATCACACTCACTGCGAAGGCAGGGCTTAT
TTGCCACATAGGATGGGGAAGACCCCTCCCATGCTCAATGTACCAGAGCACT
T C AGAAGACC ATTC AAT AT AGGTCTTT AC AAGGGAACGATTGAGCTC AC A AT
GACCATCTACGATGATGAGTCACTGGAAGCAGCTCCTATGATCTGGGATCATT
TCAATTCTTCCAAATTTTCTGATTTCAGAGAGAAGGCCTTAATGTTTGGCCTG
ATTGTCGAGAAAAAGGCATCTGGAGCGTGGGTCCTGGATTCTATCAGCCACT
TCAAATGAGCTAGTCTAACTTCTAGCTTCTGAACAATCCCCGGTTTACTCAGT
CTCTCCTAATTCCAGCCTCTCGAACAACTAATATCCTGTCTTTTCTATCCCTAT
GAAAAAAACTAACAGAGATCGATCTGTTTACGCGTCACTATGAAGTGCCTTTT
GTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCC
ACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGC
CCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCATAC
A AGT C A A A AT GCC C A AGAGTC AC A AGGC T ATT C A AGC AGACGGTT GGAT GT G
TCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGT ATATAACACAGTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGA
AAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCT
C AAAGTT GTGGAT AT GC AACTGT GACGGAT GCCGAAGC AGT GATTGTCC AGG
TGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCA
CAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTC
TACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCA
TTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGA
AAGGAGGGC AC AGGGTT C AGAAGT AACT ACTTTGCTT AT GAAACTGGAGGC A
AGGCCTGC AAAAT GC AAT ACTGC AAGC ATT GGGGAGTC AGACTCCC ATC AGG
TGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTG
AATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTA
AGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAAC
CTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATC
TTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCT
C T C A AG A AT GGT C GG A AT GAT C AGT GG A AC T AC C AC AG A A AGGG A AC TGT GG
GAT GACTGGGC ACC AT AT GAAGACGT GGAAATTGGACCC AAT GGAGTTCTGA
GGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTG
GACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACAT
TCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATA
CTGGGCT ATCC AAAAATCC AATCGAGCTTGT AGAAGGTT GGTTC AGT AGTT G
GAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATT
CTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGA
AAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAA
ATCCTGCTAGGTATGAAAAAAACTAACaGATATCACGCTCGAGCCACCATGTT
CGTGTTTCTGGTGCTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAACTTCACCA
CAAGGACCCAGCTGCCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTAC
TATCCCGACAAGGTGTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTT
TCTGCCTTTCTTTTCTAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCA
CCAATGGCACAAAGCGGTTCGCCAATCCAGTGCTGCCCTTTAACGATGGCGT
GTACTTCGCCTCCACCGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCA
CCACACTGGACAGCAAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAA
CGTGGTCATCAAGGTGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCG
TGTACTATCACAAGAACAATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTA TTCCTCTGCCAACAATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGG
ACCTGGAGGGCAAGCAGGGCAATTTCAAGAACCTGAGGGAGTTCGTGTTTAA
GAATATCGATGGCTACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTG
GTGCGCGGCCTGCCACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCC
CATCGGCATCAACATCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGC
TACCTGACACCAGGCGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCT
ACTATGTGGGCTATCTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAA
TGGCACCATCACAGACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACC
AAGTGTACACTGAAGAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCA
ATTTCAGGGTGCAGCCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAAC
CTGTGCCCTTTTGGCGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGC
CTGGAATAGGAAGCGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACA
ACAGCGCCTCCTTCTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTG
AATGACCTGTGCTTTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGA
CGAGGTGCGCCAGATCGCACCAGGACAGACAGGCAATATCGCAGACTACAAT
TATAAGCTGCCTGACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAA
TCTGGATAGCAAAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGA
AAGTCTAATCTGAAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGG
CCGGCTCTACCCCCTGCAATGGCGTGAAGGGCTTTAACTGTTATTTCCCTCTG
CAGAGCTACGGCTTCCAGCCAACATATGGCGTGGGCTATCAGCCCTACCGCG
TGGTGGTGCTGTCTTTTGAGCTGCTGCACGCACCTGCAACAGTGTGCGGACCA
AAGAAGAGCACCAATCTGGTGAAGAACAAGTGCGTGAACTTCAACTTCAACG
GACTGACCGGAACAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTT
TCAGCAGTTCGGCAGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCT
CAGACCCTGGAGATCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGT
GATCACACCAGGCACCAATACAAGCAACCAGGTGGCCGTGCTGTATCAGGGC
GTGAATTGTACCGAGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTA
CAT GGCGGGTGT ACTCT ACCGGC AGC AACGT GTTCC AGAC AAGAGCCGGATG
CCTGATCGGAGCAGAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATC
GGCGCCGGCATCTGTGCCTCCTACCAGACCCAGACAAACTCCCCAAGGTCTG
T GGGCGAT AC AGGC CTGTCC A AGA AT C C A ATCGAGC T GGT AGAGGGC T GGTT
CAGCAGTTGGAAAAGCTCCATCGCCTCCTTTTTCTTTATCATCGGCCTGATCA
TCGGACTGTTCCTGGTGCTCCGCGTGGGTATCCACCTGTGCATCAAGCTGAAG
CACACCAAGAAAAGACAGATTTATACAGACATCGAGATGAACCGCCTGGGA AAGTGAGCTAGCCAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCAT
GCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAACTA
ACAGCAATCATGGAAGTCCACGATTTTGAGACCGACGAGTTCAATGATTTCA
AT GA AGAT GAC T AT GC C AC A AG AGA ATTCC T GA ATCC CGAT GAGC GC AT GAC
GTACTTGAATCATGCTGATTACAATTTGAATTCTCCTCTAATTAGTGATGATAT
TGACAATTTGATCAGGAAATTCAATTCTCTTCCGATTCCCTCGATGTGGGATA
GT A AGA ACTGGGAT GGAGTTC TT GAG AT GTT A AC AT CAT GT C A AGC C A AT C C
CATCTCAACATCTCAGATGCATAAATGGATGGGAAGTTGGTTAATGTCTGATA
AT CAT GAT GC C AGT C A AGGGT AT AGTTTTTT AC AT GA AGT GG AC A A AGAGGC
AGAAATAACATTTGACGTGGTGGAGACCTTCATCCGCGGCTGGGGCAACAAA
CCA ATT GA AT AC AT C A A A A AGG A A AGAT GGAC T GAC TC ATT C A A A ATTC TC G
CTTATTTGTGTCAAAAGTTTTTGGACTTACACAAGTTGACATTAATCTTAAAT
GCTGTCTCTGAGGTGGAATTGCTCAACTTGGCGAGGACTTTCAAAGGCAAAG
TCAGAAGAAGTTCTCATGGAACGAACATATGCAGGATTAGGGTTCCCAGCTT
GGGTCCTACTTTTATTTCAGAAGGATGGGCTTACTTCAAGAAACTTGATATTC
T A AT GGAC C G A A AC TTTCTGTT A AT GGT C A A AG AT GT GAT TAT AGGG AGG AT
GCA A AC GGT GCT AT C CAT GGT AT GT AGA AT AGAC A AC CTGTTCTC AGAGC A A
GACATCTTCTCCCTTCTAAATATCTACAGAATTGGAGATAAAATTGTGGAGAG
GCAGGGAAATTTTTCTTATGACTTGATTAAAATGGTGGAACCGATATGCAACT
T GAAGCTGAT GAAATT AGC AAGAGAAT C AAGGCCTTT AGTCCC AC AATTCCC
TCATTTTGAAAATCATATCAAGACTTCTGTTGATGAAGGGGCAAAAATTGACC
GAGGT AT A AG ATTCC TCC AT GAT C AGAT A AT GAGT GT GA A A AC AGT GGAT C T
CACACTGGTGATTTATGGATCGTTCAGACATTGGGGTCATCCTTTTATAGATT
ATTACACTGGACTAGAAAAATTACATTCCCAAGTAACCATGAAGAAAGATAT
TGATGTGTCATATGCAAAAGCACTTGCAAGTGATTTAGCTCGGATTGTTCTAT
TTCAACAGTTCAATGATCATAAAAAGTGGTTCGTGAATGGAGACTTGCTCCCT
CATGATCATCCCTTTAAAAGTCATGTTAAAGAAAATACATGGCCCACAGCTG
CTCAAGTTCAAGATTTTGGAGATAAATGGCATGAACTTCCGCTGATTAAATGT
TTTGAAATACCCGACTTACTAGACCCATCGATAATATACTCTGACAAAAGTCA
TTC AAT GAAT AGGT C AGAGGT GTTGAAAC AT GTCCGAAT GAATCCGAAC ACT
CCTATCCCTAGTAAAAAGGTGTTGCAGACTATGTTGGACACAAAGGCTACCA
ATTGGAAAGAATTTCTTAAAGAGATTGATGAGAAGGGCTTAGATGATGATGA
TCT A ATT ATT GGT C TT A A AGG A A AGG AG AGGG A AC T GA AGTT GGC AGGT AGA
TTTTTCTCCCTAATGTCTTGGAAATTGCGAGAATACTTTGTAATTACCGAATAT TTGATAAAGACTCATTTCGTCCCTATGTTTAAAGGCCTGACAATGGCGGACGA
TCTAACTGCAGTCATTAAAAAGATGTTAGATTCCTCATCCGGCCAAGGATTGA
AGT CAT ATGAGGC AATTT GC AT AGCC AATC AC ATTGATT ACGAAA AATGGA A
TAACCACCAAAGGAAGTTATCAAACGGCCCAGTGTTCCGAGTTATGGGCCAG
TTCTTAGGTTATCCATCCTTAATCGAGAGAACTCATGAATTTTTTGAGAAAAG
TCTTATATACTACAATGGAAGACCAGACTTGATGCGTGTTCACAACAACACA
CTGATCAATTCAACCTCCCAACGAGTTTGTTGGCAAGGACAAGAGGGTGGAC
TGGAAGGTCTACGGCAAAAAGGATGGACTATCCTCAATCTACTGGTTATTCA
A AGAGAGGCT A A A ATC AGA A AC AC T GC T GT C A A AGT C TT GGC AC A AGGT GAT
AAT C AAGTT ATTT GC AC AC AGT AT AAAACGAAGAAATCGAGAAACGTTGT AG
AATTACAGGGTGCTCTCAATCAAATGGTTTCTAATAATGAGAAAATTATGACT
GCA AT C A A A AT AGGG AC AGGG AAGTT AGGAC TTTT GAT A A AT GACGAT GAGA
CTATGCAATCTGCAGATTACTTGAATTATGGAAAAATACCGATTTTCCGTGGA
GTGATTAGAGGGTTAGAGACCAAGAGATGGTCACGAGTGACTTGTGTCACCA
ATGACCAAATACCCACTTGTGCTAATATAATGAGCTCAGTTTCCACAAATGCT
CTCACCGTAGCTCATTTTGCTGAGAACCCAATCAATGCCATGATACAGTACAA
TTATTTTGGGACATTTGCTAGACTCTTGTTGATGATGCATGATCCTGCTCTTCG
TCAATCATTGTATGAAGTTCAAGATAAGATACCGGGCTTGCACAGTTCTACTT
TCAAATACGCCATGTTGTATTTGGACCCTTCCATTGGAGGAGTGTCGGGCATG
TCTTTGTCCAGGTTTTTGATTAGAGCCTTCCCAGATCCCGTAACAGAAAGTCT
CTCATTCTGGAGATTCATCCATGTACATGCTCGAAGTGAGCATCTGAAGGAG
ATGAGTGCAGTATTTGGAAACCCCGAGATAGCCAAGTTTCGAATAACTCACA
TAGACAAGCTAGTAGAAGATCCAACCTCTCTGAACATCGCTATGGGAATGAG
TCCAGCGAACTTGTTAAAGACTGAGGTTAAAAAATGCTTAATCGAATCAAGA
CAAACCATCAGGAACCAGGTGATTAAGGATGCAACCATATATTTGTATCATG
AAGAGGATCGGCTCAGAAGTTTCTTATGGTCAATAAATCCTCTGTTCCCTAGA
TTTTTAAGTGAATTCAAATCAGGCACTTTTTTGGGAGTCGCAGACGGGCTCAT
CAGTCTATTTCAAAATTCTCGTACTATTCGGAACTCCTTTAAGAAAAAGTATC
AT AGGGAATT GGAT GATTT GATTGT GAGGAGT GAGGT ATCCTCTTT GAC AC AT
TT AGGGA A ACTT C ATTT GAGA AGGGGAT CAT GT A A A AT GT GGAC AT GTT C AG
CTACTCATGCTGACACATTAAGATACAAATCCTGGGGCCGTACAGTTATTGGG
ACAACTGTACCCCATCCATTAGAAATGTTGGGTCCACAACATCGAAAAGAGA
CTCCTTGTGCACCATGTAACACATCAGGGTTCAATTATGTTTCTGTGCATTGTC
CAGACGGGATCCATGACGTCTTTAGTTCACGGGGACCATTGCCTGCTTATCTA GGGTCT AAAAC ATCTGAATCT AC ATCT ATTTT GC AGCCTTGGGAA AGGGAAA
GCAAAGTCCCACTGATTAAAAGAGCTACACGTCTTAGAGATGCTATCTCTTGG
TTTGTTGAACCCGACTCTAAACTAGCAATGACTATACTTTCTAACATCCACTC
TTTAACAGGCGAAGAATGGACCAAAAGGCAGCATGGGTTCAAAAGAACAGG
GTCTGCCCTTCATAGGTTTTCGACATCTCGGATGAGCCATGGTGGGTTCGCAT
CTCAGAGCACTGCAGCATTGACCAGGTTGATGGCAACTACAGACACCATGAG
GGATCTGGGAGATCAGAATTTCGACTTTTTATTCCAAGCAACGTTGCTCTATG
CTCAAATTACCACCACTGTTGCAAGAGACGGATGGATCACCAGTTGTACAGA
TCATTATCATATTGCCTGTAAGTCCTGTTTGAGACCCATAGAAGAGATCACCC
TGGACTCAAGTATGGACTACACGCCCCCAGATGTATCCCATGTGCTGAAGAC
AT GGAGGAAT GGGGAAGGTTCGT GGGGAC A AGAGAT A AAAC AGATCT ATCC
TTT AGAAGGGAATTGGAAGAATTT AGC ACCTGCTGAGC AATCCT AT C AAGT C
GGCAGATGTATAGGTTTTCTATATGGAGACTTGGCGTATAGAAAATCTACTCA
TGCCGAGGACAGTTCTCTATTTCCTCTATCTATACAAGGTCGTATTAGAGGTC
GAGGTTTCTTAAAAGGGTTGCTAGACGGATTAATGAGAGCAAGTTGCTGCCA
AGTAATACACCGGAGAAGTCTGGCTCATTTGAAGAGGCCGGCCAACGCAGTG
TACGGAGGTTTGATTTACTTGATTGATAAATTGAGTGTATCACCTCCATTCCTT
TCTCTTACTAGATCAGGACCTATTAGAGACGAATTAGAAACGATTCCCCACA
AGATCCCAACCTCCTATCCGACAAGCAACCGTGATATGGGGGTGATTGTCAG
AAATTACTTCAAATACCAATGCCGTCTAATTGAAAAGGGAAAATACAGATCA
CATTATTCACAATTATGGTTATTCTCAGATGTCTTATCCATAGACTTCATTGGA
CCATTCTCTATTTCCACCACCCTCTTGCAAATCCTATACAAGCCATTTTTATCT
GGGAAAGAT AAGAATGAGTT GAGAGAGCTGGC AAATCTTTCTTC ATT GCT AA
GAT C AGGAG AGGGGT GGGA AGAC AT AC AT GT GA A ATTCTT C AC C A AGG AC AT
ATTATTGTGTCCAGAGGAAATCAGACATGCTTGCAAGTTCGGGATTGCTAAG
GAT AAT A AT A A AG AC AT GAGCT ATCCCCCTTGGGGAAGGGAATCC AGAGGGA
CAATTACAACAATCCCTGTTTATTATACGACCACCCCTTACCCAAAGATGCTA
GAGATGCCTCCAAGAATCCAAAATCCCCTGCTGTCCGGAATCAGGTTGGGCC
AATTACCAACTGGCGCTCATTATAAAATTCGGAGTATATTACATGGAATGGG
AATCC ATT AC AGGGACTTCTT GAGTTGT GGAGACGGCTCCGGAGGGAT GACT
GCTGCATTACTACGAGAAAATGTGCATAGCAGAGGAATATTCAATAGTCTGT
TAGAATTATCAGGGTCAGTCATGCGAGGCGCCTCTCCTGAGCCCCCCAGTGCC
C T AG A A AC TTT AGG AGG AG AT A A AT C GAG AT GT GT A A AT GGT G A A AC AT GT T
GGGAATATCCATCTGACTTATGTGACCCAAGGACTTGGGACTATTTCCTCCGA CTC AAAGC AGGCTTGGGGCTTC AAATTGATTT AATTGT AATGGAT AT GGAAGT
TCGGGATTCTTCTACTAGCCTGAAAATTGAGACGAATGTTAGAAATTATGTGC
ACCGGATTTTGGATGAGCAAGGAGTTTTAATCTACAAGACTTATGGAACATAT
ATTTGTGAGAGCGAAAAGAATGCAGTAACAATCCTTGGTCCCATGTTCAAGA
CGGTCGACTTAGTTCAAACAGAATTTAGTAGTTCTCAAACGTCTGAAGTATAT
ATGGTATGTAAAGGTTTGAAGAAATTAATCGATGAACCCAATCCCGATTGGT
CTTCCATCAATGAATCCTGGAAAAACCTGTACGCATTCCAGTCATCAGAACA
GGAATTTGCCAGAGCAAAGAAGGTTAGTACATACTTTACCTTGACAGGTATT
CCCTCCCAATTCATTCCTGATCCTTTTGTAAACATTGAGACTATGCTACAAAT
ATTCGGAGTACCCACGGGTGTGTCTCATGCGGCTGCCTTAAAATCATCTGATA
GACCTGCAGATTTATTGACCATTAGCCTTTTTTATATGGCGATTATATCGTATT
ATAACATCAATCATATCAGAGTAGGACCGATACCTCCGAACCCCCCATCAGA
TGGAATTGCACAAAATGTGGGGATCGCTATAACTGGTATAAGCTTTTGGCTGA
GTTTGATGGAGAAAGACATTCCACTATATCAACAGTGTTTAGCAGTTATCCAG
C AAT C ATTCCCGATT AGGT GGGAGGCTGTTT C AGT AAAAGGAGGAT AC AAGC
AGAAGT GGAGT ACT AGAGGT GAT GGGCTCCC AAAAGAT ACCCGAACTTC AGA
CTCCTTGGCCCCAATCGGGAACTGGATCAGATCTCTGGAATTGGTCCGAAACC
AAGTTCGTCTAAATCCATTCAATGAGATCTTGTTCAATCAGCTATGTCGTACA
GT GGAT AAT C ATTTG A A AT GGT C A A ATTTGC GA AGA A AC AC AGGA AT GATT G
AAT GGAT C AAT AGACGAATTT C AAAAGAAGACCGGTCT AT ACTGAT GTT GAA
GAGTGACCTACACGAGGAAAACTCTTGGAGAGATTAAAAAATCATGAGGAG
ACTCCAAACTTTAAGTATGAAAAAAACTTTGATCCTTAAGACCCTCTTGTGGT
TTTTATTTTTTATCTGGTTTTGTGGTCTTCGT.
In some embodiments, the nucleic acid comprises the sequence of SEQ ID NO:
20, shown below (VSV vector: Convac V2 China):
ACGAAGAC AAAC AAACC ATT ATT AT C ATT AAAAGGCTC AGGAGAAACTTT AA C AGT AAT C AAA ATGTCTGTT AC AGTC AAGAGAAT C ATTGAC AAC AC AGTC AT AGTTCCAAAACTTCCTGCAAATGAGGATCCAGTGGAATACCCGGCAGATTAC TTCAGAAAATCAAAGGAGATTCCTCTTTACATCAATACTACAAAAAGTTTGTC AGATCTAAGAGGATATGTCTACCAAGGCCTCAAATCCGGAAATGTATCAATC AT AC AT GT C A AC AGC T AC TT GT AT GG AGC ATT A A AGG AC ATC C GGGGT A AGT T GGAT A A AG AT T GGT C A AGTT T C GG A AT AAAC ATC GGG A A AGC AGGGG AT AC AATCGGAATATTTGACCTTGTATCCTTGAAAGCCCTGGACGGCGTACTTCCAG AT GGAGT ATCGG AT GCTTCC AGAACC AGCGC AGAT GAC AAAT GGTT GCCTTT GT AT C T AC TT GGCTT AT AC AGAGT GGGC AG A AC AC A A AT GCC T GA AT AC AGA
A A A A AGC TC AT GGAT GGGC T GAC A A AT C A AT GCA A A AT GAT C A AT GA AC AGT
TTGAACCTCTTGTGCCAGAAGGTCGTGACATTTTTGATGTGTGGGGAAATGAC
AGTAATTACACAAAAATTGTCGCTGCAGTGGACATGTTCTTCCACATGTTCAA
AAAACATGAATGTGCCTCGTTCAGATACGGAACTATTGTTTCCAGATTCAAAG
ATTGTGCTGCATTGGCAACATTTGGACACCTCTGCAAAATAACCGGAATGTCT
ACAGAAGATGTAACGACCTGGATCTTGAACCGAGAAGTTGCAGATGAAATGG
TCCAAATGATGCTTCCAGGCCAAGAAATTGACAAGGCCGATTCATACATGCC
TTATTTGATCGACTTTGGATTGTCTTCTAAGTCTCCATATTCTTCCGTCAAAAA
CCCTGCCTTCCACTTCTGGGGGCAATTGACAGCTCTTCTGCTCAGATCCACCA
GAGCAAGGAATGCCCGACAGCCTGATGACATTGAGTATACATCTCTTACTAC
AGCAGGTTTGTTGTACGCTTATGCAGTAGGATCCTCTGCCGACTTGGCACAAC
AGTTTTGTGTTGGAGATAACAAATACACTCCAGATGATAGTACCGGAGGATT
GACGACTAATGCACCGCCACAAGGCAGAGATGTGGTCGAATGGCTCGGATGG
T TT G A AG AT C A A A AC AG A A A AC C GAC TC C T GAT AT GAT GC AGT AT GC G A A A A
GAGCAGTCATGTCACTGCAAGGCCTAAGAGAGAAGACAATTGGCAAGTATGC
TAAGTCAGAATTTGACAAATGACCCTATAATTCTCAGATCACCTATTATATAT
TATGCTACATATGAAAAAAACTAACAGATATCATGGATAATCTCACAAAAGT
TCGTGAGTATCTCAAGTCCTATTCTCGTCTGGATCAGGCGGTAGGAGAGATAG
ATGAGATCGAAGCACAACGAGCTGAAAAGTCCAATTATGAGTTGTTCCAAGA
GGATGGAGTGGAAGAGCATACTAAGCCCTCTTATTTTCAGGCAGCAGATGAT
TCTGAC AC AGA AT C T GA AC C AGA A ATT GA AG AC A AT C A AGGTTT GT AT GC AC
CAGATCCAGAAGCTGAGCAAGTTGAAGGCTTTATACAGGGGCCTTTAGATGA
CT AT GC AGAT GAGGAAGT GGAT GTT GT ATTT ACTTCGGACTGGAAAC AGCCT
GAGCTTGAATCTGACGAGCATGGAAAGACCTTACGGTTGACATCGCCAGAGG
GTTTAAGTGGAGAGCAGAAATCCCAGTGGCTTTCGACGATTAAAGCAGTCGT
GC AAAGTGCC AAAT ACTGGAATCTGGC AGAGT GC AC ATTTGAAGC ATCGGGA
G A AGGGGT C AT T AT G A AGG AGC GC C AG AT A AC T C C GGAT GT AT AT A AGGT C A
CTCCAGTGATGAACACACATCCGTCCCAATCAGAAGCAGTATCAGATGTTTG
GTCTCTCTCAAAGACATCCATGACTTTCCAACCCAAGAAAGCAAGTCTTCAGC
CTCTCACCATATCCTTGGATGAATTGTTCTCATCTAGAGGAGAGTTCATCTCT
GTCGGAGGTGACGGACGAATGTCTCATAAAGAGGCCATCCTGCTCGGCCTGA
GATACAAAAAGTTGTACAATCAGGCGAGAGTCAAATATTCTCTGTAGACTAT
GAAAAAAAGTAACAGATATCACGATCTAAGTGTTATCCCAATCCATTCATCA T G AGTT C C TT A A AG A AG AT TC TC GGT C T G A AGGGG A A AGGT A AG A A AT C T A A
GAAATTAGGGATCGCACCACCCCCTTATGAAGAGGACACTAGCATGGAGTAT
GCTCCGAGCGCTCCAATTGACAAATCCTATTTTGGAGTTGACGAGATGGACA
CCTATGATCCGAATCAATTAAGATATGAGAAATTCTTCTTTACAGTGAAAATG
ACGGTTAGATCTAATCGTCCGTTCAGAACATACTCAGATGTGGCAGCCGCTGT
ATCCCATTGGGATCACATGTACATCGGAATGGCAGGGAAACGTCCCTTCTAC
AAAATCTTGGCTTTTTTGGGTTCTTCTAATCTAAAGGCCACTCCAGCGGTATT
GGCAGATCAAGGTCAACCAGAGTATCACACTCACTGCGAAGGCAGGGCTTAT
TTGCCACATAGGATGGGGAAGACCCCTCCCATGCTCAATGTACCAGAGCACT
T C AGAAGACC ATTC AAT AT AGGTCTTT AC AAGGGAACGATTGAGCTC AC A AT
GACCATCTACGATGATGAGTCACTGGAAGCAGCTCCTATGATCTGGGATCATT
TCAATTCTTCCAAATTTTCTGATTTCAGAGAGAAGGCCTTAATGTTTGGCCTG
ATTGTCGAGAAAAAGGCATCTGGAGCGTGGGTCCTGGATTCTATCAGCCACT
TCAAATGAGCTAGTCTAACTTCTAGCTTCTGAACAATCCCCGGTTTACTCAGT
CTCTCCTAATTCCAGCCTCTCGAACAACTAATATCCTGTCTTTTCTATCCCTAT
GAAAAAAACTAACAGAGATCGATCTGTTTACGCGTCACTATGAAGTGCCTTTT
GTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCC
ACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGC
CCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCATAC
A AGT C A A A AT GCC C A AGAGTC AC A AGGC T ATT C A AGC AGACGGTT GGAT GT G
TCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGT
ATATAACACAGTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGA
AAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCT
C AAAGTT GTGGAT AT GC AACTGT GACGGAT GCCGAAGC AGT GATTGTCC AGG
TGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCA
CAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTC
TACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCA
TTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGA
AAGGAGGGC AC AGGGTT C AGAAGT AACT ACTTTGCTT AT GAAACTGGAGGC A
AGGCCTGC AAAAT GC AAT ACTGC AAGC ATT GGGGAGTC AGACTCCC ATC AGG
TGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTG
AATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTA
AGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAAC
CTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATC TTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCT
C T C A AG A AT GGT C GG A AT GAT C AGT GG A AC T AC C AC AG A A AGGG A AC TGT GG
GAT GACTGGGC ACC AT AT GAAGACGT GGAAATTGGACCC AAT GGAGTTCTGA
GGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTG
GACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACAT
TCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATA
CTGGGCT ATCC AAAAATCC AATCGAGCTTGT AGAAGGTT GGTTC AGT AGTT G
GAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATT
CTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGA
AAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAA
ATCCTGCTAGGTATGAAAAAAACTAACaGATATCACGCTCGAGCGTACGCCA
CCATGTTCGTGTTTCTGGTGCTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAAC
CTGACCACAAGGACCCAGCTGCCCCCTGCCTATACCAATTCCTTCACACGGGG
CGTGTACTATCCCGACAAGGTGTTCCGGAGCAGCGTGCTGCACTCCACACAG
GATCTGTTTCTGCCTTTCTTTTCTAACGTGACCTGGTTCCACGCCATCCACGTG
AGCGGCACCAATGGCACAAAGCGGTTCGACAATCCAGTGCTGCCCTTTAACG
ATGGCGTGTACTTCGCCTCCACCGAGAAGTCTAACATCATCAGAGGCTGGAT
CTTTGGCACCACACTGGACAGCAAGACACAGTCCCTGCTGATCGTGAACAAT
GCCACCAACGTGGTCATCAAGGTGTGCGAGTTCCAGTTTTGTAATGATCCATT
CC T GGGC GT GT AC T AT C AC A AG A AC A AT A AGT C TT GGAT GGAGAGC GAGTTT
CGCGTGTATTCCTCTGCCAACAATTGCACATTTGAGTACGTGTCCCAGCCCTT
CCTGAT GGACCTGGAGGGC AAGC AGGGC AATTT C AAGA ACCTGAGGGAGTT C
GTGTTTAAGAATATCGATGGCTACTTCAAAATCTACTCCAAGCACACCCCAAT
CAACCTGGTGCGCGACCTGCCACAGGGCTTCTCTGCCCTGGAGCCACTGGTG
GATCTGCCCATCGGCATCAACATCACCCGGTTTCAGACACTGCTGGCCCTGCA
CAGAAGCTACCTGACACCAGGCGACAGCTCCTCTGGATGGACCGCAGGAGCA
GCAGCCTACTATGTGGGCTATCTGCAGCCCAGGACCTTCCTGCTGAAGTACAA
CGAGAATGGCACCATCACAGACGCCGTGGATTGCGCCCTGGATCCCCTGTCT
GAGACCAAGTGTACACTGAAGAGCTTTACCGTGGAGAAGGGCATCTATCAGA
CAAGCAATTTCAGGGTGCAGCCTACCGAGTCCATCGTGCGCTTTCCCAATATC
ACAAACCTGTGCCCTTTTGGCGAGGTGTTCAACGCAACCCGCTTCGCCAGCGT
GTACGCCTGGAATAGGAAGCGCATCTCCAACTGCGTGGCCGACTATTCTGTG
CTGTACAACAGCGCCTCCTTCTCTACCTTTAAGTGCTATGGCGTGAGCCCCAC AAAGCTGAATGACCTGTGCTTTACCAACGTGTACGCCGATTCCTTCGTGATCA
GGGGCGACGAGGTGCGCCAGATCGCACCAGGACAGACAGGCAAGATCGCAG
ACTACAATTATAAGCTGCCTGACGATTTCACCGGCTGCGTGATCGCCTGGAAC
TC T A AC A AT C T GG AT AGC A A AGT GGGC GGC A AC T AC A AT T AT C T GT AC C GGC
TGTTTAGAAAGTCTAATCTGAAGCCATTCGAGAGGGACATCTCCACAGAAAT
CTACCAGGCCGGCTCTACCCCCTGCAATGGCGTGGAGGGCTTTAACTGTTATT
TCCCTCTGCAGAGCTACGGCTTCCAGCCAACAAACGGCGTGGGCTATCAGCC
CTACCGCGTGGTGGTGCTGTCTTTTGAGCTGCTGCACGCACCTGCAACAGTGT
GCGGACC A AAGAAGAGC ACC AATCTGGT GAAGAAC AAGT GCGT GAACTTC A
ACTTC AACGGACTGACCGGAAC AGGCGT GCTGACCGAGTCC A AC AAGAAGTT
CCTGCCTTTTCAGCAGTTCGGCAGGGACATCGCAGATACCACAGACGCCGTG
CGCGACCCTCAGACCCTGGAGATCCTGGACATCACACCATGCTCCTTCGGCG
GCGTGTCTGTGATCACACCAGGCACCAATACAAGCAACCAGGTGGCCGTGCT
GT ATC AGGACGT GAATTGT ACCGAGGT GCC AGT GGC AATCC ACGC AGAT C AG
CTGACCCCTACATGGCGGGTGTACTCTACCGGCAGCAACGTGTTCCAGACAA
GAGCCGGATGCCTGATCGGAGCAGAGCACGTGAACAATAGCTATGAGTGCGA
CATCCCTATCGGCGCCGGCATCTGTGCCTCCTACCAGACCCAGACAAACTCCC
CAAGGTCTGTGGGAGATGAGGCCGAAGACTTTGTGGAAGTCCACCTGCCTGA
T GT GC AT A AC C AGGT GT C T GGCGT C GAC CTGGG ACTGCC A A ATT GGGGC A AG
TACGTGCTGCTGAGTGCTGGAGCACTGACTGCCCTGATGCTGATCATTTTCCT
GATGACCTGCTGTCGGCGCGTGAACAGAAGTGAGCCCACTCAGCACAATCTG
CGAGGAACCGGGAGAGAAGTGTCAGTCACACCTCAGAGCGGGAAAATCATT
AGT AGTT GGGAAT C AC AT AAAAGCGGGGGCGAGACC AGGCTGTGAGCT AGC
CAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGC
CTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAACTAACAGCAATCATG
GAAGTCCACGATTTTGAGACCGACGAGTTCAATGATTTCAATGAAGATGACT
ATGCCACAAGAGAATTCCTGAATCCCGATGAGCGCATGACGTACTTGAATCA
TGCTGATTACAATTTGAATTCTCCTCTAATTAGTGATGATATTGACAATTTGAT
CAGGAAATTCAATTCTCTTCCGATTCCCTCGATGTGGGATAGTAAGAACTGGG
ATGGAGTTCTTGAGATGTTAACATCATGTCAAGCCAATCCCATCTCAACATCT
C AGAT GC AT AAAT GGATGGGA AGTT GGTT AAT GTCTGAT AATC ATGAT GCC A
GT C AAGGGT AT AGTTTTTT AC ATGA AGTGGAC AAAGAGGC AGAAAT AAC ATT
TGACGTGGTGGAGACCTTCATCCGCGGCTGGGGCAACAAACCAATTGAATAC
AT C AAAAAGGA AAGATGGACTGACTC ATTC AAAATTCTCGCTT ATTTGTGT C A AAAGTTTTTGGACTTACACAAGTTGACATTAATCTTAAATGCTGTCTCTGAGG
TGGAATTGCTCAACTTGGCGAGGACTTTCAAAGGCAAAGTCAGAAGAAGTTC
TCATGGAACGAACATATGCAGGATTAGGGTTCCCAGCTTGGGTCCTACTTTTA
TTTCAGAAGGATGGGCTTACTTCAAGAAACTTGATATTCTAATGGACCGAAA
CTTTCTGTT AAT GGTC AAAGAT GTGATT AT AGGGAGGAT GC AA ACGGT GCT AT
CCATGGTATGTAGAATAGACAACCTGTTCTCAGAGCAAGACATCTTCTCCCTT
CT AAAT ATCT AC AGAATT GGAGAT AAAATTGT GGAGAGGC AGGGAAATTTTT
CTTATGACTTGATTAAAATGGTGGAACCGATATGCAACTTGAAGCTGATGAA
ATTAGCAAGAGAATCAAGGCCTTTAGTCCCACAATTCCCTCATTTTGAAAATC
ATATCAAGACTTCTGTTGATGAAGGGGCAAAAATTGACCGAGGTATAAGATT
CC TC CAT GATC AGAT AAT GAGT GT GA A A AC AGT GGAT C T C AC AC T GGT GATTT
AT GGAT C GTT C AG AC ATT GGGGT C ATCC TTTT AT AG ATT ATT AC AC T GGACT A
GAAAAATTACATTCCCAAGTAACCATGAAGAAAGATATTGATGTGTCATATG
CAAAAGCACTTGCAAGTGATTTAGCTCGGATTGTTCTATTTCAACAGTTCAAT
GATCATAAAAAGTGGTTCGTGAATGGAGACTTGCTCCCTCATGATCATCCCTT
T A A A AGT CAT GTT A A AGA A A AT AC AT GGCC C AC AGCTGC TC A AGTT C A AGAT
TTTGGAGATAAATGGCATGAACTTCCGCTGATTAAATGTTTTGAAATACCCGA
CTTACTAGACCCATCGATAATATACTCTGACAAAAGTCATTCAATGAATAGGT
CAGAGGTGTTGAAACATGTCCGAATGAATCCGAACACTCCTATCCCTAGTAA
AAAGGTGTTGCAGACTATGTTGGACACAAAGGCTACCAATTGGAAAGAATTT
CTT AAAGAGATT GAT GAG AAGGGCTT AGAT GATGATGATCT AATT ATTGGTCT
TAAAGGAAAGGAGAGGGAACTGAAGTTGGCAGGTAGATTTTTCTCCCTAATG
TCTTGGAAATTGCGAGAATACTTTGTAATTACCGAATATTTGATAAAGACTCA
TTTCGTCCCTATGTTTAAAGGCCTGACAATGGCGGACGATCTAACTGCAGTCA
TTAAAAAGATGTTAGATTCCTCATCCGGCCAAGGATTGAAGTCATATGAGGC
AATTTGCATAGCCAATCACATTGATTACGAAAAATGGAATAACCACCAAAGG
AAGTTATCAAACGGCCCAGTGTTCCGAGTTATGGGCCAGTTCTTAGGTTATCC
ATCCTTAATCGAGAGAACTCATGAATTTTTTGAGAAAAGTCTTATATACTACA
ATGGAAGACCAGACTTGATGCGTGTTCACAACAACACACTGATCAATTCAAC
CTCCCAACGAGTTTGTTGGCAAGGACAAGAGGGTGGACTGGAAGGTCTACGG
CAAAAAGGATGGACTATCCTCAATCTACTGGTTATTCAAAGAGAGGCTAAAA
T C AGA A AC AC T GCTGT C A A AGT CTT GGC AC A AGGT GAT AAT C A AGTT ATTT GC
AC AC AGT AT A A A ACGA AG A A AT C GAGA A AC GTT GT AGAATT AC AGGGT GC T C
T C A AT C A A AT GGTTTCT A AT AAT GAGA A A ATT AT GAC T GCA AT C A A A AT AGG GAC AGGGAAGTT AGGACTTTT GAT AAAT GACGAT GAGACT AT GC AATCTGC A
GATTACTTGAATTATGGAAAAATACCGATTTTCCGTGGAGTGATTAGAGGGTT
AG AG AC C A AG AG AT GGT C AC GAGT GACTTGT GT C AC C A AT GACC A A AT AC CC
ACTTGTGCTAATATAATGAGCTCAGTTTCCACAAATGCTCTCACCGTAGCTCA
TTTTGCTGAGAACCC AAT C AAT GCC ATGAT AC AGT AC A ATT ATTTT GGGAC AT
TTGCTAGACTCTTGTTGATGATGCATGATCCTGCTCTTCGTCAATCATTGTATG
AAGTTCAAGATAAGATACCGGGCTTGCACAGTTCTACTTTCAAATACGCCATG
TTGTATTTGGACCCTTCCATTGGAGGAGTGTCGGGCATGTCTTTGTCCAGGTTT
TTGATTAGAGCCTTCCCAGATCCCGTAACAGAAAGTCTCTCATTCTGGAGATT
CATCCATGTACATGCTCGAAGTGAGCATCTGAAGGAGATGAGTGCAGTATTT
GGAAACCCCGAGATAGCCAAGTTTCGAATAACTCACATAGACAAGCTAGTAG
AAGATCCAACCTCTCTGAACATCGCTATGGGAATGAGTCCAGCGAACTTGTT
AAAGACTGAGGTTAAAAAATGCTTAATCGAATCAAGACAAACCATCAGGAAC
CAGGTGATTAAGGATGCAACCATATATTTGTATCATGAAGAGGATCGGCTCA
GAAGTTTCTTATGGTCAATAAATCCTCTGTTCCCTAGATTTTTAAGTGAATTCA
AATCAGGCACTTTTTTGGGAGTCGCAGACGGGCTCATCAGTCTATTTCAAAAT
TCTCGTACTATTCGGAACTCCTTTAAGAAAAAGTATCATAGGGAATTGGATGA
TTTGATTGTGAGGAGTGAGGTATCCTCTTTGACACATTTAGGGAAACTTCATT
T GAGA AGGGGAT CAT GT A A A AT GT GGAC AT GTT C AGC T ACTC AT GCTGAC AC
ATTAAGATACAAATCCTGGGGCCGTACAGTTATTGGGACAACTGTACCCCAT
CCATTAGAAATGTTGGGTCCACAACATCGAAAAGAGACTCCTTGTGCACCAT
GTAACACATCAGGGTTCAATTATGTTTCTGTGCATTGTCCAGACGGGATCCAT
GACGTCTTTAGTTCACGGGGACCATTGCCTGCTTATCTAGGGTCTAAAACATC
TGAATCTACATCTATTTTGCAGCCTTGGGAAAGGGAAAGCAAAGTCCCACTG
ATTAAAAGAGCTACACGTCTTAGAGATGCTATCTCTTGGTTTGTTGAACCCGA
CTCTAAACTAGCAATGACTATACTTTCTAACATCCACTCTTTAACAGGCGAAG
AATGGACCAAAAGGCAGCATGGGTTCAAAAGAACAGGGTCTGCCCTTCATAG
GTTTTCGACATCTCGGATGAGCCATGGTGGGTTCGCATCTCAGAGCACTGCAG
C ATTGACC AGGTT GATGGC AACT AC AGAC ACC ATGAGGGATCTGGGAGAT C A
GAATTTCGACTTTTTATTCCAAGCAACGTTGCTCTATGCTCAAATTACCACCA
CTGTTGCAAGAGACGGATGGATCACCAGTTGTACAGATCATTATCATATTGCC
TGTAAGTCCTGTTTGAGACCCATAGAAGAGATCACCCTGGACTCAAGTATGG
ACTACACGCCCCCAGATGTATCCCATGTGCTGAAGACATGGAGGAATGGGGA
AGGTTCGTGGGGAC AAGAGAT AAAAC AGATCT ATCCTTT AGAAGGGAATTGG AAGAATTTAGCACCTGCTGAGCAATCCTATCAAGTCGGCAGATGTATAGGTTT
TCTATATGGAGACTTGGCGTATAGAAAATCTACTCATGCCGAGGACAGTTCTC
TATTTCCTCTATCTATACAAGGTCGTATTAGAGGTCGAGGTTTCTTAAAAGGG
TTGCT AGACGGATT AAT GAGAGC A AGTT GCTGCC AAGT AAT AC ACCGGAGAA
GTCTGGCTCATTTGAAGAGGCCGGCCAACGCAGTGTACGGAGGTTTGATTTA
CTTGATTGATAAATTGAGTGTATCACCTCCATTCCTTTCTCTTACTAGATCAGG
ACCTATTAGAGACGAATTAGAAACGATTCCCCACAAGATCCCAACCTCCTAT
CCGACAAGCAACCGTGATATGGGGGTGATTGTCAGAAATTACTTCAAATACC
AATGCCGTCTAATTGAAAAGGGAAAATACAGATCACATTATTCACAATTATG
GTTATTCTCAGATGTCTTATCCATAGACTTCATTGGACCATTCTCTATTTCCAC
CACCCTCTTGCAAATCCTATACAAGCCATTTTTATCTGGGAAAGATAAGAATG
AGTTGAGAGAGCTGGCAAATCTTTCTTCATTGCTAAGATCAGGAGAGGGGTG
GGA AGAC AT AC AT GT GA A ATTC TT C AC C A AGGAC AT ATT ATT GT GT C C AGAG
GAAAT C AG AC AT GCTTGC AAGTTCGGGATTGCT AAGGAT AAT A AT AAAGAC A
TGAGCTATCCCCCTTGGGGAAGGGAATCCAGAGGGACAATTACAACAATCCC
TGTTTATTATACGACCACCCCTTACCCAAAGATGCTAGAGATGCCTCCAAGAA
TCCAAAATCCCCTGCTGTCCGGAATCAGGTTGGGCCAATTACCAACTGGCGCT
CATTATAAAATTCGGAGTATATTACATGGAATGGGAATCCATTACAGGGACTT
CTTGAGTTGTGGAGACGGCTCCGGAGGGATGACTGCTGCATTACTACGAGAA
AATGTGCATAGCAGAGGAATATTCAATAGTCTGTTAGAATTATCAGGGTCAG
TCATGCGAGGCGCCTCTCCTGAGCCCCCCAGTGCCCTAGAAACTTTAGGAGG
AG AT A A AT C GAG AT GT GT A A AT GGT G A A AC AT GT T GGG A AT ATCCATCT G AC
TTATGTGACCCAAGGACTTGGGACTATTTCCTCCGACTCAAAGCAGGCTTGGG
GCTTCAAATTGATTTAATTGTAATGGATATGGAAGTTCGGGATTCTTCTACTA
GCCTGAAAATTGAGACGAATGTTAGAAATTATGTGCACCGGATTTTGGATGA
GC A AGGAGTTTT AATCT AC AAGACTT AT GGAAC AT AT ATTTGT GAGAGC GAA
A AG A AT GC AGT A AC A AT C CTT GGTCC C AT GTT C A AGAC GGTCGAC TT AGTT C A
AACAGAATTTAGTAGTTCTCAAACGTCTGAAGTATATATGGTATGTAAAGGTT
TGAAGAAATTAATCGATGAACCCAATCCCGATTGGTCTTCCATCAATGAATCC
TGGAAAAACCTGTACGCATTCCAGTCATCAGAACAGGAATTTGCCAGAGCAA
AGAAGGTTAGTACATACTTTACCTTGACAGGTATTCCCTCCCAATTCATTCCT
GATCCTTTTGTAAACATTGAGACTATGCTACAAATATTCGGAGTACCCACGGG
TGTGTCTCATGCGGCTGCCTTAAAATCATCTGATAGACCTGCAGATTTATTGA
CCATTAGCCTTTTTTATATGGCGATTATATCGTATTATAACATCAATCATATCA GAGTAGGACCGATACCTCCGAACCCCCCATCAGATGGAATTGCACAAAATGT
GGGGATCGCTATAACTGGTATAAGCTTTTGGCTGAGTTTGATGGAGAAAGAC
ATTCCACTATATCAACAGTGTTTAGCAGTTATCCAGCAATCATTCCCGATTAG
GT GGGAGGCTGTTTC AGT AAAAGGAGGAT AC AAGC AGAAGT GGAGT ACT AG
AGGTGATGGGCTCCCAAAAGATACCCGAACTTCAGACTCCTTGGCCCCAATC
GGGAACTGGATCAGATCTCTGGAATTGGTCCGAAACCAAGTTCGTCTAAATC
CATTCAATGAGATCTTGTTCAATCAGCTATGTCGTACAGTGGATAATCATTTG
AAAT GGT C AAATTT GCGAAGAAAC AC AGGAAT GATT GAAT GGATC AAT AGAC
GAATTTCAAAAGAAGACCGGTCTATACTGATGTTGAAGAGTGACCTACACGA
GGA A A AC TC TT GGAGAGATT A A A A A AT CAT GAGGAGACTCC A A AC TTT A AGT
ATGAAAAAAACTTTGATCCTTAAGACCCTCTTGTGGTTTTTATTTTTTATCTGG
TTTTGTGGTCTTCGT.
In other embodiments, the nucleic acid comprises the sequence of SEQ ID NO:
21, shown below (VSV vector: Convac V2 South Africa):
ACGAAGAC AAAC AAACC ATT ATT AT C ATT AAAAGGCTC AGGAGAAACTTT AA
C AGT AAT C AAA ATGTCTGTT AC AGTC AAGAGAAT C ATTGAC AAC AC AGTC AT
AGTTCCAAAACTTCCTGCAAATGAGGATCCAGTGGAATACCCGGCAGATTAC
TTCAGAAAATCAAAGGAGATTCCTCTTTACATCAATACTACAAAAAGTTTGTC
AGATCTAAGAGGATATGTCTACCAAGGCCTCAAATCCGGAAATGTATCAATC
AT AC AT GT C A AC AGC T AC TT GT AT GG AGC ATT A A AGG AC ATC C GGGGT A AGT
TGGATAAAGATTGGTCAAGTTTCGGAATAAACATCGGGAAAGCAGGGGATAC
AATCGGAATATTTGACCTTGTATCCTTGAAAGCCCTGGACGGCGTACTTCCAG
AT GGAGT ATCGG AT GCTTCC AGAACC AGCGC AGAT GAC AAAT GGTT GCCTTT
GTATCTACTTGGCTTATACAGAGTGGGCAGAACACAAATGCCTGAATACAGA
A A A A AGC TC AT GGAT GGGC T GAC A A AT C A AT GCA A A AT GAT C A AT GA AC AGT
TTGAACCTCTTGTGCCAGAAGGTCGTGACATTTTTGATGTGTGGGGAAATGAC
AGTAATTACACAAAAATTGTCGCTGCAGTGGACATGTTCTTCCACATGTTCAA
AAAACATGAATGTGCCTCGTTCAGATACGGAACTATTGTTTCCAGATTCAAAG
ATTGTGCTGCATTGGCAACATTTGGACACCTCTGCAAAATAACCGGAATGTCT
ACAGAAGATGTAACGACCTGGATCTTGAACCGAGAAGTTGCAGATGAAATGG
TCCAAATGATGCTTCCAGGCCAAGAAATTGACAAGGCCGATTCATACATGCC
TTATTTGATCGACTTTGGATTGTCTTCTAAGTCTCCATATTCTTCCGTCAAAAA
CCCTGCCTTCCACTTCTGGGGGCAATTGACAGCTCTTCTGCTCAGATCCACCA
GAGCAAGGAATGCCCGACAGCCTGATGACATTGAGTATACATCTCTTACTAC AGCAGGTTTGTTGTACGCTTATGCAGTAGGATCCTCTGCCGACTTGGCACAAC
AGTTTTGTGTTGGAGATAACAAATACACTCCAGATGATAGTACCGGAGGATT
GACGACTAATGCACCGCCACAAGGCAGAGATGTGGTCGAATGGCTCGGATGG
T TT G A AG AT C A A A AC AG A A A AC C G AC TC C T GAT AT GAT GC AGT AT GC G A A A A
GAGCAGTCATGTCACTGCAAGGCCTAAGAGAGAAGACAATTGGCAAGTATGC
TAAGTCAGAATTTGACAAATGACCCTATAATTCTCAGATCACCTATTATATAT
TATGCTACATATGAAAAAAACTAACAGATATCATGGATAATCTCACAAAAGT
TCGTGAGTATCTCAAGTCCTATTCTCGTCTGGATCAGGCGGTAGGAGAGATAG
ATGAGATCGAAGCACAACGAGCTGAAAAGTCCAATTATGAGTTGTTCCAAGA
GGATGGAGTGGAAGAGCATACTAAGCCCTCTTATTTTCAGGCAGCAGATGAT
TCTGAC AC AGA AT C T GA AC C AG A A ATT GA AG AC A AT C A AGGTTT GT AT GC AC
CAGATCCAGAAGCTGAGCAAGTTGAAGGCTTTATACAGGGGCCTTTAGATGA
CT AT GC AGAT GAGGAAGT GGAT GTT GT ATTT ACTTCGGACTGGAAAC AGCCT
GAGCTTGAATCTGACGAGCATGGAAAGACCTTACGGTTGACATCGCCAGAGG
GTTTAAGTGGAGAGCAGAAATCCCAGTGGCTTTCGACGATTAAAGCAGTCGT
GC AAAGTGCC AAAT ACTGGAATCTGGC AGAGT GC AC ATTTGAAGC ATCGGGA
G A AGGGGT C AT T AT G A AGG AGC GC C AG AT A AC T C C GGAT GT AT AT A AGGT C A
CTCCAGTGATGAACACACATCCGTCCCAATCAGAAGCAGTATCAGATGTTTG
GTCTCTCTCAAAGACATCCATGACTTTCCAACCCAAGAAAGCAAGTCTTCAGC
CTCTCACCATATCCTTGGATGAATTGTTCTCATCTAGAGGAGAGTTCATCTCT
GTCGGAGGTGACGGACGAATGTCTCATAAAGAGGCCATCCTGCTCGGCCTGA
GATACAAAAAGTTGTACAATCAGGCGAGAGTCAAATATTCTCTGTAGACTAT
GAAAAAAAGTAACAGATATCACGATCTAAGTGTTATCCCAATCCATTCATCA
T G AGTT C C TT A A AG A AG AT TC TC GGT C T G A AGGGG A A AGGT A AG A A AT C T A A
GAAATTAGGGATCGCACCACCCCCTTATGAAGAGGACACTAGCATGGAGTAT
GCTCCGAGCGCTCCAATTGACAAATCCTATTTTGGAGTTGACGAGATGGACA
CCTATGATCCGAATCAATTAAGATATGAGAAATTCTTCTTTACAGTGAAAATG
ACGGTTAGATCTAATCGTCCGTTCAGAACATACTCAGATGTGGCAGCCGCTGT
ATCCCATTGGGATCACATGTACATCGGAATGGCAGGGAAACGTCCCTTCTAC
AAAATCTTGGCTTTTTTGGGTTCTTCTAATCTAAAGGCCACTCCAGCGGTATT
GGCAGATCAAGGTCAACCAGAGTATCACACTCACTGCGAAGGCAGGGCTTAT
TTGCCACATAGGATGGGGAAGACCCCTCCCATGCTCAATGTACCAGAGCACT
T C AGAAGACC ATTC AAT AT AGGTCTTT AC AAGGGAACGATTGAGCTC AC A AT
GACCATCTACGATGATGAGTCACTGGAAGCAGCTCCTATGATCTGGGATCATT TCAATTCTTCCAAATTTTCTGATTTCAGAGAGAAGGCCTTAATGTTTGGCCTG
ATTGTCGAGAAAAAGGCATCTGGAGCGTGGGTCCTGGATTCTATCAGCCACT
TCAAATGAGCTAGTCTAACTTCTAGCTTCTGAACAATCCCCGGTTTACTCAGT
CTCTCCTAATTCCAGCCTCTCGAACAACTAATATCCTGTCTTTTCTATCCCTAT
GAAAAAAACTAACAGAGATCGATCTGTTTACGCGTCACTATGAAGTGCCTTTT
GTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCC
ACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGC
CCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCATAC
A AGT C A A A AT GCC C A AGAGTC AC A AGGC T ATT C A AGC AGACGGTT GGAT GT G
TCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGT
ATATAACACAGTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGA
AAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCT
C AAAGTT GTGGAT AT GC AACTGT GACGGAT GCCGAAGC AGT GATTGTCC AGG
TGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCA
CAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTC
TACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCA
TTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGA
AAGGAGGGC AC AGGGTT C AGAAGT AACT ACTTTGCTT AT GAAACTGGAGGC A
AGGCCTGC AAAAT GC AAT ACTGC AAGC ATT GGGGAGTC AGACTCCC ATC AGG
TGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTG
AATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTA
AGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAAC
CTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATC
TTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCT
C T C A AG A AT GGT C GG A AT GAT C AGT GG A AC T AC C AC AG A A AGGG A AC TGT GG
GAT GACTGGGC ACC AT AT GAAGACGT GGAAATTGGACCC AAT GGAGTTCTGA
GGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTG
GACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACAT
TCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATA
CTGGGCT ATCC AAAAATCC AATCGAGCTTGT AGAAGGTT GGTTC AGT AGTT G
GAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATT
CTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGA
AAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAA ATCCTGCTAGGTATGAAAAAAACTAACaGATATCACGCTCGAGCGTACGCCA
CCATGTTCGTGTTTCTGGTGCTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAAC
TTCACCACAAGGACCCAGCTGCCCCCTGCCTATACCAATTCCTTCACACGGGG
CGTGTACTATCCCGACAAGGTGTTCCGGAGCAGCGTGCTGCACTCCACACAG
GATCTGTTTCTGCCTTTCTTTTCTAACGTGACCTGGTTCCACGCCATCCACGTG
AGCGGCACCAATGGCACAAAGCGGTTCGCCAATCCAGTGCTGCCCTTTAACG
ATGGCGTGTACTTCGCCTCCACCGAGAAGTCTAACATCATCAGAGGCTGGAT
CTTTGGCACCACACTGGACAGCAAGACACAGTCCCTGCTGATCGTGAACAAT
GCCACCAACGTGGTCATCAAGGTGTGCGAGTTCCAGTTTTGTAATGATCCATT
CC T GGGC GT GT AC T AT C AC A AG A AC A AT A AGT C TT GGAT GGAGAGC GAGTTT
CGCGTGTATTCCTCTGCCAACAATTGCACATTTGAGTACGTGTCCCAGCCCTT
CCTGAT GGACCTGGAGGGC AAGC AGGGC AATTT C AAGA ACCTGAGGGAGTT C
GTGTTTAAGAATATCGATGGCTACTTCAAAATCTACTCCAAGCACACCCCAAT
CAACCTGGTGCGCGGCCTGCCACAGGGCTTCTCTGCCCTGGAGCCACTGGTG
GATCTGCCCATCGGCATCAACATCACCCGGTTTCAGACACTGCTGGCCCTGCA
CAGAAGCTACCTGACACCAGGCGACAGCTCCTCTGGATGGACCGCAGGAGCA
GCAGCCTACTATGTGGGCTATCTGCAGCCCAGGACCTTCCTGCTGAAGTACAA
CGAGAATGGCACCATCACAGACGCCGTGGATTGCGCCCTGGATCCCCTGTCT
GAGACCAAGTGTACACTGAAGAGCTTTACCGTGGAGAAGGGCATCTATCAGA
CAAGCAATTTCAGGGTGCAGCCTACCGAGTCCATCGTGCGCTTTCCCAATATC
ACAAACCTGTGCCCTTTTGGCGAGGTGTTCAACGCAACCCGCTTCGCCAGCGT
GTACGCCTGGAATAGGAAGCGCATCTCCAACTGCGTGGCCGACTATTCTGTG
CTGTACAACAGCGCCTCCTTCTCTACCTTTAAGTGCTATGGCGTGAGCCCCAC
AAAGCTGAATGACCTGTGCTTTACCAACGTGTACGCCGATTCCTTCGTGATCA
GGGGCGACGAGGTGCGCCAGATCGCACCAGGACAGACAGGCAATATCGCAG
ACTACAATTATAAGCTGCCTGACGATTTCACCGGCTGCGTGATCGCCTGGAAC
TC T A AC A AT C T GGAT AGC A A AGT GGGC GGC A AC T AC A AT T AT C T GT AC C GGC
TGTTTAGAAAGTCTAATCTGAAGCCATTCGAGAGGGACATCTCCACAGAAAT
CTACCAGGCCGGCTCTACCCCCTGCAATGGCGTGAAGGGCTTTAACTGTTATT
TCCCTCTGCAGAGCTACGGCTTCCAGCCAACATATGGCGTGGGCTATCAGCCC
TACCGCGTGGTGGTGCTGTCTTTTGAGCTGCTGCACGCACCTGCAACAGTGTG
CGGACC A A AGA AGAGC AC C A ATCTGGT GA AG A AC A AGT GC GT GA ACTT C A A
CTTCAACGGACTGACCGGAACAGGCGTGCTGACCGAGTCCAACAAGAAGTTC
CTGCCTTTTCAGCAGTTCGGCAGGGACATCGCAGATACCACAGACGCCGTGC GCGACCCTCAGACCCTGGAGATCCTGGACATCACACCATGCTCCTTCGGCGG
CGTGTCTGTGATCACACCAGGCACCAATACAAGCAACCAGGTGGCCGTGCTG
TATCAGGGCGTGAATTGTACCGAGGTGCCAGTGGCAATCCACGCAGATCAGC
TGACCCCTACATGGCGGGTGTACTCTACCGGCAGCAACGTGTTCCAGACAAG
AGCCGGATGCCTGATCGGAGCAGAGCACGTGAACAATAGCTATGAGTGCGAC
ATCCCTATCGGCGCCGGCATCTGTGCCTCCTACCAGACCCAGACAAACTCCCC
AGAATCAAGCGTGATTCCTCTGGTCCATCCACTGGCAGATCCCTCCACAGTGT
TCAAAGACGGAGATGAGGCCGAAGACTTTGTGGAAGTCCACCTGCCTGATGT
GCATAACCAGGTGTCTGGCGTCGACCTGGGACTGCCAAATTGGGGCAAGTAC
GTGCTGCTGAGTGCTGGAGCACTGACTGCCCTGATGCTGATCATTTTCCTGAT
GACCTGCTGTCGGCGCGTGAACAGAAGTGAGCCCACTCAGCACAATCTGCGA
GGAACCGGGAGAGAAGTGTCAGTCACACCTCAGAGCGGGAAAATCATTAGT
AGTTGGGAATCACATAAAAGCGGGGGCGAGACCAGGCTGTGAGCTAGCCAG
ATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTC
AATT AT ATTT GAGTTTTT AATTTTT ATGA AAAAAACT AAC AGC AAT CAT GGAA
GTCCACGATTTTGAGACCGACGAGTTCAATGATTTCAATGAAGATGACTATGC
CACAAGAGAATTCCTGAATCCCGATGAGCGCATGACGTACTTGAATCATGCT
GATTACAATTTGAATTCTCCTCTAATTAGTGATGATATTGACAATTTGATCAG
GAAATTCAATTCTCTTCCGATTCCCTCGATGTGGGATAGTAAGAACTGGGATG
GAGTTCTTGAGATGTTAACATCATGTCAAGCCAATCCCATCTCAACATCTCAG
AT GC AT A A AT GGAT GGGA AGTTGGTT AAT GT C T GAT AAT CAT GAT GCC AGT C
AAGGGT AT AGTTTTTT AC ATGA AGTGGAC AAAGAGGC AGAAAT AAC ATTT GA
CGT GGTGGAGACCTT CATCCGCGGCTGGGGC AAC AA ACC AATT GAAT AC AT C
AAAAAGGAAAGATGGACTGACTCATTCAAAATTCTCGCTTATTTGTGTCAAA
AGTTTTTGGACTTACACAAGTTGACATTAATCTTAAATGCTGTCTCTGAGGTG
GAATTGCTCAACTTGGCGAGGACTTTCAAAGGCAAAGTCAGAAGAAGTTCTC
ATGGAACGAACATATGCAGGATTAGGGTTCCCAGCTTGGGTCCTACTTTTATT
TCAGAAGGATGGGCTTACTTCAAGAAACTTGATATTCTAATGGACCGAAACT
TTCTGTTAATGGTCAAAGATGTGATTATAGGGAGGATGCAAACGGTGCTATCC
ATGGTATGTAGAATAGACAACCTGTTCTCAGAGCAAGACATCTTCTCCCTTCT
AAAT ATCT AC AGAATTGGAGAT AAAATTGTGGAGAGGC AGGGAAATTTTTCT
T AT GAC TT GATT A A A AT GGT GGA ACC GAT AT GCA AC TT GA AGC T GAT GA A AT
TAGCAAGAGAATCAAGGCCTTTAGTCCCACAATTCCCTCATTTTGAAAATCAT
ATCAAGACTTCTGTTGATGAAGGGGCAAAAATTGACCGAGGTATAAGATTCC TCCATGATCAGATAATGAGTGTGAAAACAGTGGATCTCACACTGGTGATTTAT
GGATCGTTCAGACATTGGGGTCATCCTTTTATAGATTATTACACTGGACTAGA
A A A ATT AC ATTCC C A AGT A AC CAT GA AG A A AG AT ATT GAT GT GT CAT AT GCA
AAAGCACTTGCAAGTGATTTAGCTCGGATTGTTCTATTTCAACAGTTCAATGA
TCATAAAAAGTGGTTCGTGAATGGAGACTTGCTCCCTCATGATCATCCCTTTA
AAAGT C ATGTT AAAGAAAAT AC AT GGCCC AC AGCTGCTC AAGTTC AAGATTT
TGGAGATAAATGGCATGAACTTCCGCTGATTAAATGTTTTGAAATACCCGACT
TACTAGACCCATCGATAATATACTCTGACAAAAGTCATTCAATGAATAGGTC
AGAGGTGTTGAAACATGTCCGAATGAATCCGAACACTCCTATCCCTAGTAAA
AAGGT GTT GC AG ACT AT GTTGGAC AC AAAGGCT ACC AATTGGAAAGAATTTC
TTAAAGAGATTGATGAGAAGGGCTTAGATGATGATGATCTAATTATTGGTCTT
AAAGGAAAGGAGAGGGAACTGAAGTTGGCAGGTAGATTTTTCTCCCTAATGT
CTTGGAAATTGCGAGAATACTTTGTAATTACCGAATATTTGATAAAGACTCAT
TTCGTCCCTATGTTTAAAGGCCTGACAATGGCGGACGATCTAACTGCAGTCAT
T A A A A AG AT GTT AGATTC CTC AT C CGGC C A AGGATT GA AGT CAT AT G AGGC A
ATTT GC AT AGCC A ATC AC ATTGATT ACGAAAAAT GGAAT AACC ACC AAAGGA
AGTTATCAAACGGCCCAGTGTTCCGAGTTATGGGCCAGTTCTTAGGTTATCCA
TCCTTAATCGAGAGAACTCATGAATTTTTTGAGAAAAGTCTTATATACTACAA
TGGAAGACCAGACTTGATGCGTGTTCACAACAACACACTGATCAATTCAACC
TCCC AACGAGTTTGTTGGC AAGGAC A AGAGGGT GGACTGGAAGGTCT ACGGC
AAAAAGGAT GGACT ATCCTC AATCT ACTGGTT ATT C AAAGAGAGGCT AAAAT
C AGA AAC ACTGCTGT CAAAGTCTTGGC AC AAGGT GAT AATC AAGTT ATTTGC
AC AC AGT AT A A A ACGA AG A A AT C GAGA A AC GTT GT AG A ATT AC AGGGT GC T C
T C A AT C A A AT GGTTTCT A AT A AT GAGA A A ATT AT GAC T GCA AT C A A A AT AGG
GACAGGG AAGTT AGGACTTTT GAT AAAT GACGAT GAGACT AT GC AATCTGC A
GATTACTTGAATTATGGAAAAATACCGATTTTCCGTGGAGTGATTAGAGGGTT
AG AG AC C A AG AG AT GGT C AC GAGT GACTTGT GT C AC C A AT GACC A A AT AC CC
ACTTGTGCTAATATAATGAGCTCAGTTTCCACAAATGCTCTCACCGTAGCTCA
TTTTGCTGAGAACCC AAT C AAT GCC ATGAT AC AGT AC A ATT ATTTT GGGAC AT
TTGCTAGACTCTTGTTGATGATGCATGATCCTGCTCTTCGTCAATCATTGTATG
AAGTTCAAGATAAGATACCGGGCTTGCACAGTTCTACTTTCAAATACGCCATG
TTGTATTTGGACCCTTCCATTGGAGGAGTGTCGGGCATGTCTTTGTCCAGGTTT
TTGATTAGAGCCTTCCCAGATCCCGTAACAGAAAGTCTCTCATTCTGGAGATT
CATCCATGTACATGCTCGAAGTGAGCATCTGAAGGAGATGAGTGCAGTATTT GGAAACCCCGAGATAGCCAAGTTTCGAATAACTCACATAGACAAGCTAGTAG
AAGATCCAACCTCTCTGAACATCGCTATGGGAATGAGTCCAGCGAACTTGTT
AAAGACTGAGGTTAAAAAATGCTTAATCGAATCAAGACAAACCATCAGGAAC
CAGGTGATTAAGGATGCAACCATATATTTGTATCATGAAGAGGATCGGCTCA
GAAGTTTCTTATGGTCAATAAATCCTCTGTTCCCTAGATTTTTAAGTGAATTCA
AATCAGGCACTTTTTTGGGAGTCGCAGACGGGCTCATCAGTCTATTTCAAAAT
TCTCGTACTATTCGGAACTCCTTTAAGAAAAAGTATCATAGGGAATTGGATGA
TTTGATTGTGAGGAGTGAGGTATCCTCTTTGACACATTTAGGGAAACTTCATT
T GAGA AGGGGAT CAT GT A A A AT GT GGAC AT GTT C AGC T ACTC AT GCTGAC AC
ATTAAGATACAAATCCTGGGGCCGTACAGTTATTGGGACAACTGTACCCCAT
CCATTAGAAATGTTGGGTCCACAACATCGAAAAGAGACTCCTTGTGCACCAT
GTAACACATCAGGGTTCAATTATGTTTCTGTGCATTGTCCAGACGGGATCCAT
GACGTCTTTAGTTCACGGGGACCATTGCCTGCTTATCTAGGGTCTAAAACATC
TGAATCTACATCTATTTTGCAGCCTTGGGAAAGGGAAAGCAAAGTCCCACTG
ATTAAAAGAGCTACACGTCTTAGAGATGCTATCTCTTGGTTTGTTGAACCCGA
CTCTAAACTAGCAATGACTATACTTTCTAACATCCACTCTTTAACAGGCGAAG
AATGGACCAAAAGGCAGCATGGGTTCAAAAGAACAGGGTCTGCCCTTCATAG
GTTTTCGACATCTCGGATGAGCCATGGTGGGTTCGCATCTCAGAGCACTGCAG
C ATTGACC AGGTT GATGGC AACT AC AGAC ACC ATGAGGGATCTGGGAGAT C A
GAATTTCGACTTTTTATTCCAAGCAACGTTGCTCTATGCTCAAATTACCACCA
CTGTTGCAAGAGACGGATGGATCACCAGTTGTACAGATCATTATCATATTGCC
TGTAAGTCCTGTTTGAGACCCATAGAAGAGATCACCCTGGACTCAAGTATGG
ACTACACGCCCCCAGATGTATCCCATGTGCTGAAGACATGGAGGAATGGGGA
AGGTTCGTGGGGAC AAGAGAT AAAAC AGATCT ATCCTTT AGAAGGGAATTGG
AAGAATTTAGCACCTGCTGAGCAATCCTATCAAGTCGGCAGATGTATAGGTTT
TCTATATGGAGACTTGGCGTATAGAAAATCTACTCATGCCGAGGACAGTTCTC
TATTTCCTCTATCTATACAAGGTCGTATTAGAGGTCGAGGTTTCTTAAAAGGG
TTGCT AGAC GG ATT AAT GAGAGC A AGTT GCTGCC AAGT AAT AC ACCGGAGAA
GTCTGGCTCATTTGAAGAGGCCGGCCAACGCAGTGTACGGAGGTTTGATTTA
CTTGATTGATAAATTGAGTGTATCACCTCCATTCCTTTCTCTTACTAGATCAGG
ACCTATTAGAGACGAATTAGAAACGATTCCCCACAAGATCCCAACCTCCTAT
CCGACAAGCAACCGTGATATGGGGGTGATTGTCAGAAATTACTTCAAATACC
AATGCCGTCTAATTGAAAAGGGAAAATACAGATCACATTATTCACAATTATG
GTTATTCTCAGATGTCTTATCCATAGACTTCATTGGACCATTCTCTATTTCCAC CACCCTCTTGCAAATCCTATACAAGCCATTTTTATCTGGGAAAGATAAGAATG
AGTTGAGAGAGCTGGCAAATCTTTCTTCATTGCTAAGATCAGGAGAGGGGTG
GGA AGAC AT AC AT GT GA A ATTC TT C AC C A AGGAC AT ATT ATT GT GT C C AGAG
GAAAT C AG AC AT GCTTGC AAGTTCGGGATTGCT AAGGAT AAT A AT AAAGAC A
TGAGCTATCCCCCTTGGGGAAGGGAATCCAGAGGGACAATTACAACAATCCC
TGTTTATTATACGACCACCCCTTACCCAAAGATGCTAGAGATGCCTCCAAGAA
TCCAAAATCCCCTGCTGTCCGGAATCAGGTTGGGCCAATTACCAACTGGCGCT
CATTATAAAATTCGGAGTATATTACATGGAATGGGAATCCATTACAGGGACTT
CTTGAGTTGTGGAGACGGCTCCGGAGGGATGACTGCTGCATTACTACGAGAA
AATGTGCATAGCAGAGGAATATTCAATAGTCTGTTAGAATTATCAGGGTCAG
TCATGCGAGGCGCCTCTCCTGAGCCCCCCAGTGCCCTAGAAACTTTAGGAGG
AG AT A A AT C GAG AT GT GT A A AT GGT G A A AC AT GT T GGG A AT ATCCATCT G AC
TTATGTGACCCAAGGACTTGGGACTATTTCCTCCGACTCAAAGCAGGCTTGGG
GCTTCAAATTGATTTAATTGTAATGGATATGGAAGTTCGGGATTCTTCTACTA
GCCTGAAAATTGAGACGAATGTTAGAAATTATGTGCACCGGATTTTGGATGA
GC A AGGAGTTTT AATCT AC AAGACTT AT GGAAC AT AT ATTTGT GAGAGCGAA
A AG A AT GC AGT A AC A AT C CTT GGTCC C AT GTT C A AGAC GGTCGAC TT AGTT C A
AACAGAATTTAGTAGTTCTCAAACGTCTGAAGTATATATGGTATGTAAAGGTT
TGAAGAAATTAATCGATGAACCCAATCCCGATTGGTCTTCCATCAATGAATCC
TGGAAAAACCTGTACGCATTCCAGTCATCAGAACAGGAATTTGCCAGAGCAA
AGAAGGTTAGTACATACTTTACCTTGACAGGTATTCCCTCCCAATTCATTCCT
GATCCTTTTGTAAACATTGAGACTATGCTACAAATATTCGGAGTACCCACGGG
TGTGTCTCATGCGGCTGCCTTAAAATCATCTGATAGACCTGCAGATTTATTGA
CCATTAGCCTTTTTTATATGGCGATTATATCGTATTATAACATCAATCATATCA
GAGTAGGACCGATACCTCCGAACCCCCCATCAGATGGAATTGCACAAAATGT
GGGGATCGCTATAACTGGTATAAGCTTTTGGCTGAGTTTGATGGAGAAAGAC
ATTCCACTATATCAACAGTGTTTAGCAGTTATCCAGCAATCATTCCCGATTAG
GT GGGAGGCTGTTTC AGT AAAAGGAGGAT AC AAGC AGAAGT GGAGT ACT AG
AGGTGATGGGCTCCCAAAAGATACCCGAACTTCAGACTCCTTGGCCCCAATC
GGGAACTGGATCAGATCTCTGGAATTGGTCCGAAACCAAGTTCGTCTAAATC
CATTCAATGAGATCTTGTTCAATCAGCTATGTCGTACAGTGGATAATCATTTG
AAAT GGT C AAATTT GCGAAGAAAC AC AGGAAT GATT GAAT GGATC AAT AGAC
GAATTTCAAAAGAAGACCGGTCTATACTGATGTTGAAGAGTGACCTACACGA
GGA A A AC TC TT GGAGAGATT A A A A A AT CAT GAGGAGACTCC A A AC TTT A AGT ATGAAAAAAACTTTGATCCTTAAGACCCTCTTGTGGTTTTTATTTTTTATCTGG
TTTTGTGGTCTTCGT.
In one embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 22, shown below (VSV vector: Convac V3 China):
ACGAAGAC AAAC AAACC ATT ATT AT C ATT AAAAGGCTC AGGAGAAACTTT AA
C AGT AAT C AAA ATGTCTGTT AC AGTC AAGAGAAT C ATTGAC AAC AC AGTC AT
AGTTCCAAAACTTCCTGCAAATGAGGATCCAGTGGAATACCCGGCAGATTAC
TTCAGAAAATCAAAGGAGATTCCTCTTTACATCAATACTACAAAAAGTTTGTC
AGATCTAAGAGGATATGTCTACCAAGGCCTCAAATCCGGAAATGTATCAATC
AT AC AT GT C A AC AGC T AC TT GT AT GG AGC ATT A A AGG AC ATC C GGGGT A AGT
TGGATAAAGATTGGTCAAGTTTCGGAATAAACATCGGGAAAGCAGGGGATAC
AATCGGAATATTTGACCTTGTATCCTTGAAAGCCCTGGACGGCGTACTTCCAG
AT GGAGT ATCGGAT GCTTCC AGAACC AGCGC AGAT GAC AAAT GGTT GCCTTT
GTATCTACTTGGCTTATACAGAGTGGGCAGAACACAAATGCCTGAATACAGA
A A A A AGC TC AT GGAT GGGC T GAC A A AT C A AT GCA A A AT GAT C A AT GA AC AGT
TTGAACCTCTTGTGCCAGAAGGTCGTGACATTTTTGATGTGTGGGGAAATGAC
AGTAATTACACAAAAATTGTCGCTGCAGTGGACATGTTCTTCCACATGTTCAA
AAAACATGAATGTGCCTCGTTCAGATACGGAACTATTGTTTCCAGATTCAAAG
ATTGTGCTGCATTGGCAACATTTGGACACCTCTGCAAAATAACCGGAATGTCT
ACAGAAGATGTAACGACCTGGATCTTGAACCGAGAAGTTGCAGATGAAATGG
TCCAAATGATGCTTCCAGGCCAAGAAATTGACAAGGCCGATTCATACATGCC
TTATTTGATCGACTTTGGATTGTCTTCTAAGTCTCCATATTCTTCCGTCAAAAA
CCCTGCCTTCCACTTCTGGGGGCAATTGACAGCTCTTCTGCTCAGATCCACCA
GAGCAAGGAATGCCCGACAGCCTGATGACATTGAGTATACATCTCTTACTAC
AGCAGGTTTGTTGTACGCTTATGCAGTAGGATCCTCTGCCGACTTGGCACAAC
AGTTTTGTGTTGGAGATAACAAATACACTCCAGATGATAGTACCGGAGGATT
GACGACTAATGCACCGCCACAAGGCAGAGATGTGGTCGAATGGCTCGGATGG
T TT G A AG AT C A A A AC AG A A A AC C GAC TC C T GAT AT GAT GC AGT AT GC G A A A A
GAGCAGTCATGTCACTGCAAGGCCTAAGAGAGAAGACAATTGGCAAGTATGC
TAAGTCAGAATTTGACAAATGACCCTATAATTCTCAGATCACCTATTATATAT
TATGCTACATATGAAAAAAACTAACAGATATCATGGATAATCTCACAAAAGT
TCGTGAGTATCTCAAGTCCTATTCTCGTCTGGATCAGGCGGTAGGAGAGATAG
ATGAGATCGAAGCACAACGAGCTGAAAAGTCCAATTATGAGTTGTTCCAAGA
GGATGGAGTGGAAGAGCATACTAAGCCCTCTTATTTTCAGGCAGCAGATGAT TCTGAC AC AGA AT C T GA AC C AG A A ATT GA AG AC A AT C A AGGTTT GT AT GC AC
CAGATCCAGAAGCTGAGCAAGTTGAAGGCTTTATACAGGGGCCTTTAGATGA
CT AT GC AGAT GAGGAAGT GGAT GTT GT ATTT ACTTCGGACTGGAAAC AGCCT
GAGCTTGAATCTGACGAGCATGGAAAGACCTTACGGTTGACATCGCCAGAGG
GTTTAAGTGGAGAGCAGAAATCCCAGTGGCTTTCGACGATTAAAGCAGTCGT
GC AAAGTGCC AAAT ACTGGAATCTGGC AGAGT GC AC ATTTGAAGC ATCGGGA
G A AGGGGT C AT T AT G A AGG AGC GC C AG AT A AC T C C GGAT GT AT AT A AGGT C A
CTCCAGTGATGAACACACATCCGTCCCAATCAGAAGCAGTATCAGATGTTTG
GTCTCTCTCAAAGACATCCATGACTTTCCAACCCAAGAAAGCAAGTCTTCAGC
CTCTCACCATATCCTTGGATGAATTGTTCTCATCTAGAGGAGAGTTCATCTCT
GTCGGAGGTGACGGACGAATGTCTCATAAAGAGGCCATCCTGCTCGGCCTGA
GATACAAAAAGTTGTACAATCAGGCGAGAGTCAAATATTCTCTGTAGACTAT
GAAAAAAAGTAACAGATATCACGATCTAAGTGTTATCCCAATCCATTCATCA
T G AGTT C C TT A A AG A AG AT TC TC GGT C T G A AGGGG A A AGGT A AG A A AT C T A A
GAAATTAGGGATCGCACCACCCCCTTATGAAGAGGACACTAGCATGGAGTAT
GCTCCGAGCGCTCCAATTGACAAATCCTATTTTGGAGTTGACGAGATGGACA
CCTATGATCCGAATCAATTAAGATATGAGAAATTCTTCTTTACAGTGAAAATG
ACGGTTAGATCTAATCGTCCGTTCAGAACATACTCAGATGTGGCAGCCGCTGT
ATCCCATTGGGATCACATGTACATCGGAATGGCAGGGAAACGTCCCTTCTAC
AAAATCTTGGCTTTTTTGGGTTCTTCTAATCTAAAGGCCACTCCAGCGGTATT
GGCAGATCAAGGTCAACCAGAGTATCACACTCACTGCGAAGGCAGGGCTTAT
TTGCCACATAGGATGGGGAAGACCCCTCCCATGCTCAATGTACCAGAGCACT
T C AGAAGACC ATTC AAT AT AGGTCTTT AC AAGGGAACGATTGAGCTC AC A AT
GACCATCTACGATGATGAGTCACTGGAAGCAGCTCCTATGATCTGGGATCATT
TCAATTCTTCCAAATTTTCTGATTTCAGAGAGAAGGCCTTAATGTTTGGCCTG
ATTGTCGAGAAAAAGGCATCTGGAGCGTGGGTCCTGGATTCTATCAGCCACT
TCAAATGAGCTAGTCTAACTTCTAGCTTCTGAACAATCCCCGGTTTACTCAGT
CTCTCCTAATTCCAGCCTCTCGAACAACTAATATCCTGTCTTTTCTATCCCTAT
GAAAAAAACTAACAGAGATCGATCTGTTTACGCGTCACTATGAAGTGCCTTTT
GTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCC
ACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGC
CCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCATAC
A AGT C A A A AT GCC C A AGAGTC AC A AGGC T ATT C A AGC AGACGGTT GGAT GT G
TCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGT ATATAACACAGTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGA
AAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCT
C AAAGTT GTGGAT AT GC AACTGT GACGGAT GCCGAAGC AGT GATTGTCC AGG
TGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCA
CAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTC
TACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCA
TTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGA
AAGGAGGGC AC AGGGTT C AGAAGT AACT ACTTTGCTT AT GAAACTGGAGGC A
AGGCCTGC AAAAT GC AAT ACTGC AAGC ATT GGGGAGTC AGACTCCC ATC AGG
TGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTG
AATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTA
AGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAAC
CTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATC
TTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCT
C T C A AG A AT GGT C GG A AT GAT C AGT GG A AC T AC C AC AG A A AGGG A AC TGT GG
GAT GACTGGGC ACC AT AT GAAGACGT GGAAATTGGACCC AAT GGAGTTCTGA
GGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTG
GACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACAT
TCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATA
CTGGGCT ATCC AAAAATCC AATCGAGCTTGT AGAAGGTT GGTTC AGT AGTT G
GAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATT
CTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGA
AAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAA
ATCCTGCT AGGT ATGA AAAAAACT AACaGAT ATC ACGCtcgagGCC ACC AT GTT C
GTGTTTCTGGTGCTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAACCTGACCAC
AAGGACCCAGCTGCCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACT
ATCCCGACAAGGTGTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTT
CTGCCTTTCTTTTCTAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCAC
CAATGGCACAAAGCGGTTCGACAATCCAGTGCTGCCCTTTAACGATGGCGTG
TACTTCGCCTCCACCGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCAC
CACACTGGACAGCAAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAAC
GTGGTCATCAAGGTGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGT
GT ACT AT C AC A AG A AC A AT A AGT C TT GGAT GGAGAGCG AGTTTC GCGT GT AT TCCTCTGCCAACAATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGA
CCTGGAGGGCAAGCAGGGCAATTTCAAGAACCTGAGGGAGTTCGTGTTTAAG
AATATCGATGGCTACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGT
GCGCGACCTGCCACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCA
TCGGCATCAACATCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTA
CCTGACACCAGGCGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTAC
TATGTGGGCTATCTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATG
GCACCATCACAGACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAA
GTGTACACTGAAGAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAAT
TTCAGGGTGCAGCCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCT
GTGCCCTTTTGGCGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCT
GGAATAGGAAGCGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAA
CAGCGCCTCCTTCTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGA
ATGACCTGTGCTTTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGAC
GAGGTGCGCCAGATCGCACCAGGACAGACAGGCAAGATCGCAGACTACAAT
TATAAGCTGCCTGACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAA
TCTGGATAGCAAAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGA
AAGTCTAATCTGAAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGG
CCGGCTCTACCCCCTGCAATGGCGTGGAGGGCTTTAACTGTTATTTCCCTCTG
CAGAGCTACGGCTTCCAGCCAACAAACGGCGTGGGCTATCAGCCCTACCGCG
TGGTGGTGCTGTCTTTTGAGCTGCTGCACGCACCTGCAACAGTGTGCGGACCA
AAGAAGAGCACCAATCTGGTGAAGAACAAGTGCGTGAACTTCAACTTCAACG
GACTGACCGGAACAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTT
TCAGCAGTTCGGCAGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCT
CAGACCCTGGAGATCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGT
GATCACACCAGGCACCAATACAAGCAACCAGGTGGCCGTGCTGTATCAGGAC
GTGAATTGTACCGAGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTA
CAT GGCGGGTGT ACTCT ACCGGC AGC AACGT GTTCC AGAC AAGAGCCGGATG
CCTGATCGGAGCAGAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATC
GGCGCCGGCATCTGTGCCTCCTACCAGACCCAGACAAACTCCCCAAGGTCTG
GATCCGGCTACATCCCCGAGGCCCCCAGAGACGGCCAGGCCTACGTGCGGAA
GGACGGCGAGTGGGTACTGctcagcaccttcctgggcAGCAGTTGGAAAAGCTCCATCG
CCTCCTTTTTCTTTATCATCGGCCTGATCATCGGACTGTTCCTGGTGCTCCGCG
T GGGT ATCC ACCTGT GC AT C AAGCTGAAGC AC ACC AAGA AAAGAC AGATTT A TACAGACATCGAGATGAACCGACTTGGAAAGTAAGCTAGCCAGATTCTTCAT
GTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATT
TGAGTTTTTAATTTTTATGAAAAAAACTAACAGCAATCATGGAAGTCCACGAT
TTTGAGACCGACGAGTTCAATGATTTCAATGAAGATGACTATGCCACAAGAG
AATTCCTGAATCCCGATGAGCGCATGACGTACTTGAATCATGCTGATTACAAT
TTGAATTCTCCTCTAATTAGTGATGATATTGACAATTTGATCAGGAAATTCAA
TTCTCTTCCGATTCCCTCGATGTGGGATAGTAAGAACTGGGATGGAGTTCTTG
AGATGTTAACATCATGTCAAGCCAATCCCATCTCAACATCTCAGATGCATAAA
T GGAT GGGA AGTT GGTT A AT GTCTG AT A AT CAT GAT GC C AGT C A AGGGT AT A
GTTTTTTACATGAAGTGGACAAAGAGGCAGAAATAACATTTGACGTGGTGGA
GACCTTCATCCGCGGCTGGGGCAACAAACCAATTGAATACATCAAAAAGGAA
AGATGGACTGACTCATTCAAAATTCTCGCTTATTTGTGTCAAAAGTTTTTGGA
CTTACACAAGTTGACATTAATCTTAAATGCTGTCTCTGAGGTGGAATTGCTCA
ACTTGGCGAGGACTTT C AAAGGC AAAGT C AGAAGAAGTTCTC AT GGAACGAA
CATATGCAGGATTAGGGTTCCCAGCTTGGGTCCTACTTTTATTTCAGAAGGAT
GGGCTTACTTCAAGAAACTTGATATTCTAATGGACCGAAACTTTCTGTTAATG
GT C A A AG AT GT GATT AT AGGGAGGAT GC A A ACGGT GCT AT C CAT GGT AT GT A
GAATAGACAACCTGTTCTCAGAGCAAGACATCTTCTCCCTTCTAAATATCTAC
AGAATTGGAGATAAAATTGTGGAGAGGCAGGGAAATTTTTCTTATGACTTGA
TTAAAATGGTGGAACCGATATGCAACTTGAAGCTGATGAAATTAGCAAGAGA
ATCAAGGCCTTTAGTCCCACAATTCCCTCATTTTGAAAATCATATCAAGACTT
CTGTTGATGAAGGGGCAAAAATTGACCGAGGTATAAGATTCCTCCATGATCA
GAT AATGAGT GT GAAAAC AGT GGATCTC AC ACTGGT GATTT ATGGATCGTTC A
GACATTGGGGTCATCCTTTTATAGATTATTACACTGGACTAGAAAAATTACAT
TCCC A AGT A AC CAT GA AG A A AG AT ATT GAT GT GTC AT AT GC A A A AGC AC TTG
CAAGTGATTTAGCTCGGATTGTTCTATTTCAACAGTTCAATGATCATAAAAAG
TGGTTCGTGAATGGAGACTTGCTCCCTCATGATCATCCCTTTAAAAGTCATGT
TAAAGAAAATACATGGCCCACAGCTGCTCAAGTTCAAGATTTTGGAGATAAA
TGGCATGAACTTCCGCTGATTAAATGTTTTGAAATACCCGACTTACTAGACCC
ATCGATAATATACTCTGACAAAAGTCATTCAATGAATAGGTCAGAGGTGTTG
AAACATGTCCGAATGAATCCGAACACTCCTATCCCTAGTAAAAAGGTGTTGC
AGACTATGTTGGACACAAAGGCTACCAATTGGAAAGAATTTCTTAAAGAGAT
T GAT G AG A AGGGC T T AG AT GAT GAT GAT C T A AT T ATT GGT C TT A A AGG A A AG
GAGAGGGAACTGAAGTTGGCAGGTAGATTTTTCTCCCTAATGTCTTGGAAATT GCGAGAATACTTTGTAATTACCGAATATTTGATAAAGACTCATTTCGTCCCTA
TGTTTAAAGGCCTGACAATGGCGGACGATCTAACTGCAGTCATTAAAAAGAT
GTTAGATTCCTCATCCGGCCAAGGATTGAAGTCATATGAGGCAATTTGCATAG
CCAATCACATTGATTACGAAAAATGGAATAACCACCAAAGGAAGTTATCAAA
CGGCCCAGTGTTCCGAGTTATGGGCCAGTTCTTAGGTTATCCATCCTTAATCG
AGAGAACTCATGAATTTTTTGAGAAAAGTCTTATATACTACAATGGAAGACC
AGACTTGATGCGTGTTCACAACAACACACTGATCAATTCAACCTCCCAACGA
GTTT GTT GGC AAGGAC AAGAGGGT GGACTGGAAGGTCT ACGGC AAAAAGGA
T GGACT ATCCTC AATCT ACTGGTT ATT C AA AGAGAGGCT AAAAT C AGAA AC A
CTGCTGT C AAAGTCTTGGC AC AAGGT GAT AATC AAGTT ATTTGC AC AC AGT AT
AAAACGAAGAAATCGAGA AACGTTGT AGAATT AC AGGGT GCTCTC AATC AAA
T GGTT T C T A AT A AT GAG A A A AT TAT G AC T GC A AT C AAAAT AGGG AC AGGG A A
GTT AGGACTTTT GAT AAAT GACGAT GAGACT AT GC AATCTGC AGATT ACTT GA
ATTATGGAAAAATACCGATTTTCCGTGGAGTGATTAGAGGGTTAGAGACCAA
GAGATGGTCACGAGTGACTTGTGTCACCAATGACCAAATACCCACTTGTGCT
AATATAATGAGCTCAGTTTCCACAAATGCTCTCACCGTAGCTCATTTTGCTGA
GAACCC AAT C AAT GCC ATGAT AC AGT AC AATT ATTTTGGGAC ATTT GCT AGAC
TCTTGTTGATGATGCATGATCCTGCTCTTCGTCAATCATTGTATGAAGTTCAAG
ATAAGATACCGGGCTTGCACAGTTCTACTTTCAAATACGCCATGTTGTATTTG
GACCCTTCCATTGGAGGAGTGTCGGGCATGTCTTTGTCCAGGTTTTTGATTAG
AGCCTTCCCAGATCCCGTAACAGAAAGTCTCTCATTCTGGAGATTCATCCATG
T AC AT GC T C GA AGT GAGC ATCTGA AGGAGAT GAGT GC AGT ATTT GGA A AC CC
CGAGAT AGCC AAGTTTCGAAT AACTC AC AT AGAC AAGCT AGT AGAAGATCC A
ACCTCTCTGAACATCGCTATGGGAATGAGTCCAGCGAACTTGTTAAAGACTG
AGGTT A A A A A AT GC TT A ATCGA AT C A AG AC A A AC CAT C AGGA AC C AGGT GAT
TAAGGATGCAACCATATATTTGTATCATGAAGAGGATCGGCTCAGAAGTTTCT
TATGGTCAATAAATCCTCTGTTCCCTAGATTTTTAAGTGAATTCAAATCAGGC
ACTTTTTTGGGAGTCGCAGACGGGCTCATCAGTCTATTTCAAAATTCTCGTAC
T ATTCGGAACTCCTTT AAGAAAAAGT AT CAT AGGG AATT GGAT GATTT GATT G
TGAGGAGTGAGGTATCCTCTTTGACACATTTAGGGAAACTTCATTTGAGAAGG
GGATCATGTAAAATGTGGACATGTTCAGCTACTCATGCTGACACATTAAGAT
ACAAATCCTGGGGCCGTACAGTTATTGGGACAACTGTACCCCATCCATTAGA
AATGTTGGGTCCACAACATCGAAAAGAGACTCCTTGTGCACCATGTAACACA
TCAGGGTTCAATTATGTTTCTGTGCATTGTCCAGACGGGATCCATGACGTCTT TAGTTCACGGGGACCATTGCCTGCTTATCTAGGGTCTAAAACATCTGAATCTA
C ATCT ATTTT GC AGCCTTGGGAAAGGGAAAGC AAAGTCCC ACTGATT AAA AG
AGCTACACGTCTTAGAGATGCTATCTCTTGGTTTGTTGAACCCGACTCTAAAC
TAGCAATGACTATACTTTCTAACATCCACTCTTTAACAGGCGAAGAATGGACC
AAAAGGC AGC AT GGGTTC AAAAGAAC AGGGTCTGCCCTT CAT AGGTTTTCGA
CATCTCGGATGAGCCATGGTGGGTTCGCATCTCAGAGCACTGCAGCATTGAC
C AGGTT GATGGC AACT AC AGAC ACC ATGAGGGATCTGGGAGAT C AGAATTTC
GACTTTTTATTCCAAGCAACGTTGCTCTATGCTCAAATTACCACCACTGTTGC
A AG AG AC GGAT GGAT C AC C AGTT GT AC AGATC ATT ATC AT ATTGC CTGT A AG
TCCTGTTTGAGACCCATAGAAGAGATCACCCTGGACTCAAGTATGGACTACA
CGCCCCCAGATGTATCCCATGTGCTGAAGACATGGAGGAATGGGGAAGGTTC
GT GGGGAC A AG AGAT A A A AC AG AT C T ATCC TTT AGA AGGGA ATTGGA AGA AT
TTAGCACCTGCTGAGCAATCCTATCAAGTCGGCAGATGTATAGGTTTTCTATA
TGGAGACTTGGCGTATAGAAAATCTACTCATGCCGAGGACAGTTCTCTATTTC
CTCTATCTATACAAGGTCGTATTAGAGGTCGAGGTTTCTTAAAAGGGTTGCTA
GACGGATTAATGAGAGCAAGTTGCTGCCAAGTAATACACCGGAGAAGTCTGG
CTCATTTGAAGAGGCCGGCCAACGCAGTGTACGGAGGTTTGATTTACTTGATT
GATAAATTGAGTGTATCACCTCCATTCCTTTCTCTTACTAGATCAGGACCTATT
AGAGACGAATTAGAAACGATTCCCCACAAGATCCCAACCTCCTATCCGACAA
GCAACCGTGATATGGGGGTGATTGTCAGAAATTACTTCAAATACCAATGCCG
TCT AATTGAAAAGGGAAAAT AC AGAT C AC ATT ATT C AC AATT AT GGTT ATTCT
CAGATGTCTTATCCATAGACTTCATTGGACCATTCTCTATTTCCACCACCCTCT
TGCAAATCCTATACAAGCCATTTTTATCTGGGAAAGATAAGAATGAGTTGAG
AGAGCTGGC AAATCTTTCTTC ATT GCT AAGAT C AGGAGAGGGGT GGGAAGAC
AT AC AT GTGAAATTCTT C ACC AAGGAC AT ATT ATT GT GTCC AGAGGAAATC A
GACATGCTTGCAAGTTCGGGATTGCTAAGGATAATAATAAAGACATGAGCTA
TCCCCCTTGGGGAAGGGAATCCAGAGGGACAATTACAACAATCCCTGTTTAT
TATACGACCACCCCTTACCCAAAGATGCTAGAGATGCCTCCAAGAATCCAAA
ATCCCCTGCTGTCCGGAATCAGGTTGGGCCAATTACCAACTGGCGCTCATTAT
AAAATTCGGAGTATATTACATGGAATGGGAATCCATTACAGGGACTTCTTGA
GTTGTGGAGACGGCTCCGGAGGGATGACTGCTGCATTACTACGAGAAAATGT
GC AT AGC AGAGGA AT ATT C A AT AGTCTGTT AGA ATT AT C AGGGT C AGTC AT G
CGAGGCGCCTCTCCTGAGCCCCCCAGTGCCCTAGAAACTTTAGGAGGAGATA
A ATCGAGAT GT GT A A AT GGT GA A AC AT GTT GGGA AT ATCC AT C T GAC TT AT GT GACCCAAGGACTTGGGACTATTTCCTCCGACTCAAAGCAGGCTTGGGGCTTC
AAATTGATTTAATTGTAATGGATATGGAAGTTCGGGATTCTTCTACTAGCCTG
AAAATTGAGACGAAT GTT AGAAATT ATGT GC ACCGGATTTT GGAT GAGC AAG
GAGTTTTAATCTACAAGACTTATGGAACATATATTTGTGAGAGCGAAAAGAA
TGCAGTAACAATCCTTGGTCCCATGTTCAAGACGGTCGACTTAGTTCAAACAG
A ATTT AGT AGTTCTC A A AC GT C T GA AGT AT AT AT GGT AT GT A A AGGTTT GA AG
AAATTAATCGATGAACCCAATCCCGATTGGTCTTCCATCAATGAATCCTGGAA
A A AC CTGT AC GC ATTC C AGT CAT C AGA AC AGGA ATTT GCC AG AGC A A AGA AG
GTTAGTACATACTTTACCTTGACAGGTATTCCCTCCCAATTCATTCCTGATCCT
TTTGTAAACATTGAGACTATGCTACAAATATTCGGAGTACCCACGGGTGTGTC
TCATGCGGCTGCCTTAAAATCATCTGATAGACCTGCAGATTTATTGACCATTA
GCCTTTTTTATATGGCGATTATATCGTATTATAACATCAATCATATCAGAGTA
GGACCGATACCTCCGAACCCCCCATCAGATGGAATTGCACAAAATGTGGGGA
TCGCTATAACTGGTATAAGCTTTTGGCTGAGTTTGATGGAGAAAGACATTCCA
CTATATCAACAGTGTTTAGCAGTTATCCAGCAATCATTCCCGATTAGGTGGGA
GGCTGTTT C AGT A A A AGGAGGAT AC A AGC AGA AGT GG AGT AC T AGAGGT GAT
GGGCTCCCAAAAGATACCCGAACTTCAGACTCCTTGGCCCCAATCGGGAACT
GGATCAGATCTCTGGAATTGGTCCGAAACCAAGTTCGTCTAAATCCATTCAAT
GAGATCTTGTTCAATCAGCTATGTCGTACAGTGGATAATCATTTGAAATGGTC
AAATTT GCGA AGAAAC AC AGGAATGATT GAAT GGAT C AAT AGACGAATTTC A
AAAGAAGACCGGTCTATACTGATGTTGAAGAGTGACCTACACGAGGAAAACT
CTTGGAGAGATT AAAAAAT C ATGAGGAGACTCC AAACTTT AAGT AT GAAAA A
AACTTTGATCCTTAAGACCCTCTTGTGGTTTTTATTTTTTATCTGGTTTTGTGGT
CTTCGT.
In another embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 23, shown below (VSV vector: Convac V3 South Africa):
ACGAAGAC AAAC AAACC ATT ATT AT C ATT AAAAGGCTCAGGAG AAACTTT AA C AGT AAT C AAA ATGTCTGTT AC AGTC AAGAGAAT C ATTGAC AAC AC AGTC AT AGTTCCAAAACTTCCTGCAAATGAGGATCCAGTGGAATACCCGGCAGATTAC TTCAGAAAATCAAAGGAGATTCCTCTTTACATCAATACTACAAAAAGTTTGTC AGATCTAAGAGGATATGTCTACCAAGGCCTCAAATCCGGAAATGTATCAATC AT AC AT GT C A AC AGC T AC TT GT AT GG AGC ATT A A AGG AC ATC C GGGGT AAGT T GGAT A A AG AT T GGT C A AGTT T C GG A AT AAAC ATC GGG A A AGC AGGGG AT AC AATCGGAATATTTGACCTTGTATCCTTGAAAGCCCTGGACGGCGTACTTCCAG AT GGAGT ATCGGAT GCTTCC AGAACC AGCGC AGAT GAC AAAT GGTT GCCTTT
GTATCTACTTGGCTTATACAGAGTGGGCAGAACACAAATGCCTGAATACAGA
A A A A AGC TC AT GGAT GGGC T GAC A A AT C A AT GCA A A AT GAT C A AT GA AC AGT
TTGAACCTCTTGTGCCAGAAGGTCGTGACATTTTTGATGTGTGGGGAAATGAC
AGTAATTACACAAAAATTGTCGCTGCAGTGGACATGTTCTTCCACATGTTCAA
AAAACATGAATGTGCCTCGTTCAGATACGGAACTATTGTTTCCAGATTCAAAG
ATTGTGCTGCATTGGCAACATTTGGACACCTCTGCAAAATAACCGGAATGTCT
ACAGAAGATGTAACGACCTGGATCTTGAACCGAGAAGTTGCAGATGAAATGG
TCCAAATGATGCTTCCAGGCCAAGAAATTGACAAGGCCGATTCATACATGCC
TTATTTGATCGACTTTGGATTGTCTTCTAAGTCTCCATATTCTTCCGTCAAAAA
CCCTGCCTTCCACTTCTGGGGGCAATTGACAGCTCTTCTGCTCAGATCCACCA
GAGCAAGGAATGCCCGACAGCCTGATGACATTGAGTATACATCTCTTACTAC
AGCAGGTTTGTTGTACGCTTATGCAGTAGGATCCTCTGCCGACTTGGCACAAC
AGTTTTGTGTTGGAGATAACAAATACACTCCAGATGATAGTACCGGAGGATT
GACGACTAATGCACCGCCACAAGGCAGAGATGTGGTCGAATGGCTCGGATGG
T TT G A AG AT C A A A AC AG A A A AC C GAC TC C T GAT AT GAT GC AGT AT GC G A A A A
GAGCAGTCATGTCACTGCAAGGCCTAAGAGAGAAGACAATTGGCAAGTATGC
TAAGTCAGAATTTGACAAATGACCCTATAATTCTCAGATCACCTATTATATAT
TATGCTACATATGAAAAAAACTAACAGATATCATGGATAATCTCACAAAAGT
TCGTGAGTATCTCAAGTCCTATTCTCGTCTGGATCAGGCGGTAGGAGAGATAG
ATGAGATCGAAGCACAACGAGCTGAAAAGTCCAATTATGAGTTGTTCCAAGA
GGATGGAGTGGAAGAGCATACTAAGCCCTCTTATTTTCAGGCAGCAGATGAT
TCTGAC AC AGA AT C T GA AC C AG A A ATT GA AG AC A AT C A AGGTTT GT AT GC AC
CAGATCCAGAAGCTGAGCAAGTTGAAGGCTTTATACAGGGGCCTTTAGATGA
CT AT GC AGAT GAGGAAGT GGAT GTT GT ATTT ACTTCGGACTGGAAAC AGCCT
GAGCTTGAATCTGACGAGCATGGAAAGACCTTACGGTTGACATCGCCAGAGG
GTTTAAGTGGAGAGCAGAAATCCCAGTGGCTTTCGACGATTAAAGCAGTCGT
GC AAAGTGCC AAAT ACTGGAATCTGGC AGAGT GC AC ATTTGAAGC ATCGGGA
G A AGGGGT C AT T AT G A AGG AGC GC C AG AT A AC T C C GGAT GT AT AT A AGGT C A
CTCCAGTGATGAACACACATCCGTCCCAATCAGAAGCAGTATCAGATGTTTG
GTCTCTCTCAAAGACATCCATGACTTTCCAACCCAAGAAAGCAAGTCTTCAGC
CTCTCACCATATCCTTGGATGAATTGTTCTCATCTAGAGGAGAGTTCATCTCT
GTCGGAGGTGACGGACGAATGTCTCATAAAGAGGCCATCCTGCTCGGCCTGA
GATACAAAAAGTTGTACAATCAGGCGAGAGTCAAATATTCTCTGTAGACTAT GAAAAAAAGTAACAGATATCACGATCTAAGTGTTATCCCAATCCATTCATCA
T G AGTT C C TT A A AG A AG AT TC TC GGT C T G A AGGGG A A AGGT A AG A A AT C T A A
GAAATTAGGGATCGCACCACCCCCTTATGAAGAGGACACTAGCATGGAGTAT
GCTCCGAGCGCTCCAATTGACAAATCCTATTTTGGAGTTGACGAGATGGACA
CCTATGATCCGAATCAATTAAGATATGAGAAATTCTTCTTTACAGTGAAAATG
ACGGTTAGATCTAATCGTCCGTTCAGAACATACTCAGATGTGGCAGCCGCTGT
ATCCCATTGGGATCACATGTACATCGGAATGGCAGGGAAACGTCCCTTCTAC
AAAATCTTGGCTTTTTTGGGTTCTTCTAATCTAAAGGCCACTCCAGCGGTATT
GGCAGATCAAGGTCAACCAGAGTATCACACTCACTGCGAAGGCAGGGCTTAT
TTGCCACATAGGATGGGGAAGACCCCTCCCATGCTCAATGTACCAGAGCACT
T C AGAAGACC ATTC AAT AT AGGTCTTT AC AAGGGAACGATTGAGCTC AC A AT
GACCATCTACGATGATGAGTCACTGGAAGCAGCTCCTATGATCTGGGATCATT
TCAATTCTTCCAAATTTTCTGATTTCAGAGAGAAGGCCTTAATGTTTGGCCTG
ATTGTCGAGAAAAAGGCATCTGGAGCGTGGGTCCTGGATTCTATCAGCCACT
TCAAATGAGCTAGTCTAACTTCTAGCTTCTGAACAATCCCCGGTTTACTCAGT
CTCTCCTAATTCCAGCCTCTCGAACAACTAATATCCTGTCTTTTCTATCCCTAT
GAAAAAAACTAACAGAGATCGATCTGTTTACGCGTCACTATGAAGTGCCTTTT
GTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCC
ACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGC
CCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCATAC
A AGT C A A A AT GCC C A AGAGTC AC A AGGC T ATT C A AGC AGACGGTT GGAT GT G
TCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGT
ATATAACACAGTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGA
AAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCT
C AAAGTT GTGGAT AT GC AACTGT GACGGAT GCCGAAGC AGT GATTGTCC AGG
TGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCA
CAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTC
TACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCA
TTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGA
AAGGAGGGC AC AGGGTT C AGAAGT AACT ACTTTGCTT AT GAAACTGGAGGC A
AGGCCTGC AAAAT GC AAT ACTGC AAGC ATT GGGGAGTC AGACTCCC ATC AGG
TGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTG
AATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTA
AGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAAC CTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATC
TTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCT
C T C A AG A AT GGT C GG A AT GAT C AGT GG A AC T AC C AC AG A A AGGG A AC TGT GG
GAT GACTGGGC ACC AT AT GAAGACGT GGAAATTGGACCC AAT GGAGTTCTGA
GGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTG
GACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACAT
TCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATA
CTGGGCT ATCC AAAAATCC AATCGAGCTTGT AGAAGGTT GGTTC AGT AGTT G
GAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATT
CTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGA
AAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAA
ATCCTGCT AGGT ATGA AAAAAACT AACaGAT ATC ACGCtcgagGCC ACC AT GTT C
GTGTTTCTGGTGCTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAACTTCACCAC
AAGGACCCAGCTGCCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACT
ATCCCGACAAGGTGTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTT
CTGCCTTTCTTTTCTAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCAC
CAATGGCACAAAGCGGTTCGCCAATCCAGTGCTGCCCTTTAACGATGGCGTG
TACTTCGCCTCCACCGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCAC
CACACTGGACAGCAAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAAC
GTGGTCATCAAGGTGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGT
GT ACT AT C AC A AG A AC A AT A AGT C TT GGAT GGAGAGCG AGTTTC GCGT GT AT
TCCTCTGCCAACAATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGA
CCTGGAGGGCAAGCAGGGCAATTTCAAGAACCTGAGGGAGTTCGTGTTTAAG
AATATCGATGGCTACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGT
GCGCGGCCTGCCACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCA
TCGGCATCAACATCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTA
CCTGACACCAGGCGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTAC
TATGTGGGCTATCTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATG
GCACCATCACAGACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAA
GTGTACACTGAAGAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAAT
TTCAGGGTGCAGCCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCT
GTGCCCTTTTGGCGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCT
GGAATAGGAAGCGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAA CAGCGCCTCCTTCTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGA
ATGACCTGTGCTTTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGAC
GAGGTGCGCCAGATCGCACCAGGACAGACAGGCAATATCGCAGACTACAATT
ATAAGCTGCCTGACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAAT
CTGGATAGCAAAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGAA
AGTCTAATCTGAAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGGC
CGGCTCTACCCCCTGCAATGGCGTGAAGGGCTTTAACTGTTATTTCCCTCTGC
AGAGCTACGGCTTCCAGCCAACATATGGCGTGGGCTATCAGCCCTACCGCGT
GGTGGTGCTGTCTTTTGAGCTGCTGCACGCACCTGCAACAGTGTGCGGACCAA
AGAAGAGC ACC AATCTGGTGAAGA AC AAGT GCGT GAACTTC AACTTC AACGG
ACTGACCGGAACAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTT
CAGCAGTTCGGCAGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCTC
AGACCCTGGAGATCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGTG
AT C AC ACC AGGC ACC AAT AC AAGC AACC AGGT GGCCGTGCTGT ATC AGGGCG
TGAATTGTACCGAGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTAC
AT GGCGGGT GT ACTCT ACCGGC AGC AACGT GTTCC AGAC AAGAGCCGGATGC
CTGATCGGAGCAGAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATCG
GCGCCGGCATCTGTGCCTCCTACCAGACCCAGACAAACTCCCCAAGGGGATC
CGGCTACATCCCCGAGGCCCCCAGAGACGGCCAGGCCTACGTGCGGAAGGAC
GGCGAGT GGGT ACTGctcagcaccttcctgggc AGC AGTTGGAAAAGCTCC ATCGCCTC
CTTTTTCTTTATCATCGGCCTGATCATCGGACTGTTCCTGGTGCTCCGCGTGGG
TATCCACCTGTGCATCAAGCTGAAGCACACCAAGAAAAGACAGATTTATACA
GACATCGAGATGAACCGACTTGGAAAGTAAGCTAGCCAGATTCTTCATGTTT
GGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGA
GTTTTTAATTTTTATGAAAAAAACTAACAGCAATCATGGAAGTCCACGATTTT
GAGACCGACGAGTTCAATGATTTCAATGAAGATGACTATGCCACAAGAGAAT
TCCTGAATCCCGATGAGCGCATGACGTACTTGAATCATGCTGATTACAATTTG
AATTCTCCTCTAATTAGTGATGATATTGACAATTTGATCAGGAAATTCAATTC
TCTTCCGATTCCCTCGATGTGGGATAGTAAGAACTGGGATGGAGTTCTTGAGA
TGTTAACATCATGTCAAGCCAATCCCATCTCAACATCTCAGATGCATAAATGG
AT GGGAAGTT GGTT AAT GTCTGAT AAT CAT GAT GCC AGTC AAGGGT AT AGTTT
TTT AC AT GAAGT GGAC AAAGAGGC AGAAAT A AC ATTT GACGT GGT GGAGACC
TT C ATCCGCGGCTGGGGC AAC AAACC AATT GAAT AC AT C AAAAAGGAAAGAT
GGACTGACTCATTCAAAATTCTCGCTTATTTGTGTCAAAAGTTTTTGGACTTAC ACAAGTTGACATTAATCTTAAATGCTGTCTCTGAGGTGGAATTGCTCAACTTG
GCGAGGACTTT C AAAGGC AAAGT C AGAAGAAGTTCTC AT GGAACGAAC AT AT
GCAGGATTAGGGTTCCCAGCTTGGGTCCTACTTTTATTTCAGAAGGATGGGCT
TACTTCAAGAAACTTGATATTCTAATGGACCGAAACTTTCTGTTAATGGTCAA
AG AT GT GATT AT AGGG AGGAT GCA A AC GGT GC T ATCC AT GGT AT GT AGA AT A
GACAACCTGTTCTCAGAGCAAGACATCTTCTCCCTTCTAAATATCTACAGAAT
T GGAGAT AAAATT GT GGAGAGGC AGGGAAATTTTTCTT ATGACTT GATT AAA
AT GGT GG A AC C GAT AT GCA AC T T G A AGC T GAT G A A AT T AGC A AG AG A AT C A A
GGCCTTTAGTCCCACAATTCCCTCATTTTGAAAATCATATCAAGACTTCTGTT
GAT GA AGGGGC A A A A ATT GAC CGAGGT AT A AGATTC CTC CAT GAT C AGAT A A
TGAGTGTGAAAACAGTGGATCTCACACTGGTGATTTATGGATCGTTCAGACAT
TGGGGTCATCCTTTTATAGATTATTACACTGGACTAGAAAAATTACATTCCCA
AGT A AC CAT G A AG A A AG AT ATT GAT GT GT CAT AT GC A A A AGC AC TT GC A AGT
GATTTAGCTCGGATTGTTCTATTTCAACAGTTCAATGATCATAAAAAGTGGTT
CGTGAATGGAGACTTGCTCCCTCATGATCATCCCTTTAAAAGTCATGTTAAAG
AAAAT AC AT GGCCC AC AGCTGCTC A AGTT C AAGATTTTGGAGAT AA ATGGC A
TGAACTTCCGCTGATTAAATGTTTTGAAATACCCGACTTACTAGACCCATCGA
T A AT AT ACTCTGAC A A A AGTC ATT C A AT GA AT AGGT C AGAGGT GTT GA A AC A
TGTCCGAATGAATCCGAACACTCCTATCCCTAGTAAAAAGGTGTTGCAGACT
AT GTT GGAC AC AAAGGCT ACC AATTGGAAAGAATTTCTT AAAGAGATT GATG
AGAAGGGCTTAGATGATGATGATCTAATTATTGGTCTTAAAGGAAAGGAGAG
GGAACTGAAGTT GGC AGGT AGATTTTTCTCCCT AAT GTCTT GGAAATTGCGAG
AATACTTTGTAATTACCGAATATTTGATAAAGACTCATTTCGTCCCTATGTTTA
AAGGCCTGACAATGGCGGACGATCTAACTGCAGTCATTAAAAAGATGTTAGA
TTCCTCATCCGGCCAAGGATTGAAGTCATATGAGGCAATTTGCATAGCCAATC
AC ATTGATT ACGA A A A AT GGA AT A AC C AC C A A AGGA AGTT AT C A A AC GGCCC
AGTGTTCCGAGTTATGGGCCAGTTCTTAGGTTATCCATCCTTAATCGAGAGAA
CTCATGAATTTTTTGAGAAAAGTCTTATATACTACAATGGAAGACCAGACTTG
ATGCGTGTTCACAACAACACACTGATCAATTCAACCTCCCAACGAGTTTGTTG
GC A AGGAC A AGAGGGT GGAC T GGA AGGTCT ACGGC A A A A AGGAT GGACT AT
CCTCAATCTACTGGTTATTCAAAGAGAGGCTAAAATCAGAAACACTGCTGTC
AAAGTCTTGGC AC AAGGTGAT AAT C AAGTT ATTT GC AC AC AGT AT AAAACGA
AGAAATCGAGAAACGTTGT AGAATT AC AGGGT GCTCTC AAT C AAAT GGTTT C
T AAT AAT GAG A A A ATT AT GAC T GC AAT C A A A AT AGGG AC AGGG A AGT T AGGA CTTTTGATAAATGACGATGAGACTATGCAATCTGCAGATTACTTGAATTATGG
AAAAATACCGATTTTCCGTGGAGTGATTAGAGGGTTAGAGACCAAGAGATGG
TCACGAGTGACTTGTGTCACCAATGACCAAATACCCACTTGTGCTAATATAAT
GAGCTCAGTTTCCACAAATGCTCTCACCGTAGCTCATTTTGCTGAGAACCCAA
TCAATGCCATGATACAGTACAATTATTTTGGGACATTTGCTAGACTCTTGTTG
ATGATGCATGATCCTGCTCTTCGTCAATCATTGTATGAAGTTCAAGATAAGAT
ACCGGGCTTGCACAGTTCTACTTTCAAATACGCCATGTTGTATTTGGACCCTT
CCATTGGAGGAGTGTCGGGCATGTCTTTGTCCAGGTTTTTGATTAGAGCCTTC
CCAGATCCCGTAACAGAAAGTCTCTCATTCTGGAGATTCATCCATGTACATGC
TCGAAGTGAGCATCTGAAGGAGATGAGTGCAGTATTTGGAAACCCCGAGATA
GCCAAGTTTCGAATAACTCACATAGACAAGCTAGTAGAAGATCCAACCTCTC
TGAACATCGCTATGGGAATGAGTCCAGCGAACTTGTTAAAGACTGAGGTTAA
AAAATGCTTAATCGAATCAAGACAAACCATCAGGAACCAGGTGATTAAGGAT
GCAACCATATATTTGTATCATGAAGAGGATCGGCTCAGAAGTTTCTTATGGTC
AATAAATCCTCTGTTCCCTAGATTTTTAAGTGAATTCAAATCAGGCACTTTTTT
GGGAGTCGCAGACGGGCTCATCAGTCTATTTCAAAATTCTCGTACTATTCGGA
ACTCCTTTAAGAAAAAGTATCATAGGGAATTGGATGATTTGATTGTGAGGAG
TGAGGTATCCTCTTTGACACATTTAGGGAAACTTCATTTGAGAAGGGGATCAT
GT AAAAT GTGGAC ATGTTC AGCT ACTC AT GCTGAC AC ATT AAGAT AC AAAT C
CTGGGGCCGTACAGTTATTGGGACAACTGTACCCCATCCATTAGAAATGTTGG
GTCC AC AAC ATCGAAAAGAGACTCCTT GT GC ACC AT GT AAC AC AT C AGGGTT
CAATTATGTTTCTGTGCATTGTCCAGACGGGATCCATGACGTCTTTAGTTCAC
GGGGACCATTGCCTGCTTATCTAGGGTCTAAAACATCTGAATCTACATCTATT
TTGCAGCCTTGGGAAAGGGAAAGCAAAGTCCCACTGATTAAAAGAGCTACAC
GTCTTAGAGATGCTATCTCTTGGTTTGTTGAACCCGACTCTAAACTAGCAATG
ACTATACTTTCTAACATCCACTCTTTAACAGGCGAAGAATGGACCAAAAGGC
AGCATGGGTTCAAAAGAACAGGGTCTGCCCTTCATAGGTTTTCGACATCTCGG
ATGAGCCATGGTGGGTTCGCATCTCAGAGCACTGCAGCATTGACCAGGTTGA
TGGCAACTACAGACACCATGAGGGATCTGGGAGATCAGAATTTCGACTTTTT
ATTCCAAGCAACGTTGCTCTATGCTCAAATTACCACCACTGTTGCAAGAGACG
GATGGATCACCAGTTGTACAGATCATTATCATATTGCCTGTAAGTCCTGTTTG
AGACCCATAGAAGAGATCACCCTGGACTCAAGTATGGACTACACGCCCCCAG
AT GT AT C C C AT GT GC T G A AG AC AT GG AGG A AT GGGG A AGGT T C GT GGGG AC A
AGAGATAAAACAGATCTATCCTTTAGAAGGGAATTGGAAGAATTTAGCACCT GCTGAGCAATCCTATCAAGTCGGCAGATGTATAGGTTTTCTATATGGAGACTT
GGCGTATAGAAAATCTACTCATGCCGAGGACAGTTCTCTATTTCCTCTATCTA
T AC AAGGTCGT ATT AGAGGTCGAGGTTTCTT AAAAGGGTT GCT AGACGGATT
AATGAGAGCAAGTTGCTGCCAAGTAATACACCGGAGAAGTCTGGCTCATTTG
AAGAGGCCGGCC AACGC AGT GT ACGGAGGTTTGATTT ACTTGATT GAT AAAT
TGAGTGTATCACCTCCATTCCTTTCTCTTACTAGATCAGGACCTATTAGAGAC
GAATTAGAAACGATTCCCCACAAGATCCCAACCTCCTATCCGACAAGCAACC
GTGATATGGGGGTGATTGTCAGAAATTACTTCAAATACCAATGCCGTCTAATT
GAAAAGGGAAAATACAGATCACATTATTCACAATTATGGTTATTCTCAGATGT
CTTATCCATAGACTTCATTGGACCATTCTCTATTTCCACCACCCTCTTGCAAAT
CCT AT AC AAGCC ATTTTT ATCTGGGAAAGAT AAGAAT GAGTTGAGAGAGCTG
GCA A AT C TTTC TT C ATTGC T A AGAT C AGGAGAGGGGT GGGA AGAC AT AC AT G
TGAAATTCTTCACCAAGGACATATTATTGTGTCCAGAGGAAATCAGACATGCT
TGCAAGTTCGGGATTGCTAAGGATAATAATAAAGACATGAGCTATCCCCCTT
GGGGA AGGGA AT C C AGAGGGAC A ATT AC A AC A AT C CC T GTTT ATT AT AC GAC
CACCCCTTACCCAAAGATGCTAGAGATGCCTCCAAGAATCCAAAATCCCCTG
CTGTCCGGAATCAGGTTGGGCCAATTACCAACTGGCGCTCATTATAAAATTCG
GAGTATATTACATGGAATGGGAATCCATTACAGGGACTTCTTGAGTTGTGGA
GACGGCTCCGGAGGGATGACTGCTGCATTACTACGAGAAAATGTGCATAGCA
G AGG A AT AT TC A AT AGT C T GT T AG A ATT AT C AGGGT C AGT CAT GC G AGGC GC
CTCTCCTGAGCCCCCCAGTGCCCTAGAAACTTTAGGAGGAGATAAATCGAGA
TGTGTAAATGGTGAAACATGTTGGGAATATCCATCTGACTTATGTGACCCAAG
GACTTGGGACTATTTCCTCCGACTCAAAGCAGGCTTGGGGCTTCAAATTGATT
TAATTGTAATGGATATGGAAGTTCGGGATTCTTCTACTAGCCTGAAAATTGAG
ACGAATGTTAGAAATTATGTGCACCGGATTTTGGATGAGCAAGGAGTTTTAAT
CT AC AAGACTT AT GGAAC AT AT ATTTGT GAGAGCGAAAAGAAT GC AGT AAC A
ATCCTTGGTCCCATGTTCAAGACGGTCGACTTAGTTCAAACAGAATTTAGTAG
T TC T C A A AC GT C T G A AGT AT AT AT GGT AT GT A A AGGT TT G A AG A A ATT A AT C G
ATGAACCCAATCCCGATTGGTCTTCCATCAATGAATCCTGGAAAAACCTGTAC
GC ATTCC AGT CAT C AGAAC AGGAATTT GCC AGAGC AAAGAAGGTT AGT AC AT
ACTTTACCTTGACAGGTATTCCCTCCCAATTCATTCCTGATCCTTTTGTAAACA
TTGAGACTATGCTACAAATATTCGGAGTACCCACGGGTGTGTCTCATGCGGCT
GCCTTAAAATCATCTGATAGACCTGCAGATTTATTGACCATTAGCCTTTTTTAT
ATGGCGATTATATCGTATTATAACATCAATCATATCAGAGTAGGACCGATACC TCCGAACCCCCCATCAGATGGAATTGCACAAAATGTGGGGATCGCTATAACT
GGTATAAGCTTTTGGCTGAGTTTGATGGAGAAAGACATTCCACTATATCAACA
GTGTTTAGCAGTTATCCAGCAATCATTCCCGATTAGGTGGGAGGCTGTTTCAG
T A A A AGGAGGAT AC A AGC AG A AGT GGAGT AC T AGAGGT GAT GGGCTCC C A A
AAGATACCCGAACTTCAGACTCCTTGGCCCCAATCGGGAACTGGATCAGATC
TCTGGAATTGGTCCGAAACCAAGTTCGTCTAAATCCATTCAATGAGATCTTGT
TCAATCAGCTATGTCGTACAGTGGATAATCATTTGAAATGGTCAAATTTGCGA
AG A A AC AC AGG A AT GAT T G A AT GG AT C A AT AG AC G A AT TT C A A A AG A AG AC
C GGT C T AT AC T GAT GTT G A AG AGT G AC C T AC AC G AGG A A A AC TC TT GG AG AG
ATT AAAAAATC AT GAGGAGACTCC AAACTTT AAGT ATGAA AAAAACTTT GAT
CCTTAAGACCCTCTTGTGGTTTTTATTTTTTATCTGGTTTTGTGGTCTTCGT.
In some embodiments, the nucleic acid comprises the sequence of SEQ ID NO:
24, shown below (VSV vector: Convac V4 China):
ACGAAGAC AAAC AAACC ATT ATT AT C ATT AAAAGGCTCAGGAG AAACTTT AA
C AGT AAT C AAA ATGTCTGTT AC AGTC AAGAGAAT C ATTGAC AAC AC AGTC AT
AGTTCCAAAACTTCCTGCAAATGAGGATCCAGTGGAATACCCGGCAGATTAC
TTCAGAAAATCAAAGGAGATTCCTCTTTACATCAATACTACAAAAAGTTTGTC
AGATCTAAGAGGATATGTCTACCAAGGCCTCAAATCCGGAAATGTATCAATC
AT AC AT GT C A AC AGC T AC TT GT AT GG AGC ATT A A AGG AC ATC C GGGGT AAGT
T GG AT A A AG AT T GGT C A AGTT T C GG A AT AAAC ATC GGG A A AGC AGGGG AT AC
AATCGGAATATTTGACCTTGTATCCTTGAAAGCCCTGGACGGCGTACTTCCAG
AT GGAGT ATCGG AT GCTTCC AGAACC AGCGC AGAT GAC AAAT GGTT GCCTTT
GTATCTACTTGGCTTATACAGAGTGGGCAGAACACAAATGCCTGAATACAGA
A A A A AGC TC AT GGAT GGGC T GAC A A AT C A AT GCA A A AT GAT C A AT GA AC AGT
TTGAACCTCTTGTGCCAGAAGGTCGTGACATTTTTGATGTGTGGGGAAATGAC
AGTAATTACACAAAAATTGTCGCTGCAGTGGACATGTTCTTCCACATGTTCAA
AAAACATGAATGTGCCTCGTTCAGATACGGAACTATTGTTTCCAGATTCAAAG
ATTGTGCTGCATTGGCAACATTTGGACACCTCTGCAAAATAACCGGAATGTCT
ACAGAAGATGTAACGACCTGGATCTTGAACCGAGAAGTTGCAGATGAAATGG
TCCAAATGATGCTTCCAGGCCAAGAAATTGACAAGGCCGATTCATACATGCC
TTATTTGATCGACTTTGGATTGTCTTCTAAGTCTCCATATTCTTCCGTCAAAAA
CCCTGCCTTCCACTTCTGGGGGCAATTGACAGCTCTTCTGCTCAGATCCACCA
GAGCAAGGAATGCCCGACAGCCTGATGACATTGAGTATACATCTCTTACTAC
AGCAGGTTTGTTGTACGCTTATGCAGTAGGATCCTCTGCCGACTTGGCACAAC AGTTTTGTGTTGGAGATAACAAATACACTCCAGATGATAGTACCGGAGGATT
GACGACTAATGCACCGCCACAAGGCAGAGATGTGGTCGAATGGCTCGGATGG
T TT G A AG AT C A A A AC AG A A A AC C G AC TC C T GAT AT GAT GC AGT AT GC G A A A A
GAGCAGTCATGTCACTGCAAGGCCTAAGAGAGAAGACAATTGGCAAGTATGC
TAAGTCAGAATTTGACAAATGACCCTATAATTCTCAGATCACCTATTATATAT
TATGCTACATATGAAAAAAACTAACAGATATCATGGATAATCTCACAAAAGT
TCGTGAGTATCTCAAGTCCTATTCTCGTCTGGATCAGGCGGTAGGAGAGATAG
ATGAGATCGAAGCACAACGAGCTGAAAAGTCCAATTATGAGTTGTTCCAAGA
GGATGGAGTGGAAGAGCATACTAAGCCCTCTTATTTTCAGGCAGCAGATGAT
TCTGAC AC AGA AT C T GA AC C AG A A ATT GA AG AC A AT C A AGGTTT GT AT GC AC
CAGATCCAGAAGCTGAGCAAGTTGAAGGCTTTATACAGGGGCCTTTAGATGA
CT AT GC AGAT GAGGAAGT GGAT GTT GT ATTT ACTTCGGACTGGAAAC AGCCT
GAGCTTGAATCTGACGAGCATGGAAAGACCTTACGGTTGACATCGCCAGAGG
GTTTAAGTGGAGAGCAGAAATCCCAGTGGCTTTCGACGATTAAAGCAGTCGT
GC AAAGTGCC AAAT ACTGGAATCTGGC AGAGT GC AC ATTTGAAGC ATCGGGA
G A AGGGGT C AT T AT G A AGG AGC GC C AG AT A AC T C C GGAT GT AT AT A AGGT C A
CTCCAGTGATGAACACACATCCGTCCCAATCAGAAGCAGTATCAGATGTTTG
GTCTCTCTCAAAGACATCCATGACTTTCCAACCCAAGAAAGCAAGTCTTCAGC
CTCTCACCATATCCTTGGATGAATTGTTCTCATCTAGAGGAGAGTTCATCTCT
GTCGGAGGTGACGGACGAATGTCTCATAAAGAGGCCATCCTGCTCGGCCTGA
GATACAAAAAGTTGTACAATCAGGCGAGAGTCAAATATTCTCTGTAGACTAT
GAAAAAAAGTAACAGATATCACGATCTAAGTGTTATCCCAATCCATTCATCA
T G AGTT C C TT A A AG A AG AT TC TC GGT C T G A AGGGG A A AGGT A AG A A AT C T A A
GAAATTAGGGATCGCACCACCCCCTTATGAAGAGGACACTAGCATGGAGTAT
GCTCCGAGCGCTCCAATTGACAAATCCTATTTTGGAGTTGACGAGATGGACA
CCTATGATCCGAATCAATTAAGATATGAGAAATTCTTCTTTACAGTGAAAATG
ACGGTTAGATCTAATCGTCCGTTCAGAACATACTCAGATGTGGCAGCCGCTGT
ATCCCATTGGGATCACATGTACATCGGAATGGCAGGGAAACGTCCCTTCTAC
AAAATCTTGGCTTTTTTGGGTTCTTCTAATCTAAAGGCCACTCCAGCGGTATT
GGCAGATCAAGGTCAACCAGAGTATCACACTCACTGCGAAGGCAGGGCTTAT
TTGCCACATAGGATGGGGAAGACCCCTCCCATGCTCAATGTACCAGAGCACT
T C AGAAGACC ATTC AAT AT AGGTCTTT AC AAGGGAACGATTGAGCTC AC A AT
GACCATCTACGATGATGAGTCACTGGAAGCAGCTCCTATGATCTGGGATCATT
TCAATTCTTCCAAATTTTCTGATTTCAGAGAGAAGGCCTTAATGTTTGGCCTG ATTGTCGAGAAAAAGGCATCTGGAGCGTGGGTCCTGGATTCTATCAGCCACT
TCAAATGAGCTAGTCTAACTTCTAGCTTCTGAACAATCCCCGGTTTACTCAGT
CTCTCCTAATTCCAGCCTCTCGAACAACTAATATCCTGTCTTTTCTATCCCTAT
GAAAAAAACTAACAGAGATCGATCTGTTTACGCGTGCCACCATGTTCGTGTTT
CTGGTGCTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAACCTGACCACAAGGA
CCCAGCTGCCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACTATCCC
GACAAGGTGTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTTCTGCC
TTTCTTTTCTAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCACCAATG
GCACAAAGCGGTTCGACAATCCAGTGCTGCCCTTTAACGATGGCGTGTACTTC
GCCTCCACCGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCACCACAC
T GGAC AGC A AGAC AC AGT C CC T GC T GAT C GT GA AC A AT GC C AC C A AC GT GGT
CATCAAGGTGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGTGTACT
ATCACAAGAACAATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTATTCCTCT
GCCAACAATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGACCTGGA
GGGC AAGC AGGGC AATTT C AAGAACCTGAGGGAGTTCGT GTTT AAGAAT ATC
GATGGCTACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGTGCGCG
ACCTGCCACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCATCGGC
ATCAACATCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTACCTGA
CACCAGGCGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTACTATGT
GGGCTATCTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATGGCACC
ATCACAGACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAAGTGTA
CACTGAAGAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAATTTCAG
GGTGCAGCCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCTGTGCC
CTTTTGGCGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCTGGAAT
AGGAAGCGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAACAGCG
CCTCCTTCTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGAATGAC
CTGTGCTTTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGACGAGGT
GCGCCAGATCGCACCAGGACAGACAGGCAAGATCGCAGACTACAATTATAA
GCTGCCTGACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAATCTGG
ATAGCAAAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGAAAGTC
TAATCTGAAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGGCCGGC
TCTACCCCCTGCAATGGCGTGGAGGGCTTTAACTGTTATTTCCCTCTGCAGAG
CTACGGCTTCCAGCCAACAAACGGCGTGGGCTATCAGCCCTACCGCGTGGTG
GTGCTGTCTTTTGAGCTGCTGCACGCACCTGCAACAGTGTGCGGACCAAAGA AGAGCACCAATCTGGTGAAGAACAAGTGCGTGAACTTCAACTTCAACGGACT
GACCGGAACAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTTCAG
CAGTTCGGCAGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCTCAGA
CCCTGGAGATCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGTGATC
ACACCAGGCACCAATACAAGCAACCAGGTGGCCGTGCTGTATCAGGACGTGA
ATTGTACCGAGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTACATG
GCGGGTGTACTCTACCGGCAGCAACGTGTTCCAGACAAGAGCCGGATGCCTG
ATCGGAGCAGAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATCGGCG
CCGGCATCTGTGCCTCCTACCAGACCCAGACAAACTCCCCAAGGTCTGTGGG
CGATACAGGCCTGTCCAAGAATCCAATCGAGCTGGTAGAGGGCTGGTTCAGC
AGTTGGAAAAGCTCCATCGCCTCCTTTTTCTTTATCATCGGCCTGATCATCGG
ACTGTTCCTGGTGCTCCGCGTGGGTATCCACCTGTGCATCAAGCTGAAGCACA
CCAAGAAAAGACAGATTTATACAGACATCGAGATGAACCGCCTGGGAAAGgg atccggctccggcgagggcaggggaagtctactaacatgcggggacgtggaggaaaatcccggccccATGAAGTGC
CTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTT
TTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTA
TTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCA
TACAAGTCAAAATGCCCAAGAGTCACAAGGCTATTCAAGCAGACGGTTGGAT
GTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGA
AGTATATAACACAGTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAG
GAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTC
CTC A A AGTT GT GGAT AT GCA AC T GT GAC GGAT GC CGA AGC AGT GATT GT CCA
GGT GACTCCTC AC CAT GT GC T GGTT GAT GA AT AC AC AGGAGA AT GGGTTGAT
TCACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATA
ACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAAC
CTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCT
GGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGA
GGC AAGGCCTGC AAAAT GC AAT ACTGC AAGC ATT GGGGAGT C AGACTCCC AT
CAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTC
CCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGA
TGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAG
AAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAG
CTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATG
GTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCA AT C C T C T C A AG A AT GGT C GG A AT GAT C AGT GG A AC T AC C AC AG A A AGGG A AC
T GT GGGAT GAC T GGGC ACC AT AT GA AGACGT GGA A ATT GGACC C A AT GGAGT
TCTGAGGACC AGTT C AGGAT AT AAGTTTCCTTT AT AC AT GATTGGAC AT GGT A
TGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCT
CACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGG
TGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGT
AGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGA
CTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACC
AAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAAg
CTAGCCAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAA
GAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAACTAACAGCAA
T CAT GGAAGTCC ACGATTTTGAGACCGACGAGTT C A ATGATTT C AAT GAAGA
TGACTATGCCACAAGAGAATTCCTGAATCCCGATGAGCGCATGACGTACTTG
AATCATGCTGATTACAATTTGAATTCTCCTCTAATTAGTGATGATATTGACAA
TTTGATCAGGAAATTCAATTCTCTTCCGATTCCCTCGATGTGGGATAGTAAGA
ACTGGGATGGAGTTCTTGAGATGTTAACATCATGTCAAGCCAATCCCATCTCA
ACATCTCAGATGCATAAATGGATGGGAAGTTGGTTAATGTCTGATAATCATG
AT GCC AGTC AAGGGT AT AGTTTTTT AC ATGAAGT GGAC AA AGAGGC AGAAAT
AACATTTGACGTGGTGGAGACCTTCATCCGCGGCTGGGGCAACAAACCAATT
GAATACATCAAAAAGGAAAGATGGACTGACTCATTCAAAATTCTCGCTTATT
TGTGTCAAAAGTTTTTGGACTTACACAAGTTGACATTAATCTTAAATGCTGTC
TCTGAGGTGGAATTGCTCAACTTGGCGAGGACTTTCAAAGGCAAAGTCAGAA
GAAGTTCTCATGGAACGAACATATGCAGGATTAGGGTTCCCAGCTTGGGTCC
TACTTTTATTTCAGAAGGATGGGCTTACTTCAAGAAACTTGATATTCTAATGG
ACC GA A AC TTTC T GTT A AT GGT C A A AGAT GT GATT AT AGGG AGGAT GCA A AC
GGTGCTATCCATGGTATGTAGAATAGACAACCTGTTCTCAGAGCAAGACATC
TTCTCCCTTCT AAAT ATCT AC AGAATT GGAGAT AAAATTGT GG AGAGGC AGG
GAAATTTTTCTTATGACTTGATTAAAATGGTGGAACCGATATGCAACTTGAAG
CTGATGAAATTAGCAAGAGAATCAAGGCCTTTAGTCCCACAATTCCCTCATTT
TGAAAATCATATCAAGACTTCTGTTGATGAAGGGGCAAAAATTGACCGAGGT
AT A AG AT TCCTCCAT GAT C AGAT AAT G AGT GT G A A A AC AGT GG AT C T C AC AC
TGGTGATTTATGGATCGTTCAGACATTGGGGTCATCCTTTTATAGATTATTAC
ACTGGACTAGAAAAATTACATTCCCAAGTAACCATGAAGAAAGATATTGATG
TGTCATATGCAAAAGCACTTGCAAGTGATTTAGCTCGGATTGTTCTATTTCAA CAGTTCAATGATCATAAAAAGTGGTTCGTGAATGGAGACTTGCTCCCTCATGA
TCATCCCTTTAAAAGTCATGTTAAAGAAAATACATGGCCCACAGCTGCTCAA
GTTCAAGATTTTGGAGATAAATGGCATGAACTTCCGCTGATTAAATGTTTTGA
AATACCCGACTTACTAGACCCATCGATAATATACTCTGACAAAAGTCATTCAA
TGAATAGGTCAGAGGTGTTGAAACATGTCCGAATGAATCCGAACACTCCTAT
CCCTAGTAAAAAGGTGTTGCAGACTATGTTGGACACAAAGGCTACCAATTGG
AAAGAATTTCTTAAAGAGATTGATGAGAAGGGCTTAGATGATGATGATCTAA
TTATTGGTCTTAAAGGAAAGGAGAGGGAACTGAAGTTGGCAGGTAGATTTTT
CTCCCTAATGTCTTGGAAATTGCGAGAATACTTTGTAATTACCGAATATTTGA
TAAAGACTCATTTCGTCCCTATGTTTAAAGGCCTGACAATGGCGGACGATCTA
ACTGC AGTC ATT AAAAAGAT GTT AGATTCCTC ATCCGGCC AAGGATT GAAGT
CATATGAGGCAATTTGCATAGCCAATCACATTGATTACGAAAAATGGAATAA
CCACCAAAGGAAGTTATCAAACGGCCCAGTGTTCCGAGTTATGGGCCAGTTC
TTAGGTTATCCATCCTTAATCGAGAGAACTCATGAATTTTTTGAGAAAAGTCT
T AT AT ACT AC AAT GGAAGACC AGACTT GAT GCGT GTT C AC A AC AAC AC ACTG
AT C AATTC AACCTCCC AACGAGTTTGTT GGC AAGGAC AAGAGGGT GGACTGG
AAGGTCTACGGCAAAAAGGATGGACTATCCTCAATCTACTGGTTATTCAAAG
AGAGGCT A A A AT C AGA A AC AC T GC T GTC A A AGT C TT GGC AC A AGGT GAT AAT
C A AGTT ATTTGC AC AC AGT AT A A A ACG A AGA A ATCGAGA A AC GTT GT AG A AT
T AC AGGGT GCTCTC A AT C A A AT GGTTTCT A AT AAT GAGA A A ATT AT GAC T GCA
ATCAAAATAGGGACAGGGAAGTTAGGACTTTTGATAAATGACGATGAGACTA
TGCAATCTGCAGATTACTTGAATTATGGAAAAATACCGATTTTCCGTGGAGTG
ATTAGAGGGTTAGAGACCAAGAGATGGTCACGAGTGACTTGTGTCACCAATG
ACCAAATACCCACTTGTGCTAATATAATGAGCTCAGTTTCCACAAATGCTCTC
ACCGTAGCTCATTTTGCTGAGAACCCAATCAATGCCATGATACAGTACAATTA
TTTTGGGACATTTGCTAGACTCTTGTTGATGATGCATGATCCTGCTCTTCGTCA
AT C ATTGT ATGA AGTT C AAGAT AAGAT ACCGGGCTTGC AC AGTTCT ACTTTC A
AATACGCCATGTTGTATTTGGACCCTTCCATTGGAGGAGTGTCGGGCATGTCT
TTGTCCAGGTTTTTGATTAGAGCCTTCCCAGATCCCGTAACAGAAAGTCTCTC
ATTCTGGAGATTC ATCC AT GT AC AT GCTCGAAGT GAGC ATCTGAAGGAGAT G
AGTGCAGTATTTGGAAACCCCGAGATAGCCAAGTTTCGAATAACTCACATAG
AC AAGCT AGT AGAAGATCC AACCTCTCTGAAC ATCGCT ATGGGAAT GAGTCC
AGCGAACTTGTT AAAGACTGAGGTT AAAAAAT GCTT AATCGAAT C AAGAC AA
ACCATCAGGAACCAGGTGATTAAGGATGCAACCATATATTTGTATCATGAAG AGGATCGGCTCAGAAGTTTCTTATGGTCAATAAATCCTCTGTTCCCTAGATTT
TTAAGTGAATTCAAATCAGGCACTTTTTTGGGAGTCGCAGACGGGCTCATCAG
TCTATTTCAAAATTCTCGTACTATTCGGAACTCCTTTAAGAAAAAGTATCATA
GGGAATTGGATGATTTGATTGTGAGGAGTGAGGTATCCTCTTTGACACATTTA
GGGAAACTTCATTTGAGAAGGGGATCATGTAAAATGTGGACATGTTCAGCTA
CTCATGCTGACACATTAAGATACAAATCCTGGGGCCGTACAGTTATTGGGAC
AACTGT ACCCC ATCC ATT AGAAAT GTT GGGTCC AC AAC ATCGAAAAGAGACT
CCTTGTGCACCATGTAACACATCAGGGTTCAATTATGTTTCTGTGCATTGTCC
AGACGGGATCCATGACGTCTTTAGTTCACGGGGACCATTGCCTGCTTATCTAG
GGTCTAAAACATCTGAATCTACATCTATTTTGCAGCCTTGGGAAAGGGAAAG
CAAAGTCCCACTGATTAAAAGAGCTACACGTCTTAGAGATGCTATCTCTTGGT
TTGTTGAACCCGACTCTAAACTAGCAATGACTATACTTTCTAACATCCACTCT
TTAACAGGCGAAGAATGGACCAAAAGGCAGCATGGGTTCAAAAGAACAGGG
TCTGCCCTTCATAGGTTTTCGACATCTCGGATGAGCCATGGTGGGTTCGCATC
T C AGAGC ACTGC AGC ATTGACC AGGTT GAT GGC AACT AC AGAC ACC AT GAGG
GATCTGGGAGATCAGAATTTCGACTTTTTATTCCAAGCAACGTTGCTCTATGC
TCAAATTACCACCACTGTTGCAAGAGACGGATGGATCACCAGTTGTACAGAT
CATTATCATATTGCCTGTAAGTCCTGTTTGAGACCCATAGAAGAGATCACCCT
GGACTCAAGTATGGACTACACGCCCCCAGATGTATCCCATGTGCTGAAGACA
TGGAGGAATGGGGAAGGTTCGTGGGGACAAGAGATAAAACAGATCTATCCTT
T AGAAGGGAATTGGAAGA ATTT AGC ACCTGCTGAGC AATCCT AT C AAGTCGG
CAGATGTATAGGTTTTCTATATGGAGACTTGGCGTATAGAAAATCTACTCATG
CCGAGGACAGTTCTCTATTTCCTCTATCTATACAAGGTCGTATTAGAGGTCGA
GGTTTCTT A AAAGGGTT GCT AGAC GG ATT AAT GAGAGC AAGTT GCTGCC AAG
TAATACACCGGAGAAGTCTGGCTCATTTGAAGAGGCCGGCCAACGCAGTGTA
CGGAGGTTTGATTTACTTGATTGATAAATTGAGTGTATCACCTCCATTCCTTTC
TCTTACTAGATCAGGACCTATTAGAGACGAATTAGAAACGATTCCCCACAAG
ATCCCAACCTCCTATCCGACAAGCAACCGTGATATGGGGGTGATTGTCAGAA
ATTACTTCAAATACCAATGCCGTCTAATTGAAAAGGGAAAATACAGATCACA
TTATTCACAATTATGGTTATTCTCAGATGTCTTATCCATAGACTTCATTGGACC
ATTCTCTATTTCCACCACCCTCTTGCAAATCCTATACAAGCCATTTTTATCTGG
GAAAGATAAGAATGAGTTGAGAGAGCTGGCAAATCTTTCTTCATTGCTAAGA
TCAGGAGAGGGGTGGGAAGACATACATGTGAAATTCTTCACCAAGGACATAT
T ATT GTGTCC AGAGGAAAT C AGAC AT GCTTGC AAGTTCGGGATT GCT AAGGA TAATAATAAAGACATGAGCTATCCCCCTTGGGGAAGGGAATCCAGAGGGACA
ATTACAACAATCCCTGTTTATTATACGACCACCCCTTACCCAAAGATGCTAGA
GATGCCTCCAAGAATCCAAAATCCCCTGCTGTCCGGAATCAGGTTGGGCCAA
TTACCAACTGGCGCTCATTATAAAATTCGGAGTATATTACATGGAATGGGAAT
CCATTACAGGGACTTCTTGAGTTGTGGAGACGGCTCCGGAGGGATGACTGCT
GCATTACTACGAGAAAATGTGCATAGCAGAGGAATATTCAATAGTCTGTTAG
AATTATCAGGGTCAGTCATGCGAGGCGCCTCTCCTGAGCCCCCCAGTGCCCTA
GA A AC TTT AGGAGGAGAT A A ATCGAGAT GT GT A A AT GGT GA A AC AT GTT GGG
AATATCCATCTGACTTATGTGACCCAAGGACTTGGGACTATTTCCTCCGACTC
AAAGC AGGCTTGGGGCTTC AAATT GATTT AATT GT AAT GGAT AT GGAAGTTCG
GGATTCTTCTACTAGCCTGAAAATTGAGACGAATGTTAGAAATTATGTGCACC
GGATTTTGGAT GAGC A AGGAGTTTT A AT C T AC A AG AC TT AT GGA AC AT AT ATT
TGTGAGAGCGAAAAGAATGCAGTAACAATCCTTGGTCCCATGTTCAAGACGG
TCGACTTAGTTCAAACAGAATTTAGTAGTTCTCAAACGTCTGAAGTATATATG
GTATGTAAAGGTTTGAAGAAATTAATCGATGAACCCAATCCCGATTGGTCTTC
CAT C AAT GAATCCTGGAA AAACCTGT ACGC ATTCC AGT CAT C AGAAC AGGAA
TTT GCC AGAGC AAAGAAGGTT AGT AC AT ACTTT ACCTT GAC AGGT ATTCCCTC
CCAATTCATTCCTGATCCTTTTGTAAACATTGAGACTATGCTACAAATATTCG
GAGTACCCACGGGTGTGTCTCATGCGGCTGCCTTAAAATCATCTGATAGACCT
GCAGATTTATTGACCATTAGCCTTTTTTATATGGCGATTATATCGTATTATAAC
ATCAATCATATCAGAGTAGGACCGATACCTCCGAACCCCCCATCAGATGGAA
TTGCACAAAATGTGGGGATCGCTATAACTGGTATAAGCTTTTGGCTGAGTTTG
ATGGAGAAAGACATTCCACTATATCAACAGTGTTTAGCAGTTATCCAGCAAT
C ATTCCCGATT AGGT GGGAGGCTGTTTC AGT AAAAGGAGGAT AC AAGC AGAA
GTGGAGTACTAGAGGTGATGGGCTCCCAAAAGATACCCGAACTTCAGACTCC
TTGGCCCCAATCGGGAACTGGATCAGATCTCTGGAATTGGTCCGAAACCAAG
TTCGTCTAAATCCATTCAATGAGATCTTGTTCAATCAGCTATGTCGTACAGTG
GATAATCATTTGAAATGGTCAAATTTGCGAAGAAACACAGGAATGATTGAAT
GGATCAATAGACGAATTTCAAAAGAAGACCGGTCTATACTGATGTTGAAGAG
T GACCT AC AC GAGGA A A AC TC TT GGAGAGATT A A A A A AT CAT GAGGAGAC T C
CAAACTTTAAGTATGAAAAAAACTTTGATCCTTAAGACCCTCTTGTGGTTTTT
ATTTTTTATCTGGTTTTGTGGTCTTCGT.
In other embodiments, the nucleic acid comprises the sequence of SEQ ID NO:
25, shown below (VSV vector: Convac V4 South Africa): ACGAAGAC AAAC AAACC ATT ATT AT C ATT AAAAGGCTC AGGAGAAACTTT AA
C AGT AAT C AAA ATGTCTGTT AC AGTC AAGAGAAT C ATTGAC AAC AC AGTC AT
AGTTCCAAAACTTCCTGCAAATGAGGATCCAGTGGAATACCCGGCAGATTAC
TTCAGAAAATCAAAGGAGATTCCTCTTTACATCAATACTACAAAAAGTTTGTC
AGATCTAAGAGGATATGTCTACCAAGGCCTCAAATCCGGAAATGTATCAATC
AT AC AT GT C A AC AGC T AC TT GT AT GG AGC ATT A A AGG AC ATC C GGGGT A AGT
T GG AT A A AG AT T GGT C A AGTT T C GG A AT AAAC ATC GGG A A AGC AGGGG AT AC
AATCGGAATATTTGACCTTGTATCCTTGAAAGCCCTGGACGGCGTACTTCCAG
AT GGAGT ATCGGAT GCTTCC AGAACC AGCGC AGAT GAC AAAT GGTT GCCTTT
GTATCTACTTGGCTTATACAGAGTGGGCAGAACACAAATGCCTGAATACAGA
A A A A AGC TC AT GGAT GGGC T GAC A A AT C A AT GCA A A AT GAT C A AT GA AC AGT
TTGAACCTCTTGTGCCAGAAGGTCGTGACATTTTTGATGTGTGGGGAAATGAC
AGTAATTACACAAAAATTGTCGCTGCAGTGGACATGTTCTTCCACATGTTCAA
AAAACATGAATGTGCCTCGTTCAGATACGGAACTATTGTTTCCAGATTCAAAG
ATTGTGCTGCATTGGCAACATTTGGACACCTCTGCAAAATAACCGGAATGTCT
ACAGAAGATGTAACGACCTGGATCTTGAACCGAGAAGTTGCAGATGAAATGG
TCCAAATGATGCTTCCAGGCCAAGAAATTGACAAGGCCGATTCATACATGCC
TTATTTGATCGACTTTGGATTGTCTTCTAAGTCTCCATATTCTTCCGTCAAAAA
CCCTGCCTTCCACTTCTGGGGGCAATTGACAGCTCTTCTGCTCAGATCCACCA
GAGCAAGGAATGCCCGACAGCCTGATGACATTGAGTATACATCTCTTACTAC
AGCAGGTTTGTTGTACGCTTATGCAGTAGGATCCTCTGCCGACTTGGCACAAC
AGTTTTGTGTTGGAGATAACAAATACACTCCAGATGATAGTACCGGAGGATT
GACGACTAATGCACCGCCACAAGGCAGAGATGTGGTCGAATGGCTCGGATGG
T TT G A AG AT C A A A AC AG A A A AC C GAC TC C T GAT AT GAT GC AGT AT GC G A A A A
GAGCAGTCATGTCACTGCAAGGCCTAAGAGAGAAGACAATTGGCAAGTATGC
TAAGTCAGAATTTGACAAATGACCCTATAATTCTCAGATCACCTATTATATAT
TATGCTACATATGAAAAAAACTAACAGATATCATGGATAATCTCACAAAAGT
TCGTGAGTATCTCAAGTCCTATTCTCGTCTGGATCAGGCGGTAGGAGAGATAG
ATGAGATCGAAGCACAACGAGCTGAAAAGTCCAATTATGAGTTGTTCCAAGA
GGATGGAGTGGAAGAGCATACTAAGCCCTCTTATTTTCAGGCAGCAGATGAT
TCTGAC AC AGA AT C T GA AC C AG A A ATT GA AG AC A AT C A AGGTTT GT AT GC AC
CAGATCCAGAAGCTGAGCAAGTTGAAGGCTTTATACAGGGGCCTTTAGATGA
CT AT GC AGAT GAGGAAGT GGAT GTT GT ATTT ACTTCGGACTGGAAAC AGCCT
GAGCTTGAATCTGACGAGCATGGAAAGACCTTACGGTTGACATCGCCAGAGG GTTTAAGTGGAGAGCAGAAATCCCAGTGGCTTTCGACGATTAAAGCAGTCGT
GC AAAGTGCC AAAT ACTGGAATCTGGC AGAGT GC AC ATTTGAAGC ATCGGGA
G A AGGGGT C AT T AT G A AGG AGC GC C AG AT A AC T C C GG AT GT AT AT A AGGT C A
CTCCAGTGATGAACACACATCCGTCCCAATCAGAAGCAGTATCAGATGTTTG
GTCTCTCTCAAAGACATCCATGACTTTCCAACCCAAGAAAGCAAGTCTTCAGC
CTCTCACCATATCCTTGGATGAATTGTTCTCATCTAGAGGAGAGTTCATCTCT
GTCGGAGGTGACGGACGAATGTCTCATAAAGAGGCCATCCTGCTCGGCCTGA
GATACAAAAAGTTGTACAATCAGGCGAGAGTCAAATATTCTCTGTAGACTAT
GAAAAAAAGTAACAGATATCACGATCTAAGTGTTATCCCAATCCATTCATCA
T G AGTT C C TT A A AG A AG AT TC TC GGT C T G A AGGGG A A AGGT A AG A A AT C T A A
GAAATTAGGGATCGCACCACCCCCTTATGAAGAGGACACTAGCATGGAGTAT
GCTCCGAGCGCTCCAATTGACAAATCCTATTTTGGAGTTGACGAGATGGACA
CCTATGATCCGAATCAATTAAGATATGAGAAATTCTTCTTTACAGTGAAAATG
ACGGTTAGATCTAATCGTCCGTTCAGAACATACTCAGATGTGGCAGCCGCTGT
ATCCCATTGGGATCACATGTACATCGGAATGGCAGGGAAACGTCCCTTCTAC
AAAATCTTGGCTTTTTTGGGTTCTTCTAATCTAAAGGCCACTCCAGCGGTATT
GGCAGATCAAGGTCAACCAGAGTATCACACTCACTGCGAAGGCAGGGCTTAT
TTGCCACATAGGATGGGGAAGACCCCTCCCATGCTCAATGTACCAGAGCACT
T C AGAAGACC ATTC AAT AT AGGTCTTT AC AAGGGAACGATTGAGCTC AC A AT
GACCATCTACGATGATGAGTCACTGGAAGCAGCTCCTATGATCTGGGATCATT
TCAATTCTTCCAAATTTTCTGATTTCAGAGAGAAGGCCTTAATGTTTGGCCTG
ATTGTCGAGAAAAAGGCATCTGGAGCGTGGGTCCTGGATTCTATCAGCCACT
TCAAATGAGCTAGTCTAACTTCTAGCTTCTGAACAATCCCCGGTTTACTCAGT
CTCTCCTAATTCCAGCCTCTCGAACAACTAATATCCTGTCTTTTCTATCCCTAT
GAAAAAAACTAACAGAGATCGATCTGTTTACGCGTGCCACCATGTTCGTGTTT
CTGGTGCTGCTGCCTCTGGTGAGCTCCCAGTGCGTGAACTTCACCACAAGGAC
CCAGCTGCCCCCTGCCTATACCAATTCCTTCACACGGGGCGTGTACTATCCCG
ACAAGGTGTTCCGGAGCAGCGTGCTGCACTCCACACAGGATCTGTTTCTGCCT
TTCTTTTCTAACGTGACCTGGTTCCACGCCATCCACGTGAGCGGCACCAATGG
CACAAAGCGGTTCGCCAATCCAGTGCTGCCCTTTAACGATGGCGTGTACTTCG
CCTCCACCGAGAAGTCTAACATCATCAGAGGCTGGATCTTTGGCACCACACT
GGACAGCAAGACACAGTCCCTGCTGATCGTGAACAATGCCACCAACGTGGTC
ATCAAGGTGTGCGAGTTCCAGTTTTGTAATGATCCATTCCTGGGCGTGTACTA
TCACAAGAACAATAAGTCTTGGATGGAGAGCGAGTTTCGCGTGTATTCCTCTG CCAACAATTGCACATTTGAGTACGTGTCCCAGCCCTTCCTGATGGACCTGGAG
GGC AAGC AGGGC AATTT C AAGAACCTGAGGGAGTTCGT GTTT AAGAAT ATCG
ATGGCTACTTCAAAATCTACTCCAAGCACACCCCAATCAACCTGGTGCGCGG
CCTGCCACAGGGCTTCTCTGCCCTGGAGCCACTGGTGGATCTGCCCATCGGCA
TCAACATCACCCGGTTTCAGACACTGCTGGCCCTGCACAGAAGCTACCTGAC
ACCAGGCGACAGCTCCTCTGGATGGACCGCAGGAGCAGCAGCCTACTATGTG
GGCTATCTGCAGCCCAGGACCTTCCTGCTGAAGTACAACGAGAATGGCACCA
TCACAGACGCCGTGGATTGCGCCCTGGATCCCCTGTCTGAGACCAAGTGTAC
ACTGAAGAGCTTTACCGTGGAGAAGGGCATCTATCAGACAAGCAATTTCAGG
GTGCAGCCTACCGAGTCCATCGTGCGCTTTCCCAATATCACAAACCTGTGCCC
TTTTGGCGAGGTGTTCAACGCAACCCGCTTCGCCAGCGTGTACGCCTGGAATA
GGAAGCGCATCTCCAACTGCGTGGCCGACTATTCTGTGCTGTACAACAGCGC
CTCCTTCTCTACCTTTAAGTGCTATGGCGTGAGCCCCACAAAGCTGAATGACC
TGTGCTTTACCAACGTGTACGCCGATTCCTTCGTGATCAGGGGCGACGAGGTG
CGCCAGATCGCACCAGGACAGACAGGCAATATCGCAGACTACAATTATAAGC
TGCCTGACGATTTCACCGGCTGCGTGATCGCCTGGAACTCTAACAATCTGGAT
AGCAAAGTGGGCGGCAACTACAATTATCTGTACCGGCTGTTTAGAAAGTCTA
ATCTGAAGCCATTCGAGAGGGACATCTCCACAGAAATCTACCAGGCCGGCTC
TACCCCCTGCAATGGCGTGAAGGGCTTTAACTGTTATTTCCCTCTGCAGAGCT
ACGGCTTCCAGCCAACATATGGCGTGGGCTATCAGCCCTACCGCGTGGTGGT
GCTGTCTTTTGAGCTGCTGCACGCACCTGCAACAGTGTGCGGACCAAAGAAG
AGCACCAATCTGGTGAAGAACAAGTGCGTGAACTTCAACTTCAACGGACTGA
CCGGAACAGGCGTGCTGACCGAGTCCAACAAGAAGTTCCTGCCTTTTCAGCA
GTTCGGCAGGGACATCGCAGATACCACAGACGCCGTGCGCGACCCTCAGACC
CTGGAGATCCTGGACATCACACCATGCTCCTTCGGCGGCGTGTCTGTGATCAC
ACC AGGC ACC AAT AC AAGC AACC AGGT GGCCGTGCTGT AT C AGGGC GT GAAT
TGTACCGAGGTGCCAGTGGCAATCCACGCAGATCAGCTGACCCCTACATGGC
GGGTGTACTCTACCGGCAGCAACGTGTTCCAGACAAGAGCCGGATGCCTGAT
CGGAGCAGAGCACGTGAACAATAGCTATGAGTGCGACATCCCTATCGGCGCC
GGCATCTGTGCCTCCTACCAGACCCAGACAAACTCCCCAAGGTCTGTGGGCG
ATACAGGCCTGTCCAAGAATCCAATCGAGCTGGTAGAGGGCTGGTTCAGCAG
TTGGAAAAGCTCCATCGCCTCCTTTTTCTTTATCATCGGCCTGATCATCGGACT
GTTCCTGGTGCTCCGCGTGGGTATCCACCTGTGCATCAAGCTGAAGCACACCA
AGAAAAGACAGATTTATACAGACATCGAGATGAACCGCCTGGGAAAGggatccg gctccggcgagggcaggggaagtctactaacatgcggggacgtggaggaaaatcccggccccATGAAGTGCCTT
TTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTT
CCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATT
GCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCAT
AC AAGTC AAAAT GCCC AAGAGT C AC AAGGCT ATT C A AGC AGACGGTT GGAT G
TGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAA
GTATATAACACAGTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGG
AAAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCC
TCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAG
GTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTC
ACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAAC
TCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCT
CATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGG
GAAAGGAGGGC AC AGGGTTC AGAAGT AACT ACTTT GCTT ATGAAACTGGAGG
CAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCA
GGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCC
TGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATG
TAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAA
ACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCT
ATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGT
ACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAAT
CCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAAGGGAACTG
TGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTC
TGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATG
TTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCA
CATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTG
AT ACTGGGCT ATCC AAAAATCC AATCGAGCTTGT AGAAGGTTGGTT C AGT AG
TTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACT
ATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCA
AGAAAAGAC AGATTT AT AC AG AC AT AGAGATGAACCGACTT GGAAAGT AAgC
TAGCCAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAG
AGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAACTAACAGCAAT
CAT GGAAGTCC ACGATTTTGAGACCGACGAGTTC AATGATTTC AAT GAAGAT
GACTATGCCACAAGAGAATTCCTGAATCCCGATGAGCGCATGACGTACTTGA ATCATGCTGATTACAATTTGAATTCTCCTCTAATTAGTGATGATATTGACAATT
TGATCAGGAAATTCAATTCTCTTCCGATTCCCTCGATGTGGGATAGTAAGAAC
TGGGATGGAGTTCTTGAGATGTTAACATCATGTCAAGCCAATCCCATCTCAAC
AT C T C AG AT GC AT A A AT GG AT GGG A AGT T GGT T A AT GT C T GAT A AT CAT GAT G
CC AGTC AAGGGT AT AGTTTTTT AC AT GAAGT GGAC AAAGAGGC AGAAAT AAC
ATTT GACGT GGT GGAGACCTT C ATCCGCGGCTGGGGC A AC AAACC AATTGAA
TACATCAAAAAGGAAAGATGGACTGACTCATTCAAAATTCTCGCTTATTTGTG
TCAAAAGTTTTTGGACTTACACAAGTTGACATTAATCTTAAATGCTGTCTCTG
AGGTGGAATTGCTCAACTTGGCGAGGACTTTCAAAGGCAAAGTCAGAAGAAG
TTCTCATGGAACGAACATATGCAGGATTAGGGTTCCCAGCTTGGGTCCTACTT
TTATTTCAGAAGGATGGGCTTACTTCAAGAAACTTGATATTCTAATGGACCGA
AACTTTCTGTTAATGGTCAAAGATGTGATTATAGGGAGGATGCAAACGGTGC
TATCCATGGTATGTAGAATAGACAACCTGTTCTCAGAGCAAGACATCTTCTCC
CTTCTAAATATCTACAGAATTGGAGATAAAATTGTGGAGAGGCAGGGAAATT
TTTCTTATGACTTGATTAAAATGGTGGAACCGATATGCAACTTGAAGCTGATG
AAATTAGCAAGAGAATCAAGGCCTTTAGTCCCACAATTCCCTCATTTTGAAAA
TCATATCAAGACTTCTGTTGATGAAGGGGCAAAAATTGACCGAGGTATAAGA
TTCCTCCATGATCAGATAATGAGTGTGAAAACAGTGGATCTCACACTGGTGAT
TTATGGATCGTTCAGACATTGGGGTCATCCTTTTATAGATTATTACACTGGAC
T AGAAAAATT AC ATTCCC AAGT AACC AT GAAGAAAGAT ATT GATGT GT CAT A
TGCAAAAGCACTTGCAAGTGATTTAGCTCGGATTGTTCTATTTCAACAGTTCA
ATGATCATAAAAAGTGGTTCGTGAATGGAGACTTGCTCCCTCATGATCATCCC
TTTAAAAGTCATGTTAAAGAAAATACATGGCCCACAGCTGCTCAAGTTCAAG
ATTTTGGAGATAAATGGCATGAACTTCCGCTGATTAAATGTTTTGAAATACCC
GACTTACTAGACCCATCGATAATATACTCTGACAAAAGTCATTCAATGAATA
GGTCAGAGGTGTTGAAACATGTCCGAATGAATCCGAACACTCCTATCCCTAG
T AAAAAGGTGTTGC AGACT AT GTTGGAC AC AAAGGCT ACC AATT GGAAAGAA
TTTCTT AAAGAGATT GAT GAGAAGGGCTT AG AT GAT GATGATCT AATT ATTGG
TCTT AAAGGAA AGGAGAGGGAACTGAAGTTGGC AGGT AGATTTTTCTCCCT A
ATGTCTTGGAAATTGCGAGAATACTTTGTAATTACCGAATATTTGATAAAGAC
TCATTTCGTCCCTATGTTTAAAGGCCTGACAATGGCGGACGATCTAACTGCAG
T C ATT AAAAAGAT GTT AGATTCCTC ATCCGGCC AAGGATTGAAGT CAT AT GA
GGCAATTTGCATAGCCAATCACATTGATTACGAAAAATGGAATAACCACCAA
AGGAAGTTATCAAACGGCCCAGTGTTCCGAGTTATGGGCCAGTTCTTAGGTTA TCCATCCTTAATCGAGAGAACTCATGAATTTTTTGAGAAAAGTCTTATATACT
ACAATGGAAGACCAGACTTGATGCGTGTTCACAACAACACACTGATCAATTC
AACCTCCCAACGAGTTTGTTGGCAAGGACAAGAGGGTGGACTGGAAGGTCTA
CGGCAAAAAGGATGGACTATCCTCAATCTACTGGTTATTCAAAGAGAGGCTA
AAAT C AGAAAC ACTGCTGTC AAAGTCTTGGC AC A AGGTGAT AATC AAGTT AT
TTGCACACAGTATAAAACGAAGAAATCGAGAAACGTTGTAGAATTACAGGGT
GCTCTCAATCAAATGGTTTCTAATAATGAGAAAATTATGACTGCAATCAAAAT
AGGG AC AGGG AAGTT AGGACTTTT GAT A AATGACGAT GAGACT ATGC AATCT
GCAGATTACTTGAATTATGGAAAAATACCGATTTTCCGTGGAGTGATTAGAG
GGTTAGAGACCAAGAGATGGTCACGAGTGACTTGTGTCACCAATGACCAAAT
ACCCACTTGTGCTAATATAATGAGCTCAGTTTCCACAAATGCTCTCACCGTAG
CTCATTTTGCTGAGAACCCAATCAATGCCATGATACAGTACAATTATTTTGGG
ACATTTGCTAGACTCTTGTTGATGATGCATGATCCTGCTCTTCGTCAATCATTG
TATGAAGTTCAAGATAAGATACCGGGCTTGCACAGTTCTACTTTCAAATACGC
CATGTTGTATTTGGACCCTTCCATTGGAGGAGTGTCGGGCATGTCTTTGTCCA
GGTTTTTGATTAGAGCCTTCCCAGATCCCGTAACAGAAAGTCTCTCATTCTGG
AGATTCATCCATGTACATGCTCGAAGTGAGCATCTGAAGGAGATGAGTGCAG
TATTTGGAAACCCCGAGATAGCCAAGTTTCGAATAACTCACATAGACAAGCT
AGT AGAAGATCC AACCTCTCTGAAC ATCGCT ATGGGAAT GAGTCC AGCGAAC
TTGTT AAAGACTGAGGTT AAAAAAT GCTT AATCGAAT C AAGAC AA ACC ATC A
GGA AC C AGGT GATT A AGG AT GCA ACC AT AT ATTT GT AT CAT GA AGAGGAT C G
GCTCAGAAGTTTCTTATGGTCAATAAATCCTCTGTTCCCTAGATTTTTAAGTGA
ATTCAAATCAGGCACTTTTTTGGGAGTCGCAGACGGGCTCATCAGTCTATTTC
AAAATTCTCGTACTATTCGGAACTCCTTTAAGAAAAAGTATCATAGGGAATTG
GATGATTTGATTGTGAGGAGTGAGGTATCCTCTTTGACACATTTAGGGAAACT
T C ATTTGAGAAGGGGAT C ATGT AAAATGT GGAC AT GTTC AGCT ACTC AT GCTG
ACACATTAAGATACAAATCCTGGGGCCGTACAGTTATTGGGACAACTGTACC
CCATCCATTAGAAATGTTGGGTCCACAACATCGAAAAGAGACTCCTTGTGCA
CCATGTAACACATCAGGGTTCAATTATGTTTCTGTGCATTGTCCAGACGGGAT
CCATGACGTCTTTAGTTCACGGGGACCATTGCCTGCTTATCTAGGGTCTAAAA
C ATCTGAATCT AC ATCT ATTTT GC AGCCTTGGGAAAGGGAAAGC AAAGTCCC
ACTGATTAAAAGAGCTACACGTCTTAGAGATGCTATCTCTTGGTTTGTTGAAC
CCGACTCTAAACTAGCAATGACTATACTTTCTAACATCCACTCTTTAACAGGC
GAAGAATGGACCAAAAGGCAGCATGGGTTCAAAAGAACAGGGTCTGCCCTTC ATAGGTTTTCGACATCTCGGATGAGCCATGGTGGGTTCGCATCTCAGAGCACT
GC AGC ATTGAC C AGGTTG AT GGC A ACT AC AG AC AC CAT GAGGGAT C T GGG AG
ATCAGAATTTCGACTTTTTATTCCAAGCAACGTTGCTCTATGCTCAAATTACC
ACCACTGTTGCAAGAGACGGATGGATCACCAGTTGTACAGATCATTATCATA
TTGCCTGTAAGTCCTGTTTGAGACCCATAGAAGAGATCACCCTGGACTCAAGT
ATGGACTACACGCCCCCAGATGTATCCCATGTGCTGAAGACATGGAGGAATG
GGG A AGGT T C GT GGGG AC A AG AG AT A A A AC AG AT CTATCCTTT AG A AGGG A
ATTGGAAGAATTTAGCACCTGCTGAGCAATCCTATCAAGTCGGCAGATGTAT
AGGTTTTCTATATGGAGACTTGGCGTATAGAAAATCTACTCATGCCGAGGAC
AGTTCTCTATTTCCTCTATCTATACAAGGTCGTATTAGAGGTCGAGGTTTCTTA
AAAGGGTTGCTAGACGGATTAATGAGAGCAAGTTGCTGCCAAGTAATACACC
GGAGAAGTCTGGCTCATTTGAAGAGGCCGGCCAACGCAGTGTACGGAGGTTT
GATTTACTTGATTGATAAATTGAGTGTATCACCTCCATTCCTTTCTCTTACTAG
ATCAGGACCTATTAGAGACGAATTAGAAACGATTCCCCACAAGATCCCAACC
TCCTATCCGACAAGCAACCGTGATATGGGGGTGATTGTCAGAAATTACTTCA
AAT ACC A ATGCCGTCT AATT GAAAAGGGAAAAT AC AGAT C AC ATT ATTC AC A
ATTATGGTTATTCTCAGATGTCTTATCCATAGACTTCATTGGACCATTCTCTAT
TTCCACCACCCTCTTGCAAATCCTATACAAGCCATTTTTATCTGGGAAAGATA
AGAATGAGTTGAGAGAGCTGGCAAATCTTTCTTCATTGCTAAGATCAGGAGA
GGGGT GGGAAGAC AT AC AT GT GAAATTCTTC ACC AAGGAC AT ATT ATTGT GT
CCAGAGGAAATCAGACATGCTTGCAAGTTCGGGATTGCTAAGGATAATAATA
AAGACATGAGCTATCCCCCTTGGGGAAGGGAATCCAGAGGGACAATTACAAC
AATCCCTGTTTATTATACGACCACCCCTTACCCAAAGATGCTAGAGATGCCTC
CAAGAATCCAAAATCCCCTGCTGTCCGGAATCAGGTTGGGCC AATT ACC AAC
TGGCGCTCATTATAAAATTCGGAGTATATTACATGGAATGGGAATCCATTACA
GGGACTTCTTGAGTTGTGGAGACGGCTCCGGAGGGATGACTGCTGCATTACT
ACGAGAAAATGTGCATAGCAGAGGAATATTCAATAGTCTGTTAGAATTATCA
GGGTCAGTCATGCGAGGCGCCTCTCCTGAGCCCCCCAGTGCCCTAGAAACTTT
AGGAGGAG AT A A ATCG AGAT GT GT A A AT GGT GA A AC AT GTT GGG A AT ATC C A
TCTGACTTATGTGACCCAAGGACTTGGGACTATTTCCTCCGACTCAAAGCAGG
CTTGGGGCTTCAAATTGATTTAATTGTAATGGATATGGAAGTTCGGGATTCTT
CTACTAGCCTGAAAATTGAGACGAATGTTAGAAATTATGTGCACCGGATTTTG
GAT GAGC A AGGAGTTTT AATCT AC AAGACTT AT GGAAC AT AT ATTTGT GAGA
GCGAAAAGAATGCAGTAACAATCCTTGGTCCCATGTTCAAGACGGTCGACTT AGTTCAAACAGAATTTAGTAGTTCTCAAACGTCTGAAGTATATATGGTATGTA
AAGGTTTGAAGAAATTAATCGATGAACCCAATCCCGATTGGTCTTCCATCAAT
GAATCCTGGAAAAACCTGTACGCATTCCAGTCATCAGAACAGGAATTTGCCA
GAGCAAAGAAGGTTAGTACATACTTTACCTTGACAGGTATTCCCTCCCAATTC
ATTCCTGATCCTTTTGTAAACATTGAGACTATGCTACAAATATTCGGAGTACC
CACGGGTGTGTCTCATGCGGCTGCCTTAAAATCATCTGATAGACCTGCAGATT
TATTGACCATTAGCCTTTTTTATATGGCGATTATATCGTATTATAACATCAATC
ATATCAGAGTAGGACCGATACCTCCGAACCCCCCATCAGATGGAATTGCACA
AAATGTGGGGATCGCTATAACTGGTATAAGCTTTTGGCTGAGTTTGATGGAGA
AAGACATTCCACTATATCAACAGTGTTTAGCAGTTATCCAGCAATCATTCCCG
ATT AGGT GGGAGGCTGTTTC AGT AAA AGGAGGAT AC AAGC AGAAGT GGAGT A
CTAGAGGTGATGGGCTCCCAAAAGATACCCGAACTTCAGACTCCTTGGCCCC
AATCGGGAACTGGATCAGATCTCTGGAATTGGTCCGAAACCAAGTTCGTCTA
AATCCATTCAATGAGATCTTGTTCAATCAGCTATGTCGTACAGTGGATAATCA
TTT GA A AT GGT C A A ATTTGC GA AGA A AC AC AGGA AT GATTGA AT GGAT C A AT
AGACGAATTTC AAAAGAAGACCGGTCT AT ACTGAT GTT GAAGAGT GACCT AC
ACGAGGAAAACTCTTGGAGAGATTAAAAAATCATGAGGAGACTCCAAACTTT
AAGTATGAAAAAAACTTTGATCCTTAAGACCCTCTTGTGGTTTTTATTTTTTAT
CTGGTTTTGTGGTCTTCGT.
In one embodiment, the nucleic acid comprises the sequence of SEQ ID NO: 26, shown below (VSV vector: Convac V5 China):
ACGAAGAC AAAC AAACC ATT ATT AT C ATT AAAAGGCTC AGGAGAAACTTT AA C AGT AAT C AAA ATGTCTGTT AC AGTC AAGAGAAT C ATTGAC AAC AC AGTC AT AGTTCCAAAACTTCCTGCAAATGAGGATCCAGTGGAATACCCGGCAGATTAC TTCAGAAAATCAAAGGAGATTCCTCTTTACATCAATACTACAAAAAGTTTGTC AGATCTAAGAGGATATGTCTACCAAGGCCTCAAATCCGGAAATGTATCAATC AT AC AT GT C A AC AGC T AC TT GT AT GG AGC ATT A A AGG AC ATC C GGGGT A AGT T GGAT A A AG AT T GGT C A AGTT T C GG A AT AAAC ATC GGG A A AGC AGGGG AT AC AATCGGAATATTTGACCTTGTATCCTTGAAAGCCCTGGACGGCGTACTTCCAG AT GGAGT ATCGG AT GCTTCC AGAACC AGCGC AGAT GAC AAAT GGTT GCCTTT GT AT C T AC TT GGCTT AT AC AG AGT GGGC AG A AC AC A A AT GCC T GA AT AC AGA A A A A AGC TC AT GGAT GGGC T GAC A A AT C A AT GCA A A AT GAT C A AT GA AC AGT TTGAACCTCTTGTGCCAGAAGGTCGTGACATTTTTGATGTGTGGGGAAATGAC AGTAATTACACAAAAATTGTCGCTGCAGTGGACATGTTCTTCCACATGTTCAA AAAACATGAATGTGCCTCGTTCAGATACGGAACTATTGTTTCCAGATTCAAAG
ATTGTGCTGCATTGGCAACATTTGGACACCTCTGCAAAATAACCGGAATGTCT
ACAGAAGATGTAACGACCTGGATCTTGAACCGAGAAGTTGCAGATGAAATGG
TCCAAATGATGCTTCCAGGCCAAGAAATTGACAAGGCCGATTCATACATGCC
TTATTTGATCGACTTTGGATTGTCTTCTAAGTCTCCATATTCTTCCGTCAAAAA
CCCTGCCTTCCACTTCTGGGGGCAATTGACAGCTCTTCTGCTCAGATCCACCA
GAGCAAGGAATGCCCGACAGCCTGATGACATTGAGTATACATCTCTTACTAC
AGCAGGTTTGTTGTACGCTTATGCAGTAGGATCCTCTGCCGACTTGGCACAAC
AGTTTTGTGTTGGAGATAACAAATACACTCCAGATGATAGTACCGGAGGATT
GACGACTAATGCACCGCCACAAGGCAGAGATGTGGTCGAATGGCTCGGATGG
T TT G A AG AT C A A A AC AG A A A AC C G AC TC C T GAT AT GAT GC AGT AT GC G A A A A
GAGCAGTCATGTCACTGCAAGGCCTAAGAGAGAAGACAATTGGCAAGTATGC
TAAGTCAGAATTTGACAAATGACCCTATAATTCTCAGATCACCTATTATATAT
TATGCTACATATGAAAAAAACTAACAGATATCATGGATAATCTCACAAAAGT
TCGTGAGTATCTCAAGTCCTATTCTCGTCTGGATCAGGCGGTAGGAGAGATAG
ATGAGATCGAAGCACAACGAGCTGAAAAGTCCAATTATGAGTTGTTCCAAGA
GGATGGAGTGGAAGAGCATACTAAGCCCTCTTATTTTCAGGCAGCAGATGAT
TCTGAC AC AGA AT C T GA AC C AG A A ATT GA AG AC A AT C A AGGTTT GT AT GC AC
CAGATCCAGAAGCTGAGCAAGTTGAAGGCTTTATACAGGGGCCTTTAGATGA
CT AT GC AGAT GAGGAAGT GGAT GTT GT ATTT ACTTCGGACTGGAAAC AGCCT
GAGCTTGAATCTGACGAGCATGGAAAGACCTTACGGTTGACATCGCCAGAGG
GTTTAAGTGGAGAGCAGAAATCCCAGTGGCTTTCGACGATTAAAGCAGTCGT
GC AAAGTGCC AAAT ACTGGAATCTGGC AGAGT GC AC ATTTGAAGC ATCGGGA
G A AGGGGT C AT T AT G A AGG AGC GC C AG AT A AC T C C GGAT GT AT AT A AGGT C A
CTCCAGTGATGAACACACATCCGTCCCAATCAGAAGCAGTATCAGATGTTTG
GTCTCTCTCAAAGACATCCATGACTTTCCAACCCAAGAAAGCAAGTCTTCAGC
CTCTCACCATATCCTTGGATGAATTGTTCTCATCTAGAGGAGAGTTCATCTCT
GTCGGAGGTGACGGACGAATGTCTCATAAAGAGGCCATCCTGCTCGGCCTGA
GATACAAAAAGTTGTACAATCAGGCGAGAGTCAAATATTCTCTGTAGACTAT
GAAAAAAAGTAACAGATATCACGATCTAAGTGTTATCCCAATCCATTCATCA
T G AGTT C C TT A A AG A AG AT TC TC GGT C T G A AGGGG A A AGGT A AG A A AT C T A A
GAAATTAGGGATCGCACCACCCCCTTATGAAGAGGACACTAGCATGGAGTAT
GCTCCGAGCGCTCCAATTGACAAATCCTATTTTGGAGTTGACGAGATGGACA
CCTATGATCCGAATCAATTAAGATATGAGAAATTCTTCTTTACAGTGAAAATG ACGGTTAGATCTAATCGTCCGTTCAGAACATACTCAGATGTGGCAGCCGCTGT
ATCCCATTGGGATCACATGTACATCGGAATGGCAGGGAAACGTCCCTTCTAC
AAAATCTTGGCTTTTTTGGGTTCTTCTAATCTAAAGGCCACTCCAGCGGTATT
GGCAGATCAAGGTCAACCAGAGTATCACACTCACTGCGAAGGCAGGGCTTAT
TTGCCACATAGGATGGGGAAGACCCCTCCCATGCTCAATGTACCAGAGCACT
T C AGAAGACC ATTC AAT AT AGGTCTTT AC AAGGGAACGATTGAGCTC AC A AT
GACCATCTACGATGATGAGTCACTGGAAGCAGCTCCTATGATCTGGGATCATT
TCAATTCTTCCAAATTTTCTGATTTCAGAGAGAAGGCCTTAATGTTTGGCCTG
ATTGTCGAGAAAAAGGCATCTGGAGCGTGGGTCCTGGATTCTATCAGCCACT
TCAAATGAGCTAGTCTAACTTCTAGCTTCTGAACAATCCCCGGTTTACTCAGT
CTCTCCTAATTCCAGCCTCTCGAACAACTAATATCCTGTCTTTTCTATCCCTAT
GAAAAAAACTAACAGAGATCGATCTGTTTACGCGTCACTATGAAGTGCCTTTT
GTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCC
ACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGC
CCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCATAC
A AGT C A A A AT GCC C A AGAGTC AC A AGGC T ATT C A AGC AGACGGTT GGAT GT G
TCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGT
ATATAACACAGTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGA
AAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCT
C AAAGTT GTGGAT AT GC AACTGT GACGGAT GCCGAAGC AGT GATTGTCC AGG
TGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCA
CAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTC
TACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCA
TTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGA
AAGGAGGGC AC AGGGTT C AGAAGT AACT ACTTTGCTT AT GAAACTGGAGGC A
AGGCCTGC AAAAT GC AAT ACTGC AAGC ATT GGGGAGTC AGACTCCC ATC AGG
TGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTG
AATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTA
AGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAAC
CTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATC
TTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCT
C T C A AG A AT GGT C GG A AT GAT C AGT GG A AC T AC C AC AG A A AGGG A AC TGT GG
GAT GACTGGGC ACC AT AT GAAGACGT GGAAATTGGACCC AAT GGAGTTCTGA GGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTG
GACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACAT
TCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATA
CTGGGCT ATCC AAAAATCC AATCGAGCTTGT AGAAGGTT GGTTC AGT AGTT G
GAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATT
CTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGA
AAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAA
ATCCTGCTAGGTATGAAAAAAACTAACaGATATCACGCtcgagGCCACCATGAA
GTGCCTGTTGTACTTAGCCTTCCTGTTCATCGGGGTGAATTGCCGCTTTCCCAA
TATCACAAACCTGTGCCCTTTTGGCGAGGTGTTCAACGCAACCCGCTTCGCCA
GCGTGTACGCCTGGAATAGGAAGCGCATCTCCAACTGCGTGGCCGACTATTC
TGTGCTGTACAACAGCGCCTCCTTCTCTACCTTTAAGTGCTATGGCGTGAGCC
CCACAAAGCTGAATGACCTGTGCTTTACCAACGTGTACGCCGATTCCTTCGTG
ATCAGGGGCGACGAGGTGCGCCAGATCGCACCAGGACAGACAGGCAAGATC
GCAGACTACAATTATAAGCTGCCTGACGATTTCACCGGCTGCGTGATCGCCTG
GAACTCTAACAATCTGGATAGCAAAGTGGGCGGCAACTACAATTATCTGTAC
CGGCTGTTTAGAAAGTCTAATCTGAAGCCATTCGAGAGGGACATCTCCACAG
AAATCTACCAGGCCGGCTCTACCCCCTGCAATGGCGTGGAGGGCTTTAACTGT
TATTTCCCTCTGCAGAGCTACGGCTTCCAGCCAACAAACGGCGTGGGCTATCA
GCCCTACCGCGTGGTGGTGCTGTCTTTTGAGCTGCTGCACGCACCTGCAACAG
T GTGCGGACC AA AGAAGAGC ACC AATCTGGT GAAGAAC AAGT GCGT GAACTT
CAAcggCTCTGGATCCGGCTACATCCCCGAGGCCCCCAGAGACGGCCAGGCCT
ACGTGCGGAAGGACGGCGAGTGGGTACTGctcagcaccttcctgggcAGCAGTTGGAA
AAGCTCCATCGCCTCCTTTTTCTTTATCATCGGCCTGATCATCGGACTGTTCCT
GGTGCTCCGCGTGGGTATCCACCTGTGCATCAAGCTGAAGCACACCAAGAAA
AGACAGATTTATACAGACATCGAGATGAACCGACTTGGAAAGTAAGCTAGCC
AGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCC
T C AATT AT ATTTGAGTTTTT AATTTTT AT GAAAA AAACT AAC AGC AAT CAT GG
AAGTCC ACGATTTTGAGACCGACGAGTTC AAT GATTT C AAT GAAGATGACT A
TGCCACAAGAGAATTCCTGAATCCCGATGAGCGCATGACGTACTTGAATCAT
GCTGATTACAATTTGAATTCTCCTCTAATTAGTGATGATATTGACAATTTGATC
AGGAAATTCAATTCTCTTCCGATTCCCTCGATGTGGGATAGTAAGAACTGGGA
TGGAGTTCTTGAGATGTTAACATCATGTCAAGCCAATCCCATCTCAACATCTC
AG AT GC AT A A AT GGAT GGGA AGTT GGTT AAT GT C T GAT AAT CAT GAT GC C AG T C AAGGGT AT AGTTTTTT AC AT GAAGT GGAC AAAGAGGC AGAAAT AAC ATTT
GACGTGGTGGAGACCTTCATCCGCGGCTGGGGCAACAAACCAATTGAATACA
T C AAAAAGGAAAGAT GGACTGACTC ATTC AAAATTCTCGCTT ATTTGTGT C AA
AAGTTTTTGGACTTACACAAGTTGACATTAATCTTAAATGCTGTCTCTGAGGT
GGAATTGCTCAACTTGGCGAGGACTTTCAAAGGCAAAGTCAGAAGAAGTTCT
CATGGAACGAACATATGCAGGATTAGGGTTCCCAGCTTGGGTCCTACTTTTAT
TTCAGAAGGATGGGCTTACTTCAAGAAACTTGATATTCTAATGGACCGAAAC
T TT C T GTT A AT GGT C A A AG AT GT GAT TAT AGGG AGG AT GCA A AC GGT GC T AT C
CATGGTATGTAGAATAGACAACCTGTTCTCAGAGCAAGACATCTTCTCCCTTC
T AAAT ATCT AC AGA ATT GGAGAT AAAATTGT GGAGAGGC AGGGAAATTTTTC
TTATGACTTGATTAAAATGGTGGAACCGATATGCAACTTGAAGCTGATGAAA
TTAGCAAGAGAATCAAGGCCTTTAGTCCCACAATTCCCTCATTTTGAAAATCA
TATCAAGACTTCTGTTGATGAAGGGGCAAAAATTGACCGAGGTATAAGATTC
CTCCATGATCAGATAATGAGTGTGAAAACAGTGGATCTCACACTGGTGATTT
AT GGAT C GTT C AG AC ATT GGGGT C ATCC TTTT AT AG ATT ATT AC AC T GGACT A
GAAAAATTACATTCCCAAGTAACCATGAAGAAAGATATTGATGTGTCATATG
CAAAAGCACTTGCAAGTGATTTAGCTCGGATTGTTCTATTTCAACAGTTCAAT
GATCATAAAAAGTGGTTCGTGAATGGAGACTTGCTCCCTCATGATCATCCCTT
T A A A AGT CAT GTT A A AGA A A AT AC AT GGCC C AC AGCTGC TC A AGTT C A AGAT
TTTGGAGATAAATGGCATGAACTTCCGCTGATTAAATGTTTTGAAATACCCGA
CTTACTAGACCCATCGATAATATACTCTGACAAAAGTCATTCAATGAATAGGT
CAGAGGTGTTGAAACATGTCCGAATGAATCCGAACACTCCTATCCCTAGTAA
AAAGGTGTTGCAGACTATGTTGGACACAAAGGCTACCAATTGGAAAGAATTT
CTT AAAGAGATT GAT GAG AAGGGCTT AGAT GATGATGATCT AATT ATTGGTCT
TAAAGGAAAGGAGAGGGAACTGAAGTTGGCAGGTAGATTTTTCTCCCTAATG
TCTTGGAAATTGCGAGAATACTTTGTAATTACCGAATATTTGATAAAGACTCA
TTTCGTCCCTATGTTTAAAGGCCTGACAATGGCGGACGATCTAACTGCAGTCA
TTAAAAAGATGTTAGATTCCTCATCCGGCCAAGGATTGAAGTCATATGAGGC
AATTTGCATAGCCAATCACATTGATTACGAAAAATGGAATAACCACCAAAGG
AAGTTATCAAACGGCCCAGTGTTCCGAGTTATGGGCCAGTTCTTAGGTTATCC
ATCCTTAATCGAGAGAACTCATGAATTTTTTGAGAAAAGTCTTATATACTACA
ATGGAAGACCAGACTTGATGCGTGTTCACAACAACACACTGATCAATTCAAC
CTCCCAACGAGTTTGTTGGCAAGGACAAGAGGGTGGACTGGAAGGTCTACGG
CAAAAAGGATGGACTATCCTCAATCTACTGGTTATTCAAAGAGAGGCTAAAA T C AG A A AC AC T GCTGT C A A AGT C TT GGC AC A AGGT GAT A AT C A AGTT ATTT GC
AC AC AGT AT A A A ACGA AG A A AT C GAGA A AC GTT GT AG A ATT AC AGGGT GC T C
T C A AT C A A AT GGTTTCT A AT A AT GAGA A A ATT AT GAC T GCA AT C A A A AT AGG
GAC AGGGAAGTT AGGACTTTT GAT AAAT GACGAT GAGACT AT GC AATCTGC A
GATTACTTGAATTATGGAAAAATACCGATTTTCCGTGGAGTGATTAGAGGGTT
AG AG AC C A AG AG AT GGT C AC GAGT GACTTGT GT C AC C A AT GACC A A AT AC CC
ACTTGTGCTAATATAATGAGCTCAGTTTCCACAAATGCTCTCACCGTAGCTCA
TTTTGCTGAGAACCC AAT C AAT GCC ATGAT AC AGT AC A ATT ATTTT GGGAC AT
TTGCTAGACTCTTGTTGATGATGCATGATCCTGCTCTTCGTCAATCATTGTATG
AAGTTCAAGATAAGATACCGGGCTTGCACAGTTCTACTTTCAAATACGCCATG
TTGTATTTGGACCCTTCCATTGGAGGAGTGTCGGGCATGTCTTTGTCCAGGTTT
TTGATTAGAGCCTTCCCAGATCCCGTAACAGAAAGTCTCTCATTCTGGAGATT
CATCCATGTACATGCTCGAAGTGAGCATCTGAAGGAGATGAGTGCAGTATTT
GGAAACCCCGAGATAGCCAAGTTTCGAATAACTCACATAGACAAGCTAGTAG
AAGATCCAACCTCTCTGAACATCGCTATGGGAATGAGTCCAGCGAACTTGTT
AAAGACTGAGGTTAAAAAATGCTTAATCGAATCAAGACAAACCATCAGGAAC
CAGGTGATTAAGGATGCAACCATATATTTGTATCATGAAGAGGATCGGCTCA
GAAGTTTCTTATGGTCAATAAATCCTCTGTTCCCTAGATTTTTAAGTGAATTCA
AATCAGGCACTTTTTTGGGAGTCGCAGACGGGCTCATCAGTCTATTTCAAAAT
TCTCGTACTATTCGGAACTCCTTTAAGAAAAAGTATCATAGGGAATTGGATGA
TTTGATTGTGAGGAGTGAGGTATCCTCTTTGACACATTTAGGGAAACTTCATT
T GAGA AGGGGAT CAT GT A A A AT GT GGAC AT GTT C AGC T ACTC AT GCTGAC AC
ATTAAGATACAAATCCTGGGGCCGTACAGTTATTGGGACAACTGTACCCCAT
CCATTAGAAATGTTGGGTCCACAACATCGAAAAGAGACTCCTTGTGCACCAT
GTAACACATCAGGGTTCAATTATGTTTCTGTGCATTGTCCAGACGGGATCCAT
GACGTCTTTAGTTCACGGGGACCATTGCCTGCTTATCTAGGGTCTAAAACATC
TGAATCTACATCTATTTTGCAGCCTTGGGAAAGGGAAAGCAAAGTCCCACTG
ATTAAAAGAGCTACACGTCTTAGAGATGCTATCTCTTGGTTTGTTGAACCCGA
CTCTAAACTAGCAATGACTATACTTTCTAACATCCACTCTTTAACAGGCGAAG
AATGGACCAAAAGGCAGCATGGGTTCAAAAGAACAGGGTCTGCCCTTCATAG
GTTTTCGACATCTCGGATGAGCCATGGTGGGTTCGCATCTCAGAGCACTGCAG
C ATTGACC AGGTT GATGGC AACT AC AGAC ACC ATGAGGGATCTGGGAGAT C A
GAATTTCGACTTTTTATTCCAAGCAACGTTGCTCTATGCTCAAATTACCACCA
CTGTTGCAAGAGACGGATGGATCACCAGTTGTACAGATCATTATCATATTGCC TGTAAGTCCTGTTTGAGACCCATAGAAGAGATCACCCTGGACTCAAGTATGG
ACTACACGCCCCCAGATGTATCCCATGTGCTGAAGACATGGAGGAATGGGGA
AGGTTCGTGGGGAC AAGAGAT AAAAC AGATCT ATCCTTT AGAAGGGAATTGG
AAGAATTTAGCACCTGCTGAGCAATCCTATCAAGTCGGCAGATGTATAGGTTT
TCTATATGGAGACTTGGCGTATAGAAAATCTACTCATGCCGAGGACAGTTCTC
TATTTCCTCTATCTATACAAGGTCGTATTAGAGGTCGAGGTTTCTTAAAAGGG
TTGCT AGACGGATT AAT GAGAGC A AGTT GCTGCC AAGT AAT AC ACCGGAGAA
GTCTGGCTCATTTGAAGAGGCCGGCCAACGCAGTGTACGGAGGTTTGATTTA
CTTGATTGATAAATTGAGTGTATCACCTCCATTCCTTTCTCTTACTAGATCAGG
ACCTATTAGAGACGAATTAGAAACGATTCCCCACAAGATCCCAACCTCCTAT
CCGACAAGCAACCGTGATATGGGGGTGATTGTCAGAAATTACTTCAAATACC
AATGCCGTCTAATTGAAAAGGGAAAATACAGATCACATTATTCACAATTATG
GTTATTCTCAGATGTCTTATCCATAGACTTCATTGGACCATTCTCTATTTCCAC
CACCCTCTTGCAAATCCTATACAAGCCATTTTTATCTGGGAAAGATAAGAATG
AGTTGAGAGAGCTGGCAAATCTTTCTTCATTGCTAAGATCAGGAGAGGGGTG
GGA AGAC AT AC AT GT GA A ATTC TT C AC C A AGGAC AT ATT ATT GT GT C C AGAG
GAAAT C AG AC AT GCTTGC AAGTTCGGGATTGCT AAGGAT AAT A AT AAAGAC A
TGAGCTATCCCCCTTGGGGAAGGGAATCCAGAGGGACAATTACAACAATCCC
TGTTTATTATACGACCACCCCTTACCCAAAGATGCTAGAGATGCCTCCAAGAA
TCCAAAATCCCCTGCTGTCCGGAATCAGGTTGGGCCAATTACCAACTGGCGCT
CATTATAAAATTCGGAGTATATTACATGGAATGGGAATCCATTACAGGGACTT
CTTGAGTTGTGGAGACGGCTCCGGAGGGATGACTGCTGCATTACTACGAGAA
AATGTGCATAGCAGAGGAATATTCAATAGTCTGTTAGAATTATCAGGGTCAG
TCATGCGAGGCGCCTCTCCTGAGCCCCCCAGTGCCCTAGAAACTTTAGGAGG
AG AT A A AT C GAG AT GT GT A A AT GGT G A A AC AT GT T GGG A AT ATCCATCT G AC
TTATGTGACCCAAGGACTTGGGACTATTTCCTCCGACTCAAAGCAGGCTTGGG
GCTTCAAATTGATTTAATTGTAATGGATATGGAAGTTCGGGATTCTTCTACTA
GCCTGAAAATTGAGACGAATGTTAGAAATTATGTGCACCGGATTTTGGATGA
GC A AGGAGTTTT AATCT AC AAGACTT AT GGAAC AT AT ATTTGT GAGAGC GAA
A AG A AT GC AGT A AC A AT C CTT GGTCC C AT GTT C A AGAC GGTCGAC TT AGTT C A
AACAGAATTTAGTAGTTCTCAAACGTCTGAAGTATATATGGTATGTAAAGGTT
TGAAGAAATTAATCGATGAACCCAATCCCGATTGGTCTTCCATCAATGAATCC
TGGAAAAACCTGTACGCATTCCAGTCATCAGAACAGGAATTTGCCAGAGCAA
AGAAGGTTAGTACATACTTTACCTTGACAGGTATTCCCTCCCAATTCATTCCT GATCCTTTTGTAAACATTGAGACTATGCTACAAATATTCGGAGTACCCACGGG
TGTGTCTCATGCGGCTGCCTTAAAATCATCTGATAGACCTGCAGATTTATTGA
CCATTAGCCTTTTTTATATGGCGATTATATCGTATTATAACATCAATCATATCA
GAGTAGGACCGATACCTCCGAACCCCCCATCAGATGGAATTGCACAAAATGT
GGGGATCGCTATAACTGGTATAAGCTTTTGGCTGAGTTTGATGGAGAAAGAC
ATTCCACTATATCAACAGTGTTTAGCAGTTATCCAGCAATCATTCCCGATTAG
GT GGGAGGCTGTTTC AGT AAAAGGAGGAT AC AAGC AGAAGT GGAGT ACT AG
AGGTGATGGGCTCCCAAAAGATACCCGAACTTCAGACTCCTTGGCCCCAATC
GGGAACTGGATCAGATCTCTGGAATTGGTCCGAAACCAAGTTCGTCTAAATC
CATTCAATGAGATCTTGTTCAATCAGCTATGTCGTACAGTGGATAATCATTTG
AAAT GGT C AAATTT GCGAAGAAAC AC AGGAAT GATT GAAT GGATC AAT AGAC
GAATTTCAAAAGAAGACCGGTCTATACTGATGTTGAAGAGTGACCTACACGA
GGA A A AC TC TT GGAGAGATT A A A A A AT CAT GAGGAGACTCC A A AC TTT A AGT
ATGAAAAAAACTTTGATCCTTAAGACCCTCTTGTGGTTTTTATTTTTTATCTGG
TTTTGTGGTCTTCGT.
In other embodiments, the nucleic acid comprises the sequence of SEQ ID NO:
27, shown below (VSV vector: Convac V5 South Africa):
ACGAAGAC AAAC AAACC ATT ATT AT C ATT AAAAGGCTC AGGAGAAACTTT AA
C AGT AAT C AAA ATGTCTGTT AC AGTC AAGAGAAT C ATTGAC AAC AC AGTC AT
AGTTCCAAAACTTCCTGCAAATGAGGATCCAGTGGAATACCCGGCAGATTAC
TTCAGAAAATCAAAGGAGATTCCTCTTTACATCAATACTACAAAAAGTTTGTC
AGATCTAAGAGGATATGTCTACCAAGGCCTCAAATCCGGAAATGTATCAATC
AT AC AT GT C A AC AGC T AC TT GT AT GG AGC ATT A A AGG AC ATC C GGGGT A AGT
T GG AT A A AG AT T GGT C A AGTT T C GGA AT AAAC ATC GGG A A AGC AGGGG AT AC
AATCGGAATATTTGACCTTGTATCCTTGAAAGCCCTGGACGGCGTACTTCCAG
AT GGAGT ATCGG AT GCTTCC AGAACC AGCGC AGAT GAC AAAT GGTT GCCTTT
GTATCTACTTGGCTTATACAGAGTGGGCAGAACACAAATGCCTGAATACAGA
A A A A AGC TC AT GGAT GGGC T GAC A A AT C A AT GCA A A AT GAT C A AT GA AC AGT
TTGAACCTCTTGTGCCAGAAGGTCGTGACATTTTTGATGTGTGGGGAAATGAC
AGTAATTACACAAAAATTGTCGCTGCAGTGGACATGTTCTTCCACATGTTCAA
AAAACATGAATGTGCCTCGTTCAGATACGGAACTATTGTTTCCAGATTCAAAG
ATTGTGCTGCATTGGCAACATTTGGACACCTCTGCAAAATAACCGGAATGTCT
ACAGAAGATGTAACGACCTGGATCTTGAACCGAGAAGTTGCAGATGAAATGG
TCCAAATGATGCTTCCAGGCCAAGAAATTGACAAGGCCGATTCATACATGCC TTATTTGATCGACTTTGGATTGTCTTCTAAGTCTCCATATTCTTCCGTCAAAAA
CCCTGCCTTCCACTTCTGGGGGCAATTGACAGCTCTTCTGCTCAGATCCACCA
GAGCAAGGAATGCCCGACAGCCTGATGACATTGAGTATACATCTCTTACTAC
AGCAGGTTTGTTGTACGCTTATGCAGTAGGATCCTCTGCCGACTTGGCACAAC
AGTTTTGTGTTGGAGATAACAAATACACTCCAGATGATAGTACCGGAGGATT
GACGACTAATGCACCGCCACAAGGCAGAGATGTGGTCGAATGGCTCGGATGG
T TT G A AG AT C A A A AC AG A A A AC C G AC TC C T GAT AT GAT GC AGT AT GC G A A A A
GAGCAGTCATGTCACTGCAAGGCCTAAGAGAGAAGACAATTGGCAAGTATGC
TAAGTCAGAATTTGACAAATGACCCTATAATTCTCAGATCACCTATTATATAT
TATGCTACATATGAAAAAAACTAACAGATATCATGGATAATCTCACAAAAGT
TCGTGAGTATCTCAAGTCCTATTCTCGTCTGGATCAGGCGGTAGGAGAGATAG
ATGAGATCGAAGCACAACGAGCTGAAAAGTCCAATTATGAGTTGTTCCAAGA
GGATGGAGTGGAAGAGCATACTAAGCCCTCTTATTTTCAGGCAGCAGATGAT
TCTGAC AC AGA AT C T GA AC C AG A A ATT GA AG AC A AT C A AGGTTT GT AT GC AC
CAGATCCAGAAGCTGAGCAAGTTGAAGGCTTTATACAGGGGCCTTTAGATGA
CT AT GC AGAT GAGGAAGT GGAT GTT GT ATTT ACTTCGGACTGGAAAC AGCCT
GAGCTTGAATCTGACGAGCATGGAAAGACCTTACGGTTGACATCGCCAGAGG
GTTTAAGTGGAGAGCAGAAATCCCAGTGGCTTTCGACGATTAAAGCAGTCGT
GC AAAGTGCC AAAT ACTGGAATCTGGC AGAGT GC AC ATTTGAAGC ATCGGGA
G A AGGGGT C AT T AT G A AGG AGC GC C AG AT A AC T C C GGAT GT AT AT A AGGT C A
CTCCAGTGATGAACACACATCCGTCCCAATCAGAAGCAGTATCAGATGTTTG
GTCTCTCTCAAAGACATCCATGACTTTCCAACCCAAGAAAGCAAGTCTTCAGC
CTCTCACCATATCCTTGGATGAATTGTTCTCATCTAGAGGAGAGTTCATCTCT
GTCGGAGGTGACGGACGAATGTCTCATAAAGAGGCCATCCTGCTCGGCCTGA
GATACAAAAAGTTGTACAATCAGGCGAGAGTCAAATATTCTCTGTAGACTAT
GAAAAAAAGTAACAGATATCACGATCTAAGTGTTATCCCAATCCATTCATCA
T G AGTT C C TT A A AG A AG AT TC TC GGT C T G A AGGGG A A AGGT A AG A A AT C T A A
GAAATTAGGGATCGCACCACCCCCTTATGAAGAGGACACTAGCATGGAGTAT
GCTCCGAGCGCTCCAATTGACAAATCCTATTTTGGAGTTGACGAGATGGACA
CCTATGATCCGAATCAATTAAGATATGAGAAATTCTTCTTTACAGTGAAAATG
ACGGTTAGATCTAATCGTCCGTTCAGAACATACTCAGATGTGGCAGCCGCTGT
ATCCCATTGGGATCACATGTACATCGGAATGGCAGGGAAACGTCCCTTCTAC
AAAATCTTGGCTTTTTTGGGTTCTTCTAATCTAAAGGCCACTCCAGCGGTATT
GGCAGATCAAGGTCAACCAGAGTATCACACTCACTGCGAAGGCAGGGCTTAT TTGCCACATAGGATGGGGAAGACCCCTCCCATGCTCAATGTACCAGAGCACT
T C AGAAGACC ATTC AAT AT AGGTCTTT AC AAGGGAACGATTGAGCTC AC A AT
GACCATCTACGATGATGAGTCACTGGAAGCAGCTCCTATGATCTGGGATCATT
TCAATTCTTCCAAATTTTCTGATTTCAGAGAGAAGGCCTTAATGTTTGGCCTG
ATTGTCGAGAAAAAGGCATCTGGAGCGTGGGTCCTGGATTCTATCAGCCACT
TCAAATGAGCTAGTCTAACTTCTAGCTTCTGAACAATCCCCGGTTTACTCAGT
CTCTCCTAATTCCAGCCTCTCGAACAACTAATATCCTGTCTTTTCTATCCCTAT
GAAAAAAACTAACAGAGATCGATCTGTTTACGCGTCACTATGAAGTGCCTTTT
GTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCC
ACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGC
CCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCATAC
A AGT C A A A AT GCC C A AGAGTC AC A AGGC T ATT C A AGC AGACGGTT GGAT GT G
TCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGT
ATATAACACAGTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGA
AAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCT
C AAAGTT GTGGAT AT GC AACTGT GACGGAT GCCGAAGC AGT GATTGTCC AGG
TGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCA
CAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTC
TACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCA
TTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGA
AAGGAGGGC AC AGGGTT C AGAAGT AACT ACTTTGCTT AT GAAACTGGAGGC A
AGGCCTGC AAAAT GC AAT ACTGC AAGC ATT GGGGAGTC AGACTCCC ATC AGG
TGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTG
AATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTA
AGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAAC
CTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATC
TTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCT
C T C A AG A AT GGT C GG A AT GAT C AGT GG A AC T AC C AC AG A A AGGG A AC TGT GG
GAT GACTGGGC ACC AT AT GAAGACGT GGAAATTGGACCC AAT GGAGTTCTGA
GGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTG
GACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACAT
TCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATA
CTGGGCT ATCC AAAAATCC AATCGAGCTTGT AGAAGGTT GGTTC AGT AGTT G GAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATT
CTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGA
AAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAA
ATCCTGCTAGGTATGAAAAAAACTAACaGATATCACGCtcgagGCCACCATGAA
GTGCCTGTTGTACTTAGCCTTCCTGTTCATCGGGGTGAATTGCCGCTTTCCCAA
TATCACAAACCTGTGCCCTTTTGGCGAGGTGTTCAACGCAACCCGCTTCGCCA
GCGTGTACGCCTGGAATAGGAAGCGCATCTCCAACTGCGTGGCCGACTATTC
TGTGCTGTACAACAGCGCCTCCTTCTCTACCTTTAAGTGCTATGGCGTGAGCC
CCACAAAGCTGAATGACCTGTGCTTTACCAACGTGTACGCCGATTCCTTCGTG
AT C AGGGGC GACGAGGT GCGC C AGAT C GC AC C AGGAC AGAC AGGC A AT AT C
GCAGACTACAATTATAAGCTGCCTGACGATTTCACCGGCTGCGTGATCGCCTG
GAACTCTAACAATCTGGATAGCAAAGTGGGCGGCAACTACAATTATCTGTAC
CGGCTGTTTAGAAAGTCTAATCTGAAGCCATTCGAGAGGGACATCTCCACAG
AAATCTACCAGGCCGGCTCTACCCCCTGCAATGGCGTGAAGGGCTTTAACTGT
TATTTCCCTCTGCAGAGCTACGGCTTCCAGCCAACATATGGCGTGGGCTATCA
GCCCTACCGCGTGGTGGTGCTGTCTTTTGAGCTGCTGCACGCACCTGCAACAG
T GTGCGGACC AA AGAAGAGC ACC AATCTGGT GAAGAAC AAGT GCGT GAACTT
CAAcggCTCTGGATCCGGCTACATCCCCGAGGCCCCCAGAGACGGCCAGGCCT
ACGTGCGGAAGGACGGCGAGTGGGTACTGctcagcaccttcctgggcAGCAGTTGGAA
AAGCTCCATCGCCTCCTTTTTCTTTATCATCGGCCTGATCATCGGACTGTTCCT
GGTGCTCCGCGTGGGTATCCACCTGTGCATCAAGCTGAAGCACACCAAGAAA
AGACAGATTTATACAGACATCGAGATGAACCGACTTGGAAAGTAAGCTAGCC
AGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCC
T C AATT AT ATTTGAGTTTTT AATTTTT AT GAAAA AAACT AAC AGC AAT CAT GG
AAGTCC ACGATTTTGAGACCGACGAGTTC AAT GATTT C AAT GAAGATGACT A
TGCCACAAGAGAATTCCTGAATCCCGATGAGCGCATGACGTACTTGAATCAT
GCTGATTACAATTTGAATTCTCCTCTAATTAGTGATGATATTGACAATTTGATC
AGGAAATTCAATTCTCTTCCGATTCCCTCGATGTGGGATAGTAAGAACTGGGA
TGGAGTTCTTGAGATGTTAACATCATGTCAAGCCAATCCCATCTCAACATCTC
AGAT GC AT A A AT GGAT GGGA AGTT GGTT AAT GT C T GAT AAT CAT GAT GC C AG
T C AAGGGT AT AGTTTTTT AC AT GAAGT GGAC AAAGAGGC AGAAAT AAC ATTT
GACGTGGTGGAGACCTTCATCCGCGGCTGGGGCAACAAACCAATTGAATACA
T C AAAAAGGAAAGAT GGACTGACTC ATTC AAAATTCTCGCTT ATTTGTGT C AA
AAGTTTTTGGACTTACACAAGTTGACATTAATCTTAAATGCTGTCTCTGAGGT GGAATTGCTCAACTTGGCGAGGACTTTCAAAGGCAAAGTCAGAAGAAGTTCT
CATGGAACGAACATATGCAGGATTAGGGTTCCCAGCTTGGGTCCTACTTTTAT
TTCAGAAGGATGGGCTTACTTCAAGAAACTTGATATTCTAATGGACCGAAAC
T TT C T GTT A AT GGT C A A AG AT GT GAT TAT AGGG AGG AT GCA A AC GGT GC T AT C
CATGGTATGTAGAATAGACAACCTGTTCTCAGAGCAAGACATCTTCTCCCTTC
T AAAT ATCT AC AGA ATT GGAGAT AAAATTGT GGAGAGGC AGGGAAATTTTTC
TTATGACTTGATTAAAATGGTGGAACCGATATGCAACTTGAAGCTGATGAAA
TTAGCAAGAGAATCAAGGCCTTTAGTCCCACAATTCCCTCATTTTGAAAATCA
TATCAAGACTTCTGTTGATGAAGGGGCAAAAATTGACCGAGGTATAAGATTC
CTCCATGATCAGATAATGAGTGTGAAAACAGTGGATCTCACACTGGTGATTT
AT GGAT C GTT C AG AC ATT GGGGT C ATCC TTTT AT AG ATT ATT AC AC T GGACT A
GAAAAATTACATTCCCAAGTAACCATGAAGAAAGATATTGATGTGTCATATG
CAAAAGCACTTGCAAGTGATTTAGCTCGGATTGTTCTATTTCAACAGTTCAAT
GATCATAAAAAGTGGTTCGTGAATGGAGACTTGCTCCCTCATGATCATCCCTT
T A A A AGT CAT GTT A A AGA A A AT AC AT GGCC C AC AGCTGC TC A AGTT C A AGAT
TTTGGAGATAAATGGCATGAACTTCCGCTGATTAAATGTTTTGAAATACCCGA
CTTACTAGACCCATCGATAATATACTCTGACAAAAGTCATTCAATGAATAGGT
CAGAGGTGTTGAAACATGTCCGAATGAATCCGAACACTCCTATCCCTAGTAA
AAAGGTGTTGCAGACTATGTTGGACACAAAGGCTACCAATTGGAAAGAATTT
CTT AAAGAGATT GAT GAG AAGGGCTT AGAT GATGATGATCT AATT ATTGGTCT
TAAAGGAAAGGAGAGGGAACTGAAGTTGGCAGGTAGATTTTTCTCCCTAATG
TCTTGGAAATTGCGAGAATACTTTGTAATTACCGAATATTTGATAAAGACTCA
TTTCGTCCCTATGTTTAAAGGCCTGACAATGGCGGACGATCTAACTGCAGTCA
TTAAAAAGATGTTAGATTCCTCATCCGGCCAAGGATTGAAGTCATATGAGGC
AATTTGCATAGCCAATCACATTGATTACGAAAAATGGAATAACCACCAAAGG
AAGTTATCAAACGGCCCAGTGTTCCGAGTTATGGGCCAGTTCTTAGGTTATCC
ATCCTTAATCGAGAGAACTCATGAATTTTTTGAGAAAAGTCTTATATACTACA
ATGGAAGACCAGACTTGATGCGTGTTCACAACAACACACTGATCAATTCAAC
CTCCCAACGAGTTTGTTGGCAAGGACAAGAGGGTGGACTGGAAGGTCTACGG
CAAAAAGGATGGACTATCCTCAATCTACTGGTTATTCAAAGAGAGGCTAAAA
T C AGA A AC AC T GCTGT C A A AGT CTT GGC AC A AGGT GAT A AT C A AGTT ATTT GC
AC AC AGT AT A A A ACGA AG A A AT C GAGA A AC GTT GT AGA ATT AC AGGGT GC T C
T C A AT C A A AT GGTTTCT A AT A AT GAGA A A ATT AT GAC T GCA AT C A A A AT AGG
GAC AGGG AAGTT AGG ACTTTT GAT AAAT GACGAT GAGACT AT GC AATCTGC A GATTACTTGAATTATGGAAAAATACCGATTTTCCGTGGAGTGATTAGAGGGTT
AG AG AC C A AG AG AT GGT C AC GAGT GACTTGT GT C AC C A AT GACC A A AT AC CC
ACTTGTGCTAATATAATGAGCTCAGTTTCCACAAATGCTCTCACCGTAGCTCA
TTTTGCTGAGAACCC AAT C AAT GCC ATGAT AC AGT AC A ATT ATTTT GGGAC AT
TTGCTAGACTCTTGTTGATGATGCATGATCCTGCTCTTCGTCAATCATTGTATG
AAGTTCAAGATAAGATACCGGGCTTGCACAGTTCTACTTTCAAATACGCCATG
TTGTATTTGGACCCTTCCATTGGAGGAGTGTCGGGCATGTCTTTGTCCAGGTTT
TTGATTAGAGCCTTCCCAGATCCCGTAACAGAAAGTCTCTCATTCTGGAGATT
CATCCATGTACATGCTCGAAGTGAGCATCTGAAGGAGATGAGTGCAGTATTT
GGAAACCCCGAGATAGCCAAGTTTCGAATAACTCACATAGACAAGCTAGTAG
AAGATCCAACCTCTCTGAACATCGCTATGGGAATGAGTCCAGCGAACTTGTT
AAAGACTGAGGTTAAAAAATGCTTAATCGAATCAAGACAAACCATCAGGAAC
CAGGTGATTAAGGATGCAACCATATATTTGTATCATGAAGAGGATCGGCTCA
GAAGTTTCTTATGGTCAATAAATCCTCTGTTCCCTAGATTTTTAAGTGAATTCA
AATCAGGCACTTTTTTGGGAGTCGCAGACGGGCTCATCAGTCTATTTCAAAAT
TCTCGTACTATTCGGAACTCCTTTAAGAAAAAGTATCATAGGGAATTGGATGA
TTTGATTGTGAGGAGTGAGGTATCCTCTTTGACACATTTAGGGAAACTTCATT
T GAGA AGGGGAT CAT GT A A A AT GT GGAC AT GTT C AGC T ACTC AT GCTGAC AC
ATTAAGATACAAATCCTGGGGCCGTACAGTTATTGGGACAACTGTACCCCAT
CCATTAGAAATGTTGGGTCCACAACATCGAAAAGAGACTCCTTGTGCACCAT
GTAACACATCAGGGTTCAATTATGTTTCTGTGCATTGTCCAGACGGGATCCAT
GACGTCTTTAGTTCACGGGGACCATTGCCTGCTTATCTAGGGTCTAAAACATC
TGAATCTACATCTATTTTGCAGCCTTGGGAAAGGGAAAGCAAAGTCCCACTG
ATTAAAAGAGCTACACGTCTTAGAGATGCTATCTCTTGGTTTGTTGAACCCGA
CTCTAAACTAGCAATGACTATACTTTCTAACATCCACTCTTTAACAGGCGAAG
AATGGACCAAAAGGCAGCATGGGTTCAAAAGAACAGGGTCTGCCCTTCATAG
GTTTTCGACATCTCGGATGAGCCATGGTGGGTTCGCATCTCAGAGCACTGCAG
C ATTGACC AGGTT GATGGC AACT AC AGAC ACC ATGAGGGATCTGGGAGAT C A
GAATTTCGACTTTTTATTCCAAGCAACGTTGCTCTATGCTCAAATTACCACCA
CTGTTGCAAGAGACGGATGGATCACCAGTTGTACAGATCATTATCATATTGCC
TGTAAGTCCTGTTTGAGACCCATAGAAGAGATCACCCTGGACTCAAGTATGG
ACTACACGCCCCCAGATGTATCCCATGTGCTGAAGACATGGAGGAATGGGGA
AGGTTCGTGGGGAC AAGAGAT AAAAC AGATCT ATCCTTT AGAAGGGAATTGG
AAGAATTTAGCACCTGCTGAGCAATCCTATCAAGTCGGCAGATGTATAGGTTT TCTATATGGAGACTTGGCGTATAGAAAATCTACTCATGCCGAGGACAGTTCTC
TATTTCCTCTATCTATACAAGGTCGTATTAGAGGTCGAGGTTTCTTAAAAGGG
TTGCT AGACGGATT AAT GAGAGC A AGTT GCTGCC AAGT AAT AC ACCGGAGAA
GTCTGGCTCATTTGAAGAGGCCGGCCAACGCAGTGTACGGAGGTTTGATTTA
CTTGATTGATAAATTGAGTGTATCACCTCCATTCCTTTCTCTTACTAGATCAGG
ACCTATTAGAGACGAATTAGAAACGATTCCCCACAAGATCCCAACCTCCTAT
CCGACAAGCAACCGTGATATGGGGGTGATTGTCAGAAATTACTTCAAATACC
AATGCCGTCTAATTGAAAAGGGAAAATACAGATCACATTATTCACAATTATG
GTTATTCTCAGATGTCTTATCCATAGACTTCATTGGACCATTCTCTATTTCCAC
CACCCTCTTGCAAATCCTATACAAGCCATTTTTATCTGGGAAAGATAAGAATG
AGTTGAGAGAGCTGGCAAATCTTTCTTCATTGCTAAGATCAGGAGAGGGGTG
GGA AGAC AT AC AT GT GA A ATTC TT C AC C A AGGAC AT ATT ATT GT GT C C AGAG
GAAAT C AG AC AT GCTTGC AAGTTCGGGATTGCT AAGGAT AAT A AT AAAGAC A
TGAGCTATCCCCCTTGGGGAAGGGAATCCAGAGGGACAATTACAACAATCCC
TGTTTATTATACGACCACCCCTTACCCAAAGATGCTAGAGATGCCTCCAAGAA
TCCAAAATCCCCTGCTGTCCGGAATCAGGTTGGGCCAATTACCAACTGGCGCT
CATTATAAAATTCGGAGTATATTACATGGAATGGGAATCCATTACAGGGACTT
CTTGAGTTGTGGAGACGGCTCCGGAGGGATGACTGCTGCATTACTACGAGAA
AATGTGCATAGCAGAGGAATATTCAATAGTCTGTTAGAATTATCAGGGTCAG
TCATGCGAGGCGCCTCTCCTGAGCCCCCCAGTGCCCTAGAAACTTTAGGAGG
AG AT A A AT C GAG AT GT GT A A AT GGT G A A AC AT GT T GGG A AT ATCCATCT G AC
TTATGTGACCCAAGGACTTGGGACTATTTCCTCCGACTCAAAGCAGGCTTGGG
GCTTCAAATTGATTTAATTGTAATGGATATGGAAGTTCGGGATTCTTCTACTA
GCCTGAAAATTGAGACGAATGTTAGAAATTATGTGCACCGGATTTTGGATGA
GC A AGGAGTTTT AATCT AC AAGACTT AT GGAAC AT AT ATTTGT GAGAGC GAA
A AG A AT GC AGT A AC A AT C CTT GGTCC C AT GTT C A AGAC GGTCGAC TT AGTT C A
AACAGAATTTAGTAGTTCTCAAACGTCTGAAGTATATATGGTATGTAAAGGTT
TGAAGAAATTAATCGATGAACCCAATCCCGATTGGTCTTCCATCAATGAATCC
TGGAAAAACCTGTACGCATTCCAGTCATCAGAACAGGAATTTGCCAGAGCAA
AGAAGGTTAGTACATACTTTACCTTGACAGGTATTCCCTCCCAATTCATTCCT
GATCCTTTTGTAAACATTGAGACTATGCTACAAATATTCGGAGTACCCACGGG
TGTGTCTCATGCGGCTGCCTTAAAATCATCTGATAGACCTGCAGATTTATTGA
CCATTAGCCTTTTTTATATGGCGATTATATCGTATTATAACATCAATCATATCA
GAGTAGGACCGATACCTCCGAACCCCCCATCAGATGGAATTGCACAAAATGT GGGGATCGCTATAACTGGTATAAGCTTTTGGCTGAGTTTGATGGAGAAAGAC
ATTCCACTATATCAACAGTGTTTAGCAGTTATCCAGCAATCATTCCCGATTAG
GT GGGAGGCTGTTTC AGT AAAAGGAGGAT AC AAGC AGAAGT GGAGT ACT AG
AGGTGATGGGCTCCCAAAAGATACCCGAACTTCAGACTCCTTGGCCCCAATC
GGGAACTGGATCAGATCTCTGGAATTGGTCCGAAACCAAGTTCGTCTAAATC
CATTCAATGAGATCTTGTTCAATCAGCTATGTCGTACAGTGGATAATCATTTG
AAAT GGT C AAATTT GCGAAGAAAC AC AGGAAT GATT GAAT GGATC AAT AGAC
GAATTTCAAAAGAAGACCGGTCTATACTGATGTTGAAGAGTGACCTACACGA
GGA A A AC TC TT GGAGAGATT A A A A A AT CAT GAGGAGACTCC A A AC TTT A AGT
ATGAAAAAAACTTTGATCCTTAAGACCCTCTTGTGGTTTTTATTTTTTATCTGG
TTTTGTGGTCTTCGT.
In another aspect, the invention provides an isolated nucleic acid encoding a recombinant fusion protein comprising (a) a glycoprotein (G) of a virus or a portion thereof, and (b) a SARS-CoV-2 spike protein (S) or a portion thereof. In some embodiments, the virus is a rhabdovirus. In some embodiments, the virus is a rabies virus or a vesicular stomatitis virus (VSV). In a particular embodiment, the virus is a rabies virus.
In one embodiment, the portion of the SARS-CoV-2 spike protein (S) is a receptor binding site of the SARS-CoV-2 spike protein (S). In another embodiment, the portion of the SARS-CoV-2 spike protein (S) is the SI domain. In another embodiment, the portion of the SARS-CoV-2 spike protein (S) is the N-terminal 750 amino acids of the SARS- CoV-2 spike protein (S).
In some embodiments, the glycoprotein (G) comprises a mutation substituting arginine with glutamic acid at position 333. In some embodiments, the portion of glycoprotein (G) comprises an ectodomain, a cytoplasmic domain, and a transmembrane domain. In some embodiments, the portion of the glycoprotein (G) comprises 31 amino acids of the ectodomain. In some embodiments, the glycoprotein (G) comprises 31 amino acids of the ectodomain and the full-length cytoplasmic domain.
In some embodiments, the sequence encoding the SARS-CoV-2 spike protein (S) or portion thereof is codon-optimized for expression in a human cell. In some embodiments, the sequence encoding the the SARS-CoV-2 spike protein (S) or portion thereof fused to a glycoprotein (G) or portion thereof is codon-optimized for expression in a human cell. In some embodiments, the recombinant fusion protein comprises the sequence of the SI domain of the SARS-CoV-2 spike protein (S) fused to a rabies glycoprotein (G) or portion thereof, shown as element “WuSl-RABVG” in “BNSP333-COVID19-S1-RVG” in FIG 18. In some embodiments, the recombinant fusion protein comprises the sequence of the SI domain of the SARS-CoV-2 spike protein (S) fused to a VSV glycoprotein (G) or portion thereof, shown as element “WuhanS-coVSV-G-tail” in “VSV-COVID19-S1- VSVG” in FIG 17.
In other aspects, the present invention provides nucleic acid molecules having double-stranded, single-stranded, and/or combinations of double- and single-stranded regions as well as full or partial complements of any of the sequences of the present disclosure.
In some aspects, the present disclosure provides the following sequences, or complements thereof:
Figure imgf000250_0001
Figure imgf000251_0001
Figure imgf000252_0001
Pharmaceutical Compositions and Formulations.
The vaccine of the invention may be formulated as a pharmaceutical composition. In some embodiments, the vaccine contains a live virus. In some embodiments, the vaccine contains deactivated viral particles in some embodiments, the virus is a recombinant virus encoded by any one of the nucleic acid constructs as described herein.
Such a pharmaceutical composition may be in a form suitable for administration to a subject (i.e. mammal), or the pharmaceutical composition may further comprise one or more pharmaceutically acceptable carriers, one or more additional ingredients, or some combination of these. The various components of the pharmaceutical composition may be present in the form of a physiologically acceptable salt, such as in combination with a physiologically acceptable cation or anion, as is well known in the art.
In one embodiment, the pharmaceutical compositions useful for practicing the method of the invention may comprise an adjuvant. Non-limiting examples of suitable adjuvants are Freund’s complete adjuvant, Freund’s incomplete adjuvant, Quil A, Detox, ISCOMs or squalene. In one embodiment, the adjuvant is an ADVAX™ adjuvant. In another embodiment, the adjuvant comprises Sepivac SWE™ adjuvant. In another embodiment, the adjuvant is monophosphoryl Lipid A (MPLA) (PFLAD®) in squalene.
In one embodiment, the adjuvant is MPLA 3D(6-acyl) PHAD® in 2% squalene. In one embodiment, the adjuvant increases or induces a Th-1 type immune response. The pharmaceutical composition or vaccine composition can comprise any one or more of the adjuvants described herein.
In some embodiments, the adjuvant comprises inulin e.g., delta inulin (e.g, delta inulin manufactured under current Good Manufacturing Practices is referred to in the art as Advax).
In one embodiment, the adjuvant comprises a delta inulin polysaccharide formulated with the TLR9 agonist (e.g, CpG oligodeoxynucleotides (CpG ODN)). In some embodiments, the adjuvant is Advax-SM™ (Vaxine Pty Ltd, Bedford Park, Australia). In some embodiments, the adjuvant comprises a mixture of an oil component and a surfactant component.
In one embodiment, the composition may be an oil/surf actant dispersion or an oil/surf actant solution.
In other embodiments, the adjuvant comprises an emulsion e.g., an oil in water (o/w) emulsion.
In one embodiment, the composition includes an oil component which is formed from one or more oil(s).
In another embodiment, the oil(s) and the surfactant(s) in the composition are metabolizable (biodegradable) and biocompatible.
In some embodiments, the composition further comprises component(s) in addition to the oil and surfactant components.
In other embodiments, the proportions of the oil component and the surfactant component can vary. In some embodiments, an oil-in-water emulsion comprises oil droplets (e.g, submicron oil droplets as determined by e.g, dynamic light scattering (DLS)) when mixed with a volume of an aqueous material (e.g, water). In other embodiments, the oil droplets have an average diameter of less than about 300 nm when mixed with a volume of an aqueous material (e.g, water), illustratively, about 50 to about 290 nm, about 60 to about 280 nm, about 70 to about 270 nm, about 80 to about 260 nm, about 90 to about 250 nm, about 100 to about 240 nm, about 110 to about 230 nm, about 120 to about 220 nm, about 130 to about 210 nm, and about 140 to about 200 nm. In some embodiments, the oil droplets have an average diameter of about 160 nm (e.g, 160 ± 10 nm), about 155 nm (e.g, 155 ± 10 nm), about 142 nm (e.g, 142 ± 5 nm), about 120 nm (e.g, 120 ± 40 nm), or about 100 nm (e.g, 10 ± 20 nm). In some embodiments, the oil droplets have an average diameter of about 142 nm (e.g, 142 ± 5 nm).
In one embodiment, the total oil component is about 50% to about 90% by volume of the adjuvant composition. In another embodiment, the total oil component is no more than about 50%, no more than about 55%, no more than about 60%, no more than about 65%, no more than about 70%, no more than about 75%, no more than about 80%, no more than about 85%, or no more than about 90% by volume of the adjuvant composition.
In some embodiments, the oil comprises a terpenoid (e.g, a branched, unsaturated terpenoid).
In one embodiment, the oil comprises squalene. In another embodiment, the oil comprises a saturated analog to squalene. In one embodiment, saturated analog to squalene is squalane.
In one embodiment, the adjuvant comprises a squalene oil in water emulsion. In another embodiment, the squalene in water emulsion comprises one or more non-ionic surfactants and/or other oils and/or stabilizers.
In other embodiments, the adjuvant comprises about 7 mgs to about 13 mgs, about 8 mgs to about 12 mgs, about 8 mgs to about 11 mgs, about 9 mgs to about 10 mgs, about 9.5 mgs to about 9.75 mgs of squalene ( e.g ., (mgs of squalene per 0.25 ml) or in 0.5 ml vaccine dose)). In one embodiment, the adjuvant comprises about 8.6 mgs, 9.75 mgs, 10.75 mgs, or 12.5 mgs of squalene.
In another embodiment, the adjuvant is a squalene in water emulsion comprising about 7 to about 13 mgs of squalene (e.g., (mgs of squalene per 0.25 ml) or in 0.5 ml vaccine dose)), illustratively, about 7 to about 13 mgs, about 8 to about 12 mgs, about 8 to about 11 mgs, about 9 to about 10 mgs, about 9.5 to about 9.75 mgs of squalene (e.g, (mgs per 0.25 ml) or in 0.5 ml vaccine dose)). In one embodiment, the adjuvant is a squalene in water emulsion comprising about 9.75 mgs of squalene (e.g, (mgs of squalene per 0.25 ml) or in 0.5 ml vaccine dose)).
In other embodiments, the oil component comprises one or more tocopherols (e.g, a, b, g, d, e, x tocopherol). In one embodiment, the tocopherol is D- a-tocopherol and/or DL- a-tocopherol. In another embodiment, the a-tocopherol is DL-a-tocopherol. In other embodiments, the oil component of the adjuvant is an oil combination comprising squalene and a tocopherol (e.g. DL-a-tocopherol).
In some embodiments, the surfactant component comprises an ionic, a non-ionic, or a zwitterionic surfactant, and any combination thereof. In one embodiment, the surfactant component comprises only non-ionic surfactant(s).
Examples of surfactants include, but are not limited to, the polyoxyethylene sorbitan esters surfactants (e.g, Tweens, polysorbates, such as, e.g, polysorbate 80 (e.g, Tween™ 80), copolymers of ethylene oxide, propylene oxide, butylene oxide), sorbitan esters (e.g, sorbitan trioleate (e.g, Span™ 85), sorbitan monolaurate), and polyoxyethylene lauryl ether (e.g, Emulgen 104P), octoxynols (e.g, Triton X-100, IGEPAL CA-630/NP-40), phospholipids (e.g, lecithin), and Brij surfactants (e.g, polyoxyl 4 lauryl ether (Brij 30)).
In some embodiments, the surfactant in the composition (% by volume of the oil/surfactant composition) is no more than about: 49%, 48%, 47%, 46%, 45%, 44%, 43%, 42%, 41%, 40%, 39%, 38%, 37%, 36%, 35%, 34%, 33%, 32%, 31%, 30%, 29%, 28%, 27%, 26%, 25%, 24%, 23%, 22%, 21%, 20%, 19%, 18%, 17%, 16%, 15%, 14%, 13%, 12%, 11%, or 10%.
In one embodiment, the surfactant component consists of a mixture of polysorbate 80 ( e.g ., Tween™ 80) and sorbitan trioleate (e.g, Span™ 85). In another embodiment, the surfactant component consists of a mixture of polysorbate 80 (e.g, Tween™ 80) and sorbitan trioleate (e.g, Span™ 85) in a volume ratio having more sorbitan trioleate (e.g, Span™ 85) than polysorbate 80 (e.g, Tween™ 80). In some embodiments, the surfactant component consists of a mixture of polysorbate 80 (e.g., Tween™ 80) and sorbitan trioleate (e.g, Span™ 85) in a volume ratio that achieves a HLB of about 8. In some embodiments, the surfactant component consists of a mixture (e.g, (mgs of squalene per 0.25 ml) or in 0.5 ml vaccine dose)) of about 1.175 mgs polysorbate 80 (e.g, Tween™
80) and about 1.175 mgs sorbitan trioleate (e.g, Span™ 85).
In other embodiments, the aqueous component (e.g, water) further comprises one or more components e.g. solutes/salts/buffers. In one embodiment, the salts (e.g, sodium salts) form a pH buffer (e.g. citrate, phosphate). In another embodiments, one or more buffers include, but are not limited to, a citrate buffer, phosphate buffer (e.g., phosphate buffered saline, ammonium phosphate), a Tris buffer, a borate buffer, a succinate buffer, or a histidine buffer. In some embodiment, a buffered aqueous component comprises about 1 to about 20 mM of total buffer.
In other embodiments, the pH of the aqueous component is buffered at about pH 5.5 to about pH 8.0, illustratively, about pH 6.1 to about pH 7.9, about pH 6.2 to about pH 7.8, about pH 6.3 to about pH 7.7, about pH 6.4 to about pH 7.6, about pH 6.5 to about pH 7.5, about pH 6.6 to about pH 7.4, about pH 6.7 to about pH 7.3, about pH 6.8 to about pH 7.2, and about pH 6.9 to about pH 7.1. In one embodiment, the pH of the aqueous component is buffered at about pH: 5.7, 6.0, 6.5, 6.8, or 7.2. In another embodiment, the pH of the aqueous component is buffered at about pH 6.0 to about pH 6.5. In other embodiments, the buffer is 10 mM citrate buffer with a pH of about 6.5.
In other embodiments, the adjuvant is a squalene in water emulsion comprising (e.g, (mgs of squalene per 0.25 ml) or in 0.5 ml vaccine dose)) about 9.75 mgs squalene, 1.175 mgs polysorbate 80 (e.g, Tween™ 80), 1.175 mgs sorbitan trioleate (e.g, Span™ 85), citrate buffer, and a pH of about 6.5.
In some embodiments, an adjuvant of the present disclosure is co-formulated or co-administered with the vaccine. In other embodiments, an adjuvant of the present disclosure is not co-formulated or co-administered with the vaccine.
Pharmaceutical compositions that are useful in the methods of the invention may be suitably developed for inhalation, oral, rectal, vaginal, parenteral, topical, transdermal, pulmonary, intranasal, buccal, ophthalmic, intrathecal, intravenous or another route of administration. Other contemplated formulations include projected nanoparticles, liposomal preparations, resealed erythrocytes containing the active ingredient, and immunologically-based formulations. The route(s) of administration is readily apparent to the skilled artisan and depends upon any number of factors including the type and severity of the disease being treated, the type and age of the veterinary or human patient being treated, and the like.
Although the descriptions of pharmaceutical compositions provided herein are principally directed to pharmaceutical compositions suitable for ethical administration to humans, it is understood by the skilled artisan that such compositions are generally suitable for administration to animals of all sorts. Modification of pharmaceutical compositions suitable for administration to humans in order to render the compositions suitable for administration to various animals is well understood, and the ordinarily skilled veterinary pharmacologist can design and perform such modification with merely ordinary, if any, experimentation.
The composition of the invention may comprise a preservative from about 0.005% to 2.0% by total weight of the composition. The preservative is used to prevent spoilage in the case of exposure to contaminants in the environment.
Administration/Dosing
The regimen of administration of the compositions of the present invention may affect what constitutes an effective amount. For example, the vaccines, polypeptides, and/or the nucleic acids of the invention may be administered to the subject (i.e. mammal) in a single dose, in several divided dosages, as well as staggered dosages may be administered daily or sequentially, or the dose may be continuously infused, or may be a bolus injection. Further, the dosages may be proportionally increased or decreased as indicated by the exigencies of the therapeutic or prophylactic situation.
Administration of the compositions of the present invention to a subject, preferably a mammal, more preferably a human, may be carried out using known procedures, at dosages and for periods of time effective to treat the disease in the subject. An effective amount of the composition necessary to achieve the intended result will vary and will depend on factors such as the disease to be treated or prevented, the age, sex, weight, condition, general health and prior medical history of the subject being treated, and like factors well-known in the medical arts. In particular embodiments, it is especially advantageous to formulate the composition in dosage unit form for ease of administration and uniformity of dosage. Dosage unit form as used herein refers to physically discrete units suited as unitary dosages for the subjects to be treated; each unit containing a predetermined quantity of therapeutic compound calculated to produce the desired therapeutic effect in association with the required pharmaceutical vehicle. The dosage unit forms of the invention are dictated by and directly dependent on (a) the unique characteristics of the composition and the heterologous protein to be expressed, and the particular therapeutic effect to be achieved.
In some embodiments, the vaccine administered may be in an amount that will depend e.g., on the subject to be treated, the capacity of the subject's immune system to develop the desired immune response, and/or the degree of protection desired.
In other embodiments, the administration of the vaccines of the present invention can be in accordance with any suitable vaccination schedule, e.g, day 0, one month, four months, and twelve months from day 0. In other embodiments, the vaccines described herein may also be given in a single dose schedule, or a multiple dose schedule in which a primary course of vaccination may be with 1-10 separate doses, followed by other doses given at subsequent time intervals required to maintain and/or reinforce the immune response, for example, at 1-4 months for a second dose, and if needed, a subsequent dose(s) after several months. In some embodiment, other examples of suitable immunization schedules include, but are not limited to: (i) 0, 1 month and 6 months, (ii)
0, 7 days and 1 month, (iii) 0 and 1 month, (iv) 0 and 6 months, (v) 0, 1 month and 2 months, or other schedules sufficient to elicit the desired immune responses expected to confer protective immunity, and/or reduce disease symptoms, or reduce severity of disease.
In one embodiment, the administration of the vaccines of the present can be in accordance with any suitable vaccination schedule and/or dosage(s) effective to produce an antigen-specific immune response. In some embodiments, an antigen-specific immune response comprises a B and/or T cell response. In other embodiments, the antigen- specific immune response comprises administration of a single dose (no booster dose). In some embodiments, a second (booster) dose of the vaccine may be administered. In other embodiments, additional doses may be administered.
In some embodiments, the administration of the vaccines of the present can be in accordance with any suitable vaccination schedule and/or dosage(s) effective such that the subjects exhibit a seroconversion rate of at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, or at least 95% following the first dose or the second (booster) dose of the vaccine.
In other embodiments, the administration of the vaccines of the present can be in accordance with any suitable vaccination schedule and/or dosage(s) effective to produce an antigen-specific immune response in the subject, wherein the anti-antigen antibody titer produced in the subject is increased by at least 1 log relative to a control.
In some embodiments, the control is an anti-antigen antibody titer produced in a subject who has not been administered a vaccine of the present disclosure. In other embodiments, the control is a titer produced in a subject that has been administered a live attenuated or inactivated vaccine; a recombinant or purified protein vaccine; or a virus like particle vaccine.
In one embodiment, the titer produced in the subject is increased by 1-3 log relative to the control. In another embodiment, the titer produced in a subject is increased at least 2 times relative to the control. In other embodiments, the titer produced in the subject is increased at least 3, 4, 5, 10 or more times relative to the control. In one embodiment, the titer produced in the subject is increased at least 10 times relative to a control. In another embodiment, the titer produced in the subject is increased 2-10 times relative to a control.
In some embodiments, the vaccine of the present disclosure is administered to a subject in an effective amount ( e.g an amount effective to induce an immune response). In some embodiments, the effective amount is a dose equivalent to an at least 2-fold, at least 4-fold, at least 10-fold, at least 100-fold, at least 1000-fold reduction in the standard of care dose of a recombinant protein vaccine, wherein the anti-antigen antibody titer produced in the subject is equivalent to an anti-antigen antibody titer produced in a control subject administered the standard of care dose of a recombinant protein vaccine, a purified protein vaccine, a live attenuated vaccine, an inactivated vaccine, or a VLP vaccine. In some embodiments, the effective amount is a dose equivalent to 2- 1000-fold reduction in the standard of care dose of a recombinant protein vaccine, a purified protein vaccine, a live attenuated vaccine, an inactivated vaccine, or a VLP vaccine. In other embodiments, the effective amount of the vaccine administered comprises a total dose of about 0.1 pg to about 1000 pg of the vaccine or active ingredient (e.g,
VLP, virion, viral vector, antigen, or nucleic acid molecule), illustratively, about 1 pg to about 900 pg, about 5 pg to about 700 pg, about 10 pg to about 500 pg, about 15 pg to about 300 pg, about 20 pg to about 200 pg, and about 25 pg to about 100 pg, In some embodiments, the effective amount is a total dose of about 25 pg, about 50 pg, or about 100 pg. In other embodiments, the effective amount is a total dose of not less than (NLT) about 1 pg, about 5 pg, about 10 pg, about 15 pg, about 20 pg, about 25 pg, about 30 pg, about 35 pg, about 40pg, about 45 pg, about 50 pg, about 55 pg, about 60 pg, about 65 pg, about 70 pg, about 75 pg, about 80 pg, about 85 pg, about 90 pg, about 95 pg, or about 100 pg. In other embodiments, the effective amount is a total dose of about 0.1 pg to about 10 pg.
In some embodiments, doses of the vaccine are based on quantification of DNase- resistant particles (DRPs). In one embodiment, DRPs are equivalent to encapsidated vector genomes. In some embodiments, the subject receives at least one dose (e.g, a first dose at time zero) of the vaccine of about 105 to 1020 about DRPs, illustratively, about 106 to 1018, about 107 to 1017, about 108 to 1016, about 109 to 1015, about 1010 to 1014, and about 1011 to 1013 DRPS. In other embodiments, the subject receives at least one dose (e.g, a first does at time zero) of at least about 105, at least about 106, at least about 107, at least about 108, at least about 109, at least about 1010, at least about 1011, at least about 1012, at least about 1013, at least about 1014, at least about 1015, at least about 1016, at least about 1017, at least about 1018, at least about 1019, or at least about 1020 DRPs.
In some embodiments, the effective amount is a dose administered to the subject a total of one, two, three, four, five, or more times.
In some embodiments, the efficacy or effectiveness of a vaccine of the present disclosure is equal to or greater than about 60%. Vaccine efficacy or effectiveness may be assessed using e.g, standard analyses and protocols known in the art. In one embodiment, the efficacy or effectiveness of the vaccine is at least about 60%, at least about 65%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, or at least about 90%.
In some embodiments, the vaccine immunizes the subject against a coronavirus (e.g, SARS-CoV-2 virus) for up to 6 months, 1 year or 2 years. In some embodiments, the vaccine immunizes the subject against a coronavirus (e.g, SARS-CoV-2 virus) for at least about 6 months, at least about 1 year, at least about 2 years, at least about 3 years, at least about 4 years, or about 5 years to about 10 years, or more.
Routes of Administration
One skilled in the art will recognize that although more than one route can be used for administration, a particular route can provide a more immediate and more effective reaction than another route. Routes of administration of any of the compositions of the invention include inhalation, oral, nasal, rectal, parenteral, sublingual, transdermal, transmucosal (e.g., sublingual, lingual, (trans)buccal, (trans)urethral, vaginal (e.g., trans- and perivaginally), (intra)nasal, and (trans)rectal), intravesical, intrapulmonary, intraduodenal, intragastrical, intrathecal, subcutaneous, intramuscular, intradermal, intra arterial, intravenous, intrabronchial, inhalation, electroporation and topical administration.
Kits
In some embodiments a kit is provided for treating, preventing, or ameliorating an a given disease, disorder or condition, or a symptom thereof, as described herein wherein the kit comprises: a) a compound or compositions as described herein; and optionally b) an additional agent or therapy as described herein. The kit can further include instructions or a label for using the kit to treat, prevent, or ameliorate the disease, disorder or condition. In yet other embodiments, the invention extends to kits assays for a given disease, disorder or condition, or a symptom thereof, as described herein. Such kits may, for example, contain the reagents from PCR or other nucleic acid hybridization technology (microarrays) or reagents for immunologically based detection techniques (e.g., ELISpot, ELISA).
Methods of Treatment
In one aspect, the invention includes a method of generating an immune response against a SARS-CoV-2 virus in a subject in need thereof. In another aspect, a method of vaccinating a subject against a SARS-CoV-2 virus is provided. In yet another aspect, a method of providing immunity against a SARS-CoV-2 virus in a subject is provided. In still another aspect, a method of treating and/or preventing a disease or disorder associated with SARS-CoV-2 virus in a subject in need thereof. In some embodiments, the method comprises administering to the subject an effective amount of a recombinant virus as described herein. In some embodiments, the method comprises administering to the subject an effective amount of a vaccine described herein. In some embodiments, the disease or disorder associated with the SARS-CoV-2 virus is a respiratory disease. In some embodiments, the disease or disorder associated with the SARS-CoV-2 virus is coronavirus disease. In some embodiments, the disease or disorder associated with the SARS-CoV-2 virus is COVID-19.
Pharmaceutical compositions comprising the vaccine of the present invention may be administered in a manner appropriate to the disease to be treated (or prevented). The quantity and frequency of administration will be determined by such factors as the condition of the patient, and the type and severity of the patient’s disease, although appropriate dosages may be determined by clinical trials.
The administration of the vaccine of the invention may be carried out in any convenient manner known to those of skill in the art. The vaccine of the present invention may be administered to a subject by aerosol inhalation, injection, ingestion, transfusion, implantation or transplantation. The compositions described herein may be administered to a patient transarterially, subcutaneously, intradermally, intratumorally, intranodally, intramedullary, intramuscularly, by intravenous (z.v.) injection, or intraperitoneally.
Subjects to which administration of the pharmaceutical compositions of the invention is contemplated include, but are not limited to, humans and other primates, mammals, and birds, including commercially relevant mammals and birds such as cattle, pigs, horses, sheep, chicken, ducks, cats, dogs, and ferrets.
In some embodiments, the subject is a domesticated animal. In some embodiments, the subject is a domestic pet. In some embodiments, the animal is a captive animal, e.g., an animal maintained in an exhibit or in a zoological park. In some embodiments, the animal is livestock. In some embodiments, the subject is an animal susceptible to infection with SARS-CoV-2 and can be a reservoir for the SARS-CoV-2 virus. In some embodiments, the subject is a feline. In some other embodiments, the subject is a canine. In some embodiments, the subject is a member of the Mustelidae family, such as a weasel, polecat, stoat, marten, mink, badger, otter, or ferret. In some embodiments, the subject is a cat. In some other embodiments, the subject is a dog. In some embodiments, the subject is a ferret.
In one aspect, a method of preventing SARS-CoV-2 infection or providing immunity to SARS-CoV-2 in a subject is provided, the method comprising administering to a subject a SARS-CoV-2 vaccine described herein, wherein the subject is a domestic pet selected from a cat, a dog, and a ferret. In particular, felines and ferrets have been identified as a potential host for SARS-CoV-2 (J. Shi etal. , Science 10.1126/science. abb7015 (2020)). Cats are one of the most favored pets of the USA's citizens. In the United States, one in three households owns a pet cat, with an average of 2.2 cats per cat-owning household. However, pet cats are only a part of the total cat population in the country, which is estimated to be around 76.5 million.
Currently, rabies vaccination is recommended for cats, dogs, and ferrets. CDC guidelines recommend that all dogs, cats, and ferrets should be vaccinated and revaccinated against rabies according to product label directions (www.cdc.gov/rabies/ specific groups/ veterinarians/vaccination. html). If a previously vaccinated animal is overdue for a booster, it should be revaccinated. Immediately following the booster, the animal is considered currently vaccinated and should be placed on a vaccination schedule according to the labeled duration of the vaccine used.
The existing RABV vaccine for cats, dogs, or ferrets can be replaced with a rabies virus-based SARS-CoV-2 vaccine to induce protection from both diseases. Thus, in one aspect, a method of providing immunity to rabies and a SARS-CoV-2 associated disease in a subject is provided, wherein the subject is a cat, dog, or ferret. The method includes the step of administering to the subject a vaccine comprising a rabies virus-based SARS- CoV-2 vaccine. In another aspect, a vaccine for cats, dogs, or ferrets is provided, the vaccine comprising a rabies virus-based SARS-CoV-2 vaccine. In some embodiments, the vaccine comprises a recombinant rabies virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof. In some embodiments, the vaccine comprises a recombinant rabies virus comprising a fusion of (a) a glycoprotein (G) of a virus or a portion thereof, and (b) a SARS-CoV-2 spike protein (S) or a portion thereof. In some embodiments, the vaccine comprises an inactivated virus. In particular embodiments, the vaccine comprises an adjuvant. In some embodiments, the vaccine is formulated for administration to a cat. In some other embodiments, the vaccine is formulated for administration to a dog. In still other embodiments, the vaccine is formulated for administration to a ferret.
It should be understood that the method and compositions that would be useful in the present invention are not limited to the particular formulations set forth in the examples. The following examples are put forth so as to provide those of ordinary skill in the art with a complete disclosure and description of how to make and use the cells, expansion and culture methods, and therapeutic methods of the invention, and are not intended to limit the scope of what the inventors regard as their invention. The practice of the present invention employs, unless otherwise indicated, conventional techniques of molecular biology (including recombinant techniques), microbiology, cell biology, biochemistry and immunology, which are well within the purview of the skilled artisan. Such techniques are explained fully in the literature, such as, “Molecular Cloning: A Laboratory Manual”, fourth edition (Green, M. R. & Sambrook, L, Cold Spring Harbor Laboratory Press, 2012); “Oligonucleotide Synthesis, a practical approach” (PaselkR. A., edited by Gait, M. L, IRL Press, Oxford, 1984); “Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications, Sixth Edition” (Freshney, R. L, John Wiley & Sons, Inc., 2010); “Methods in Enzymology” (Vol. 152, Guide to Molecular Cloning Techniques, Berger and Kimmel, Eds., San Diego: Academic Press, Inc., 1987); “Handbook of Experimental Immunology” (Herzenberg L.A., Weir, D.M., Blackwell, C., Wiley, 1997); “Gene Transfer Vectors for Mammalian Cells” (Miller and Calos, eds., Cold Spring Harbor Laboratory, Cold Spring Harbor, 1987); “Short Protocols in Molecular Biology” (Ausubel, F. M., et al ., ed., John Wiley & Sons, 2002); “Polymerase Chain Reaction: Principles, Applications and Troubleshooting” (Babar, M. E., publisher VDM Verlag Dr. Miiller, 2011); “Current Protocols in Immunology” (Colligan, J. E., et al ., ed., Greene Pub. Associates and Wiley- Interscience, 2002). These techniques are applicable to the production of the polynucleotides and polypeptides of the invention, and, as such, may be considered in making and practicing the invention. Particularly useful techniques for particular embodiments will be discussed in the sections that follow.
EXPERIMENTAL EXAMPLES
The invention is now described with reference to the following Examples. These Examples are provided for the purpose of illustration only, and the invention is not limited to these Examples, but rather encompasses all variations that are evident as a result of the teachings provided herein.
Example 1
RABV, VSV, and MV expressing Covid S or Covid-Sl
The materials and methods employed in Examples 1-5 are now described. Generation of RABV-. VSV-. and MV- based vaccines against COVID-19 The SARS-CoV-2 spike protein (S) was used in generating the vaccines against COVID- 19 described herein. SARS-CoV-2 causes Convid-19. The SI domain (receptor binding site of the S protein) was incorporated into the Genome of rabies virus (RABV) and vesicular stomatitis virus (VSV). For both constructs part of their native G protein was used to promote the incorporation of the SI domain. The full-length SARS-CoV-2 S was found to interfere with viral growth (VSV or RABV G) making it almost impossible to produce the vaccine; thus the SI domain was used instead.
Three measles virus (MV)-based vaccine expressing full-length SARS-CoV-2 spike protein (S) were also prepared. These three viruses express the SARS-CoV-2 spike protein (S) from position 2, 3, or 6 of the genome. Previous research indicates that for measles virus the position a foreign gene is expressed is important for MV replication and immunogenicity of the trans-gene. However this depends on the antigen, so three different viruses were prepared.
Testing of RABV-. VSV-. and MV- based vaccines against COVID-19 in animals
In the next phase, the vaccines are tested in animals. The receptor for both viruses is believed to be ACE 2. The model that will be used is a hamster or mice (transgenic expressing ACE2 or wildtype infected with an Adenovirus expressing ACE2).
Both live and killed viruses are tested. After immunization mice or hamster are challenged with the SAR.S-CoV-2 (Convid-19).
Immunological parameters of the 2019-nCoV vaccine.
The parameters of the induced humoral and cellular immune responses will be studied after i.m. inoculation of mice (including 2019-nCoV challenge), and non-human primate (NHP) (immunogenicity). ELISA and virus neutralization assays (VNA) will be utilized to analyze the humoral immune response. These assays are developed for mice and NHP and, based on the limited space, only briefly described below. Previous experience will be used in the development of such assays especially in the field of coronaviruses ELISA assay for detection of 2019-nCoV SI and vector RABV G-specific humoral responses.
Preparation of highly purified antigens against 2019-nCoV SI or RABV G. Purification of the HA-tagged soluble protein from the supernatant of transfected 293 T cells is carried out as described previously for MERS-CoV (17). Purified proteins can be prepared in the mg range sufficient for large numbers of assay plates. Approximately 10- 20 mg of purified RABV G is produced on a regular basis in the Schnell laboratory.
To determine antibody responses to the 2019-nCoV S or RABV G, an indirect ELISA will be developed utilizing purified S 1 or G protein (26) and unpublished. Sera from vaccinated mice or NHP will be used at different dilutions to determine the EC50 over time. Serum IgM and IgG antibodies (total IgM, IgG, IgGl, IgG2 for NHP, IgG2c and IgGl for B6) to each vaccine antigen will be measured by a qualified ELISA that is well established in the Thomas Jefferson University (TJU) laboratories. Prior to performing the ELISA assays, we will qualify the assay for each vaccine antigen. Our ELISA platform will be standardized to measure serum IgG specific for the vaccine antigens by characterizing assay variability, determining the limit of quantitation, defining the positive and negative quality control ranges, and defining assay acceptance criteria. TJU has substantial experience in qualifying and performing ELISA assays using this platform and plan to use it for future clinical studies as well. Assays will be transferred for the human clinical samples to a contractor via IQ VIA.
Virus Neutralization assays (VNA) for RABV are well established in the TJU laboratory (12, 27, 28) for mouse, monkey, and human sera. Use of an internal WHO standard, allows determining the international unit (I.U.) achieved by the immunization. The presence of 0.5 I.U or more in the sera is considered a correlate of protection from rabies. VNA for MERS-CoV are established at the University of Maryland in the Frieman lab. Dr. Frieman has a virus sample from CDC from the Washington St patient. He is also recreating multiple strains using his infectious clone and synthesizing full genomes. Cellular responses
Most likely, humoral responses are the key for protection based on previous studies of coronaviruses but as a research part, frequencies and cytokine expression profiles of vaccine antigen-specific T cells will be measured in splenocytes or cryopreserved NHP PBMCs using a qualified 13-color ICS assay. In order to assess potential for durable antibody responses, antigen specific IgG+ ELISPOT analysis will be performed to detect antibody-secreting plasma cells in the bone marrow 28 days post-boost immunization.
The results of the experiments are now described.
RABV, VSV, and MV expressing Covid S or Covid-Sl
VS V expressing codon-optimized Covid-Sl, RABV expressing codon-optimized Covid-Sl, and MV expressing codon-optimized Covid-S from positions 2, 3, and 6 of the genome were generated (FIGS. l-5; FIGs. 17-21).
FIG. 6 shows characterization of RABV (RABV-COV19-S1) and VSV (VSV- COV19-S1) expressing a chimeric Sl-G fusion protein. SDS-PAGE analysis of purified virions after sucrose gradient purification. Letters indicate the positions of the VSV or RABV L, G, N, P, and M proteins. Numbers to the left indicate the sizes of the molecular mass standards. The Covid-19 SI protein is indicated. The controls show VSV and RABV virions.
Example 2
A rabies vaccine based bivalent vaccine against 2019-nCoV
Technologies developed for MERS-CoV and SARS-CoV can be transferred to the 2019-nCov. Most vaccine design has focused on the major immunodominant antigen, the Spike (S) protein located on the surface of the virion, which serves as the ligand for the MERS-CoV receptor dipeptidyl peptidase 4 (DPP4, also known as CD26) (1). Similar to MERS-CoV S 2019-nCoV S is a transmembrane glycoprotein that is likely cleaved by the furin protease into SI and S2 domains as MERS-CoV S (2). Without intending to be bound by theory, it is believed that, as for other coronaviruses such as MERS-CoV, virus neutralizing antibodies (VNA), which are produced in response to infection or vaccination with MERS-CoV S, will neutralize virus infection in vitro and protect lungs from infection in mouse models of disease (3-6).
Described herein is a Rhabdovirus-based vaccine that offers a combination of features that could prove desirable for an effective 2019-nCoV vaccine. Rhabdovirus- vectored vaccine candidates have been developed for several human pathogens (7). More recently both RABV and VSV have been successfully utilized as Ebola virus (EBOV) vaccines and both approaches are either close to clinical trials (RABV) or have already completed phase 2 clinical trials (VSV) (8, 9). Chemically inactivated RABV vaccines are widely used and safe for humans; approximately 100 million doses of inactivated RABV vaccines are administered to humans every year, demonstrating an excellent safety profile (10). Both live and chemically inactivated RABV vaccines are shown to be safe for animals. In a proof of concept study both live-attenuated as well as inactivated RABV-EBOV have been utilized successfully against EBOV and this vaccine enters a phase 1 clinical trial in 2020. (11-14).
Construction of an attenuated RABV 2019-CoV based on the well-characterized MERS- CoV vaccine (FIG. 12 and (15)).
The nucleotide sequence encoding 2019-nCoV SI protein was inserted into the CBNSP333 vector (FIG. 12; FIG. 18 “BN8R333 qnΐϋ19-81^nq”). 2019-nCoV S is a glycoprotein anchored in the membrane of the 2019-nCoV virions that projects from the surface of the virus to act as a ligand to susceptible cells, and is therefore a major immunogen. The BNSP333 vaccine vector utilized is derived from the attenuated RABV strain SAD-B19 (16). Several modifications were introduced into the parent strain to increase safety and maximize expression of foreign genes. It was previously shown that foreign genes can be stably introduced into this vector (14, 17-20). Moreover, it was shown that expression of foreign antigens from a position between the RABV N and P gene, as well as codon optimization for human cells of the target gene, results in the highest expression level of the foreign antigen (14). Additionally, replacing the arginine with glutamic acid at position 333 (333R->333E) within the RABV glycoprotein (G) further reduces the pathogenicity of the already highly attenuated vector (19). This improved vector was successfully used to generate candidate vaccines against several emerging zoonotic viral diseases like EBOV and Henipaviruses (14, 21). However, expression of full length CoV S was found to inhibit expression of RABV G protein and reduces viral titers dramatically. However, expression of SI fused to the C-terminal part of RABV G resulted in strong incorporation of RABV G-MERS-CoV-Sl fusion protein. The RABV G-2019-nCoV-Sl vaccine is similar to the MERS-CoV 331 -SI =
MERSRAB) expressing the N-terminal 750 aa of 2019-nCoV S fused to a truncated RABV glycoprotein, which comprises 31 aa of the ectodomain (ED) of RABV G and the complete CD and the transmembrane domain of RABV G to allow chimeric glycoprotein incorporation into RABV virions. The chimeric 2019-nCoV Sl/RABV G protein utilizes the original 2019-CoV ER translocation sequence (SS) and is generated by PCR of codon optimized cDNA fragments (FIG. 12).
All the following results are presented from previous studies with the MERS construct (MERSRAB). For MERSRAB, infectious virus was recovered. The new virus expressing the SI fragment grew to similar titers of roughly 108 FFU/mL as the control virus BNSP333 on Vero cells, which are approved for human vaccine production. The BNSP333 RABV expressing the SI was entitled MERSRAB and the animal efficacy studies listed below resulted from this constructs. The RABV-based MERSRAB vaccine proved efficacious in three different animal models: mice transduced with an Ad5 virus expressing human hDPP4 (the receptor for MERS-CoV), CRISPR-CASc mice expressing human hDPP4 and Alpacas (camelid).
MERSRAB is immunogenic in mice and protects against challenge with MERS- CoV. To analyze the immunogenicity of the MERSRAB (FIG. 12 and FIG. 13), we immunized 4 groups of BALB/c mice (5 mice per group) with 10 pg of the control virus FILORABl (Ebola virus vaccine, groupl), 10 pg of MERSRAB (groups 2 and 3), or PBS (group 4) at day 0, 7, and 21 post-inoculations. We followed the immune response against RABV G and MERS-CoV S by antigen-specific ELISAs. The antigen-specific IgG responses increased over time and after each immunization; they reached high antibody levels against both RABV G and MERS-CoV S after the third inoculations. MERS-CoV- S specific immune responses were only detected in groups 2 and 3, but RABV G specific IgG was detected in groups 1-3. None of the animals of group 4, which were mock immunized, demonstrated immune responses against RABV G or MERS-CoV S protein, confirming the specificity of the ELISAs assays. Whereas the RABV G-specific ELISA titers are known to predict protection against RABV challenge (22-24), the protective abilities of the MERS-CoV S-directed antibodies are unknown. Therefore VNA was performed against MERS-CoV of sera on day 35 of the immunized mice of all four groups. Low levels of MERS-CoV neutralizing antibodies were detected in the sera of mice from group 1 (FILORAB1) or mock (PBS) immunized mice (group 4), but the sera of mice immunized with MERSRAB (group 2 and 3) neutralized MERS-CoV at serum dilutions between 1:1280 and 1:5120. This demonstrates a high level of anti-MERS-CoV neutralizing antibody produced in the BNSP333-S1 vaccinated mice.
Efficacy testing of the RABV-MERS vaccine was performed using the adenovirus-hDPP4 transduced mouse model (25). All four groups of mice were transduced, and after five days, mice in groups 1, 2, and 4 were challenged intranasally (IN) with MERS-CoV at 1 x 105 pfu/mouse (strain Jordan-n3/2012). Four days after the challenge, the mice were euthanized, and their lungs were dissected, homogenized, and assayed for viral load by qRT-PCR and a viral plaque assay. For BNSP333-S1 immunized mice, both genomic and mRNA were reduced to background levels similar to those found in mice not transduced by the Ad5 -expressing hDPP4. Moreover, the immunization with BNSP333-S1 reduced the viral load in the lungs to a level below detection of the assay. In the next step the RABV based vaccine MERSRAB was tested in the CRISPR-CAS generated transgenic mouse model (mice expressing human hDPP4). Transgenic mice in groups of 10 mice were immunized with 10 pg of the control virus FILORAB (Empty vector, group Rabies control vaccine), 10 pg of MERSRAB (MERS/Rabies dual vaccine), at day 0, 7, and 28 or only at day 0 and 28 (FIG. 13). The immune response against RABV G and MERS-CoV S was followed by antigen-specific ELISAs. The antigen- specific IgG responses increased over time and after each immunization; they reached high antibody levels against both RABV G and MERS-CoV S after the second or third immunization. MERS-CoV-S specific immune responses were only detected in groups 1 and 2 (MERS-Rabies), but RAB V G specific IgG was detected in all three groups.
Whereas the RABV G-specific ELISA titers are known to predict protection against RABV challenge (22-24), the protective abilities of the MERS-CoV S-directed antibodies are not well characterized. The transgenic mice were therefore challenged with pathogenic MERS-CoV at day 56. As shown in FIG. 14A all immunized mice survived the infection whereas 40% of the mock immunized animals succumbed to the infection. As shown all mice, which received one or two inoculation with the MERSRAB were protected from weight-loss completely. Moreover, immunization did reduce viral loads to undetectable levels (FIGS. 14A-14C) whereas the MERS-CoV replicated to very high levels in empty vector immunized animals (FIG. 14C). This can also be seen in FIG. 15. Two or three inoculations with MERSRAB protect animals from viral replication in the lung and MERS-CoV antigen in lungs of immunized mice is detected at day three after challenge, no antigen is detected at day six. In contrast, the lung tissue of animal immunized with the vector only, large amount of tissue damage and viral antigen can be detected at both time points consistent with the viral load shown in FIGS. 14A-14C.
Lastly, to determine the potential of preventing transmission from host species to humans, the next study tested if the MERSRAB vaccine was efficacious in Camelids. In brief, a group of five Alpacas were immunized with 107 foci forming units (ffu) of live MERSRAB i.m., or intranasally or immunized i.m. with 100 pg or 300 pg of the inactivated MERSRAB vaccine. After 56 days the animals were challenged with MERS- CoV intranasally and nasal swabs were taken over time to analyse viral shedding. No disease was detected after immunization with either the live or the killed MERSRAB vaccine. As shown in FIG. 15, two inoculations with 100 or 300 pg resulted in almost complete suppression of viral shedding from the infected animals.
Inactivated RABV has a 30-year long history as an efficient and safe vaccine. Taken together, the results presented above clearly indicate that a vaccine based on deactivated RABV particles is a strong candidate against 2019-nCoV infection.
Furthermore, the use of an adjuvant might allow clinical benefit after just one vaccination. Appropriate adjuvant selection is likely be critical to design of a safe and effective nCoV vaccine. Notably, vaccine-enhanced eosinophilic lung disease was seen to be exacerbated when SARS vaccines were formulated with aluminium salt adjuvants whereas it was completely prevented when the same SARS vaccines were formulated with Advax-SM adjuvant, which is a formulation of polysaccharide particles combined with a potent TLR9 agonist. The addition of Advax to a broad range of vaccines results in significant benefits including enhanced protection associated with higher antibody titers, increased B cell receptor affinity maturation, IgG subtype diversification, enhanced memory CD4 and CD8 T cell responses and antigen dose sparing. Advax adjuvant have been shown to provide protective immunity with a single dose in neonatal pups. A particular advantage of Advax adjuvants is that they have already been shown to be safe and well tolerated in human clinical trials in combination with many different antigens thereby facilitating rapid translation of successful vaccines from preclinical studies to human trials.
Adjuvants increase the immunity of vaccines and can also change the antibody isotype. It was previously shown for a rabies virus platform that the addition of MPLA in squalene (PHAD®) increased both the total humoral responses as well as the Thl/TH2 bias. For most viral vaccines, it has been shown that a THl-bias is beneficial. It has been demonstrated a TH1 bias is necessary for robust protection against EBOV by the FILORABl vaccine. For the 2019-nCoV vaccine, the MPLA 3D(6-acyl)PHAD® in 2% Squalene can be used as well as an adjuvant with the potential to increase immunity and induce TH1 responses (e.g., CpG-Oligodeoxynucleotide).
Example 3 Preclinical studies
The following describes preclinical studies to test the 2019-nCoV vaccine:
1) Most critical is the ability to test efficacy in animal models (small animal and NHP), which will be performed in parallel to the proposed Phase 1 clinical trial to evaluate safety and immunogenicity and potential adverse effects such as enhancement of infection after vaccination. Because 2019-nCoV and the SARS-CoV seem to utilize the same receptor the human ACE2 transgenic mice may be a suitable model for 2019-nCoV, however evaluation of this model has not been characterized and experiments to confirm the model are in the planning stages. NHP animal modelling is expected to start in mid- March 2020. Cynomolgus monkeys, African Green monkeys, common marmosets, and rhesus monkeys will be evaluated for disease development following intratracheal, small- particle aerosol, or large-particle aerosol. The IRF-Frederick has experience with MERS, ebola virus, nipah virus and cowpox aerosol models. The unique positron emission tomography with computed tomography (PET/CT will be incorporated into the animal model to measure disease progression since the nonhuman primate model is expected to be sublethal. CT has been used previously to demonstrate vaccine efficacy and to complement small molecule countermeasure efficacy tests (www.ncbi.nlm.nih.gov/pubmed/26218507 and www.ncbi.nlm.nih.gov/pmc/articles/PMC5640857/).
CT has also been used to evaluated a MERS monoclonal antibody in the rhesus monkey model of MERS and to evaluate disease progression in the common marmoset model of MERS (www.ncbi.nlm.nih.gov/pubmed/26828465 and www.ncbi.nlm.nih.gov/pubmed/26342468)
2) Characterization of the 2019-nCoV vaccine by biochemical and virological assay at TJU
3) Recovery of the vaccine at BBIL under GLP
4) Establish VNA against the 2019-nCoV strain. Establish pseudotype VNA assay for BSL2
5) ELISA for 2019-nCoV S - similar to the previously developed ELISA for MERS-CoV S.
6) Formulation of the vaccine and adjuvant.
Example 4 Clinical studies
The following describes clinical studies to test the 2019-nCoV vaccine:
Based on the information from preclinical studies, efficacy in animal models will be performed in parallel to the proposed Phase 1 clinical trial to evaluate safety and immunogenicity in human subjects. Of note, our previous discussion (pre-IND) with the FDA for a similar killed rabies-virus based vaccine against EBOV was agreed not to require a toxicity study based on the safety history of deactivated rabies vaccines applied to more than 100 million people. The phase 1 study, if successful, would be followed by a Phase 2 clinical trial to increase the upper end of the age spectrum (since older persons have most severe 2019 nCoV disease) and to expand the cohort size to obtain statistically valid data related to the immune response.
Target populations: Healthy U.S. adults 18 through 55 years of age, inclusive.
Clinical Trial Design: Phase 1 Clinical Trial.
The Phase 1 trial is a randomized, observer-blinded, dose-escalation study to evaluate the safety, reactogenicity, and immunogenicity of the inactivated rabies virus (RABV) based 2019-nCoV vaccine candidates (RABV-nCoV). The clinical trial will be performed at a single site at the University of Maryland, Baltimore, in healthy adults 18 through 55 years of age. Enrolment will proceed in a staged fashion. We will being with 8 subjects in cohort 1. If no pausing rules are met by day 8 following the first dose of vaccine, then cohort 2 can begin immediately after full enrolment of Cohort 1, with no pausing. Cohorts 3 and 4 will proceed simultaneously after review of day 8 data in cohort 2 (assuming no halting rules are met. Importantly, we will include a single dose arm with adjuvant that will commence simultaneously with the 100 ug group (so groups 3 and 4 will be enrolled together after safety data available from all of group 2 through day 8). The study consists of four cohorts totaling 64 subjects (2 rabies vaccine controls and 14 investigational vaccines in each cohort). All study injections will be administered by the intramuscular (IM) route. Treatment assignments are outlined in Table 1.
Table 1: Treatment Assignment for the Phase I Ranging Safety Study of the nCoVRAB Vaccine
Figure imgf000272_0001
Primary Objective: To assess the safety and tolerability of a 2-dose schedule of the unadjuvanted nCoVRAB and a 1-dose schedule of the adjuvanted vaccine candidates delivered IM at 0 and 28 days.
Secondary Objective: To evaluate the immunogenicity of the nCoVRAB vaccine candidates delivered IM at 0 and 28 days (or day 0 for adjuvanted) at escalating dose levels at Days 0, 28, 56, 120 (with primary measure at day 56 for unadjuvanted and day 28 for adjuvanted). Primary Endpoints: The number and percentage of study participants who experience any study injection -associated adverse events, solicited systemic events, or serious adverse events at the following time points:
• Solicited events for 7 days after each study injection.
• Unsolicited events through 28 days after the last study injection (Day 56).
• Serious adverse events (SAEs) for 56 days and at Days 56 and 120 and 365 per a scripted interview.
• Number of participants with early discontinuation of study inj ections and reason for discontinuation.
Secondary Endpoints: Immunogenicity as measured by ELISA to 2019-nCoV and rabies GP.
• nCoV SI- and nCoV SI and RABV G specific serum IgG ELISA titers per time point through Day 120: geometric mean antibody titers (GMT) and percentage of subjects seroconverting (4-fold rise over baseline).
• nCoV and rabies neutralizing antibody titers through Day 120: GMT and percentage of subjects seroconverting (4-fold rise over baseline); for rabies, percentage of subjects with titers > 0.5 IU/ml (correlate of protection).
Exploratory (future studies)
• Antigen-specific serum IgM, IgA and IgG subclasses (selected time-points).
• T cell responses (Thl, Th2 and Thl7 cytokines and chemokines post vaccination).
• B cell responses (magnitude of antigen-specific plasmablasts and memory B cells post vaccination).
• IgG avidity.
Phase 2 Clinical Trial
This clinical trial is proposed as a Phase 2, randomized, observer-blinded, single antigen level study to evaluate the safety and immunogenicity of a two Dose Rabies- Vectored nCoVRAB Vaccine (or a one dose adjuvanted regimen). Given the demographics of the current NCoV outbreak, we will expand the upper age to 70 years . Volunteers will be assessed before the injection and days 1, 3, 7, 14, and 28 after the vaccine for safety, reactogenicity, and immunogenicity. The clinical trial will be performed in healthy adults meeting all inclusion criteria and no exclusion criteria at 2 sites in the US - Baltimore, MD and one additional site total of 200 adults will be consecutively enrolled into groups, stratified by age. All study injections will be administered by the intramuscular (IM) route. Treatment assignments are outlined in Table 2 below.
Table 2: Treatment Assignment for the First Dose Ranging Safety Study of the nCoVRAB Vaccine*
Figure imgf000274_0002
Figure imgf000274_0001
* The overall antigen dose, the relative concentration of the antigen component used for this study will depend upon the outcome of the Phase 1 clinical trial.
Primary Objective: To assess the safety and tolerability of a leading nCoVRAB vaccine candidates delivered IM at 0 and 28 days.
Secondary Objective: To evaluate the immunogenicity of the nCoVRAB vaccine candidates delivered IM at 0 and 28 days at Days 7, 14, 28, 35, 42, 56, 90, 120, 180, and 365.
Primary Endpoints: The number and percentage of study participants who experience any study injection-associated adverse events or serious adverse events at the following time point:
• Solicited events for 7 days after each study injection.
• Unsolicited events through 28 days after the last study injection (Day 56).
• Serious adverse events (SAEs) for 56 days and at Days 56 and 120 and 365 per a scripted interview.
• Number of participants with early discontinuation of study inj ections and reason for discontinuation.
Secondary Endpoints/Exploratory endpoints see above (Phase 1 Clinical Trial.)
Example 5 Manufacturing
In the setting of the public health emergency of 2019 Novel Coronavirus (2019- nCoV or SARS-CoV-2), considerations for the development of a 2019-nCoV vaccine must balance manufacturing speed and technical feasibility with clinical safety and immunogenicity considerations. Ultimately, the manufacturing must be scalable, and the delivery simple in order to reach the maximum number of people in the shortest period of time. A collaborator, Bharat Biotech Ltd (BBIL) is a large vaccine manufacturer with the ability to scale production of such a vaccine to millions of doses rapidly. Relying on an existing technology to maximize feasibility and speed of development is the best approach to achieving this goal.
BBIL experience in positioning licensed vaccines for International supplies is summarized in the table below.
Experience in manufacture and scale-up/ Infrastructures and facilities
BBIL has several facilities for the manufacturing of Viral, Bacterial and recombinant Drug Substance. BBIL is the largest viral vaccine manufacturer in India. For the manufacturing of viral vaccines, it possesses expertise in the utilization of Vero, MDCK cell lines and platforms like Cell factories, Micro carriers and fermenters. There are 5 viral bulk manufacturing facilities including a pilot plant, these facilities have capabilities ranging from 50 L to 1000 L fermentation and purification by TFF, Gel permeation and Affinity chromatography. These automated facilities can produce up to 500 million doses of vaccines.
BBIL also has capabilities of manufacturing recombinant and bacterial drug substances and these are manufactured in 6 facilities including one pilot plant, BBIL expertise ranges from usage of recombinant E. coli, Yeast, Toxins producing bacteria such as, Diphtheria, tetanus and Whole cell bacteria viz pertussis and Cholera. These organisms are processed from 50 L to 1500 L fermenters and subsequent purifications are carried out using either Ion Exchange, Gel permeation chromatography’s.
For Drug Product, all bulk product is either filled in vials, PFS or BFS ranging from 0.5 ML to 25 ml capacities in filling machine having capacity from 50 - 300 vials per min.Keeping in view, of the various products manufactured and also the products to be manufactured in future, BBIL has a Developmental QC Lab, which in involved in the development and validation of different assays and a Strong QC department for routine batch testing and release of all vaccines and biotherapeutics.
Manufacturing capacity: Approximately, 500 million doses of vaccines and 4 million units of Bio-therapeutics are manufactured per year. About 20-30% of the vaccines are supplied to GAVI countries. With a strong QC department, BBIL manufacture, test and release following vaccines and biotherapeutics. Apart from the facilities available at BBIL, in case of Emergency situation, higher manufacturing capacities of 5,000 L, at BSL3/Ag+ facility is available at BIO VET, Bengaluru.
Example 6
CORA VAX (rDNA-BBV151)
To evaluate the reactogenicity and safety of BBV151 (inactivated rabies vector platform Corona Vims) vaccine administered via the intramuscular route, a dose escalation study of an intramuscular inactivated rabies vector platform Corona Vims Vaccine (rDNA-BBV151) in healthy volunteers will be performed.
CORAVAX (rDNA-BBV151) is an adjuvanted rabies vectored Corona vims vaccine, that express the S 1 domain of the SARSCoV-2 spike (S) protein fused to part of the N terminal domain of the RABV glycoprotein (G) and is incorporated in RABV particles. CORAVAX (rDNA- BBV151) vaccine has two presentations.
Figure imgf000276_0001
PRESENTATION 1 (BBV151-A) - Ingredients I and II will be provided as two separate vials (each 0.5 mL) and these two vials (A and B) will be mixed at the time of administration. The final reconstituted 1.0 mL volume is equivalent to 2 doses. BBV151-A presentation has two vaccine formulations with a variation in the dosage strength of active ingredient (Figure XA): BBV151-A1: BBV151-A1 formulation has 15 meg of the active ingredient.
BBV151-A2: BBV151-A2 formulation has 30 meg of the active ingredient. PRESENTATION 2 (BBV151-B): Ingredients I and II will be mixed together, before itself and will be provided as a single vial (0.5mL dose volume). BBV151-B presentation has only one formulation (Figure XB):
BBV151-B: BBV151-B formulation has 30 meg of the active ingredient.
The study is designed to evaluate the safety, reactogenicity, and immunogenicity of four groups of healthy volunteers who receive either vaccine or placebo.
Group 1 (BBV151-A1): In this group, 15 participants will be recruited and administered with BBV151-Al vaccine formulation on day 0 and day 28 via intramuscular route.
Group 2 (BBV151-A2): In this group, 15 participants will be recruited and administered with BBV151-A2 vaccine formulation on day 0 and day 28 via intramuscular route.
Group 3 (BBV151-B): In this group, 15 participants will be recruited and administered with BBV151-B vaccine formulation on day 0 via intramuscular route.
Data will be un-blinded to the third-party bio-statistician and an interim analysis will be performed at day 42 for Immunogenicity and Safety. nAb titer of the COVID-19 virus will be assessed by the MNT/PRNT assay and evaluate the immunogenicity in terms of GMT of vaccine comparison with the placebo group. Serum samples will be assessed for nAb. Binding antibody titer against spike protein of SARS-CoV-2 virus will be assessed for serum samples by using ELISA. Cell Mediated Immunity will be assessed from the subset of the study population.
The GMT will be calculated for neutralization titers in each vaccine group (one dose and two doses) separately. A two-sided 95% confidence interval (Cl) for the GMT will be calculated from a 95% Cl for the mean of logio-transformed titer, using a normal approximation for the distribution of logio (titer). The ratio of GMTs in the two vaccine groups (GMT with two doses / GMT with one dose) and the corresponding 95% Cl will also be presented. The two-sided 95% Cl for the GMT ratio will be calculated from a 95% Cl for the difference in means of logio (titer). The two vaccine groups will be compared using a two-sided two-sample t-test on the means of logio- transformed titers, at the 5% significance level.
To evaluate the humoral immune responses of BBV151, GMT and four-fold seroconversion rate (SCR) of neutralizing antibodies (NAb’s) by MNT/PRNT assays across the three groups, from baseline to days 28±2, 42±2, 90±7 and 180±7, will be performed.
To compare the humoral responses between single dose group and double dose group, GMT and four-fold seroconversion rate (SCR) of neutralizing antibodies (NAb’s) by MNT/PRNT assays across the three groups, from baseline to days 28+2, 42+2, 90+7 and 180+7.
To evaluate the immune responses against spike protein of SARS-CoV-2 virus and Rabies vector, GMT and four-fold seroconversion rate of binding antibodies (bAb’s) IgA and IgG against spike protein across the three groups, from baseline to days 28+2, 42+2, 90+7 and 180+7, will be determined. Immune response (binding/ or neutralization) to the vector will be assessed by ELISA from baseline to days 28+2, 42+2, 90+7 and 180+7.
To evaluate the safety of the vaccine in terms of assessing adverse event of special interest (AESI), the occurrence of AESI will be monitored and documented throughout the study duration.
References
1. Raj VS, Mou H, Smits SL, Dekkers DH, Muller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, Thiel V, Drosten C, Rottier PJ, Osterhaus AD, Bosch BJ, Haagmans BL. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495(7440):251-4. doi: 10.1038/naturel2005. PubMed PMID: 23486063
2. Burkard C, Verheije MH, Wicht O, van Kasteren SI, van Kuppeveld FJ,
Haagmans BL, Pelkmans L, Rottier PJ, Bosch BJ, de Haan CA. Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner. PLoS pathogens. 2014; 10(1 l):el004502. doi: 10.1371/joumal.ppat.1004502. PubMed PMID: 25375324; PMCID: PMC422306
3. Volz A, Kupke A, Song F, Jany S, Fux R, Shams-Eldin H, Schmidt J, Becker C, Eickmann M, Becker S, Sutter G. Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein. J Virol. 2015;89(16): 8651 -6. doi: 10.1128/JVI.00614-15. PubMed PMID: 26018172; PMCID: PMC4524222
4. Ma C, Wang L, Tao X, Zhang N, Yang Y, Tseng CT, Li F, Zhou Y, Jiang S, Du L. Searching for an ideal vaccine candidate among different MERS coronavirus receptor binding fragments— the importance of immunofocusing in subunit vaccine design.
Vaccine. 2014;32(46):6170-6. doi: 10.1016/j.vaccine.2014.08.086. PubMed PMID: 25240756; PMCID: PMC4194190
5. Hudacek AW, Al-Saleem FH, Willet M, Eisemann T, Mattis JA, Simpson LL, Schnell MJ. Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo. Molecular therapy Methods & clinical development. 2014;1:14046. doi: 10.1038/mtm.2014.46. PubMed PMID: 26015984; PMCID: 4362357
6. Muthumani K, Falzarano D, Reuschel EL, Tingey C, Flingai S, Villarreal DO, Wise M, Patel A, Izmirly A, Aljuaid A, Seliga AM, Soule G, Morrow M, Kraynyak KA, Khan AS, Scott DP, Feldmann F, LaCasse R, Meade-White K, Okumura A, Ugen KE, Sardesai NY, Kim JJ, Kobinger G, Feldmann H, Weiner DB. A synthetic consensus anti spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Sci Transl Med. 2015;7(301):301ral32. doi: 10.1126/scitranslmed.aac7462. PubMed PMID: 26290414; PMCID: PMC4573558
7. Pfaller CK, Cattaneo R, Schnell MJ. Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics. Virology. 2015;479-480:331-44. doi: 10.1016/j.virol.2015.01.029. PubMed PMID: 25702088; PMCID: 4557643
8. Willet M, Kurup D, Papaneri A, Wirblich C, Hooper JW, Kwilas SA, Keshwara R, Hudacek A, Beilfuss S, Rudolph G, Pommerening E, Vos A, Neubert A, Jahrling P, Blaney JE, Johnson RF, Schnell MJ. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses. J Infect Dis. 2015;212 Suppl 2:S414-24. doi: 10.1093/infdis/j iv251. PubMed PMID: 26063224; PMCID: 4564550
9. Huttner A, Dayer JA, Yerly S, Combescure C, Auderset F, Desmeules J, Eickmann M, Finckh A, Goncalves AR, Hooper JW, Kaya G, Krahling V, Kwilas S, Lemaitre B, Matthey A, Silvera P, Becker S, Fast PE, Moorthy V, Kieny MP, Kaiser L, Siegrist CA, Consortium VS-E. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial. Lancet Infect Dis. 2015; 15(10): 1156-66. doi: 10.1016/S 1473-3099(15)00154- 1. PubMed PMID: 26248510
10. WHO. Rabies, Fact Sheet #99. 2015.
11. Blaney JE, Marzi A, Willet M, Papaneri AB, Wirblich C, Feldmann F, Holbrook M, Jahrling P, Feldmann H, Schnell MJ. Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine. PLoS pathogens. 2013;9(5):el003389. doi: 10.1371/journal. ppat.1003389. PubMed PMID: 23737747; PMCID: 3667758.
12. Blaney JE, Wirblich C, Papaneri AB, Johnson RF, Myers CJ, Juelich TL, Holbrook MR, Freiberg AN, Bernbaum JG, Jahrling PB, Paragas J, Schnell MJ. Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses. J Virol. 2011 ;85(20): 10605- 16. Epub 2011/08/19. doi: 10.1128/JVI.00558- 11. PubMed PMID: 21849459; PMCID: 3187516.
13. Blaney JE, Wirblich C, Papaneri AB, Johnson RF, Myers CJ, Juelich TL, Holbrook MR, Freiberg AN, Bernbaum JG, Jahrling PB, Paragas J, Schnell MJ. Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses. J Virol. 2011;85(20):10605-16. Epub 2011/08/19. doi: 10.1128/JVI.00558- 11. PubMed PMID: 21849459; PMCID: 3187516.
14. Willet M, Kurup D, Papaneri A, Wirblich C, Hooper JW, Kwilas SA, Keshwara R, Hudacek A, Beilfuss S, Rudolph G, Pommerening E, Vos A, Neubert A, Jahrling P, Blaney JE, Johnson RF, Schnell MJ. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses. J Infect Dis. 2015. doi: 10.1093/infdis/jiv251. PubMed PMID: 26063224
15. Wirblich C, Coleman CM, Kurup D, Abraham TS, Bembaum JG, Jahrling PB, Hensley LE, Johnson RF, Frieman MB, Schnell MJ. One-Health: a Safe, Efficient, Dual- Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus. Journal of virology. 2017;91(2). Epub 2016/11/04. doi: 10.1128/JVI.02040-16. PubMed PMID: 27807241; PMCID: PMC5215356
16. Conzelmann KK, Cox JH, Schneider LG, Thiel HJ. Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19. Virology. 1990;175(2):485-99. PubMed PMID: 2139267
17. Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ. Rhabdoviral-Based Vaccine Platforms against Henipaviruses. J Virol. 2014. doi: 10.1128/JVI.02308-14. PubMed PMID: 25320306
18. Hudacek AW, Al-Saleem FH, Willet M, Eisemann T, Mattis JA, Simpson LL, Schnell MJ. Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo. Molecular Therapy — Methods & Clinical Development. 2014; 1
19. McGettigan JP, Pomerantz RJ, Siler CA, McKenna PM, Foley HD, Dietzschold B, Schnell MJ. Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic. J Virol. 2003;77(l):237-44. Epub 2002/12/13. PubMed PMID: 12477829; PMCID: 140592.
20. McGettigan JP, Naper K, Orenstein J, Koser M, McKenna PM, Schnell MJ. Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome. J Virol. 2003;77(20): 10889-99. Epub 2003/09/27. PubMed PMID: 14512539; PMCID: 224996
21. Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ. Rhabdovirus-based vaccine platforms against henipaviruses. J Virol. 2015;89(1): 144-54. doi:
10.1128/JVI.02308-14. PubMed PMID: 25320306; PMCID: 4301098 22. Servat A, Feyssaguet M, Blanchard I, Morize JL, Schereffer JL, Boue F, Cliquet
F. A quantitative indirect ELISA to monitor the effectiveness of rabies vaccination in domestic and wild carnivores. J Immunol Methods. 2007;318(1-2): 1-10. doi: 10.1016/j.jim.2006.07.026. PubMed PMID: 17166510
23. Wasniewski M, Cliquet F. Evaluation of ELISA for detection of rabies antibodies in domestic carnivores. J Virol Methods. 2012; 179(1): 166-75. doi:
10.1016/j.jviromet.2011.10.019. PubMed PMID: 22080853
24. Wasniewski M, Guiot AL, Schereffer JL, Tribout L, Mahar K, Cliquet F. Evaluation of an ELISA to detect rabies antibodies in orally vaccinated foxes and raccoon dogs sampled in the field. J Virol Methods. 2013;187(2):264-70. doi:
10.1016/j.jviromet.2012.11.022. PubMed PMID: 23201293
25. Zhao J, Li K, Wohlford-Lenane C, Agnihothram SS, Fett C, Gale MJ, Jr., Baric RS, Enjuanes L, Gallagher T, McCray PB, Jr., Perlman S. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci U S A.
2014; 111(13):4970-5. Epub 2014/03/07. doi: 10.1073/pnas.1323279111. PubMed PMID: 24599590; PMCID: 3977243
26. Blaney JE, Wirblich C, Papaneri AB, Johnson RF, Myers CJ, Juelich TL, Holbrook MR, Freiberg AN, Bernbaum JG, Jahrling PB, Paragas J, Schnell MJ. Inactivated or Live- Attenuated Bivalent Vaccines that Confer Protection against Rabies and Ebola Viruses. PLoS Pathog, under review. 2011
27. Johnson RF, Kurup D, Hagen KR, Fisher C, Keshwara R, Papaneri A, Perry DL, Cooper K, Jahrling PB, Wang JT, Ter Meulen J, Wirblich C, Schnell MJ. An Inactivated Rabies Virus-Based Ebola Vaccine, FILORABl, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models. The Journal of infectious diseases. 2016;214(suppl 3):S342-S54. doi: 10.1093/infdis/jiw231. PubMed PMID: 27456709; PMCID: PMC5050469
28. Papaneri AB, Wirblich C, Marissen WE, Schnell MJ. Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment. Vaccine. 2013;31(49):5897-902. Epub 2013/10/15. doi:
10.1016/j. vaccine.2013.09.038. PubMed PMID: 24120673
29. Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, Juvekar S, Muliyil J, Arya A, Shaikh H, Abraham V, Vrati S, Proschan M, Kohberger R, Thiry G, Glass R, Greenberg HB, Curlin
G, Mohan K, Harshavardhan GVJA, Prasad S, Rao TS, Boslego J, Bhan MK, Group IRV. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life. Vaccine. 2014;32 Suppl l:A110-6. doi:
10.1016/j. vaccine.2014.04.079. PubMed PMID: 25091663; PMCID: 25091663
30. Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, Juvekar S, Muliyil J, Arya A, Shaikh H, Abraham V, Vrati S, Proschan M, Kohberger R, Thiry G, Glass R, Greenberg HB, Curlin G, Mohan K, Harshavardhan GV, Prasad S, Rao TS, Boslego J, Bhan MK. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383(9935):2136-43. Epub 2014/03/19. doi: 10.1016/s0140-6736(13)62630-6. PubMed PMID: 24629994; PMCID: PMC4532697
31. Bhandari N, Sharma P, Taneja S, Kumar T, Rongsen-Chandola T, Appaiahgari MB, Mishra A, Singh S, Vrati S. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. J Infect Dis. 2009;200(3):421-9. Epub 2009/06/24. doi: 10.1086/600104. PubMed PMID: 19545211
32. Bhandari N, Sharma P, Glass RI, Ray P, Greenberg H, Taneja S, Saksena M, Rao CD, Gentsch JR, Parashar U, Maldonado Y, Ward RL, Bhan MK. Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and 1321, in infants: results of a randomised controlled trial. Vaccine. 2006;24(31-32):5817- 23. Epub 2006/06/01. doi: 10.1016/j .vaccine.2006.05.001. PubMed PMID: 16735085
33. Mohan VK, Varanasi V, Singh A, Pasetti MF, Levine MM, Venkatesan R, Ella KM. Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015;61(3):393-402. Epub 2015/04/15. doi: 10.1093/cid/civ295. PubMed PMID: 25870324
34. Shakya M, Colin-Jones R, Theiss-Nyland K, Voysey M, Pant D, Smith N, Liu X, Tonks S, Mazur O, Farooq YG, Clarke J, Hill J, Adhikari A, Dongol S, Karkey A, Bajracharya B, Kelly S, Gurung M, Baker S, Neuzil KM, Shrestha S, Basnyat B, Pollard AJ. Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal. New England Journal of Medicine. 2019;381(23):2209-18. doi: 10.1056/NEJMoal 905047 35. Voysey M, Pollard AJ. Seroefficacy of Vi Polysaccharide-Tetanus Toxoid Typhoid Conjugate Vaccine (Typbar TCV). Clinical Infectious Diseases. 2018;67(1): 18- 24. doi: 10.1093/cid/cixll45
36. Jin C, Gibani MM, Moore M, Juel HB, Jones E, Meiring J, Harris V, Gardner J, Nebykova A, Kerridge SA, Hill J, Thomaides-Brears H, Blohmke CJ, Yu L-M, Angus B, Pollard AJ. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial. The Lancet. 2017;390(10111):2472-80. doi: doi.org/10.1016/S0140-6736(17)32149-9
37. Vadrevu KM, Potula V, Khalatkar V, Mahantshetty NS, Shah A, Ella R. Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine. The Journal of Infectious Diseases. 2019. doi: 10.1093/infdis/jiz672
38. Singh A, Mitra M, Sampath G, Venugopal P, Rao JV, Krishnamurthy B, Gupta MK, Sri Krishna S, Sudhakar B, Rao NB, Kaushik Y, Gopinathan K, Hegde NR, Gore MM, Krishna Mohan V, Ella KM. A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains. The Journal of Infectious Diseases. 2015;212(5):715-25. doi: 10.1093/infdis/jiv023
Other Embodiments
The recitation of a listing of elements in any definition of a variable herein includes definitions of that variable as any single element or combination (or subcombination) of listed elements. The recitation of an embodiment herein includes that embodiment as any single embodiment or in combination with any other embodiments or portions thereof.
The disclosures of each and every patent, patent application, and publication cited herein are hereby incorporated herein by reference in their entirety. While this invention has been disclosed with reference to specific embodiments, it is apparent that other embodiments and variations of this invention may be devised by others skilled in the art without departing from the true spirit and scope of the invention. The appended claims are intended to be construed to include all such embodiments and equivalent variations.

Claims

What is claimed is:
1. An isolated nucleic acid encoding a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
2. An isolated nucleic acid encoding a virus selected from a rabies virus, a vesicular stomatitis virus (VSV), and a measles virus, wherein the virus comprises a SARS-CoV-2 spike protein (S) or a portion thereof.
3. The isolated nucleic acid of claim 1, wherein the virus is a rabies virus, a vesicular stomatitis virus (VSV), or a measles virus.
4. The isolated nucleic acid of claim 1, wherein the virus is a rhabdovirus.
5. The isolated nucleic acid of any one of claims 1-4, wherein the portion of the SARS-CoV-2 spike protein (S) is a receptor binding site of the SARS-CoV-2 spike protein (S).
6. The isolated nucleic acid of any one of claims 1-5, wherein the portion of the SARS-CoV-2 spike protein (S) is the SI domain.
7. The isolated nucleic acid of any one of claims 1-6, wherein the isolated nucleic acid comprises a sequence encoding at least a portion of the genome of the virus.
8. The isolated nucleic acid of any one of claims 1-7, wherein the nucleic acid comprises (a) a sequence encoding at least a portion of the genome of a measles virus and (b) a sequence encoding a SARS-CoV-2 spike protein (S) or a portion thereof.
9. The isolated nucleic acid of claim 8, wherein the sequence encoding the SARS- CoV-2 spike protein (S) or portion thereof is inserted into positions 2, 3, or 6 of the genome of the measles virus.
10. The isolated nucleic acid of any one of claims 1-7, wherein the nucleic acid comprises (a) a sequence encoding at least a portion of the genome of a rabies virus and (b) a sequence encoding a protein comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
11. The isolated nucleic acid of claim 10, wherein the at least a portion of the genome of the rabies virus comprises an N gene and a P gene, and the sequence encoding the protein comprising the SARS-CoV-2 spike protein (S) or portion thereof is inserted into a position between the N gene and P gene.
12. The isolated nucleic acid of any one of claims 1-7, wherein the nucleic acid comprises (a) a sequence encoding at least a portion of the genome of a vesicular stomatitis virus (VSV), and (b) a sequence encoding a protein comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
13. The isolated nucleic acid of any one of claims 10-12, wherein the protein comprising a SARS-CoV-2 spike protein (S) or a portion thereof is a fusion protein comprising a glycoprotein (G) or a portion thereof and a SARS-CoV-2 spike protein (S) or a portion thereof.
14. The isolated nucleic acid of claim 13, wherein the fusion protein comprises a glycoprotein (G) or portion thereof fused to the SI domain of a SARS-CoV-2 spike protein (S).
15. The isolated nucleic acid of any one of claims 1-14, wherein the nucleic acid comprises a sequence set forth in SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, or SEQ ID NO: 5.
16. An isolated nucleic acid encoding a recombinant fusion protein comprising (a) a glycoprotein (G) of a virus or a portion thereof, and (b) a SARS-CoV-2 spike protein (S) or a portion thereof.
17. The isolated nucleic acid of claim 16, wherein the virus is a rabies virus or a vesicular stomatitis virus (VSV).
18. The isolated nucleic acid of claim 16 or 17, wherein the portion of the SARS- CoV-2 spike protein (S) is a receptor binding site of the SARS-CoV-2 spike protein (S).
19. The isolated nucleic acid of any one of claims 16-18, wherein the portion of the SARS-CoV-2 spike protein (S) is the SI domain.
20. The isolated nucleic acid of any one of claims 16-19, wherein the fusion protein comprises a rabies virus glycoprotein (G) or portion thereof fused to the SI domain of the SARS-CoV-2 spike protein (S).
21. The isolated nucleic acid of any one of claims 16-19, wherein the fusion protein comprises a vesicular stomatitis virus (VSV) glycoprotein (G) or portion thereof fused to the SI domain of the SARS-CoV-2 spike protein (S).
22. A recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
23. A recombinant virus selected from a rabies virus, a vesicular stomatitis virus (VSV), and a measles virus, wherein the virus comprises a SARS-CoV-2 spike protein (S) or a portion thereof.
24. The recombinant virus of claim 22 or 23, wherein the virus is a rabies virus, a vesicular stomatitis virus (VSV), or a measles virus.
25. The recombinant virus of claim 22, wherein the virus is a rhabdovirus.
26. The recombinant virus of any one of claims 22-25, wherein the portion of the SARS-CoV-2 spike protein (S) is a receptor binding site of the SARS-CoV-2 spike protein (S).
27. The recombinant virus of any one of claims 22-26, wherein the portion of the SARS-CoV-2 spike protein (S) is the SI domain.
28. The recombinant virus of any one of claims 22-27, wherein the virus comprises a fusion protein comprising a glycoprotein (G) or portion thereof and a SARS-CoV-2 spike protein (S) or a portion thereof.
29. The recombinant virus of claim 28, wherein the fusion protein comprises a glycoprotein (G) or portion thereof fused to the SI domain of a SARS-CoV-2 spike protein (S).
30. The recombinant virus of any one of claims 22-29, wherein the virus is encoded by a nucleic acid of any one of claims 1-15.
31. A recombinant fusion protein comprising (a) a glycoprotein (G) of a virus or a portion thereof, and (b) a SARS-CoV-2 spike protein (S) or a portion thereof.
32. The recombinant fusion protein of claim 31, wherein the virus is a rabies virus or a vesicular stomatitis virus (VSV).
33. The recombinant fusion protein of claim 31 or 32, wherein the portion of the SARS-CoV-2 spike protein (S) is a receptor binding site of the SARS-CoV-2 spike protein (S).
34. The recombinant fusion protein of any one of claims 31-33, wherein the portion of the SARS-CoV-2 spike protein (S) is the SI domain.
35. The recombinant fusion protein of any one of claims 31-34, wherein the fusion protein comprises a rabies virus glycoprotein (G) or portion thereof fused to the SI domain of the SARS-CoV-2 spike protein (S).
36. The recombinant fusion protein of any one of claims 31-34, wherein the fusion protein comprises a vesicular stomatitis virus (VSV) glycoprotein (G) or portion thereof fused to the SI domain of the SARS-CoV-2 spike protein (S).
37. The recombinant fusion protein of any one of claims 31-36, wherein the fusion protein is encoded by the nucleic acid of any one of claims 16-21.
38. A vector comprising the nucleic acid of any one of claims 1-21.
39. A vaccine comprising the recombinant virus of any one of claims 22-30 or the recombinant fusion protein of any one of claims 31-37, and a pharmaceutically acceptable carrier.
40. The vaccine of claim 39, further comprising an adjuvant.
41. The vaccine of claim 39 or 40, wherein the adjuvant is MPLA 3D(6-acyl) (PHAD®) in 2% squalene.
42. The vaccine of any one of claims 39-41, wherein the virus is deactivated.
43. A method of generating an immune response against a SARS-CoV-2 virus in a subject in need thereof, the method comprising administering to the subject an effective amount of the recombinant virus of any one of claims 22-30, the recombinant fusion protein of any one of claims 31-37, or the vaccine of any one of claims 39-42.
44. A method of vaccinating a subject against a SARS-CoV-2 virus, the method comprising administering to the subject an effective amount of the recombinant virus of any one of claims 22-30, the recombinant fusion protein of any one of claims 31-37, or the vaccine of any one of claims 39-42.
45. A method of providing immunity against a SARS-CoV-2 virus in a subject, the method comprising administering to the subject an effective amount of the recombinant virus of any one of claims 22-30, the recombinant fusion protein of any one of claims 31- 37, or the vaccine of any one of claims 39-42.
46. A method of treating and/or preventing a disease or disorder associated with a SARS-CoV-2 virus in a subject in need thereof, the method comprising administering to the subject an effective amount of the recombinant virus of any one of claims 22-30, the recombinant fusion protein of any one of claims 31-37, or the vaccine of any one of claims 39-42.
47. The method of any one of claims 42-46, wherein the subject is a human.
48. The method of any one of claims 42-46, wherein the subject is a cat.
49. The method of any one of claims 42-46, wherein the subject is a dog.
50. The method of any one of claims 42-46, wherein the subject is a ferret.
51. The method of claim 46, wherein the disease or disorder is COVID-19.
52. An isolated nucleic acid encoding a recombinant rabies virus comprising the SI domain of a SARS-CoV2 spike protein fused to a rabies glycoprotein (G) or portion thereof.
53. The isolated nucleic acid of claim 52, wherein the nucleic acid comprises (a) a sequence encoding at least a portion of the genome of a rabies virus, the portion comprising an N gene and a P gene, and (b) a sequence encoding the SI domain fused to the glycoprotein (G), wherein the sequence encoding the S 1 domain fused to the glycoprotein (G) is inserted into a position between the N gene and the P gene.
54. The isolated nucleic acid of claim 52 or 53, wherein the glycoprotein (G) comprises a mutation substituting arginine with glutamic acid at position 333.
55. The isolated nucleic acid of any one of claims 52-54, wherein the SI domain of the SARS-CoV2 spike protein is fused to a portion of the glycoprotein (G), the portion comprising an ectodomain, a cytoplasmic domain, and a transmembrane domain.
56. The isolated nucleic acid of claim 55, wherein the portion of the glycoprotein (G) comprises 31 amino acids of the ectodomain and the full-length cytoplasmic domain.
57. The isolated nucleic acid of any one of claims 52-56, wherein the SI domain is fused to the C-terminus of the glycoprotein (G).
58. The isolated nucleic acid of any one of claims 53-57, wherein the sequence encoding the SI domain fused to the glycoprotein (G) is codon-optimized for expression in a cell.
59. A recombinant virus encoded by the nucleic acid of any one of claims 52-58.
60. The recombinant virus of claim 59, wherein the virus is deactivated.
61. A vaccine comprising the recombinant virus of claim 59 or 60, and a pharmaceutically acceptable carrier.
62. The vaccine of claim 61, further comprising an adjuvant.
63. The vaccine of claim 62, wherein the adjuvant is MPLA 3D(6-acyl) (PHAD®) in 2% squalene.
64. A method of generating an immune response against a SARS-CoV-2 virus in a subject in need thereof, the method comprising administering to the subject an effective amount of the recombinant virus of any one of claims 59-60 or the vaccine of any one of claims 61-63.
65. A method of vaccinating a subject against a SARS-CoV-2 virus, the method comprising administering to the subject an effective amount of the recombinant virus of any one of claims 59-60 or the vaccine any one of claims 61-63.
66. A method of providing immunity against a SARS-CoV-2 virus in a subject, the method comprising administering to the subject an effective amount of the recombinant virus of any one of claims 59-60 or the vaccine any one of claims 61-63.
67. A method of treating and/or preventing a disease or disorder associated with SARS-CoV-2 virus in a subject in need thereof, the method comprising administering to the subject an effective amount of the recombinant virus of any one of claims 59-60 or the vaccine any one of claims 61-63.
68. The method of any one of claims 64-67, wherein the subject is a human.
69. The method of any one of claims 64-67, wherein the subject is a cat.
70. The method of any one of claims 64-67, wherein the subject is a dog.
71. The method of any one of claims 64-67, wherein the subject is a ferret.
72. The method of claim 67, wherein the disease or disorder is COVID-19.
73. A method of generating an immune response against a rabies virus and a SARS- CoV-2 virus in a subject in need thereof, the method comprising administering to the subject an effective amount of a vaccine comprising a recombinant rabies virus comprising a SARS-CoV-2 spike protein (S) or portion thereof.
74. A method of vaccinating a subject against a rabies virus and a SARS-CoV-2 virus, the method comprising administering to the subject an effective amount of a vaccine comprising a recombinant rabies virus comprising a SARS-CoV-2 spike protein (S) or portion thereof.
75. A method of providing immunity against a rabies virus and a SARS-CoV-2 virus in a subject, the method comprising administering to the subject an effective amount of a vaccine comprising a recombinant rabies virus comprising a SARS-CoV-2 spike protein (S) or portion thereof.
76. A method of treating and/or preventing a disease or disorder associated with a rabies virus and a disease or disorder associated with SARS-CoV-2 virus in a subject in need thereof, the method comprising administering to the subject an effective amount of a vaccine comprising a recombinant rabies virus comprising a SARS-CoV-2 spike protein (S) or portion thereof.
77. The method of any one of claims 73-76, wherein the recombinant rabies virus comprises an SI domain of a SARS-CoV-2 spike protein fused to a rabies glycoprotein (G) or portion thereof.
78. The method of any one of claims 73-77, wherein the recombinant rabies virus is deactivated.
79. The method of any one of claims 73-78, wherein the vaccine comprises an adjuvant.
80. The method of any one of claims 73-79, wherein the subject is non-human.
81. The method of any one of claims 73-80, wherein the subject is a mammal.
82. The method of any one of claims 73-81, wherein the subject is a domestic pet or livestock.
83. The method of any one of claims 73-82, wherein the subject is a cat.
84. The method of any one of claims 73-82, wherein the subject is a dog.
85. The method of any one of claims 73-82, wherein the subject is a ferret.
PCT/US2021/021200 2020-03-06 2021-03-05 Coronavirus disease (covid-19) vaccine WO2021178886A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2022553021A JP2023516729A (en) 2020-03-06 2021-03-05 Coronavirus disease (COVID-19) vaccine
CN202180032144.3A CN116194140A (en) 2020-03-06 2021-03-05 Coronavirus disease (covd-19) vaccine
EP21764958.1A EP4114461A1 (en) 2020-03-06 2021-03-05 Coronavirus disease (covid-19) vaccine
IL296128A IL296128A (en) 2020-03-06 2021-03-05 Coronavirus disease (covid-19) vaccine
CA3170422A CA3170422A1 (en) 2020-03-06 2021-03-05 Coronavirus disease (covid-19) vaccine

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202062986396P 2020-03-06 2020-03-06
US62/986,396 2020-03-06
US202063017241P 2020-04-29 2020-04-29
US63/017,241 2020-04-29

Publications (1)

Publication Number Publication Date
WO2021178886A1 true WO2021178886A1 (en) 2021-09-10

Family

ID=77612970

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2021/021200 WO2021178886A1 (en) 2020-03-06 2021-03-05 Coronavirus disease (covid-19) vaccine

Country Status (7)

Country Link
US (3) US11478543B1 (en)
EP (1) EP4114461A1 (en)
JP (1) JP2023516729A (en)
CN (1) CN116194140A (en)
CA (1) CA3170422A1 (en)
IL (1) IL296128A (en)
WO (1) WO2021178886A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11458209B2 (en) 2020-03-23 2022-10-04 Hdt Bio Corp. Compositions and methods for delivery of nucleic acid-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigen
WO2023023332A1 (en) * 2021-08-20 2023-02-23 Thomas Jefferson University Monophosphoryl lipid adjuvant (mpla) compositions, vaccine compositions thereof, and methods of preparing and using the same
WO2023048759A1 (en) * 2021-09-22 2023-03-30 Hdt Bio Corp. Sars-cov-2 rna vaccine compositions and methods of use
US11679163B2 (en) 2019-09-20 2023-06-20 Hdt Bio Corp. Compositions and methods for delivery of RNA
WO2023114912A3 (en) * 2021-12-16 2023-08-03 Thomas Jefferson University A therapeutic against crimean-congo hemorrhagic fever virus

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4104854A3 (en) * 2016-04-04 2023-03-08 The United States of America as represented by the Secretary of the Department of Health and Human Services Multivalent vaccines for rabies virus and coronaviruses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190062785A1 (en) * 2016-04-04 2019-02-28 The United States of America, as represented by the Secretary, Department of Health & Human Servic Multivalent vaccines for rabies virus and coronoviruses

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190062785A1 (en) * 2016-04-04 2019-02-28 The United States of America, as represented by the Secretary, Department of Health & Human Servic Multivalent vaccines for rabies virus and coronoviruses

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUN ET AL.: "SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development", BIORXIV, 20 February 2020 (2020-02-20), XP055812679, Retrieved from the Internet <URL:https://www.biorxiv.org/content/biorxiv/early/2020/02/20/2020.02.16.951723.full.pdf> [retrieved on 20210628] *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11679163B2 (en) 2019-09-20 2023-06-20 Hdt Bio Corp. Compositions and methods for delivery of RNA
US11458209B2 (en) 2020-03-23 2022-10-04 Hdt Bio Corp. Compositions and methods for delivery of nucleic acid-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigen
US11534497B2 (en) 2020-03-23 2022-12-27 Hdt Bio Corp. Compositions and methods for delivery of RNA
US11559584B2 (en) 2020-03-23 2023-01-24 Hdt Bio Corp. Compositions and methods for delivery of RNA
US11648321B2 (en) 2020-03-23 2023-05-16 Hdt Bio Corp. Compositions and methods for delivery of RNA
US11648322B2 (en) 2020-03-23 2023-05-16 Hdt Bio Corp. Compositions and methods for delivery of RNA
US11654200B2 (en) 2020-03-23 2023-05-23 Hdt Bio Corp. Compositions and methods for delivery of RNA
US11752218B2 (en) 2020-03-23 2023-09-12 Hdt Bio Corp. Nucleic acid-small diameter and liquid core nanoparticle complexed compositions
US11896677B2 (en) 2020-03-23 2024-02-13 Hdt Bio Corp. Compositions and methods for delivery of RNA
WO2023023332A1 (en) * 2021-08-20 2023-02-23 Thomas Jefferson University Monophosphoryl lipid adjuvant (mpla) compositions, vaccine compositions thereof, and methods of preparing and using the same
WO2023048759A1 (en) * 2021-09-22 2023-03-30 Hdt Bio Corp. Sars-cov-2 rna vaccine compositions and methods of use
WO2023114912A3 (en) * 2021-12-16 2023-08-03 Thomas Jefferson University A therapeutic against crimean-congo hemorrhagic fever virus

Also Published As

Publication number Publication date
US20230338513A1 (en) 2023-10-26
EP4114461A1 (en) 2023-01-11
CA3170422A1 (en) 2021-09-10
US11478543B1 (en) 2022-10-25
CN116194140A (en) 2023-05-30
US11660336B2 (en) 2023-05-30
JP2023516729A (en) 2023-04-20
US20230057428A1 (en) 2023-02-23
IL296128A (en) 2022-11-01

Similar Documents

Publication Publication Date Title
WO2021178886A1 (en) Coronavirus disease (covid-19) vaccine
US10428314B2 (en) Human ebola virus species and compositions and methods thereof
SA518400172B1 (en) Multivalent vaccines for rabies virus and coronaviruses
CA3184878A1 (en) Sars-cov-2 and influenza combination vaccine
Jiang et al. Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy
WO2021226348A2 (en) Recombinant newcastle disease virus expressing sars-cov-2 spike protein and uses thereof
KR20220021670A (en) Cold-adapted live attenuated severe acute respiratory syndrome coronavirus and vaccine comprising the same
CN117098551A (en) Influenza virus encoding truncated NS1 protein and SARS-COV receptor binding domain
CN113151196A (en) Recombinant vaccinia virus, vaccinia virus vector vaccine, application and preparation method thereof
DK2874656T3 (en) IMPROVED PIG INFLUENZA VACCINES AND PROCEDURES FOR PREPARING AND USING THEREOF
Kirisawa et al. Genomic reassortants of pandemic A (H1N1) 2009 virus and endemic porcine H1 and H3 viruses in swine in Japan
Nagai et al. Nosocomial outbreak of respiratory syncytial virus subgroup B variants with the 60 nucleotides‐duplicated G protein gene
KR101908905B1 (en) Recombinant influenza virus to form cross-protection against multiple subtypes h9 and h5 of influenza viruses and vaccine comprising the same
JPH06100594A (en) Anti-human influenzal virus antibody
Rola et al. Sequence analysis of ORFs 5, 6 and 7 of equine arteritis virus during persistent infection of the stallion—A 7-year study
Kanpipit et al. Immunogenicity of transmembrane deleted-G protein of bovine ephemeral fever virus (BEFV) expressed in insect cells
US20230398201A1 (en) Gene shuffled lyssavirus vaccine
Muniraju Establishment of reverse genetics system for PPR virus to develop recombinant vaccines
Singh et al. Immunological Response of the Respiratory Tract in the SARS-CoV-2 Infection
KR20120103677A (en) Novel pneumovirus compositions and methods for using the same
Bukreyev et al. Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses.
CA3215468A1 (en) Chimeric newcastle disease virus expressing apmv hn and f proteins
RU2416641C1 (en) Vaccine strain of a/17/brisbane/07/28 (h1n1) influenza virus for preparing live influenza intranasal vaccine for adults and children
MX2011002722A (en) Recombinant vaccine of porcine rubulavirus.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21764958

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 3170422

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2022553021

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2021764958

Country of ref document: EP

Effective date: 20221006

NENP Non-entry into the national phase

Ref country code: DE